
<html lang="en"     class="pb-page"  data-request-id="63d6a6e6-5240-4f80-a52b-88c49a6fda86"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01672;issue:issue:10.1021/jmcmar.2017.60.issue-18;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects" /></meta><meta name="dc.Creator" content="Zhangjian  Huang" /></meta><meta name="dc.Creator" content="Junjie  Fu" /></meta><meta name="dc.Creator" content="Yihua  Zhang" /></meta><meta name="dc.Description" content="The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly sugg..." /></meta><meta name="Description" content="The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly sugg..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 23, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01672" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01672" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01672" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01672" /></link>
        
    
    

<title>Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01672" /></meta><meta property="og:title" content="Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0016.jpeg" /></meta><meta property="og:description" content="The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly suggest the potential adoption of NO donor-based therapy in clinical practice, and this has been supported by several clinical studies in the past decade. In this review, we first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy. Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity. In addition, we briefly describe inducible NO synthase gene therapy and nanotechnology, which have recently entered the field of NO donor therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01672"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01672">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01672&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01672&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01672&amp;href=/doi/10.1021/acs.jmedchem.6b01672" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7617-7635</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00143" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhangjian++Huang">Zhangjian Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junjie++Fu">Junjie Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2741-7469" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihua++Zhang">Yihua Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2378-7064" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Medicinal Chemistry, School of Pharmacy, Nanjing Medical University, Nanjing 211166, P.R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: +86 025 83271015. E-mail: <a href="/cdn-cgi/l/email-protection#473d3e2f332023077671746924282a"><span class="__cf_email__" data-cfemail="e49e9d8c908380a4d5d2d7ca878b89">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01672&amp;href=/doi/10.1021%2Facs.jmedchem.6b01672" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7617–7635</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 15, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 November 2016</li><li><span class="item_label"><b>Published</b> online</span>23 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01672" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01672</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7617%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhangjian%2BHuang%252C%2BJunjie%2BFu%252C%2BYihua%2BZhang%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D18%26contentID%3Dacs.jmedchem.6b01672%26title%3DNitric%2BOxide%2BDonor-Based%2BCancer%2BTherapy%253A%2BAdvances%2Band%2BProspects%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7635%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01672"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5470</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">138</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01672" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhangjian&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Junjie&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Yihua&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7617-7635&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01672&quot;},&quot;abstract&quot;:&quot;The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly suggest the potential adoption of NO donor-based therapy in clinical practice, and this has been supported by several clinical studies in the past decade. In this review, we first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy. Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity. In addition, we briefly describe inducible NO synthase gene therapy and nanotechnology, which have recently entered the field of NO donor therapy.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01672&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01672" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01672&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01672" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01672&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01672" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01672&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01672&amp;href=/doi/10.1021/acs.jmedchem.6b01672" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01672" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01672" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01672%26sid%3Dliteratum%253Aachs%26pmid%3D28505442%26genre%3Darticle%26aulast%3DHuang%26date%3D2017%26atitle%3DNitric%2BOxide%2BDonor-Based%2BCancer%2BTherapy%253A%2BAdvances%2Band%2BProspects%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D18%26spage%3D7617%26epage%3D7635%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292519" title="Cancer therapy">Cancer therapy</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/jmcmar.2017.60.issue-18/20170928/jmcmar.2017.60.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly suggest the potential adoption of NO donor-based therapy in clinical practice, and this has been supported by several clinical studies in the past decade. In this review, we first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy. Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity. In addition, we briefly describe inducible NO synthase gene therapy and nanotechnology, which have recently entered the field of NO donor therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2">1.1 Nitric Oxide and Nitric Oxide Synthases</h3><div class="NLM_p last">As an important signaling molecule or effector, nitric oxide (NO) plays an important role in various biological systems.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> NO is synthesized in vivo by three different NO synthases (NOSs), among which nNOS and eNOS are constitutively expressed in neuronal and endothelial cells, respectively, and iNOS is regulated transcriptionally and induced by inflammatory cytokines, oxidative stress, aging hypoxia, and various endotoxins.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> NOS catalytically converts <span class="smallcaps smallerCapital">l</span>-arginine and O<sub>2</sub> into NO and <span class="smallcaps smallerCapital">l</span>-citrulline, depending on the availability of several cofactors and cosubstrates, such as nicotinamide adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), and tetrahydrobiopterin (BH<sub>4</sub>). NOS isoforms produce different levels of NO, varying from nanomolar (nM) to micromolar (μM), with nNOS and eNOS producing lower basal levels and iNOS generating transient higher concentrations (μM).<a onclick="showRef(event, 'ref4 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref4 ref9 ref10">(4, 9, 10)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.2 Chemical Biology of NO</h3><div class="NLM_p">The biological effects of NO are divided into direct and indirect effects, which highly rely on the concentration of NO over a 1000-fold concentration range.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Low levels of NO produced by nNOS and eNOS directly interact with specific molecules, such as metals, lipid radicals, and DNA radicals. For instance, the interaction of NO with the iron moiety of soluble guanylyl cyclase (sGC) occurs at nanomolar levels. In contrast, high levels of NO generated by iNOS reacts with various reactive oxygen species (ROS) to produce reactive nitrogen species (RNS), which exert indirect effects, such as oxidation, nitration, and nitrosation. The biological signaling involved in NO’s indirect effects is very complicated, including but is not exclusive to the following examples: (i) The reaction of NO with superoxide anion (O<sub>2</sub><sup>•–</sup>) at equal levels leads to the generation of peroxynitrite (ONOO<sup>–</sup>), which further yields powerful oxidants during degradation. (ii) The reaction of NO with O<sub>2</sub> (auto-oxidation) or ONOO<sup>–</sup> produces nitrogen dioxide (NO<sub>2</sub>), which may result in nitration of tyrosine residues in proteins with an accompanying change in their function.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Therefore, ONOO<sup>–</sup> can be considered to function as an NO<sub>2</sub> donor or an intermediate in the conversion of NO to NO<sub>2</sub> via O<sub>2</sub><sup>•–</sup>. (iii) NO<sub>2</sub> further reacts with NO to form dinitrogen trioxide (N<sub>2</sub>O<sub>3</sub>), which leads to the S-nitrosation of thiol-containing proteins via NO<sup>+</sup> transferring.<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11, 13)</a> The production of <i>S</i>-nitrosothiol is a post-translational modification (PTM) process that has become increasingly prominent, competing with known PTMs, such as phosphorylation and ubiquitination.</div><div class="NLM_p last">It is worth noting that, in addition to concentration, other factors such as the duration of NO exposure and the kinetic behaviors of NO are also key determinants in NO’s biological signaling. Several excellent reviews for detailed information are now available.<a onclick="showRef(event, 'ref5 ref14'); return false;" href="javascript:void(0);" class="ref ref5 ref14">(5, 14)</a></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.3 Effects of NO on Cancer Biology</h3><div class="NLM_p">NO has broad effects on cancer, from cancer initiation of cellular transformation to cancer progression of the metastatic cascade. Several recent reviews have described the role of NO in cancer.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> NO participates in various signaling pathways, including Ras, extracellular signal-regulated kinases (ERKs), Akt, cyclin D1/retinoblastoma (Rb), and mammalian target of rapamycin (mTOR), which are crucial for tumor cells.</div><div class="NLM_p">Numerous investigations have shown that low levels of NO promote cancer growth by stimulating cancer cell progression and by enhancing angiogenesis and metastasis, while higher concentrations of NO depress cancer progression by inducing apoptosis, sensitizing tumors to chemo-, radio-, or immunotherapy, reversing resistance to chemotherapy, and retarding the angiogenic and metastatic cascades.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><div class="NLM_p">The Wink group examined the effects of five distinct concentrations of NO on MCF-7 cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Low levels of NO target cGMP (1–30 nM), phosphorylate Akt (30–100 nM) and stabilize hypoxia-inducible factor 1α (HIF-1α) (100–300 nM), favoring progrowth and antiapoptotic responses. When the NO levels are high enough to induce p53 phosphorylation (>400 nM) and nitrosative stress (>1 μM), cytostatic and apoptotic responses were observed. Although the NO levels to exert these effects may vary among different cell lines, it nicely exemplified how the bimodal behavior of NO in specific cancer cells could be accurately quantified by its concentrations.</div><div class="NLM_p">High levels of NO may exert their anticancer activity through various mechanisms, including (i) apoptosis stimulation by upregulation of p53;<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (ii) antiapoptotic proteasomal molecule degradation;<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (iii) cytochrome C release and mitochondrial permeability increase;<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (iv) Smac/DIABLO release;<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and (v) peroxinitrite or ONOO<sup>–</sup> formation, leading to p53 increase,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> cell cycle arrest,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> cell necrosis,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> angiogenesis inhibition,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and cytotoxicity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Bonavidaet et al. proposed that direct NF-κB (p50 and p65) <i>S</i>-nitrosylation, the metastasis inducer Snail, a zinc-finger transcription factor, and the transcription factor Yin Yang 1 (YY1) are involved in the inhibitory mechanism of NO on tumor cell resistance and metastasis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Other in vivo mechanisms have been reviewed eleswhere.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">More recently, Scicinski and co-workers proposed an epigenetic mechanism through which NO oxidation of critical cysteine residues can inhibit histone deacetylases (HDACs) and DNA methyltransferases (DNMTs), which results in multiple biological effects, such as the promotion of p53 expression.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">The role of NO in cancer therapy can also be described from the perspective of the hypoxia and hyponitroxia axis. Hypoxia, a widely accepted hallmark of solid tumors, leads to hyponitroxia by inhibiting NO synthesis, and hyponitroxia heightens hypoxia due to the lack of NO-modulated blood flow.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The mutually reinforcing cycle of hypoxia/hyponitroxia promotes tumor progression, and either O<sub>2</sub> or NO can be targeted for cancer therapy. Since the attempted restoration of O<sub>2</sub> in tumor has been largely unsuccessful, NO becomes the relatively operable target. The persistently low NO levels (hyponitroxia) induced by hypoxia in cancer are an optimal “zone” for cancer promotion. If NO levels are shifted even slightly up or down, the “safe zone” becomes a “kill zone” or “inhibition zone” for cancer.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This provides a therapeutic opportunity to target cancer either by lowering the concentration of NO using NOS inhibitors to inhibit tumor growth or by increasing the level of NO using NO donor-based therapy to induce tumor cell death (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Tumors’ response to different concentrations of NO, which provides a therapeutic opportunity for cancer. Tumors require an optimal concentration of NO for proliferation (safe zone). Very low intratumoral levels of NO inhibit tumor growth (inhibition zone), and very high levels of NO induce tumor cell death (kill zone).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A large quantity of studies that shift intratumoral NO above the “safe zone” have been conducted and have yielded significant advances in NO donor-based therapy, including (i) NO donor alone; (ii) combination of NO donor(s) with other therapeutics, such as chemo-, radio-, or immunotherapy to achieve synergistic potency; (iii) hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance activity or specificity or to reduce toxicity; (iv) iNOS gene therapy to endogenously generate high levels of NO; and (v) utilization of nanotechnology to deliver high levels of NO to the cancer site.</div><div class="NLM_p last">In the present review, we describe the achievements in NO donor-based therapy with a focus on the advances made in the past decade.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">2 Therapeutic Applications of NO Donor-Based Therapy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.1 From NO to NO Donor Compounds</h3><div class="NLM_p">The direct use of NO inhalation for the clinical treatment of persistent pulmonary hypertension of newborn (PPHN) was initiated many years ago and is still on going.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, due to the high reactivity and inconvenient handling of this gaseous species, NO donors have gained increasing interest. NO donors are compounds capable of generating NO. Glyceryl trinitrate (GTN) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), a well-known organic nitrate that has been clinically used for 150 years to relieve acute attacks of angina pectoris, was not recognized as a NO donor until the 1980s. Other organic nitrates able to release NO include isosorbide dinitrate, isosorbide mononitrate, nicorandil, etc. Several biotransformations of organic nitrates into NO using enzymes have been proposed, including glutathione-<i>S</i>-transferases (GSTs), cytochrome P450 reductase, xanthine oxidoreductase, and aldehyde dehydrogenase-2 (ALDH2).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The catalysis of ALDH2 has been verified using mutants in vitro and transgenic mice lacking mtADH genes in vivo.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> In addition to organic nitrites, many compounds with various structures can generate NO in vitro or in vivo, and each class of compounds generates NO through a different mechanism, e.g., enzymatic, nonenzymatic, and reductive/oxidative. The chemical activities and biological applications of major classes of NO donors, including the organic nitrates, diazeniumdiolates, metal–NO complexes, furoxans, <i>S</i>-nitrosothiols, and sydnonimines (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), have been comprehensively reviewed by Wang,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Megson,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and Bonavida.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of some important NO donors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Organic nitrates have recently joined the clinical field of cancer therapy. Organic nitrates affect the tumor vasculature by improving tumor oxygenation and enhancing tumor perfusion.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> GTN and some other nitrates alone or in combination with an anticancer drug exerted significant anticancer activity (see below). Preclinical and clinical data on the anticancer properties of GTN are summarized and discussed elsewhere.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Glycidyl nitrate (GLYN) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) triggered NO release in the M21 melanoma cell line, sensitized SCC VII xenografts to γ irradiation and cisplatin, and increased blood flow in the tumor, which makes it particularly beneficial in tumors with significant hypoxic areas. In addition, GLYN showed good safety at an effective dose of up to 150 mg/kg in mice.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p"><i>N</i>-Diazeniumdiolates (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) are composed of a diazeniumdiolate [N(O)═NO<sup>–</sup>] moiety bound to a nucleophile amine, including a primary or secondary amine or polyamine, via a nitrogen atom. The salts (usually sodium salts) of diazeniumdiolates are relatively stable in the form of a dry solid but can spontaneously liberate two molecules of NO at physiological conditions following first-order kinetics with a range of half-lives, from a few seconds to several hours.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Furthermore, the O<sup>2</sup>-protection (see below) of diazeniumdiolates generates stable neutral prodrugs that can be enzymatically cleaved in tumor cells in a controllable decomposition rate<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> to produce diazeniumdiolate anion and subsequently release NO spontaneously in situ, exhibiting selective and potent antiproliferative activity.</div><div class="NLM_p">As recently documented by Bonavida and Baritaki, the diazeniumdiolate DETA/NO (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) exerted anticancer activity by preventing or reversing drug resistance, inhibiting the epithelial–mesenchymal transition, and interfering with the NF-κB/Snail/YY1/RKIP cascade.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Metal nitrosyl complexes have also been explored as NO donors. Sodium nitroprusside (SNP) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), a representative iron–NO complex, has shown therapeutic potential in a series of cancer models through invasion suppression, HIF-1α interference, and radiosensitization.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> It was recently reported that SNP sensitized AGS, SGC7901, MKN45, and MKN28 gastric cancer cell lines to tumor necrosis factor (TNF) related apoptosisinducing ligand (TRAIL) induced apoptosis.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> However, the in vivo effects of SNP were not investigated due to the spontaneous and nonselective NO release. NO-coordinated ruthenium complexes constitute another class of NO donors with the general structure <i>trans</i>-[Ru<sup>II</sup>(NO<sup>+</sup>)(L<sub>1</sub>)<sub><i>x</i></sub>(L<sub>2</sub>)]<sup><i>n</i>+</sup>, which can be thermally or photochemically activated to release NO. Compared with other metal nitrosyl compounds, ruthenium nitrosyl complexes have several unique properties, such as high water solubility, stability toward air oxidation, and low cytotoxicity against host cells. The cytotoxicity of some ruthenium nitrosyl complexes against cancer cells has been shown in several studies. For example, <i>trans</i>-[Ru<sup>II</sup>(NO<sup>+</sup>)(NH<sub>3</sub>)<sub>4</sub>(Py)]<sup>3+</sup> induced apoptosis in HepG2 cells by decreasing membrane potential and ATP levels, generating ROS, and lowering mitochondrial permeability transition.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> More details are described in the recent reviews by Franco<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and Van de Voorde.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">1,2,5-Oxadiazole <i>N</i>-oxides (furoxans) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) are a class of NO donors that release NO in response to thiol-containing molecules, thus generating potent anticancer activity. Furoxans or benzofuroxans are used as synthetic precursors in the preparation of new NO donor hybrids, which have been reviewed elsewhere.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a></div><div class="NLM_p">Nitrosothiols (RSNOs, one representative is <i>S</i>-nitroso-<i>N</i>-acetylpenicillamine (SNAP)) and sydnonimine (one representative is 3morpholinosydnonimine (SIN1, <b>1</b>)) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) are also important NO donors that have been investigated for therapeutic potential in cancers and have been reviewed elsewhere.<a onclick="showRef(event, 'ref29 ref35'); return false;" href="javascript:void(0);" class="ref ref29 ref35">(29, 35)</a></div><div class="NLM_p">1-Bromoacetyl-3,3-dinitroazetidine (RRx-001, <b>2</b>) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), originally derived from energetic materials, was first synthesized by ATK Aerospace Systems in the U.S.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>2</b> exhibited potent antiproliferative activity against a variety of cell lines in different oxygen concentrations in vitro and against multiple tumor types in vivo. Moreover, toxicity studies indicated that <b>2</b> was not myelosuppressive, and no dose-limiting toxicity was observed following daily administration for 14 days in mice.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Importantly, <b>2</b> acted as a potent radiosensitizer, and its synergistic effects with radiation were intensively studied in different models and reviewed by Oronsky.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p">Recently, studies on the metabolism of <b>2</b> have confirmed its role as a novel NO donor with unique mechanism of action (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52-54)</a> Upon intravenous infusion in rats, approximately 26% of <b>2</b> rapidly and irreversibly bound to thiols-containing electrophiles, such as glutathione (GSH) and cysteine, via the bromoacetamide group to produce soluble GSH/Cys adductive metabolites, which were mainly excreted in the urine in the first 8 h.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Binding to GSH resulted in depletion of GSH and its precursors in red blood cells (RBCs), increasing oxidative stress and contributing to anticancer activity. Importantly, the rest of infused <b>2</b> could permeate into RBCs and rapidly and irreversibly bound to the β-Cys93 residue of hemoglobin (Hb), which endows <b>2</b> with an extended half-life of days to months.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The binding of <b>2</b> with β-Cys93 mimics a ligand–receptor interaction, significantly enhancing the pseudoenzymatic ability of Hb to convert NO<sub>2</sub><sup>–</sup> to NO under profoundly hypoxic conditions in tumors.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This in situ generated NO under hypoxia could react with ROS to generate ONOO<sup>–</sup>, N<sub>2</sub>O<sub>3</sub>, and other reactive and toxic nitrogen oxides, inducing DNA damage, ATP depletion, apoptosis, and necrosis. In addition, these RNSs could epigenetically modulate DNA methylation, histone deacetylation, and lysine demethylation, leading to p53 reactivation.<a onclick="showRef(event, 'ref50 ref54'); return false;" href="javascript:void(0);" class="ref ref50 ref54">(50, 54)</a> As a result, <b>2</b> indirectly and locally delivered NO to the tumor site without systemic toxicity, such as hypotension, headaches, and methemoglobinemia, in preclinical toxicology studies.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mechanism underlying NO release by compound <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The phase I clinical trial of <b>2</b> demonstrated its good activity and tolerance without clinically significant toxic effects at the tested doses.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> On the basis of the above studies, <b>2</b> has moved forward to phase II. Pretreatment of <b>2</b> for 4 cycles sensitized or resensitized not only refractory small-cell lung cancer (SCLC) patients but also EGFR-inhibitor-resistance and T790M-negative nonsquamous cell lung cancer patients to the first-line chemotherapeutic drug carboplatin.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2 Combination of NO Donors with Other Anticancer Therapies</h3><div class="NLM_p">The application of NO donors in combination with other anticancer therapies has been strongly supported by numerous preclinical and clinical studies. Increased anticancer activity was observed when NO donors were coadministered with conventional chemotherapeutic drugs due to their synergistic anticancer activity. NO donors usually act as sensitizing agents against chemo- or radioresistant cancer cells, which are commonly characterized by hypoxia and the expression of high levels of HIF-1α. Accordingly, NO donors reduce the stabilization of HIF-1α in cancer cells, leading to increased tumor blood flow and oxygenation.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a></div><div class="NLM_p">GTN has been clinically demonstrated as a promising chemosensitizing agent, and the most commonly performed clinical trials of GTN are against advanced non-small-cell lung cancers (NSCLCs), which are usually associated with poor chemotherapy outcomes due to tumor hypoxia.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In a randomized phase II clinical trial in 120 Asian NSCLC patients at stage IIIB/IV in 2006, transdermally applied GTN (25 mg/patient daily for 5 days) plus vinorelbine (25 mg/m<sup>2</sup> on days 1 and 8)/cisplatin (80 mg/m<sup>2</sup> on day 1) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) led to an improved time to progress (TTP) value compared with vinorelbine/cisplatin alone (327 vs 185 days).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Similar results were reported in 2014 by Reinmuth et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and Arrieta et al.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> from phase II studies conducted in Germany and Mexico, respectively. The chemo- and radiosensitizing effects of GTN have been confirmed by investigations involving colon cancer, prostate cancer, and rectal cancer.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In a recent small-scale phase I study, Illum et al. evaluated the maximum tolerated dose of topical GTN in combination with 5-FU (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) (225 mg/m<sup>2</sup> per day) and radiation therapy against advanced operable rectal cancer. No severe toxicity was observed when GTN transdermal patches were applied at a maximum dose of 0.6 mg/h, indicating its good tolerance and safety in clinical use.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Anticancer drugs used in combination with NO donors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Diazeniumdiolates are also widely used in combination with cytotoxic drugs/agents to achieve synergistic effects in cancer therapy. Concurrent intravenous infusion of PROLI/NO (10<sup>–6</sup> M) and carboplatin (20 mg/kg) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) resulted in a 40% increase in survival in rats with C-6 gliomas compared with carboplatin or PROLI/NO alone, suggesting that intravenous infusion of PROLI/NO may increase blood–brain barrier (BBB) permeability.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The combination of DETA/NO (25–100 μM) with the fanesyltransferase inhibitor SCH56582 (<b>3</b>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) at 25 μM led to selective apoptosis of breast cancer cells, accompanied by reduced cytotoxicity on normal breast epithelial cells.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The chemosensitizing ability of DETA/NO to reverse hypoxia-mediated resistance to chemotherapeutic drugs, such as 5-FU, doxorubicin, cisplatin, and fludarabine (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), in many types of cancers was observed, including breast cancer, melanoma, neck squamous cancer, and chronic lymphocytic leukemia.<a onclick="showRef(event, 'ref29 ref67'); return false;" href="javascript:void(0);" class="ref ref29 ref67">(29, 67)</a> In addition, the immune-sensitization function of DETA/NO has been demonstrated. DETA/NO at 1 mM sensitized prostate cancer cell lines to TRAIL- and FasL-mediated apoptosis through NF-κB inhibition via the S-nitrosation of p50. The combination of DETA/NO with TRAIL activated the mitochondrial pathway, as indicated by upregulated caspases 9 and 3.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Other NO donors acting as potential chemo-, radio-, or immunosensitizers include SNP, SNAP, and <b>2</b> (see above). For instance, SNP sensitized human gastric cancer cells to TRAIL-induced apoptosis.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p last">Another important application of NO donors in combinational therapy is coadministration with ROS-inducing drugs, such as cisplatin and doxorubicin. NO donor pretreatment in cancer cells could increase the transcriptional activity of the transcription factors activator protein-1 (AP-1) or facilitate the nuclear translocation of NF-κB, both of which augment the rate of transcription of iNOS.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> This NO-iNOS positive feedback generates toxic levels of NO, which reacted with the superoxide anions produced by ROS inducers to yield various apoptosis-inducing reactive nitrogen oxides.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> For example, exogenous application of the NO donor SNAP resulted in improved cisplatin cytotoxicity in ovarian cancer cells.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.3 Hybridization of NO Donor(s) with an Anticancer Drug/Agent/Fragment</h3><div class="NLM_p">Given that NO is involved in a myriad of biological processes and displays dichotomous (pro- and antitumorigenic) effects of NO on cancer cells, the selective and effective delivery of NO to tumors is of great importance and has been investigated using a “hybridization” strategy with considerable progress. The strategy usually exploits the abnormalities existing in tumor cells that exist to a lesser extent or not at all in normal cells, such as high or overexpression of certain enzymes, bioreductive environment, acidic microenvironment, and hypoxia conditions, to design target compounds by hybridization of NO donor(s) with an anticancer drug/agent/fragment, preferably via a cancer-targeted linker.</div><div id="sec2_3_0_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.3.1 O<sup>2</sup>-Protected Diazeniumdiolates</h4><div class="NLM_p">As mentioned above, diazeniumdiolates spontaneously release NO under physiological conditions (pH 7.4, 37 °C) with half-lives ranging from a few seconds to several hours. O<sup>2</sup>-Protection of diazeniumdiolate has frequently been used to enhance their stability and selectivity by anchoring the O<sup>2</sup>-anion to a fragment that can directly act against cancer cells and be activated by specific enzymes that are highly or overexpressed in cancer cells to remove the protective fragment, generating the free diazeniumdiolate which automatically releases cytotoxic NO in situ against cancer. With reliance on the type of enzymes utilized for activation, different groups of O<sup>2</sup>-protected diazeniumdiolates have been designed and reviewed by Keefer.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a></div><div id="sec2_3_0_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i10" class="anchor-spacer"></div><h5 class="article-section__title" id="_i10">2.3.1.1 <i>O</i><sup>2</sup>-(Carbonyloxymethyl) Diazeniumdiolates Activatable by Esterases</h5><div class="NLM_p">In contrast to their corresponding free diazeniumdiolates, <i>O</i><sup>2</sup>-(acetoxymethyl) diazeniumdiolates <b>4</b> and <b>5</b> are stable in pH 7.4 buffer but are rapidly hydrolyzed to form the free diazeniumdiolate and subsequently release quantitative NO when exposed to porcine liver esterase (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Furthermore, incubation of <b>4</b> and <b>5</b> in leukemia cells, such as HL-60 and U937, also releases a large amount of NO with a different half-life and potently induces apoptosis of the cells. This strategy has been widely expanded to hybridize anticancer agents with diazeniumdiolates using the <i>O</i><sup>2</sup>-(carbonyloxymethyl) protective approach to produce compounds such as diazeniumdiolate/peptide hybrids<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and diazeniumdiolate/5-FU hybrids.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> However, stability of the <i>O</i><sup>2</sup>-(carbonyloxymethyl) moiety in blood plasma remains an innegligible issue.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>O</i><sup>2</sup>-(Carbonyloxymethyl) diazeniumdiolates <b>4</b> and <b>5</b> and their metabolic pathway by esterase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_0_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i11" class="anchor-spacer"></div><h5 class="article-section__title" id="_i11">2.3.1.2 <i>O</i><sup>2</sup>-2,4-(Dinitrobenzene) Diazeniumdiolates Activatable by GSH/GST</h5><div class="NLM_p">GSTs are a superfamily of enzymes that promote the nucleophilic conjugation of the thiol group of GSH with an electrophilic xenobiotic, thus increasing its solubility and improving the excretion of the xenobiotic from the cells. GSTs are often overexpressed in cancer cells and are implicated in the development of drug resistance.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Chlorodinitrobenzene (CDNB), a model substrate used extensively for evaluating the activity of GST, has been reported to conjugate with GSH to form a stable Meisenheimer complex, leading to chloride elimination (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Keefer et al. replaced the chloride in CDNB with a diazeniumdiolate moiety to obtain a new class of <i>O</i><sup>2</sup>-dinitrobenzene diazeniumdiolate derivatives.<a onclick="showRef(event, 'ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77">(75-77)</a> One representative compound, <i>O</i><sup>2</sup>-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate (JS-K) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), is the most active antiproliferative agent against HL-60 cells, with an IC<sub>50</sub> of 0.2–0.5 μM. Administration of JS-K (iv 4 μmol/kg) reduced HL-60 xenografts by approximately 50% without inducing significant hypotension.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Further mechanism studies revealed that JS-K increased mitochondrial superoxide levels by nitrating MnSOD at the active site in H1073 cells, caused GSH depletion through the arylating property of JS-K, activated the intrinsic apoptotic pathway in NSCLC cells, blocked androgen receptor and WNT-signaling in prostate cancer cells, and inhibited the transcriptional activity of β-catenin, a protein that plays an important role in cell–cell adhesion and leukemia proliferation, which in turn reduced the levels of cyclin D. McMurtry et al. found that JS-K increased acidic vesicle organelle formation in breast cancer cells, suggesting the ability of JS-K to induce cancer cell autophagy, which was further confirmed by electron microscopy. In addition, Western blotting showed that JS-K induced the expression of autophagy marker microtubule light chain 3-II in breast cancer cells. Importantly, no autophagy was observed in normal human mammary epithelial cells.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The investigation on the mechanisms underlying autophagy was awarded the 2016 Nobel Prize. Thus, a deeper understanding of the role of NO in cancer cell autophagy would be of great significance in future research.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Rational design of JS-K and its mechanism of NO release in the presence of GSH/GST.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further enzymatic studies showed that the reaction of JS-K with GSH was activated by GST-α at a rate 100 times more efficient than the GST-π isoform. Since GST-π is overexpressed in many tumors and GST-α is also expressed in normal cells, PABA/NO was synthesized by replacing the bulky piperazine moiety with a dimethylamine and introducing a substituent on the 5-position of the benzene ring to make the O<sup>2</sup>-arylated derivatives activated specifically by GST-π (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref77 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref79">(77, 79)</a> PABA/NO was more efficiently metabolized by GST-π than by GST-α and exclusively released a greater amount of cytotoxic NO into tumor cells, thus enhancing the antiproliferative activity against A2780 human ovarian cancer xenografts in SCID mice, with an IC<sub>50</sub> comparable to that of cisplatin and without weight loss and renal toxicity. PABA/NO increased the nitration of proteins in a dose- and time-dependent manner in mouse skin fibroblast NIH3T3 (WT) cells. A similar positive correlation between dose and cytotoxicity of PABA/NO was observed in HL-60 cells. However, the ester bond in PABA/NO renders it susceptible to hydrolysis, forming a phenol compound, which preferentially equilibrates to its phenolate ion, and this anion resists nucleophilic attack by GSH, resulting in diminished NO release and anticancer activity.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of PABA/NO and JS-K analogues <b>6</b>–<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several structural modification studies were conducted to improve the activity and selectivity of JS-K-based diazeniumdiolates for the GST-π isozyme and to achieve a better balance between activity and stability. For example, homopiperazine analogue <b>6</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) exhibited potent antiproliferative activity against NSCLC cells in vitro and in vivo, concomitant with activation of the SAPK/JNK stress pathway and upregulation of its downstream effector ATF3.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Compound <b>7</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), with nitro-to-cyano substitution, showed increased half-life in the presence of GSH without compromising the compound’s in vivo antitumor activity.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Recently, a new class of <i>O</i><sup>2</sup>-(2,4-dinitrophenyl)-1-[<i>N</i>,<i>N</i>-bis(2-substituted ethyl)amino]diazen-1-ium-1,2-diolates was prepared by our group.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The most active compound <b>8</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) caused significant DNA damage by releasing <i>N</i>,<i>N</i>-bis(2-TsO ethyl)amine and two molecules of NO after activation by GSH/GST in cancer cells. Compound <b>8</b> was more cytotoxic than JS-K against human colon carcinoma HCT116, human ovarian OVCAR5, and murine gliosarcoma 9L-2 cells, suggesting that the strategy can be extended to other O<sup>2</sup>-protected diazeniumdiolates to improve their anticancer activity.</div></div><div id="sec2_3_0_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12">2.3.1.3 INDQ/Diazeniumdiolates Activatable by DT-Diaphorase</h5><div class="NLM_p">DT-diaphorase (DTD) is an obligate two-electron reductase. DTD levels are elevated in a number of tumor types, which enables targeted activation of chemotherapeutic quinones in the tumor with minimized normal tissue toxicity.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Indolequinone is a known substrate for DTD and has been widely used to couple with DNA alkylating compounds at the C-10 position to produce several DTD-activatable prodrugs.<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85-87)</a> DTD, along with its cofactors NADPH and FAD, can reduce indolequinone to dihydroxyindole, which has increased electron density on the indole nitrogen, triggering rearrangement to release the substituted moiety at the C-10 position. Chakrapani et al. connected a diazeniumdiolate moiety to the C-10 of the indolequinone, generating DTD-activatable NO prodrugs INDQ/NO and 2-Me INDQ/NO (<b>9</b>) (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> In a standard cell viability assay, INDQ/NO was a potent inhibitor at low micromolar concentrations, more active than analogue <b>9</b>, against human adenocarcinoma cells (DLD-1), urinary bladder cells (T24 cells), and cervical cancer cells (HeLa) cells, which are known to overexpress DT-diaphorase.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. DT-diaphorase promoted NO release from INDQ/NO and 2-Me INDQ/NO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_0_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13">2.3.1.4 <i>O</i><sup>2</sup>-(<i>p</i>-Substituted benzyl) Diazeniumdiolates Activatable by NTR or H<sub>2</sub>O<sub>2</sub></h5><div class="NLM_p">The site-specific activation of nontoxic prodrugs has recently been proposed to enhance the selectivity of drugs for cancer cells. Generally, the prodrugs comprise three parts, i.e., trigger, linker, and effector. 1,6-Elimination-based self-immolative linker systems are often used for tumor-activated prodrug therapy,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> which usually involves a trigger masking the linker, such as aniline, <i>N</i>-hydroxyaniline, or phenol moiety, with the drug (effector) attached to the benzylic position directly or through a carbamate or carbonate linkage (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). This concept has been successfully employed for the design of site-specific NO donor hybrids, in which the diazeniumdiolate moiety acts as an effector, exemplified by the following two <i>O</i><sup>2</sup>-(<i>p</i>-substituted benzyl) diazeniumdiolates.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Prodrugs with 1,6-elimination-based linker systems, where XH is masked as a trigger. (B, C) <i>O</i><sup>2</sup>-(<i>p</i>-Substituted benzyl) diazeniumdiolate <b>10</b> and BORO/NO are activatable by NTR and H<sub>2</sub>O<sub>2</sub>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Chakrapani and co-workers designed and synthesized a new class of <i>O</i><sup>2</sup>-(4-nitrobenzyl) diazeniumdiolates <b>10</b> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In the presence of nitroreductase (NTR), the nitro group in <b>10</b> can be reduced to a hydroxylamine. As a consequence, the electron density on the benzyl groups is substantially increased, and the diazeniumdiolate anion is expelled to release NO via a 1,6-elimination. In vitro assay demonstrated that the antiproliferative activity of <b>10</b> against DLD-1 and HeLa cells was significantly enhanced relative to the parent diazeniumdiolate. Similarly, the arylboronate ester-based diazeniumdiolate BORO/NO is activated by hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) to generate NO (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Since H<sub>2</sub>O<sub>2</sub> is one of the most common ROS produced in large amounts in several human tumor cells, the potential antineoplastic application of this type of diazeniumdiolate should be investigated.</div></div><div id="sec2_3_0_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i14" class="anchor-spacer"></div><h5 class="article-section__title" id="_i14">2.3.1.5 <i>O</i><sup>2</sup>-β-Galactosyl Diazeniumdiolates Activatable by β-Galactosidase</h5><div class="NLM_p"><i>O</i><sup><b>2</b></sup><b>-</b>β-Galactosylpyrrolidinyl diazeniumdiolate (β-Gal-NONOate) was synthesized by Wang and colleagues and released NO only when hydrolyzed by β-galactosidase in rat glioma cell line 9L with transformed LacZ gene, leading to its more powerful cytotoxicity than that of the free diazeniumdiolate.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92, 93)</a> In addition, O<sup>2</sup>-sialated diazeniumdiolate <b>11</b> could be efficiently hydrolyzed by neuraminidase to release NO with a <i>K</i><sub>m</sub> of 0.14 mM,<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> and <i>O</i><sup>2</sup>-β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>-acetylglucosaminyl diazeniumdiolates <b>12</b> and <b>13</b> could selectively release NO in macrophages (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> While some of these enzymes are not tumor-specific, application of a site-specific NO-releasing strategy might be worthwhile for the design of novel anticancer drugs/agents.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of <i>O</i><sup><b>2</b></sup><b>-</b>β-galactosyl diazeniumdiolates (β-Gal-NONOate) as well as <i>O</i><sup>2</sup>-sialated- and <i>O</i><sup>2</sup>-β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>-acetylglucosaminyl diazeniumdiolates <b>11</b>–<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">2.3.2 Hybridization of NO Donor(s) with a Known Cytotoxic Drug</h4><div class="NLM_p">The most straightforward method to utilize the anticancer activity of NO is hybridization of NO donors with a known cytotoxic drug. The design of hybrids from NO donors and nucleoside analogues is among the earliest attempts to assess the anticancer activity of NO hybrids. The Naimi group synthesized a group of 3′- and 5′-nitrooxypyrimidine nucleoside nitrate esters and evaluated their anticancer activity in a variety of cancer cell lines. The cytotoxicity of the target compounds was comparable to that of 5-iodo-2′-deoxyuridine but lower than that of 5-fluoro-2′-deoxyuridine.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The Cai group synthesized diazeniumdiolate/5-FU hybrids, among which <b>14</b> and <b>15</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) showed greater inhibitory activity against HeLa and DU145 cancer cells than 5-FU, indicating that the nucleoside and NO could have synergistic anticancer effects in biological systems.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Hybrids from NO donor(s) and cytotoxic drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, hybridization of NO donor(s) with gemcitabine was reported by Li et al.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Hybrid <b>16</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) showed stronger antitumor activity than gemcitabine due to the synergistic effects of NO and gemcitabine.</div><div class="NLM_p">Platinum-based anticancer drugs are among the most important groups of chemotherapeutic agents. Gou and colleagues developed complexes containing NO donor and platinum-based moieties to improve the cytotoxicity. Compound <b>17</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) was highly toxic to human HCT-116 and SGC-7901 cells. Synergistic effects via DNA binding and NO-donating from the furoxan moiety were confirmed.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In another work from the same group, organic nitrate/platinum hybrids were investigated as novel anticancer agents. The cytotoxic effect of hybrid <b>18</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) was comparable to that of cisplatin against HCT-116, HepG2, and MCF-7 cells. However, <b>18</b> was 5-fold less cytotoxic than cisplatin to nontumorigenic human liver cell line LO2, suggesting that <b>18</b> may be a promising anticancer candidate with selective cytotoxicity to cancer cells.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><div class="NLM_p last">Other examples in this class of hybrids include NO/tamibarotene,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> NO/thalidomide,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and NO/abiraterone,<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a>as represented by compounds <b>19</b>–<b>21</b>, respectively (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>).</div></div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.3.3 Hybridization of NO Donor(s) with an Enzyme Inhibitor</h4><div class="NLM_p">Enzyme inhibitors are an important class of anticancer drugs/agents due to their ability to regulate tumor-related signaling events through enzyme blocking. The hybridization of apoptosis-inducing NO donor(s) with an enzyme inhibitor endows the parent molecule with enhanced anticancer potency and multitarget capacity. NO itself can act as an inhibitor of some enzymes through S-modification. Exemplified below are four successfully designed NO donor/enzyme inhibitor hybrids published in the <i>Journal of Medicinal Chemistry</i>.</div><div class="NLM_p">Farnesylthiosalicylic acid (FTS) inhibits cancer cell proliferation by functioning as a Ras protein antagonist. Ling et al. designed furoxan/FTS hybrids and tested their anti-HCC activity. Compounds <b>22</b> and <b>23</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) significantly inhibited the proliferation of human hepatocellular carcinoma (HCC) cells, superior to either FTS or the furoxan moiety, suggesting that high levels of NO and the inhibition of Ras-involved signaling may yield a synergistic anticancer effect.<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103, 104)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Enzyme inhibitors and their hybrids with NO donor(s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">WZ4002 (<b>24)</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) is a promising irreversible epidermal growth factor receptor (EGFR) inhibitor with outstanding selectivity against the EGFR 790M mutant. A group of hybrids from phenylsulfonylfuroxan and anilinopyrimidine, the key scaffold of <b>24</b>, were synthesized by Han et al. for intervention of NSCLC. Compound <b>25</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) selectively inhibited EGFR mutant L858R/T790M with an IC<sub>50</sub> of 0.047 μM. Additionally, <b>25</b> exhibited strong antiproliferative activity against EGFR mutation NSCLC cell lines and substantial growth inhibitory effects in an H1975 xenograft mouse model. The NO released from <b>25</b> suppressed NF-κB activation, which might improve the response of EGFR mutation-harboring NSCLC to the EGFR inhibitor.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><div class="NLM_p">Histone deacetylase inhibitors (HDACIs) bearing a hydroxamic acid moiety have been exploited as potential anticancer agents, e.g., the approved drug SAHA (vorinostat). On the basis of the fact that NO also inhibits HDACs through S-nitrosation, Duan et al. designed a novel series of hybrids from furoxan and SAHA. Among the target compounds, <b>26</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) exhibited strong antiproliferative activity against a broad panel of cancer cells in vitro and showed dose-dependent antitumor growth effects in an HEL cell xenograft model in vivo.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><div class="NLM_p">Poly ADP-ribose polymerase 1 (PARP-1) inhibitors, such as olaparib, have been intensively evaluated as promising chemopotentiators in several cancer types. However, the targeted delivery of PARP-1 inhibitors to cancer cells remains an unmet need. Maciag et al. conceived a new method to solve this problem by designing NO donor/PARP-1 inhibitor hybrids. Compounds <b>27</b> and <b>28</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) were synthesized by hybridization of O<sup>2</sup>-arylated diazeniumdiolate with olaparib. Upon activation by GST-π, which is overexpressed in several cancer cells, the hybrid molecules simultaneously generated NO and the PARP-1 inhibitor, leading to DNA damage or cross-linking glutathionylation of proteins. The in vivo anticancer effects of <b>27</b> and <b>28</b> were confirmed using A549 human lung adenocarcinoma xenograft models, and no significant systemic toxicity was observed.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><div class="NLM_p last">Selective human carbonic anhydrase (hCA) inhibitors, such as sulfonamide and sulfamate derivatives, represent another class of compounds with broad pharmacological activity. A wide variety of NO donor/hCA inhibitor hybrids were synthesized and tested for their anticancer activity and were recently reviewed by Carradori et al.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Another example in this category is the NO donor/saquinavir hybrid (<b>29</b>) (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">2.3.4 Hybridization of NO Donor(s) with an Active Natural Product</h4><div class="NLM_p">Natural products provide an important source of anticancer lead compounds. During the past decade, one of our group’s interests has been to develop novel anticancer agents through hybridization of NO donor(s) with oleanolic acid (OA), a naturally existing pentacyclic triterpenoid with demonstrated inhibitory activity against hepatitis and tumors. The first candidate, <b>30</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), was discovered by Chen et al. from a group of furoxan-based NO donor/OA hybrids. Compound <b>30</b> exhibited strong cytotoxicity selectively against human HCC cells and drastically impeded the growth of HCC tumors in vivo.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> However, the low aqueous solubility of <b>30</b> was a major challenge for its further clinical application. To overcome this problem, Huang et al. synthesized a series of glycosylated prodrugs of <b>30</b>, among which the galactosylated derivative <b>31</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>) showed encouraging anti-HCC activity, with an approximately 8 times greater aqueous solubility than that of <b>30</b>.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Subsequently, O<sup>2</sup>-protected diazeniumdiolates were used instead of furoxan to construct new NO donor/OA hybrids to further enhance cancer cell selectivity. Compound <b>32</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), bearing an O<sup>2</sup>-glycosylated diazeniumdiolate moiety, inhibited HCC tumor growth in mice at 3 mg/kg (iv) and showed low acute toxicity (LD<sub>50</sub> = 173.3 mg/kg).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Fu et al. designed hybrids from <i>O</i><sup>2</sup>-(2,4-dinitrophenyl)diazeniumdiolate and OA using various amino acids as linkers. The hybrid <b>33</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), with GST-π selectivity, released high levels of NO in HCC cells, which may contribute to its remarkable antiproliferative activity in vitro and significant tumor-suppressing ability in vivo. Compared with JS-K and PABA/NO (<a class="ref internalNav" href="#fig6" aria-label="Figures 6">Figures 6</a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), <b>33</b> showed significantly enhanced stability toward GSH in the absence of GST-π, thus avoiding the off-target release of NO from <b>33</b> during blood circulation.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Further investigation led to the identification of hybrid <b>34</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), which acted as a potential agent for colon cancer intervention through the nitration of tyrosine residues in mitochondrial protein, down-regulation of the Wnt/β-catenin pathway, and inhibition of the COX-2 centered signaling loop in colon cancer cells.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Natural products/derivatives and their hybrids with NO donor(s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The introduction of a cancer-targeted moiety into the hybrid represents another useful strategy to achieve tumor selectivity. As a proof of concept, Fang et al. synthesized nitrate/OA hybrids with an amino acid/dipeptide moiety as a linker attached to the C28 of OA. The amino acid/dipeptide moiety is utilized to mimic the substrate of peptide transporter 1 (PepT1), which is relatively overexpressed in several cancer cell lines. Two hybrids, <b>35</b> and <b>36</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), showed potent cytotoxicity because of their higher PepT1 affinity. Meanwhile, the hydrophilic peptide moiety resulted in improved aqueous solubility of the hybrids.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">Most recently, Fang et al. designed OA/NO/platinum(II) trihybrid molecules. The trihybrid <b>37</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>) selectively inhibited HCC cells as a result of the synergistic effects of cytotoxic NO and OA and the DNA-binding activity of Pt(II).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div><div class="NLM_p">Synthetic OA derivatives, such as 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO), CDDO-Me, CDDO-Im, and olean-28,13β-olide, are promising lead compounds with remarkably enhanced anticancer activity relative to OA. Ai et al. synthesized CDDO-PepT1 targeting linker-NO donor trihybrids to achieve combined effects. The most active compound, <b>38</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), inhibited the proliferation of not only drug-sensitive colon cancer cells but also their drug-resistant counterparts. Furthermore, <b>38</b> repressed the growth of human drug-resistant colon cancer xenografts in mice by ∼60%.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><div class="NLM_p last">Other examples of NO donor/natural product hybrids for cancer intervention include NO/glycyrrhetinic acid (GA),<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> NO/oridonin,<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119, 120)</a> and NO/matrine,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> represented by compounds <b>39</b>–<b>41</b>, respectively (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).</div></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.3.5 Hybridization of NO Donor(s) with an MDR Reversal Agent</h4><div class="NLM_p">Multidrug resistance (MDR) in cancer cells is a major hurdle to efficient chemotherapy. One of the main mechanisms of MDR originates from overexpressed ATP-binding cassette (ABC) transporter P-glycoprotein (Pgp). Classical NO donors, such as SNAP, SNP, <i>S</i>-nitrosoglutathione (GSNO), and furoxan derivatives, are able to inhibit ABC transporters overexpressed in MDR tumor cells by nitrating critical tyrosine residues. It has been shown that impairment of these transporters reduces the efflux of doxorubicine (DOX) in cancer cells, with a resulting increase in cytotoxicity.<a onclick="showRef(event, 'ref122 ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref122 ref123 ref124">(122-124)</a> On this basis, Riganti and colleagues synthesized NO-donating DOXs, represented by compounds <b>42</b> and <b>43</b>, which increased DOX accumulation in MDR cancer cells with a resulting increase in cytotoxicity.<a onclick="showRef(event, 'ref125 ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref125 ref126 ref127">(125-127)</a>The potential use of NO donor/MDR reversal agent hybrids has also been intensively investigated. NO donors are usually linked to Pgp inhibitors or modulators with MDR reversal activity. Zou et al. synthesized a panel of furoxan-based NO donor/tetrahydroisoquinoline (THIQ) hybrids. At a concentration of 10 μM, hybrids <b>44</b>–<b>46</b> (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) produced 9–13 μM nitrites in K562/A02 cells as revealed by the Griess assay, which might account for their potent MDR reversal activity.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Hybrids from NO donor(s) and MDR reversal agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our group is interested in the development of hybrids from NO donors and dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphen-yl-2,2′-dicarboxylate (DDB), which was demonstrated to reverse Pgp-mediated MDR through intracellular anticancer drug accumulation and induction of Pgp inhibition-mediated apoptosis. Tang et al. discovered that hybrids <b>47</b> and <b>48</b> (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) significantly reversed the resistance of MCF-7/Adr cells to doxorubicin. After treatment of MCF-7/Adr cells with <b>47</b> or <b>48</b> in addition to doxorubicin, the intracellular concentration of doxorubicin was markedly increased via down-regulation of Pgp expression and blockage of Pgp-mediated drug efflux. The NO released by <b>47</b> and <b>48</b> exerted synergistic effects and chemosensitized MCF-7/Adr cells.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> More recently, Gu et al. synthesized compounds <b>49</b> and <b>50</b>, which effectively inhibited the viability of both drug-sensitive and MDR tumor cells. They concluded that <b>49</b> and <b>50</b> induced mitochondrial tyrosine nitration and apoptosis, down-regulated HIF-1α expression, and suppressed the activation of AKT, ERK, and NF-κB in MDR cells.<a onclick="showRef(event, 'ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref130 ref131">(130, 131)</a></div></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.3.6 Hybridization of NO Donor(s) with an NSAID</h4><div class="NLM_p">Nonsteroidal anti-inflammatory drugs (NSAIDs) have recently received increased interest due to their potential protective role against cancer. Hybrids of NO donors and NSAIDs (NO-NSAIDs) have emerged as promising anticancer agents. A large group of NO-NSAIDs with the structure “NSAID-linker-NO donor” was synthesized by Thatcher and co-workers and was conventionally named with the prefix “NCX”.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> For instance, NCX-4016 (<b>51</b>) and NCX-4040 (<b>52</b>) (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>) are NO-aspirin hybrids in which the nitrate moiety is connected to the carboxylic acid group of aspirin via a benzyl moiety. NO-aspirin possesses increased antiproliferative and proapoptotic activities compared to aspirin or the NO donor alone,<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> and their mechanisms of action include inhibition of cancer cell growth through redox-dependent signaling,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> suppression of NF-κB signaling in estrogen receptor negative breast cancer cells,<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> and G2/M phase cell cycle arrest by regulating phase transition proteins.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Both NO and aspirin are essential for the anticancer activity, and some studies also claimed that the quinonemethide intermediate plays a key role.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Another successful example of NO-NSAIDs is the hybridization of NO donors with sulindac to yield NO-sulindac, such as NCX-1102 (<b>53</b>) (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>). Stewart et al. demonstrated that <b>53</b> exhibited proapoptotic and anti-invasive effects against PC3 prostate cancer cells, superior to sulindac. Treatment with <b>53</b> decreased HIF-1α expression and reduced Akt phosphorylation in the cells.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Other NO-NSAIDs with confirmed anticancer activity include NO-salicylic acid, NO-ibuprofen, and NO-flurbiprofen, which have been reviewed by Rigas and Kashfi.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Hybrids (<b>51</b>–<b>55</b>) from NO donor(s) and NSAIDs as well as NOSH-aspirin from NO/H<sub>2</sub>S donors and aspirin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The hybridization of furoxan with (<i>S</i>,<i>R</i>)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid led to another well-studied NO-NSAID, GIT-27NO (<b>54</b>) (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>).<a onclick="showRef(event, 'ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref139 ref140">(139, 140)</a> While the anti-inflammatory parental drug showed no anticancer effects, hybrid <b>54</b> acquired powerful anticancer activity, which was confirmed both in vitro and in vivo. The mechanism of action study revealed that <b>54</b> activated mitogen-activated protein kinase (MAPK) family members ERK, p38, and Jun N-terminal kinase (JNK). Additionally, <b>54</b> triggered different types of programmed cell death (PCD) in various cell lines. In some cell lines, such as the astrocytoma C6 and melanoma B16, no classical apoptotic signs were induced by <b>54</b>; however, high levels of autophagosomes were observed in the cytoplasm, suggesting that <b>54</b> may induce cancer cell death by autophagy in these cell lines.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><div class="NLM_p last">In recent years, an even bolder design from the Kashfi group led to the discovery of “super” aspirin, designated NOSH-aspirin (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>), where hydrogen sulfide (H<sub>2</sub>S) donor and NO donor moieties are covalently linked to the 1,2 positions of aspirin. NOSH-aspirin inhibited the growth of colon cancer HT-29 cells with nanomolar IC<sub>50</sub> values (9000 times more potent than the sum activity of aspirin, the NO donor, and H<sub>2</sub>S donor moieties).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> As claimed by the authors, “this is the first NSAID based agent with such high degree of potency”. In vivo investigation revealed that NOSH-aspirin caused an 85% reduction in the volume of human colon cancer xenografts in mice. Currently, studies aiming to develop NOSH-aspirin analogues and to clarify the structure–activity relationship of these compounds are in progress.<a onclick="showRef(event, 'ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref142 ref143">(142, 143)</a> Meanwhile, the “dual donor” strategy has been applied to produce NOSH-sulindac (<b>55</b>) (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>), which inhibited the growth of several human cancer cells at rates 1000–9000 times more potent than sulindac.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">2.4 iNOS Gene Therapy</h3><div class="NLM_p last">The role of iNOS in tumor development is very complex, and both carcinogenic and anticarcinogenic effects of iNOS have been reported. Either induction or inhibition of iNOS has anticancer potential based on the tumor response to different concentrations of NO (see above). The hypoxic environment resulting from iNOS inhibition can be utilized to boost the cytotoxicity of bioreductive drugs. However, it might interfere with the potency of traditional chemotherapy and radiotherapy.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Conversely, iNOS-based suicide gene therapy, which produces elevated NO levels to elicit tumoricidal effects through more specific and localized expression of the iNOS gene, represents a promising strategy. Currently, many types of vectors have been employed for iNOS gene delivery, including adenoviral vectors, cationic liposomes, bioinspired recombinant vectors, and retroviral vectors. The effects of iNOS gene therapy have been demonstrated on various cancer cells, such as ZR-75-1 breast cancer, A549 lung cancer, and T24 bladder carcinoma.<a onclick="showRef(event, 'ref146 ref147 ref148'); return false;" href="javascript:void(0);" class="ref ref146 ref147 ref148">(146-148)</a> Furthermore, the in vivo anticancer potency was confirmed in numerous animal models, including human medullary thyroid carcinoma-bearing rat, human colon cancer xenografts in mice, colorectal adenocarcinoma xenografts in SCID mice, and the A549 metastasis model.<a onclick="showRef(event, 'ref147 ref149 ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref147 ref149 ref150 ref151">(147, 149-151)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">2.5 NO-Donating Nanoparticle Systems</h3><div class="NLM_p">As an alternative to small NO donor molecules, the development of NO-donating nanoparticles as potent tumoricidal agents has recently attracted significant attention due to their unique advantages. First, nanoparticles can strengthen the stability of the NO donor within the nanosystems compared with the free NO donor. Second, because of the high surface area, nanoparticles can load large amounts of NO and undergo passive targeting to solid tumors via the well-known phenomenon of the “enhanced permeability and retention” (EPR) effect.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Third, there is a possibility of triggering NO release from the nanomaterial directly to the tumor site by regulating the light input, temperature, pH, and magnetic field. In this regard, NO-donating nanoparticle systems could localize high concentrations of NO in a sustained manner to the tumor site rather than circulating to other organs, thus avoiding systemic toxicity. Many NO-donating nanoparticle systems to fight against tumor cells have been prepared based on polymeric nanoparticles, dendritic polymers, liposomes, silica nanoparticles, metallic nanoparticles, and quantum dots and have been reviewed.<a onclick="showRef(event, 'ref153 ref154 ref155 ref156'); return false;" href="javascript:void(0);" class="ref ref153 ref154 ref155 ref156">(153-156)</a> Of course, each of these systems has pros and cons that should be carefully considered when being utilized. In addition, some NO-donating nanoparticle systems are complicated and contain nonbiocompatible or nonbiodegradable components, which lower the repeatability or druggability. The preparation of a truly biocompatible and biodegradable platform for NO delivery is still under research.</div><div class="NLM_p last">Another unique property of NO-donating nanoparticle systems is that it provides an easy and flexible method to combine an NO donor with cytotoxic agents. For example, a hollow microsphere (HM) system carrying the anticancer agents irinotecan and DETA/NO was utilized to treat MDR cancer.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Upon injection of this system into slightly acidic tumor tissue, environmental protons infiltrate the shell of the HMs and react with their encapsulated DETA/NO to produce NO bubbles that initiate localized drug release, which can serve as a Pgp-mediated MDR reversal agent. The site-specific drug release and the NO-reduced Pgp-mediated transport result in the intracellular accumulation of the drug at a concentration that exceeds the cell-killing threshold, eventually inducing cancer cell apoptosis.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">3 Conclusion and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NO donor-based therapy mainly consists of iNOS gene therapy and NO donor(s) alone or in combination/hybridization with an anticancer drug/agent/fragment. While iNOS gene therapy can enhance NO delivery for the intervention of cancers, this strategy must overcome two substantial obstacles before making breakthrough progress. One is the risk from the viral vectors that are required to deliver the gene therapy, and the other is the early death of iNOS transfectants.<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158, 159)</a> In contrast, NO donor(s) alone or in combination/hybridization with an anticancer drug/agent/fragment can induce a multitude of antitumor activities, encompassing induction of apoptosis, sensitization to chemo-, radio-, or immunotherapy, and inhibition of metastasis, angiogenesis, and hypoxia. Accordingly, therapeutic application of these approaches may be considered a promising anticancer strategy.</div><div class="NLM_p">Among the current NO donors, only organic nitrates and SNP are available for clinical use. However, patients taking long-term nitrates often develop tolerance, and prolonged SNP administration may lead to cyanide accumulation in the body. How to address these issues remains a challenging subject for NO donor-based therapy. The recently emerging dinitroazetidine compounds, such as <b>2</b>, which function essentially as NO donors, generate and selectively deliver high levels of NO under hypoxic conditions at a sustained but accelerated speed to exert potent antitumor activity. At therapeutic doses, these compounds do not show the systemic toxicity that is associated with several well-known NO donors. Further investigations of this type of compound will expand the structural scope of NO donors and promote the clinical application of NO donor-based therapy.</div><div class="NLM_p">The combination of an anticancer drug/agent with NO donor(s) continues to be a good choice for NO donor-based therapy. The most important factors are the type, amount, and/or preparation formulation of NO donor(s) to achieve the best synergistic effects.</div><div class="NLM_p">The hybridization of an anticancer drug/agent/fragment with NO donor(s) via a cancer-targeted linker, by acting in tumors to display synergistic antitumoral effects while sparing healthy cells, may result in hybrids that are more effective and less toxic than the parent drug/agent. However, the real beneficial effects should be observed in both pharmacodynamic and pharmacokinetic studies in vivo.</div><div class="NLM_p">In addition, NO-donating nanoparticle systems, which have recently been applied to the field of NO donor-based therapy, possess great potential to store and site-specifically deliver high levels of NO to the cancer site and deserve intensive investigation.</div><div class="NLM_p">Low constitutive levels of NO induced by hypoxia in tumors are optimal for the mediation of aberrant, proliferative signaling, leading to progression of cancer cells, whereas levels above or below this optimal range can have the opposite effect and activate signal transduction pathways that may cause cell growth inhibition or cell death.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These studies suggest that it may be essential to ascertain the minimum threshold dose of NO before a switchlike response from promotion to inhibition or killing of a tumor is elicited. In this regard, it should first be precisely determined what levels of NO are optimal for cancer cell promotion and then specifically kill or inhibit tumor cells in vivo using NO donor-based therapy at appropriate doses with the knowledge of the interactions of NO with the signaling proteins in tumor cells.</div><div class="NLM_p">As for the new generation of NO donors, chemical synthesis is not a difficult job from the viewpoint of medicinal chemistry, but for therapeutic uses, these compounds must have tissue selectivity and demonstrate cancer-targeted NO release in a controlled and sustained manner to avoid the drawbacks related to the rapid burst of NO associated with traditional NO donors, such as nitrates. The O<sup>2</sup>-protected diazeniumdiolates may be preferable to other NO donors since a rationally designed protecting group that can be metabolically removed by enzymes that are highly or overexpressed in cancer tissues or cells would result in relatively slow and long-lasting NO release at the cancer site. Additionally, further studies into new imaging examinations will be required. For instance, NO-donating compounds may be connected to a fluorescent group to monitor and/or capture the in vivo effects of NO on tumors.</div><div class="NLM_p">It is also worth mentioning that in some cases, the anticancer activity of a NO donor cannot be simply attributed to NO release alone. For example, compound <b>1</b> is activated by O<sub>2</sub> to produce both NO and O<sub>2</sub><sup>–</sup>, leading to ONOO<sup>–</sup> formation. The anticancer mechanisms of <b>2</b> and JS-K involve GSH depletion. The anticancer potency of NO donor hybrids usually results from the synergistic effects of NO and the conjugated moiety. The linker can also act as a tumor-targeting motif or decompose into an active metabolite, such as the quinonemethide generated from compounds <b>51</b> and <b>52</b>. Therefore, there is great flexibility for organic chemists and medicinal chemists to design NO-donating anticancer agents using state-of-the-art methods. Of course, it also poses more challenge for the comprehensive mechanism of action studies on these compounds.</div><div class="NLM_p last">There is an unmet medical need for the discovery and study of a new generation of NO donor-based therapy with controlled release of appropriate levels of NO at the cancer site to generate a desired response, thereby tipping the balance from cancer cell survival to death. We believe that this innovative NO donor-based cancer therapy may facilitate the clinical development of anticancer drugs.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01672" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihua Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug
Discovery for Metabolic Diseases, China
Pharmaceutical University, Nanjing 210009, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2378-7064" title="Orcid link">http://orcid.org/0000-0003-2378-7064</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#afd5d6c7dbc8cbef9e999c81ccc0c2"><span class="__cf_email__" data-cfemail="2d575445594a496d1c1b1e034e4240">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhangjian Huang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug
Discovery for Metabolic Diseases, China
Pharmaceutical University, Nanjing 210009, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junjie Fu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Nanjing Medical University, Nanjing 211166, P.R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2741-7469" title="Orcid link">http://orcid.org/0000-0002-2741-7469</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.H. and J.F. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Zhangjian Huang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=BIO-d47e2328-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhangjian Huang</b> received his B.S. and Ph.D. degrees from China Pharmaceutical University (CPU) in 2004 and 2009, respectively. From 2009 to 2012, he worked as a postdoctoral fellow supervised by Prof. Edward E. Knaus at University of Alberta in Canada. He joined the research group of Prof. Yihua Zhang at CPU in 2013. He is now Professor of Medicinal Chemistry at CPU. His research interests involve the discovery of novel anticancer, anti-inflammation, and cardiovascular-disease-related agents based on gaseous messengers such as nitric oxide (NO), nitroxyl (HNO), hydrogen sulfide (H<sub>2</sub>S), and some natural products.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Junjie Fu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=BIO-d47e2336-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Junjie Fu</b> obtained his Ph.D. degree in Medicinal Chemistry from China Pharmaceutical University (CPU) under the supervision of Prof. Yihua Zhang and Prof. Sixun Peng in 2013. Afterward, he worked as a postdoctoral fellow in the Department of Medicinal Chemistry at University of Florida until 2015. At present, he is an Associate Professor of Medicinal Chemistry in Nanjing Medical University. His research activity is focused on using rational drug design to identify and develop novel anticancer drugs including NO-donating agents.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Yihua Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=BIO-d47e2341-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yihua Zhang</b> graduated from China Pharmaceutical University (CPU) in 1970. He continued his education in medicinal chemistry under the supervision of Prof. Sixun Peng at CPU in 1979 and received his M.S. degree in 1981. He completed his Ph.D. studies in Organic Chemistry under the direction of Prof. Salo Gronowitz at Lund University in Sweden in 1994. He subsequently joined the group of Prof. T. Y. Shen as a postdoctoral fellow in medicinal chemistry at University of Virginia in the United States. Since 1997, he has been Professor of Medicinal Chemistry working at CPU. His research interests mainly focus on the nitric oxide donating drugs.</p></figure></div><div class="ack" id="ACK-d47e1889-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Natural Science Foundation of China (Grants 81273378, 21372261, 81673305, and 81602960) and Jiangsu Province Funds for Distinguished Young Scientists (Grant BK20160033). Part of the work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Program for New Century Excellent Talents in University (Grant NCET-13-1033), Startup Funding for Introduced Talents of Nanjing Medical University (Grant KY109RC1602), and Jiangsu Shuang Chuang team.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">ALDH2</td><td class="NLM_def"><p class="first last">aldehyde dehydrogenase-2</p></td></tr><tr><td class="NLM_term">AP-1</td><td class="NLM_def"><p class="first last">activator protein 1</p></td></tr><tr><td class="NLM_term">ATF3</td><td class="NLM_def"><p class="first last">activating transcription factor 3</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BH<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrahydrobiopterin</p></td></tr><tr><td class="NLM_term">CDNB</td><td class="NLM_def"><p class="first last">chlorodinitrobenzene</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine monophosphate</p></td></tr><tr><td class="NLM_term">COX-2</td><td class="NLM_def"><p class="first last">cyclooxygenase 2</p></td></tr><tr><td class="NLM_term">DNMT</td><td class="NLM_def"><p class="first last">DNA methyltransferase</p></td></tr><tr><td class="NLM_term">DTD</td><td class="NLM_def"><p class="first last">DT-diaphorase</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">eNOS</td><td class="NLM_def"><p class="first last">endothelial NO synthase</p></td></tr><tr><td class="NLM_term">EPR</td><td class="NLM_def"><p class="first last">enhanced permeability and retention</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">FTS</td><td class="NLM_def"><p class="first last">farnesylthioslicylic acid</p></td></tr><tr><td class="NLM_term">GA</td><td class="NLM_def"><p class="first last">glycyrrhetinic acid</p></td></tr><tr><td class="NLM_term">GLYN</td><td class="NLM_def"><p class="first last">glycidyl nitrate</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione-<i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">GTN</td><td class="NLM_def"><p class="first last">glyceryl trinitrate</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">hCA</td><td class="NLM_def"><p class="first last">human carbonic anhydrase</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HDACI</td><td class="NLM_def"><p class="first last">histone deacetylase inhibitor</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor 1α</p></td></tr><tr><td class="NLM_term">HM</td><td class="NLM_def"><p class="first last">hollow microsphere</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible NO synthase</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">N<sub>2</sub>O<sub>3</sub></td><td class="NLM_def"><p class="first last">dinitrogen trioxide</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl <span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">nNOS</td><td class="NLM_def"><p class="first last">neuronal NO synthase</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NO<sup>+</sup></td><td class="NLM_def"><p class="first last">nitrosonium ion</p></td></tr><tr><td class="NLM_term">NO<sub>2</sub></td><td class="NLM_def"><p class="first last">nitrogen dioxide</p></td></tr><tr><td class="NLM_term">NO<sub>2</sub><sup>–</sup></td><td class="NLM_def"><p class="first last">nitrite anion</p></td></tr><tr><td class="NLM_term">NOS</td><td class="NLM_def"><p class="first last">NO synthase</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">O<sub>2</sub><sup>•–</sup></td><td class="NLM_def"><p class="first last">superoxide anion</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">oleanolic acid</p></td></tr><tr><td class="NLM_term">ONOO<sup>–</sup></td><td class="NLM_def"><p class="first last">peroxynitrite</p></td></tr><tr><td class="NLM_term">PARP-1</td><td class="NLM_def"><p class="first last">poly ADP-ribose polymerase 1</p></td></tr><tr><td class="NLM_term">PCD</td><td class="NLM_def"><p class="first last">programmed cell death</p></td></tr><tr><td class="NLM_term">PepT1</td><td class="NLM_def"><p class="first last">peptide transporter 1</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PPHN</td><td class="NLM_def"><p class="first last">persistent pulmonary hypertension of newborn</p></td></tr><tr><td class="NLM_term">PTM</td><td class="NLM_def"><p class="first last">post-translational modification</p></td></tr><tr><td class="NLM_term">RKIP</td><td class="NLM_def"><p class="first last">Raf kinase inhibitor protein</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAPK</td><td class="NLM_def"><p class="first last">stress activated protein kinase</p></td></tr><tr><td class="NLM_term">SCLC</td><td class="NLM_def"><p class="first last">small-cell lung cancer</p></td></tr><tr><td class="NLM_term">sGC</td><td class="NLM_def"><p class="first last">soluble guanylyl cyclase</p></td></tr><tr><td class="NLM_term">Smac/DIABLO</td><td class="NLM_def"><p class="first last">second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI</p></td></tr><tr><td class="NLM_term">SNP</td><td class="NLM_def"><p class="first last">sodium nitroprusside</p></td></tr><tr><td class="NLM_term">STAT1</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 1</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">tumor necrosis factor related apoptosis-inducing ligand</p></td></tr><tr><td class="NLM_term">TTP</td><td class="NLM_def"><p class="first last">time to progress</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 159 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Palmer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrige, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxing Factor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1038/327524a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2F327524a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=3495737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaL2sXktlCjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=1987&pages=524-526&author=R.+M.+Palmerauthor=A.+G.+Ferrigeauthor=S.+Moncada&title=Nitric+Oxide+Release+Accounts+for+the+Biological+Activity+of+Endothelium-Derived+Relaxing+Factor&doi=10.1038%2F327524a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor</span></div><div class="casAuthors">Palmer, R. M. J.; Ferrige, A. G.; Moncada, S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">6122</span>),
    <span class="NLM_cas:pages">524-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The release of endothelium-derived relaxing factor (EDRF) and NO from porcine aortic endothelial cells in culture was examd.  NO was detd. as the chemiluminescent product of its reaction with ozone.  The biol. activity of EDRF and of NO was measured by bioassay.  The relaxation of the bioassay tissues induced by EDRF was indistinguishable from that induced by NO.  Both substances were equally unstable.  Bradykinin caused concn.-dependent release of NO from the cells in amts. sufficient to account for the biol. activity of EDRF.  The relaxations induced by EDRF and NO were inhibited by Hb and enhanced by superoxide dismutase to a similar degree.  Thus, NO released from endothelial cells is indistinguishable from EDRF in terms of biol. activity, stability, and susceptibility to an inhibitor and to a potentiator.  EDRF and NO are probably identical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv1cVPcdhBb7Vg90H21EOLACvtfcHk0lgzycB0sxUeVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktlCjs70%253D&md5=6afcb0594f86da2a398d0b6b792a2d75</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F327524a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F327524a0%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DR.%2BM.%26aulast%3DFerrige%26aufirst%3DA.%2BG.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DNitric%2520Oxide%2520Release%2520Accounts%2520for%2520the%2520Biological%2520Activity%2520of%2520Endothelium-Derived%2520Relaxing%2520Factor%26jtitle%3DNature%26date%3D1987%26volume%3D327%26spage%3D524%26epage%3D526%26doi%3D10.1038%2F327524a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ignarro, L. J.</span><span> </span><span class="NLM_article-title">Signal Transduction Mechanisms Involving Nitric Oxide</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1016/0006-2952(91)90618-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2F0006-2952%2891%2990618-F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1991&pages=485-490&author=L.+J.+Ignarro&title=Signal+Transduction+Mechanisms+Involving+Nitric+Oxide&doi=10.1016%2F0006-2952%2891%2990618-F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2891%2990618-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252891%252990618-F%26sid%3Dliteratum%253Aachs%26aulast%3DIgnarro%26aufirst%3DL.%2BJ.%26atitle%3DSignal%2520Transduction%2520Mechanisms%2520Involving%2520Nitric%2520Oxide%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1991%26volume%3D41%26spage%3D485%26epage%3D490%26doi%3D10.1016%2F0006-2952%2891%2990618-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ignarro, L. J.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Mediated Vasorelaxation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=7694386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK3sXks1ylurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1993&pages=148-151&author=L.+J.+Ignarro&title=Nitric+Oxide-Mediated+Vasorelaxation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-mediated vasorelaxation</span></div><div class="casAuthors">Ignarro, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">148-51</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    </div><div class="casAbstract">A review, with 45 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZRloAH1S_7Vg90H21EOLACvtfcHk0lgMQrqcd8pkFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1ylurY%253D&md5=10babfe7712ca5e9775d944a7a0ee4b3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIgnarro%26aufirst%3DL.%2BJ.%26atitle%3DNitric%2520Oxide-Mediated%2520Vasorelaxation%26jtitle%3DThromb.%2520Haemostasis%26date%3D1993%26volume%3D70%26spage%3D148%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Thomas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridnour, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isenberg, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores-Santana, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Switzer, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donzelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolocci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colton, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, D. A.</span><span> </span><span class="NLM_article-title">The Chemical Biology of Nitric Oxide: Implications in Cellular Signaling</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2008.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.freeradbiomed.2008.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18439435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2008&pages=18-31&author=D.+D.+Thomasauthor=L.+A.+Ridnourauthor=J.+S.+Isenbergauthor=W.+Flores-Santanaauthor=C.+H.+Switzerauthor=S.+Donzelliauthor=P.+Hussainauthor=C.+Vecoliauthor=N.+Paolocciauthor=S.+Ambsauthor=C.+A.+Coltonauthor=C.+C.+Harrisauthor=D.+D.+Robertsauthor=D.+A.+Wink&title=The+Chemical+Biology+of+Nitric+Oxide%3A+Implications+in+Cellular+Signaling&doi=10.1016%2Fj.freeradbiomed.2008.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical biology of nitric oxide: Implications in cellular signaling</span></div><div class="casAuthors">Thomas, Douglas D.; Ridnour, Lisa A.; Isenberg, Jeffrey S.; Flores-Santana, Wilmarie; Switzer, Christopher H.; Donzelli, Sonia; Hussain, Perwez; Vecoli, Cecilia; Paolocci, Nazareno; Ambs, Stefan; Colton, Carol A.; Harris, Curtis C.; Roberts, David D.; Wink, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-31</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  NO has earned the reputation of being a signaling mediator with many diverse and often opposing biol. activities.  The diversity in response to this simple diat. mol. comes from the enormous variety of chem. reactions and biol. properties assocd. with it.  In the past few years, the importance of steady-state NO concns. has emerged as a key determinant of its biol. function.  Precise cellular responses are differentially regulated by specific NO concn.  The authors propose 5 basic distinct concn. levels of NO activity: cGMP-mediated processes ([NO] < 1-30 nM), Akt phosphorylation ([NO] = 30-100 nM), stabilization of HIF-1α ([NO] = 100-300 nM), phosphorylation of p53 ([NO] > 400 nM), and nitrosative stress (1 μM).  In general, lower NO concns. promote cell survival and proliferation, whereas higher levels favor cell cycle arrest, apoptosis, and senescence.  Free radical interactions will also influence NO signaling.  One of the consequences of reactive O species generation is to reduce NO concns.  This antagonizes the signaling of NO and in some cases results in converting a cell-cycle arrest profile to a cell survival profile.  The resulting reactive N species that are generated from these reactions can also have biol. effects and increase oxidative and nitrosative stress responses.  A no. of factors det. the formation of NO and its concn., such as diffusion, consumption, and substrate availability, which are referred to as kinetic determinants for mol. target interactions.  These are the chem. and biochem. parameters that shape cellular responses to NO.  Here, the authors discuss signal transduction and the biochem. of NO in terms of the direct and indirect reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBy1CNbcvHq7Vg90H21EOLACvtfcHk0lgMQrqcd8pkFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D&md5=927163ba426538f3e1733797f69621f6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2008.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2008.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DIsenberg%26aufirst%3DJ.%2BS.%26aulast%3DFlores-Santana%26aufirst%3DW.%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DDonzelli%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DP.%26aulast%3DVecoli%26aufirst%3DC.%26aulast%3DPaolocci%26aufirst%3DN.%26aulast%3DAmbs%26aufirst%3DS.%26aulast%3DColton%26aufirst%3DC.%2BA.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DRoberts%26aufirst%3DD.%2BD.%26aulast%3DWink%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Chemical%2520Biology%2520of%2520Nitric%2520Oxide%253A%2520Implications%2520in%2520Cellular%2520Signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2008%26volume%3D45%26spage%3D18%26epage%3D31%26doi%3D10.1016%2Fj.freeradbiomed.2008.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Basudhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridnour, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesarwala, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinecke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, D. A.</span><span> </span><span class="NLM_article-title">Biological Signaling by Small Inorganic Molecules</span> <span class="citation_source-journal">Coord. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1016/j.ccr.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.ccr.2015.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26688591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaqs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2016&pages=708-723&author=D.+Basudharauthor=L.+A.+Ridnourauthor=R.+Chengauthor=A.+H.+Kesarwalaauthor=J.+Heineckeauthor=D.+A.+Wink&title=Biological+Signaling+by+Small+Inorganic+Molecules&doi=10.1016%2Fj.ccr.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Biological signaling by small inorganic molecules</span></div><div class="casAuthors">Basudhar, Debashree; Ridnour, Lisa A.; Cheng, Robert; Kesarwala, Aparna H.; Heinecke, Julie; Wink, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">Part_2</span>),
    <span class="NLM_cas:pages">708-723</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small redox active mols. such as reactive nitrogen and oxygen species and hydrogen sulfide have emerged as important biol. mediators that are involved in various physiol. and pathophysiol. processes.  Advancement in understanding of cellular mechanisms that tightly regulate both generation and reactivity of these mols. is central to improved management of various disease states including cancer and cardiovascular dysfunction.  Imbalance in the prodn. of redox active mols. can lead to damage of crit. cellular components such as cell membranes, proteins and DNA and thus may trigger the onset of disease.  These small inorg. mols. react independently as well as in a concerted manner to mediate physiol. responses.  This review provides a general overview of the redox biol. of these key mols., their diverse chem. relevant to physiol. processes and their interrelated nature in cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqlgyvo8_XM7Vg90H21EOLACvtfcHk0lgMHAKgYDFy_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaqs7rP&md5=a2797cbb9b2c833d8205da8bad20383c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBasudhar%26aufirst%3DD.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DKesarwala%26aufirst%3DA.%2BH.%26aulast%3DHeinecke%26aufirst%3DJ.%26aulast%3DWink%26aufirst%3DD.%2BA.%26atitle%3DBiological%2520Signaling%2520by%2520Small%2520Inorganic%2520Molecules%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2016%26volume%3D306%26spage%3D708%26epage%3D723%26doi%3D10.1016%2Fj.ccr.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Geller, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussler, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Silvio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowenstein, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiar, T. R.</span><span> </span><span class="NLM_article-title">Cytokines, Endotoxin, and Glucocorticoids Regulate the Expression of Inducible Nitric Oxide Synthase in Hepatocytes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1073/pnas.90.2.522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1073%2Fpnas.90.2.522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=7678458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK3sXnvFWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=522-526&author=D.+A.+Gellerauthor=A.+K.+Nusslerauthor=M.+Di+Silvioauthor=C.+J.+Lowensteinauthor=R.+A.+Shapiroauthor=S.+C.+Wangauthor=R.+L.+Simmonsauthor=T.+R.+Billiar&title=Cytokines%2C+Endotoxin%2C+and+Glucocorticoids+Regulate+the+Expression+of+Inducible+Nitric+Oxide+Synthase+in+Hepatocytes&doi=10.1073%2Fpnas.90.2.522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes</span></div><div class="casAuthors">Geller, David A.; Nussler, Andreas K.; Silvio, Mauricio Di; Lowenstein, Charles J.; Shapiro, Richard A.; Wang, Stewart C.; Simmons, Richard L.; Billiar, Timothy R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">522-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The authors measured the levels of rat hepatocyte nitric oxide synthase (NOS) mRNA by Northern blot anal. after stimulation by various combinations of endotoxin (lipopolysaccharide) and cytokines in vitro.  The mRNA for hepatocyte NOS appeared as a single band at ≈4.5 kilobases and was maximally up-regulated (≈70-fold) by the combination of tumor necrosis factor (TNF), interleukin-1 (IL-1), interferon-γ (IFN-γ), and lipopolysaccharide (LPS).  Abundance of NOS mRNA peaked 6-8 h after stimulation and then declined by 25% at 24 h.  As single agents, TNF and IL-1 were the most effective inducers of hepatocyte NOS mRNA.  Combinations of 2 or 3 stimuli revealed strong synergy between TNF, IL-1, and IFN-γ.  Dexamethasone and cycloheximide inhibited induction of mRNA for hepatocyte NOS in a dose-dependent fashion.  Induction of mRNA correlated with increased NOS activity.  The inducible hepatocyte NOS mRNA was also detected in rat hepatocytes following chronic hepatic inflammation triggered by Corynebacterium parvum injection in vivo.  Thus, the inducible NOS is functional in rat hepatocytes both in vitro and in vivo and this pathway is under complex control.  Endotoxin and inflammatory cytokines act synergistically to up-regulate gene expression for hepatocyte NOS, whereas glucocorticoids down-regulate the mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAmNgc7G9Wl7Vg90H21EOLACvtfcHk0lgMHAKgYDFy_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXnvFWisQ%253D%253D&md5=c3bd81106e709aa0c00cba7a1f8f0ce3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.2.522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.2.522%26sid%3Dliteratum%253Aachs%26aulast%3DGeller%26aufirst%3DD.%2BA.%26aulast%3DNussler%26aufirst%3DA.%2BK.%26aulast%3DDi%2BSilvio%26aufirst%3DM.%26aulast%3DLowenstein%26aufirst%3DC.%2BJ.%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BC.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26atitle%3DCytokines%252C%2520Endotoxin%252C%2520and%2520Glucocorticoids%2520Regulate%2520the%2520Expression%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520in%2520Hepatocytes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D522%26epage%3D526%26doi%3D10.1073%2Fpnas.90.2.522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pervin, S.; Singh, R.; Sen, S.; Chaudhuri, G.</span><span> </span><span class="NLM_article-title">Dual Role of Nitric Oxide in Cancer Biology</span> In  <span class="citation_source-book">Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy</span>; <span class="NLM_contrib-group">Bonavida, B.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-1-4419-1432-3_3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2F978-1-4419-1432-3_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=39-57&author=S.+Pervin&author=R.+Singh&author=S.+Sen&author=G.+Chaudhuriauthor=B.+Bonavida&title=Nitric+Oxide+%28NO%29+and+Cancer%3A+Prognosis%2C+Prevention%2C+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-1432-3_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-1432-3_3%26sid%3Dliteratum%253Aachs%26aulast%3DPervin%26aufirst%3DS.%26atitle%3DDual%2520Role%2520of%2520Nitric%2520Oxide%2520in%2520Cancer%2520Biology%26btitle%3DNitric%2520Oxide%2520%2528NO%2529%2520and%2520Cancer%253A%2520Prognosis%252C%2520Prevention%252C%2520and%2520Therapy%26aulast%3DBonavida%26aufirst%3DB.%26pub%3DSpringer%26date%3D2010%26spage%3D39%26epage%3D57%26doi%3D10.1007%2F978-1-4419-1432-3_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Knowles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Nitric-Oxide Synthases in Mammals</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1042/bj2980249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1042%2Fbj2980249" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=1994&pages=249-258&author=R.+G.+Knowlesauthor=S.+Moncada&title=Nitric-Oxide+Synthases+in+Mammals&doi=10.1042%2Fbj2980249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2Fbj2980249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2980249%26sid%3Dliteratum%253Aachs%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DNitric-Oxide%2520Synthases%2520in%2520Mammals%26jtitle%3DBiochem.%2520J.%26date%3D1994%26volume%3D298%26spage%3D249%26epage%3D258%26doi%3D10.1042%2Fbj2980249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kiechle, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinski, T.</span><span> </span><span class="NLM_article-title">Nitric Oxide. Biochemistry, Pathophysiology, and Detection</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1093/ajcp/100.5.567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1093%2Fajcp%2F100.5.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=7504395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVWgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1993&pages=567-575&author=F.+L.+Kiechleauthor=T.+Malinski&title=Nitric+Oxide.+Biochemistry%2C+Pathophysiology%2C+and+Detection&doi=10.1093%2Fajcp%2F100.5.567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide: biochemistry, pathophysiology, and detection</span></div><div class="casAuthors">Kiechle, Frederick L.; Malinski, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">567-75</span>CODEN:
                <span class="NLM_cas:coden">AJCPAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">A review, with 92 refs., on nitric oxide synthase, mol. interactions of nitric oxide, pathophysiol., and measurements of nitric oxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaccbeCtVoTLVg90H21EOLACvtfcHk0lhd1Hn3_dig5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVWgtr8%253D&md5=e88dc4bc2e6c68c2eabcf326f3f56a0d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fajcp%2F100.5.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcp%252F100.5.567%26sid%3Dliteratum%253Aachs%26aulast%3DKiechle%26aufirst%3DF.%2BL.%26aulast%3DMalinski%26aufirst%3DT.%26atitle%3DNitric%2520Oxide.%2520Biochemistry%252C%2520Pathophysiology%252C%2520and%2520Detection%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D1993%26volume%3D100%26spage%3D567%26epage%3D575%26doi%3D10.1093%2Fajcp%2F100.5.567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Malinski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopp, M.</span><span> </span><span class="NLM_article-title">Nitric Oxide Measured by a Porphyrinic Microsensor in Rat Brain after Transient Middle Cerebral Artery Occlusion</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1038/jcbfm.1993.48</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fjcbfm.1993.48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=8478395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFakt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=355-358&author=T.+Malinskiauthor=F.+Baileyauthor=Z.+G.+Zhangauthor=M.+Chopp&title=Nitric+Oxide+Measured+by+a+Porphyrinic+Microsensor+in+Rat+Brain+after+Transient+Middle+Cerebral+Artery+Occlusion&doi=10.1038%2Fjcbfm.1993.48"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion</span></div><div class="casAuthors">Malinski, T.; Bailey, F.; Zhang, Z. G.; Chopp, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-8</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">The authors measured, in vivo, the local concn. of nitric oxide (NO) in cerebral tissue, during and after transient middle cerebral artery occlusion in the rat (n = 8).  Baseline concn. of NO was <10-8 M; upon initiation of ischemia, NO concn. increased to ∼10-6 M and then declined.  Reperfusion likewise stimulated an increase in NO concn. to above baseline level.  Administration of N-nitro-L-arginine Me ester (n = 4), an inhibitor of nitric oxide synthase, before onset of ischemia, maintained NO at basal levels.  Data indicate that large increases in NO occur at onset of ischemia, which may affect tissue response to an ischemic insult.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkd5Mpn0yeyrVg90H21EOLACvtfcHk0lhd1Hn3_dig5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFakt7g%253D&md5=f367fb921e1cba0c48334a2dd5d11376</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1993.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1993.48%26sid%3Dliteratum%253Aachs%26aulast%3DMalinski%26aufirst%3DT.%26aulast%3DBailey%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.%2BG.%26aulast%3DChopp%26aufirst%3DM.%26atitle%3DNitric%2520Oxide%2520Measured%2520by%2520a%2520Porphyrinic%2520Microsensor%2520in%2520Rat%2520Brain%2520after%2520Transient%2520Middle%2520Cerebral%2520Artery%2520Occlusion%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1993%26volume%3D13%26spage%3D355%26epage%3D358%26doi%3D10.1038%2Fjcbfm.1993.48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hanafy, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumenacker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murad, F.</span><span> </span><span class="NLM_article-title">NO, Nitrotyrosine, and Cyclic GMP in Signal Transduction</span> <span class="citation_source-journal">Med. Sci. Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11433215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Ojs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=801-819&author=K.+A.+Hanafyauthor=J.+S.+Krumenackerauthor=F.+Murad&title=NO%2C+Nitrotyrosine%2C+and+Cyclic+GMP+in+Signal+Transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">NO, nitrotyrosine, and cyclic GMP in signal transduction</span></div><div class="casAuthors">Hanafy, Khalid A.; Krumenacker, Joshua S.; Murad, Ferid</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">801-819</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1234-1010</span>.
    
            (<span class="NLM_cas:orgname">Medical Science International Publishing</span>)
        </div><div class="casAbstract">A review, with 203 refs.  Over the past 25 yr, the role of NO in biol. has evolved from being recognized as an environmental pollutant to an endogenously produced substance involved in cell communication and signal transduction.  NO is produced by a family of enzymes called nitric oxide synthases (NOSs), which can be stimulated by a variety of factors that mediate responses to various stimuli.  NO can initiate its biol. effects through activation of the heterodimeric enzyme, sol. guanylyl cyclase, (sGC), or through several other chem. reactions.  Activation of sGC results in the prodn. of cGMP, an intracellular second messenger signaling mol., which can subsequently mediate such diverse physiol. events such as vasodilatation and immunomodulation.  Chem. reactive NO can affect physiol. changes through modifications to cellular proteins, 1 of which is tyrosine nitration.  The demonstration that NO is involved in so many biol. pathways indicates the importance of this endogenously produced substance, and suggests that there is much more to be discovered about its role in biol. in years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqolBurvoNi6LVg90H21EOLACvtfcHk0lhd1Hn3_dig5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Ojs78%253D&md5=866c48818cc042f2a03c0a5c9504eb9f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanafy%26aufirst%3DK.%2BA.%26aulast%3DKrumenacker%26aufirst%3DJ.%2BS.%26aulast%3DMurad%26aufirst%3DF.%26atitle%3DNO%252C%2520Nitrotyrosine%252C%2520and%2520Cyclic%2520GMP%2520in%2520Signal%2520Transduction%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2001%26volume%3D7%26spage%3D801%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Beckman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppenol, W. H.</span><span> </span><span class="NLM_article-title">Nitric Oxide, Superoxide, and Peroxynitrite: the Good, the Bad, and Ugly</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">C1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">C1437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1152%2Fajpcell.1996.271.5.C1424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=8944624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK28XntFymtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=C1424-C1437&author=J.+S.+Beckmanauthor=W.+H.+Koppenol&title=Nitric+Oxide%2C+Superoxide%2C+and+Peroxynitrite%3A+the+Good%2C+the+Bad%2C+and+Ugly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly</span></div><div class="casAuthors">Beckman, Joseph S.; Koppenol, Willem H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">C1424-C1437</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 109 refs., exploring why nitric oxide itself is far less reactive and toxic at baiol. relevant concns. than in vitro expts. suggest.  Nitric oxide contrasts with most intercellular messengers because it diffuses rapidly and isotropically through most tissues with little reaction but cannot be transported through the vasculature due to rapid destruction by oxyHb.  The rapid diffusion of nitric oxide between cells allows it to locally integrate the responses of blood vessels to turbulence, modulate synaptic plasticity in neurons, and control the oscillatory behavior of neuronal networks.  Nitric oxide is not necessarily short lived and is intrinsically no more reactive than oxygen.  The reactivity of nitric oxide per se has been greatly overestimated in vitro, because no drain is provided to remove nitric oxide.  Nitric oxide persists in soln. for several minutes in micromolar concns. before it reacts with oxygen to form much stronger oxidants like nitrogen dioxide.  Nitric oxide is removed within seconds in vivo by diffusion over 100 μm through tissues to enter red blood cells and react with oxyHb.  The direct toxicity of nitric oxide is modest but is greatly enhanced by reacting with superoxide to form peroxynitrite (ONOO-).  Nitric oxide is the only biol. mol. produced in high enough concns. to out-compete superoxide dismutase for superoxide.  Peroxynitrite reacts relatively slowly with most biol. mols., making peroxynitrite a selective oxidant.  Peroxynitrite modifies tyrosine in proteins to create nitrotyrosines, leaving a footprint detectable in vivo.  Nitration of structural proteins, including neurofilaments and actin, can disrupt filament assembly with major pathol. consequences.  Antibodies to nitrotyrosine have revealed nitration in human atherosclerosis, myocardial ischemia, septic and distressed lung, inflammatory bowel disease, and amyotrophic lateral sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtUe3HiUtAkbVg90H21EOLACvtfcHk0ljsEJizvwXnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFymtrc%253D&md5=67f1fee41f7c4c905911b0300fa24e80</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.1996.271.5.C1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.1996.271.5.C1424%26sid%3Dliteratum%253Aachs%26aulast%3DBeckman%26aufirst%3DJ.%2BS.%26aulast%3DKoppenol%26aufirst%3DW.%2BH.%26atitle%3DNitric%2520Oxide%252C%2520Superoxide%252C%2520and%2520Peroxynitrite%253A%2520the%2520Good%252C%2520the%2520Bad%252C%2520and%2520Ugly%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1996%26volume%3D271%26spage%3DC1424%26epage%3DC1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Martinez-Ruiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, S.</span><span> </span><span class="NLM_article-title">S-Nitrosylation: A Potential New Paradigm in Signal Transduction</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.cardiores.2004.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.cardiores.2004.01.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=43-52&author=A.+Martinez-Ruizauthor=S.+Lamas&title=S-Nitrosylation%3A+A+Potential+New+Paradigm+in+Signal+Transduction&doi=10.1016%2Fj.cardiores.2004.01.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2004.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2004.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Ruiz%26aufirst%3DA.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DS-Nitrosylation%253A%2520A%2520Potential%2520New%2520Paradigm%2520in%2520Signal%2520Transduction%26jtitle%3DCardiovasc.%2520Res.%26date%3D2004%26volume%3D62%26spage%3D43%26epage%3D52%26doi%3D10.1016%2Fj.cardiores.2004.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Heinrich, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Silva, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Switzer, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuto, J. M.</span><span> </span><span class="NLM_article-title">Biological Nitric Oxide Signalling: Chemistry and Terminology</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span><span class="refDoi"> DOI: 10.1111/bph.12217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fbph.12217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23617570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=1417-1429&author=T.+A.+Heinrichauthor=R.+S.+da+Silvaauthor=K.+M.+Mirandaauthor=C.+H.+Switzerauthor=D.+A.+Winkauthor=J.+M.+Fukuto&title=Biological+Nitric+Oxide+Signalling%3A+Chemistry+and+Terminology&doi=10.1111%2Fbph.12217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biological nitric oxide signalling: chemistry and terminology</span></div><div class="casAuthors">Heinrich, Tassiele A.; da Silva, Roberto S.; Miranda, Katrina M.; Switzer, Christopher H.; Wink, David A.; Fukuto, Jon M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-1429</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Biol. nitrogen oxide signalling and stress is an area of extreme clin., pharmacol., toxicol., biochem. and chem. research interest.  The utility of nitric oxide and derived species as signalling agents is due to their novel and vast chem. interactions with a variety of biol. targets.  Herein, the chem. assocd. with the interaction of the biol. relevant nitrogen oxide species with fundamental biochem. targets is discussed.  Specifically, the chem. interactions of nitrogen oxides with nucleophiles (e.g. thiols), metals (e.g. hemeproteins) and paramagnetic species (e.g. dioxygen and superoxide) are addressed.  Importantly, the terms assocd. with the mechanisms by which NO (and derived species) react with their resp. biol. targets have been defined by numerous past chem. studies.  Thus, in order to assist researchers in referring to chem. processes assocd. with nitrogen oxide biol., the vernacular assocd. with these chem. interactions is addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHPDeOsvoA6LVg90H21EOLACvtfcHk0ljsEJizvwXnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsrfE&md5=2c32c0bf3320ded8e2e2f167badc7d28</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fbph.12217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12217%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%2BA.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BS.%26aulast%3DMiranda%26aufirst%3DK.%2BM.%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DFukuto%26aufirst%3DJ.%2BM.%26atitle%3DBiological%2520Nitric%2520Oxide%2520Signalling%253A%2520Chemistry%2520and%2520Terminology%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D1417%26epage%3D1429%26doi%3D10.1111%2Fbph.12217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khineche, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta-Yepez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garban, H.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Nitric Oxide in Cancer</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.drup.2006.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.drup.2006.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16822706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslOguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=157-173&author=B.+Bonavidaauthor=S.+Khinecheauthor=S.+Huerta-Yepezauthor=H.+Garban&title=Therapeutic+Potential+of+Nitric+Oxide+in+Cancer&doi=10.1016%2Fj.drup.2006.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of nitric oxide in cancer</span></div><div class="casAuthors">Bonavida, Benjamin; Khineche, Soraya; Huerta-Yepez, Sara; Garban, Hermes</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-173</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, several novel approaches have been developed to overcome tumor cell resistance to conventional therapeutics.  Such approaches include genetic manipulations, vaccine development and exploitation of the anti-tumor host immune response.  The overall development of tumor cell resistance to therapeutics is, in large part, the result of the ability of tumor cells to develop specific mechanisms to overcome cell death or apoptosis.  Therefore, the possibility to interfere selectively in the regulation of the apoptotic signaling pathways may result in either the direct induction of cell death and/or sensitization of the cells to cytotoxic stimuli.  A novel approach based on modifying gene products that regulate resistance to apoptosis involves nitric oxide (NO).  NO is a ubiquitous mol. with diverse cellular effects that depend on the source, concn., latency, cell type and phenotype.  This review describes the role played by NO in cancer including carcinogenesis, pathogenesis, angiogenesis, chemoprevention and as a novel therapeutic to overcome resistance when used alone or as a sensitizing agent used in combination with other therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6H3vMI8M27Vg90H21EOLACvtfcHk0lhtKD4C7bOucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslOguro%253D&md5=e2cfbf3f70666bcad40502e8beb200c7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2006.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2006.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DKhineche%26aufirst%3DS.%26aulast%3DHuerta-Yepez%26aufirst%3DS.%26aulast%3DGarban%26aufirst%3DH.%26atitle%3DTherapeutic%2520Potential%2520of%2520Nitric%2520Oxide%2520in%2520Cancer%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2006%26volume%3D9%26spage%3D157%26epage%3D173%26doi%3D10.1016%2Fj.drup.2006.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bonavida, B.; Baritaki, S.; Huerta-Yepez, S.; Vega, M. I.; Jazirehi, A. R.; Berenson, J.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors Are a New Class of Anti-Cancer Therapeutics for the Reversal of Resistance and Inhibition of Metastasis</span> In  <span class="citation_source-book">Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy</span>; <span class="NLM_contrib-group">Bonavida, B.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-1-4419-1432-3_24</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2F978-1-4419-1432-3_24" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=459-477&author=B.+Bonavida&author=S.+Baritaki&author=S.+Huerta-Yepez&author=M.+I.+Vega&author=A.+R.+Jazirehi&author=J.+Berensonauthor=B.+Bonavida&title=Nitric+Oxide+%28NO%29+and+Cancer%3A+Prognosis%2C+Prevention%2C+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-1432-3_24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-1432-3_24%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520Oxide%2520Donors%2520Are%2520a%2520New%2520Class%2520of%2520Anti-Cancer%2520Therapeutics%2520for%2520the%2520Reversal%2520of%2520Resistance%2520and%2520Inhibition%2520of%2520Metastasis%26btitle%3DNitric%2520Oxide%2520%2528NO%2529%2520and%2520Cancer%253A%2520Prognosis%252C%2520Prevention%252C%2520and%2520Therapy%26aulast%3DBonavida%26aufirst%3DB.%26pub%3DSpringer%26date%3D2010%26spage%3D459%26epage%3D477%26doi%3D10.1007%2F978-1-4419-1432-3_24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Alexandrova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvetkova, E.</span><span> </span><span class="NLM_article-title">Nitric Oxide and Cancer (Minirevew)</span> <span class="citation_source-journal">Exp. Pathol. Parasitol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=13-18&author=R.+Alexandrovaauthor=M.+Milevaauthor=E.+Zvetkova&title=Nitric+Oxide+and+Cancer+%28Minirevew%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and cancer</span></div><div class="casAuthors">Alexandrova, R.; Mileva, M.; Zvetkova, E.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Pathology and Parasitology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">13-18</span>CODEN:
                <span class="NLM_cas:coden">EPPXAN</span>;
        ISSN:<span class="NLM_cas:issn">1311-6851</span>.
    
            (<span class="NLM_cas:orgname">Akademichno Izdatelstvo "Prof. Marin Drinov"</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO), a potent biol. mediator, plays a key role in physiol. as well as pathol. processes.  An area of great interest is the role of nitric oxide in the growth and metastasis of solid tumors, where it seems to have a complex action including both inhibitory and tumor-promoting activities.  Modification of nitric oxide synthetase (NOS) activity in tumors, and hence NO biosynthesis, may be regarded as a promising means for selective tumor blood flow modification providing a novel approach for reducing tumor oxygenation aimed at enhancing the efficiency of hypoxia-mediated, bioreductively activated anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCe38FC4OrtLVg90H21EOLACvtfcHk0lhtKD4C7bOucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVSgu78%253D&md5=9cad6d2a9f779e31096d40ad876bdb35</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandrova%26aufirst%3DR.%26aulast%3DMileva%26aufirst%3DM.%26aulast%3DZvetkova%26aufirst%3DE.%26atitle%3DNitric%2520Oxide%2520and%2520Cancer%2520%2528Minirevew%2529%26jtitle%3DExp.%2520Pathol.%2520Parasitol%26date%3D2001%26volume%3D4%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fukumura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">The Role of Nitric Oxide in Tumour Progression</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1038/nrc1910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fnrc1910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16794635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=521-534&author=D.+Fukumuraauthor=S.+Kashiwagiauthor=R.+K.+Jain&title=The+Role+of+Nitric+Oxide+in+Tumour+Progression&doi=10.1038%2Fnrc1910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nitric oxide in tumour progression</span></div><div class="casAuthors">Fukumura, Dai; Kashiwagi, Satoshi; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">521-534</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) and nitric oxide synthases are ubiquitous in malignant tumors and are known to exert both pro- and anti-tumor effects.  We summarize our current understanding of the role of NO in tumor progression, esp. in relation to angiogenesis and vascular functions.  We also discuss potential strategies for cancer treatment that modulate NO prodn. and/or its downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorTlzSMm-9dbVg90H21EOLACvtfcHk0lhtKD4C7bOucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D&md5=ee546d1b8e37e216ef373374ba15209c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrc1910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1910%26sid%3Dliteratum%253Aachs%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DKashiwagi%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DThe%2520Role%2520of%2520Nitric%2520Oxide%2520in%2520Tumour%2520Progression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D521%26epage%3D534%26doi%3D10.1038%2Fnrc1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wink, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodovotz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deluca, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">The Role of Nitric Oxide Chemistry in Cancer Treatment</span> <span class="citation_source-journal">Biochemistry (Moscow)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=9721332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Cnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=802-809&author=D.+A.+Winkauthor=Y.+Vodovotzauthor=J.+A.+Cookauthor=M.+C.+Krishnaauthor=S.+Kimauthor=D.+Coffinauthor=W.+DeGraffauthor=A.+M.+Delucaauthor=J.+Liebmannauthor=J.+B.+Mitchell&title=The+Role+of+Nitric+Oxide+Chemistry+in+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nitric oxide chemistry in cancer treatment</span></div><div class="casAuthors">Wink, D. A.; Vodovotz, Y.; Cook, J. A.; Krishna, M. C.; Kim, S.; Coffin, D.; DeGraff, W.; Deluca, A. M.; Liebmann, J.; Mitchell, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry (Moscow)(Translation of Biokhimiya (Moscow))</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">802-809</span>CODEN:
                <span class="NLM_cas:coden">BIORAK</span>;
        ISSN:<span class="NLM_cas:issn">0006-2979</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">Over the last decade the role of nitric oxide (NO) in various disease states has become apparent.  In cancer, NO plays a variety of roles which are at times contradictory.  On one hand, NO is involved in different etiol. mechanisms as well as promoting tumor growth.  Yet, NO derived from leukocytes plays a seminal role in their tumoricidal activity.  In cancer treatment, NO also has diverse effects.  Whereas in vitro, NO can enhance the cytotoxic efficacy of some chemotherapeutic agents as well as radiation, NO donors can provide whole body protection against these same agents.  This manuscript will discuss some mechanisms involved with NO and cancer treatment modalities and the potential application of these findings to cancer therapy.  This article is reviewed by 65 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18igQCe3OrrVg90H21EOLACvtfcHk0lhSSawp9zU0WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Cnurs%253D&md5=8d039eea3d6f02b23e82e1177c645c16</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DVodovotz%26aufirst%3DY.%26aulast%3DCook%26aufirst%3DJ.%2BA.%26aulast%3DKrishna%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DCoffin%26aufirst%3DD.%26aulast%3DDeGraff%26aufirst%3DW.%26aulast%3DDeluca%26aufirst%3DA.%2BM.%26aulast%3DLiebmann%26aufirst%3DJ.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520Role%2520of%2520Nitric%2520Oxide%2520Chemistry%2520in%2520Cancer%2520Treatment%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26date%3D1998%26volume%3D63%26spage%3D802%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Forrester, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupold, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapust, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillare, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felley-Bosco, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geller, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiar, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Induced p53 Accumulation and Regulation of Inducible Nitric Oxide Synthase Expression by Wild-Type p53</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">2442</span><span class="NLM_x">–</span> <span class="NLM_lpage">2447</span><span class="refDoi"> DOI: 10.1073/pnas.93.6.2442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1073%2Fpnas.93.6.2442" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=2442-2447&author=K.+Forresterauthor=S.+Ambsauthor=S.+E.+Lupoldauthor=R.+B.+Kapustauthor=E.+A.+Spillareauthor=W.+C.+Weinbergauthor=E.+Felley-Boscoauthor=X.+W.+Wangauthor=D.+A.+Gellerauthor=E.+Tzengauthor=T.+R.+Billiarauthor=C.+C.+Harris&title=Nitric+Oxide-Induced+p53+Accumulation+and+Regulation+of+Inducible+Nitric+Oxide+Synthase+Expression+by+Wild-Type+p53&doi=10.1073%2Fpnas.93.6.2442"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.6.2442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.6.2442%26sid%3Dliteratum%253Aachs%26aulast%3DForrester%26aufirst%3DK.%26aulast%3DAmbs%26aufirst%3DS.%26aulast%3DLupold%26aufirst%3DS.%2BE.%26aulast%3DKapust%26aufirst%3DR.%2BB.%26aulast%3DSpillare%26aufirst%3DE.%2BA.%26aulast%3DWeinberg%26aufirst%3DW.%2BC.%26aulast%3DFelley-Bosco%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DX.%2BW.%26aulast%3DGeller%26aufirst%3DD.%2BA.%26aulast%3DTzeng%26aufirst%3DE.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26atitle%3DNitric%2520Oxide-Induced%2520p53%2520Accumulation%2520and%2520Regulation%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Expression%2520by%2520Wild-Type%2520p53%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D2442%26epage%3D2447%26doi%3D10.1073%2Fpnas.93.6.2442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Glockzin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Knethen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, B.</span><span> </span><span class="NLM_article-title">Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">19581</span><span class="NLM_x">–</span> <span class="NLM_lpage">19586</span><span class="refDoi"> DOI: 10.1074/jbc.274.28.19581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1074%2Fjbc.274.28.19581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10391892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1MXksFKmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=19581-19586&author=S.+Glockzinauthor=A.+von+Knethenauthor=M.+Scheffnerauthor=B.+Brune&title=Activation+of+the+Cell+Death+Program+by+Nitric+Oxide+Involves+Inhibition+of+the+Proteasome&doi=10.1074%2Fjbc.274.28.19581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the cell death program by nitric oxide involves inhibition of the proteasome</span></div><div class="casAuthors">Glockzin, Sandra; Von Knethen, Andreas; Scheffner, Martin; Brune, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">19581-19586</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The ubiquitin/proteasome pathway mediates the degrdn. of many short-lived proteins that are critically involved in the regulation of cell proliferation and cell death, including the tumor suppressor protein p53.  Accumulation of p53 and induction of apoptosis in RAW 264.7 macrophages in response to nitric oxide are well established.  However, the mol. mechanisms involved in nitric oxide-induced p53 accumulation are unknown.  Here we show that, similar to nitric oxide, treatment of macrophages with specific proteasome inhibitors, including clastolactacystin-β-lactone, induces p53 accumulation and apoptosis, suggesting that nitric oxide may affect the activity of the proteasome.  In support of this hypothesis, both exposure of cells to S-nitrosoglutathione and stimulation of endogenous nitric oxide prodn. by lipopolysaccharide/interferon-γ treatment result in inhibition of proteasome activity as measured in vitro by the degrdn. of the proteasome-specific substrate succinyl-Leu-Leu-Val-Tyr-4-methyl-coumarin-7-amide.  Moreover, chem. diverse nitric oxide donors interfere with proteasome-mediated degrdn. of polyubiquitinated p53 in vitro.  These data imply that nitric oxide-induced apoptosis and accumulation of p53 are, at least in part, mediated by inhibition of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj-iyl6E0VEbVg90H21EOLACvtfcHk0lhSSawp9zU0WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFKmtr0%253D&md5=ff981f62f6768ac01f4f9aed9fa56184</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.28.19581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.28.19581%26sid%3Dliteratum%253Aachs%26aulast%3DGlockzin%26aufirst%3DS.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26aulast%3DScheffner%26aufirst%3DM.%26aulast%3DBrune%26aufirst%3DB.%26atitle%3DActivation%2520of%2520the%2520Cell%2520Death%2520Program%2520by%2520Nitric%2520Oxide%2520Involves%2520Inhibition%2520of%2520the%2520Proteasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D19581%26epage%3D19586%26doi%3D10.1074%2Fjbc.274.28.19581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Boyd, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadenas, E.</span><span> </span><span class="NLM_article-title">Nitric Oxide and Cell Signaling Pathways in Mitochondrial-Dependent Apoptosis</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1515/BC.2002.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1515%2FBC.2002.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2002&pages=411-423&author=C.+S.+Boydauthor=E.+Cadenas&title=Nitric+Oxide+and+Cell+Signaling+Pathways+in+Mitochondrial-Dependent+Apoptosis&doi=10.1515%2FBC.2002.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1515%2FBC.2002.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2002.045%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DC.%2BS.%26aulast%3DCadenas%26aufirst%3DE.%26atitle%3DNitric%2520Oxide%2520and%2520Cell%2520Signaling%2520Pathways%2520in%2520Mitochondrial-Dependent%2520Apoptosis%26jtitle%3DBiol.%2520Chem.%26date%3D2002%26volume%3D383%26spage%3D411%26epage%3D423%26doi%3D10.1515%2FBC.2002.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Li, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanigan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofseth, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wogan, G. N.</span><span> </span><span class="NLM_article-title">Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-Type or Mutant p53</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3022</span><span class="NLM_x">–</span> <span class="NLM_lpage">3029</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-1880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F0008-5472.CAN-03-1880" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3022-3029&author=C.+Q.+Liauthor=A.+I.+Roblesauthor=C.+L.+Haniganauthor=L.+J.+Hofsethauthor=L.+J.+Trudelauthor=C.+C.+Harrisauthor=G.+N.+Wogan&title=Apoptotic+Signaling+Pathways+Induced+by+Nitric+Oxide+in+Human+Lymphoblastoid+Cells+Expressing+Wild-Type+or+Mutant+p53&doi=10.1158%2F0008-5472.CAN-03-1880"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-1880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-1880%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BQ.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DHanigan%26aufirst%3DC.%2BL.%26aulast%3DHofseth%26aufirst%3DL.%2BJ.%26aulast%3DTrudel%26aufirst%3DL.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DWogan%26aufirst%3DG.%2BN.%26atitle%3DApoptotic%2520Signaling%2520Pathways%2520Induced%2520by%2520Nitric%2520Oxide%2520in%2520Human%2520Lymphoblastoid%2520Cells%2520Expressing%2520Wild-Type%2520or%2520Mutant%2520p53%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3022%26epage%3D3029%26doi%3D10.1158%2F0008-5472.CAN-03-1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lala, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, C.</span><span> </span><span class="NLM_article-title">Role of Nitric Oxide in Carcinogenesis and Tumour Progression</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1016/S1470-2045(00)00256-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS1470-2045%2800%2900256-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11902565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVymtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=149-156&author=P.+K.+Lalaauthor=C.+Chakraborty&title=Role+of+Nitric+Oxide+in+Carcinogenesis+and+Tumour+Progression&doi=10.1016%2FS1470-2045%2800%2900256-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Role of nitric oxide in carcinogenesis and tumour progression</span></div><div class="casAuthors">Lala, Peeyush K.; Chakraborty, Chandan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-156</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is a short-lived mol. required for many physiol. functions, produced from L-arginine by NO synthases (NOS).  It is a free radical, producing many reactive intermediates that account for its bioactivity.  Sustained induction of the inducible form of NOS (iNOS) in chronic inflammation may be mutagenic, through NO-mediated DNA damage or hindrance to DNA repair, and thus potentially carcinogenic.  Expression of iNOS is pos. assocd. with P53 mutation in tumors of the colon, lung, and oropharynx.  Progression of a large majority of human and exptl. tumors seems to be stimulated by NO resulting from activation of iNOS or constitutive NOS, whereas inhibition is documented in others.  This discrepancy is largely explained by differential sensitivity of tumor cells to NO-mediated cytostasis or apoptosis and clonal evolution of NO-resistant and NO-dependent cells.  P53 mutation or loss is one of many events linked with NO resistance and dependence.  NO can stimulate tumor growth and metastasis by promoting migratory, invasive, and angiogenic abilities of tumor cells, which may also be triggered by activation of cyclo-oxygenase (COX)-2.  Thus, selective inhibitors of NOS, COX, or both may have a therapeutic role in certain cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmbXiC9xpCQrVg90H21EOLACvtfcHk0ljqPiwmhvWn5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVymtbc%253D&md5=41e1634ebe3047abb0c28e6e611351c7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2800%2900256-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252800%252900256-4%26sid%3Dliteratum%253Aachs%26aulast%3DLala%26aufirst%3DP.%2BK.%26aulast%3DChakraborty%26aufirst%3DC.%26atitle%3DRole%2520of%2520Nitric%2520Oxide%2520in%2520Carcinogenesis%2520and%2520Tumour%2520Progression%26jtitle%3DLancet%2520Oncol.%26date%3D2001%26volume%3D2%26spage%3D149%26epage%3D156%26doi%3D10.1016%2FS1470-2045%2800%2900256-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Schaer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschhorn-Cymerman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span> </span><span class="NLM_article-title">Targeting Tumor-Necrosis Factor Receptor Pathways for Tumor Immunotherapy</span> <span class="citation_source-journal">J. Immunother Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="refDoi"> DOI: 10.1186/2051-1426-2-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1186%2F2051-1426-2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24855562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvFagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=7&author=D.+A.+Schaerauthor=D.+Hirschhorn-Cymermanauthor=J.+D.+Wolchok&title=Targeting+Tumor-Necrosis+Factor+Receptor+Pathways+for+Tumor+Immunotherapy&doi=10.1186%2F2051-1426-2-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy</span></div><div class="casAuthors">Schaer David A; Hirschhorn-Cymerman Daniel; Wolchok Jedd D; Schaer David A; Wolchok Jedd D; Wolchok Jedd D; Wolchok Jedd D</div><div class="citationInfo"><span class="NLM_cas:title">Journal for immunotherapy of cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>
        ISSN:<span class="NLM_cas:issn">2051-1426</span>.
    </div><div class="casAbstract">With the success of ipilimumab and promise of programmed death-1 pathway-targeted agents, the field of tumor immunotherapy is expanding rapidly.  Newer targets for clinical development include select members of the tumor necrosis factor receptor (TNFR) family.  Agonist antibodies to these co-stimulatory molecules target both T and B cells, modulating T-cell activation and enhancing immune responses.  In vitro and in vivo preclinical data have provided the basis for continued development of 4-1BB, OX40, glucocorticoid-induced TNFR-related gene, herpes virus entry mediator, and CD27 as potential therapies for patients with cancer.  In this review, we summarize the immune response to tumors, consider preclinical and early clinical data on select TNFR family members, discuss potential translational challenges and suggest possible combination therapies with the aim of inducing durable antitumor responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9mMH7P4hI_5Pq5LRczm8ffW6udTcc2ebKkiD2udZsRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvFagtw%253D%253D&md5=62ae96d839cef7f86d060c844bd37975</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2F2051-1426-2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2051-1426-2-7%26sid%3Dliteratum%253Aachs%26aulast%3DSchaer%26aufirst%3DD.%2BA.%26aulast%3DHirschhorn-Cymerman%26aufirst%3DD.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26atitle%3DTargeting%2520Tumor-Necrosis%2520Factor%2520Receptor%2520Pathways%2520for%2520Tumor%2520Immunotherapy%26jtitle%3DJ.%2520Immunother%2520Cancer%26date%3D2014%26volume%3D2%26spage%3D7%26doi%3D10.1186%2F2051-1426-2-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pipili-Synetos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papageorgiou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakkoula, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karakiulakis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maragoudakis, M. E.</span><span> </span><span class="NLM_article-title">Inhibition of Angiogenesis, Tumour Growth and Metastasis by the NO-Releasing Vasodilators, Isosorbide Mononitrate and Dinitrate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb16670.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fj.1476-5381.1995.tb16670.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=8528567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK2MXosVaisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1995&pages=1829-1834&author=E.+Pipili-Synetosauthor=A.+Papageorgiouauthor=E.+Sakkoulaauthor=G.+Sotiropoulouauthor=T.+Fotsisauthor=G.+Karakiulakisauthor=M.+E.+Maragoudakis&title=Inhibition+of+Angiogenesis%2C+Tumour+Growth+and+Metastasis+by+the+NO-Releasing+Vasodilators%2C+Isosorbide+Mononitrate+and+Dinitrate&doi=10.1111%2Fj.1476-5381.1995.tb16670.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate</span></div><div class="casAuthors">Pipili-Synetos, Eva; Papageorgiou, A.; Sakkoula, Eleni; Sotiropoulou, Georgia; Fotsis, T.; Karakiulakis, G.; Maragoudakis, M. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1829-34</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The effect of the nitric oxide (NO)-producing nitro vasodilators isosorbide mononitrate (ISMN) and isosorbide dinitrate (ISDN) were assessed on (a) the in vivo model of angiogenesis of the chick chorioallantoic membrane (CAM) and (b) on the growth and metastatic properties of the Lewis Lung carcinoma (LLC) in mice.  Isosorbide 5-mononitrate (ISMN) and isosorbide dinitrate (ISDN) inhibited angiogenesis in the CAM dose-dependently.  ISMN was more potent in inhibiting this process.  Both compds. were capable of completely reversing the angiogenic effect of α-thrombin.  These effects of ISMN and ISDN on angiogenesis were comparable to those previously obsd. with sodium nitroprusside which generates NO nonenzymically.  Mice, implanted i.m. with LLC, received daily i.p. injections of ISMN for 14 days resulting in a significant decrease in the size of the primary tumor and a redn. in the no. and size of metastatic foci in the lungs.  ISDN had a similar but less pronounced effect than that obsd. with ISMN.  Addn. of ISMN or ISDN to cultures of bovine, rabbit and human endothelial cells and to cultures of LLC cells had no effect on their growth characteristics.  These results indicate that ISMN and ISDN inhibit angiogenesis and tumor growth and metastasis in an animal tumor model.  The possibility should therefore be considered that these nitro vasodilators which are widely used therapeutically and have well characterized pharmacol. profiles, may also possess antitumor properties in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjXi6RhNYZGrVg90H21EOLACvtfcHk0lhkC5CnL6tsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosVaisbw%253D&md5=13c270f896c0fe31d8a536eaeccb3dac</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb16670.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb16670.x%26sid%3Dliteratum%253Aachs%26aulast%3DPipili-Synetos%26aufirst%3DE.%26aulast%3DPapageorgiou%26aufirst%3DA.%26aulast%3DSakkoula%26aufirst%3DE.%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DFotsis%26aufirst%3DT.%26aulast%3DKarakiulakis%26aufirst%3DG.%26aulast%3DMaragoudakis%26aufirst%3DM.%2BE.%26atitle%3DInhibition%2520of%2520Angiogenesis%252C%2520Tumour%2520Growth%2520and%2520Metastasis%2520by%2520the%2520NO-Releasing%2520Vasodilators%252C%2520Isosorbide%2520Mononitrate%2520and%2520Dinitrate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D116%26spage%3D1829%26epage%3D1834%26doi%3D10.1111%2Fj.1476-5381.1995.tb16670.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kroncke, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehsel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb-Bachofen, V.</span><span> </span><span class="NLM_article-title">Nitric Oxide: Cytotoxicity versus Cytoprotection--How, Why, When, and Where?</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1006/niox.1997.0118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1006%2Fniox.1997.0118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1997&pages=107-120&author=K.+D.+Kronckeauthor=K.+Fehselauthor=V.+Kolb-Bachofen&title=Nitric+Oxide%3A+Cytotoxicity+versus+Cytoprotection%2D%2DHow%2C+Why%2C+When%2C+and+Where%3F&doi=10.1006%2Fniox.1997.0118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1006%2Fniox.1997.0118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fniox.1997.0118%26sid%3Dliteratum%253Aachs%26aulast%3DKroncke%26aufirst%3DK.%2BD.%26aulast%3DFehsel%26aufirst%3DK.%26aulast%3DKolb-Bachofen%26aufirst%3DV.%26atitle%3DNitric%2520Oxide%253A%2520Cytotoxicity%2520versus%2520Cytoprotection--How%252C%2520Why%252C%2520When%252C%2520and%2520Where%253F%26jtitle%3DNitric%2520Oxide%26date%3D1997%26volume%3D1%26spage%3D107%26epage%3D120%26doi%3D10.1006%2Fniox.1997.0118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baritaki, S.</span><span> </span><span class="NLM_article-title">Dual Role of NO Donors in the Reversal of Tumor Cell Resistance and EMT: Downregulation of the NF-kappaB/Snail/YY1/RKIP Circuitry</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/j.niox.2010.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2010.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1-7&author=B.+Bonavidaauthor=S.+Baritaki&title=Dual+Role+of+NO+Donors+in+the+Reversal+of+Tumor+Cell+Resistance+and+EMT%3A+Downregulation+of+the+NF-kappaB%2FSnail%2FYY1%2FRKIP+Circuitry&doi=10.1016%2Fj.niox.2010.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2010.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2010.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DBaritaki%26aufirst%3DS.%26atitle%3DDual%2520Role%2520of%2520NO%2520Donors%2520in%2520the%2520Reversal%2520of%2520Tumor%2520Cell%2520Resistance%2520and%2520EMT%253A%2520Downregulation%2520of%2520the%2520NF-kappaB%252FSnail%252FYY1%252FRKIP%2520Circuitry%26jtitle%3DNitric%2520Oxide%26date%3D2011%26volume%3D24%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.niox.2010.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Huerta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors: Novel Cancer Therapeutics (Review)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span><span class="refDoi"> DOI: 10.3892/ijo_00000079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3892%2Fijo_00000079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18949354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaiu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=909-927&author=S.+Huertaauthor=S.+Chilkaauthor=B.+Bonavida&title=Nitric+Oxide+Donors%3A+Novel+Cancer+Therapeutics+%28Review%29&doi=10.3892%2Fijo_00000079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide donors: novel cancer therapeutics (review)</span></div><div class="casAuthors">Huerta, Sergio; Chilka, Sapna; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">909-927</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A review.  The development of cancer cell resistance to various cytotoxic stimuli continues to be a major challenge in oncol. and novel therapeutic approaches are urgently needed.  Nitric oxide (NO) is emerging as a potential anti-oncogenic agent to overcome tumor cell resistance to conventional therapeutic agents.  NO is a ubiquitous, water-sol., free radical gas that exerts a wide range of biol. effects.  The actions of nitric oxide are highly variable in oncol. with reports in the literature on both sides of the spectrum as an anti-neoplastic vs. a pro-neoplastic agent.  The final activity of NO in oncol. is dependent on its working microenvironment, including the type of cell exposed to the compd., the redox state of the reaction, as well as the final intracellular concn. and the duration of intracellular exposure to nitric oxide.  There is, however, no unifying mechanistic explanation for the biphasic role of nitric oxide in oncol.  Nitric oxide donors mimic continuous prodn. of NO in a wide range of time intervals (seconds to days).  Thus, multiple biol. and (pro- vs. anti-) neoplastic responses are elicited from NO donors depending on the half-life and the type of cell exposed to the compd.  The large variety of nitric oxide donors may serve as a tool to explore the wide range of oncol. properties of NO in cancer.  In the present report, we discuss classic nitric oxide donors and their potential therapeutic roles as cytotoxic agents or chemo-radio or -immune-sensitizing compds. in the treatment of drug-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMqnUJYvYinbVg90H21EOLACvtfcHk0lhkC5CnL6tsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaiu77F&md5=86082801f5789427802fed253ef0926b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3892%2Fijo_00000079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo_00000079%26sid%3Dliteratum%253Aachs%26aulast%3DHuerta%26aufirst%3DS.%26aulast%3DChilka%26aufirst%3DS.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520Oxide%2520Donors%253A%2520Novel%2520Cancer%2520Therapeutics%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2008%26volume%3D33%26spage%3D909%26epage%3D927%26doi%3D10.3892%2Fijo_00000079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span> </span><span class="NLM_article-title">The Implications of Hyponitroxia in Cancer</span> <span class="citation_source-journal">Transl. Oncol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.tranon.2014.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.tranon.2014.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24731473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2cnjsVanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=167-173&author=B.+Oronskyauthor=G.+R.+Fangerauthor=N.+Oronskyauthor=S.+Knoxauthor=J.+Scicinski&title=The+Implications+of+Hyponitroxia+in+Cancer&doi=10.1016%2Fj.tranon.2014.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The implications of hyponitroxia in cancer</span></div><div class="casAuthors">Oronsky Bryan; Fanger Gary R; Oronsky Neil; Knox Susan; Scicinski Jan</div><div class="citationInfo"><span class="NLM_cas:title">Translational oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumors are spatially heterogeneous, with regions of relative hypoxia and normoxia.  The tumor microenvironment is an important determinant of both tumor growth and response to a variety of cytotoxic and targeted therapies.  In the tumor microenvironment, reactive oxygen species and nitric oxide (NO) are important mediators of the level of expression of many transcription factors and signaling cascades that affect tumor growth and responses to therapy.  The primary objective of this review is to explore and discuss the seemingly dichotomous actions of NO in cancer biology as both a tumor promoter and suppressor with an emphasis on understanding the role of persistently low NO concentrations or hyponitroxia as a key mediator in tumor progression.  This review will also discuss the potential role of hyponitroxia as a novel therapeutic target to treat cancer and outline an approach that provides new opportunities for pharmacological intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxKrJmw2UWzPcsfMJQC1ZdfW6udTcc2ebsLFmik7Lkrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnjsVanuw%253D%253D&md5=caffba6e3afba83e514fb928db090005</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tranon.2014.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tranon.2014.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DFanger%26aufirst%3DG.%2BR.%26aulast%3DOronsky%26aufirst%3DN.%26aulast%3DKnox%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26atitle%3DThe%2520Implications%2520of%2520Hyponitroxia%2520in%2520Cancer%26jtitle%3DTransl.%2520Oncol%26date%3D2014%26volume%3D7%26spage%3D167%26epage%3D173%26doi%3D10.1016%2Fj.tranon.2014.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Abman, S. H.</span><span> </span><span class="NLM_article-title">Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1007/978-3-662-45805-1_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2F978-3-662-45805-1_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24092344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVOjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2013&pages=257-276&author=S.+H.+Abman&title=Inhaled+Nitric+Oxide+for+the+Treatment+of+Pulmonary+Arterial+Hypertension&doi=10.1007%2F978-3-662-45805-1_11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Abman, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">Pharmacotherapy of Pulmonary Hypertension</span>),
    <span class="NLM_cas:pages">257-276</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Following the recognition of nitric oxide (NO) as the "endothelium-derived relaxing factor," an explosion of lab. and clin. research led to the development of inhaled NO as a potential therapy for patients with pulmonary arterial hypertension (PAH).  Despite clear demonstration of its selective and potent pulmonary vasodilator properties, inhaled NO therapy has only been formally approved by the US Food and Drug Administration and European Medicine Evaluation Agency for clin. use in the treatment of term and near-term infants with severe persistent pulmonary hypertension of the newborn (PPHN) with acute hypoxemic respiratory failure.  Over the past decades, inhaled NO remains the central therapy for PPHN and is commonly used for acute pulmonary vasoreactivity testing during right heart catheterization and for treating pediatric and adult patients with PAH assocd. with postoperative cardiac surgery, severe respiratory failure, pulmonary hypertension crises, and other disorders.  This review will describe the current use of inhaled NO in clin. practice and briefly discuss its potential role for the treatment of chronic PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvZeLrmtGYarVg90H21EOLACvtfcHk0liZ0j43B2WbPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVOjtLY%253D&md5=62ca78771a6e1d36ed03943409e716db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F978-3-662-45805-1_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-662-45805-1_11%26sid%3Dliteratum%253Aachs%26aulast%3DAbman%26aufirst%3DS.%2BH.%26atitle%3DInhaled%2520Nitric%2520Oxide%2520for%2520the%2520Treatment%2520of%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D218%26spage%3D257%26epage%3D276%26doi%3D10.1007%2F978-3-662-45805-1_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mironov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mironov, A. A.</span><span> </span><span class="NLM_article-title">Clinical Features of Nonclostridium Anaerobic Infection in the Pathology of E.N.T. Organs</span> <span class="citation_source-journal">Vestn. Otorinolaringol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=2048254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADyaK3M3mtleisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=49-51&author=A.+Mironovauthor=A.+A.+Mironov&title=Clinical+Features+of+Nonclostridium+Anaerobic+Infection+in+the+Pathology+of+E.N.T.+Organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features of nonclostridium anaerobic infection in the pathology of E.N.T. organs</span></div><div class="casAuthors">Mironov A Iu; Mironov A A</div><div class="citationInfo"><span class="NLM_cas:title">Vestnik otorinolaringologii</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">49-51</span>
        ISSN:<span class="NLM_cas:issn">0042-4668</span>.
    </div><div class="casAbstract">The study of clinical features of nonclostridial anaerobic infection in 80 patients with purulent and inflammatory pathologies of ENT-organs (purulent sinusitis, purulent otitis media, paratonsillar abscesses) showed them to be as follows: prolonged, slow and often subclinical development of the disease; disseminated necrotic changes of tissues; disagreement between the level of clinical symptoms and destructive changes (prevalence of destructive changes over clinical symptoms); phenomenon of false anesthesia; existence of crumbs-like pus with a strong bad smell sometimes filled with air bubbles; limited bleeding from cut tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcQinY0YQcD75oR8RchjrrfW6udTcc2ebsLFmik7Lkrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3mtleisA%253D%253D&md5=242aed016359675d1f5a26966e1fb74d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMironov%26aufirst%3DA.%26aulast%3DMironov%26aufirst%3DA.%2BA.%26atitle%3DClinical%2520Features%2520of%2520Nonclostridium%2520Anaerobic%2520Infection%2520in%2520the%2520Pathology%2520of%2520E.N.T.%2520Organs%26jtitle%3DVestn.%2520Otorinolaringol.%26date%3D1991%26spage%3D49%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamler, J. S.</span><span> </span><span class="NLM_article-title">An Essential Role for Mitochondrial Aldehyde Dehydrogenase in Nitroglycerin Bioactivation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12159</span><span class="NLM_x">–</span> <span class="NLM_lpage">12164</span><span class="refDoi"> DOI: 10.1073/pnas.0503723102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1073%2Fpnas.0503723102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12159-12164&author=Z.+Chenauthor=M.+W.+Fosterauthor=J.+Zhangauthor=L.+Maoauthor=H.+A.+Rockmanauthor=T.+Kawamotoauthor=K.+Kitagawaauthor=K.+I.+Nakayamaauthor=D.+T.+Hessauthor=J.+S.+Stamler&title=An+Essential+Role+for+Mitochondrial+Aldehyde+Dehydrogenase+in+Nitroglycerin+Bioactivation&doi=10.1073%2Fpnas.0503723102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0503723102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0503723102%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFoster%26aufirst%3DM.%2BW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DKitagawa%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26aulast%3DHess%26aufirst%3DD.%2BT.%26aulast%3DStamler%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520Essential%2520Role%2520for%2520Mitochondrial%2520Aldehyde%2520Dehydrogenase%2520in%2520Nitroglycerin%2520Bioactivation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12159%26epage%3D12164%26doi%3D10.1073%2Fpnas.0503723102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Opelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eroglu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldeck-Weiermair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russwurm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koesling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassett, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrammel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, B.</span><span> </span><span class="NLM_article-title">Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is Necessary and Sufficient for Vascular Bioactivation of Nitroglycerin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">24076</span><span class="NLM_x">–</span> <span class="NLM_lpage">24084</span><span class="refDoi"> DOI: 10.1074/jbc.M116.752071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1074%2Fjbc.M116.752071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=24076-24084&author=M.+Opeltauthor=E.+Erogluauthor=M.+Waldeck-Weiermairauthor=M.+Russwurmauthor=D.+Koeslingauthor=R.+Malliauthor=W.+F.+Graierauthor=J.+T.+Fassettauthor=A.+Schrammelauthor=B.+Mayer&title=Formation+of+Nitric+Oxide+by+Aldehyde+Dehydrogenase-2+Is+Necessary+and+Sufficient+for+Vascular+Bioactivation+of+Nitroglycerin&doi=10.1074%2Fjbc.M116.752071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.752071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.752071%26sid%3Dliteratum%253Aachs%26aulast%3DOpelt%26aufirst%3DM.%26aulast%3DEroglu%26aufirst%3DE.%26aulast%3DWaldeck-Weiermair%26aufirst%3DM.%26aulast%3DRusswurm%26aufirst%3DM.%26aulast%3DKoesling%26aufirst%3DD.%26aulast%3DMalli%26aufirst%3DR.%26aulast%3DGraier%26aufirst%3DW.%2BF.%26aulast%3DFassett%26aufirst%3DJ.%2BT.%26aulast%3DSchrammel%26aufirst%3DA.%26aulast%3DMayer%26aufirst%3DB.%26atitle%3DFormation%2520of%2520Nitric%2520Oxide%2520by%2520Aldehyde%2520Dehydrogenase-2%2520Is%2520Necessary%2520and%2520Sufficient%2520for%2520Vascular%2520Bioactivation%2520of%2520Nitroglycerin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D24076%26epage%3D24084%26doi%3D10.1074%2Fjbc.M116.752071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wang, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janczuk, A. J.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors: Chemical Activities and Biological Applications</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span><span class="refDoi"> DOI: 10.1021/cr000040l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr000040l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=1091-1134&author=P.+G.+Wangauthor=M.+Xianauthor=X.+Tangauthor=X.+Wuauthor=Z.+Wenauthor=T.+Caiauthor=A.+J.+Janczuk&title=Nitric+Oxide+Donors%3A+Chemical+Activities+and+Biological+Applications&doi=10.1021%2Fcr000040l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Donors: Chemical Activities and Biological Applications</span></div><div class="casAuthors">Wang, Peng George; Xian, Ming; Tang, Xiaoping; Wu, Xuejun; Wen, Zhong; Cai, Tingwei; Janczuk, Adam J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1091-1134</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review that summarizes the syntheses, chem./enzymic mechanisms of NO release, biomedical applications, and current trends on the development of NO donor compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKMz2kGr2TM7Vg90H21EOLACvtfcHk0lgyUcW2dAOHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCqu78%253D&md5=92f50e5bf78c5244a217c0413e20b0cd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcr000040l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000040l%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%2BG.%26aulast%3DXian%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DJanczuk%26aufirst%3DA.%2BJ.%26atitle%3DNitric%2520Oxide%2520Donors%253A%2520Chemical%2520Activities%2520and%2520Biological%2520Applications%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D1091%26epage%3D1134%26doi%3D10.1021%2Fcr000040l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Miller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megson, I. L.</span><span> </span><span class="NLM_article-title">Recent Developments in Nitric Oxide Donor Drugs</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fsj.bjp.0707224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=17401442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslCqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=305-321&author=M.+R.+Millerauthor=I.+L.+Megson&title=Recent+Developments+in+Nitric+Oxide+Donor+Drugs&doi=10.1038%2Fsj.bjp.0707224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in nitric oxide donor drugs</span></div><div class="casAuthors">Miller, M. R.; Megson, I. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-321</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial signalling mol., with wide-ranging functions in the cardiovascular, nervous and immune systems.  Aside from providing a credible explanation for the actions of org. nitrates and sodium nitroprusside that have long been used in the treatment of angina and hypertensive crises resp., the discovery generated great hopes for new NO-based treatments for a wide variety of ailments.  Decades later, however, we are still awaiting novel licensed agents in this arena, despite an enormous research effort to this end.  This review explores some of the most promising recent advances in NO donor drug development and addresses the challenges assocd. with NO as a therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUd52ordEe4rVg90H21EOLACvtfcHk0lgyUcW2dAOHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslCqtb0%253D&md5=72d55be79ab7ca606e82e8102e0aabcc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707224%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BR.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26atitle%3DRecent%2520Developments%2520in%2520Nitric%2520Oxide%2520Donor%2520Drugs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D305%26epage%3D321%26doi%3D10.1038%2Fsj.bjp.0707224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Yasuda, H.</span><span> </span><span class="NLM_article-title">Solid Tumor Physiology and Hypoxia-Induced Chemo/Radio-Resistance: Novel Strategy for Cancer Therapy: Nitric Oxide Donor as a Therapeutic Enhancer</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.niox.2008.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2008.04.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=205-216&author=H.+Yasuda&title=Solid+Tumor+Physiology+and+Hypoxia-Induced+Chemo%2FRadio-Resistance%3A+Novel+Strategy+for+Cancer+Therapy%3A+Nitric+Oxide+Donor+as+a+Therapeutic+Enhancer&doi=10.1016%2Fj.niox.2008.04.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2008.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2008.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DH.%26atitle%3DSolid%2520Tumor%2520Physiology%2520and%2520Hypoxia-Induced%2520Chemo%252FRadio-Resistance%253A%2520Novel%2520Strategy%2520for%2520Cancer%2520Therapy%253A%2520Nitric%2520Oxide%2520Donor%2520as%2520a%2520Therapeutic%2520Enhancer%26jtitle%3DNitric%2520Oxide%26date%3D2008%26volume%3D19%26spage%3D205%26epage%3D216%26doi%3D10.1016%2Fj.niox.2008.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sukhatme, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meheus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhatme, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantziarka, P.</span><span> </span><span class="NLM_article-title">Repurposing Drugs in Oncology (ReDO)-Nitroglycerin as an Anti-Cancer Agent</span> <span class="citation_source-journal">Ecancermedicalscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="refDoi"> DOI: 10.3332/ecancer.2015.568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3332%2Fecancer.2015.568" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=568&author=V.+Sukhatmeauthor=G.+Boucheauthor=L.+Meheusauthor=V.+P.+Sukhatmeauthor=P.+Pantziarka&title=Repurposing+Drugs+in+Oncology+%28ReDO%29-Nitroglycerin+as+an+Anti-Cancer+Agent&doi=10.3332%2Fecancer.2015.568"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3332%2Fecancer.2015.568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3332%252Fecancer.2015.568%26sid%3Dliteratum%253Aachs%26aulast%3DSukhatme%26aufirst%3DV.%26aulast%3DBouche%26aufirst%3DG.%26aulast%3DMeheus%26aufirst%3DL.%26aulast%3DSukhatme%26aufirst%3DV.%2BP.%26aulast%3DPantziarka%26aufirst%3DP.%26atitle%3DRepurposing%2520Drugs%2520in%2520Oncology%2520%2528ReDO%2529-Nitroglycerin%2520as%2520an%2520Anti-Cancer%2520Agent%26jtitle%3DEcancermedicalscience%26date%3D2015%26volume%3D9%26spage%3D568%26doi%3D10.3332%2Fecancer.2015.568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span> </span><span class="NLM_article-title">Novel Nitric Oxide Generating Compound Glycidyl Nitrate Enhances the Therapeutic Efficacy of Chemotherapy and Radiotherapy</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bbrc.2014.04.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2014&pages=537-542&author=S.+Ningauthor=M.+Bednarskiauthor=B.+Oronskyauthor=J.+Scicinskiauthor=S.+J.+Knox&title=Novel+Nitric+Oxide+Generating+Compound+Glycidyl+Nitrate+Enhances+the+Therapeutic+Efficacy+of+Chemotherapy+and+Radiotherapy&doi=10.1016%2Fj.bbrc.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DS.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DNovel%2520Nitric%2520Oxide%2520Generating%2520Compound%2520Glycidyl%2520Nitrate%2520Enhances%2520the%2520Therapeutic%2520Efficacy%2520of%2520Chemotherapy%2520and%2520Radiotherapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D447%26spage%3D537%26epage%3D542%26doi%3D10.1016%2Fj.bbrc.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Konter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abuo-Rahma, G. E.-D. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Emam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">Synthesis of Diazen-1-ium-1,2-diolates Monitored by the “NOtizer” Apparatus: Relationship between Formation Rates, Molecular Structure and the Release of Nitric Oxide</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1002/ejoc.200600662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fejoc.200600662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=616-624&author=J.+Konterauthor=G.+E.-D.+A.+A.+Abuo-Rahmaauthor=A.+El-Emamauthor=J.+Lehmann&title=Synthesis+of+Diazen-1-ium-1%2C2-diolates+Monitored+by+the+%E2%80%9CNOtizer%E2%80%9D+Apparatus%3A+Relationship+between+Formation+Rates%2C+Molecular+Structure+and+the+Release+of+Nitric+Oxide&doi=10.1002%2Fejoc.200600662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200600662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200600662%26sid%3Dliteratum%253Aachs%26aulast%3DKonter%26aufirst%3DJ.%26aulast%3DAbuo-Rahma%26aufirst%3DG.%2BE.-D.%2BA.%2BA.%26aulast%3DEl-Emam%26aufirst%3DA.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520Diazen-1-ium-1%252C2-diolates%2520Monitored%2520by%2520the%2520%25E2%2580%259CNOtizer%25E2%2580%259D%2520Apparatus%253A%2520Relationship%2520between%2520Formation%2520Rates%252C%2520Molecular%2520Structure%2520and%2520the%2520Release%2520of%2520Nitric%2520Oxide%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D616%26epage%3D624%26doi%3D10.1002%2Fejoc.200600662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hrabie, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Chemistry of the Nitric Oxide-Releasing Diazeniumdiolate ("Nitrosohydroxylamine") Functional Group and Its Oxygen-Substituted Derivatives</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1021/cr000028t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr000028t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=1135-1154&author=J.+A.+Hrabieauthor=L.+K.+Keefer&title=Chemistry+of+the+Nitric+Oxide-Releasing+Diazeniumdiolate+%28%22Nitrosohydroxylamine%22%29+Functional+Group+and+Its+Oxygen-Substituted+Derivatives&doi=10.1021%2Fcr000028t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fcr000028t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000028t%26sid%3Dliteratum%253Aachs%26aulast%3DHrabie%26aufirst%3DJ.%2BA.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DChemistry%2520of%2520the%2520Nitric%2520Oxide-Releasing%2520Diazeniumdiolate%2520%2528%2522Nitrosohydroxylamine%2522%2529%2520Functional%2520Group%2520and%2520Its%2520Oxygen-Substituted%2520Derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D1135%26epage%3D1154%26doi%3D10.1021%2Fcr000028t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span><span class="refDoi"> DOI: 10.1021/cb200274r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200274r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cqtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1147-1155&author=L.+K.+Keefer&title=Fifty+Years+of+Diazeniumdiolate+Research.+From+Laboratory+Curiosity+to+Broad-Spectrum+Biomedical+Advances&doi=10.1021%2Fcb200274r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances</span></div><div class="casAuthors">Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1147-1155</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A historical review.  Here I show that a "pure" research project, seemingly totally lacking in practical application when it was first published, can years later spark a whole new scientific field with the potential to revolutionize clin. practice.  A 1961 publication describing adducts of nitric oxide (NO) with certain nucleophiles attracted little notice at the time, but later work showing that the adducts could be hydrolyzed to regenerate the NO in bioactive form has provided the foundation for a host of biomedical applications.  Crucial to the discovery of widely used tools for studying NO's chem. biol. as well as for the design of a variety of promising therapeutic advances has been the increasingly detailed understanding of the physicochem. properties of these "diazeniumdiolates" (also known as NONOates).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-FydiOhE67Vg90H21EOLACvtfcHk0ljCY4o-EmX9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cqtb7K&md5=76d7360af80b21065daeaa6b4f0b4b8c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fcb200274r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200274r%26sid%3Dliteratum%253Aachs%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DFifty%2520Years%2520of%2520Diazeniumdiolate%2520Research.%2520From%2520Laboratory%2520Curiosity%2520to%2520Broad-Spectrum%2520Biomedical%2520Advances%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1147%26epage%3D1155%26doi%3D10.1021%2Fcb200274r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, D.</span><span> </span><span class="NLM_article-title">Sodium Nitroprusside (SNP) Sensitizes Human Gastric Cancer Cells to TRAIL-Induced Apoptosis</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.intimp.2013.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.intimp.2013.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23871247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=383-389&author=L.+Yangauthor=C.+Lanauthor=Y.+Fangauthor=Y.+Zhangauthor=J.+Wangauthor=J.+Guoauthor=S.+Wanauthor=S.+Yangauthor=R.+Wangauthor=D.+Fang&title=Sodium+Nitroprusside+%28SNP%29+Sensitizes+Human+Gastric+Cancer+Cells+to+TRAIL-Induced+Apoptosis&doi=10.1016%2Fj.intimp.2013.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium nitroprusside (SNP) sensitizes human gastric cancer cells to TRAIL-induced apoptosis</span></div><div class="casAuthors">Yang, Liuqin; Lan, Chunhui; Fang, Yu; Zhang, Yafei; Wang, Jun; Guo, Jun; Wan, Shunmei; Yang, Shiming; Wang, Rongquan; Fang, Dianchun</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-389</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To investigate the effects of the nitrous oxide (NO)-donor sodium nitroprusside (SNP) on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric cancer cells.  The MTT assay and flow cytometry were used to detect cellular proliferation and markers of apoptosis, resp.  Expression levels of caspases-8, and 9 were detd. by Western blot.  Changes in Nitric Oxide Synthase (NOS) activity, NO prodn., and caspase activation were also evaluated.  We found that TRAIL induced apoptosis and cell cycle arrest in human gastric cancer cell lines, and that this effect was mediated by NO prodn., and activation of both the extrinsic and intrinsic signaling pathways of apoptosis.  In addn., we found that the NO-donor SNP sensitizes gastric cancer cells to TRAIL-mediated apoptosis.  Treatment of cells with both TRAIL and SNP resulted in increased activation of caspase-8 and caspase-9 and NO release.  Inhibition of caspase-8 blocked cell TRAIL-induced apoptosis, while a selective caspase-9 inhibitor was unable to prevent apoptosis induced by either TRAIL or TRAIL plus SNP.  Inhibition of NOS could block the activation of caspase-9, but had no obvious effect on cell apoptosis.  SNP-sensitized gastric cancer cells to TRAIL-induced cytotoxicity by stimulating the release of NO, in turn facilitating the mitochondria-mediated signal transduction pathway.  The engagement of the mitochondria signaling pathways along with the TRAIL death receptor signaling pathway synergistically increase levels of apoptosis in these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmz3BORScZGLVg90H21EOLACvtfcHk0ljCY4o-EmX9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtb%252FN&md5=2d693f0bffcb051bae6bc41c0b2d465a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2013.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2013.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLan%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DD.%26atitle%3DSodium%2520Nitroprusside%2520%2528SNP%2529%2520Sensitizes%2520Human%2520Gastric%2520Cancer%2520Cells%2520to%2520TRAIL-Induced%2520Apoptosis%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2013%26volume%3D17%26spage%3D383%26epage%3D389%26doi%3D10.1016%2Fj.intimp.2013.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Pestana, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelippin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polizello, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorta, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyemura, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tfouni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curti, C.</span><span> </span><span class="NLM_article-title">Effects on Mitochondria of Mitochondria-Induced Nitric Oxide Release from A Ruthenium Nitrosyl Complex</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.niox.2008.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2008.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=24-30&author=C.+R.+Pestanaauthor=D.+P.+Phelippinauthor=A.+C.+Polizelloauthor=D.+J.+Dortaauthor=S.+A.+Uyemuraauthor=A.+C.+Santosauthor=F.+G.+Doroauthor=F.+P.+Rodriguesauthor=E.+Tfouniauthor=C.+Curti&title=Effects+on+Mitochondria+of+Mitochondria-Induced+Nitric+Oxide+Release+from+A+Ruthenium+Nitrosyl+Complex&doi=10.1016%2Fj.niox.2008.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2008.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2008.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DPestana%26aufirst%3DC.%2BR.%26aulast%3DPhelippin%26aufirst%3DD.%2BP.%26aulast%3DPolizello%26aufirst%3DA.%2BC.%26aulast%3DDorta%26aufirst%3DD.%2BJ.%26aulast%3DUyemura%26aufirst%3DS.%2BA.%26aulast%3DSantos%26aufirst%3DA.%2BC.%26aulast%3DDoro%26aufirst%3DF.%2BG.%26aulast%3DRodrigues%26aufirst%3DF.%2BP.%26aulast%3DTfouni%26aufirst%3DE.%26aulast%3DCurti%26aufirst%3DC.%26atitle%3DEffects%2520on%2520Mitochondria%2520of%2520Mitochondria-Induced%2520Nitric%2520Oxide%2520Release%2520from%2520A%2520Ruthenium%2520Nitrosyl%2520Complex%26jtitle%3DNitric%2520Oxide%26date%3D2009%26volume%3D20%26spage%3D24%26epage%3D30%26doi%3D10.1016%2Fj.niox.2008.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Tfouni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truzzi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, D. W.</span><span> </span><span class="NLM_article-title">Biological Activity of Ruthenium Nitrosyl Complexes</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/j.niox.2011.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2011.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=22178685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=38-53&author=E.+Tfouniauthor=D.+R.+Truzziauthor=A.+Tavaresauthor=A.+J.+Gomesauthor=L.+E.+Figueiredoauthor=D.+W.+Franco&title=Biological+Activity+of+Ruthenium+Nitrosyl+Complexes&doi=10.1016%2Fj.niox.2011.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity of ruthenium nitrosyl complexes</span></div><div class="casAuthors">Tfouni, Elia; Truzzi, Daniela Ramos; Tavares, Aline; Gomes, Anderson Jesus; Figueiredo, Leonardo Elias; Franco, Douglas Wagner</div><div class="citationInfo"><span class="NLM_cas:title">Nitric Oxide</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-53</span>CODEN:
                <span class="NLM_cas:coden">NIOXF5</span>;
        ISSN:<span class="NLM_cas:issn">1089-8603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide plays an important role in various biol. processes, such as neurotransmission, blood pressure control, immunol. responses, and antioxidant action.  The control of its local concn., which is crucial for obtaining the desired effect, can be achieved with exogenous NO-carriers.  Coordination compds., in particular ruthenium(III) and (II) amines, are good NO-captors and -deliverers.  The chem. and photochem. properties of several ruthenium amine complexes as NO-carriers in vitro and in vivo have been reviewed.  These nitrosyl complexes can stimulate mice hippocampus slices, promote the lowering of blood pressure in several in vitro and in vivo models, and control Trypanosoma cruzi and Leishmania major infections, and they are also effective against tumor cells in different models of cancer.  These complexes can be activated chem. or photochem., and the obsd. biol. effects can be attributed to the presence of NO in the compd.  Their efficiencies are explained on the basis of the [RuIINO+]3+/[RuIINO0]2+ redn. potential, the specific rate const. for NO liberation from the [RuNO]2+ moiety, and the quantum yield of NO release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh118z2McsV7Vg90H21EOLACvtfcHk0ljCY4o-EmX9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOisrg%253D&md5=d74d502aed5ef414e2d285c5cd870170</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2011.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2011.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DTfouni%26aufirst%3DE.%26aulast%3DTruzzi%26aufirst%3DD.%2BR.%26aulast%3DTavares%26aufirst%3DA.%26aulast%3DGomes%26aufirst%3DA.%2BJ.%26aulast%3DFigueiredo%26aufirst%3DL.%2BE.%26aulast%3DFranco%26aufirst%3DD.%2BW.%26atitle%3DBiological%2520Activity%2520of%2520Ruthenium%2520Nitrosyl%2520Complexes%26jtitle%3DNitric%2520Oxide%26date%3D2012%26volume%3D26%26spage%3D38%26epage%3D53%26doi%3D10.1016%2Fj.niox.2011.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Pauwels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boydens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanden Daele, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Voorde, J.</span><span> </span><span class="NLM_article-title">Ruthenium-Based Nitric Oxide-Donating and Carbon Monoxide-Donating Molecules</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1111/jphp.12511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fjphp.12511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26773555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=293-304&author=B.+Pauwelsauthor=C.+Boydensauthor=L.+Vanden+Daeleauthor=J.+Van+de+Voorde&title=Ruthenium-Based+Nitric+Oxide-Donating+and+Carbon+Monoxide-Donating+Molecules&doi=10.1111%2Fjphp.12511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules</span></div><div class="casAuthors">Pauwels, Bart; Boydens, Charlotte; Vanden Daele, Laura; Van de Voorde, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives : Over the past few years, the use of metallocomplexes for medical purposes has considerably grown.  Because of its favorable characteristics, ruthenium has taken a significant place in this expanding field of research.  Several ruthenium-contg. metal compds. have been developed as delivery agents of physiol. important mols. such as nitric oxide (NO) and carbon monoxide (CO).  Key findings : This review focuses on the (vaso)relaxant capacity of ruthenium-based NO-donating and CO-donating mols. in view of their potential usefulness in the treatment of cardiovascular diseases and erectile dysfunction.  Summary : Ruthenium seems to be a valuable candidate for the design of NO-donating and CO-donating mols.  To date, ruthenium remains of interest in drug research as the search for new alternatives is still necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJlHNcv6XUWLVg90H21EOLACvtfcHk0lgSIGmhMPNELA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslektg%253D%253D&md5=cb38cf9cc5d36cb7050028d02e4f87ae</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12511%26sid%3Dliteratum%253Aachs%26aulast%3DPauwels%26aufirst%3DB.%26aulast%3DBoydens%26aufirst%3DC.%26aulast%3DVanden%2BDaele%26aufirst%3DL.%26aulast%3DVan%2Bde%2BVoorde%26aufirst%3DJ.%26atitle%3DRuthenium-Based%2520Nitric%2520Oxide-Donating%2520and%2520Carbon%2520Monoxide-Donating%2520Molecules%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2016%26volume%3D68%26spage%3D293%26epage%3D304%26doi%3D10.1111%2Fjphp.12511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Chugunova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burilov, A. R.</span><span> </span><span class="NLM_article-title">Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans: Mini-Review</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span><span class="refDoi"> DOI: 10.2174/1568026616666160927145822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F1568026616666160927145822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27697059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVOqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=986-1005&author=E.+A.+Chugunovaauthor=A.+R.+Burilov&title=Novel+Structural+Hybrids+on+the+Base+of+Benzofuroxans+and+Furoxans%3A+Mini-Review&doi=10.2174%2F1568026616666160927145822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review</span></div><div class="casAuthors">Chugunova, Elena A.; Burilov, Alexander R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">986-1005</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Hybrid drug strategy is based on the combination of two or more pharmacophores into a new chem. entity to improve the properties of the original compds. or to obtain double action of resulting mol.  Hybrid mols., comprised of some pharmacophore and nitric oxide (NO) donor moiety, constitute one of the more promising approaches for the design of drugs.  Furoxans and benzofuroxans are considered NO releasing prodrugs and are of great interest for researchers.  In this review we will focus on furoxan and benzofuroxan hybrids described in literature during the last years (from 2005 to 2016).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou9SR5WqrUW7Vg90H21EOLACvtfcHk0lgSIGmhMPNELA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVOqtrY%253D&md5=6b097e0e59fa3e2643f9da8b033fbf56</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160927145822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160927145822%26sid%3Dliteratum%253Aachs%26aulast%3DChugunova%26aufirst%3DE.%2BA.%26aulast%3DBurilov%26aufirst%3DA.%2BR.%26atitle%3DNovel%2520Structural%2520Hybrids%2520on%2520the%2520Base%2520of%2520Benzofuroxans%2520and%2520Furoxans%253A%2520Mini-Review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D986%26epage%3D1005%26doi%3D10.2174%2F1568026616666160927145822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jovene, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugunova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goumont, R.</span><span> </span><span class="NLM_article-title">The Properties and the Use of Substituted Benzofuroxans in Pharmaceutical and Medicinal Chemistry: a Comprehensive Review</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.2174/1389557511313080001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F1389557511313080001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1089-1136&author=C.+Joveneauthor=E.+A.+Chugunovaauthor=R.+Goumont&title=The+Properties+and+the+Use+of+Substituted+Benzofuroxans+in+Pharmaceutical+and+Medicinal+Chemistry%3A+a+Comprehensive+Review&doi=10.2174%2F1389557511313080001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F1389557511313080001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511313080001%26sid%3Dliteratum%253Aachs%26aulast%3DJovene%26aufirst%3DC.%26aulast%3DChugunova%26aufirst%3DE.%2BA.%26aulast%3DGoumont%26aufirst%3DR.%26atitle%3DThe%2520Properties%2520and%2520the%2520Use%2520of%2520Substituted%2520Benzofuroxans%2520in%2520Pharmaceutical%2520and%2520Medicinal%2520Chemistry%253A%2520a%2520Comprehensive%2520Review%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1089%26epage%3D1136%26doi%3D10.2174%2F1389557511313080001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hiskey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, D. E.</span><span> </span><span class="NLM_article-title">D. E. Preparation of 1-Substituted-3,3-Dinitroazetidines</span> <span class="citation_source-journal">J. Energ. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1080/07370659908216106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1080%2F07370659908216106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1MXktFWrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=233-252&author=M.+A.+Hiskeyauthor=M.+C.+Johnsonauthor=D.+E.+Chavez&title=D.+E.+Preparation+of+1-Substituted-3%2C3-Dinitroazetidines&doi=10.1080%2F07370659908216106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 1-substituted 3,3-dinitroazetidines</span></div><div class="casAuthors">Hiskey, Michael A.; Johnson, M. Catherine; Chavez, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Energetic Materials</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2 & 3</span>),
    <span class="NLM_cas:pages">233-252</span>CODEN:
                <span class="NLM_cas:coden">JOEMDK</span>;
        ISSN:<span class="NLM_cas:issn">0737-0652</span>.
    
            (<span class="NLM_cas:orgname">Dowden, Brodman & Devine, Inc.</span>)
        </div><div class="casAbstract">DNAZ (3,3-dinitroazetidine) readily undergoes nucleophilic addn. reactions with electron deficient haloaroms., cyanogen bromide, S-methyl-N-nitroisothiourea and dichloroglyoxime to afford novel, energetic 1-substituted 3,3-dinitroazetidines.  N-Nitrosation of DNAZ readily occurs, and Mannich condensations of DNAZ with polynitro alcs. are also described.  The synthesis and properties of the energetic materials derived from these reactions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYQA3m4RPcsbVg90H21EOLACvtfcHk0lizmUaZroMjxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFWrtL4%253D&md5=502a56df049cdb7a7b8bec48629234eb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F07370659908216106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07370659908216106%26sid%3Dliteratum%253Aachs%26aulast%3DHiskey%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DM.%2BC.%26aulast%3DChavez%26aufirst%3DD.%2BE.%26atitle%3DD.%2520E.%2520Preparation%2520of%25201-Substituted-3%252C3-Dinitroazetidines%26jtitle%3DJ.%2520Energ.%2520Mater.%26date%3D1999%26volume%3D17%26spage%3D233%26epage%3D252%26doi%3D10.1080%2F07370659908216106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saul, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span> </span><span class="NLM_article-title">Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2600</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F0008-5472.CAN-11-2303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=22589277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2600-2608&author=S.+Ningauthor=M.+Bednarskiauthor=B.+Oronskyauthor=J.+Scicinskiauthor=G.+Saulauthor=S.+J.+Knox&title=Dinitroazetidines+Are+a+Novel+Class+of+Anticancer+Agents+and+Hypoxia-Activated+Radiation+Sensitizers+Developed+from+Highly+Energetic+Materials&doi=10.1158%2F0008-5472.CAN-11-2303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials</span></div><div class="casAuthors">Ning, Shoucheng; Bednarski, Mark; Oronsky, Bryan; Scicinski, Jan; Saul, Gordon; Knox, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2600-2608</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In an effort to develop cancer therapies that maximize cytotoxicity, while minimizing unwanted side effects, we studied a series of novel compds. based on the highly energetic heterocyclic scaffold, dinitroazetidine.  In this study, we report the preclin. validation of 1-bromoacetyl-3,3-dinitroazetidine (ABDNAZ), a representative lead compd. currently in a phase I clin. trial in patients with cancer.  In tumor cell culture, ABDNAZ generated reactive free radicals in a concn.- and time-dependent manner, modulating intracellular redox status and triggering apoptosis.  When administered to mice as a single agent, ABDNAZ exhibited greater cytotoxicity than cisplatin or tirapazamine under hypoxic conditions.  However, compared with cisplatin, ABDNAZ was better tolerated at submaximal doses, yielding significant tumor growth inhibition in the absence of systemic toxicity.  Similarly, when combined with radiation, ABDNAZ accentuated antitumor efficacy along with the therapeutic index.  Toxicity studies indicated that ABDNAZ was not myelosuppressive and no dose-limiting toxicity was apparent following daily administration for 14 days.  Taken together, our findings offer preclin. proof-of-concept for ABDNAZ as a promising new anticancer agent with a favorable toxicity profile, either as a chemotherapeutic agent or a radiosensitizer.  Cancer Res; 72(10); 2600-8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojcgmi5BKp-7Vg90H21EOLACvtfcHk0lizmUaZroMjxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ntbo%253D&md5=dc41734ee7a24c30a2ce2e20224d4db1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2303%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DS.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DSaul%26aufirst%3DG.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DDinitroazetidines%2520Are%2520a%2520Novel%2520Class%2520of%2520Anticancer%2520Agents%2520and%2520Hypoxia-Activated%2520Radiation%2520Sensitizers%2520Developed%2520from%2520Highly%2520Energetic%2520Materials%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2600%26epage%3D2608%26doi%3D10.1158%2F0008-5472.CAN-11-2303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S.</span><span> </span><span class="NLM_article-title">RRx-001, a Novel Dinitroazetidine Radiosensitizer</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1007/s10637-016-0326-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2Fs10637-016-0326-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=371-377&author=B.+Oronskyauthor=J.+Scicinskiauthor=S.+Ningauthor=D.+Peehlauthor=A.+Oronskyauthor=P.+Cabralesauthor=M.+Bednarskiauthor=S.+Knox&title=RRx-001%2C+a+Novel+Dinitroazetidine+Radiosensitizer&doi=10.1007%2Fs10637-016-0326-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0326-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0326-y%26sid%3Dliteratum%253Aachs%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DNing%26aufirst%3DS.%26aulast%3DPeehl%26aufirst%3DD.%26aulast%3DOronsky%26aufirst%3DA.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DKnox%26aufirst%3DS.%26atitle%3DRRx-001%252C%2520a%2520Novel%2520Dinitroazetidine%2520Radiosensitizer%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2016%26volume%3D34%26spage%3D371%26epage%3D377%26doi%3D10.1007%2Fs10637-016-0326-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuypers, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span> </span><span class="NLM_article-title">A Look Inside the Mechanistic Black Box: Are Red Blood Cells the Critical Effectors of RRx-001 Cytotoxicity?</span> <span class="citation_source-journal">Med. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="refDoi"> DOI: 10.1007/s12032-016-0775-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2Fs12032-016-0775-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27229330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FktFGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=63&author=P.+Cabralesauthor=J.+Scicinskiauthor=T.+Reidauthor=F.+Kuypersauthor=S.+Larkinauthor=M.+Fensauthor=A.+Oronskyauthor=B.+Oronsky&title=A+Look+Inside+the+Mechanistic+Black+Box%3A+Are+Red+Blood+Cells+the+Critical+Effectors+of+RRx-001+Cytotoxicity%3F&doi=10.1007%2Fs12032-016-0775-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?</span></div><div class="casAuthors">Cabrales Pedro; Scicinski Jan; Oronsky Bryan; Reid Tony; Kuypers Frans; Larkin Sandra; Fens Marcel; Oronsky Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The therapeutic potential of epi-immunotherapeutic anticancer agent RRx-001 in cancer has been validated with preclinical and clinical studies, since RRx-001 has successfully completed a phase 1 trial and multiple single-agent and combination phase 2 trials with preliminary evidence of promising activity are underway.  Previous experimental work has implicated diverse anticancer mechanisms such as oxidative stress, ATP and NADPH depletion, anti-angiogenesis and epigenetic modulation in the overall antitumor effect of RRx-001.  The hypothesis of this study was that the RRx-001 red blood cells are the essential and de facto intermediaries responsible for the reprograming of tumor behavior via transfer of their intracellular and membrane contents.  To test this hypothesis, and thereby resolve the "black box" incompleteness in the continuity of the mechanism, the fate of red blood cells incubated with RRx-001 was explored in vitro and in vivo both in healthy animals and in tumor-bearing mice.  The collective results establish that RRx-001-derivatized red blood cells are the critical "missing links" to explain the specificity and anticancer activity of RRx-001, including its immunomodulatory effects on tumor-associated macrophages.  These experimental results delineate a novel erythrocyte-based mechanism without precedent in the annals of oncology and open the door to rational combination strategies with RRx-001 both in cancer therapy and beyond, particularly in disease states that affect red blood cell and vascular function such as malaria, leishmaniasis, sickle-cell disease and hemorrhagic shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxqiQRMELtSvEeosoOnpOLfW6udTcc2eaIEyGcTXJwmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FktFGmsw%253D%253D&md5=3a01dd404fceb01d7ea8f6300c2f3d55</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs12032-016-0775-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-016-0775-3%26sid%3Dliteratum%253Aachs%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DReid%26aufirst%3DT.%26aulast%3DKuypers%26aufirst%3DF.%26aulast%3DLarkin%26aufirst%3DS.%26aulast%3DFens%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DA.%26aulast%3DOronsky%26aufirst%3DB.%26atitle%3DA%2520Look%2520Inside%2520the%2520Mechanistic%2520Black%2520Box%253A%2520Are%2520Red%2520Blood%2520Cells%2520the%2520Critical%2520Effectors%2520of%2520RRx-001%2520Cytotoxicity%253F%26jtitle%3DMed.%2520Oncol.%26date%3D2016%26volume%3D33%26spage%3D63%26doi%3D10.1007%2Fs12032-016-0775-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, W. L.</span><span> </span><span class="NLM_article-title">Preclinical Evaluation of the Metabolism and Disposition of RRx-001, a Novel Investigative Anticancer Agent</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1810</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span><span class="refDoi"> DOI: 10.1124/dmd.112.046755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1124%2Fdmd.112.046755" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1810-1816&author=J.+Scicinskiauthor=B.+Oronskyauthor=M.+Taylorauthor=G.+Luoauthor=T.+Musickauthor=J.+Mariniauthor=C.+M.+Adamsauthor=W.+L.+Fitch&title=Preclinical+Evaluation+of+the+Metabolism+and+Disposition+of+RRx-001%2C+a+Novel+Investigative+Anticancer+Agent&doi=10.1124%2Fdmd.112.046755"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046755%26sid%3Dliteratum%253Aachs%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DMusick%26aufirst%3DT.%26aulast%3DMarini%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DFitch%26aufirst%3DW.%2BL.%26atitle%3DPreclinical%2520Evaluation%2520of%2520the%2520Metabolism%2520and%2520Disposition%2520of%2520RRx-001%252C%2520a%2520Novel%2520Investigative%2520Anticancer%2520Agent%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1810%26epage%3D1816%26doi%3D10.1124%2Fdmd.112.046755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M.</span><span> </span><span class="NLM_article-title">Epigenetic Effects of RRx-001: A Possible Unifying Mechanism of Anticancer Activity</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">43172</span><span class="NLM_x">–</span> <span class="NLM_lpage">43181</span><span class="refDoi"> DOI: 10.18632/oncotarget.6526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.18632%2Foncotarget.6526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=43172-43181&author=H.+Zhaoauthor=S.+Ningauthor=J.+Scicinskiauthor=B.+Oronskyauthor=S.+J.+Knoxauthor=D.+M.+Peehl&title=Epigenetic+Effects+of+RRx-001%3A+A+Possible+Unifying+Mechanism+of+Anticancer+Activity&doi=10.18632%2Foncotarget.6526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6526%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DNing%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26atitle%3DEpigenetic%2520Effects%2520of%2520RRx-001%253A%2520A%2520Possible%2520Unifying%2520Mechanism%2520of%2520Anticancer%2520Activity%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D43172%26epage%3D43181%26doi%3D10.18632%2Foncotarget.6526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Reid, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scribner, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrouk, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J. R.</span><span> </span><span class="NLM_article-title">Safety and Activity of RRx-001 in Patients with Advanced Cancer: a First-in-Human, Open-Label, Dose-Escalation Phase 1 Study</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span><span class="refDoi"> DOI: 10.1016/S1470-2045(15)00089-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS1470-2045%2815%2900089-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26296952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKnurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1133-1142&author=T.+Reidauthor=B.+Oronskyauthor=J.+Scicinskiauthor=C.+L.+Scribnerauthor=S.+J.+Knoxauthor=S.+Ningauthor=D.+M.+Peehlauthor=R.+Kornauthor=M.+Stirnauthor=C.+A.+Carterauthor=A.+Oronskyauthor=M.+J.+Taylorauthor=W.+L.+Fitchauthor=P.+Cabralesauthor=M.+M.+Kimauthor=H.+A.+Burrisauthor=C.+D.+Laoauthor=N.+E.+Abroukauthor=G.+R.+Fangerauthor=J.+R.+Infante&title=Safety+and+Activity+of+RRx-001+in+Patients+with+Advanced+Cancer%3A+a+First-in-Human%2C+Open-Label%2C+Dose-Escalation+Phase+1+Study&doi=10.1016%2FS1470-2045%2815%2900089-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study</span></div><div class="casAuthors">Reid, Tony; Oronsky, Bryan; Scicinski, Jan; Scribner, Curt L.; Knox, Susan J.; Ning, Shoucheng; Peehl, Donna M.; Korn, Ron; Stirn, Meaghan; Carter, Corey A.; Oronsky, Arnold; Taylor, Michael J.; Fitch, William L.; Cabrales, Pedro; Kim, Michelle M.; Burris, Howard A., III; Lao, Christopher D.; Abrouk, Nacer E. D.; Fanger, Gary R.; Infante, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1133-1142</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Epigenetic alterations have been strongly assocd. with tumor formation and resistance to chemotherapeutic drugs, and epigenetic modifications are an attractive target in cancer research.  RRx-001 is activated by hypoxia and induces the generation of reactive oxygen and nitrogen species that can epigenetically modulate DNA methylation, histone deacetylation, and lysine demethylation.  The aim of this phase 1 study was to assess the safety, tolerability, and pharmacokinetics of RRx-001.  In this open-label, dose-escalation, phase 1 study, we recruited adult patients (aged >18 years) with histol. or cytol. confirmed diagnosis of advanced, malignant, incurable solid tumors from University of California at San Diego, CA, USA, and Sarah Cannon Research Institute, Nashville, TN, USA.  Key eligibility criteria included evaluable disease, Eastern Cooperative Group performance status of 2 or less, an estd. life expectancy of at least 12 wk, adequate lab. parameters, discontinuation of all previous antineoplastic therapies at least 6 wk before intervention, and no residual side-effects from previous therapies.  Patients were assigned to receive i.v. infusions of RRx-001 at increasing doses (10 mg/m2, 16·7 mg/m2, 24·6 mg/m2, 33 mg/m2, 55 mg/m2, and 83 mg/m2) either once or twice-weekly for at least 4 wk, with at least three patients per dose cohort and allowing a 2-wk observation period before dose escalation.  Samples for safety and pharmacokinetics anal., including std. chem. and haematol. panels, were taken on each treatment day.  The primary objective was to assess safety, tolerability, and dose-limiting toxic effects of RRx-001, to det. single-dose pharmacokinetics, and to identify a recommended dose for phase 2 trials.  All analyses were done per protocol.  Accrual is complete and follow-up is still on-going.  This trial is registered with ClinicalTrials.gov, no. NCT01359982.  Between Oct 10, 2011, and March 18, 2013, we enrolled 25 patients and treated six patients in the 10 mg/m2 cohort, three patients in the 16·7 mg/m2 cohort, three patients in the 24·6 mg/m2 cohort, four patients in the 33 mg/m2 cohort, three patients in the 55 mg/m2, and six patients in the 83 mg/m2 cohort.  Pain at the injection site, mostly grade 1 and grade 2, was the most common adverse event related to treatment, experienced by 21 (84%) patients.  Other common drug-related adverse events included arm swelling or edema (eight [32%] patients), and vein hardening (seven [28%] patients).  No dose-limiting toxicities were obsd.  Time constraints related to management of infusion pain from RRx-001 resulted in a maximally feasible dose of 83 mg/m2.  Of the 21 evaluable patients, one (5%) patient had a partial response, 14 (67%) patients had stable disease, and six (29%) patients had progressive disease; all responses were across a variety of tumor types.  Four patients who had received RRx-001 were subsequently rechallenged with a treatment that they had become refractory to; all four responded to the rechallenge.  RRx-001 is a well-tolerated novel compd. without clin. significant toxic effects at the tested doses.  Preliminary evidence of activity is promising and, on the basis of all findings, a dose of 16·7 mg/m2 was recommended as the targeted dose for phase 2 trials.EpicentRx (formerly RadioRx).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9rkaWij3XxLVg90H21EOLACvtfcHk0lh9q-KPIpk6-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKnurzN&md5=7f48e9d2108e1aaad8fdf987360c19d8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2815%2900089-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252815%252900089-3%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DT.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DScribner%26aufirst%3DC.%2BL.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26aulast%3DNing%26aufirst%3DS.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DKorn%26aufirst%3DR.%26aulast%3DStirn%26aufirst%3DM.%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DOronsky%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DFitch%26aufirst%3DW.%2BL.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DM.%2BM.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DLao%26aufirst%3DC.%2BD.%26aulast%3DAbrouk%26aufirst%3DN.%2BE.%26aulast%3DFanger%26aufirst%3DG.%2BR.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26atitle%3DSafety%2520and%2520Activity%2520of%2520RRx-001%2520in%2520Patients%2520with%2520Advanced%2520Cancer%253A%2520a%2520First-in-Human%252C%2520Open-Label%252C%2520Dose-Escalation%2520Phase%25201%2520Study%26jtitle%3DLancet%2520Oncol.%26date%3D2015%26volume%3D16%26spage%3D1133%26epage%3D1142%26doi%3D10.1016%2FS1470-2045%2815%2900089-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caroen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degesys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzezniak, C.</span><span> </span><span class="NLM_article-title">Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets</span> <span class="citation_source-journal">Case Rep. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1159/000446209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1159%2F000446209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27403127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ps1Cksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=285-289&author=C.+A.+Carterauthor=B.+Oronskyauthor=S.+Caroenauthor=J.+Scicinskiauthor=A.+Degesysauthor=P.+Cabralesauthor=T.+R.+Reidauthor=C.+Brzezniak&title=Partial+Response+in+an+RRx-001-Primed+Patient+with+Refractory+Small-Cell+Lung+Cancer+after+a+Third+Introduction+of+Platinum+Doublets&doi=10.1159%2F000446209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets</span></div><div class="casAuthors">Carter Corey A; Degesys Aiste; Brzezniak Christina; Oronsky Bryan; Caroen Scott; Scicinski Jan; Cabrales Pedro; Reid Tony R</div><div class="citationInfo"><span class="NLM_cas:title">Case reports in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Small-cell lung cancer (SCLC), initially exquisitely sensitive to first-line cisplatin/etoposide, invariably relapses and acquires a multidrug chemoresistant phenotype that generally renders retreatment with first-line therapy both futile and counterproductive.  This report presents the case of a 77-year-old Caucasian male with extensive-stage refractory SCLC who was restarted on platinum doublets as part of a clinical trial called TRIPLE THREAT (NCT02489903) involving pretreatment with the epi-immunotherapeutic agent RRx-001, and who achieved a partial response after only 4 cycles.  The patient had received a platinum drug twice before, in 2009 for a diagnosis of non-small-cell lung cancer (squamous cell carcinoma) and in 2015 for SCLC, suggesting that RRx-001 pretreatment may sensitize or resensitize refractory SCLC patients to first-line chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVxgRO-rO9H2yYR5VtavbzfW6udTcc2eaj1na239tmMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ps1Cksg%253D%253D&md5=3a204cb7b3028a54daae7306367bac9e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1159%2F000446209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000446209%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DCaroen%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DDegesys%26aufirst%3DA.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DReid%26aufirst%3DT.%2BR.%26aulast%3DBrzezniak%26aufirst%3DC.%26atitle%3DPartial%2520Response%2520in%2520an%2520RRx-001-Primed%2520Patient%2520with%2520Refractory%2520Small-Cell%2520Lung%2520Cancer%2520after%2520a%2520Third%2520Introduction%2520of%2520Platinum%2520Doublets%26jtitle%3DCase%2520Rep.%2520Oncol.%26date%3D2016%26volume%3D9%26spage%3D285%26epage%3D289%26doi%3D10.1159%2F000446209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caroen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degesys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzezniak, C.</span><span> </span><span class="NLM_article-title">Partial Response to Carboplatin in an RRx-001 Pretreated Patient with EGFR-Inhibitor-Resistance and T790M-Negative NSCLC</span> <span class="citation_source-journal">Respir. Med. Case Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.rmcr.2016.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.rmcr.2016.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27330954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2s7isl2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=62-65&author=C.+A.+Carterauthor=B.+Oronskyauthor=S.+Caroenauthor=J.+Scicinskiauthor=P.+Cabralesauthor=A.+Degesysauthor=C.+Brzezniak&title=Partial+Response+to+Carboplatin+in+an+RRx-001+Pretreated+Patient+with+EGFR-Inhibitor-Resistance+and+T790M-Negative+NSCLC&doi=10.1016%2Fj.rmcr.2016.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC</span></div><div class="casAuthors">Carter Corey A; Degesys Aiste; Brzezniak Christina; Oronsky Bryan; Caroen Scott; Scicinski Jan; Cabrales Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine case reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Few therapeutic options are available for T790M-negative non-small cell lung cancer (NSCLC) after failure of primary epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy.  This report presents the case of a 71-year-old Asian female never smoker with EGFR mutated T790M negative non squamous cell lung cancer (NSCLC) pre-treated with the experimental epi-immunotherapeutic agent, RRx-001, that re-responded to single agent carboplatin after failure of platinum doublets, TKIs, pemetrexed and nivolumab.  The management of advanced EGFR mutation-positive NSCLC is briefly reviewed herein and the emerging paradigm of episensitization, which contradicts the long-standing and widely accepted tenet about the immutability of resistance and the futility of therapeutic rechallenge, is introduced as a strategy to avert treatment failure and thereby stave off deterioration and death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbyt8aJkvHFBjv2lLSLOxFfW6udTcc2eaj1na239tmMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7isl2mtA%253D%253D&md5=937af93aea51d096036ee2517220674d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.rmcr.2016.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmcr.2016.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DCaroen%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DDegesys%26aufirst%3DA.%26aulast%3DBrzezniak%26aufirst%3DC.%26atitle%3DPartial%2520Response%2520to%2520Carboplatin%2520in%2520an%2520RRx-001%2520Pretreated%2520Patient%2520with%2520EGFR-Inhibitor-Resistance%2520and%2520T790M-Negative%2520NSCLC%26jtitle%3DRespir.%2520Med.%2520Case%2520Rep.%26date%3D2016%26volume%3D18%26spage%3D62%26epage%3D65%26doi%3D10.1016%2Fj.rmcr.2016.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Diez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calatayud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esplugues, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrachina, M. D.</span><span> </span><span class="NLM_article-title">Nitric Oxide, Derived from Inducible Nitric Oxide Synthase, Decreases Hypoxia Inducible Factor-1alpha in Macrophages during Aspirin-Induced Mesenteric Inflammation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1636</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00654.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fj.1476-5381.2010.00654.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=20233223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC3c3lvVCisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2010&pages=1636-1645&author=I.+Diezauthor=S.+Calatayudauthor=C.+Hernandezauthor=E.+Quintanaauthor=J.+E.+O%E2%80%99Connorauthor=J.+V.+Espluguesauthor=M.+D.+Barrachina&title=Nitric+Oxide%2C+Derived+from+Inducible+Nitric+Oxide+Synthase%2C+Decreases+Hypoxia+Inducible+Factor-1alpha+in+Macrophages+during+Aspirin-Induced+Mesenteric+Inflammation&doi=10.1111%2Fj.1476-5381.2010.00654.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor-1alpha in macrophages during aspirin-induced mesenteric inflammation</span></div><div class="casAuthors">Diez I; Calatayud S; Hernandez C; Quintana E; O'Connor J E; Esplugues J V; Barrachina M D</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1636-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Nitric oxide (NO) modulates expression of hypoxia inducible factor-1 (HIF-1), a transcription factor regulating function of myeloid cells.  Here, we have assessed the role played by NO, formed by inducible NOS (iNOS), in the inflammation induced by aspirin in the gut, by modulating HIF-1 activity.  EXPERIMENTAL APPROACH:  The role of iNOS-derived NO on leucocyte-endothelial interactions induced by aspirin was evaluated by intravital microscopy in mesenteric venules of rats pretreated with selective iNOS inhibitors, 1400W or l-N6-(1-iminoethyl)-lysine.  NO was localized by fluorescence microscopy, using DAF-FM. iNOS, HIF-1alpha and CD36 were localized by immunohistochemistry.  KEY RESULTS:  Leucocyte-endothelial interactions increased at 6 h and returned to normal levels 24 h after aspirin administration.  Numbers of migrated leucocytes were similar between 6 and 24 h after aspirin. iNOS expression and iNOS-derived NO synthesis were observed in leucocytes of the mesentery of aspirin-treated rats.  Blockade of iNOS activity in aspirin-treated rats: (i) did not modify leucocyte infiltration at 6 h, but reduced the number of polymorphonuclear leucocyte and increased that of macrophages at 24 h; (ii) increased HIF-1alpha immunostaining in macrophages of the mesentery; and (iii) prevented the decrease in CD36 immunostaining induced by aspirin in these cells.  CONCLUSIONS AND IMPLICATIONS:  NO, associated with acute gut inflammation induced by aspirin, diminished HIF-1alpha stabilization in macrophages.  Early inhibition of iNOS-derived NO synthesis, by increasing the activity of HIF-1 in these cells, may accelerate the clearance of leucocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSm3zG7MgWoa_6BottYdIAWfW6udTcc2eb7l4Zcaqj4qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3lvVCisw%253D%253D&md5=2f62dfc071a9b6268abe5fa8edf77ae8</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00654.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00654.x%26sid%3Dliteratum%253Aachs%26aulast%3DDiez%26aufirst%3DI.%26aulast%3DCalatayud%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DC.%26aulast%3DQuintana%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BE.%26aulast%3DEsplugues%26aufirst%3DJ.%2BV.%26aulast%3DBarrachina%26aufirst%3DM.%2BD.%26atitle%3DNitric%2520Oxide%252C%2520Derived%2520from%2520Inducible%2520Nitric%2520Oxide%2520Synthase%252C%2520Decreases%2520Hypoxia%2520Inducible%2520Factor-1alpha%2520in%2520Macrophages%2520during%2520Aspirin-Induced%2520Mesenteric%2520Inflammation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D159%26spage%3D1636%26epage%3D1645%26doi%3D10.1111%2Fj.1476-5381.2010.00654.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Hagen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1alpha</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span><span class="refDoi"> DOI: 10.1126/science.1088805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1126%2Fscience.1088805" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1975-1978&author=T.+Hagenauthor=C.+T.+Taylorauthor=F.+Lamauthor=S.+Moncada&title=Redistribution+of+Intracellular+Oxygen+in+Hypoxia+by+Nitric+Oxide%3A+Effect+on+HIF1alpha&doi=10.1126%2Fscience.1088805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1126%2Fscience.1088805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1088805%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DC.%2BT.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DRedistribution%2520of%2520Intracellular%2520Oxygen%2520in%2520Hypoxia%2520by%2520Nitric%2520Oxide%253A%2520Effect%2520on%2520HIF1alpha%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1975%26epage%3D1978%26doi%3D10.1126%2Fscience.1088805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Dingemans, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herder, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahce, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgers, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Borne, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Noort, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aerts, J. G.</span><span> </span><span class="NLM_article-title">A Randomized Phase II Study Comparing Paclitaxel-Carboplatin-Bevacizumab with or without Nitroglycerin Patches in Patients with Stage IV Nonsquamous Nonsmall-Cell Lung Cancer: NVALT12 (NCT01171170)Dagger</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2286</span><span class="NLM_x">–</span> <span class="NLM_lpage">2293</span><span class="refDoi"> DOI: 10.1093/annonc/mdv370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1093%2Fannonc%2Fmdv370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26347109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC287pvFCksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2286-2293&author=A.+M.+Dingemansauthor=H.+J.+Groenauthor=G.+J.+Herderauthor=J.+A.+Stigtauthor=E.+F.+Smitauthor=I.+Bahceauthor=J.+A.+Burgersauthor=B.+E.+van+den+Borneauthor=B.+Biesmaauthor=A.+Vincentauthor=V.+van+der+Noortauthor=J.+G.+Aerts&title=A+Randomized+Phase+II+Study+Comparing+Paclitaxel-Carboplatin-Bevacizumab+with+or+without+Nitroglycerin+Patches+in+Patients+with+Stage+IV+Nonsquamous+Nonsmall-Cell+Lung+Cancer%3A+NVALT12+%28NCT01171170%29Dagger&doi=10.1093%2Fannonc%2Fmdv370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†</span></div><div class="casAuthors">Dingemans A-M C; Groen H J M; Herder G J M; Stigt J A; Smit E F; Bahce I; Burgers J A; van den Borne B E E M; Biesma B; Vincent A; van der Noort V; Aerts J G</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2286-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Nitroglycerin (NTG) increases tumor blood flow and oxygenation by inhibiting hypoxia-inducible-factor (HIF)-1.  A randomized phase II study has shown improved outcome when NTG patches were added to vinorelbine/cisplatin in patients with advanced nonsmall-cell lung cancer (NSCLC).  In addition, there is evidence that the combination of bevacizumab and HIF-1 inhibitors increases antitumor activity.  PATIENTS AND METHODS:  In this randomized phase II trial, chemo-naive patients with stage IV nonsquamous NSCLC were randomized to four cycles of carboplatin (area under the curve 6)-paclitaxel (200 mg/m(2))-bevacizumab 15 mg/kg on day 1 every 3 weeks with or without NTG patches 15 mg (day -2 to +2) followed by bevacizumab with or without NTG until progression.  Response was assessed every two cycles.  Primary end point was progression-free survival (PFS).  The study was powered (80%) to detect a decrease in the hazard of tumor progression of 33% at α = 0.05 with a two-sided log-rank test when 222 patients were enrolled and followed until 195 events were observed.  RESULTS:  Between 1 January 2011 and 1 January 2013, a total of 223 patients were randomized; 112 control arm and 111 experimental arm; response rate was 54% in control arm and 38% in experimental arm.  Median [95% confidence interval (CI)] PFS in control arm was 6.8 months (5.6-7.3) and 5.1 months (4.2-5.8) in experimental arm, hazard ratio (HR) 1.27 (95% CI 0.96-1.67).  Overall survival (OS) was 11.6 months (8.8-13.6) in control arm and 9.4 months (7.8-11.3) in experimental arm, HR 1.02 (95% CI 0.71-1.46).  In the experimental arm, no additional toxicity was observed except headache (6% versus 52% in patients treated with NTG).  CONCLUSION:  Adding NTG to first-line carboplatin-paclitaxel-bevacizumab did not improve PFS and OS in patients with stage IV nonsquamous NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwXOyvA6ZXA9j_Vg2vObihfW6udTcc2eb7l4Zcaqj4qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287pvFCksQ%253D%253D&md5=7c6b3acf8525690f078bc993ffbd5446</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv370%26sid%3Dliteratum%253Aachs%26aulast%3DDingemans%26aufirst%3DA.%2BM.%26aulast%3DGroen%26aufirst%3DH.%2BJ.%26aulast%3DHerder%26aufirst%3DG.%2BJ.%26aulast%3DStigt%26aufirst%3DJ.%2BA.%26aulast%3DSmit%26aufirst%3DE.%2BF.%26aulast%3DBahce%26aufirst%3DI.%26aulast%3DBurgers%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2Bden%2BBorne%26aufirst%3DB.%2BE.%26aulast%3DBiesma%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BNoort%26aufirst%3DV.%26aulast%3DAerts%26aufirst%3DJ.%2BG.%26atitle%3DA%2520Randomized%2520Phase%2520II%2520Study%2520Comparing%2520Paclitaxel-Carboplatin-Bevacizumab%2520with%2520or%2520without%2520Nitroglycerin%2520Patches%2520in%2520Patients%2520with%2520Stage%2520IV%2520Nonsquamous%2520Nonsmall-Cell%2520Lung%2520Cancer%253A%2520NVALT12%2520%2528NCT01171170%2529Dagger%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3D2286%26epage%3D2293%26doi%3D10.1093%2Fannonc%2Fmdv370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Yasuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span> </span><span class="NLM_article-title">Randomized Phase II Trial Comparing Nitroglycerin plus Vinorelbine and Cisplatin with Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span><span class="refDoi"> DOI: 10.1200/JCO.2005.04.0436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1200%2FJCO.2005.04.0436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16446342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFKhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=688-694&author=H.+Yasudaauthor=M.+Yamayaauthor=K.+Nakayamaauthor=T.+Sasakiauthor=S.+Ebiharaauthor=A.+Kandaauthor=M.+Asadaauthor=D.+Inoueauthor=T.+Suzukiauthor=T.+Okazakiauthor=H.+Takahashiauthor=M.+Yoshidaauthor=T.+Kanetaauthor=K.+Ishizawaauthor=S.+Yamandaauthor=N.+Tomitaauthor=M.+Yamasakiauthor=A.+Kikuchiauthor=H.+Kuboauthor=H.+Sasaki&title=Randomized+Phase+II+Trial+Comparing+Nitroglycerin+plus+Vinorelbine+and+Cisplatin+with+Vinorelbine+and+Cisplatin+Alone+in+Previously+Untreated+Stage+IIIB%2FIV+Non-Small-Cell+Lung+Cancer&doi=10.1200%2FJCO.2005.04.0436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer</span></div><div class="casAuthors">Yasuda, Hiroyasu; Yamaya, Mutsuo; Nakayama, Katsutoshi; Sasaki, Takahiko; Ebihara, Satoru; Kanda, Akio; Asada, Masanori; Inoue, Daisuke; Suzuki, Tomoko; Okazaki, Tatsuma; Takahashi, Hidenori; Yoshida, Motoki; Kaneta, Tomohiro; Ishizawa, Kota; Yamanda, Shinsuke; Tomita, Naoki; Yamasaki, Miyako; Kikuchi, Akiko; Kubo, Hiroshi; Sasaki, Hidetada</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">688-694</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To investigate the efficacy and safety of nitroglycerin plus vinorelbine and cisplatin in patients with previously untreated stage IIIB/IV non-small-cell lung cancer (NSCLC) as the exptl. arm for the next phase III trial.  Patients and Methods: One hundred twenty patients with stage IIIB/IV NSCLC were randomly assigned to vinorelbine 25 mg/m2 on days 1 and 8 and cisplatin 80 mg/m2 on day 1, with transdermally applied nitroglycerin (25 mg/patient daily for 5 days; arm A) or with placebo patch (arm B) every 3 wk for a max. of four cycles in a double-blind and controlled trial.  Primary efficacy end points were the best confirmed response rate and time to disease progression (TTP).  Results: The response rate in arm A (72%; 43 of 60 patients) was significantly higher than that for patients in arm B (42%; 25 of 60 patients; P < .001).  Median TTP in arm A was longer than that in arm B (327 v 185 days).  No severe adverse effect was recognized for either arm.  The rate of grade 1 to 2 headache in arm A (30%; 18 of 60 patients) was significantly higher than that in arm B (2%; one of 60 patients; P < .001, χ2 test).  Conclusion: Use of nitroglycerin combined with vinorelbine and cisplatin may improve overall response and TTP in patients with stage IIIB/IV NSCLC.  The arm A regimen is being evaluated in a large phase III trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_eytTE64OzLVg90H21EOLACvtfcHk0lj8skRDxKDo2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFKhtLc%253D&md5=6a409beea03b7207333c7a53a35fa02e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.04.0436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.04.0436%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DH.%26aulast%3DYamaya%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DEbihara%26aufirst%3DS.%26aulast%3DKanda%26aufirst%3DA.%26aulast%3DAsada%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DD.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKaneta%26aufirst%3DT.%26aulast%3DIshizawa%26aufirst%3DK.%26aulast%3DYamanda%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DKubo%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DH.%26atitle%3DRandomized%2520Phase%2520II%2520Trial%2520Comparing%2520Nitroglycerin%2520plus%2520Vinorelbine%2520and%2520Cisplatin%2520with%2520Vinorelbine%2520and%2520Cisplatin%2520Alone%2520in%2520Previously%2520Untreated%2520Stage%2520IIIB%252FIV%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D688%26epage%3D694%26doi%3D10.1200%2FJCO.2005.04.0436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Reinmuth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwigsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skock-Lober, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerecke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Held, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reck, M.</span><span> </span><span class="NLM_article-title">Randomized, Double-Blind Phase II Study to Compare Nitroglycerin plus Oral Vinorelbine plus Cisplatin with Oral Vinorelbine plus Cisplatin Alone in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1016/j.lungcan.2014.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.lungcan.2014.01.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=363-368&author=N.+Reinmuthauthor=A.+Meyerauthor=D.+Hartwigsenauthor=C.+Schaeperauthor=G.+Huebnerauthor=R.+Skock-Loberauthor=A.+Bierauthor=U.+Gereckeauthor=C.+P.+Heldauthor=M.+Reck&title=Randomized%2C+Double-Blind+Phase+II+Study+to+Compare+Nitroglycerin+plus+Oral+Vinorelbine+plus+Cisplatin+with+Oral+Vinorelbine+plus+Cisplatin+Alone+in+Patients+with+Stage+IIIB%2FIV+Non-Small+Cell+Lung+Cancer+%28NSCLC%29&doi=10.1016%2Fj.lungcan.2014.01.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2014.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2014.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DReinmuth%26aufirst%3DN.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DHartwigsen%26aufirst%3DD.%26aulast%3DSchaeper%26aufirst%3DC.%26aulast%3DHuebner%26aufirst%3DG.%26aulast%3DSkock-Lober%26aufirst%3DR.%26aulast%3DBier%26aufirst%3DA.%26aulast%3DGerecke%26aufirst%3DU.%26aulast%3DHeld%26aufirst%3DC.%2BP.%26aulast%3DReck%26aufirst%3DM.%26atitle%3DRandomized%252C%2520Double-Blind%2520Phase%2520II%2520Study%2520to%2520Compare%2520Nitroglycerin%2520plus%2520Oral%2520Vinorelbine%2520plus%2520Cisplatin%2520with%2520Oral%2520Vinorelbine%2520plus%2520Cisplatin%2520Alone%2520in%2520Patients%2520with%2520Stage%2520IIIB%252FIV%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520%2528NSCLC%2529%26jtitle%3DLung%2520Cancer%26date%3D2014%26volume%3D83%26spage%3D363%26epage%3D368%26doi%3D10.1016%2Fj.lungcan.2014.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Arrieta, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Mata-Moya, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corona, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander-Alatorre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Rincon, D.</span><span> </span><span class="NLM_article-title">Phase II Study. Concurrent Chemotherapy and Radiotherapy with Nitroglycerin in Locally Advanced Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Radiother. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1016/j.radonc.2014.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.radonc.2014.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24836861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVaqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=311-315&author=O.+Arrietaauthor=M.+Blakeauthor=M.+D.+de+la+Mata-Moyaauthor=F.+Coronaauthor=J.+Turcottauthor=D.+Ortaauthor=J.+Alexander-Alatorreauthor=D.+Gallardo-Rincon&title=Phase+II+Study.+Concurrent+Chemotherapy+and+Radiotherapy+with+Nitroglycerin+in+Locally+Advanced+Non-Small+Cell+Lung+Cancer&doi=10.1016%2Fj.radonc.2014.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer</span></div><div class="casAuthors">Arrieta, Oscar; Blake, Monika; de la Mata-Moya, Maria Dolores; Corona, Francisco; Turcott, Jenny; Orta, David; Alexander-Alatorre, Jorge; Gallardo-Rincon, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-315</span>CODEN:
                <span class="NLM_cas:coden">RAONDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Nitroglycerin, a nitric oxide donor agent, reduces the expression of hypoxia-inducible factor-1α (HIF-1α) and could be a normalizer of the tumor microenvironment.  Both factors are assocd. with chemo-radio-resistance.  The aim of this study was to det. the safety profile and efficacy of nitroglycerin administration with chemo-radiotherapy in patients with locally advanced non-small cell lung cancer (NSCLC).  This is a phase II trial of locally advanced NSCLC patients treated with cisplatin and vinorelbine plus concurrent nitroglycerin with radiotherapy.  A 25-mg NTG patch was administered to the patients for 5 days (1 day before and 4 days after chemotherapy induction and consolidation) and all day during chemo-radiotherapy.  VEGF plasmatic level was detd. before and after two cycles of chemotherapy.  Thirty-five patients were enrolled in this trial.  Sixty-three percent of patients achieved an overall response after induction of chemotherapy, and 75% achieved an overall response after chemo-radiotherapy.  The median progression-free survival was 13.5 mo (95% CI, 8.8-18.2), and the median overall survival was 26.9 mo (95% CI, 15.3-38.5).  Redn. of VEGF level was assocd. with better OS.  The toxicity profile related to nitroglycerin included headache (20%) and hypotension (2.9%).  The addn. of nitroglycerin to induction chemotherapy and concurrent chemoradiotherapy in patients with locally advanced NSCLC has an acceptable toxicity profile and supports the possibility to add nitroglycerin to chemotherapy and radiotherapy.  A randomized trial is warranted to confirm these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJPoRgcw7V4rVg90H21EOLACvtfcHk0lg11hPdNZ4xXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVaqsb4%253D&md5=f15e376b5dd9889921b5a875395a3664</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2014.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2014.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DArrieta%26aufirst%3DO.%26aulast%3DBlake%26aufirst%3DM.%26aulast%3Dde%2Bla%2BMata-Moya%26aufirst%3DM.%2BD.%26aulast%3DCorona%26aufirst%3DF.%26aulast%3DTurcott%26aufirst%3DJ.%26aulast%3DOrta%26aufirst%3DD.%26aulast%3DAlexander-Alatorre%26aufirst%3DJ.%26aulast%3DGallardo-Rincon%26aufirst%3DD.%26atitle%3DPhase%2520II%2520Study.%2520Concurrent%2520Chemotherapy%2520and%2520Radiotherapy%2520with%2520Nitroglycerin%2520in%2520Locally%2520Advanced%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DRadiother.%2520Oncol.%26date%3D2014%26volume%3D111%26spage%3D311%26epage%3D315%26doi%3D10.1016%2Fj.radonc.2014.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Illum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hittson, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrisi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta, S.</span><span> </span><span class="NLM_article-title">Phase I Dose Escalation Trial of Nitroglycerin in Addition to 5-Fluorouracil and Radiation Therapy for Neoadjuvant Treatment of Operable Rectal Cancer</span> <span class="citation_source-journal">Surgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1016/j.surg.2015.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.surg.2015.04.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2015&pages=460-465&author=H.+Illumauthor=D.+H.+Wangauthor=J.+E.+Dowellauthor=W.+J.+Hittsonauthor=J.+R.+Torrisiauthor=J.+Meyerauthor=S.+Huerta&title=Phase+I+Dose+Escalation+Trial+of+Nitroglycerin+in+Addition+to+5-Fluorouracil+and+Radiation+Therapy+for+Neoadjuvant+Treatment+of+Operable+Rectal+Cancer&doi=10.1016%2Fj.surg.2015.04.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.surg.2015.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.surg.2015.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DIllum%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%2BH.%26aulast%3DDowell%26aufirst%3DJ.%2BE.%26aulast%3DHittson%26aufirst%3DW.%2BJ.%26aulast%3DTorrisi%26aufirst%3DJ.%2BR.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DHuerta%26aufirst%3DS.%26atitle%3DPhase%2520I%2520Dose%2520Escalation%2520Trial%2520of%2520Nitroglycerin%2520in%2520Addition%2520to%25205-Fluorouracil%2520and%2520Radiation%2520Therapy%2520for%2520Neoadjuvant%2520Treatment%2520of%2520Operable%2520Rectal%2520Cancer%26jtitle%3DSurgery%26date%3D2015%26volume%3D158%26spage%3D460%26epage%3D465%26doi%3D10.1016%2Fj.surg.2015.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Weyerbrock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walbridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluta, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E. H.</span><span> </span><span class="NLM_article-title">Selective Opening of the Blood-Tumor Barrier by a Nitric Oxide Donor and Long-Term Survival in Rats with C6 Gliomas</span> <span class="citation_source-journal">J. Neurosurg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">737</span><span class="refDoi"> DOI: 10.3171/jns.2003.99.4.0728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3171%2Fjns.2003.99.4.0728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=14567609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=728-737&author=A.+Weyerbrockauthor=S.+Walbridgeauthor=R.+M.+Plutaauthor=J.+E.+Saavedraauthor=L.+K.+Keeferauthor=E.+H.+Oldfield&title=Selective+Opening+of+the+Blood-Tumor+Barrier+by+a+Nitric+Oxide+Donor+and+Long-Term+Survival+in+Rats+with+C6+Gliomas&doi=10.3171%2Fjns.2003.99.4.0728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas</span></div><div class="casAuthors">Weyerbrock, Astrid; Walbridge, Stuart; Pluta, Ryszard M.; Saavedra, Joseph E.; Keefer, Larry K.; Oldfield, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurosurgery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">728-737</span>CODEN:
                <span class="NLM_cas:coden">JONSAC</span>;
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neurological Surgeons</span>)
        </div><div class="casAbstract">Object: The response of brain tumors to systemic chemotherapy is limited by the blood-tumor barrier (BTB).  Nitric oxide (NO) has been implicated in the regulation of vascular permeability and blood flow.  The authors evaluated the effects of exogenous NO, which was released from a short-acting NO donor (Proli/NO), and those of NO metabolites on the capillary permeability of tumors and normal brain tissue by using quant. autoradiog. in a C6 glioma model in rats.  Methods: The Proli/NO was infused at a wide dose range (10-2 to 10-12 M) either i.v. or into the internal carotid artery (ICA) and demonstrated substantial tumor-selective increases in blood-brain barrier (BBB) permeability in response to various-sized tracers ([14C]aminoisobutyric acid, [14C]sucrose, [14C]dextran).  Internal carotid artery or i.v. administration of sodium nitrite had a comparable effect on BTB permeability.  The NO effect on microvascular permeability could be obtained without causing hemodynamic side effects.  The effect of NO on the efficacy of carboplatin chemotherapy was investigated in intracerebral C6 gliomas.  Simultaneous i.v. infusions of Proli/NO (10-6M) and carboplatin (20 mg/kg) led to long-term survival in 40% of rats harboring intracerebral C6 gliomas compared with control animals receiving ICA or i.v. infusions of carboplatin, Proli/NO, or vehicle alone.  No residual tumor was demonstrated on histol. or magnetic resonance imaging studies performed in rats treated with Proli/NO and carboplatin, and no toxicity was obsd.  Conclusions: This new approach demonstrated the in vivo efficacy and safety of NO and nitrite in enhancing the delivery of systemically delivered radiolabeled tracers and carboplatin into rat gliomas.  The NO-induced tumor-selective BBB disruption and i.v. carboplatin chemotherapy may be more efficacious than current chemotherapy strategies against brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq65ERaBxc3tLVg90H21EOLACvtfcHk0lg11hPdNZ4xXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlGht7Y%253D&md5=eadaf39862f167b837939aebe68c6b00</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.3171%2Fjns.2003.99.4.0728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252Fjns.2003.99.4.0728%26sid%3Dliteratum%253Aachs%26aulast%3DWeyerbrock%26aufirst%3DA.%26aulast%3DWalbridge%26aufirst%3DS.%26aulast%3DPluta%26aufirst%3DR.%2BM.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DOldfield%26aufirst%3DE.%2BH.%26atitle%3DSelective%2520Opening%2520of%2520the%2520Blood-Tumor%2520Barrier%2520by%2520a%2520Nitric%2520Oxide%2520Donor%2520and%2520Long-Term%2520Survival%2520in%2520Rats%2520with%2520C6%2520Gliomas%26jtitle%3DJ.%2520Neurosurg.%26date%3D2003%26volume%3D99%26spage%3D728%26epage%3D737%26doi%3D10.3171%2Fjns.2003.99.4.0728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Pervin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gau, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edamatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, G.</span><span> </span><span class="NLM_article-title">Potentiation of Nitric Oxide-Induced Apoptosis of MDA-MB-468 Cells by Farnesyltransferase Inhibitor: Implications in Breast Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4701-4706&author=S.+Pervinauthor=R.+Singhauthor=C.+L.+Gauauthor=H.+Edamatsuauthor=F.+Tamanoiauthor=G.+Chaudhuri&title=Potentiation+of+Nitric+Oxide-Induced+Apoptosis+of+MDA-MB-468+Cells+by+Farnesyltransferase+Inhibitor%3A+Implications+in+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPervin%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGau%26aufirst%3DC.%2BL.%26aulast%3DEdamatsu%26aufirst%3DH.%26aulast%3DTamanoi%26aufirst%3DF.%26aulast%3DChaudhuri%26aufirst%3DG.%26atitle%3DPotentiation%2520of%2520Nitric%2520Oxide-Induced%2520Apoptosis%2520of%2520MDA-MB-468%2520Cells%2520by%2520Farnesyltransferase%2520Inhibitor%253A%2520Implications%2520in%2520Breast%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4701%26epage%3D4706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollica, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, L.</span><span> </span><span class="NLM_article-title">Nitric Oxide in Cancer Metastasis</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/j.canlet.2014.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.canlet.2014.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=25079686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2014&pages=1-7&author=H.+Chengauthor=L.+Wangauthor=M.+Mollicaauthor=A.+T.+Reauthor=S.+Wuauthor=L.+Zuo&title=Nitric+Oxide+in+Cancer+Metastasis&doi=10.1016%2Fj.canlet.2014.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide in cancer metastasis</span></div><div class="casAuthors">Cheng, Huiwen; Wang, Lei; Mollica, Molly; Re, Anthony T.; Wu, Shiyong; Zuo, Li</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis is the spread and growth of tumor cells from the original neoplasm to further organs.  This review analyzes the role of nitric oxide (NO·), a signaling mol., in the regulation of cancer formation, progression, and metastasis.  The action of NO· on cancer relies on multiple factors including cell type, metastasis stage, and organs involved.  Various chemotherapy drugs cause cells to release NO·, which in turn induces cytotoxic death of breast, liver, and skin tumors.  However, NO· has also been clin. connected to a poor cancer prognosis because of its role in angiogenesis and intravasation.  This supports the claim that NO· can be characterized as both pro-metastatic and anti-metastatic, depending on specific factors.  The inhibition of cell proliferation and anti-apoptosis pathways by NO· donors has been proposed as a novel therapy to various cancers.  Studies suggest that NO·-releasing non-steroidal anti-inflammatory drugs act on cancer cells in several ways that may make them ideal for cancer therapy.  This review summarizes the biol. significance of NO· in each step of cancer metastasis, its controversial effects for cancer progression, and its therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojyaaZ0M2vlrVg90H21EOLACvtfcHk0lhOoCmXX5L2ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr3P&md5=f711f0dcfb072e6e847a1000b84f673e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMollica%26aufirst%3DM.%26aulast%3DRe%26aufirst%3DA.%2BT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DL.%26atitle%3DNitric%2520Oxide%2520in%2520Cancer%2520Metastasis%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D353%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.canlet.2014.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Huerta-Yepez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazirehi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garban, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span> </span><span class="NLM_article-title">Nitric Oxide Sensitizes Prostate Carcinoma Cell Lines to TRAIL-Mediated Apoptosis via Inactivation of NF-kappa B and Inhibition of Bcl-xl Expression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">5003</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fsj.onc.1207655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15048072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVOgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4993-5003&author=S.+Huerta-Yepezauthor=M.+Vegaauthor=A.+Jazirehiauthor=H.+Garbanauthor=F.+Hongoauthor=G.+Chengauthor=B.+Bonavida&title=Nitric+Oxide+Sensitizes+Prostate+Carcinoma+Cell+Lines+to+TRAIL-Mediated+Apoptosis+via+Inactivation+of+NF-kappa+B+and+Inhibition+of+Bcl-xl+Expression&doi=10.1038%2Fsj.onc.1207655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression</span></div><div class="casAuthors">Huerta-Yepez, Sara; Vega, Mario; Jazirehi, Ali; Garban, Hermes; Hongo, Fumiya; Cheng, Genhong; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">4993-5003</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be selective in the induction of apoptosis in cancer cells with minimal toxicity to normal tissues and this prompted its potential therapeutic application in cancer.  However, not all cancers are sensitive to TRAIL-mediated apoptosis and, therefore, TRAIL-resistant cancer cells must be sensitized first to become sensitive to TRAIL.  Treatment of prostate cancer (CaP) cell lines (DU145, PC-3, CL-1, and LNCaP) with nitric oxide donors (e.g. (Z)-1-[2-(2-aminoethyl)-N-(2-ammonio-ethyl)amino]diazen-1-ium-1, 2-diolate (DETANONOate)) sensitized CaP cells to TRAIL-induced apoptosis and synergy was achieved.  The mechanism by which DETANONOate mediated the sensitization was examd.  DETANONOate inhibited the constitutive NF-κB activity as assessed by EMSA.  Also, p50 was S-nitrosylated by DETANONOate resulting in inhibition of NF-κB.  Inhibition of NF-κB activity by the chem. inhibitor Bay 11-7085, like DETANONOate, sensitized CaP to TRAIL apoptosis.  In addn., DETANONOate downregulated the expression of Bcl-2 related gene (Bcl-xL) which is under the transcriptional regulation of NF-κB.  The regulation of NF-κB and Bcl-xL by DETANONOate was corroborated by the use of Bcl-xL and Bcl-x κB reporter systems.  DETANONOate inhibited luciferase activity in the wild type and had no effect on the mutant cells.  Inhibition of NF-κB resulted in downregulation of Bcl-xL expression and sensitized CaP to TRAIL-induced apoptosis.  The role of Bcl-xL in the regulation of TRAIL apoptosis was corroborated by inhibiting Bcl-xL function by the chem. inhibitor 2-methoxyantimycin A3 and this resulted in sensitization of the cells to TRAIL apoptosis.  Signaling by DETANONOate and TRAIL for apoptosis was examd.  DETANONOate altered the mitochondria by inducing membrane depolarization and releasing modest amts. of cytochrome c and Smac/DIABLO in the absence of downstream activation of caspases 9 and 3.  However, the combination of DETANONOate and TRAIL resulted in activation of the mitochondrial pathway and activation of caspases 9 and 3, and induction of apoptosis.  These findings demonstrate that DETANONOate-mediated sensitization of CaP to TRAIL-induced apoptosis is via inhibition of constitutive NF-κB activity and Bcl-xL expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvoc0SpgHnVbVg90H21EOLACvtfcHk0lhOoCmXX5L2ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVOgu7k%253D&md5=e03b48d73ce4da043cefc45fefacace3</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207655%26sid%3Dliteratum%253Aachs%26aulast%3DHuerta-Yepez%26aufirst%3DS.%26aulast%3DVega%26aufirst%3DM.%26aulast%3DJazirehi%26aufirst%3DA.%26aulast%3DGarban%26aufirst%3DH.%26aulast%3DHongo%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520Oxide%2520Sensitizes%2520Prostate%2520Carcinoma%2520Cell%2520Lines%2520to%2520TRAIL-Mediated%2520Apoptosis%2520via%2520Inactivation%2520of%2520NF-kappa%2520B%2520and%2520Inhibition%2520of%2520Bcl-xl%2520Expression%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D4993%26epage%3D5003%26doi%3D10.1038%2Fsj.onc.1207655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Perez-Sala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cernuda-Morollon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Cazorla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Pascual, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, S.</span><span> </span><span class="NLM_article-title">Posttranscriptional Regulation of Human iNOS by the NO/cGMP Pathway</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">F466</span><span class="NLM_x">–</span> <span class="NLM_lpage">F473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11181408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD3M7lvVyiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2001&pages=F466-F473&author=D.+Perez-Salaauthor=E.+Cernuda-Morollonauthor=M.+Diaz-Cazorlaauthor=F.+Rodriguez-Pascualauthor=S.+Lamas&title=Posttranscriptional+Regulation+of+Human+iNOS+by+the+NO%2FcGMP+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranscriptional regulation of human iNOS by the NO/cGMP pathway</span></div><div class="casAuthors">Perez-Sala D; Cernuda-Morollon E; Diaz-Cazorla M; Rodriguez-Pascual F; Lamas S</div><div class="citationInfo"><span class="NLM_cas:title">American journal of physiology. Renal physiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">F466-73</span>
        ISSN:<span class="NLM_cas:issn">1931-857X</span>.
    </div><div class="casAbstract">Nitric oxide (NO) and cGMP may exert positive or negative effects on inducible NO synthase (iNOS) expression.  We have explored the influence of the NO/cGMP pathway on iNOS levels in human mesangial cells.  Inhibition of NOS activity during an 8-h stimulation with IL-1beta plus tumor necrosis factor (TNF)-alpha reduced iNOS levels, while NO donors amplified iNOS induction threefold.  However, time-course studies revealed a subsequent inhibitory effect of NO donors on iNOS protein and mRNA levels.  This suggests that NO may contribute both to iNOS induction and downregulation.  Soluble guanylyl cyclase (sGC) activation may be involved in these effects.  Inhibition of sGC attenuated IL-1beta/TNF-alpha-elicited iNOS induction and reduced NO-driven amplification.  Interestingly, cGMP analogs also modulated iNOS protein and mRNA levels in a biphasic manner.  Inhibition of transcription unveiled a negative posttranscriptional modulation of the iNOS transcript by NO and cGMP at late times of induction.  Supplementation with 8-bromo-cGMP (8-BrcGMP) reduced iNOS mRNA stability by 50%.  These observations evidence a complex feedback regulation of iNOS expression, in which posttranscriptional mechanisms may play an important role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtD3RE95x5gHqj_yg7twvpfW6udTcc2eaB1yORjN81Wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7lvVyiug%253D%253D&md5=e3b6661482094369a26b0c4320ace409</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Sala%26aufirst%3DD.%26aulast%3DCernuda-Morollon%26aufirst%3DE.%26aulast%3DDiaz-Cazorla%26aufirst%3DM.%26aulast%3DRodriguez-Pascual%26aufirst%3DF.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DPosttranscriptional%2520Regulation%2520of%2520Human%2520iNOS%2520by%2520the%2520NO%252FcGMP%2520Pathway%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2001%26volume%3D280%26spage%3DF466%26epage%3DF473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Somasundaram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadhan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">K. Hemalatha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Sengodan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivas, P.</span><span> </span><span class="NLM_article-title">Nitric Oxide and Reactive Oxygen Species: Clues to Target Oxidative Damage Repair Defective Breast Cancers</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1016/j.critrevonc.2016.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.critrevonc.2016.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27017408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC28fktFCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=184-192&author=V.+Somasundaramauthor=R.+Nadhanauthor=S.+K.+Hemalathaauthor=S.+Kumar+Sengodanauthor=P.+Srinivas&title=Nitric+Oxide+and+Reactive+Oxygen+Species%3A+Clues+to+Target+Oxidative+Damage+Repair+Defective+Breast+Cancers&doi=10.1016%2Fj.critrevonc.2016.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers</span></div><div class="casAuthors">Somasundaram Veena; Nadhan Revathy; K Hemalatha Sreelatha; Kumar Sengodan Satheesh; Srinivas Priya</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">184-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The identification of various biomolecules in cancer progression and therapy has led to the exploration of the roles of two cardinal players, namely Nitric Oxide (NO) and Reactive Oxygen Species (ROS) in cancer.  Both ROS and NO display bimodal fashions of functional activity in a concentration dependent manner, by inducing either pro- or anti- tumorigenic signals.  Researchers have identified the potential capability of NO and ROS in therapies owing to their role in eliciting pro-apoptotic signals at higher concentrations and their ability to sensitize cancer cells to one another as well as to other therapeutics.  We review the prospects of NO and ROS in cancer progression and therapy, and analyze the role of a combinatorial therapy wherein an NO donor (SNAP) is used to sensitize the oxidative damage repair defective, triple negative breast cancer cells (HCC 1937) to a potent ROS inducer.  Preliminary findings support the potential to employ various combinatorial regimes for anti-cancer therapies with regard to exploiting the chemo-sensitization property of NO donors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHDyAqvzDMu56KlWarZTAzfW6udTcc2eZspNwaHAT1frntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fktFCruw%253D%253D&md5=7b4d294d5f3f0d680c0d44197d791db7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2016.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSomasundaram%26aufirst%3DV.%26aulast%3DNadhan%26aufirst%3DR.%26aulast%3DK.%2BHemalatha%26aufirst%3DS.%26aulast%3DKumar%2BSengodan%26aufirst%3DS.%26aulast%3DSrinivas%26aufirst%3DP.%26atitle%3DNitric%2520Oxide%2520and%2520Reactive%2520Oxygen%2520Species%253A%2520Clues%2520to%2520Target%2520Oxidative%2520Damage%2520Repair%2520Defective%2520Breast%2520Cancers%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2016%26volume%3D101%26spage%3D184%26epage%3D192%26doi%3D10.1016%2Fj.critrevonc.2016.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Leung, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Exercise, Vascular Wall and Cardiovascular Diseases: an Update (Part 1)</span> <span class="citation_source-journal">Sports Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span><span class="refDoi"> DOI: 10.2165/00007256-200838120-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2165%2F00007256-200838120-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=19026018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD1cjmtVemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1009-1024&author=F.+P.+Leungauthor=L.+M.+Yungauthor=I.+Laherauthor=X.+Yaoauthor=Z.+Y.+Chenauthor=Y.+Huang&title=Exercise%2C+Vascular+Wall+and+Cardiovascular+Diseases%3A+an+Update+%28Part+1%29&doi=10.2165%2F00007256-200838120-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Exercise, vascular wall and cardiovascular diseases: an update (Part 1)</span></div><div class="casAuthors">Leung Fung Ping; Yung Lai Ming; Laher Ismail; Yao Xiaoqiang; Chen Zhen Yu; Huang Yu</div><div class="citationInfo"><span class="NLM_cas:title">Sports medicine (Auckland, N.Z.)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1009-24</span>
        ISSN:<span class="NLM_cas:issn">0112-1642</span>.
    </div><div class="casAbstract">Cardiovascular disease (CVD) remains the leading cause of morbidity and premature mortality in both women and men in most industrialized countries, and has for some time also established a prominent role in developing nations.  In fact, obesity, diabetes mellitus and hypertension are now commonplace even in children and youths.  Regular exercise is rapidly gaining widespread advocacy as a preventative measure in schools, medical circles and in the popular media.  There is overwhelming evidence garnered from a number of sources, including epidemiological, prospective cohort and intervention studies, suggesting that CVD is largely a disease associated with physical inactivity.  A rapidly advancing body of human and animal data confirms an important beneficial role for exercise in the prevention and treatment of CVD.  In Part 1 of this review we discuss the impact of exercise on CVD, and we highlight the effects of exercise on (i) endothelial function by regulation of endothelial genes mediating oxidative metabolism, inflammation, apoptosis, cellular growth and proliferation, increased superoxide dismutase (SOD)-1, down-regulation of p67phox, changes in intracellular calcium level, increased vascular endothelial nitric oxide synthase (eNOS), expression and eNOS Ser-1177 phosphorylation; (ii) vascular smooth muscle function by either an increased affinity of the Ca2+ extrusion mechanism or an augmented Ca2+ buffering system by the superficial sarcoplasmic reticulum to increase Ca2+ sequestration, increase in K+ channel activity and/or expression, and increase in L-type Ca2+ current density; (iii) antioxidant systems by elevation of Mn-SOD, Cu/Zn-SOD and catalase, increases in glutathione peroxidase activity and activation of vascular nicotinamide adenine dinucleotide phosphate [(NAD(P)H] oxidase and p22phox expression; (iv) heat shock protein (HSP) expression by stimulating HSP70 expression in myocardium, skeletal muscle and even in human leucocytes, probably through heat shock transcription factor 1 activity; (v) inflammation by reducing serum inflammatory cytokines such as high-sensitivity C-reactive protein (hCRP), interleukin (IL)-6, IL-18 and tumour necrosis factor-alpha and by regulating Toll-like receptor 4 pathway.  Exercise also alters vascular remodelling, which involves two forms of vessel growth including angiogenesis and arteriogenesis.  Angiogenesis refers to the formation of new capillary networks.  Arteriogenesis refers to the growth of pre-existent collateral arterioles leading to formation of large conductance arteries that are well capable to compensate for the loss of function of occluded arteries.  Another aim of this review is to focus on exercise-related cardiovascular protection against CVD and associated risk factors such as aging, coronary heart disease, hypertension, heart failure, diabetes mellitus and peripheral arterial diseases mediated by vascular remodelling.  Lastly, this review examines the benefits of exercise in mitigating pre-eclampsia during pregnancy by mechanisms that include improved blood flow, reduced blood pressure, enhanced placental growth and vascularity, increased activity of antioxidant enzymes, reduced oxidative stress and restored vascular endothelial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4BLIm92IRbJVVjGoY74BafW6udTcc2eZspNwaHAT1frntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjmtVemtA%253D%253D&md5=f180f24da17acc3c04872470100bf219</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2165%2F00007256-200838120-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00007256-200838120-00005%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DF.%2BP.%26aulast%3DYung%26aufirst%3DL.%2BM.%26aulast%3DLaher%26aufirst%3DI.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DExercise%252C%2520Vascular%2520Wall%2520and%2520Cardiovascular%2520Diseases%253A%2520an%2520Update%2520%2528Part%25201%2529%26jtitle%3DSports%2520Med.%26date%3D2008%26volume%3D38%26spage%3D1009%26epage%3D1024%26doi%3D10.2165%2F00007256-200838120-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Esterase-Sensitive Nitric Oxide Donors of the Diazeniumdiolate Family: in Vitro Antileukemic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1021/jm9903850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9903850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=261-269&author=J.+E.+Saavedraauthor=P.+J.+Shamiauthor=L.+Y.+Wangauthor=K.+M.+Daviesauthor=M.+N.+Boothauthor=M.+L.+Citroauthor=L.+K.+Keefer&title=Esterase-Sensitive+Nitric+Oxide+Donors+of+the+Diazeniumdiolate+Family%3A+in+Vitro+Antileukemic+Activity&doi=10.1021%2Fjm9903850"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm9903850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9903850%26sid%3Dliteratum%253Aachs%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DBooth%26aufirst%3DM.%2BN.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DEsterase-Sensitive%2520Nitric%2520Oxide%2520Donors%2520of%2520the%2520Diazeniumdiolate%2520Family%253A%2520in%2520Vitro%2520Antileukemic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D261%26epage%3D269%26doi%3D10.1021%2Fjm9903850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trikha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honn, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Synthesis of Peptide-Diazeniumdiolate Conjugates: Towards Enzyme Activated Antitumor Agents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2625</span><span class="NLM_x">–</span> <span class="NLM_lpage">2629</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)00263-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS0040-4039%2801%2900263-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=2625-2629&author=X.+Tangauthor=M.+Xianauthor=M.+Trikhaauthor=K.+V.+Honnauthor=P.+G.+Wang&title=Synthesis+of+Peptide-Diazeniumdiolate+Conjugates%3A+Towards+Enzyme+Activated+Antitumor+Agents&doi=10.1016%2FS0040-4039%2801%2900263-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900263-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900263-5%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXian%26aufirst%3DM.%26aulast%3DTrikha%26aufirst%3DM.%26aulast%3DHonn%26aufirst%3DK.%2BV.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520of%2520Peptide-Diazeniumdiolate%2520Conjugates%253A%2520Towards%2520Enzyme%2520Activated%2520Antitumor%2520Agents%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D2625%26epage%3D2629%26doi%3D10.1016%2FS0040-4039%2801%2900263-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Cai, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagorski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauschweiger, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and Cytotoxicity of 5-Fluorouracil/Diazeniumdiolate Conjugates</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4971</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span><span class="refDoi"> DOI: 10.1016/j.bmc.2003.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2003.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4971-4975&author=T.+B.+Caiauthor=X.+Tangauthor=J.+Nagorskiauthor=P.+G.+Brauschweigerauthor=P.+G.+Wang&title=Synthesis+and+Cytotoxicity+of+5-Fluorouracil%2FDiazeniumdiolate+Conjugates&doi=10.1016%2Fj.bmc.2003.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2003.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2003.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DT.%2BB.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DNagorski%26aufirst%3DJ.%26aulast%3DBrauschweiger%26aufirst%3DP.%2BG.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520Cytotoxicity%2520of%25205-Fluorouracil%252FDiazeniumdiolate%2520Conjugates%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4971%26epage%3D4975%26doi%3D10.1016%2Fj.bmc.2003.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifant, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diwan, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">JS-K, a Glutathione/Glutathione S-Transferase-Activated Nitric Oxide Donor of the Diazeniumdiolate Class with Potent Antineoplastic Activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=12700285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=409-417&author=P.+J.+Shamiauthor=J.+E.+Saavedraauthor=L.+Y.+Wangauthor=C.+L.+Bonifantauthor=B.+A.+Diwanauthor=S.+V.+Singhauthor=Y.+Guauthor=S.+D.+Foxauthor=G.+S.+Buzardauthor=M.+L.+Citroauthor=D.+J.+Waterhouseauthor=K.+M.+Daviesauthor=X.+Jiauthor=L.+K.+Keefer&title=JS-K%2C+a+Glutathione%2FGlutathione+S-Transferase-Activated+Nitric+Oxide+Donor+of+the+Diazeniumdiolate+Class+with+Potent+Antineoplastic+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity</span></div><div class="casAuthors">Shami, Paul J.; Saavedra, Joseph E.; Wang, Lai Y.; Bonifant, Challice L.; Diwan, Bhalchandra A.; Singh, Shivendra V.; Gu, Yijun; Fox, Stephen D.; Buzard, Gregory S.; Citro, Michael L.; Waterhouse, David J.; Davies, Keith M.; Ji, Xinhua; Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have previously shown that nitric oxide (NO) inhibits growth and induces differentiation and apoptosis in acute myeloid leukemia cells, with the HL-60 human myeloid leukemia line being particularly sensitive to NO-mediated cytolysis.  With the goal of identifying a prodrug that can target NO to the leukemia cells without inducing NO-mediated systemic hypotension, we have screened a series of O2-aryl diazeniumdiolates designed to be stable at physiol. pH but to release NO upon reaction with glutathione.  O2-(2,4-Dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate (JS-K) proved to be the most active antiproliferative agent among those tested in HL-60 cells, with an IC50 of 0.2-0.5 μM.  After 5 days of exposure to 0.5 μM JS-K, HL-60 cells had differentiated and acquired some of the phenotypic features of normal monocytes.  One- to 2-day treatment with JS-K at concns. of 0.5-1 μM resulted in apoptosis induction in a concn.- and caspase-dependent manner.  JS-K also inhibited the growth of solid tumor cell lines but to a lesser extent than HL-60 cells.  JS-K was administered i.v. to nonobese diabetic-severe combined immune deficient mice at doses of up to 4 μmol/kg without inducing significant hypotension.  The growth of s.c. implanted HL-60 cells was reduced by ∼50% when the mice received i.v. injections three times/wk with 4 μmol/kg boluses of JS-K.  Histol. examn. of tumor explants from JS-K-treated animals revealed extensive necrosis.  Similar results were seen with s.c. human prostate cancer (PPC-1) xenografts.  Our data indicate that JS-K is a promising lead compd. for the possible development of a novel class of antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq3gucZoE5B7Vg90H21EOLACvtfcHk0lhHYCyBxeHPIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVykurw%253D&md5=8fce66d93ad3af64032d4216ce03663c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DBonifant%26aufirst%3DC.%2BL.%26aulast%3DDiwan%26aufirst%3DB.%2BA.%26aulast%3DSingh%26aufirst%3DS.%2BV.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DFox%26aufirst%3DS.%2BD.%26aulast%3DBuzard%26aufirst%3DG.%2BS.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DWaterhouse%26aufirst%3DD.%2BJ.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DJS-K%252C%2520a%2520Glutathione%252FGlutathione%2520S-Transferase-Activated%2520Nitric%2520Oxide%2520Donor%2520of%2520the%2520Diazeniumdiolate%2520Class%2520with%2520Potent%2520Antineoplastic%2520Activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifant, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanklin, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flippen-Anderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">The Secondary Amine/Nitric Oxide Complex Ion R(2)N[N(O)NO](-) as Nucleophile and Leaving Group in S<sub>N</sub>Ar Reactions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">3090</span><span class="NLM_x">–</span> <span class="NLM_lpage">3098</span><span class="refDoi"> DOI: 10.1021/jo0016529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0016529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=3090-3098&author=J.+E.+Saavedraauthor=A.+Srinivasanauthor=C.+L.+Bonifantauthor=J.+Chuauthor=A.+P.+Shanklinauthor=J.+L.+Flippen-Andersonauthor=W.+G.+Riceauthor=J.+A.+Turpinauthor=K.+M.+Daviesauthor=L.+K.+Keefer&title=The+Secondary+Amine%2FNitric+Oxide+Complex+Ion+R%282%29N%5BN%28O%29NO%5D%28-%29+as+Nucleophile+and+Leaving+Group+in+SNAr+Reactions&doi=10.1021%2Fjo0016529"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjo0016529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0016529%26sid%3Dliteratum%253Aachs%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DBonifant%26aufirst%3DC.%2BL.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DShanklin%26aufirst%3DA.%2BP.%26aulast%3DFlippen-Anderson%26aufirst%3DJ.%2BL.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DTurpin%26aufirst%3DJ.%2BA.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DThe%2520Secondary%2520Amine%252FNitric%2520Oxide%2520Complex%2520Ion%2520R%25282%2529N%255BN%2528O%2529NO%255D%2528-%2529%2520as%2520Nucleophile%2520and%2520Leaving%2520Group%2520in%2520SNAr%2520Reactions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D3090%26epage%3D3098%26doi%3D10.1021%2Fjo0016529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifant, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udupi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaviya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Antitumor Activity of JS-K [O<sup>2</sup>-(2,4-Dinitrophenyl) 1-[(4-Ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and Related O<sup>2</sup>-Aryl Diazeniumdiolates in Vitro and in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4366</span><span class="refDoi"> DOI: 10.1021/jm060022h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060022h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4356-4366&author=P.+J.+Shamiauthor=J.+E.+Saavedraauthor=C.+L.+Bonifantauthor=J.+Chuauthor=V.+Udupiauthor=S.+Malaviyaauthor=B.+I.+Carrauthor=S.+Karauthor=M.+Wangauthor=L.+Jiaauthor=X.+Jiauthor=L.+K.+Keefer&title=Antitumor+Activity+of+JS-K+%5BO2-%282%2C4-Dinitrophenyl%29+1-%5B%284-Ethoxycarbonyl%29piperazin-1-yl%5Ddiazen-1-ium-1%2C2-diolate%5D+and+Related+O2-Aryl+Diazeniumdiolates+in+Vitro+and+in+Vivo&doi=10.1021%2Fjm060022h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm060022h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060022h%26sid%3Dliteratum%253Aachs%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DBonifant%26aufirst%3DC.%2BL.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DUdupi%26aufirst%3DV.%26aulast%3DMalaviya%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DB.%2BI.%26aulast%3DKar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DAntitumor%2520Activity%2520of%2520JS-K%2520%255BO2-%25282%252C4-Dinitrophenyl%2529%25201-%255B%25284-Ethoxycarbonyl%2529piperazin-1-yl%255Ddiazen-1-ium-1%252C2-diolate%255D%2520and%2520Related%2520O2-Aryl%2520Diazeniumdiolates%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4356%26epage%3D4366%26doi%3D10.1021%2Fjm060022h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">McMurtry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieves-Alicea, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span> </span><span class="NLM_article-title">JS-K, a Nitric Oxide-Releasing Prodrug, Induces Breast Cancer Cell Death while Sparing Normal Mammary Epithelial Cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span><span class="refDoi"> DOI: 10.3892/ijo.2011.925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3892%2Fijo.2011.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21271218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ansbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=963-971&author=V.+McMurtryauthor=J.+E.+Saavedraauthor=R.+Nieves-Aliceaauthor=A.+M.+Simeoneauthor=L.+K.+Keeferauthor=A.+M.+Tari&title=JS-K%2C+a+Nitric+Oxide-Releasing+Prodrug%2C+Induces+Breast+Cancer+Cell+Death+while+Sparing+Normal+Mammary+Epithelial+Cells&doi=10.3892%2Fijo.2011.925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells</span></div><div class="casAuthors">McMurtry, Vanity; Saavedra, Joseph E.; Nieves-Alicea, Rene; Simeone, Ann-Marie; Keefer, Larry K.; Tari, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">963-971</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Targeted therapy with reduced side effects is a major goal in cancer research.  We investigated the effects of JS-K, a nitric oxide (NO) prodrug designed to release high levels of NO when suitably activated, on human breast cancer cell lines, on non-transformed human MCF-10A mammary cells, and on normal human mammary epithelial cells (HMECs).  Cell viability assay, flow cytometry, electron microscopy, and Western blot anal. were used to study the effects of JS-K on breast cancer and on mammary epithelial cells.  After a 3-day incubation, the IC50s of JS-K against the breast cancer cells ranged from 0.8 to 3 μM.  However, JS-K decreased the viability of the MCF-10A cells by only 20% at 10-μM concn., and HMECs were unaffected by 10 μM JS-K.  Flow cytometry indicated that JS-K increased the percentages of breast cancer cells under-going apoptosis.  Interestingly, flow cytometry indicated that JS-K increased acidic vesicle organelle formation in breast cancer cells, suggesting that JS-K induced autophagy in breast cancer cells.  Electron microscopy confirmed that JS-K-treated breast cancer cells underwent autophagic cell death.  Western blot anal. showed that JS-K induced the expression of microtubule light chain 3-II, another autophagy marker, in breast cancer cells.  However, JS-K did not induce apoptosis or autophagy in normal human mammary epithelial cells.  These data indicate that JS-K selectively induces programmed cell death in breast cancer cells while sparing normal mammary epithelial cells under the same conditions.  The selective antitumor activity of JS-K warrants its further investigation in breast tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTq-8Uk8jxErVg90H21EOLACvtfcHk0lie62s_jiFC7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ansbY%253D&md5=2b6454ea99b81468c4d99c8efb8fbc94</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3892%2Fijo.2011.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2011.925%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurtry%26aufirst%3DV.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DNieves-Alicea%26aufirst%3DR.%26aulast%3DSimeone%26aufirst%3DA.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DTari%26aufirst%3DA.%2BM.%26atitle%3DJS-K%252C%2520a%2520Nitric%2520Oxide-Releasing%2520Prodrug%252C%2520Induces%2520Breast%2520Cancer%2520Cell%2520Death%2520while%2520Sparing%2520Normal%2520Mammary%2520Epithelial%2520Cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3D963%26epage%3D971%26doi%3D10.3892%2Fijo.2011.925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuellar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span><span class="refDoi"> DOI: 10.1021/jm050700k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050700k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1157-1164&author=J.+E.+Saavedraauthor=A.+Srinivasanauthor=G.+S.+Buzardauthor=K.+M.+Daviesauthor=D.+J.+Waterhouseauthor=K.+Inamiauthor=T.+C.+Wildeauthor=M.+L.+Citroauthor=M.+Cuellarauthor=J.+R.+Deschampsauthor=D.+Parrishauthor=P.+J.+Shamiauthor=V.+J.+Findlayauthor=D.+M.+Townsendauthor=K.+D.+Tewauthor=S.+Singhauthor=L.+Jiaauthor=X.+Jiauthor=L.+K.+Keefer&title=PABA%2FNO+as+an+Anticancer+Lead%3A+Analogue+Synthesis%2C+Structure+Revision%2C+Solution+Chemistry%2C+Reactivity+toward+Glutathione%2C+and+in+Vitro+Activity&doi=10.1021%2Fjm050700k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity</span></div><div class="casAuthors">Saavedra, Joseph E.; Srinivasan, Aloka; Buzard, Gregory S.; Davies, Keith M.; Waterhouse, David J.; Inami, Keiko; Wilde, Thomas C.; Citro, Michael L.; Cuellar, Matthew; Deschamps, Jeffrey R.; Parrish, Damon; Shami, Paul J.; Findlay, Victoria J.; Townsend, Danyelle M.; Tew, Kenneth D.; Singh, Shivendra; Jia, Lee; Ji, Xinhua; Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1157-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PABA/NO is a diazeniumdiolate of structure Me2NN(O):NOAr (where Ar is a 5-substituted-2,4-dinitrophenyl ring whose 5-substituent is N-methyl-p-aminobenzoic acid).  It has shown activity against human ovarian cancer xenografts in mice rivaling that of cisplatin, but it is poorly sol. and relatively unstable in water.  Here the authors report structure-based optimization efforts resulting in three analogs with improved soly. and stability in aq. soln.  The authors sought to explain PABA/NO's physicochem. uniqueness among these four compds., whose aminobenzoic acid precursors differ structurally only in the presence or absence of the N-Me group and/or the position of the carboxyl moiety (meta or para).  Studies revealed that PABA/NO's N-methyl-p-aminobenzoic acid substituent is bound to the dinitrobenzene ring via its carboxyl oxygen while the other three are linked through the aniline nitrogen.  This constitutes a revision of the previously published PABA/NO structure.  All four analogs reacted with GSH to produce bioactive nitric oxide (NO), but PABA/NO was the most reactive.  Consistent with PABA/NO's potent suppression of A2780 human ovarian cancer xenograft growth in mice, it was the most potent of the four in the OVCAR-3 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6_G3hkDYlCrVg90H21EOLACvtfcHk0ljLNrpqBpTpVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGnsg%253D%253D&md5=93c8ea5bcdf33ee7d920099bac125794</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm050700k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050700k%26sid%3Dliteratum%253Aachs%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DBuzard%26aufirst%3DG.%2BS.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DWaterhouse%26aufirst%3DD.%2BJ.%26aulast%3DInami%26aufirst%3DK.%26aulast%3DWilde%26aufirst%3DT.%2BC.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DCuellar%26aufirst%3DM.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DParrish%26aufirst%3DD.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DFindlay%26aufirst%3DV.%2BJ.%26aulast%3DTownsend%26aufirst%3DD.%2BM.%26aulast%3DTew%26aufirst%3DK.%2BD.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DPABA%252FNO%2520as%2520an%2520Anticancer%2520Lead%253A%2520Analogue%2520Synthesis%252C%2520Structure%2520Revision%252C%2520Solution%2520Chemistry%252C%2520Reactivity%2520toward%2520Glutathione%252C%2520and%2520in%2520Vitro%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1157%26epage%3D1164%26doi%3D10.1021%2Fjm050700k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Chakrapani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodblatt, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span> </span><span class="NLM_article-title">Synthesis, Nitric Oxide Release, and Anti-Leukemic Activity of Glutathione-Activated Nitric Oxide Prodrugs: Structural Analogues of PABA/NO, an Anti-Cancer Lead Compound</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.11.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2007.11.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2657-2664&author=H.+Chakrapaniauthor=T.+C.+Wildeauthor=M.+L.+Citroauthor=M.+M.+Goodblattauthor=L.+K.+Keeferauthor=J.+E.+Saavedra&title=Synthesis%2C+Nitric+Oxide+Release%2C+and+Anti-Leukemic+Activity+of+Glutathione-Activated+Nitric+Oxide+Prodrugs%3A+Structural+Analogues+of+PABA%2FNO%2C+an+Anti-Cancer+Lead+Compound&doi=10.1016%2Fj.bmc.2007.11.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.035%26sid%3Dliteratum%253Aachs%26aulast%3DChakrapani%26aufirst%3DH.%26aulast%3DWilde%26aufirst%3DT.%2BC.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DGoodblatt%26aufirst%3DM.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%252C%2520Nitric%2520Oxide%2520Release%252C%2520and%2520Anti-Leukemic%2520Activity%2520of%2520Glutathione-Activated%2520Nitric%2520Oxide%2520Prodrugs%253A%2520Structural%2520Analogues%2520of%2520PABA%252FNO%252C%2520an%2520Anti-Cancer%2520Lead%2520Compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2657%26epage%3D2664%26doi%3D10.1016%2Fj.bmc.2007.11.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Maciag, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandurdikar, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diwan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span> </span><span class="NLM_article-title">Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7751</span><span class="NLM_x">–</span> <span class="NLM_lpage">7758</span><span class="refDoi"> DOI: 10.1021/jm2004128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2004128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7751-7758&author=A.+E.+Maciagauthor=R.+S.+Nandurdikarauthor=S.+Y.+Hongauthor=H.+Chakrapaniauthor=B.+Diwanauthor=N.+L.+Morrisauthor=P.+J.+Shamiauthor=Y.+H.+Shiaoauthor=L.+M.+Andersonauthor=L.+K.+Keeferauthor=J.+E.+Saavedra&title=Activation+of+the+c-Jun+N-terminal+Kinase%2FActivating+Transcription+Factor+3+%28ATF3%29+Pathway+Characterizes+Effective+Arylated+Diazeniumdiolate-Based+Nitric+Oxide-Releasing+Anticancer+Prodrugs&doi=10.1021%2Fjm2004128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm2004128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004128%26sid%3Dliteratum%253Aachs%26aulast%3DMaciag%26aufirst%3DA.%2BE.%26aulast%3DNandurdikar%26aufirst%3DR.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BY.%26aulast%3DChakrapani%26aufirst%3DH.%26aulast%3DDiwan%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DN.%2BL.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DShiao%26aufirst%3DY.%2BH.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26atitle%3DActivation%2520of%2520the%2520c-Jun%2520N-terminal%2520Kinase%252FActivating%2520Transcription%2520Factor%25203%2520%2528ATF3%2529%2520Pathway%2520Characterizes%2520Effective%2520Arylated%2520Diazeniumdiolate-Based%2520Nitric%2520Oxide-Releasing%2520Anticancer%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7751%26epage%3D7758%26doi%3D10.1021%2Fjm2004128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Nandurdikar, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span> </span><span class="NLM_article-title">Structural Modifications Modulate Stability of Glutathione-Activated Arylated Diazeniumdiolate Prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3094</span><span class="NLM_x">–</span> <span class="NLM_lpage">3099</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.02.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2012.02.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3094-3099&author=R.+S.+Nandurdikarauthor=A.+E.+Maciagauthor=R.+J.+Hollandauthor=Z.+Caoauthor=P.+J.+Shamiauthor=L.+M.+Andersonauthor=L.+K.+Keeferauthor=J.+E.+Saavedra&title=Structural+Modifications+Modulate+Stability+of+Glutathione-Activated+Arylated+Diazeniumdiolate+Prodrugs&doi=10.1016%2Fj.bmc.2012.02.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.02.045%26sid%3Dliteratum%253Aachs%26aulast%3DNandurdikar%26aufirst%3DR.%2BS.%26aulast%3DMaciag%26aufirst%3DA.%2BE.%26aulast%3DHolland%26aufirst%3DR.%2BJ.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26atitle%3DStructural%2520Modifications%2520Modulate%2520Stability%2520of%2520Glutathione-Activated%2520Arylated%2520Diazeniumdiolate%2520Prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3094%26epage%3D3099%26doi%3D10.1016%2Fj.bmc.2012.02.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Xue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Diazeniumdiolate-Based DNA Cross-Linking Agents Activatable by Glutathione S-Transferase</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5196</span><span class="NLM_x">–</span> <span class="NLM_lpage">5199</span><span class="refDoi"> DOI: 10.1021/acs.orglett.6b02222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b02222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=5196-5199&author=R.+Xueauthor=J.+Wuauthor=X.+Luoauthor=Y.+Gongauthor=Y.+Huangauthor=X.+Shenauthor=H.+Zhangauthor=Y.+Zhangauthor=Z.+Huang&title=Design%2C+Synthesis%2C+and+Evaluation+of+Diazeniumdiolate-Based+DNA+Cross-Linking+Agents+Activatable+by+Glutathione+S-Transferase&doi=10.1021%2Facs.orglett.6b02222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b02222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b02222%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Diazeniumdiolate-Based%2520DNA%2520Cross-Linking%2520Agents%2520Activatable%2520by%2520Glutathione%2520S-Transferase%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D5196%26epage%3D5199%26doi%3D10.1021%2Facs.orglett.6b02222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Danson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranson, M.</span><span> </span><span class="NLM_article-title">DT-Diaphorase: a Target for New Anticancer Drugs</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1016/j.ctrv.2004.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.ctrv.2004.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15245776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=437-449&author=S.+Dansonauthor=T.+H.+Wardauthor=J.+Butlerauthor=M.+Ranson&title=DT-Diaphorase%3A+a+Target+for+New+Anticancer+Drugs&doi=10.1016%2Fj.ctrv.2004.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase: a target for new anticancer drugs</span></div><div class="casAuthors">Danson, S.; Ward, T. H.; Butler, J.; Ranson, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">437-449</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  DT-diaphorase (DTD) is an obligate two-electron reductase which bioactivates chemotherapeutic quinones.  DTD levels are elevated in a no. of tumor types, including non-small cell lung carcinoma, colorectal carcinoma, liver cancers and breast carcinomas, when compared to the surrounding normal tissue.  The differential in DTD between tumor and normal tissue should allow targeted activation of chemotherapeutic quinones in the tumor while minimizing normal tissue toxicity.  The prototypical bioreductive drug is Mitomycin C (MMC) which is widely used in clin. practice.  However, MMC is actually a relatively poor substrate for DTD and its metab. is pH-dependent.  Other bioreductive drugs have failed because of poor soly. and inability to surpass other agents in use.  RH1, a novel diaziridinylbenzoquinone, is a more efficient substrate for DTD.  It has been demonstrated to have antitumor effects both in vitro and in vivo and demonstrates a relation between DTD expression levels and drug response.  RH1 has recently entered a phase I clin. trial in solid tumors under the auspices of Cancer Research UK.  Recent work has demonstrated that DTD is present in the nucleus and is assocd. with both p53 and the heat shock protein, HSP-70.  Furthermore, DTD is inducible by several non-toxic compds. and therefor much interest has focused on increasing the differential in DTD levels between tumor and normal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTa2ivqkvQC7Vg90H21EOLACvtfcHk0lhVDARybHEYbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyiu7o%253D&md5=9a43dc5c2a78dbf513a7a775b80082b3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2004.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2004.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DDanson%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DT.%2BH.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DRanson%26aufirst%3DM.%26atitle%3DDT-Diaphorase%253A%2520a%2520Target%2520for%2520New%2520Anticancer%2520Drugs%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2004%26volume%3D30%26spage%3D437%26epage%3D449%26doi%3D10.1016%2Fj.ctrv.2004.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Hernick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borch, R. F.</span><span> </span><span class="NLM_article-title">Studies on the Mechanisms of Activation of Indolequinone Phosphoramidate Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span><span class="refDoi"> DOI: 10.1021/jm0203229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0203229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=148-154&author=M.+Hernickauthor=R.+F.+Borch&title=Studies+on+the+Mechanisms+of+Activation+of+Indolequinone+Phosphoramidate+Prodrugs&doi=10.1021%2Fjm0203229"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm0203229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0203229%26sid%3Dliteratum%253Aachs%26aulast%3DHernick%26aufirst%3DM.%26aulast%3DBorch%26aufirst%3DR.%2BF.%26atitle%3DStudies%2520on%2520the%2520Mechanisms%2520of%2520Activation%2520of%2520Indolequinone%2520Phosphoramidate%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D148%26epage%3D154%26doi%3D10.1021%2Fjm0203229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Hernick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flader, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borch, R. F.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Indolequinone Phosphoramidate Prodrugs Targeted to DT-Diaphorase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3540</span><span class="NLM_x">–</span> <span class="NLM_lpage">3548</span><span class="refDoi"> DOI: 10.1021/jm020191b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020191b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3540-3548&author=M.+Hernickauthor=C.+Fladerauthor=R.+F.+Borch&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Indolequinone+Phosphoramidate+Prodrugs+Targeted+to+DT-Diaphorase&doi=10.1021%2Fjm020191b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm020191b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020191b%26sid%3Dliteratum%253Aachs%26aulast%3DHernick%26aufirst%3DM.%26aulast%3DFlader%26aufirst%3DC.%26aulast%3DBorch%26aufirst%3DR.%2BF.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Indolequinone%2520Phosphoramidate%2520Prodrugs%2520Targeted%2520to%2520DT-Diaphorase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3540%26epage%3D3548%26doi%3D10.1021%2Fjm020191b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">The Synthesis of a c(RGDyK) Targeted SN38 Prodrug with an Indolequinone Structure for Bioreductive Drug Release</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1021/ol1002626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol1002626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1384-1387&author=B.+Huangauthor=A.+Desaiauthor=S.+Tangauthor=T.+P.+Thomasauthor=J.+R.+Baker&title=The+Synthesis+of+a+c%28RGDyK%29+Targeted+SN38+Prodrug+with+an+Indolequinone+Structure+for+Bioreductive+Drug+Release&doi=10.1021%2Fol1002626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release</span></div><div class="casAuthors">Huang, Baohua; Desai, Ankur; Tang, Shengzhuang; Thomas, Thommey P.; Baker, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1384-1387</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prepn. of a novel c(RGDyK) targeted SN38 prodrug incorporating an indolequinone structure for bioreductively triggered drug release is described.  This design yields a prodrug that targets surface mols. on tumor cells (αvβ3 integrins) and releases drug under bioreductive conditions.  There are three moieties in the prodrug design, namely a therapeutic drug SN38, an indolequinone structure serving as a drug releasing trigger, and an αvβ3 integrin targeting peptide c(RGDyK).  Preliminary studies showed that SN38 is released in the presence of a bioreductive enzyme (DT-diaphorase).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMclRawXbgtLVg90H21EOLACvtfcHk0ljZlXKjXeDOFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D&md5=36b6b14c51b9834b7f656e3cc72fce2f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fol1002626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1002626%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DDesai%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DT.%2BP.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Synthesis%2520of%2520a%2520c%2528RGDyK%2529%2520Targeted%2520SN38%2520Prodrug%2520with%2520an%2520Indolequinone%2520Structure%2520for%2520Bioreductive%2520Drug%2520Release%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1384%26epage%3D1387%26doi%3D10.1021%2Fol1002626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Sharma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2636</span><span class="NLM_x">–</span> <span class="NLM_lpage">2639</span><span class="refDoi"> DOI: 10.1021/ol400884v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol400884v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2636-2639&author=K.+Sharmaauthor=A.+Iyerauthor=K.+Senguptaauthor=H.+Chakrapani&title=INDQ%2FNO%2C+a+Bioreductively+Activated+Nitric+Oxide+Prodrug&doi=10.1021%2Fol400884v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug</span></div><div class="casAuthors">Sharma, Kavita; Iyer, Aishwarya; Sengupta, Kundan; Chakrapani, Harinath</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2636-2639</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and development of INDQ/NO (I), a novel nitric oxide (NO) prodrug targeted by a bioreductive trigger, are described.  INDQ/NO, an indolequinone-diazeniumdiolate is found to be metabolized to produce NO by DT-diaphorase, a bioreductive enzyme that is overexpressed in certain cancers and hypoxic tumors.  Cell-based assays revealed that INDQ/NO induces DNA damage and is a potent inhibitor of cancer cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRYc6gjSC-QLVg90H21EOLACvtfcHk0ljZlXKjXeDOFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D&md5=3ccdb7f8bc30a84663f69eacae91b506</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fol400884v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol400884v%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DSengupta%26aufirst%3DK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DINDQ%252FNO%252C%2520a%2520Bioreductively%2520Activated%2520Nitric%2520Oxide%2520Prodrug%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D2636%26epage%3D2639%26doi%3D10.1021%2Fol400884v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Tranoy-Opalinski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papot, S.</span><span> </span><span class="NLM_article-title">Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.2174/187152008785133065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F187152008785133065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18690826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ogsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=618-637&author=I.+Tranoy-Opalinskiauthor=A.+Fernandesauthor=M.+Thomasauthor=J.+P.+Gessonauthor=S.+Papot&title=Design+of+Self-Immolative+Linkers+for+Tumour-Activated+Prodrug+Therapy&doi=10.2174%2F187152008785133065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Design of self-immolative linkers for tumour-activated prodrug therapy</span></div><div class="casAuthors">Tranoy-Opalinski, I.; Fernandes, A.; Thomas, M.; Gesson, J.-P.; Papot, S.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-637</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The main drawback of most cancer chemotherapy is its relatively low ability to target tumor cells vs. normal cells.  As a consequence, chemotherapy is usually connected with severe side effects due to the toxicity of traditional cytostatic agents towards normal tissues.  A few years ago, the site-specific activation of nontoxic prodrugs in tumors has been proposed in order to enhance the selectivity for the killing of cancer cells.  Within this framework, most of the prodrugs that have been designed were three part compds. comprising trigger, linker and effector units.  The main function of the linker is to release the effector unit after selective trigger activation via a spontaneous chem. breakdown.  However, its structure also affects significantly many prodrug properties such as stability, pharmacokinetic, organ distribution, bioavailability or trigger activation.  This review, focussed on the linker unit, is an update of the previous article published in 2002.  It deals with recent advances in the design of prodrug linkers including new delivery systems such as elongated linkers or self-immolative dendrimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeb-2jcsWQx7Vg90H21EOLACvtfcHk0ljZlXKjXeDOFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ogsr8%253D&md5=c11a530c32537ef25c5789e0a8573d91</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.2174%2F187152008785133065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152008785133065%26sid%3Dliteratum%253Aachs%26aulast%3DTranoy-Opalinski%26aufirst%3DI.%26aulast%3DFernandes%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DPapot%26aufirst%3DS.%26atitle%3DDesign%2520of%2520Self-Immolative%2520Linkers%2520for%2520Tumour-Activated%2520Prodrug%2520Therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D618%26epage%3D637%26doi%3D10.2174%2F187152008785133065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Sharma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">Nitroreductase-Activated Nitric Oxide (NO) Prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5964</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2013.08.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5964-5967&author=K.+Sharmaauthor=K.+Senguptaauthor=H.+Chakrapani&title=Nitroreductase-Activated+Nitric+Oxide+%28NO%29+Prodrugs&doi=10.1016%2Fj.bmcl.2013.08.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.066%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DSengupta%26aufirst%3DK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DNitroreductase-Activated%2520Nitric%2520Oxide%2520%2528NO%2529%2520Prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5964%26epage%3D5967%26doi%3D10.1016%2Fj.bmcl.2013.08.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Dharmaraja, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">Arylboronate Ester Based Diazeniumdiolates (BORO/NO), a Class of Hdrogen Peroxide Inducible Nitric Oxide (NO) Donors</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2610</span><span class="NLM_x">–</span> <span class="NLM_lpage">2613</span><span class="refDoi"> DOI: 10.1021/ol5010643</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5010643" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=2610-2613&author=A.+T.+Dharmarajaauthor=G.+Ravikumarauthor=H.+Chakrapani&title=Arylboronate+Ester+Based+Diazeniumdiolates+%28BORO%2FNO%29%2C+a+Class+of+Hdrogen+Peroxide+Inducible+Nitric+Oxide+%28NO%29+Donors&doi=10.1021%2Fol5010643"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fol5010643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5010643%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26aulast%3DRavikumar%26aufirst%3DG.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DArylboronate%2520Ester%2520Based%2520Diazeniumdiolates%2520%2528BORO%252FNO%2529%252C%2520a%2520Class%2520of%2520Hdrogen%2520Peroxide%2520Inducible%2520Nitric%2520Oxide%2520%2528NO%2529%2520Donors%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D2610%26epage%3D2613%26doi%3D10.1021%2Fol5010643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Glycosylated Diazeniumdiolates: a Novel Class of Enzyme-Activated Nitric Oxide Donors</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3779</span><span class="NLM_x">–</span> <span class="NLM_lpage">3782</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)00614-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS0040-4039%2801%2900614-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=3779-3782&author=X.+Wuauthor=X.+Tangauthor=M.+Xianauthor=P.+G.+Wang&title=Glycosylated+Diazeniumdiolates%3A+a+Novel+Class+of+Enzyme-Activated+Nitric+Oxide+Donors&doi=10.1016%2FS0040-4039%2801%2900614-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900614-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900614-1%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXian%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DGlycosylated%2520Diazeniumdiolates%253A%2520a%2520Novel%2520Class%2520of%2520Enzyme-Activated%2520Nitric%2520Oxide%2520Donors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D3779%26epage%3D3782%26doi%3D10.1016%2FS0040-4039%2801%2900614-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">A Glycosylated Nitric Oxide Donor, beta-Gal-NONOate, and Its Site-Specific Antitumor Activity</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span><span class="refDoi"> DOI: 10.1002/ardp.200500262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fardp.200500262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16783837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVCntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2006&pages=366-371&author=C.+Chenauthor=Y.+Shiauthor=S.+Liauthor=Q.+Qiauthor=L.+Guauthor=J.+Songauthor=P.+G.+Wang&title=A+Glycosylated+Nitric+Oxide+Donor%2C+beta-Gal-NONOate%2C+and+Its+Site-Specific+Antitumor+Activity&doi=10.1002%2Fardp.200500262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A glycosylated nitric oxide donor, β-Gal-NONOate, and its site-specific antitumor activity</span></div><div class="casAuthors">Chen, Chang; Shi, Yanqiu; Li, Song; Qi, Qingsheng; Gu, Li; Song, Jing; Wang, Peng George</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">366-371</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">So far, nitric oxide (NO) donors have been applied to various aspects of antitumor therapy.  To selectively sensitize tumor cells and avoid unwanted side effects, we recently synthesized a β-galactosidase-activatable NO-releasing compd., β-galactosyl-pyrrolidinyl diazeniumdiolate (β-Gal-NONOate).  In this study, we first verified its superiority over its parent diazeniumdiolate (NONOate) in terms of targeted intracellular NO-releasing and antitumor activity with 9L/LacZ cells (rat glioma cell line 9L with transformed LacZ gene) in vitro.  β-Gal-NONOate only released NO when hydrolyzed by induced β-galactosidase in 9L/LacZ cells, which led to its more powerful cytotoxicity than that of NONOate.  The results showed that β-Gal-NONOate produced higher NO levels than NONOate in 9L/LacZ cells at equal concn., and hence induced optimal NO levels for antitumor activity.  However, in 9L cells, β-Gal-NONOate showed less toxicity than NONOate.  Therefore, it is demonstrated that β-Gal-NONOate is a site-specific prodrug for targeting NO intracellularly as a β-galactosidase-sensitive NO donor, and it is also expected to be a promising probe in numerous exptl. settings and a potential therapeutic drug for antitumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAn8ARlq47MrVg90H21EOLACvtfcHk0ljlKJyj_IsLPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVCntb4%253D&md5=b2405c0574573df391bc1afb38024aa0</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fardp.200500262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200500262%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DA%2520Glycosylated%2520Nitric%2520Oxide%2520Donor%252C%2520beta-Gal-NONOate%252C%2520and%2520Its%2520Site-Specific%2520Antitumor%2520Activity%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2006%26volume%3D339%26spage%3D366%26epage%3D371%26doi%3D10.1002%2Fardp.200500262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Cai, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Sialated Diazeniumdiolate: A New Sialidase-Activated Nitric Oxide Donor</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4203</span><span class="NLM_x">–</span> <span class="NLM_lpage">4205</span><span class="refDoi"> DOI: 10.1021/ol048397p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol048397p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4203-4205&author=T.+B.+Caiauthor=D.+Luauthor=M.+Landerholmauthor=P.+G.+Wang&title=Sialated+Diazeniumdiolate%3A+A+New+Sialidase-Activated+Nitric+Oxide+Donor&doi=10.1021%2Fol048397p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fol048397p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048397p%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DT.%2BB.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DLanderholm%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DSialated%2520Diazeniumdiolate%253A%2520A%2520New%2520Sialidase-Activated%2520Nitric%2520Oxide%2520Donor%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4203%26epage%3D4205%26doi%3D10.1021%2Fol048397p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Valdez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Gayar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleicher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Hydrolytic Reactivity Trends among Potential Prodrugs of the O<sup>2</sup>-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3961</span><span class="NLM_x">–</span> <span class="NLM_lpage">3970</span><span class="refDoi"> DOI: 10.1021/jm8000482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8000482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3961-3970&author=C.+A.+Valdezauthor=J.+E.+Saavedraauthor=B.+M.+Showalterauthor=K.+M.+Daviesauthor=T.+C.+Wildeauthor=M.+L.+Citroauthor=J.+J.+Barchiauthor=J.+R.+Deschampsauthor=D.+Parrishauthor=S.+El-Gayarauthor=U.+Schleicherauthor=C.+Bogdanauthor=L.+K.+Keefer&title=Hydrolytic+Reactivity+Trends+among+Potential+Prodrugs+of+the+O2-Glycosylated+Diazeniumdiolate+Family.+Targeting+Nitric+Oxide+to+Macrophages+for+Antileishmanial+Activity&doi=10.1021%2Fjm8000482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm8000482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8000482%26sid%3Dliteratum%253Aachs%26aulast%3DValdez%26aufirst%3DC.%2BA.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DShowalter%26aufirst%3DB.%2BM.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DWilde%26aufirst%3DT.%2BC.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DParrish%26aufirst%3DD.%26aulast%3DEl-Gayar%26aufirst%3DS.%26aulast%3DSchleicher%26aufirst%3DU.%26aulast%3DBogdan%26aufirst%3DC.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DHydrolytic%2520Reactivity%2520Trends%2520among%2520Potential%2520Prodrugs%2520of%2520the%2520O2-Glycosylated%2520Diazeniumdiolate%2520Family.%2520Targeting%2520Nitric%2520Oxide%2520to%2520Macrophages%2520for%2520Antileishmanial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3961%26epage%3D3970%26doi%3D10.1021%2Fjm8000482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Naimi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalili, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiebe, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, E. E.</span><span> </span><span class="NLM_article-title">Synthesis of 3′- and 5′-Nitrooxy Pyrimidine Nucleoside Nitrate Esters: "Nitric Oxide Donor" Agents for Evaluation as Anticancer and Antiviral Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1021/jm020299r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020299r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=995-1004&author=E.+Naimiauthor=A.+Zhouauthor=P.+Khaliliauthor=L.+I.+Wiebeauthor=J.+Balzariniauthor=E.+De+Clercqauthor=E.+E.+Knaus&title=Synthesis+of+3%E2%80%B2-+and+5%E2%80%B2-Nitrooxy+Pyrimidine+Nucleoside+Nitrate+Esters%3A+%22Nitric+Oxide+Donor%22+Agents+for+Evaluation+as+Anticancer+and+Antiviral+Agents&doi=10.1021%2Fjm020299r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm020299r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020299r%26sid%3Dliteratum%253Aachs%26aulast%3DNaimi%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DKhalili%26aufirst%3DP.%26aulast%3DWiebe%26aufirst%3DL.%2BI.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26atitle%3DSynthesis%2520of%25203%25E2%2580%25B2-%2520and%25205%25E2%2580%25B2-Nitrooxy%2520Pyrimidine%2520Nucleoside%2520Nitrate%2520Esters%253A%2520%2522Nitric%2520Oxide%2520Donor%2522%2520Agents%2520for%2520Evaluation%2520as%2520Anticancer%2520and%2520Antiviral%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D995%26epage%3D1004%26doi%3D10.1021%2Fjm020299r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Nitric Oxide-Releasing Hybrids from Gemcitabine and Phenylsulfonyl Furoxans as Anti-Tumor Agents</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.1039/C5MD00158G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FC5MD00158G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1130-1136&author=X.+H.+Liauthor=X.+M.+Wangauthor=C.+J.+Xuauthor=J.+K.+Huangauthor=C.+N.+Wangauthor=X.+Y.+Wangauthor=L.+Q.+Heauthor=Y.+Ling&title=Synthesis+and+Biological+Evaluation+of+Nitric+Oxide-Releasing+Hybrids+from+Gemcitabine+and+Phenylsulfonyl+Furoxans+as+Anti-Tumor+Agents&doi=10.1039%2FC5MD00158G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1039%2FC5MD00158G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00158G%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DXu%26aufirst%3DC.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DC.%2BN.%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DHe%26aufirst%3DL.%2BQ.%26aulast%3DLing%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520Hybrids%2520from%2520Gemcitabine%2520and%2520Phenylsulfonyl%2520Furoxans%2520as%2520Anti-Tumor%2520Agents%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1130%26epage%3D1136%26doi%3D10.1039%2FC5MD00158G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Antitumor Platinum(II) Complexes Containing Platinum-Based Moieties of Present Platinum Drugs and Furoxan Groups as Nitric Oxide Donors: Synthesis, DNA Interaction, and Cytotoxicity</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">10317</span><span class="NLM_x">–</span> <span class="NLM_lpage">10324</span><span class="refDoi"> DOI: 10.1021/ic301374z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic301374z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=10317-10324&author=J.+Zhaoauthor=S.+Gouauthor=Y.+Sunauthor=L.+Fangauthor=Z.+Wang&title=Antitumor+Platinum%28II%29+Complexes+Containing+Platinum-Based+Moieties+of+Present+Platinum+Drugs+and+Furoxan+Groups+as+Nitric+Oxide+Donors%3A+Synthesis%2C+DNA+Interaction%2C+and+Cytotoxicity&doi=10.1021%2Fic301374z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fic301374z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic301374z%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAntitumor%2520Platinum%2528II%2529%2520Complexes%2520Containing%2520Platinum-Based%2520Moieties%2520of%2520Present%2520Platinum%2520Drugs%2520and%2520Furoxan%2520Groups%2520as%2520Nitric%2520Oxide%2520Donors%253A%2520Synthesis%252C%2520DNA%2520Interaction%252C%2520and%2520Cytotoxicity%26jtitle%3DInorg.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D10317%26epage%3D10324%26doi%3D10.1021%2Fic301374z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. M.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donor-Based Platinum Complexes as Potential Anticancer Agents</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">14276</span><span class="NLM_x">–</span> <span class="NLM_lpage">14281</span><span class="refDoi"> DOI: 10.1002/chem.201201605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fchem.201201605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23015473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=14276-14281&author=J.+Zhaoauthor=S.+H.+Gouauthor=Y.+Y.+Sunauthor=R.+T.+Yinauthor=Z.+M.+Wang&title=Nitric+Oxide+Donor-Based+Platinum+Complexes+as+Potential+Anticancer+Agents&doi=10.1002%2Fchem.201201605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Donor-Based Platinum Complexes as Potential Anticancer Agents</span></div><div class="casAuthors">Zhao, Jian; Gou, Shaohua; Sun, Yanyan; Yin, Runting; Wang, Zhimei</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14276-14281, S14276/1-S14276/14</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Several platinum complexes contg. nitrooxy acetate or 3-(nitrooxy)cyclobutane-1,1-dicarboxylate were synthesized and characterized.  The human anticancer activity of the complexes were studied.  The DNA binding activity of the complexes was also studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfqxDcMs5D7Vg90H21EOLACvtfcHk0ljBUL-zZd92Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtr%252FL&md5=a97e8528f669f61a284ef43e27550d51</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1002%2Fchem.201201605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201201605%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DY.%2BY.%26aulast%3DYin%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DZ.%2BM.%26atitle%3DNitric%2520Oxide%2520Donor-Based%2520Platinum%2520Complexes%2520as%2520Potential%2520Anticancer%2520Agents%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2012%26volume%3D18%26spage%3D14276%26epage%3D14281%26doi%3D10.1002%2Fchem.201201605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Bian, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. F.</span><span> </span><span class="NLM_article-title">Novel Antileukemic Agents Derived from Tamibarotene and Nitric Oxide Donors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7025</span><span class="NLM_x">–</span> <span class="NLM_lpage">7029</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2011.09.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7025-7029&author=H.+Y.+Bianauthor=J.+H.+Fengauthor=M.+Y.+Liauthor=W.+F.+Xu&title=Novel+Antileukemic+Agents+Derived+from+Tamibarotene+and+Nitric+Oxide+Donors&doi=10.1016%2Fj.bmcl.2011.09.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.103%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DH.%2BY.%26aulast%3DFeng%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DW.%2BF.%26atitle%3DNovel%2520Antileukemic%2520Agents%2520Derived%2520from%2520Tamibarotene%2520and%2520Nitric%2520Oxide%2520Donors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7025%26epage%3D7029%26doi%3D10.1016%2Fj.bmcl.2011.09.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. X.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Nitric Oxide-Donating Thalidomide Analogues as Anticancer Agents</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1002/cbdv.200800014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fcbdv.200800014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=19353543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=466-474&author=T.+Wangauthor=Y.+H.+Zhangauthor=X.+W.+Kongauthor=Y.+S.+Laiauthor=H.+Jiauthor=Y.+P.+Chenauthor=S.+X.+Peng&title=Synthesis+and+Biological+Evaluation+of+Nitric+Oxide-Donating+Thalidomide+Analogues+as+Anticancer+Agents&doi=10.1002%2Fcbdv.200800014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents</span></div><div class="casAuthors">Wang, Tao; Zhang, Yi-Hua; Kong, Xiang-Wen; Lai, Yi-Sheng; Ji, Hui; Chen, Yan-Ping; Peng, Si-Xun</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-474</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">In search of more potent anticancer agents, 15 nitric oxide (NO)-donating thalidomide analogs, e.g. I [X = (CH2)2, (CH2)3, CHMe(CH2)2, (CH2)4] were designed and synthesized.  Cytotoxicity of these compds. was evaluated in vitro against three human tumor cell lines (HepG2, A549, and PC-3).  The results indicated that I [X = (CH2)2, (CH2)3, CHMe(CH2)2, (CH2)4] exhibited notable anticancer activities comparable to or stronger than that of 5-fluorouracil (5-FU).  Structure-activity relationships were also discussed, based on the exptl. data obtained.  Generally, the cytotoxic activity of target compds. is closely related to the type of NO donors, and the length of the spacers connecting to NO donors also appears important for the bioactivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAx3kHdVYDP7Vg90H21EOLACvtfcHk0ljTInr_BIs8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWgs78%253D&md5=5550fed1a768a0185674524948f4577e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200800014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200800014%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DKong%26aufirst%3DX.%2BW.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Nitric%2520Oxide-Donating%2520Thalidomide%2520Analogues%2520as%2520Anticancer%2520Agents%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D466%26epage%3D474%26doi%3D10.1002%2Fcbdv.200800014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Nortcliffe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Hagan, D.</span><span> </span><span class="NLM_article-title">Synthesis and Anticancer Properties of RGD Peptides Conjugated to Nitric Oxide Releasing Functional Groups and Abiraterone</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8343</span><span class="NLM_x">–</span> <span class="NLM_lpage">8347</span><span class="refDoi"> DOI: 10.1016/j.tet.2014.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.tet.2014.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=8343-8347&author=A.+Nortcliffeauthor=I.+N.+Flemingauthor=N.+P.+Bottingauthor=D.+O%E2%80%99Hagan&title=Synthesis+and+Anticancer+Properties+of+RGD+Peptides+Conjugated+to+Nitric+Oxide+Releasing+Functional+Groups+and+Abiraterone&doi=10.1016%2Fj.tet.2014.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer properties of RGD peptides conjugated to nitric oxide releasing functional groups and abiraterone</span></div><div class="casAuthors">Nortcliffe, Andrew; Fleming, Ian N.; Botting, Nigel P.; O'Hagan, David</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">8343-8347</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of analogs of the integrin binding aspartic acid-glycine-arginine (RGD) peptide sequence were synthesized conjugated to nitric oxide (NO) donating functional groups.  Also, the cytotoxicity of abiraterone, a prostate cancer drug, was explored when it was conjugated in three part constructs to RGD sequences and NO releasing heterocycles.  In general the analogs showed integrin binding affinity comparable to RGD ref. compds., and all released NO by the Griess test assay.  Two analogs exhibited significant cytotoxic effects against PC3 and MCF7 cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraS8pJE0xG-LVg90H21EOLACvtfcHk0ljTInr_BIs8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamt7nN&md5=f4fe0b3c9d8622b6affbc3b175665a6f</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2014.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2014.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DNortcliffe%26aufirst%3DA.%26aulast%3DFleming%26aufirst%3DI.%2BN.%26aulast%3DBotting%26aufirst%3DN.%2BP.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Properties%2520of%2520RGD%2520Peptides%2520Conjugated%2520to%2520Nitric%2520Oxide%2520Releasing%2520Functional%2520Groups%2520and%2520Abiraterone%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26spage%3D8343%26epage%3D8347%26doi%3D10.1016%2Fj.tet.2014.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Novel Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid: Synthesis and Evaluation of Antihepatocellular Carcinoma Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3251</span><span class="NLM_x">–</span> <span class="NLM_lpage">3259</span><span class="refDoi"> DOI: 10.1021/jm1014814</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1014814" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3251-3259&author=Y.+Lingauthor=X.+Yeauthor=Z.+Zhangauthor=Y.+Zhangauthor=Y.+Laiauthor=H.+Jiauthor=S.+Pengauthor=J.+Tian&title=Novel+Nitric+Oxide-Releasing+Derivatives+of+Farnesylthiosalicylic+Acid%3A+Synthesis+and+Evaluation+of+Antihepatocellular+Carcinoma+Activity&doi=10.1021%2Fjm1014814"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm1014814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014814%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DNovel%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Farnesylthiosalicylic%2520Acid%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Antihepatocellular%2520Carcinoma%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3251%26epage%3D3259%26doi%3D10.1021%2Fjm1014814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid as Anti-Tumor Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3456</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2010.03.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3448-3456&author=Y.+Lingauthor=X.+Yeauthor=H.+Jiauthor=Y.+Zhangauthor=Y.+Laiauthor=S.+Pengauthor=J.+Tian&title=Synthesis+and+Evaluation+of+Nitric+Oxide-Releasing+Derivatives+of+Farnesylthiosalicylic+Acid+as+Anti-Tumor+Agents&doi=10.1016%2Fj.bmc.2010.03.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.077%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Farnesylthiosalicylic%2520Acid%2520as%2520Anti-Tumor%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3448%26epage%3D3456%26doi%3D10.1016%2Fj.bmc.2010.03.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Han, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Novel Hybrids of (Phenylsulfonyl)Furoxan and Anilinopyrimidine as Potent and Selective Epidermal Growth Factor Receptor Inhibitors for Intervention of Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4748</span><span class="refDoi"> DOI: 10.1021/jm400463q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400463q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4738-4748&author=C.+Hanauthor=Z.+Huangauthor=C.+Zhengauthor=L.+Wanauthor=L.+Zhangauthor=S.+Pengauthor=K.+Dingauthor=H.+Jiauthor=J.+Tianauthor=Y.+Zhang&title=Novel+Hybrids+of+%28Phenylsulfonyl%29Furoxan+and+Anilinopyrimidine+as+Potent+and+Selective+Epidermal+Growth+Factor+Receptor+Inhibitors+for+Intervention+of+Non-Small-Cell+Lung+Cancer&doi=10.1021%2Fjm400463q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm400463q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400463q%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNovel%2520Hybrids%2520of%2520%2528Phenylsulfonyl%2529Furoxan%2520and%2520Anilinopyrimidine%2520as%2520Potent%2520and%2520Selective%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Inhibitors%2520for%2520Intervention%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4738%26epage%3D4748%26doi%3D10.1021%2Fjm400463q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Duan, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inks, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide Donor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4325</span><span class="NLM_x">–</span> <span class="NLM_lpage">4338</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00317</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4325-4338&author=W.+W.+Duanauthor=J.+Liauthor=E.+S.+Inksauthor=C.+J.+Chouauthor=Y.+P.+Jiaauthor=X.+J.+Chuauthor=X.+Y.+Liauthor=W.+F.+Xuauthor=Y.+J.+Zhang&title=Design%2C+Synthesis%2C+and+Antitumor+Evaluation+of+Novel+Histone+Deacetylase+Inhibitors+Equipped+with+a+Phenylsulfonylfuroxan+Module+as+a+Nitric+Oxide+Donor&doi=10.1021%2Facs.jmedchem.5b00317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00317%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DW.%2BW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DInks%26aufirst%3DE.%2BS.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DJia%26aufirst%3DY.%2BP.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DXu%26aufirst%3DW.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antitumor%2520Evaluation%2520of%2520Novel%2520Histone%2520Deacetylase%2520Inhibitors%2520Equipped%2520with%2520a%2520Phenylsulfonylfuroxan%2520Module%2520as%2520a%2520Nitric%2520Oxide%2520Donor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4325%26epage%3D4338%26doi%3D10.1021%2Facs.jmedchem.5b00317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Maciag, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehareen, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2292</span><span class="NLM_x">–</span> <span class="NLM_lpage">2302</span><span class="refDoi"> DOI: 10.1021/jm401550d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401550d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2292-2302&author=A.+E.+Maciagauthor=R.+J.+Hollandauthor=Y.+Kimauthor=V.+Kumariauthor=C.+E.+Luthersauthor=W.+S.+Sehareenauthor=D.+Biswasauthor=N.+L.+Morrisauthor=X.+H.+Jiauthor=L.+M.+Andersonauthor=J.+E.+Saavedraauthor=L.+K.+Keefer&title=Nitric+Oxide+%28NO%29+Releasing+Poly+ADP-ribose+Polymerase+1+%28PARP-1%29+Inhibitors+Targeted+to+Glutathione+S-Transferase+P1-Overexpressing+Cancer+Cells&doi=10.1021%2Fjm401550d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells</span></div><div class="casAuthors">Maciag, Anna E.; Holland, Ryan J.; Kim, Youseung; Kumari, Vandana; Luthers, Christina E.; Sehareen, Waheed S.; Biswas, Debanjan; Morris, Nicole L.; Ji, Xinhua; Anderson, Lucy M.; Saavedra, Joseph E.; Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2292-2302</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the antitumor effects of nitric oxide (NO) releasing derivs. of the PARP-1 inhibitor olaparib.  One compd. was prepd. by coupling the carboxyl group of another compd. and the free amino group of arylated diazeniumdiolated piperazine.  Anather analog has the same structure except that the F is replaced by H.  The resulting prodrugs are activated by glutathione in a reaction accelerated by glutathione S-transferase P1 (GSTP1), an enzyme frequently overexpressed in cancers.  This metab. generates NO plus a PARP-1 inhibitor simultaneously, consuming reducing equiv., leading to DNA damage concomitant with inhibition of DNA repair, and in the case of one of the compds. inducing crosslinking glutathionylation of proteins.  Two of the compds. reduced the growth rates of A549 human lung adenocarcinoma xenografts with no evidence of systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnGqAkHrJCMLVg90H21EOLACvtfcHk0ligbf0WT5dRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVWhsrc%253D&md5=01d074f9fa2adc7870bca6cdef9abab3</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm401550d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401550d%26sid%3Dliteratum%253Aachs%26aulast%3DMaciag%26aufirst%3DA.%2BE.%26aulast%3DHolland%26aufirst%3DR.%2BJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKumari%26aufirst%3DV.%26aulast%3DLuthers%26aufirst%3DC.%2BE.%26aulast%3DSehareen%26aufirst%3DW.%2BS.%26aulast%3DBiswas%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DN.%2BL.%26aulast%3DJi%26aufirst%3DX.%2BH.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DNitric%2520Oxide%2520%2528NO%2529%2520Releasing%2520Poly%2520ADP-ribose%2520Polymerase%25201%2520%2528PARP-1%2529%2520Inhibitors%2520Targeted%2520to%2520Glutathione%2520S-Transferase%2520P1-Overexpressing%2520Cancer%2520Cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2292%26epage%3D2302%26doi%3D10.1021%2Fjm401550d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Carradori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollica, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Monte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5667</span><span class="NLM_x">–</span> <span class="NLM_lpage">5679</span><span class="refDoi"> DOI: 10.3390/molecules20045667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3390%2Fmolecules20045667" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=5667-5679&author=S.+Carradoriauthor=A.+Mollicaauthor=C.+De+Monteauthor=A.+Graneseauthor=C.+T.+Supuran&title=Nitric+Oxide+Donors+and+Selective+Carbonic+Anhydrase+Inhibitors%3A+A+Dual+Pharmacological+Approach+for+the+Treatment+of+Glaucoma%2C+Cancer+and+Osteoporosis&doi=10.3390%2Fmolecules20045667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20045667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20045667%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DDe%2BMonte%26aufirst%3DC.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNitric%2520Oxide%2520Donors%2520and%2520Selective%2520Carbonic%2520Anhydrase%2520Inhibitors%253A%2520A%2520Dual%2520Pharmacological%2520Approach%2520for%2520the%2520Treatment%2520of%2520Glaucoma%252C%2520Cancer%2520and%2520Osteoporosis%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D5667%26epage%3D5679%26doi%3D10.3390%2Fmolecules20045667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Mojic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocca, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCubrey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1124/mol.112.077842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1124%2Fmol.112.077842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=700-710&author=M.+Mojicauthor=S.+Mijatovicauthor=D.+Maksimovic-Ivanicauthor=D.+Miljkovicauthor=S.+Stosic-Grujicicauthor=M.+Stankovicauthor=K.+Manganoauthor=S.+Travaliauthor=M.+Doniaauthor=P.+Fagoneauthor=M.+B.+Zoccaauthor=Y.+Al-Abedauthor=J.+A.+McCubreyauthor=F.+Nicoletti&title=Therapeutic+Potential+of+Nitric+Oxide-Modified+Drugs+in+Colon+Cancer+Cells&doi=10.1124%2Fmol.112.077842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.077842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.077842%26sid%3Dliteratum%253Aachs%26aulast%3DMojic%26aufirst%3DM.%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26aulast%3DStankovic%26aufirst%3DM.%26aulast%3DMangano%26aufirst%3DK.%26aulast%3DTravali%26aufirst%3DS.%26aulast%3DDonia%26aufirst%3DM.%26aulast%3DFagone%26aufirst%3DP.%26aulast%3DZocca%26aufirst%3DM.%2BB.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DTherapeutic%2520Potential%2520of%2520Nitric%2520Oxide-Modified%2520Drugs%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D700%26epage%3D710%26doi%3D10.1124%2Fmol.112.077842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antihepatocellular Carcinoma Activity of Nitric Oxide Releasing Derivatives of Oleanolic Acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4834</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span><span class="refDoi"> DOI: 10.1021/jm800167u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800167u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4834-4838&author=L.+Chenauthor=Y.+Zhangauthor=X.+Kongauthor=E.+Lanauthor=Z.+Huangauthor=S.+Pengauthor=D.+L.+Kaufmanauthor=J.+Tian&title=Design%2C+Synthesis%2C+and+Antihepatocellular+Carcinoma+Activity+of+Nitric+Oxide+Releasing+Derivatives+of+Oleanolic+Acid&doi=10.1021%2Fjm800167u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm800167u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800167u%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DKaufman%26aufirst%3DD.%2BL.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antihepatocellular%2520Carcinoma%2520Activity%2520of%2520Nitric%2520Oxide%2520Releasing%2520Derivatives%2520of%2520Oleanolic%2520Acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4834%26epage%3D4838%26doi%3D10.1021%2Fjm800167u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Synthesis and Anti-Human Hepatocellular Carcinoma Activity of New Nitric Oxide-Releasing Glycosyl Derivatives of Oleanolic Acid</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1039/B918846K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FB918846K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=632-639&author=Z.+Huangauthor=Y.+Zhangauthor=L.+Zhaoauthor=Y.+Jingauthor=Y.+Laiauthor=L.+Zhangauthor=Q.+Guoauthor=S.+Yuanauthor=J.+Zhangauthor=L.+Chenauthor=S.+Pengauthor=J.+Tian&title=Synthesis+and+Anti-Human+Hepatocellular+Carcinoma+Activity+of+New+Nitric+Oxide-Releasing+Glycosyl+Derivatives+of+Oleanolic+Acid&doi=10.1039%2FB918846K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1039%2FB918846K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB918846K%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DJing%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Anti-Human%2520Hepatocellular%2520Carcinoma%2520Activity%2520of%2520New%2520Nitric%2520Oxide-Releasing%2520Glycosyl%2520Derivatives%2520of%2520Oleanolic%2520Acid%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D632%26epage%3D639%26doi%3D10.1039%2FB918846K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Glycosylated Diazeniumdiolate-Based Oleanolic Acid Derivatives: Synthesis, in Vitro and in Vivo Biological Evaluation as Anti-Human Hepatocellular Carcinoma Agents</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3882</span><span class="NLM_x">–</span> <span class="NLM_lpage">3891</span><span class="refDoi"> DOI: 10.1039/c2ob25252j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2Fc2ob25252j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=3882-3891&author=Z.+Huangauthor=J.+Fuauthor=L.+Liuauthor=Y.+Sunauthor=Y.+Laiauthor=H.+Jiauthor=E.+E.+Knausauthor=J.+Tianauthor=Y.+Zhang&title=Glycosylated+Diazeniumdiolate-Based+Oleanolic+Acid+Derivatives%3A+Synthesis%2C+in+Vitro+and+in+Vivo+Biological+Evaluation+as+Anti-Human+Hepatocellular+Carcinoma+Agents&doi=10.1039%2Fc2ob25252j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25252j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25252j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DGlycosylated%2520Diazeniumdiolate-Based%2520Oleanolic%2520Acid%2520Derivatives%253A%2520Synthesis%252C%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Biological%2520Evaluation%2520as%2520Anti-Human%2520Hepatocellular%2520Carcinoma%2520Agents%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D3882%26epage%3D3891%26doi%3D10.1039%2Fc2ob25252j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Fu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Hybrid Molecule from O<sup>2</sup>-(2,4-Dinitrophenyl)diazeniumdiolate and Oleanolic Acid: A Glutathione S-Transferase π-Activated Nitric Oxide Prodrug with Selective Anti-Human Hepatocellular Carcinoma Activity and Improved Stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4641</span><span class="NLM_x">–</span> <span class="NLM_lpage">4655</span><span class="refDoi"> DOI: 10.1021/jm400393u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400393u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4641-4655&author=J.+J.+Fuauthor=L.+Liuauthor=Z.+J.+Huangauthor=Y.+S.+Laiauthor=H.+Jiauthor=S.+X.+Pengauthor=J.+D.+Tianauthor=Y.+H.+Zhang&title=Hybrid+Molecule+from+O2-%282%2C4-Dinitrophenyl%29diazeniumdiolate+and+Oleanolic+Acid%3A+A+Glutathione+S-Transferase+%CF%80-Activated+Nitric+Oxide+Prodrug+with+Selective+Anti-Human+Hepatocellular+Carcinoma+Activity+and+Improved+Stability&doi=10.1021%2Fjm400393u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm400393u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400393u%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DTian%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DHybrid%2520Molecule%2520from%2520O2-%25282%252C4-Dinitrophenyl%2529diazeniumdiolate%2520and%2520Oleanolic%2520Acid%253A%2520A%2520Glutathione%2520S-Transferase%2520%25CF%2580-Activated%2520Nitric%2520Oxide%2520Prodrug%2520with%2520Selective%2520Anti-Human%2520Hepatocellular%2520Carcinoma%2520Activity%2520and%2520Improved%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4641%26epage%3D4655%26doi%3D10.1021%2Fjm400393u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Fu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Identification of Nitric Oxide-Releasing Derivatives of Oleanolic Acid as Potential Anti-Colon Cancer Agents</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">19445</span><span class="NLM_x">–</span> <span class="NLM_lpage">19454</span><span class="refDoi"> DOI: 10.1039/C5RA00270B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FC5RA00270B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis1Sksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=19445-19454&author=J.+J.+Fuauthor=Y.+Zouauthor=Z.+J.+Huangauthor=C.+Yanauthor=Q.+M.+Zhouauthor=H.+B.+Zhangauthor=Y.+S.+Laiauthor=S.+Pengauthor=Y.+H.+Zhang&title=Identification+of+Nitric+Oxide-Releasing+Derivatives+of+Oleanolic+Acid+as+Potential+Anti-Colon+Cancer+Agents&doi=10.1039%2FC5RA00270B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of nitric oxide-releasing derivatives of oleanolic acid as potential anti-colon cancer agents</span></div><div class="casAuthors">Fu, Junjie; Zou, Yu; Huang, Zhangjian; Yan, Chang; Zhou, Qimeng; Zhang, Huibin; Lai, Yisheng; Peng, Sixun; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">19445-19454</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A group of nitric oxide (NO)-releasing derivs. of oleanolic acid (OA) (5-13) were designed, synthesized and biol. evaluated for their anti-colon cancer activity.  It was found that the most potent compd. 6 preferably released high levels of NO in colon cancer cells but not in normal cells, leading to potent cytotoxicity against colon cancer cells.  In addn., 6 was more prone to produce NO catalyzed by GSTπ relative to GSTα.  Furthermore, 6 significantly inhibited the tumor growth in a mouse xenograft model.  Finally, 6 induced nitration of tyrosine residues in mitochondrial protein, down-regulated Wnt/β-catenin pathway, and inhibited COX-2 centered signaling loop in colon cancer cells.  Collectively, our findings suggested that 6 could be a promising candidate for the intervention of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzi5ww8O1WP7Vg90H21EOLACvtfcHk0ljDpAijjCsOHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis1Sksb0%253D&md5=24e752bc643fe8b81bce9d8c67f5b20c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1039%2FC5RA00270B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA00270B%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DQ.%2BM.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DIdentification%2520of%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Oleanolic%2520Acid%2520as%2520Potential%2520Anti-Colon%2520Cancer%2520Agents%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D19445%26epage%3D19454%26doi%3D10.1039%2FC5RA00270B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, F.</span><span> </span><span class="NLM_article-title">Combination of Amino Acid/Dipeptide with Nitric Oxide Donating Oleanolic Acid Derivatives as PepT1 Targeting Antitumor Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1120</span><span class="refDoi"> DOI: 10.1021/jm401634d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401634d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1116-1120&author=L.+Fangauthor=M.+Wangauthor=S.+H.+Gouauthor=X.+Y.+Liuauthor=H.+Zhangauthor=F.+Cao&title=Combination+of+Amino+Acid%2FDipeptide+with+Nitric+Oxide+Donating+Oleanolic+Acid+Derivatives+as+PepT1+Targeting+Antitumor+Prodrugs&doi=10.1021%2Fjm401634d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Amino Acid/Dipeptide with Nitric Oxide Donating Oleanolic Acid Derivatives as PepT1 Targeting Antitumor Prodrugs</span></div><div class="casAuthors">Fang, Lei; Wang, Meng; Gou, Shaohua; Liu, Xuying; Zhang, Huan; Cao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1116-1120</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of the cytotoxic effect of nitric oxide (NO) and PepT1 for mol.-targeted drug delivery, a series of amino acid/dipeptide diester prodrugs of NO-donating oleanolic acid derivs. were designed and synthesized.  Two prodrugs 6a and 8a showed potent cytotoxcity, which is probably due to their high PepT1 affinity and NO-releasing ability.  Furthermore, the aq. soly. of the prodrugs was also significantly enhanced because of the hydrophilic amino acid/dipeptide promoiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9pR7AdIqo7Vg90H21EOLACvtfcHk0ljDpAijjCsOHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D&md5=34d4a03853bb2b0bc6400f85c885ff4c</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm401634d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401634d%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGou%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DF.%26atitle%3DCombination%2520of%2520Amino%2520Acid%252FDipeptide%2520with%2520Nitric%2520Oxide%2520Donating%2520Oleanolic%2520Acid%2520Derivatives%2520as%2520PepT1%2520Targeting%2520Antitumor%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1116%26epage%3D1120%26doi%3D10.1021%2Fjm401634d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S.</span><span> </span><span class="NLM_article-title">Oleanolic Acid-NO Donor-Platinum(II) Trihybrid Molecules: Targeting Cytotoxicity on Hepatoma Cells with Combined Action Mode and Good Safety</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4619</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.07.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2016.07.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=4611-4619&author=L.+Fangauthor=M.+Fengauthor=F.+Chenauthor=X.+Liuauthor=H.+Shenauthor=J.+Zhaoauthor=S.+Gou&title=Oleanolic+Acid-NO+Donor-Platinum%28II%29+Trihybrid+Molecules%3A+Targeting+Cytotoxicity+on+Hepatoma+Cells+with+Combined+Action+Mode+and+Good+Safety&doi=10.1016%2Fj.bmc.2016.07.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.07.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.07.066%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DS.%26atitle%3DOleanolic%2520Acid-NO%2520Donor-Platinum%2528II%2529%2520Trihybrid%2520Molecules%253A%2520Targeting%2520Cytotoxicity%2520on%2520Hepatoma%2520Cells%2520with%2520Combined%2520Action%2520Mode%2520and%2520Good%2520Safety%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D4611%26epage%3D4619%26doi%3D10.1016%2Fj.bmc.2016.07.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Ai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Synthesis of CDDO-Amino Acid-Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2464</span><span class="refDoi"> DOI: 10.1021/jm5019302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2452-2464&author=Y.+Aiauthor=F.+H.+Kangauthor=Z.+J.+Huangauthor=X.+W.+Xueauthor=Y.+S.+Laiauthor=S.+X.+Pengauthor=J.+D.+Tianauthor=Y.+H.+Zhang&title=Synthesis+of+CDDO-Amino+Acid-Nitric+Oxide+Donor+Trihybrids+as+Potential+Antitumor+Agents+against+Both+Drug-Sensitive+and+Drug-Resistant+Colon+Cancer&doi=10.1021%2Fjm5019302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm5019302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019302%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DF.%2BH.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DXue%26aufirst%3DX.%2BW.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DTian%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DSynthesis%2520of%2520CDDO-Amino%2520Acid-Nitric%2520Oxide%2520Donor%2520Trihybrids%2520as%2520Potential%2520Antitumor%2520Agents%2520against%2520Both%2520Drug-Sensitive%2520and%2520Drug-Resistant%2520Colon%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2452%26epage%3D2464%26doi%3D10.1021%2Fjm5019302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Glycyrrhetinic Acid as Anti-Hepatocellular Carcinoma Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6416</span><span class="NLM_x">–</span> <span class="NLM_lpage">6420</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2010.09.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6416-6420&author=Y.+Laiauthor=L.+Shenauthor=Z.+Zhangauthor=W.+Liuauthor=Y.+Zhangauthor=H.+Jiauthor=J.+Tian&title=Synthesis+and+Biological+Evaluation+of+Furoxan-Based+Nitric+Oxide-Releasing+Derivatives+of+Glycyrrhetinic+Acid+as+Anti-Hepatocellular+Carcinoma+Agents&doi=10.1016%2Fj.bmcl.2010.09.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.070%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Furoxan-Based%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Glycyrrhetinic%2520Acid%2520as%2520Anti-Hepatocellular%2520Carcinoma%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6416%26epage%3D6420%26doi%3D10.1016%2Fj.bmcl.2010.09.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Li, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Y.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin as Potential Anti-Tumor Agents</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7556</span><span class="NLM_x">–</span> <span class="NLM_lpage">7568</span><span class="refDoi"> DOI: 10.3390/molecules17067556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3390%2Fmolecules17067556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=7556-7568&author=D.+H.+Liauthor=L.+Wangauthor=H.+Caiauthor=Y.+H.+Zhangauthor=J.+Y.+Xu&title=Synthesis+and+Biological+Evaluation+of+Novel+Furozan-Based+Nitric+Oxide-Releasing+Derivatives+of+Oridonin+as+Potential+Anti-Tumor+Agents&doi=10.3390%2Fmolecules17067556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3390%2Fmolecules17067556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules17067556%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DXu%26aufirst%3DJ.%2BY.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Furozan-Based%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Oridonin%2520as%2520Potential%2520Anti-Tumor%2520Agents%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D7556%26epage%3D7568%26doi%3D10.3390%2Fmolecules17067556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Xu, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Y.</span><span> </span><span class="NLM_article-title">Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2795</span><span class="NLM_x">–</span> <span class="NLM_lpage">2800</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2016.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2795-2800&author=S.+T.+Xuauthor=G.+Y.+Wangauthor=Y.+Linauthor=Y.+J.+Zhangauthor=L.+L.+Peiauthor=H.+Yaoauthor=M.+Huauthor=Y.+Y.+Qiuauthor=Z.+J.+Huangauthor=Y.+H.+Zhangauthor=J.+Y.+Xu&title=Novel+Anticancer+Oridonin+Derivatives+Possessing+a+Diazen-1-ium-1%2C2-diolate+Nitric+Oxide+Donor+Moiety%3A+Design%2C+Synthesis%2C+Biological+Evaluation+and+Nitric+Oxide+Release+Studies&doi=10.1016%2Fj.bmcl.2016.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%2BT.%26aulast%3DWang%26aufirst%3DG.%2BY.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DPei%26aufirst%3DL.%2BL.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DY.%2BY.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DXu%26aufirst%3DJ.%2BY.%26atitle%3DNovel%2520Anticancer%2520Oridonin%2520Derivatives%2520Possessing%2520a%2520Diazen-1-ium-1%252C2-diolate%2520Nitric%2520Oxide%2520Donor%2520Moiety%253A%2520Design%252C%2520Synthesis%252C%2520Biological%2520Evaluation%2520and%2520Nitric%2520Oxide%2520Release%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2795%26epage%3D2800%26doi%3D10.1016%2Fj.bmcl.2016.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">He, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. S.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives as Anticancer Agents</span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1016/j.cclet.2009.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.cclet.2009.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=381-384&author=L.+Q.+Heauthor=J.+Liuauthor=D.+K.+Yinauthor=Y.+H.+Zhangauthor=X.+S.+Wangauthor=L.+Q.+Heauthor=J.+Liuauthor=D.+K.+Yinauthor=Y.+H.+Zhangauthor=X.+S.+Wang&title=Synthesis+and+Biological+Evaluation+of+Nitric+Oxide-Releasing+Matrine+Derivatives+as+Anticancer+Agents&doi=10.1016%2Fj.cclet.2009.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitric oxide-releasing matrine derivatives as anticancer agents</span></div><div class="casAuthors">He, Li Qin; Liu, Jing; Yin, Deng Ke; Zhang, Yi Hua; Wang, Xiao Shan</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-384</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of furoxan-based nitric oxide-releasing matrine derivs. I [X = O(CH2)n, OCH(Me)(CH2)2, O(CH2)2O(CH2)2O, NH(CH2)2, n = 2, 3, 4] was synthesized.  The biol. evaluation showed that compds.. I [X = O(CH2)n, O(CH2)2O(CH2)2O, NH(CH2)2, n = 2, 3] had stronger cytotoxic activities than 5-fluorouracil against human hepatoma cells (HepG2) in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWmZF74h9p0LVg90H21EOLACvtfcHk0liyw0VhdyiH8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKjur0%253D&md5=ad3af7e99fe4f4e68f3c5bde374117b2</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2009.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2009.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BS.%26aulast%3DHe%26aufirst%3DL.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BS.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520Matrine%2520Derivatives%2520as%2520Anticancer%2520Agents%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D21%26spage%3D381%26epage%3D384%26doi%3D10.1016%2Fj.cclet.2009.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viarisio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costamagna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescarmona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span> </span><span class="NLM_article-title">Nitric Oxide Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15695394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=516-525&author=C.+Rigantiauthor=E.+Miragliaauthor=D.+Viarisioauthor=C.+Costamagnaauthor=G.+Pescarmonaauthor=D.+Ghigoauthor=A.+Bosia&title=Nitric+Oxide+Reverts+the+Resistance+to+Doxorubicin+in+Human+Colon+Cancer+Cells+by+Inhibiting+the+Drug+Efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span></div><div class="casAuthors">Riganti, Chiara; Miraglia, Erica; Viarisio, Daniele; Costamagna, Costanzo; Pescarmona, Gianpiero; Ghigo, Dario; Bosia, Amalia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon by which cancer cells evade the cytotoxic effects of chemotherapeutic agents.  It may occur through different mechanisms, but it often correlates with the overexpression of integral membrane transporters, such as P-glycoprotein (Pgp) and MDR-assocd. proteins (MRPs), with resulting decrease of drug accumulation and cellular death.  Doxorubicin is a substrate of Pgp; it has been suggested that its ability to induce synthesis of nitric oxide (NO) could explain, at least in part, its cytotoxic effects.  Culturing the human epithelial colon cell line HT29 in the presence of doxorubicin, we obtained a doxorubicin-resistant (HT29-dx) cell population: these cells accumulated less intracellular doxorubicin, were less sensitive to the cytotoxic effects of doxorubicin and cisplatin, overexpressed Pgp and MRP3, and exhibited a lower NO prodn. (both under basal conditions and after doxorubicin stimulation).  The resistance to doxorubicin could be reversed when HT29-dx cells were incubated with inducers of NO synthesis (cytokines mix, atorvastatin).  Some NO donors increased the drug accumulation in HT29-dx cells in a guanosine-3':5'-cyclic monophosphate-independent way; this effect was assocd. with a marked redn. of doxorubicin efflux rate in HT29 and HT29-dx cells, and tyrosine nitration in the MRP3 protein.  Our results suggest that onset of MDR and impairment of NO synthesis are related; this finding could point to a new strategy to reverse doxorubicin resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTu2bqm5O1DbVg90H21EOLACvtfcHk0liyw0VhdyiH8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D&md5=e0e7757d954680c9b9eb3470a1758da6</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DMiraglia%26aufirst%3DE.%26aulast%3DViarisio%26aufirst%3DD.%26aulast%3DCostamagna%26aufirst%3DC.%26aulast%3DPescarmona%26aufirst%3DG.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26atitle%3DNitric%2520Oxide%2520Reverts%2520the%2520Resistance%2520to%2520Doxorubicin%2520in%2520Human%2520Colon%2520Cancer%2520Cells%2520by%2520Inhibiting%2520the%2520Drug%2520Efflux%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D516%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaro, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span> </span><span class="NLM_article-title">Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-glycoprotein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5475</span><span class="refDoi"> DOI: 10.1021/jm100066y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100066y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFenu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5467-5475&author=R.+Frutteroauthor=M.+Crosettiauthor=K.+Chegaevauthor=S.+Guglielmoauthor=A.+Gascoauthor=F.+Berardiauthor=M.+Nisoauthor=R.+Perroneauthor=M.+A.+Panaroauthor=N.+A.+Colabufo&title=Phenylsulfonylfuroxans+as+Modulators+of+Multidrug-Resistance-Associated+Protein-1+and+P-glycoprotein&doi=10.1021%2Fjm100066y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein</span></div><div class="casAuthors">Fruttero, Roberta; Crosetti, Marco; Chegaev, Konstantin; Guglielmo, Stefano; Gasco, Alberto; Berardi, Francesco; Niso, Mauro; Perrone, Roberto; Panaro, Maria Antonietta; Colabufo, Nicola Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5467-5475</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of furoxan derivs. were studied for their ability to interact with P-gp and MRP1 transporters in MDCK cells overexpressing these proteins. 3-Phenylsulfonyl substituted furoxans emerged as the most interesting compds.  All of them were capable of inhibiting P-gp, and a few also were capable of inhibiting MRP1.  Substituents at the 4-position of 3-phenylsulfonylfuroxan scaffold were able to modulate the selectivity and the intensity of inhibition.  In some cases, they reverted MRP1 inhibitor activity, namely, they were capable of potentiating MRP1 dependent efflux.  When compds. 16 and 17 were coadministered with doxorubicin, they restored a high degree of the activity of the antibiotic.  Preliminary immunoblotting studies carried out on these two compds. indicate that they are capable of nitrating P-gp, which in this form is likely unable to efflux the antibiotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq7VVVj1GhhrVg90H21EOLACvtfcHk0ljGXwv8YjTsTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFenu74%253D&md5=6c302bacdb93a4e5d95603e2bf070f83</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm100066y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100066y%26sid%3Dliteratum%253Aachs%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DCrosetti%26aufirst%3DM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DPanaro%26aufirst%3DM.%2BA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26atitle%3DPhenylsulfonylfuroxans%2520as%2520Modulators%2520of%2520Multidrug-Resistance-Associated%2520Protein-1%2520and%2520P-glycoprotein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5467%26epage%3D5475%26doi%3D10.1021%2Fjm100066y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">De Boo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span> </span><span class="NLM_article-title">iNOS Activity Is Necessary for the Cytotoxic and Immunogenic Effects of Doxorubicin in Human Colon Cancer Cells</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="refDoi"> DOI: 10.1186/1476-4598-8-108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1186%2F1476-4598-8-108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=19925669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD1MjptFSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=108&author=S.+De+Booauthor=J.+Kopeckaauthor=D.+Brusaauthor=E.+Gazzanoauthor=L.+Materaauthor=D.+Ghigoauthor=A.+Bosiaauthor=C.+Riganti&title=iNOS+Activity+Is+Necessary+for+the+Cytotoxic+and+Immunogenic+Effects+of+Doxorubicin+in+Human+Colon+Cancer+Cells&doi=10.1186%2F1476-4598-8-108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells</span></div><div class="casAuthors">De Boo Sara; Kopecka Joanna; Brusa Davide; Gazzano Elena; Matera Lina; Ghigo Dario; Bosia Amalia; Riganti Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Doxorubicin is one of the few chemotherapeutic drugs able to exert both cytotoxic and pro-immunogenic effects against cancer cells.  Following the drug administration, the intracellular protein calreticulin is translocated with an unknown mechanism onto the plasma membrane, where it triggers the phagocytosis of tumour cells by dendritic cells.  Moreover doxorubicin up-regulates the inducible nitric oxide (NO) synthase (iNOS) gene in cancer cells, leading to huge amounts of NO, which in turn acts as a mediator of the drug toxicity and as a chemosensitizer agent in colon cancer.  Indeed by nitrating tyrosine on the multidrug resistance related protein 3, NO decreases the doxorubicin efflux from tumour cells and enhances the drug toxicity.  It is not clear if NO, beside playing a role in chemosensitivity, may also play a role in doxorubicin pro-immunogenic effects.  To clarify this issue, we compared the doxorubicin-sensitive human colon cancer HT29 cells with the drug-resistant HT29-dx cells and the HT29 cells silenced for iNOS (HT29 iNOS-).  RESULTS:  In both HT29-dx and HT29 iNOS- cells, doxorubicin did not induce NO synthesis, had a lower intracellular accumulation and a lower toxicity.  Moreover the drug failed to promote the translocation of calreticulin and the phagocytosis of HT29-dx and HT29 iNOS-cells, which resulted both chemoresistant and immunoresistant.  However, if NO levels were exogenously increased by sodium nitroprusside, the chemosensitivity to doxorubicin was restored in HT29 iNOS-cells.  In parallel the NO donor per se was sufficient to induce the exposure of calreticulin and to increase the phagocytosis of HT29 iNOS- cells by DCs and their functional maturation, thus mimicking the pro-immunogenic effects exerted by doxorubicin in the parental drug-sensitive HT29 cells.  CONCLUSION:  Our data suggest that chemo- and immuno-resistance to anthracyclines are associated in colon cancer cells and rely on a common mechanism, that is the inability of doxorubicin to induce iNOS.  Therefore NO donors might represent a promising strategy to restore both chemosensitivity and immunosensitivity to doxorubicin in resistant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3vmkIwk_wJcK3uFsUIZtkfW6udTcc2eZp0b-_vN2PT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjptFSrsQ%253D%253D&md5=04906da262a5f0e6c93120591f46cb2d</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-8-108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-8-108%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBoo%26aufirst%3DS.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DBrusa%26aufirst%3DD.%26aulast%3DGazzano%26aufirst%3DE.%26aulast%3DMatera%26aufirst%3DL.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DiNOS%2520Activity%2520Is%2520Necessary%2520for%2520the%2520Cytotoxic%2520and%2520Immunogenic%2520Effects%2520of%2520Doxorubicin%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26spage%3D108%26doi%3D10.1186%2F1476-4598-8-108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1021/ml100302t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100302t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=494-497&author=K.+Chegaevauthor=C.+Rigantiauthor=L.+Lazzaratoauthor=B.+Rolandoauthor=S.+Guglielmoauthor=I.+Campiaauthor=R.+Frutteroauthor=A.+Bosiaauthor=A.+Gasco&title=Nitric+Oxide+Donor+Doxorubicins+Accumulate+into+Doxorubicin-Resistant+Human+Colon+Cancer+Cells+Inducing+Cytotoxicity&doi=10.1021%2Fml100302t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fml100302t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100302t%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNitric%2520Oxide%2520Donor%2520Doxorubicins%2520Accumulate%2520into%2520Doxorubicin-Resistant%2520Human%2520Colon%2520Cancer%2520Cells%2520Inducing%2520Cytotoxicity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D494%26epage%3D497%26doi%3D10.1021%2Fml100302t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span> </span><span class="NLM_article-title">Mitochondrial-Targeting Nitrooxy-Doxorubicin: A New Approach to Overcome Drug Resistance</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1021/mp300311b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300311b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslelsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=161-174&author=C.+Rigantiauthor=B.+Rolandoauthor=J.+Kopeckaauthor=I.+Campiaauthor=K.+Chegaevauthor=L.+Lazzaratoauthor=A.+Federicoauthor=R.+Frutteroauthor=D.+Ghigo&title=Mitochondrial-Targeting+Nitrooxy-Doxorubicin%3A+A+New+Approach+to+Overcome+Drug+Resistance&doi=10.1021%2Fmp300311b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial-Targeting Nitrooxy-doxorubicin: A New Approach To Overcome Drug Resistance</span></div><div class="casAuthors">Riganti, Chiara; Rolando, Barbara; Kopecka, Joanna; Campia, Ivana; Chegaev, Konstantin; Lazzarato, Loretta; Federico, Antonella; Fruttero, Roberta; Ghigo, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In previous studies, we showed that nitric oxide (NO) donors and synthetic doxorubicins (DOXs) modified with moieties contg. NO-releasing groups-such as nitrooxy-DOX (NitDOX) or 3-phenylsulfonylfuroxan-DOX (FurDOX)-overcome drug resistance by decreasing the activity of ATP-binding cassette (ABC) transporters that can extrude the drug.  Here, we have investigated the biochem. mechanisms by which NitDOX and FurDOX exert antitumor effects.  Both NitDOX and FurDOX were more cytotoxic than DOX against drug-resistant cells.  Interestingly, NitDOX exhibited a faster uptake and an extranuclear distribution.  NitDOX was preferentially localized in the mitochondria, where it nitrated and inhibited the mitochondria-assocd. ABC transporters, decreased the flux through the tricarboxylic acid cycle, slowed down the activity of complex I, lowered the synthesis of ATP, induced oxidative and nitrosative stress, and elicited the release of cytochrome c and the activation of caspase-9 and -3 in DOX-resistant cells.  We suggest that NitDOX may represent the prototype of a new class of multifunctional anthracyclines, which have cellular targets different from conventional anthracyclines and greater efficacy against drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc2qh0P8HLcbVg90H21EOLACvtfcHk0lhP-JLSh-PVNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslelsr%252FL&md5=87c3ab54d7cb864d2b0788e268c09e47</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fmp300311b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300311b%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DFederico%26aufirst%3DA.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGhigo%26aufirst%3DD.%26atitle%3DMitochondrial-Targeting%2520Nitrooxy-Doxorubicin%253A%2520A%2520New%2520Approach%2520to%2520Overcome%2520Drug%2520Resistance%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D161%26epage%3D174%26doi%3D10.1021%2Fmp300311b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Gazzano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blangetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaratone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span> </span><span class="NLM_article-title">Overcoming Multidrug Resistance by Targeting Mitochondria with NO-Donating Doxorubicins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2016.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26822567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=967-975&author=E.+Gazzanoauthor=K.+Chegaevauthor=B.+Rolandoauthor=M.+Blangettiauthor=L.+Annaratoneauthor=D.+Ghigoauthor=R.+Frutteroauthor=C.+Riganti&title=Overcoming+Multidrug+Resistance+by+Targeting+Mitochondria+with+NO-Donating+Doxorubicins&doi=10.1016%2Fj.bmc.2016.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins</span></div><div class="casAuthors">Gazzano, Elena; Chegaev, Konstantin; Rolando, Barbara; Blangetti, Marco; Annaratone, Lorenzo; Ghigo, Dario; Fruttero, Roberta; Riganti, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A library of nitric oxide-donor doxorubicins (NO-DOXOs) was synthesized by linking appropriate NO-donor moieties at C-14 position through an ester bridge.  Their hydrolytic stability was evaluated.  The intracellular accumulation and cytotoxicity of these novel NO-DOXOs were studied in DOXO-sensitive (HT29) and DOXO-resistant (HT29/dx) tumor-cells.  Hydrolytically-stable compds. accumulated in HT29 and HT29/dx cells, thanks to the nitration of plasma-membrane efflux transporters.  Surprisingly, no close correlation was found between intracellular accumulation and cytotoxicity.  Only compds. with high mitochondria retention (due to nitration of mitochondrial efflux transporter) exert high cytotoxicity, through the activation of a mitochondrial-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl_r1-a1b_TbVg90H21EOLACvtfcHk0lhP-JLSh-PVNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKlu7Y%253D&md5=5d407feeb33c34b1aa76d32ad82af858</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DGazzano%26aufirst%3DE.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DBlangetti%26aufirst%3DM.%26aulast%3DAnnaratone%26aufirst%3DL.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DOvercoming%2520Multidrug%2520Resistance%2520by%2520Targeting%2520Mitochondria%2520with%2520NO-Donating%2520Doxorubicins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D967%26epage%3D975%26doi%3D10.1016%2Fj.bmc.2016.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Zou, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline as Anticancer and Multidrug Resistance Reversal Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5934</span><span class="NLM_x">–</span> <span class="NLM_lpage">5938</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2011.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21843940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKisr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5934-5938&author=Z.+H.+Zouauthor=X.+B.+Lanauthor=H.+Qianauthor=W.+L.+Huangauthor=Y.+M.+Li&title=Synthesis+and+Evaluation+of+Furoxan-Based+Nitric+Oxide-Releasing+Derivatives+of+Tetrahydroisoquinoline+as+Anticancer+and+Multidrug+Resistance+Reversal+Agents&doi=10.1016%2Fj.bmcl.2011.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents</span></div><div class="casAuthors">Zou, Zhi-hong; Lan, Xiao-bu; Qian, Hai; Huang, Wen-long; Li, Yun-man</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5934-5938</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multidrug resistance in tumor cells poses a major obstacle to efficient chemotherapy.  Several types of agents have been recognized as multidrug resistance inhibitors, among which the tetrahydroisoquinolines are the most studied.  In the current study, 16 furoxan-based nitric oxide-releasing derivs. of tetrahydroisoquinoline were synthesized.  Their cytotoxic activities and effects in reversing multidrug resistance have been evaluated.  The results revealed that these compds. had moderate cytotoxic effects.  Eight of the synthesized compds. showed higher cytotoxicities than the rest, but lower than adriamycin on the K562 cell line.  Compds. I-III exhibited potent MDR reversal activities on the K562/A02 cell line.  The accumulation assay indicated that compds. I-III significantly increased the intracellular accumulation of rhodamine123 in K562/A02 cells.  Furthermore, these three compds. produced high concns. of NO in K562/A02 cells.  Potentially, the high concns. of NO produced by NO donor moieties leads to an increased cytotoxicity to K562/A02 cells.  The results suggested that compds. I-III had anticancer effects, as well as multidrug resistance reversal effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7rOVI37YOCLVg90H21EOLACvtfcHk0lhP-JLSh-PVNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKisr3K&md5=1097433fc2682ee6f2f37efbb2f4b08a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DZ.%2BH.%26aulast%3DLan%26aufirst%3DX.%2BB.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DLi%26aufirst%3DY.%2BM.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Furoxan-Based%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Tetrahydroisoquinoline%2520as%2520Anticancer%2520and%2520Multidrug%2520Resistance%2520Reversal%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5934%26epage%3D5938%26doi%3D10.1016%2Fj.bmcl.2011.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Tang, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Nitric Oxide-Releasing DDB Derivatives as Potential Pgp-Mediated MDR Reversal Agents in MCF-7/Adr Cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2011.12.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=801-805&author=X.+B.+Tangauthor=X.+K.+Guauthor=H.+Aiauthor=G.+J.+Wangauthor=H.+Pengauthor=Y.+S.+Laiauthor=Y.+H.+Zhang&title=Synthesis+and+Evaluation+of+Nitric+Oxide-Releasing+DDB+Derivatives+as+Potential+Pgp-Mediated+MDR+Reversal+Agents+in+MCF-7%2FAdr+Cells&doi=10.1016%2Fj.bmcl.2011.12.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.065%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%2BB.%26aulast%3DGu%26aufirst%3DX.%2BK.%26aulast%3DAi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520DDB%2520Derivatives%2520as%2520Potential%2520Pgp-Mediated%2520MDR%2520Reversal%2520Agents%2520in%2520MCF-7%252FAdr%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D801%26epage%3D805%26doi%3D10.1016%2Fj.bmcl.2011.12.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Ren, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span> </span><span class="NLM_article-title">Anticancer Efficacy of a Nitric Oxide-Modified Derivative of Bifendate against Multidrug-Resistant Cancer Cells</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1111/jcmm.12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fjcmm.12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26864945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1095-1105&author=Z.+G.+Renauthor=X.+K.+Guauthor=B.+Luauthor=Y.+Q.+Chenauthor=G.+J.+Chenauthor=J.+N.+Fengauthor=J.+Z.+Linauthor=Y.+H.+Zhangauthor=H.+Peng&title=Anticancer+Efficacy+of+a+Nitric+Oxide-Modified+Derivative+of+Bifendate+against+Multidrug-Resistant+Cancer+Cells&doi=10.1111%2Fjcmm.12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells</span></div><div class="casAuthors">Ren, Zhiguang; Gu, Xiaoke; Lu, Bin; Chen, Yaqiong; Chen, Guojiang; Feng, Jiannan; Lin, Jizhen; Zhang, Yihua; Peng, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1105</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The development of multidrug resistance (MDR) not only actively transports a wide range of cytotoxic drugs across drug transporters but is also a complex interaction between a no. of important cellular signalling pathways.  Nitric oxide donors appear to be a new class of anticancer therapeutics for satisfying all the above conditions.  Previously, we reported furoxan-based nitric oxide-releasing compds. that exhibited selective antitumor activity in vitro and in vivo.  Herein, we demonstrate that bifendate (DDB)-nitric oxide, a synthetic furoxan-based nitric oxide-releasing deriv. of bifendate, effectively inhibits the both sensitive and MDR tumor cell viability at a comparatively low concn.  Interestingly, the potency of DDB-nitric oxide is the independent of inhibition of the functions and expressions of three major ABC transporters.  The mechanism of DDB-nitric oxide appears to be in two modes of actions by inducing mitochondrial tyrosine nitration and apoptosis, as well as by down-regulating HIF-1α expression and protein kinase B (AKT), extracellular signal-regulated kinases (ERK), nuclear factor κB (NF-κB) activation in MDR cells.  Moreover, the addn. of a typical nitric oxide scavenger significantly attenuated all the effects of DDB-nitric oxide, indicating that the cytotoxicity of DDB-nitric oxide is as a result of higher levels of nitric oxide release in MDR cancer cells.  Given that acquired MDR to nitric oxide donors is reportedly difficult to achieve and genetically unstable, compd. like DDB-nitric oxide may be a new type of therapeutic agent for the treatment of MDR tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplHi8uVSb7J7Vg90H21EOLACvtfcHk0li8HWryt-ux2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D&md5=b0bbc08e2f956075b8adf5759ca47c46</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.12796%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DZ.%2BG.%26aulast%3DGu%26aufirst%3DX.%2BK.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BQ.%26aulast%3DChen%26aufirst%3DG.%2BJ.%26aulast%3DFeng%26aufirst%3DJ.%2BN.%26aulast%3DLin%26aufirst%3DJ.%2BZ.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DPeng%26aufirst%3DH.%26atitle%3DAnticancer%2520Efficacy%2520of%2520a%2520Nitric%2520Oxide-Modified%2520Derivative%2520of%2520Bifendate%2520against%2520Multidrug-Resistant%2520Cancer%2520Cells%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2016%26volume%3D20%26spage%3D1095%26epage%3D1105%26doi%3D10.1111%2Fjcmm.12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">928</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms1yhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=928-940&author=X.+Guauthor=Z.+Huangauthor=Z.+Renauthor=X.+Tangauthor=R.+Xueauthor=X.+Luoauthor=S.+Pengauthor=H.+Pengauthor=B.+Luauthor=J.+Tianauthor=Y.+Zhang&title=Potent+Inhibition+of+Nitric+Oxide-Releasing+Bifendate+Derivatives+against+Drug-Resistant+K562%2FA02+Cells+in+Vitro+and+in+Vivo&doi=10.1021%2Facs.jmedchem.6b01075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo</span></div><div class="casAuthors">Gu, Xiaoke; Huang, Zhangjian; Ren, Zhiguang; Tang, Xiaobo; Xue, Rongfang; Luo, Xiaojun; Peng, Sixun; Peng, Hui; Lu, Bin; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance is a major obstacle to successful chemotherapy for leukemia.  In this study, a series of nitric oxide (NO)-releasing bifendate derivs. (7a-n) were synthesized.  Biol. evaluation indicated that the most active compd. (7a) produced relatively high levels of NO and significantly inhibited the proliferation of drug-resistant K562/A02 cells in vitro and in vivo.  In addn., 7a induced the mitochondrial tyrosine nitration and the intracellular accumulation of rhodamine 123 by inhibiting P-gp activity in K562/A02 cells.  Furthermore, 7a remarkably down-regulated AKT, NF-κB, and ERK activation and HIF-1α expression in K562/A02 cells, which are assocd. with the tumor cell proliferation and drug resistance.  Notably, the antitumor effects were dramatically attenuated by an NO scavenger or elimination of the NO-releasing capability of 7a, indicating that NO produced by 7a contributed to, at least partly, its cytotoxicity against drug-resistant K562/A02 cells.  Overall, 7a may be a potential agent against drug-resistant myelogenous leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhlGzOkF0JEbVg90H21EOLACvtfcHk0li8HWryt-ux2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms1yhtw%253D%253D&md5=0eb01f9dbe382d1f83783a043c8e5306</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01075%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXue%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPotent%2520Inhibition%2520of%2520Nitric%2520Oxide-Releasing%2520Bifendate%2520Derivatives%2520against%2520Drug-Resistant%2520K562%252FA02%2520Cells%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D928%26epage%3D940%26doi%3D10.1021%2Facs.jmedchem.6b01075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Thatcher, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolescu, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, V.</span><span> </span><span class="NLM_article-title">Nitrates and NO Release: Contemporary Aspects in Biological and Medicinal Chemistry</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2004.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.freeradbiomed.2004.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15451053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=1122-1143&author=G.+R.+Thatcherauthor=A.+C.+Nicolescuauthor=B.+M.+Bennettauthor=V.+Toader&title=Nitrates+and+NO+Release%3A+Contemporary+Aspects+in+Biological+and+Medicinal+Chemistry&doi=10.1016%2Fj.freeradbiomed.2004.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrates and NO release: Contemporary aspects in biological and medicinal chemistry</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Nicolescu, Adrian C.; Bennett, Brian M.; Toader, Violeta</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1122-1143</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nitroglycerin has been used clin. in the treatment of angina for 130 yr, yet important details on the mechanism of action, biotransformation, and the assocd. phenomenon of nitrate tolerance remain unanswered.  The biol. activity of org. nitrates can be said to be nitric oxide mimetic, leading to recent, exciting progress in realizing the therapeutic potential of nitrates.  Unequivocally, nitroglycerin and most other org. nitrates, including NO-NSAIDs, do not behave as NO donors in the most fundamental action: in vitro activation of sGC to produce cGMP.  The question as to whether the biol. activity of nitrates results primarily or exclusively from NO donation will not be satisfactorily answered until the location, the app., and the mechanism of redn. of nitrates to NO are defined.  Similarly, the therapeutic potential of nitrates will not be unlocked until this knowledge is attained.  Aspects of the therapeutic and biol. activity of nitrates are reviewed in the context of the chem. of nitrates and the elusive efficient 3e- redn. required to generate NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9yTqvI4h67Vg90H21EOLACvtfcHk0lgy0bJnwfHzvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D&md5=4cf397615197ffc1a76d3eec5f5c9bb6</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2004.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2004.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26aulast%3DNicolescu%26aufirst%3DA.%2BC.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DToader%26aufirst%3DV.%26atitle%3DNitrates%2520and%2520NO%2520Release%253A%2520Contemporary%2520Aspects%2520in%2520Biological%2520and%2520Medicinal%2520Chemistry%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2004%26volume%3D37%26spage%3D1122%26epage%3D1143%26doi%3D10.1016%2Fj.freeradbiomed.2004.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Rigas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">Nitric-Oxide-Donating NSAIDs as Agents for Cancer Prevention</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1016/j.molmed.2004.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.molmed.2004.05.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=324-330&author=B.+Rigasauthor=K.+Kashfi&title=Nitric-Oxide-Donating+NSAIDs+as+Agents+for+Cancer+Prevention&doi=10.1016%2Fj.molmed.2004.05.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2004.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2004.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DRigas%26aufirst%3DB.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DNitric-Oxide-Donating%2520NSAIDs%2520as%2520Agents%2520for%2520Cancer%2520Prevention%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D324%26epage%3D330%26doi%3D10.1016%2Fj.molmed.2004.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigas, B.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Donating Aspirin Inhibits the Growth of Pancreatic Cancer Cells through Redox-Dependent Signaling</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.canlet.2008.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.canlet.2008.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18805632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2gtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2009&pages=292-299&author=H.+Zhouauthor=L.+Huangauthor=Y.+Sunauthor=B.+Rigas&title=Nitric+Oxide-Donating+Aspirin+Inhibits+the+Growth+of+Pancreatic+Cancer+Cells+through+Redox-Dependent+Signaling&doi=10.1016%2Fj.canlet.2008.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling</span></div><div class="casAuthors">Zhou, Hui; Huang, Liqun; Sun, Yu; Rigas, Basil</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">292-299</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The novel chemopreventive nitric oxide-donating aspirin (NO-ASA) prevents nearly 90% of ductal adenocarcinomas in a animal tumor model.  To decipher the mechanism of this effect, we studied in BxPC-3 human pancreatic cancer cells the sequence of signaling events leading from NO-ASA treatment to cell growth inhibition.  NO-ASA inhibited the growth of BxPC-3 cells (IC50 = 13 μM), by inhibiting proliferation modestly and inducing apoptosis, necrosis and G1/S cell cycle block.  At 15 min of treatment with NO-ASA, the intracellular levels of reactive oxygen species (ROS) began increasing (peak at 8 h, baseline levels by 24 h).  ROS activated almost immediately in a time- and concn.-dependent manner the MAPK pathways p38, ERK and JNK (their activation was abrogated by the antioxidant N-acetylcysteine).  MAPK activation induced p21cip-1, which suppressed the levels of cyclin D1 that controls the G1/S cell cycle transition.  NO-ASA induced COX-2 expression starting 90 min after p21cip-1 was induced.  When COX-2 expression was knocked down using siRNA against cox-2, the expression of p21cip-1 was induced by NO-ASA, regardless of the level of expression of COX-2, suggesting a marginal, if any, role for COX-2 in the growth inhibitory effect of NO-ASA.  These findings along with the temporal sequence of individual changes indicate a signaling sequence that involves ROS → MAPKs → p21cip-1 → cyclin D1 → cell death.  Our findings establish the crit. role of ROS as proximal signaling mols. in the action of anticancer compds. and may be useful in designing mechanism-driven approaches to cancer control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUEyGWJ6_-WbVg90H21EOLACvtfcHk0lgy0bJnwfHzvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2gtbvL&md5=2dca592a252cab7b13d37d65332ad84e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DRigas%26aufirst%3DB.%26atitle%3DNitric%2520Oxide-Donating%2520Aspirin%2520Inhibits%2520the%2520Growth%2520of%2520Pancreatic%2520Cancer%2520Cells%2520through%2520Redox-Dependent%2520Signaling%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D273%26spage%3D292%26epage%3D299%26doi%3D10.1016%2Fj.canlet.2008.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Nath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodes, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazarenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Releasing Aspirin Suppresses NF-kappa B Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">12481</span><span class="NLM_x">–</span> <span class="NLM_lpage">12499</span><span class="refDoi"> DOI: 10.3390/molecules200712481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3390%2Fmolecules200712481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=12481-12499&author=N.+Nathauthor=M.+Chattopadhyayauthor=D.+B.+Rodesauthor=A.+Nazarenkoauthor=R.+Kodelaauthor=K.+Kashfi&title=Nitric+Oxide-Releasing+Aspirin+Suppresses+NF-kappa+B+Signaling+in+Estrogen+Receptor+Negative+Breast+Cancer+Cells+in+Vitro+and+in+Vivo&doi=10.3390%2Fmolecules200712481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200712481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200712481%26sid%3Dliteratum%253Aachs%26aulast%3DNath%26aufirst%3DN.%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DRodes%26aufirst%3DD.%2BB.%26aulast%3DNazarenko%26aufirst%3DA.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DNitric%2520Oxide-Releasing%2520Aspirin%2520Suppresses%2520NF-kappa%2520B%2520Signaling%2520in%2520Estrogen%2520Receptor%2520Negative%2520Breast%2520Cancer%2520Cells%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D12481%26epage%3D12499%26doi%3D10.3390%2Fmolecules200712481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Chaudhary, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmets, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopelovich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athar, M.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Releasing Sulindac Is a Novel Skin Cancer Chemopreventive Agent for UVB-Induced Photocarcinogenesis</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/j.taap.2012.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.taap.2012.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23274568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVGit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2013&pages=249-255&author=S.+C.+Chaudharyauthor=T.+Singhauthor=P.+Kapurauthor=Z.+P.+Wengauthor=A.+Arumugamauthor=C.+A.+Elmetsauthor=L.+Kopelovichauthor=M.+Athar&title=Nitric+Oxide-Releasing+Sulindac+Is+a+Novel+Skin+Cancer+Chemopreventive+Agent+for+UVB-Induced+Photocarcinogenesis&doi=10.1016%2Fj.taap.2012.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis</span></div><div class="casAuthors">Chaudhary, Sandeep C.; Singh, Tripti; Kapur, Puneet; Weng, Zhiping; Arumugam, Aadithya; Elmets, Craig A.; Kopelovich, Levy; Athar, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-255</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nitric oxide (NO)-releasing non-steroidal anti-inflammatory drugs (NO-NSAIDs) which have been synthesized to reduce gastro-intestinal and cardiovascular toxicities of NSAIDs, possess anti-proliferative, pro-apoptotic and anti-cancer activities.  Here, we show that NO-sulindac inhibited UVB-induced skin tumorigenesis in SKH-1 hairless mice.  Topical application of NO-sulindac reduced tumor incidence, no. (p < 0.05) and vol. (p < 0.005) as compared to UVB (alone)-irradiated vehicle-treated mice.  An increase in TUNEL-pos. cells in skin lesions was accompanied by the enhanced Bax:Bcl-2 ratio.  The expression of pro-apoptotic Bax was increased whereas anti-apoptotic Bcl-2 reduced.  However, proliferation was identified as the major target of NO-sulindac in this study.  A reduced expression of PCNA and cyclin D1 assocd. with the dampening of cell cycle progression was obsd.  The mechanism of this inhibition was related to the redn. in UVB-induced Notch signaling pathway.  UVB-induced inflammatory responses were diminished by NO-sulindac as obsd. by a remarkable redn. in the levels of phosphorylated MAP Kinases Erk1/2, p38 and JNK1/2.  In this regard, NO-sulindac also inhibited NFκB by enhancing IκBα as evidenced by the reduced expression of iNOS and COX-2, the direct NFκB transcription target proteins.  NO-sulindac significantly diminished the progression of benign lesions to invasive carcinomas by suppressing the tumor aggressiveness and retarding epithelial-mesenchymal transition.  A marked decrease in the expression of mesenchymal markers such as Fibronectin, N-cadherin, SNAI, Slug and Twist and an increase in epithelial cell polarity marker E-cadherin were noted in NO-sulindac-treated tumors.  Our data suggest that NO-sulindac is a potent inhibitor of UVB-induced skin carcinogenesis and acts by targeting proliferation-regulatory pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrClQbPNEDE-7Vg90H21EOLACvtfcHk0linvxTyawKexQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVGit7k%253D&md5=28cc92f41e451fc4e28c7bcbc1714d03</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2012.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2012.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DS.%2BC.%26aulast%3DSingh%26aufirst%3DT.%26aulast%3DKapur%26aufirst%3DP.%26aulast%3DWeng%26aufirst%3DZ.%2BP.%26aulast%3DArumugam%26aufirst%3DA.%26aulast%3DElmets%26aufirst%3DC.%2BA.%26aulast%3DKopelovich%26aufirst%3DL.%26aulast%3DAthar%26aufirst%3DM.%26atitle%3DNitric%2520Oxide-Releasing%2520Sulindac%2520Is%2520a%2520Novel%2520Skin%2520Cancer%2520Chemopreventive%2520Agent%2520for%2520UVB-Induced%2520Photocarcinogenesis%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D268%26spage%3D249%26epage%3D255%26doi%3D10.1016%2Fj.taap.2012.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Hulsman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongejan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span> </span><span class="NLM_article-title">Chemical Insights in the Concept of Hybrid Drugs: The Antitumor Effect of Nitric Oxide-Donating Aspirin Involves a Quinone Methide but Not Nitric Oxide nor Aspirin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2424</span><span class="NLM_x">–</span> <span class="NLM_lpage">2431</span><span class="refDoi"> DOI: 10.1021/jm061371e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061371e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Oqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2424-2431&author=N.+Hulsmanauthor=J.+P.+Medemaauthor=C.+Bosauthor=A.+Jongejanauthor=R.+Leursauthor=M.+J.+Smitauthor=I.+J.+de+Eschauthor=D.+Richelauthor=M.+Wijtmans&title=Chemical+Insights+in+the+Concept+of+Hybrid+Drugs%3A+The+Antitumor+Effect+of+Nitric+Oxide-Donating+Aspirin+Involves+a+Quinone+Methide+but+Not+Nitric+Oxide+nor+Aspirin&doi=10.1021%2Fjm061371e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Insights in the Concept of Hybrid Drugs: The Antitumor Effect of Nitric Oxide-Donating Aspirin Involves A Quinone Methide but Not Nitric Oxide nor Aspirin</span></div><div class="casAuthors">Hulsman, Niels; Medema, Jan Paul; Bos, Carina; Jongejan, Aldo; Leurs, Rob; Smit, Martine J.; de Esch, Iwan J. P.; Richel, Dick; Wijtmans, Maikel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2424-2431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hybrid drug (NO-ASA, I) continues to attract intense research from chemists and biologists alike.  It consists of ASA and a -ONO2 group connected through a spacer and is in preclin. development as an antitumor drug.  The authors report that, contrary to current beliefs, neither ASA nor NO contributes to this antitumor effect.  Rather, an unsubstituted QM was identified as the sole cytotoxic agent.  QM forms from I after carboxylic ester hydrolysis and, in accordance with the HSAB theory, selectively reacts with cellular GSH, which in turn triggers cell death.  Remarkably, a deriv. lacking ASA and the -ONO2 group is 10 times more effective than I.  Thus, our data provide a conclusive mol. mechanism for the antitumor activity of I.  Equally importantly, the authors show for the first time that a "presumed invisible" linker in a hybrid drug is not so invisible after all and is in fact solely responsible for the biol. effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKPVcYZ7n5LVg90H21EOLACvtfcHk0linvxTyawKexQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Oqtro%253D&md5=821a046928c142a7adfe410919de0878</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm061371e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061371e%26sid%3Dliteratum%253Aachs%26aulast%3DHulsman%26aufirst%3DN.%26aulast%3DMedema%26aufirst%3DJ.%2BP.%26aulast%3DBos%26aufirst%3DC.%26aulast%3DJongejan%26aufirst%3DA.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26aulast%3DRichel%26aufirst%3DD.%26aulast%3DWijtmans%26aufirst%3DM.%26atitle%3DChemical%2520Insights%2520in%2520the%2520Concept%2520of%2520Hybrid%2520Drugs%253A%2520The%2520Antitumor%2520Effect%2520of%2520Nitric%2520Oxide-Donating%2520Aspirin%2520Involves%2520a%2520Quinone%2520Methide%2520but%2520Not%2520Nitric%2520Oxide%2520nor%2520Aspirin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2424%26epage%3D2431%26doi%3D10.1021%2Fjm061371e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Stewart, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddick, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, F. K.</span><span> </span><span class="NLM_article-title">No-Sulindac Inhibits the Hypoxia Response of PC-3 Prostate Cancer Cells via the Akt Signalling Pathway</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1002/ijc.23934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fijc.23934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18924134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD1cjovFSgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=223-232&author=G.+D.+Stewartauthor=J.+Nandaauthor=D.+J.+Brownauthor=A.+C.+Riddickauthor=J.+A.+Rossauthor=F.+K.+Habib&title=No-Sulindac+Inhibits+the+Hypoxia+Response+of+PC-3+Prostate+Cancer+Cells+via+the+Akt+Signalling+Pathway&doi=10.1002%2Fijc.23934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway</span></div><div class="casAuthors">Stewart Grant D; Nanda Jyoti; Brown David J G; Riddick Antony C P; Ross James A; Habib Fouad K</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nitric oxide-donating non-steroidal anti-inflammatory drugs are safer than traditional NSAIDs and inhibit the growth of prostate cancer cells with greater potency than NSAIDs.  In vivo, prostate cancer deposits are found in a hypoxic environment which induces resistance to chemotherapy.  The aim of this study was to assess the effects and mechanism of action of a NO-NSAID called NO-sulindac on the PC-3 prostate cancer cell line under hypoxic conditions.  NO-sulindac was found to have pro-apoptotic, cytotoxic, and anti-invasive effect on PC-3 cells under normoxia and hypoxia.  NO-sulindac was significantly more cytotoxic than sulindac at all oxygen levels.  The sulindac/linker and NO-releasing subunits both contributed to the cytotoxic effects of NO-sulindac.  Resistance of PC-3 cells to NO-sulindac was induced as the oxygen concentration declined.  Hypoxia-induced chemoresistance was reversed by knocking-down hypoxia-inducible factor-1alpha (HIF-1alpha) mRNA using RNAi.  Nuclear HIF-1alpha levels were upregulated at 0.2% oxygen but reduced by treatment with NO-sulindac, as was Akt phosphorylation.  NO-sulindac treatment of hypoxic PC-3 cells transfected with a reporter construct, downregulated activation of the hypoxia response element (HRE) promoter.  Co-transfection of PC-3 cells with the HRE promoter reporter construct and myr-Akt (constitutively active Akt) plasmids reversed the NO-sulindac induced reduction in HRE activation.  Real-time polymerase chain reaction analysis of hypoxic, NO-sulindac treated PC-3 cells showed downregulation of lysyl oxidase and carbonic anhydrase IX mRNA expression.  Collectively, these novel findings demonstrate that NO-sulindac directly inhibits the hypoxia response of PC-3 prostate cancer cells by inhibiting HIF-1alpha translation via the Akt signalling pathway.  The ability of NO-sulindac to inhibit tumour adaption to hypoxia has considerable relevance to the future management of prostate cancer with the same cellular properties as PC-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_bELpR82egAqdek-gHSrIfW6udTcc2eadE0tVDJ9r17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjovFSgsA%253D%253D&md5=3321ba8a6e0cd421f95203203f53aae1</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fijc.23934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23934%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DG.%2BD.%26aulast%3DNanda%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BJ.%26aulast%3DRiddick%26aufirst%3DA.%2BC.%26aulast%3DRoss%26aufirst%3DJ.%2BA.%26aulast%3DHabib%26aufirst%3DF.%2BK.%26atitle%3DNo-Sulindac%2520Inhibits%2520the%2520Hypoxia%2520Response%2520of%2520PC-3%2520Prostate%2520Cancer%2520Cells%2520via%2520the%2520Akt%2520Signalling%2520Pathway%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2009%26volume%3D124%26spage%3D223%26epage%3D232%26doi%3D10.1002%2Fijc.23934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mojic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harhaji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabideen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevelacqua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garotta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Novel Nitric Oxide-Donating Compound (S,R)-3-Phenyl-4,5-Dihydro-5-Isoxazole Acetic Acid-Nitric Oxide (GIT-27NO) Induces p53 Mediated Apoptosis in Human A375 Melanoma Cells</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.niox.2008.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2008.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=177-183&author=S.+Mijatovicauthor=D.+Maksimovic-Ivanicauthor=M.+Mojicauthor=G.+Malaponteauthor=M.+Libraauthor=V.+Cardileauthor=D.+Miljkovicauthor=L.+Harhajiauthor=D.+Dabideenauthor=K.+F.+Chengauthor=Y.+Bevelacquaauthor=M.+Doniaauthor=G.+Garottaauthor=Y.+Al-Abedauthor=S.+Stosic-Grujicicauthor=F.+Nicoletti&title=Novel+Nitric+Oxide-Donating+Compound+%28S%2CR%29-3-Phenyl-4%2C5-Dihydro-5-Isoxazole+Acetic+Acid-Nitric+Oxide+%28GIT-27NO%29+Induces+p53+Mediated+Apoptosis+in+Human+A375+Melanoma+Cells&doi=10.1016%2Fj.niox.2008.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMojic%26aufirst%3DM.%26aulast%3DMalaponte%26aufirst%3DG.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DHarhaji%26aufirst%3DL.%26aulast%3DDabideen%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DK.%2BF.%26aulast%3DBevelacqua%26aufirst%3DY.%26aulast%3DDonia%26aufirst%3DM.%26aulast%3DGarotta%26aufirst%3DG.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DNovel%2520Nitric%2520Oxide-Donating%2520Compound%2520%2528S%252CR%2529-3-Phenyl-4%252C5-Dihydro-5-Isoxazole%2520Acetic%2520Acid-Nitric%2520Oxide%2520%2528GIT-27NO%2529%2520Induces%2520p53%2520Mediated%2520Apoptosis%2520in%2520Human%2520A375%2520Melanoma%2520Cells%26jtitle%3DNitric%2520Oxide%26date%3D2008%26volume%3D19%26spage%3D177%26epage%3D183%26doi%3D10.1016%2Fj.niox.2008.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harhaji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabideen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garotta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span> </span><span class="NLM_article-title">Anticancer Properties of the Novel Nitric Oxide-Donating Compound (S,R)-3-Phenyl-4,5-Dihydro-5-Isoxazole Acetic Acid-Nitric Oxide in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-2037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F1535-7163.MCT-07-2037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18347138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=510-520&author=D.+Maksimovic-Ivanicauthor=S.+Mijatovicauthor=L.+Harhajiauthor=D.+Miljkovicauthor=D.+Dabideenauthor=K.+Fan+Chengauthor=K.+Manganoauthor=G.+Malaponteauthor=Y.+Al-Abedauthor=M.+Libraauthor=G.+Garottaauthor=F.+Nicolettiauthor=S.+Stosic-Grujicic&title=Anticancer+Properties+of+the+Novel+Nitric+Oxide-Donating+Compound+%28S%2CR%29-3-Phenyl-4%2C5-Dihydro-5-Isoxazole+Acetic+Acid-Nitric+Oxide+in+Vitro+and+in+Vivo&doi=10.1158%2F1535-7163.MCT-07-2037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo</span></div><div class="casAuthors">Maksimovic-Ivanic, Danijela; Mijatovic, Sanja; Harhaji, Ljubica; Miljkovic, Djordje; Dabideen, Darrin; Cheng, Kai Fan; Mangano, Katia; Malaponte, Graziella; Al-Abed, Yousef; Libra, Massimo; Garotta, Gianni; Nicoletti, Ferdinando; Stosic-Grujicic, Stanislava</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">510-520</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Preclin. studies have shown that nitric oxide (NO)-donating nonsteroidal anti-inflammatory drugs possess anticancer activities.  Here, the authors report in vitro and in vivo studies showing the antitumor effect of the NO-donating isoxazole deriv. (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid (GIT-27NO).  GIT-27NO, but not the NO-deprived parental compd. VGX-1027, significantly affected viability of both rodent (L929, B16, and C6) and human (U251, BT20, HeLa, and LS174) tumor cell lines.  GIT-27NO triggered either apoptotic cell death (e.g., L929 cells) or autophagic cell death (C6 and B16 cells).  Moreover, GIT-27NO hampered the viability of cisplatin-resistant B16 cells.  NO scavenger Hb completely prevented GIT-27NO-induced death, indicating that NO release mediated the tumoricidal effect of the compd.  Increase in intracellular NO upon on the treatment was assocd. with intensified prodn. of reactive oxygen species, whereas their neutralization by antioxidant N-acetylcysteine resulted in partial recovery of cell viability.  The antitumor activity of the drug was mediated by the selective activation of mitogen-activated protein kinases in a cell-specific manner and was neutralized by their specific inhibitors.  In vivo treatment with GIT-27NO significantly reduced the B16 melanoma growth in syngeneic C57BL/6 mice.  The therapeutic effect occurred at dose (0.5 mg/mouse) up to 160 times lower than those needed to induce acute lethality (80 mg/mouse).  In addn., a dose of GIT-27NO five times higher than that found effective in the melanoma model was well tolerated by the mice when administered for 4 consecutive weeks.  These data warrant addnl. studies to evaluate the possible translation of these findings to the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowlAWTcDL2abVg90H21EOLACvtfcHk0lhV25FSyX7ZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D&md5=7e8309d0122f74aa980f12cd743e6cb2</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2037%26sid%3Dliteratum%253Aachs%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DHarhaji%26aufirst%3DL.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DDabideen%26aufirst%3DD.%26aulast%3DFan%2BCheng%26aufirst%3DK.%26aulast%3DMangano%26aufirst%3DK.%26aulast%3DMalaponte%26aufirst%3DG.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DGarotta%26aufirst%3DG.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26atitle%3DAnticancer%2520Properties%2520of%2520the%2520Novel%2520Nitric%2520Oxide-Donating%2520Compound%2520%2528S%252CR%2529-3-Phenyl-4%252C5-Dihydro-5-Isoxazole%2520Acetic%2520Acid-Nitric%2520Oxide%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D510%26epage%3D520%26doi%3D10.1158%2F1535-7163.MCT-07-2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">NOSH-aspirin (NBS-1120), a Novel Nitric Oxide- and Hydrogen Sulfide-Releasing Hybrid is a Potent Inhibitor of Colon Cancer Cell Growth in Vitro and in a Xenograft Mouse Model</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2012.02.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bbrc.2012.02.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2012&pages=523-528&author=M.+Chattopadhyayauthor=R.+Kodelaauthor=K.+R.+Olsonauthor=K.+Kashfi&title=NOSH-aspirin+%28NBS-1120%29%2C+a+Novel+Nitric+Oxide-+and+Hydrogen+Sulfide-Releasing+Hybrid+is+a+Potent+Inhibitor+of+Colon+Cancer+Cell+Growth+in+Vitro+and+in+a+Xenograft+Mouse+Model&doi=10.1016%2Fj.bbrc.2012.02.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.02.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.02.051%26sid%3Dliteratum%253Aachs%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DOlson%26aufirst%3DK.%2BR.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DNOSH-aspirin%2520%2528NBS-1120%2529%252C%2520a%2520Novel%2520Nitric%2520Oxide-%2520and%2520Hydrogen%2520Sulfide-Releasing%2520Hybrid%2520is%2520a%2520Potent%2520Inhibitor%2520of%2520Colon%2520Cancer%2520Cell%2520Growth%2520in%2520Vitro%2520and%2520in%2520a%2520Xenograft%2520Mouse%2520Model%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D419%26spage%3D523%26epage%3D528%26doi%3D10.1016%2Fj.bbrc.2012.02.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Wang, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M. L.</span><span> </span><span class="NLM_article-title">Synthesis and Antitumor Activity of ATB-429 Derivatives Containing a Nitric Oxide-Releasing Moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2355</span><span class="NLM_x">–</span> <span class="NLM_lpage">2359</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2016.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26995527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2355-2359&author=C.+L.+Wangauthor=G.+M.+Xiaauthor=X.+J.+Liuauthor=R.+Zhangauthor=Y.+Chaiauthor=J.+Zhangauthor=X.+N.+Liauthor=Y.+Yangauthor=J.+X.+Wangauthor=M.+L.+Liu&title=Synthesis+and+Antitumor+Activity+of+ATB-429+Derivatives+Containing+a+Nitric+Oxide-Releasing+Moiety&doi=10.1016%2Fj.bmcl.2016.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitumor activity of ATB-429 derivatives containing a nitric oxide-releasing moiety</span></div><div class="casAuthors">Wang, Chunlan; Xia, Guimin; Liu, Xiujun; Zhang, Rui; Chai, Yun; Zhang, Jun; Li, Xiaoning; Yang, Yang; Wang, Juxian; Liu, Mingliang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2355-2359</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel ATB-429 (an anti-inflammatory candidate) derivs. contg. a nitric oxide (NO)-releasing moiety were designed, synthesized and evaluated for their in vitro activity against six human cancer cell lines.  Our results reveal that phenylsulfonylfuroxan-based derivs. have considerable antitumor activity, and compds. 7 [VII; n = 2 (a), 3 (b)], 8 [VIII; n = 2 (a), 3 (b)], 9 (IX; IC50s: 0.256-3.024 μM) against HT-29 and PANC-1, 8a,b (IC50s: 2.677-3.051 μM) against MCF-7 and 8a (IC50: 1.270 μM) against DU145 are more active than Vandetanib (IC50s: 1.925-4.107 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoivLW50C-LfrVg90H21EOLACvtfcHk0lgs5s5eiQ0cew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGhs7o%253D&md5=e801db25b629cfb91dd8e6f0ae84d176</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BL.%26aulast%3DXia%26aufirst%3DG.%2BM.%26aulast%3DLiu%26aufirst%3DX.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DChai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%2BN.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%2BX.%26aulast%3DLiu%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520and%2520Antitumor%2520Activity%2520of%2520ATB-429%2520Derivatives%2520Containing%2520a%2520Nitric%2520Oxide-Releasing%2520Moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2355%26epage%3D2359%26doi%3D10.1016%2Fj.bmcl.2016.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Vannini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKessack-Leitch, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbach, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">Synthesis and Anti-Cancer Potential of the Positional Isomers of NOSH-aspirin (NBS-1120) a Dual Nitric Oxide and Hydrogen Sulfide Releasing Hybrid</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4677</span><span class="NLM_x">–</span> <span class="NLM_lpage">4682</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2015.08.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4677-4682&author=F.+Vanniniauthor=A.+C.+MacKessack-Leitchauthor=E.+K.+Eschbachauthor=M.+Chattopadhyayauthor=R.+Kodelaauthor=K.+Kashfi&title=Synthesis+and+Anti-Cancer+Potential+of+the+Positional+Isomers+of+NOSH-aspirin+%28NBS-1120%29+a+Dual+Nitric+Oxide+and+Hydrogen+Sulfide+Releasing+Hybrid&doi=10.1016%2Fj.bmcl.2015.08.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DVannini%26aufirst%3DF.%26aulast%3DMacKessack-Leitch%26aufirst%3DA.%2BC.%26aulast%3DEschbach%26aufirst%3DE.%2BK.%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Anti-Cancer%2520Potential%2520of%2520the%2520Positional%2520Isomers%2520of%2520NOSH-aspirin%2520%2528NBS-1120%2529%2520a%2520Dual%2520Nitric%2520Oxide%2520and%2520Hydrogen%2520Sulfide%2520Releasing%2520Hybrid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4677%26epage%3D4682%26doi%3D10.1016%2Fj.bmcl.2015.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Kashfi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span> </span><span class="NLM_article-title">NOSH-sulindac (AVT-18A) Is a Novel Nitric Oxide- and Hydrogen Sulfide-Releasing Hybrid That Is Gastrointestinal Safe and Has Potent Anti-Inflammatory, Analgesic, Antipyretic, Anti-Platelet, and Anti-Cancer Properties</span> <span class="citation_source-journal">Redox Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1016/j.redox.2015.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.redox.2015.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26298203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCrurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=287-296&author=K.+Kashfiauthor=M.+Chattopadhyayauthor=R.+Kodela&title=NOSH-sulindac+%28AVT-18A%29+Is+a+Novel+Nitric+Oxide-+and+Hydrogen+Sulfide-Releasing+Hybrid+That+Is+Gastrointestinal+Safe+and+Has+Potent+Anti-Inflammatory%2C+Analgesic%2C+Antipyretic%2C+Anti-Platelet%2C+and+Anti-Cancer+Properties&doi=10.1016%2Fj.redox.2015.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties</span></div><div class="casAuthors">Kashfi, Khosrow; Chattopadhyay, Mitali; Kodela, Ravinder</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">287-296</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulindac is chemopreventive and has utility in patients with familial adenomatous polyposis; however, side effects preclude its long-term use.  NOSH-sulindac (AVT-18A) releases nitric oxide and hydrogen sulfide, was designed to be a safer alternative.  Here we compare the gastrointestinal safety, anti-inflammatory, analgesic, anti-pyretic, anti-platelet, and anti-cancer properties of sulindac and NOSH-sulindac administered orally to rats at equimolar doses.  Gastrointestinal safety: 6 h post-administration, no./size of hemorrhagic lesions in stomachs were counted.  Tissue samples were frozen for PGE2, SOD, and MDA detn.  Anti-inflammatory: 1 h after drug administration, the vol. of carrageenan-induced rat paw edemas was measured for 5 h.  Anti-pyretic: fever was induced by LPS (i.p.) an hour before administration of the test drugs, core body temp. was measured hourly for 5 h.  Analgesic: time-dependent analgesic effects were evaluated by carrageenan-induced hyperalgesia.  Antiplatelet: anti-aggregatory effects were studied on collagen-induced platelet aggregation of human platelet-rich plasma.  Anti-cancer: We examd. the effects of NOSH-sulindac on the growth properties of 12 human cancer cell lines of six different tissue origins.  Both agents reduced PGE2 levels in stomach tissue; however, NOSH-sulindac did not cause any stomach ulcers, whereas sulindac caused significant bleeding.  Lipid peroxidn. induced by sulindac was higher than that from NOSH-sulindac.  SOD activity was significantly lowered by sulindac but increased by NOSH-sulindac.  Both agents showed similar anti-inflammatory, analgesic, anti-pyretic, and anti-platelet activities.  Sulindac increased plasma TNFα whereas this rise was lower in the NOSH-sulindac-treated animals.  NOSH-sulindac inhibited the growth of all cancer cell lines studied, with potencies of 1000- to 9000-fold greater than that of sulindac.  NOSH-sulindac inhibited cell proliferation, induced apoptosis, and caused G2/M cell cycle block.  These results demonstrate that NOSH-sulindac is gastrointestinal safe, and maintains the anti-inflammatory, analgesic, antipyretic, and antiplatelet properties of its parent compd. sulinsac, with anti-growth activity against a wide variety of human cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Qvv3YXAQurVg90H21EOLACvtfcHk0ljNpSm81x9Lzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCrurbM&md5=71c8577d2d2857c51c460c46877a7e8d</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DKashfi%26aufirst%3DK.%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DR.%26atitle%3DNOSH-sulindac%2520%2528AVT-18A%2529%2520Is%2520a%2520Novel%2520Nitric%2520Oxide-%2520and%2520Hydrogen%2520Sulfide-Releasing%2520Hybrid%2520That%2520Is%2520Gastrointestinal%2520Safe%2520and%2520Has%2520Potent%2520Anti-Inflammatory%252C%2520Analgesic%252C%2520Antipyretic%252C%2520Anti-Platelet%252C%2520and%2520Anti-Cancer%2520Properties%26jtitle%3DRedox%2520Biol.%26date%3D2015%26volume%3D6%26spage%3D287%26epage%3D296%26doi%3D10.1016%2Fj.redox.2015.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A. K.</span><span> </span><span class="NLM_article-title">Nitric Oxide: Role in Tumour Biology and iNOS/NO-Based Anticancer Therapies</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span><span class="refDoi"> DOI: 10.1007/s00280-011-1654-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2Fs00280-011-1654-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21544630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=1211-1224&author=S.+Singhauthor=A.+K.+Gupta&title=Nitric+Oxide%3A+Role+in+Tumour+Biology+and+iNOS%2FNO-Based+Anticancer+Therapies&doi=10.1007%2Fs00280-011-1654-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies</span></div><div class="casAuthors">Singh, Simendra; Gupta, Alok K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1211-1224</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Purpose The diat. radical nitric oxide (NO) has been the cause of intense debate with implication in carcinogenesis, tumor progression, invasion, angiogenesis and modulation of therapeutic responses.  The tumor biol. of NO is highly complex, and this review summarises the various protective and damaging mode of action of NO.  Methods We reviewed all published literature addressing the complexities of the role of NO in the altered biol. of cancer and evaluating promising therapeutic roles of NO/iNOS for anti-cancer therapy.  Results The available exptl. evidences highlight contrasting pro- and anti-tumor effects of iNOS expression, which appear to be reconciled by consideration of the concns. of NO involved, the temporo-spatial mode of NO action, intracellular targets, cellular redox state and the timing of an apoptotic stimulus.  Several clin. and exptl. studies indicate that the presence of NO in tumor microenvironment is detrimental to tumor cell survival and metastasis.  In contrast, numerous reports suggest that NO can have tumor-promoting effects.  NO is a double-edged sword' in cancer, and this review offers insight into the dichotomous nature of NO and discuss the therapeutic gain that can be achieved by manipulating tumor NO.  Conclusions NO may exert a biphasic response, such that when NO levels go beyond a crit. concn. that would be suitable for tumor growth and survival, growth arrest and/or apoptotic pathways are initiated.  These characteristics of NO have been exploited therapeutically with impressive effects in pre-clin. models of cancer to slow tumor growth and to enhance the efficacy of both chemotherapy and radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZAxpANjQm1bVg90H21EOLACvtfcHk0ljNpSm81x9Lzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGht7Y%253D&md5=5221d561ab8ceb256506067a8863e18e</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs00280-011-1654-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-011-1654-4%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26atitle%3DNitric%2520Oxide%253A%2520Role%2520in%2520Tumour%2520Biology%2520and%2520iNOS%252FNO-Based%2520Anticancer%2520Therapies%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D1211%26epage%3D1224%26doi%3D10.1007%2Fs00280-011-1654-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. H.</span><span> </span><span class="NLM_article-title">Apoptosis of Bladder Transitional Cell Carcinoma T24 Cells Induced by Adenovirus-Mediated Inducible Nitric Oxide Synthase Gene Transfection</span> <span class="citation_source-journal">Chin. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.3978/j.issn.1000-9604.2013.10.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3978%2Fj.issn.1000-9604.2013.10.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24255584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVWmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=593-599&author=J.+Tanauthor=Q.+Zengauthor=X.+Z.+Jiangauthor=L.+Y.+Heauthor=J.+R.+Wangauthor=K.+Yaoauthor=C.+H.+Wang&title=Apoptosis+of+Bladder+Transitional+Cell+Carcinoma+T24+Cells+Induced+by+Adenovirus-Mediated+Inducible+Nitric+Oxide+Synthase+Gene+Transfection&doi=10.3978%2Fj.issn.1000-9604.2013.10.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis of bladder transitional cell carcinoma T24 cells induced by adenovirus-mediated inducible nitric oxide synthase gene transfection</span></div><div class="casAuthors">Tan, Jing; Zeng, Qing; Jiang, Xian-Zheng; He, Le-Ye; Wang, Jin-Rong; Yao, Kun; Wang, Chang-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-599</span>CODEN:
                <span class="NLM_cas:coden">CJCRFH</span>;
        ISSN:<span class="NLM_cas:issn">1000-9604</span>.
    
            (<span class="NLM_cas:orgname">AME Publishing Company</span>)
        </div><div class="casAbstract">Objectives: To investigate the effects of adenovirus-mediated inducible nitric oxide synthase gene transfection on bladder transitional cell carcinoma T24 cells, and to provide novel insights and approaches to clin. therapies against bladder transitional cell carcinoma.  Methods: Firstly, construct recombinant adenovirus vector pAd-iNOS of iNOS, followed by transfection of pAd-iNOS into HECK293 packaging cells.  Thirdly, harvest recombinant adenovirus rAd-iNOS after amplification and purifn. procedures.  Finally, transfect the recombinant adenovirus rAd-iNOS into human bladder carcinoma T24 cells and examine the effect of rAd-iNOS transfection on apoptosis of T24 and possible mechanism.  Results: As shown by this study, the recombinant adenovirus rAd-iNOS was constructed successfully.  The virus titer was 5.8×108 PFU/mL and recombinant was verified by PCR anal.  Transfection of adenovirus rAd-iNOS into T24 cells could induce secretion of high NO concn., P53 protein expression up-regulation, as well as promotion of T24 cell apoptosis.  Conclusions: The transfection of human bladder carcinoma T24 cells from recombinant adenovirus rAd-iNOS was confirmed to induce intracellular iNOS over-expression, high prodn. of NO, up-regulation of intracellular P53 expression and promotion of cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotDMwUX4vXcbVg90H21EOLACvtfcHk0liWDzCQqd5ZCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVWmsb0%253D&md5=347fc2a1ad8cf037e191a04be809e992</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.1000-9604.2013.10.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.1000-9604.2013.10.11%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DX.%2BZ.%26aulast%3DHe%26aufirst%3DL.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BR.%26aulast%3DYao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DC.%2BH.%26atitle%3DApoptosis%2520of%2520Bladder%2520Transitional%2520Cell%2520Carcinoma%2520T24%2520Cells%2520Induced%2520by%2520Adenovirus-Mediated%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Gene%2520Transfection%26jtitle%3DChin.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D25%26spage%3D593%26epage%3D599%26doi%3D10.3978%2Fj.issn.1000-9604.2013.10.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span> </span><span class="NLM_article-title">Cationic Liposome-Mediated Nitric Oxide Synthase Gene Therapy Enhances the Antitumor Effects of Cisplatin in Lung Cancer</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.3892/ijmm.2012.1171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3892%2Fijmm.2012.1171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23128378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=33-42&author=S.+Yeauthor=W.+Yangauthor=Y.+Wangauthor=W.+Ouauthor=Q.+Maauthor=C.+Yuauthor=J.+Renauthor=G.+Zhongauthor=H.+Shiauthor=Z.+Yuanauthor=X.+Suauthor=W.+Zhu&title=Cationic+Liposome-Mediated+Nitric+Oxide+Synthase+Gene+Therapy+Enhances+the+Antitumor+Effects+of+Cisplatin+in+Lung+Cancer&doi=10.3892%2Fijmm.2012.1171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer</span></div><div class="casAuthors">Ye, Sujuan; Yang, Weihan; Wang, Yu; Ou, Wenjing; Ma, Qingping; Yu, Chuanjiang; Ren, Jiang; Zhong, Guoxing; Shi, Huashan; Yuan, Zhu; Su, Xiaolan; Zhu, Wen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">Cisplatin is one of the most effective antitumor drugs for non-small cell lung carcinoma (NSCLC) patients.  However, its efficacy has encountered a plateau due to its side effects and drug resistance.  Inducible nitric oxide (NO) synthase (iNOS) gene therapy has been reported to have antitumor effects in several types of cancers and enhances sensitivity to cisplatin, but the effects of iNOS gene therapy alone or its combination with cisplatin in lung cancer remain unclear.  In the current study, we evaluated the effects of cationic liposome (LP)-mediated iNOS gene transfection on enhancing low-dose cisplatin-mediated antitumor effects in the A549 human lung adenocarcinoma cell line in vitro.  Furthermore, we examd. whether iNOS gene therapy enhances the antitumor effects of low-dose cisplatin in two A549 human lung cancer cell xenograft mouse models.  The results revealed that iNOS gene therapy may significantly enhance low-dose cisplatin-mediated inhibition of cell proliferation, invasion, migration and promotion of cell apoptosis in A549 cells.  Intratumoral administration of the LP-pVAX-iNOS complex significantly enhanced low-dose cisplatin-mediated suppression of s.c. tumor growth.  Moreover, i.v. injection of the LP-pVAX-iNOS complex greatly enhanced low-dose cisplatin-mediated inhibition of exptl. lung metastasis and prolonged the life span of mice without significant organ-related toxicity in a nude mouse model of lung metastasis compared to the cisplatin alone-treated group.  Furthermore, iNOS gene-mediated enhancement of cisplatin-mediated antitumor effects in lung cancer may be related to the attenuation of p-mTOR, MMP2 and the activation of p-p53.  Thus, the combination treatment with iNOS gene therapy and cisplatin may be a novel and effective therapeutic strategy for lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo03qp8DzeberVg90H21EOLACvtfcHk0liWDzCQqd5ZCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCisrg%253D&md5=3b06819cd5e9f70099f4785ce0d61849</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2012.1171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2012.1171%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DCationic%2520Liposome-Mediated%2520Nitric%2520Oxide%2520Synthase%2520Gene%2520Therapy%2520Enhances%2520the%2520Antitumor%2520Effects%2520of%2520Cisplatin%2520in%2520Lung%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2013%26volume%3D31%26spage%3D33%26epage%3D42%26doi%3D10.3892%2Fijmm.2012.1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">McCarthy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zholobenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatefi, A.</span><span> </span><span class="NLM_article-title">Evaluation of a Multi-Functional Nanocarrier for Targeted Breast Cancer iNOS Gene Therapy</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2010.11.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.ijpharm.2010.11.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21134429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVWhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2011&pages=196-202&author=H.+O.+McCarthyauthor=A.+V.+Zholobenkoauthor=Y.+Wangauthor=B.+Canineauthor=T.+Robsonauthor=D.+G.+Hirstauthor=A.+Hatefi&title=Evaluation+of+a+Multi-Functional+Nanocarrier+for+Targeted+Breast+Cancer+iNOS+Gene+Therapy&doi=10.1016%2Fj.ijpharm.2010.11.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy</span></div><div class="casAuthors">McCarthy, Helen O.; Zholobenko, Alek V.; Wang, Yuhua; Canine, Brenda; Robson, Tracy; Hirst, David G.; Hatefi, Arash</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">196-202</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study dets. whether the novel designer biomimetic vector (DBV) can condense and deliver the cytotoxic iNOS gene to breast cancer cells to achieve a therapeutic effect.  We have previously shown the benefits of iNOS for cancer gene therapy but the stumbling block to future development has been the delivery system.  The DBV was expressed, purified and complexed with the iNOS gene.  The particle size and charge were detd. via dynamic light scattering techniques.  The toxicity of the DBV/iNOS nanoparticles was quantified using the cell toxicity and clonogenic assays.  Over expression of iNOS was confirmed via Western blotting and Griess test.  The DBV delivery system fully condensed the iNOS gene with nanoparticles less than 100 nm.  Transfection with the DBV/iNOS nanoparticles resulted in a max. of 62% cell killing and less than 20% clonogenicity.  INOS overexpression was confirmed and total nitrite levels were in the range of 18 μM.  We report for the first time that the DBV can successfully deliver iNOS and achieve a therapeutic effect.  There is significant cytotoxicity coupled with evidence of a bystander effect.  We conclude that the success of the DBV fusion protein in the delivery of iNOS in vitro is worthy of future in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqdHWXntBRJrVg90H21EOLACvtfcHk0liWDzCQqd5ZCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVWhsw%253D%253D&md5=a6bf9f734a7de6dfb3eca2d016915566</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2010.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2010.11.051%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DH.%2BO.%26aulast%3DZholobenko%26aufirst%3DA.%2BV.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCanine%26aufirst%3DB.%26aulast%3DRobson%26aufirst%3DT.%26aulast%3DHirst%26aufirst%3DD.%2BG.%26aulast%3DHatefi%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520a%2520Multi-Functional%2520Nanocarrier%2520for%2520Targeted%2520Breast%2520Cancer%2520iNOS%2520Gene%2520Therapy%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D405%26spage%3D196%26epage%3D202%26doi%3D10.1016%2Fj.ijpharm.2010.11.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Soler, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benihoud, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lausson, S.</span><span> </span><span class="NLM_article-title">Gene Therapy of Rat Medullary Thyroid Cancer by Naked Nitric Oxide Synthase II DNA Injection</span> <span class="citation_source-journal">J. Gene Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1002/1521-2254(200009/10)2:5<344::AID-JGM124>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11045428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD3crgtVSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=344-352&author=M.+N.+Solerauthor=P.+Bobeauthor=K.+Benihoudauthor=G.+Lemaireauthor=B.+A.+Roosauthor=S.+Lausson&title=Gene+Therapy+of+Rat+Medullary+Thyroid+Cancer+by+Naked+Nitric+Oxide+Synthase+II+DNA+Injection&doi=10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection</span></div><div class="casAuthors">Soler M N; Bobe P; Benihoud K; Lemaire G; Roos B A; Lausson S</div><div class="citationInfo"><span class="NLM_cas:title">The journal of gene medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">344-52</span>
        ISSN:<span class="NLM_cas:issn">1099-498X</span>.
    </div><div class="casAbstract">BACKGROUND:  Nitric oxide (NO), produced by NO synthase II (NOS II), is the main mediator of the tumoricidal action of activated macrophages.  In the present study we examined the potential of the NOS II gene as a suicide gene for medullary thyroid cancer (MTC) therapy.  METHODS:  We orthotopically transplanted rMTC 6-23 cells into the inbred strain of Wag/Rij rats and constructed a plasmid carrying the NOS II gene under the control of the cytomegalovirus (CMV) promoter.  RESULTS:  Successive injections of tumor cells (Day 0) and naked DNA (Day 2) caused strong inhibition of tumor growth (50%, p < 0.05).  Plasmid injection into established tumors (14-day tumors) resulted in the development of large cavities due to tumor cell destruction, with a significant reduction in tumor tissue volume (35%, p < 0.05).  Adjacent quiescent tissues were unaffected.  Cell death occurred by apoptosis as demonstrated by specific labeling.  Macrophages and CD4+ lymphocytes were recruited in the treated tumors.  However, tumor-specific T lymphocytes were undetectable in the spleen of treated rats.  In control experiments using Lac Z as a reporter gene, expression of beta-galactosidase was detected in only 1% of the tumor cells.  CONCLUSIONS:  Despite a low gene transfer efficiency, NOS II plasmid produced a strong anti-tumor action resulting from its marked 'bystander' effect mainly due to NO production and diffusion.  Therefore the NOS II gene appears to be a promising suicide gene therapy of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNvgTOQZ2Gw9XdcedVHT5tfW6udTcc2eaeF_wUx0cc57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3crgtVSmsg%253D%253D&md5=6cf49af62027d824241df55573903125</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-2254%2528200009%252F10%25292%253A5%253C344%253A%253AAID-JGM124%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DSoler%26aufirst%3DM.%2BN.%26aulast%3DBobe%26aufirst%3DP.%26aulast%3DBenihoud%26aufirst%3DK.%26aulast%3DLemaire%26aufirst%3DG.%26aulast%3DRoos%26aufirst%3DB.%2BA.%26aulast%3DLausson%26aufirst%3DS.%26atitle%3DGene%2520Therapy%2520of%2520Rat%2520Medullary%2520Thyroid%2520Cancer%2520by%2520Naked%2520Nitric%2520Oxide%2520Synthase%2520II%2520DNA%2520Injection%26jtitle%3DJ.%2520Gene%2520Med.%26date%3D2000%26volume%3D2%26spage%3D344%26epage%3D352%26doi%3D10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovesdi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodovotz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiar, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumberg, D.</span><span> </span><span class="NLM_article-title">Adenoviral Gene Transfer of the Human Inducible Nitric Oxide Synthase Gene Enhances the Radiation Response of Human Colorectal Cancer Associated with Alterations in Tumor Vascularity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-1307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F0008-5472.CAN-03-1307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1386-1395&author=Z.+Wangauthor=T.+Cookauthor=S.+Alberauthor=K.+Liuauthor=I.+Kovesdiauthor=S.+K.+Watkinsauthor=Y.+Vodovotzauthor=T.+R.+Billiarauthor=D.+Blumberg&title=Adenoviral+Gene+Transfer+of+the+Human+Inducible+Nitric+Oxide+Synthase+Gene+Enhances+the+Radiation+Response+of+Human+Colorectal+Cancer+Associated+with+Alterations+in+Tumor+Vascularity&doi=10.1158%2F0008-5472.CAN-03-1307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-1307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-1307%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCook%26aufirst%3DT.%26aulast%3DAlber%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DKovesdi%26aufirst%3DI.%26aulast%3DWatkins%26aufirst%3DS.%2BK.%26aulast%3DVodovotz%26aufirst%3DY.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DBlumberg%26aufirst%3DD.%26atitle%3DAdenoviral%2520Gene%2520Transfer%2520of%2520the%2520Human%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Gene%2520Enhances%2520the%2520Radiation%2520Response%2520of%2520Human%2520Colorectal%2520Cancer%2520Associated%2520with%2520Alterations%2520in%2520Tumor%2520Vascularity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1386%26epage%3D1395%26doi%3D10.1158%2F0008-5472.CAN-03-1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Worthington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, D. G.</span><span> </span><span class="NLM_article-title">Use of the Radiation-Inducible WAF1 Promoter to Drive iNOS Gene Therapy as a Novel Anti-Cancer Treatment</span> <span class="citation_source-journal">J. Gene Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1002/jgm.567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fjgm.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15170738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFSnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=673-680&author=J.+Worthingtonauthor=H.+O.+McCarthyauthor=E.+Barrettauthor=C.+Adamsauthor=T.+Robsonauthor=D.+G.+Hirst&title=Use+of+the+Radiation-Inducible+WAF1+Promoter+to+Drive+iNOS+Gene+Therapy+as+a+Novel+Anti-Cancer+Treatment&doi=10.1002%2Fjgm.567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment</span></div><div class="casAuthors">Worthington, Jenny; McCarthy, Helen O.; Barrett, Eimear; Adams, Catherine; Robson, Tracy; Hirst, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gene Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">673-680</span>CODEN:
                <span class="NLM_cas:coden">JGMEFG</span>;
        ISSN:<span class="NLM_cas:issn">1099-498X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Background: Inducible nitric oxide synthase (iNOS) gene therapy has been identified as a potential anti-tumor strategy.  A major problem common to most gene therapy strategies is targeting of treatment to the tumor vol.  In this study we report on the use of the x-ray-inducible WAF1 promoter to achieve targeting of iNOS expression to the tumor vol.  Methods: A WAF1/iNOS/liposome complex was injected directly into RIF-1 and HT29 tumors in mice.  A 4 Gy dose of X-rays was applied to induce the WAF1 promoter followed, 8 h later, by treatment doses of 10 or 20 Gy.  Tumor vol. was measured, and growth curves plotted.  Results: Intra-tumoral injection of WAF1/iNOS combined with a priming dose of X-rays to induce the WAF1 promoter, followed by a treatment dose, resulted in sensitizer enhancement ratios of 2.0 and 1.3 in RIF-1 and HT29 tumors, resp., compared with radiation treatment alone.  PCR anal. of organ tissue after intra-tumoral injection of WAF1/iNOS showed that vector sequences were detected in all tissue tested; however, Western blot anal. revealed that iNOS protein levels were significantly increased only in tumor and the surrounding dermal tissue that had been exposed to the 4 Gy inducing dose.  Conclusions: iNOS gene therapy in combination with an inducible promoter results in significant tumor cell radiosensitization.  The WAF1 promoter may be a good candidate for a gene therapy as it is silent in normal tissue yet can be induced by the tumor environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1kRU1YtD5bVg90H21EOLACvtfcHk0lip7gOXUjDnHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFSnsrc%253D&md5=4ca6d837fd3bc9c3307400198dc9f434</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1002%2Fjgm.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjgm.567%26sid%3Dliteratum%253Aachs%26aulast%3DWorthington%26aufirst%3DJ.%26aulast%3DMcCarthy%26aufirst%3DH.%2BO.%26aulast%3DBarrett%26aufirst%3DE.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DRobson%26aufirst%3DT.%26aulast%3DHirst%26aufirst%3DD.%2BG.%26atitle%3DUse%2520of%2520the%2520Radiation-Inducible%2520WAF1%2520Promoter%2520to%2520Drive%2520iNOS%2520Gene%2520Therapy%2520as%2520a%2520Novel%2520Anti-Cancer%2520Treatment%26jtitle%3DJ.%2520Gene%2520Med.%26date%3D2004%26volume%3D6%26spage%3D673%26epage%3D680%26doi%3D10.1002%2Fjgm.567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Maeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span> </span><span class="NLM_article-title">The EPR Effect for Macromolecular Drug Delivery to Solid Tumors: Improvement of Tumor Uptake, Lowering of Systemic Toxicity, and Distinct Tumor Imaging in Vivo</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/j.addr.2012.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.addr.2012.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23088862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=71-79&author=H.+Maedaauthor=H.+Nakamuraauthor=J.+Fang&title=The+EPR+Effect+for+Macromolecular+Drug+Delivery+to+Solid+Tumors%3A+Improvement+of+Tumor+Uptake%2C+Lowering+of+Systemic+Toxicity%2C+and+Distinct+Tumor+Imaging+in+Vivo&doi=10.1016%2Fj.addr.2012.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo</span></div><div class="casAuthors">Maeda, Hiroshi; Nakamura, Hideaki; Fang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-79</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The EPR effect results from the extravasation of macromols. or nanoparticles through tumor blood vessels.  We here provide a historical review of the EPR effect, including its features, vascular mediators found in both cancer and inflamed tissue.  In addn., architectural and physiol. differences of tumor blood vessels vs that of normal tissue are commented.  Furthermore, methods of augmentation of the EPR effect are described, that result in better tumor delivery and improved therapeutic effect, where nitroglycerin, angiotensin I-converting enzyme (ACE) inhibitor, or angiotensin II-induced hypertension are employed.  Consequently, better therapeutic effect and reduced systemic toxicity are generally obsd.  Obviously, the EPR effect based delivery of nanoprobes are also useful for tumor-selective imaging agents with using fluorescent or radio nuclei in nanoprobes.  We also commented a key difference between passive tumor targeting and the EPR effect in tumors, particularly as related to drug retention in tumors: passive targeting of low-mol.-wt. X-ray contrast agents involves a retention period of less than a few minutes, whereas the EPR effect of nanoparticles involves a prolonged retention time-days to weeks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXPSA0xq_UOrVg90H21EOLACvtfcHk0lh75QYy5D3ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsbnI&md5=26eadfb633ca2da86636493908e4cc99</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2012.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2012.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DThe%2520EPR%2520Effect%2520for%2520Macromolecular%2520Drug%2520Delivery%2520to%2520Solid%2520Tumors%253A%2520Improvement%2520of%2520Tumor%2520Uptake%252C%2520Lowering%2520of%2520Systemic%2520Toxicity%252C%2520and%2520Distinct%2520Tumor%2520Imaging%2520in%2520Vivo%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D71%26epage%3D79%26doi%3D10.1016%2Fj.addr.2012.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saravanakumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. J.</span><span> </span><span class="NLM_article-title">A Platform for Nitric Oxide Delivery</span> <span class="citation_source-journal">J. Mater. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1039/C3TB21259A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FC3TB21259A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=32261379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFGktb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=341-356&author=J.+Kimauthor=G.+Saravanakumarauthor=H.+W.+Choiauthor=D.+Parkauthor=W.+J.+Kim&title=A+Platform+for+Nitric+Oxide+Delivery&doi=10.1039%2FC3TB21259A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">A platform for nitric oxide delivery</span></div><div class="casAuthors">Kim, Jihoon; Saravanakumar, Gurusamy; Choi, Hyung Woo; Park, Dongsik; Kim, Won Jong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-356</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is one of the structurally smallest pharmaceutical mols., which shows great potential as an anti-restenosis, wound healing, anticancer, and antibacterial agent.  To date, while most of the studies have focused mainly on demonstrating the versatility of the NO-releasing materials, little effort has been made on developing successful NO-delivery strategies for advancing NO-mediated therapy.  Thus, the quest for a rationally designed NO-delivery system is becoming one of the important issues in the biomedical applications of NO.  This feature article discusses the overall research trends in the NO-delivery, focusing mainly on the various particle-type and coating platforms.  The objective of this article is not only to highlight the fundamental principle and challenges assocd. with NO-delivery, but also to provide insight for the further development of novel NO-delivery platforms for clin. applications in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8l6wFDb9_LVg90H21EOLACvtfcHk0lh75QYy5D3ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFGktb%252FI&md5=a016da9e8de21d7c833566fa1a6e6eae</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1039%2FC3TB21259A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3TB21259A%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSaravanakumar%26aufirst%3DG.%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DPark%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26atitle%3DA%2520Platform%2520for%2520Nitric%2520Oxide%2520Delivery%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2014%26volume%3D2%26spage%3D341%26epage%3D356%26doi%3D10.1039%2FC3TB21259A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Riccio, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfisch, M. H.</span><span> </span><span class="NLM_article-title">Nitric Oxide Release: Part I. Macromolecular Scaffolds</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3731</span><span class="NLM_x">–</span> <span class="NLM_lpage">3741</span><span class="refDoi"> DOI: 10.1039/c2cs15272j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2Fc2cs15272j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=22362355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1yktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=3731-3741&author=D.+A.+Riccioauthor=M.+H.+Schoenfisch&title=Nitric+Oxide+Release%3A+Part+I.+Macromolecular+Scaffolds&doi=10.1039%2Fc2cs15272j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide release: Part I. Macromolecular scaffolds</span></div><div class="casAuthors">Riccio, Daniel A.; Schoenfisch, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3731-3741</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The roles of nitric oxide (NO) in physiol. and pathophysiol. merit the use of NO as a therapeutic for certain biomedical applications.  Unfortunately, limited NO payloads, too rapid NO release, and the lack of targeted NO delivery have hindered the clin. utility of NO gas and low mol. wt. NO donor compds.  A wide-variety of NO-releasing macromol. scaffolds has thus been developed to improve NO's pharmacol. potential.  In this tutorial review, the authors provide an overview of the most promising NO release scaffolds including protein, org., inorg., and hybrid org.-inorg. systems.  The NO release vehicles selected for discussion were chosen based on their enhanced NO storage, tunable NO release characteristics, and potential as therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmcwZKk_c6k7Vg90H21EOLACvtfcHk0lh75QYy5D3ogg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1yktLs%253D&md5=136715d2bc8373e486a92b602953dd02</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1039%2Fc2cs15272j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cs15272j%26sid%3Dliteratum%253Aachs%26aulast%3DRiccio%26aufirst%3DD.%2BA.%26aulast%3DSchoenfisch%26aufirst%3DM.%2BH.%26atitle%3DNitric%2520Oxide%2520Release%253A%2520Part%2520I.%2520Macromolecular%2520Scaffolds%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2012%26volume%3D41%26spage%3D3731%26epage%3D3741%26doi%3D10.1039%2Fc2cs15272j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">Delivering Nitric Oxide with Nanoparticles</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2015.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.jconrel.2015.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=25665865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlSnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2015&pages=190-205&author=J.+F.+Quinnauthor=M.+R.+Whittakerauthor=T.+P.+Davis&title=Delivering+Nitric+Oxide+with+Nanoparticles&doi=10.1016%2Fj.jconrel.2015.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Delivering nitric oxide with nanoparticles</span></div><div class="casAuthors">Quinn, John F.; Whittaker, Michael R.; Davis, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">190-205</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While best known for its important signalling functions in human physiol., nitric oxide is also of considerable therapeutic interest.  As such, nanoparticle-based systems which enable the sustained exogenous delivery of nitric oxide have been the subject of considerable investigation in recent years.  Herein we review the various nanoparticle systems that have been used to date for nitric oxide delivery, and explore the array of potential therapeutic applications that have been reported.  Specifically, we discuss the modification of sol-gel based silica particles, functionalised metal/metal oxide nanoparticles, polymer-coated metal nanoparticles, dendrimers, micelles and star polymers to impart nitric oxide release capability.  We also consider the various areas in which therapeutic applications are envisaged: wound healing, antimicrobial applications, cardiovascular treatments, sexual medicine and cancer treatment.  Finally, we discuss possible future directions for this versatile and potentially important technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnn__5jg-3GLVg90H21EOLACvtfcHk0liqNKrIZkwGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlSnurw%253D&md5=6fd7fa9aee9be18863127239ae14efcc</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2015.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2015.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DWhittaker%26aufirst%3DM.%2BR.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DDelivering%2520Nitric%2520Oxide%2520with%2520Nanoparticles%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D205%26spage%3D190%26epage%3D205%26doi%3D10.1016%2Fj.jconrel.2015.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Seabra, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, M.</span><span> </span><span class="NLM_article-title">Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.2174/1568026615666150108122918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F1568026615666150108122918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=25579351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislels7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=298-308&author=A.+B.+Seabraauthor=R.+de+Limaauthor=M.+Calderon&title=Nitric+Oxide+Releasing+Nanomaterials+for+Cancer+Treatment%3A+Current+Status+and+Perspectives&doi=10.2174%2F1568026615666150108122918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives</span></div><div class="casAuthors">Seabra, Amedea B.; de Lima, Renata; Calderon, Marcelo</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-308</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Nitric oxide (NO) is known to have dichotomous effects on cancer biol., acting as a pro- or antineoplastic agent.  Low concns. of NO are reported to promote tumor growth, whereas high NO influx acts as a potent tumor repressor, leading to cytotoxicity and apoptosis.  There is increasing interest in developing NO-releasing materials as potent tumoricidal agents in which high and localized concns. of NO may be directly released in a sustained manner to the tumor site.  Nanomaterials allied to NO donors have emerged as a promising strategy in cancer treatment.  In this context, this review summarizes the roles of NO in cancer biol. and highlights the therapeutic potential effects of NO-releasing nanomaterials based on polymeric nanoparticles, dendritic polymers, liposomes, silica nanoparticles, metallic nanoparticles and quantum dots in combating tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgmZicgaHg-rVg90H21EOLACvtfcHk0liqNKrIZkwGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislels7Y%253D&md5=504a13af69d873fcac79decbefe00f26</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150108122918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150108122918%26sid%3Dliteratum%253Aachs%26aulast%3DSeabra%26aufirst%3DA.%2BB.%26aulast%3Dde%2BLima%26aufirst%3DR.%26aulast%3DCalderon%26aufirst%3DM.%26atitle%3DNitric%2520Oxide%2520Releasing%2520Nanomaterials%2520for%2520Cancer%2520Treatment%253A%2520Current%2520Status%2520and%2520Perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D298%26epage%3D308%26doi%3D10.2174%2F1568026615666150108122918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Chung, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, H. W.</span><span> </span><span class="NLM_article-title">A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">9890</span><span class="NLM_x">–</span> <span class="NLM_lpage">9893</span><span class="refDoi"> DOI: 10.1002/anie.201504444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fanie.201504444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWgu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=9890-9893&author=M.+F.+Chungauthor=H.+Y.+Liuauthor=K.+J.+Linauthor=W.+T.+Chiaauthor=H.+W.+Sung&title=A+pH-Responsive+Carrier+System+that+Generates+NO+Bubbles+to+Trigger+Drug+Release+and+Reverse+P-Glycoprotein-Mediated+Multidrug+Resistance&doi=10.1002%2Fanie.201504444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance</span></div><div class="casAuthors">Chung, Ming-Fan; Liu, Hung-Yi; Lin, Kun-Ju; Chia, Wei-Tso; Sung, Hsing-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">9890-9893</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) resulting from the overexpression of drug transporters such as P-glycoprotein (Pgp) increases the efflux of drugs and thereby limits the effectiveness of chemotherapy.  To address this issue, this work develops an injectable hollow microsphere (HM) system that carries the anticancer agent irinotecan (CPT-11) and a NO-releasing donor (NONOate).  Upon injection of this system into acidic tumor tissue, environmental protons infiltrate the shell of the HMs and react with their encapsulated NONOate to form NO bubbles that trigger localized drug release and serve as a Pgp-mediated MDR reversal agent.  The site-specific drug release and the NO-reduced Pgp-mediated transport can cause the intracellular accumulation of the drug at a concn. that exceeds the cell-killing threshold, eventually inducing its antitumor activity.  These results reveal that this pH-responsive HM carrier system provides a potentially effective method for treating cancers that develop MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkaRqtcsU7mrVg90H21EOLACvtfcHk0liqNKrIZkwGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWgu7vN&md5=4a07181e23906bcfabf3c74bd0c97501</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fanie.201504444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201504444%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DM.%2BF.%26aulast%3DLiu%26aufirst%3DH.%2BY.%26aulast%3DLin%26aufirst%3DK.%2BJ.%26aulast%3DChia%26aufirst%3DW.%2BT.%26aulast%3DSung%26aufirst%3DH.%2BW.%26atitle%3DA%2520pH-Responsive%2520Carrier%2520System%2520that%2520Generates%2520NO%2520Bubbles%2520to%2520Trigger%2520Drug%2520Release%2520and%2520Reverse%2520P-Glycoprotein-Mediated%2520Multidrug%2520Resistance%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D9890%26epage%3D9893%26doi%3D10.1002%2Fanie.201504444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Lehrman, S.</span><span> </span><span class="NLM_article-title">Virus Treatment Questioned after Gene Therapy Death</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1038/43977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2F43977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10524611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFCns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=517-518&author=S.+Lehrman&title=Virus+Treatment+Questioned+after+Gene+Therapy+Death&doi=10.1038%2F43977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Virus treatment questioned after gene therapy death</span></div><div class="casAuthors">Lehrman, Sally</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6753</span>),
    <span class="NLM_cas:pages">517-518</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUtFlQeEtD7Vg90H21EOLACvtfcHk0lhX-mOu2rBWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFCns7k%253D&md5=8812e61f3be8821bda8096469301d0b0</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2F43977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43977%26sid%3Dliteratum%253Aachs%26aulast%3DLehrman%26aufirst%3DS.%26atitle%3DVirus%2520Treatment%2520Questioned%2520after%2520Gene%2520Therapy%2520Death%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D517%26epage%3D518%26doi%3D10.1038%2F43977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Mocellin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronte, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitti, D.</span><span> </span><span class="NLM_article-title">Nitric Oxide, a Double Edged Sword in Cancer Biology: Searching for Therapeutic Opportunities</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1002/med.20092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fmed.20092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16991100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVGrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=317-352&author=S.+Mocellinauthor=V.+Bronteauthor=D.+Nitti&title=Nitric+Oxide%2C+a+Double+Edged+Sword+in+Cancer+Biology%3A+Searching+for+Therapeutic+Opportunities&doi=10.1002%2Fmed.20092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities</span></div><div class="casAuthors">Mocellin, Simone; Bronte, Vincenzo; Nitti, Donato</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-352</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is a pleiotropic mol. crit. to a no. of physiol. and pathol. processes.  The last decade has witnessed major advances in dissecting NO biol. and its role in cancer pathogenesis.  However, the complexity of the interactions between different levels of NO and several aspects of tumor development/progression has led to apparently conflicting findings.  Furthermore, both anti-NO and NO-based anticancer strategies appear effective in several preclin. models.  This paradoxical dichotomy is leaving investigators with a double challenge: to det. the net impact of NO on cancer behavior and to define the therapeutic role of NO-centered anticancer strategies.  Only a comprehensive and dynamic view of the cascade of mol. and cellular events underlying tumor biol. and affected by NO will allow investigators to exploit the potential antitumor properties of drugs interfering with NO metab.  Available data suggest that NO should be considered neither a universal target nor a magic bullet, but rather a signal transducer to be modulated according to the mol. makeup of each individual cancer and the interplay with conventional antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpraBBC61P0JLVg90H21EOLACvtfcHk0lhX-mOu2rBWTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVGrt7g%253D&md5=d0cffe82313a609b2f3c6d1f3d1ff2bf</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fmed.20092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20092%26sid%3Dliteratum%253Aachs%26aulast%3DMocellin%26aufirst%3DS.%26aulast%3DBronte%26aufirst%3DV.%26aulast%3DNitti%26aufirst%3DD.%26atitle%3DNitric%2520Oxide%252C%2520a%2520Double%2520Edged%2520Sword%2520in%2520Cancer%2520Biology%253A%2520Searching%2520for%2520Therapeutic%2520Opportunities%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2007%26volume%3D27%26spage%3D317%26epage%3D352%26doi%3D10.1002%2Fmed.20092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 138 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Antonino Nicolò Fallica, Carla Barbaraci, Emanuele Amata, Lorella Pasquinucci, Rita Turnaturi, Maria Dichiara, Sebastiano Intagliata, Marzia Bruna Gariboldi, Emanuela Marras, Viviana Teresa Orlandi, Claudia Ferroni, Cecilia Martini, Antonio Rescifina, Davide Gentile, Greta Varchi, <span class="NLM_string-name hlFld-ContribAuthor">Agostino Marrazzo</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitric%252BOxide%252BPhoto-Donor%252BHybrids%252Bof%252BCiprofloxacin%252Band%252BNorfloxacin%25253A%252BA%252BShift%252Bin%252BActivity%252Bfrom%252BAntimicrobial%252Bto%252BAnticancer%252BAgents%26aulast%3DFallica%26aufirst%3DAntonino%2BNicol%25C3%25B2%26date%3D2021%26date%3D2021%26date%3D21052021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juho Lee, Shwe Phyu Hlaing, Nurhasni Hasan, Dongmin Kwak, Hyunwoo Kim, Jiafu Cao, In-Soo Yoon, Hwayoung Yun, Yunjin Jung, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Wook Yoo</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2021,</strong> <em>13 </em>
                                    (26)
                                     , 30383-30396. <a href="https://doi.org/10.1021/acsami.1c07407" title="DOI URL">https://doi.org/10.1021/acsami.1c07407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.1c07407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.1c07407%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DTumor-Penetrable%252BNitric%252BOxide-Releasing%252BNanoparticles%252BPotentiate%252BLocal%252BAntimelanoma%252BTherapy%26aulast%3DLee%26aufirst%3DJuho%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22042021%26date%3D15062021%26date%3D24062021%26volume%3D13%26issue%3D26%26spage%3D30383%26epage%3D30396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chen Zhang, Xiangdan Meng, Chenchen Gong, Jianming Zhao, Kai Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Zhou Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Glutathione-Responsive Biodegradable Nanoplatform with Endogenous Esterase-Triggered Nitric Oxide Release for Gas Therapy and Enhanced Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2021,</strong> <em>4 </em>
                                    (6)
                                     , 5212-5221. <a href="https://doi.org/10.1021/acsabm.1c00384" title="DOI URL">https://doi.org/10.1021/acsabm.1c00384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.1c00384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.1c00384%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DGlutathione-Responsive%252BBiodegradable%252BNanoplatform%252Bwith%252BEndogenous%252BEsterase-Triggered%252BNitric%252BOxide%252BRelease%252Bfor%252BGas%252BTherapy%252Band%252BEnhanced%252BChemotherapy%26aulast%3DZhang%26aufirst%3DChen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29032021%26date%3D07052021%26date%3D13052021%26volume%3D4%26issue%3D6%26spage%3D5212%26epage%3D5221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Oronsky, XiaoNing Guo, XiaoHui Wang, Pedro Cabrales, David Sher, Lou Cannizzo, Bob Wardle, Nacer Abrouk, Michelle Lybeck, Scott Caroen, Arnold Oronsky, <span class="NLM_string-name hlFld-ContribAuthor">Tony R. Reid</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7261-7271. <a href="https://doi.org/10.1021/acs.jmedchem.1c00599" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00599%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BRRx-001%25252C%252Ba%252BMyc%252Band%252BCD47%252BDownregulating%252BSmall%252BMolecule%252Bwith%252BTumor%252BTargeted%252BCytotoxicity%252Band%252BHealthy%252BTissue%252BCytoprotective%252BProperties%252Bin%252BClinical%252BDevelopment%26aulast%3DOronsky%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01042021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7261%26epage%3D7271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yijing Dang, Liting Ruan, Yang Tian, Zhiai Xu, <span class="NLM_string-name hlFld-ContribAuthor">Wen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Prodrug Delivery and Release Monitoring Based on a Galactose-Modified Multifunctional Nanoprobe. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (21)
                                     , 7625-7634. <a href="https://doi.org/10.1021/acs.analchem.1c00287" title="DOI URL">https://doi.org/10.1021/acs.analchem.1c00287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.1c00287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.1c00287%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DNitric%252BOxide%252BProdrug%252BDelivery%252Band%252BRelease%252BMonitoring%252BBased%252Bon%252Ba%252BGalactose-Modified%252BMultifunctional%252BNanoprobe%26aulast%3DDang%26aufirst%3DYijing%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D06052021%26date%3D19052021%26volume%3D93%26issue%3D21%26spage%3D7625%26epage%3D7634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jordan D. Galloway, Cristian Sarabia, James C. Fettinger, Hrant P. Hratchian, <span class="NLM_string-name hlFld-ContribAuthor">Ryan D. Baxter</span>. </span><span class="cited-content_cbyCitation_article-title">Versatile New Reagent for Nitrosation under Mild Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (9)
                                     , 3253-3258. <a href="https://doi.org/10.1021/acs.orglett.1c00637" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00637%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVersatile%252BNew%252BReagent%252Bfor%252BNitrosation%252Bunder%252BMild%252BConditions%26aulast%3DGalloway%26aufirst%3DJordan%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22022021%26date%3D12042021%26volume%3D23%26issue%3D9%26spage%3D3253%26epage%3D3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Sun, Tian Lv, Jianbing Wu, Mingchao Zhu, Yue Fei, Jie Zhu, Yihua Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Zhangjian Huang</span>. </span><span class="cited-content_cbyCitation_article-title">General Strategy for Integrated Bioorthogonal Prodrugs: Pt(II)-Triggered Depropargylation Enables Controllable Drug Activation In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13899-13912. <a href="https://doi.org/10.1021/acs.jmedchem.0c01435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneral%252BStrategy%252Bfor%252BIntegrated%252BBioorthogonal%252BProdrugs%25253A%252BPt%252528II%252529-Triggered%252BDepropargylation%252BEnables%252BControllable%252BDrug%252BActivation%252BIn%252BVivo%26aulast%3DSun%26aufirst%3DTao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25082020%26date%3D03112020%26volume%3D63%26issue%3D22%26spage%3D13899%26epage%3D13912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emanuele Amata, Maria Dichiara, Davide Gentile, Agostino Marrazzo, Rita Turnaturi, Emanuela Arena, Alfonsina La Mantia, Barbara Rita Tomasello, Rosaria Acquaviva, Claudia Di Giacomo, Antonio Rescifina, <span class="NLM_string-name hlFld-ContribAuthor">Orazio Prezzavento</span>. </span><span class="cited-content_cbyCitation_article-title">Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 889-894. <a href="https://doi.org/10.1021/acsmedchemlett.9b00661" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00661%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSigma%252BReceptor%252BLigands%252BCarrying%252Ba%252BNitric%252BOxide%252BDonor%252BNitrate%252BMoiety%25253A%252BSynthesis%25252C%252BIn%252BSilico%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DAmata%26aufirst%3DEmanuele%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29122019%26date%3D09042020%26date%3D15042020%26date%3D09042020%26volume%3D11%26issue%3D5%26spage%3D889%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Leilei Gao, Bin Dong, Junmei Zhang, Ying Chen, Haishi Qiao, Zhihong Liu, Enping Chen, Yuqin Dong, Chongjiang Cao, Dechun Huang, <span class="NLM_string-name hlFld-ContribAuthor">Wei Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Biodegradable Nitric Oxide Donor-Containing Polycarbonate-Based Micelles for Reduction-Triggered Drug Release and Overcoming Multidrug Resistance. </span><span class="cited-content_cbyCitation_journal-name">ACS Macro Letters</span><span> <strong>2019,</strong> <em>8 </em>
                                    (12)
                                     , 1552-1558. <a href="https://doi.org/10.1021/acsmacrolett.9b00758" title="DOI URL">https://doi.org/10.1021/acsmacrolett.9b00758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmacrolett.9b00758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmacrolett.9b00758%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Macro%2520Letters%26atitle%3DFunctional%252BBiodegradable%252BNitric%252BOxide%252BDonor-Containing%252BPolycarbonate-Based%252BMicelles%252Bfor%252BReduction-Triggered%252BDrug%252BRelease%252Band%252BOvercoming%252BMultidrug%252BResistance%26aulast%3DGao%26aufirst%3DLeilei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25092019%26date%3D13112019%26date%3D14112019%26volume%3D8%26issue%3D12%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhong Chen, Kuo-Yen Huang, Yong Ling, Masuo Goto, Hua-Qing Duan, Xiao-Hang Tong, Yan-Li Liu, Yung-Yi Cheng, Susan L. Morris-Natschke, Pan-Chyr Yang, Shi-Lin Yang, <span class="NLM_string-name hlFld-ContribAuthor">Kuo-Hsiung Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Oleanolic Acid/Hederagenin–Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2019,</strong> <em>82 </em>
                                    (11)
                                     , 3065-3073. <a href="https://doi.org/10.1021/acs.jnatprod.9b00659" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.9b00659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.9b00659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.9b00659%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DDiscovery%252Bof%252Ban%252BOleanolic%252BAcid%25252FHederagenin%2525E2%252580%252593Nitric%252BOxide%252BDonor%252BHybrid%252Bas%252Ban%252BEGFR%252BTyrosine%252BKinase%252BInhibitor%252Bfor%252BNon-Small-Cell%252BLung%252BCancer%26aulast%3DChen%26aufirst%3DZhong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16072019%26date%3D13112019%26volume%3D82%26issue%3D11%26spage%3D3065%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Seunglee Kwon, Hyewon Ko, Dong Gil You, Kazunori Kataoka, <span class="NLM_string-name hlFld-ContribAuthor">Jae Hyung Park</span>. </span><span class="cited-content_cbyCitation_article-title">Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2019,</strong> <em>52 </em>
                                    (7)
                                     , 1771-1782. <a href="https://doi.org/10.1021/acs.accounts.9b00136" title="DOI URL">https://doi.org/10.1021/acs.accounts.9b00136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.9b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.9b00136%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DNanomedicines%252Bfor%252BReactive%252BOxygen%252BSpecies%252BMediated%252BApproach%25253A%252BAn%252BEmerging%252BParadigm%252Bfor%252BCancer%252BTreatment%26aulast%3DKwon%26aufirst%3DSeunglee%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15032019%26date%3D26062019%26volume%3D52%26issue%3D7%26spage%3D1771%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong-Li Zhong, Mark Weisel, Guy R. Humphrey, Daniel J. Muzzio, Li Zhang, Mark A. Huffman, Wendy Zhong, Kevin M. Maloney, <span class="NLM_string-name hlFld-ContribAuthor">Kevin R. Campos</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable Synthesis of Diazeniumdiolates: Application to the Preparation of MK-8150. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (11)
                                     , 4210-4214. <a href="https://doi.org/10.1021/acs.orglett.9b01401" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01401%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DScalable%252BSynthesis%252Bof%252BDiazeniumdiolates%25253A%252BApplication%252Bto%252Bthe%252BPreparation%252Bof%252BMK-8150%26aulast%3DZhong%26aufirst%3DYong-Li%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22042019%26date%3D22052019%26volume%3D21%26issue%3D11%26spage%3D4210%26epage%3D4214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yihui Hu, Tian Lv, Yu Ma, Junjie Xu, Yihua Zhang, Yanglong Hou, Zhangjian Huang, <span class="NLM_string-name hlFld-ContribAuthor">Ya Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Nanoscale Coordination Polymers for Synergistic NO and Chemodynamic Therapy of Liver Cancer. </span><span class="cited-content_cbyCitation_journal-name">Nano Letters</span><span> <strong>2019,</strong> <em>19 </em>
                                    (4)
                                     , 2731-2738. <a href="https://doi.org/10.1021/acs.nanolett.9b01093" title="DOI URL">https://doi.org/10.1021/acs.nanolett.9b01093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.nanolett.9b01093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.nanolett.9b01093%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Letters%26atitle%3DNanoscale%252BCoordination%252BPolymers%252Bfor%252BSynergistic%252BNO%252Band%252BChemodynamic%252BTherapy%252Bof%252BLiver%252BCancer%26aulast%3DHu%26aufirst%3DYihui%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16032019%26date%3D26032019%26date%3D02042019%26date%3D28032019%26volume%3D19%26issue%3D4%26spage%3D2731%26epage%3D2738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wuyang Yu, Tao Liu, Mingkang Zhang, Zixu Wang, Jingjie Ye, Chu-Xin Li, Wenlong Liu, Runqing Li, Jun Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xian-Zheng Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">O2 Economizer for Inhibiting Cell Respiration To Combat the Hypoxia Obstacle in Tumor Treatments. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2019,</strong> <em>13 </em>
                                    (2)
                                     , 1784-1794. <a href="https://doi.org/10.1021/acsnano.8b07852" title="DOI URL">https://doi.org/10.1021/acsnano.8b07852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsnano.8b07852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsnano.8b07852%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DO2%252BEconomizer%252Bfor%252BInhibiting%252BCell%252BRespiration%252BTo%252BCombat%252Bthe%252BHypoxia%252BObstacle%252Bin%252BTumor%252BTreatments%26aulast%3DYu%26aufirst%3DWuyang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D14102018%26date%3D30012019%26date%3D05022019%26date%3D30012019%26volume%3D13%26issue%3D2%26spage%3D1784%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Da Eun Kim, Chan Woo Kim, Hong Jae Lee, Kyung Hyun Min, Kyu Hwan Kwack, Hyeon-Woo Lee, Jaebeum Bang, Kiyuk Chang, <span class="NLM_string-name hlFld-ContribAuthor">Sang Cheon Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Intracellular NO-Releasing Hyaluronic Acid-Based Nanocarriers: A Potential Chemosensitizing Agent for Cancer Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2018,</strong> <em>10 </em>
                                    (32)
                                     , 26870-26881. <a href="https://doi.org/10.1021/acsami.8b06848" title="DOI URL">https://doi.org/10.1021/acsami.8b06848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.8b06848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.8b06848%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DIntracellular%252BNO-Releasing%252BHyaluronic%252BAcid-Based%252BNanocarriers%25253A%252BA%252BPotential%252BChemosensitizing%252BAgent%252Bfor%252BCancer%252BChemotherapy%26aulast%3DKim%26aufirst%3DDa%2BEun%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D24072018%26date%3D02082018%26date%3D24072018%26volume%3D10%26issue%3D32%26spage%3D26870%26epage%3D26881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tian Lv, Jianbing Wu, Fenghua Kang, Tingting Wang, Boheng Wan, Jin-Jian Lu, Yihua Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Zhangjian Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of O2-Derived Diazeniumdiolates Activatable via Bioorthogonal Chemistry Reactions in Living Cells. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (8)
                                     , 2164-2167. <a href="https://doi.org/10.1021/acs.orglett.8b00423" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00423%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BO2-Derived%252BDiazeniumdiolates%252BActivatable%252Bvia%252BBioorthogonal%252BChemistry%252BReactions%252Bin%252BLiving%252BCells%26aulast%3DLv%26aufirst%3DTian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05022018%26date%3D29032018%26volume%3D20%26issue%3D8%26spage%3D2164%26epage%3D2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhangjian Huang, Jianbing Wu, Yu Zou, Haoliang Yuan, Yinqiu Zhang, Yue Fei, Atul Bhardwaj, Jatinder Kaur, Edward E. Knaus, <span class="NLM_string-name hlFld-ContribAuthor">Yihua Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Glutathione S-Transferase π-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1833-1844. <a href="https://doi.org/10.1021/acs.jmedchem.7b01178" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01178%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlutathione%252BS-Transferase%252B%2525CF%252580-Activatable%252BO2-%252528Sulfonylethyl%252BDerived%252529%252BDiazeniumdiolates%252BPotently%252BSuppress%252BMelanoma%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DHuang%26aufirst%3DZhangjian%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D12082017%26date%3D16022018%26date%3D08022018%26volume%3D61%26issue%3D5%26spage%3D1833%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Zhen  Yang</span>, <span class="hlFld-ContribAuthor ">Liangcan  He</span>, <span class="hlFld-ContribAuthor ">Liming  Deng</span>, <span class="hlFld-ContribAuthor ">Parinaz  Fathi</span>, <span class="hlFld-ContribAuthor ">Shoujun  Zhu</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Shen</span>, <span class="hlFld-ContribAuthor ">Zhantong  Wang</span>, <span class="hlFld-ContribAuthor ">Orit  Jacobson</span>, <span class="hlFld-ContribAuthor ">Jibin  Song</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zou</span>, <span class="hlFld-ContribAuthor ">Ping  Hu</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Mu</span>, <span class="hlFld-ContribAuthor ">Yaya  Cheng</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Ma</span>, <span class="hlFld-ContribAuthor ">Longguang  Tang</span>, <span class="hlFld-ContribAuthor ">Wenpei  Fan</span>, <span class="hlFld-ContribAuthor ">Xiaoyuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-20860-3" title="DOI URL">https://doi.org/10.1038/s41467-020-20860-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-20860-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-20860-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Bhybrid%252Bsemiconducting%252Borganosilica-based%252BO2%252Bnanoeconomizer%252Bfor%252Bon-demand%252Bsynergistic%252Bphotothermally%2525C2%2525A0boosted%252Bradiotherapy%26aulast%3DTang%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nairong  Yu</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Deng</span>, <span class="hlFld-ContribAuthor ">Zhichao  Lei</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113701. <a href="https://doi.org/10.1016/j.ejmech.2021.113701" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113701%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bevaluation%252Bof%252Bnovel%252Bscopoletin-NO%252Bdonor%252Bderivatives%252Bagainst%252BMCF-7%252Bhuman%252Bbreast%252Bcancer%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DYu%26aufirst%3DNairong%26date%3D2021%26volume%3D224%26spage%3D113701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Meigui  Deng</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Shi</span>, <span class="hlFld-ContribAuthor ">Chuangnian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiongwei  Qu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Hu</span>, <span class="hlFld-ContribAuthor ">Weiwei  Wang</span>, <span class="hlFld-ContribAuthor ">Deling  Kong</span>, <span class="hlFld-ContribAuthor ">Pingsheng  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Cascaded amplification of intracellular oxidative stress and reversion of multidrug resistance by nitric oxide prodrug based-supramolecular hydrogel for synergistic cancer chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Bioactive Materials</span><span> <strong>2021,</strong> <em>6 </em>
                                    (10)
                                     , 3300-3313. <a href="https://doi.org/10.1016/j.bioactmat.2021.03.005" title="DOI URL">https://doi.org/10.1016/j.bioactmat.2021.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioactmat.2021.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioactmat.2021.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioactive%2520Materials%26atitle%3DCascaded%252Bamplification%252Bof%252Bintracellular%252Boxidative%252Bstress%252Band%252Breversion%252Bof%252Bmultidrug%252Bresistance%252Bby%252Bnitric%252Boxide%252Bprodrug%252Bbased-supramolecular%252Bhydrogel%252Bfor%252Bsynergistic%252Bcancer%252Bchemotherapy%26aulast%3DZhang%26aufirst%3DJimin%26date%3D2021%26volume%3D6%26issue%3D10%26spage%3D3300%26epage%3D3313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luiz  Gonzaga de França Lopes</span>, <span class="hlFld-ContribAuthor ">Florêncio S.  Gouveia Júnior</span>, <span class="hlFld-ContribAuthor ">Alda  Karine Medeiros Holanda</span>, <span class="hlFld-ContribAuthor ">Idalina  Maria Moreira de Carvalho</span>, <span class="hlFld-ContribAuthor ">Elisane  Longhinotti</span>, <span class="hlFld-ContribAuthor ">Tércio F.  Paulo</span>, <span class="hlFld-ContribAuthor ">Dieric S.  Abreu</span>, <span class="hlFld-ContribAuthor ">Paul V.  Bernhardt</span>, <span class="hlFld-ContribAuthor ">Marie-Alda  Gilles-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Izaura  Cirino Nogueira Diógenes</span>, <span class="hlFld-ContribAuthor ">Eduardo  Henrique Silva Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinorganic systems responsive to the diatomic gases O2, NO, and CO: From biological sensors to therapy. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>445 </em>, 214096. <a href="https://doi.org/10.1016/j.ccr.2021.214096" title="DOI URL">https://doi.org/10.1016/j.ccr.2021.214096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2021.214096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2021.214096%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DBioinorganic%252Bsystems%252Bresponsive%252Bto%252Bthe%252Bdiatomic%252Bgases%252BO2%25252C%252BNO%25252C%252Band%252BCO%25253A%252BFrom%252Bbiological%252Bsensors%252Bto%252Btherapy%26aulast%3DGonzaga%2Bde%2BFran%25C3%25A7a%2BLopes%26aufirst%3DLuiz%26date%3D2021%26volume%3D445%26spage%3D214096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Talita A.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Erik  Machado-Ferreira</span>, <span class="hlFld-ContribAuthor ">Lohaine F.  Guimarães</span>, <span class="hlFld-ContribAuthor ">Jéssica  Cavaleiro</span>, <span class="hlFld-ContribAuthor ">Alan Messala A.  Britto</span>, <span class="hlFld-ContribAuthor ">Nátaly  Redua</span>, <span class="hlFld-ContribAuthor ">Lucas Miguel Pereira  de Souza</span>, <span class="hlFld-ContribAuthor ">André S.  Pimentel</span>, <span class="hlFld-ContribAuthor ">Paulo H.S.  Picciani</span>, <span class="hlFld-ContribAuthor ">Osvaldo N.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Cléber Bonfim  Barreto</span>, <span class="hlFld-ContribAuthor ">Carlos Augusto G.  Soares</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cytotoxic amphiphilic nitro-compounds derived from a synthetic route for paraconic acids. </span><span class="cited-content_cbyCitation_journal-name">Colloids and Surfaces A: Physicochemical and Engineering Aspects</span><span> <strong>2021,</strong> <em>626 </em>, 126984. <a href="https://doi.org/10.1016/j.colsurfa.2021.126984" title="DOI URL">https://doi.org/10.1016/j.colsurfa.2021.126984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.colsurfa.2021.126984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.colsurfa.2021.126984%26sid%3Dliteratum%253Aachs%26jtitle%3DColloids%2520and%2520Surfaces%2520A%253A%2520Physicochemical%2520and%2520Engineering%2520Aspects%26atitle%3DNovel%252Bcytotoxic%252Bamphiphilic%252Bnitro-compounds%252Bderived%252Bfrom%252Ba%252Bsynthetic%252Broute%252Bfor%252Bparaconic%252Bacids%26aulast%3DRibeiro%26aufirst%3DTalita%2BA.%26date%3D2021%26volume%3D626%26spage%3D126984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanbao  Jin</span>, <span class="hlFld-ContribAuthor ">Liying  Wang</span>, <span class="hlFld-ContribAuthor ">Yumeng  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Liu</span>, <span class="hlFld-ContribAuthor ">Tian  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Self-assembled drug-polymer micelles with NO precursor loaded for synergistic cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Polymer Research</span><span> <strong>2021,</strong> <em>28 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s10965-021-02645-4" title="DOI URL">https://doi.org/10.1007/s10965-021-02645-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10965-021-02645-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10965-021-02645-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Polymer%2520Research%26atitle%3DSelf-assembled%252Bdrug-polymer%252Bmicelles%252Bwith%252BNO%252Bprecursor%252Bloaded%252Bfor%252Bsynergistic%252Bcancer%252Btherapy%26aulast%3DJin%26aufirst%3DYuanbao%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Zhou</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Tianli  Zhai</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Fengsheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yucong  Gao</span>, <span class="hlFld-ContribAuthor ">Jingjing  Jiao</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Zhou</span>, <span class="hlFld-ContribAuthor ">Shiping  Yang</span>, <span class="hlFld-ContribAuthor ">Hong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">H2O2-responsive release of Fe3+ and NO: Anti-tumor therapy of Roussin’s black salt. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Communications</span><span> <strong>2021,</strong> <em>130 </em>, 108740. <a href="https://doi.org/10.1016/j.inoche.2021.108740" title="DOI URL">https://doi.org/10.1016/j.inoche.2021.108740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.inoche.2021.108740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.inoche.2021.108740%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Communications%26atitle%3DH2O2-responsive%252Brelease%252Bof%252BFe3%25252B%252Band%252BNO%25253A%252BAnti-tumor%252Btherapy%252Bof%252BRoussin%2525E2%252580%252599s%252Bblack%252Bsalt%26aulast%3DZhou%26aufirst%3DHan%26date%3D2021%26volume%3D130%26spage%3D108740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aurore  Fraix</span>, <span class="hlFld-ContribAuthor ">Cristina  Parisi</span>, <span class="hlFld-ContribAuthor ">Mimimorena  Seggio</span>, <span class="hlFld-ContribAuthor ">Salvatore  Sortino</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Photoreleasers with Fluorescent Reporting. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>43 </em><a href="https://doi.org/10.1002/chem.202101662" title="DOI URL">https://doi.org/10.1002/chem.202101662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202101662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202101662%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DNitric%252BOxide%252BPhotoreleasers%252Bwith%252BFluorescent%252BReporting%26aulast%3DFraix%26aufirst%3DAurore%26date%3D2021%26date%3D2021%26volume%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Wu</span>, <span class="hlFld-ContribAuthor ">Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Zhuoying  Liang</span>, <span class="hlFld-ContribAuthor ">Xiling  Song</span>, <span class="hlFld-ContribAuthor ">Yadong  Huang</span>, <span class="hlFld-ContribAuthor ">Lin  Qiu</span>, <span class="hlFld-ContribAuthor ">Xiaozhong  Qiu</span>, <span class="hlFld-ContribAuthor ">Siming  Yu</span>, <span class="hlFld-ContribAuthor ">Wei  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Near infrared II laser controlled free radical releasing nanogenerator for synergistic nitric oxide and alkyl radical therapy of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale</span><span> <strong>2021,</strong> <em>13 </em>
                                    (25)
                                     , 11169-11187. <a href="https://doi.org/10.1039/D1NR01859K" title="DOI URL">https://doi.org/10.1039/D1NR01859K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NR01859K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NR01859K%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%26atitle%3DNear%252Binfrared%252BII%252Blaser%252Bcontrolled%252Bfree%252Bradical%252Breleasing%252Bnanogenerator%252Bfor%252Bsynergistic%252Bnitric%252Boxide%252Band%252Balkyl%252Bradical%252Btherapy%252Bof%252Bbreast%252Bcancer%26aulast%3DWu%26aufirst%3DWeiwei%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D25%26spage%3D11169%26epage%3D11187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun  Han</span>, <span class="hlFld-ContribAuthor ">Kemin  Shen</span>, <span class="hlFld-ContribAuthor ">Shijun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhijun  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Su</span>, <span class="hlFld-ContribAuthor ">Xi  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Hu</span>, <span class="hlFld-ContribAuthor ">Mengyao  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Lintao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 2,4-Dianilinopyrimidine Derivatives Containing 4-(Morpholinomethyl)phenyl and N-Substituted Benzamides as Potential FAK Inhibitors and Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (14)
                                     , 4187. <a href="https://doi.org/10.3390/molecules26144187" title="DOI URL">https://doi.org/10.3390/molecules26144187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26144187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26144187%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNovel%252B2%25252C4-Dianilinopyrimidine%252BDerivatives%252BContaining%252B4-%252528Morpholinomethyl%252529phenyl%252Band%252BN-Substituted%252BBenzamides%252Bas%252BPotential%252BFAK%252BInhibitors%252Band%252BAnticancer%252BAgents%26aulast%3DHan%26aufirst%3DChun%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D14%26spage%3D4187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin-Ku  Lin</span>, <span class="hlFld-ContribAuthor ">Shiu-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ren-Shen  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Reductive responsive hyaluronic acid conjugated S-nitrothiol prodrugs as drug carriers. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Polymeric Materials and Polymeric Biomaterials</span><span> <strong>2021,</strong> <em>12 </em>, 1-14. <a href="https://doi.org/10.1080/00914037.2021.1931207" title="DOI URL">https://doi.org/10.1080/00914037.2021.1931207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00914037.2021.1931207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00914037.2021.1931207%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Polymeric%2520Materials%2520and%2520Polymeric%2520Biomaterials%26atitle%3DReductive%252Bresponsive%252Bhyaluronic%252Bacid%252Bconjugated%252BS-nitrothiol%252Bprodrugs%252Bas%252Bdrug%252Bcarriers%26aulast%3DLin%26aufirst%3DYin-Ku%26date%3D2021%26date%3D2021%26volume%3D12%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Sodano</span>, <span class="hlFld-ContribAuthor ">Elena  Gazzano</span>, <span class="hlFld-ContribAuthor ">Barbara  Rolando</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Marini</span>, <span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, <span class="hlFld-ContribAuthor ">Chiara  Riganti</span>, <span class="hlFld-ContribAuthor ">Alberto  Gasco</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>111 </em>, 104911. <a href="https://doi.org/10.1016/j.bioorg.2021.104911" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104911%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DTuning%252BNO%252Brelease%252Bof%252Borganelle-targeted%252Bfuroxan%252Bderivatives%252Band%252Btheir%252Bcytotoxicity%252Bagainst%252Blung%252Bcancer%252Bcells%26aulast%3DSodano%26aufirst%3DFederica%26date%3D2021%26volume%3D111%26spage%3D104911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicja  Nowaczyk</span>, <span class="hlFld-ContribAuthor ">Magdalena  Kowalska</span>, <span class="hlFld-ContribAuthor ">Jacek  Nowaczyk</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Grześk</span>. </span><span class="cited-content_cbyCitation_article-title">Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6029. <a href="https://doi.org/10.3390/ijms22116029" title="DOI URL">https://doi.org/10.3390/ijms22116029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116029%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCarbon%252BMonoxide%252Band%252BNitric%252BOxide%252Bas%252BExamples%252Bof%252Bthe%252BYoungest%252BClass%252Bof%252BTransmitters%26aulast%3DNowaczyk%26aufirst%3DAlicja%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Xue</span>, <span class="hlFld-ContribAuthor ">Yan  Hu</span>, <span class="hlFld-ContribAuthor ">Yonghui  Deng</span>, <span class="hlFld-ContribAuthor ">Jiacan  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Design of Functional Biocompatible Hydrogels for Bone Tissue Engineering. </span><span class="cited-content_cbyCitation_journal-name">Advanced Functional Materials</span><span> <strong>2021,</strong> <em>31 </em>
                                    (19)
                                     , 2009432. <a href="https://doi.org/10.1002/adfm.202009432" title="DOI URL">https://doi.org/10.1002/adfm.202009432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adfm.202009432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadfm.202009432%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Functional%2520Materials%26atitle%3DRecent%252BAdvances%252Bin%252BDesign%252Bof%252BFunctional%252BBiocompatible%252BHydrogels%252Bfor%252BBone%252BTissue%252BEngineering%26aulast%3DXue%26aufirst%3DXu%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D19%26spage%3D2009432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Gang  Gao</span>, <span class="hlFld-ContribAuthor ">Yanbing  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Cao</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>40 </em>, 127952. <a href="https://doi.org/10.1016/j.bmcl.2021.127952" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127952%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%2525CE%2525B2-carboline-%252528phenylsulfonyl%252529furoxan%252Bhybrids%252Bas%252Bpotential%252Banti-breast%252Bcancer%252Bagents%26aulast%3DHu%26aufirst%3DXu%26date%3D2021%26volume%3D40%26spage%3D127952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shevanuja  Theivendran</span>, <span class="hlFld-ContribAuthor ">Chengzhong  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Nanochemistry Modulates Intracellular Decomposition Routes of S‐Nitrosothiol Modified Silica‐Based Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Small</span><span> <strong>2021,</strong> <em>17 </em>
                                    (21)
                                     , 2007671. <a href="https://doi.org/10.1002/smll.202007671" title="DOI URL">https://doi.org/10.1002/smll.202007671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/smll.202007671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsmll.202007671%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall%26atitle%3DNanochemistry%252BModulates%252BIntracellular%252BDecomposition%252BRoutes%252Bof%252BS%2525E2%252580%252590Nitrosothiol%252BModified%252BSilica%2525E2%252580%252590Based%252BNanoparticles%26aulast%3DTheivendran%26aufirst%3DShevanuja%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D21%26spage%3D2007671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangkai  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengbing  Yang</span>, <span class="hlFld-ContribAuthor ">Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Weimin  Ye</span>, <span class="hlFld-ContribAuthor ">Shuli  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Lingyan  Cao</span>, <span class="hlFld-ContribAuthor ">Xinquan  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Tailored theranostic nanoparticles cause efficient ferroptosis in head and neck squamous cell carcinoma through a reactive oxygen species “butterfly effect”. </span><span class="cited-content_cbyCitation_journal-name">Chemical Engineering Journal</span><span> <strong>2021,</strong> <em>68 </em>, 130083. <a href="https://doi.org/10.1016/j.cej.2021.130083" title="DOI URL">https://doi.org/10.1016/j.cej.2021.130083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cej.2021.130083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cej.2021.130083%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Engineering%2520Journal%26atitle%3DTailored%252Btheranostic%252Bnanoparticles%252Bcause%252Befficient%252Bferroptosis%252Bin%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinoma%252Bthrough%252Ba%252Breactive%252Boxygen%252Bspecies%252B%2525E2%252580%25259Cbutterfly%252Beffect%2525E2%252580%25259D%26aulast%3DZhang%26aufirst%3DXiangkai%26date%3D2021%26volume%3D68%26spage%3D130083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Fang</span>, <span class="hlFld-ContribAuthor ">Shuxian  Cai</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaowei  Chen</span>, <span class="hlFld-ContribAuthor ">Chunhua  Lu</span>, <span class="hlFld-ContribAuthor ">Huanghao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Photogenerated Holes Mediated Nitric Oxide Production for Hypoxic Tumor Treatment. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (13)
                                     , 7122-7126. <a href="https://doi.org/10.1002/ange.202015082" title="DOI URL">https://doi.org/10.1002/ange.202015082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202015082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202015082%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPhotogenerated%252BHoles%252BMediated%252BNitric%252BOxide%252BProduction%252Bfor%252BHypoxic%252BTumor%252BTreatment%26aulast%3DFang%26aufirst%3DXiao%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D13%26spage%3D7122%26epage%3D7126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Fang</span>, <span class="hlFld-ContribAuthor ">Shuxian  Cai</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaowei  Chen</span>, <span class="hlFld-ContribAuthor ">Chunhua  Lu</span>, <span class="hlFld-ContribAuthor ">Huanghao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Photogenerated Holes Mediated Nitric Oxide Production for Hypoxic Tumor Treatment. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (13)
                                     , 7046-7050. <a href="https://doi.org/10.1002/anie.202015082" title="DOI URL">https://doi.org/10.1002/anie.202015082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202015082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202015082%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPhotogenerated%252BHoles%252BMediated%252BNitric%252BOxide%252BProduction%252Bfor%252BHypoxic%252BTumor%252BTreatment%26aulast%3DFang%26aufirst%3DXiao%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D13%26spage%3D7046%26epage%3D7050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianbing  Wu</span>, <span class="hlFld-ContribAuthor ">Tao  Sun</span>, <span class="hlFld-ContribAuthor ">Chenxi  Yang</span>, <span class="hlFld-ContribAuthor ">Tian  Lv</span>, <span class="hlFld-ContribAuthor ">Yuyang  Bi</span>, <span class="hlFld-ContribAuthor ">Yuan  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Ling</span>, <span class="hlFld-ContribAuthor ">Jun  Zhao</span>, <span class="hlFld-ContribAuthor ">Rigang  Cong</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianhua  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Wen</span>, <span class="hlFld-ContribAuthor ">Hulin  Jiang</span>, <span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2021,</strong> <em>9 </em>
                                    (5)
                                     , 1816-1825. <a href="https://doi.org/10.1039/D0BM01841D" title="DOI URL">https://doi.org/10.1039/D0BM01841D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0BM01841D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0BM01841D%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DTetrazine-mediated%252Bbioorthogonal%252Bremoval%252Bof%252B3-isocyanopropyl%252Bgroups%252Benables%252Bthe%252Bcontrolled%252Brelease%252Bof%252Bnitric%252Boxide%252Bin%252Bvivo%26aulast%3DWu%26aufirst%3DJianbing%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D5%26spage%3D1816%26epage%3D1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yana  Shafran</span>, <span class="hlFld-ContribAuthor ">Mordechai  Deutsch</span>, <span class="hlFld-ContribAuthor ">Elena  Afrimzon</span>, <span class="hlFld-ContribAuthor ">Orit  Ravid-Hermesh</span>, <span class="hlFld-ContribAuthor ">Maria  Sobolev</span>, <span class="hlFld-ContribAuthor ">Zehavit  Bar-On-Eizig</span>, <span class="hlFld-ContribAuthor ">Asher  Shainberg</span>, <span class="hlFld-ContribAuthor ">Naomi  Zurgil</span>. </span><span class="cited-content_cbyCitation_article-title">Co-culture hydrogel micro-chamber array-based plate for anti-tumor drug development at single-element resolution. </span><span class="cited-content_cbyCitation_journal-name">Toxicology in Vitro</span><span> <strong>2021,</strong> <em>71 </em>, 105067. <a href="https://doi.org/10.1016/j.tiv.2020.105067" title="DOI URL">https://doi.org/10.1016/j.tiv.2020.105067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tiv.2020.105067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tiv.2020.105067%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520in%2520Vitro%26atitle%3DCo-culture%252Bhydrogel%252Bmicro-chamber%252Barray-based%252Bplate%252Bfor%252Banti-tumor%252Bdrug%252Bdevelopment%252Bat%252Bsingle-element%252Bresolution%26aulast%3DShafran%26aufirst%3DYana%26date%3D2021%26volume%3D71%26spage%3D105067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiong  Zhou</span>, <span class="hlFld-ContribAuthor ">Lang  Rao</span>, <span class="hlFld-ContribAuthor ">Guocan  Yu</span>, <span class="hlFld-ContribAuthor ">Timothy R.  Cook</span>, <span class="hlFld-ContribAuthor ">Xiaoyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Feihe  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Supramolecular cancer nanotheranostics. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (4)
                                     , 2839-2891. <a href="https://doi.org/10.1039/D0CS00011F" title="DOI URL">https://doi.org/10.1039/D0CS00011F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00011F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00011F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DSupramolecular%252Bcancer%252Bnanotheranostics%26aulast%3DZhou%26aufirst%3DJiong%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D4%26spage%3D2839%26epage%3D2891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jenna L.  Gordon</span>, <span class="hlFld-ContribAuthor ">Kristin J.  Hinsen</span>, <span class="hlFld-ContribAuthor ">Melissa M.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Tyler A.  Smith</span>, <span class="hlFld-ContribAuthor ">Haley O.  Tucker</span>, <span class="hlFld-ContribAuthor ">Mark A.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer potential of nitric oxide (NO) in neuroblastoma treatment. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (16)
                                     , 9112-9120. <a href="https://doi.org/10.1039/D1RA00275A" title="DOI URL">https://doi.org/10.1039/D1RA00275A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA00275A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA00275A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAnticancer%252Bpotential%252Bof%252Bnitric%252Boxide%252B%252528NO%252529%252Bin%252Bneuroblastoma%252Btreatment%26aulast%3DGordon%26aufirst%3DJenna%2BL.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D16%26spage%3D9112%26epage%3D9120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Vivarelli</span>, <span class="hlFld-ContribAuthor ">Luca  Falzone</span>, <span class="hlFld-ContribAuthor ">Maria Sofia  Basile</span>, <span class="hlFld-ContribAuthor ">Saverio  Candido</span>, <span class="hlFld-ContribAuthor ">Massimo  Libra</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide in Hematological Cancers: Partner or Rival?. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2021,</strong> <em>34 </em>
                                    (5)
                                     , 383-401. <a href="https://doi.org/10.1089/ars.2019.7958" title="DOI URL">https://doi.org/10.1089/ars.2019.7958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2019.7958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2019.7958%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DNitric%252BOxide%252Bin%252BHematological%252BCancers%25253A%252BPartner%252Bor%252BRival%25253F%26aulast%3DVivarelli%26aufirst%3DSilvia%26date%3D2021%26volume%3D34%26issue%3D5%26spage%3D383%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guorui  Jin</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Gao</span>, <span class="hlFld-ContribAuthor ">Yangjing  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Hanlin  Ou</span>, <span class="hlFld-ContribAuthor ">Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Dan  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Polymeric Nitric Oxide Delivery Nanoplatforms for Treating Cancer, Cardiovascular Diseases, and Infection. </span><span class="cited-content_cbyCitation_journal-name">Advanced Healthcare Materials</span><span> <strong>2021,</strong> <em>10 </em>
                                    (3)
                                     , 2001550. <a href="https://doi.org/10.1002/adhm.202001550" title="DOI URL">https://doi.org/10.1002/adhm.202001550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adhm.202001550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadhm.202001550%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Healthcare%2520Materials%26atitle%3DPolymeric%252BNitric%252BOxide%252BDelivery%252BNanoplatforms%252Bfor%252BTreating%252BCancer%25252C%252BCardiovascular%252BDiseases%25252C%252Band%252BInfection%26aulast%3DJin%26aufirst%3DGuorui%26date%3D2021%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D2001550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Yang</span>, <span class="hlFld-ContribAuthor ">Tingting  Meng</span>, <span class="hlFld-ContribAuthor ">Yajuan  Qin</span>, <span class="hlFld-ContribAuthor ">Tingyou  Li</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>, <span class="hlFld-ContribAuthor ">Jian  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric oxide-donating and reactive oxygen species-responsive prochelators based on 8-hydroxyquinoline as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113153. <a href="https://doi.org/10.1016/j.ejmech.2021.113153" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113153%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitric%252Boxide-donating%252Band%252Breactive%252Boxygen%252Bspecies-responsive%252Bprochelators%252Bbased%252Bon%252B8-hydroxyquinoline%252Bas%252Banticancer%252Bagents%26aulast%3DZhang%26aufirst%3DYuxia%26date%3D2021%26volume%3D212%26spage%3D113153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Zan  Dai</span>, <span class="hlFld-ContribAuthor ">Shevanuja  Theivendran</span>, <span class="hlFld-ContribAuthor ">Zhengying  Gu</span>, <span class="hlFld-ContribAuthor ">Liang  Zhao</span>, <span class="hlFld-ContribAuthor ">Hao  Song</span>, <span class="hlFld-ContribAuthor ">Yannan  Yang</span>, <span class="hlFld-ContribAuthor ">Chengzhong  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Nanotechnology enabled reactive species regulation in biosystems for boosting cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Nano Today</span><span> <strong>2021,</strong> <em>36 </em>, 101035. <a href="https://doi.org/10.1016/j.nantod.2020.101035" title="DOI URL">https://doi.org/10.1016/j.nantod.2020.101035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nantod.2020.101035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nantod.2020.101035%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Today%26atitle%3DNanotechnology%252Benabled%252Breactive%252Bspecies%252Bregulation%252Bin%252Bbiosystems%252Bfor%252Bboosting%252Bcancer%252Bimmunotherapy%26aulast%3DZhang%26aufirst%3DMin%26date%3D2021%26volume%3D36%26spage%3D101035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joel  Mintz</span>, <span class="hlFld-ContribAuthor ">Anastasia  Vedenko</span>, <span class="hlFld-ContribAuthor ">Omar  Rosete</span>, <span class="hlFld-ContribAuthor ">Khushi  Shah</span>, <span class="hlFld-ContribAuthor ">Gabriella  Goldstein</span>, <span class="hlFld-ContribAuthor ">Joshua M.  Hare</span>, <span class="hlFld-ContribAuthor ">Ranjith  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Himanshu  Arora</span>. </span><span class="cited-content_cbyCitation_article-title">Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Vaccines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (2)
                                     , 94. <a href="https://doi.org/10.3390/vaccines9020094" title="DOI URL">https://doi.org/10.3390/vaccines9020094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/vaccines9020094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fvaccines9020094%26sid%3Dliteratum%253Aachs%26jtitle%3DVaccines%26atitle%3DCurrent%252BAdvances%252Bof%252BNitric%252BOxide%252Bin%252BCancer%252Band%252BAnticancer%252BTherapeutics%26aulast%3DMintz%26aufirst%3DJoel%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D2%26spage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yueqi  Yang</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Li-Li  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 444-459. <a href="https://doi.org/10.1039/D0NR07484E" title="DOI URL">https://doi.org/10.1039/D0NR07484E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NR07484E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NR07484E%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%26atitle%3DAdvanced%252Bnitric%252Boxide%252Bdonors%25253A%252Bchemical%252Bstructure%252Bof%252BNO%252Bdrugs%25252C%252BNO%252Bnanomedicines%252Band%252Bbiomedical%252Bapplications%26aulast%3DYang%26aufirst%3DYueqi%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D444%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian Timothy Sembiring  Meliala</span>, <span class="hlFld-ContribAuthor ">Rendy  Hosea</span>, <span class="hlFld-ContribAuthor ">Vivi  Kasim</span>, <span class="hlFld-ContribAuthor ">Shourong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Yin and Yang of YY1 regulation on tumor metabolic reprogramming. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 79-99. <a href="https://doi.org/10.1016/B978-0-12-821909-6.00014-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-821909-6.00014-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821909-6.00014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821909-6.00014-6%26sid%3Dliteratum%253Aachs%26atitle%3DYin%252Band%252BYang%252Bof%252BYY1%252Bregulation%252Bon%252Btumor%252Bmetabolic%252Breprogramming%26aulast%3DMeliala%26aufirst%3DIan%2BTimothy%2BSembiring%26date%3D2021%26spage%3D79%26epage%3D99%26pub%3DElsevier%26atitle%3DYY1%252Bin%252Bthe%252BControl%252Bof%252Bthe%252BPathogenesis%252Band%252BDrug%252BResistance%252Bof%252BCancer%26date%3D2021%26volume%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gargi Nikhil  Vaidya</span>, <span class="hlFld-ContribAuthor ">Pooja  Rana</span>, <span class="hlFld-ContribAuthor ">Ashwini  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Deep Rohan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Darshan  Contractor</span>, <span class="hlFld-ContribAuthor ">Dinesh Parshuram  Satpute</span>, <span class="hlFld-ContribAuthor ">Mithilesh  Nagpure</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Paradigm shift of “classical” HDAC inhibitors to “hybrid” HDAC inhibitors in therapeutic interventions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112844. <a href="https://doi.org/10.1016/j.ejmech.2020.112844" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112844%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DParadigm%252Bshift%252Bof%252B%2525E2%252580%25259Cclassical%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bto%252B%2525E2%252580%25259Chybrid%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bin%252Btherapeutic%252Binterventions%26aulast%3DVaidya%26aufirst%3DGargi%2BNikhil%26date%3D2021%26volume%3D209%26spage%3D112844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr K.A.  Bass</span>, <span class="hlFld-ContribAuthor ">Mona S.  El-Zoghbi</span>, <span class="hlFld-ContribAuthor ">El-Shimaa M.  Nageeb</span>, <span class="hlFld-ContribAuthor ">Mamdouh F.A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Mohamed  Badr</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112904. <a href="https://doi.org/10.1016/j.ejmech.2020.112904" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112904%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252Breview%252Bfor%252Banticancer%252Bhybridized%252Bmultitargeting%252BHDAC%252Binhibitors%26aulast%3DBass%26aufirst%3DAmr%2BK.A.%26date%3D2021%26volume%3D209%26spage%3D112904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuradha  Kirtonia</span>, <span class="hlFld-ContribAuthor ">Kavita  Gala</span>, <span class="hlFld-ContribAuthor ">Stina George  Fernandes</span>, <span class="hlFld-ContribAuthor ">Gouri  Pandya</span>, <span class="hlFld-ContribAuthor ">Amit Kumar  Pandey</span>, <span class="hlFld-ContribAuthor ">Gautam  Sethi</span>, <span class="hlFld-ContribAuthor ">Ekta  Khattar</span>, <span class="hlFld-ContribAuthor ">Manoj  Garg</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2021,</strong> <em>68 </em>, 258-278. <a href="https://doi.org/10.1016/j.semcancer.2020.04.006" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DRepurposing%252Bof%252Bdrugs%25253A%252BAn%252Battractive%252Bpharmacological%252Bstrategy%252Bfor%252Bcancer%252Btherapeutics%26aulast%3DKirtonia%26aufirst%3DAnuradha%26date%3D2021%26volume%3D68%26spage%3D258%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuanfang  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhouqi  Meng</span>, <span class="hlFld-ContribAuthor ">Jialin  She</span>, <span class="hlFld-ContribAuthor ">Yaojia  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuan  Yi</span>, <span class="hlFld-ContribAuthor ">Hailin  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Zhong</span>, <span class="hlFld-ContribAuthor ">Ziliang  Dong</span>, <span class="hlFld-ContribAuthor ">Xiao  Han</span>, <span class="hlFld-ContribAuthor ">Muchao  Chen</span>, <span class="hlFld-ContribAuthor ">Qin  Fan</span>, <span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Near-Infrared Light-Responsive Nitric Oxide Delivery Platform for Enhanced Radioimmunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Nano-Micro Letters</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s40820-020-00431-3" title="DOI URL">https://doi.org/10.1007/s40820-020-00431-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40820-020-00431-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40820-020-00431-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNano-Micro%2520Letters%26atitle%3DNear-Infrared%252BLight-Responsive%252BNitric%252BOxide%252BDelivery%252BPlatform%252Bfor%252BEnhanced%252BRadioimmunotherapy%26aulast%3DZhou%26aufirst%3DXuanfang%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyu  Meng</span>, <span class="hlFld-ContribAuthor ">Xuezhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei  Liu</span>, <span class="hlFld-ContribAuthor ">Bo  Cai</span>, <span class="hlFld-ContribAuthor ">Nongyue  He</span>, <span class="hlFld-ContribAuthor ">Zhifei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy. </span><span class="cited-content_cbyCitation_journal-name">Applied Materials Today</span><span> <strong>2020,</strong> <em>21 </em>, 100864. <a href="https://doi.org/10.1016/j.apmt.2020.100864" title="DOI URL">https://doi.org/10.1016/j.apmt.2020.100864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apmt.2020.100864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apmt.2020.100864%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Materials%2520Today%26atitle%3DFenton%252Breaction-based%252Bnanomedicine%252Bin%252Bcancer%252Bchemodynamic%252Band%252Bsynergistic%252Btherapy%26aulast%3DMeng%26aufirst%3DXiangyu%26date%3D2020%26volume%3D21%26spage%3D100864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Masetto</span>, <span class="hlFld-ContribAuthor ">Konstantin  Chegaev</span>, <span class="hlFld-ContribAuthor ">Elena  Gazzano</span>, <span class="hlFld-ContribAuthor ">Nidula  Mullappilly</span>, <span class="hlFld-ContribAuthor ">Barbara  Rolando</span>, <span class="hlFld-ContribAuthor ">Silvia  Arpicco</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, <span class="hlFld-ContribAuthor ">Chiara  Riganti</span>, <span class="hlFld-ContribAuthor ">Massimo  Donadelli</span>. </span><span class="cited-content_cbyCitation_article-title">MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2020,</strong> <em>1867 </em>
                                    (12)
                                     , 118824. <a href="https://doi.org/10.1016/j.bbamcr.2020.118824" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2020.118824</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2020.118824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2020.118824%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DMRP5%252Bnitration%252Bby%252BNO-releasing%252Bgemcitabine%252Bencapsulated%252Bin%252Bliposomes%252Bconfers%252Bsensitivity%252Bin%252Bchemoresistant%252Bpancreatic%252Badenocarcinoma%252Bcells%26aulast%3DMasetto%26aufirst%3DFrancesca%26date%3D2020%26volume%3D1867%26issue%3D12%26spage%3D118824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  D'Este</span>, <span class="hlFld-ContribAuthor ">Emilia  Della Pietra</span>, <span class="hlFld-ContribAuthor ">Gretta Veronica  Badillo Pazmay</span>, <span class="hlFld-ContribAuthor ">Luigi E.  Xodo</span>, <span class="hlFld-ContribAuthor ">Valentina  Rapozzi</span>. </span><span class="cited-content_cbyCitation_article-title">Role of nitric oxide in the response to photooxidative stress in prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>182 </em>, 114205. <a href="https://doi.org/10.1016/j.bcp.2020.114205" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114205%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DRole%252Bof%252Bnitric%252Boxide%252Bin%252Bthe%252Bresponse%252Bto%252Bphotooxidative%252Bstress%252Bin%252Bprostate%252Bcancer%252Bcells%26aulast%3DD%2527Este%26aufirst%3DFrancesca%26date%3D2020%26volume%3D182%26spage%3D114205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faizan H.  Khan</span>, <span class="hlFld-ContribAuthor ">Eoin  Dervan</span>, <span class="hlFld-ContribAuthor ">Dibyangana D.  Bhattacharyya</span>, <span class="hlFld-ContribAuthor ">Jake D.  McAuliffe</span>, <span class="hlFld-ContribAuthor ">Katrina M.  Miranda</span>, <span class="hlFld-ContribAuthor ">Sharon A.  Glynn</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Nitric Oxide in Cancer: Master Regulator or NOt?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (24)
                                     , 9393. <a href="https://doi.org/10.3390/ijms21249393" title="DOI URL">https://doi.org/10.3390/ijms21249393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21249393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21249393%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BRole%252Bof%252BNitric%252BOxide%252Bin%252BCancer%25253A%252BMaster%252BRegulator%252Bor%252BNOt%25253F%26aulast%3DKhan%26aufirst%3DFaizan%2BH.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D24%26spage%3D9393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Huilan  Li</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Li</span>, <span class="hlFld-ContribAuthor ">Yulin  Feng</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Yanhua  Liu</span>, <span class="hlFld-ContribAuthor ">Mingdong  Li</span>, <span class="hlFld-ContribAuthor ">Ronghua  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Improved antiproliferative activity of novel
              Pulsatilla
              saponin D/α-hederin derivatives containing nitric oxide donors. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (45)
                                     , 19532-19540. <a href="https://doi.org/10.1039/D0NJ02941F" title="DOI URL">https://doi.org/10.1039/D0NJ02941F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ02941F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ02941F%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DImproved%252Bantiproliferative%252Bactivity%252Bof%252Bnovel%252BPulsatilla%252Bsaponin%252BD%25252F%2525CE%2525B1-hederin%252Bderivatives%252Bcontaining%252Bnitric%252Boxide%252Bdonors%26aulast%3DYang%26aufirst%3DZunhua%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D45%26spage%3D19532%26epage%3D19540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin'ge  Ding</span>, <span class="hlFld-ContribAuthor ">Chunxi  Liu</span>, <span class="hlFld-ContribAuthor ">Chunlong  Zhao</span>, <span class="hlFld-ContribAuthor ">Hang  Dong</span>, <span class="hlFld-ContribAuthor ">Qifu  Xu</span>, <span class="hlFld-ContribAuthor ">C.  James Chou</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological study of class I selective HDAC inhibitors with NO releasing activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104235. <a href="https://doi.org/10.1016/j.bioorg.2020.104235" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104235%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bstudy%252Bof%252Bclass%252BI%252Bselective%252BHDAC%252Binhibitors%252Bwith%252BNO%252Breleasing%252Bactivity%26aulast%3DDing%26aufirst%3DQin%2527ge%26date%3D2020%26volume%3D104%26spage%3D104235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaa  Knany</span>, <span class="hlFld-ContribAuthor ">Rotem  Engelman</span>, <span class="hlFld-ContribAuthor ">Hiba Abu  Hariri</span>, <span class="hlFld-ContribAuthor ">Shyam  Biswal</span>, <span class="hlFld-ContribAuthor ">Haguy  Wolfenson</span>, <span class="hlFld-ContribAuthor ">Moran  Benhar</span>. </span><span class="cited-content_cbyCitation_article-title">S-nitrosocysteine and glutathione depletion synergize to induce cell death in human tumor cells: Insights into the redox and cytotoxic mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2020,</strong> <em>160 </em>, 566-574. <a href="https://doi.org/10.1016/j.freeradbiomed.2020.08.026" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2020.08.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2020.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2020.08.026%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DS-nitrosocysteine%252Band%252Bglutathione%252Bdepletion%252Bsynergize%252Bto%252Binduce%252Bcell%252Bdeath%252Bin%252Bhuman%252Btumor%252Bcells%25253A%252BInsights%252Binto%252Bthe%252Bredox%252Band%252Bcytotoxic%252Bmechanisms%26aulast%3DKnany%26aufirst%3DAlaa%26date%3D2020%26volume%3D160%26spage%3D566%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas F. M.  Luxford</span>, <span class="hlFld-ContribAuthor ">Stanislav A.  Pshenichnyuk</span>, <span class="hlFld-ContribAuthor ">Nail L.  Asfandiarov</span>, <span class="hlFld-ContribAuthor ">Tomáš  Perečko</span>, <span class="hlFld-ContribAuthor ">Martin  Falk</span>, <span class="hlFld-ContribAuthor ">Jaroslav  Kočišek</span>. </span><span class="cited-content_cbyCitation_article-title">5-Nitro-2,4-Dichloropyrimidine as an Universal Model for Low-Energy Electron Processes Relevant for Radiosensitization. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 8173. <a href="https://doi.org/10.3390/ijms21218173" title="DOI URL">https://doi.org/10.3390/ijms21218173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21218173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21218173%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3D5-Nitro-2%25252C4-Dichloropyrimidine%252Bas%252Ban%252BUniversal%252BModel%252Bfor%252BLow-Energy%252BElectron%252BProcesses%252BRelevant%252Bfor%252BRadiosensitization%26aulast%3DLuxford%26aufirst%3DThomas%2BF.%2BM.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D8173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Xuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhen-Yu  Guan</span>, <span class="hlFld-ContribAuthor ">Si-Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Huo</span>, <span class="hlFld-ContribAuthor ">Guo  Cheng</span>, <span class="hlFld-ContribAuthor ">Yan-Hui  Fan</span>, <span class="hlFld-ContribAuthor ">Fang-Shuai  Zhou</span>, <span class="hlFld-ContribAuthor ">Qing-Hai  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Zinc-catalyzed asymmetric nitrooxylation of β-keto esters/amides with a benziodoxole-derived nitrooxy transfer reagent. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (21)
                                     , 3509-3514. <a href="https://doi.org/10.1039/D0QO01022G" title="DOI URL">https://doi.org/10.1039/D0QO01022G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01022G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01022G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DZinc-catalyzed%252Basymmetric%252Bnitrooxylation%252Bof%252B%2525CE%2525B2-keto%252Besters%25252Famides%252Bwith%252Ba%252Bbenziodoxole-derived%252Bnitrooxy%252Btransfer%252Breagent%26aulast%3DLi%26aufirst%3DBin%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D21%26spage%3D3509%26epage%3D3514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Parisi</span>, <span class="hlFld-ContribAuthor ">Aurore  Fraix</span>, <span class="hlFld-ContribAuthor ">Stefano  Guglielmo</span>, <span class="hlFld-ContribAuthor ">Francesca  Spyrakis</span>, <span class="hlFld-ContribAuthor ">Barbara  Rolando</span>, <span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, <span class="hlFld-ContribAuthor ">Alberto  Gasco</span>, <span class="hlFld-ContribAuthor ">Salvatore  Sortino</span>. </span><span class="cited-content_cbyCitation_article-title">DNA‐Targeted NO Release Photoregulated by Green Light. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (60)
                                     , 13627-13633. <a href="https://doi.org/10.1002/chem.202001538" title="DOI URL">https://doi.org/10.1002/chem.202001538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202001538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202001538%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDNA%2525E2%252580%252590Targeted%252BNO%252BRelease%252BPhotoregulated%252Bby%252BGreen%252BLight%26aulast%3DParisi%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D60%26spage%3D13627%26epage%3D13633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haipin  Zhou</span>, <span class="hlFld-ContribAuthor ">Yonggan  Dong</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Ma</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a novel truncated deguelin derivative possessing nitric oxide donor as a potential anti-lung cancer agent. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2020,</strong> <em>146 </em>, 104670. <a href="https://doi.org/10.1016/j.fitote.2020.104670" title="DOI URL">https://doi.org/10.1016/j.fitote.2020.104670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2020.104670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2020.104670%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DDevelopment%252Bof%252Ba%252Bnovel%252Btruncated%252Bdeguelin%252Bderivative%252Bpossessing%252Bnitric%252Boxide%252Bdonor%252Bas%252Ba%252Bpotential%252Banti-lung%252Bcancer%252Bagent%26aulast%3DZhou%26aufirst%3DHaipin%26date%3D2020%26volume%3D146%26spage%3D104670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Long Binh  Vong</span>, <span class="hlFld-ContribAuthor ">Yukio  Nagasaki</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Nano-Delivery Systems for Cancer Therapeutics: Advances and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (9)
                                     , 791. <a href="https://doi.org/10.3390/antiox9090791" title="DOI URL">https://doi.org/10.3390/antiox9090791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9090791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9090791%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DNitric%252BOxide%252BNano-Delivery%252BSystems%252Bfor%252BCancer%252BTherapeutics%25253A%252BAdvances%252Band%252BChallenges%26aulast%3DVong%26aufirst%3DLong%2BBinh%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D9%26spage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawei  Jiang</span>, <span class="hlFld-ContribAuthor ">Lei  Cheng</span>, <span class="hlFld-ContribAuthor ">Yudong  Xue</span>, <span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Chaochao  Wang</span>, <span class="hlFld-ContribAuthor ">Guoliang  Yang</span>, <span class="hlFld-ContribAuthor ">An  Xu</span>, <span class="hlFld-ContribAuthor ">Youjun  Yang</span>, <span class="hlFld-ContribAuthor ">Yun  Gao</span>, <span class="hlFld-ContribAuthor ">Weian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the lifespan of
              C. elegans
              by the controlled release of nitric oxide. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (33)
                                     , 8785-8792. <a href="https://doi.org/10.1039/C9SC06072C" title="DOI URL">https://doi.org/10.1039/C9SC06072C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC06072C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC06072C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DModulation%252Bof%252Bthe%252Blifespan%252Bof%252BC.%252Belegans%252Bby%252Bthe%252Bcontrolled%252Brelease%252Bof%252Bnitric%252Boxide%26aulast%3DJiang%26aufirst%3DDawei%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D33%26spage%3D8785%26epage%3D8792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Parisi</span>, <span class="hlFld-ContribAuthor ">Mimimorena  Seggio</span>, <span class="hlFld-ContribAuthor ">Aurore  Fraix</span>, <span class="hlFld-ContribAuthor ">Salvatore  Sortino</span>. </span><span class="cited-content_cbyCitation_article-title">A High‐Performing Metal‐Free Photoactivatable Nitric Oxide Donor with a Green Fluorescent Reporter. </span><span class="cited-content_cbyCitation_journal-name">ChemPhotoChem</span><span> <strong>2020,</strong> <em>269 </em><a href="https://doi.org/10.1002/cptc.202000100" title="DOI URL">https://doi.org/10.1002/cptc.202000100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cptc.202000100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcptc.202000100%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhotoChem%26atitle%3DA%252BHigh%2525E2%252580%252590Performing%252BMetal%2525E2%252580%252590Free%252BPhotoactivatable%252BNitric%252BOxide%252BDonor%252Bwith%252Ba%252BGreen%252BFluorescent%252BReporter%26aulast%3DParisi%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26volume%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jintong  Du</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Jianbing  Wu</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Guobo  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Li  Rao</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">New techniques and strategies in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2020,</strong> <em>31 </em>
                                    (7)
                                     , 1695-1708. <a href="https://doi.org/10.1016/j.cclet.2020.03.028" title="DOI URL">https://doi.org/10.1016/j.cclet.2020.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2020.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2020.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DNew%252Btechniques%252Band%252Bstrategies%252Bin%252Bdrug%252Bdiscovery%26aulast%3DDu%26aufirst%3DJintong%26date%3D2020%26volume%3D31%26issue%3D7%26spage%3D1695%26epage%3D1708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Liye  Wang</span>, <span class="hlFld-ContribAuthor ">Zuoxu  Xie</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Zhou</span>, <span class="hlFld-ContribAuthor ">Meiyan  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 1881. <a href="https://doi.org/10.3390/cancers12071881" title="DOI URL">https://doi.org/10.3390/cancers12071881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12071881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12071881%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNitric%252BOxide%252B%252528NO%252529%252Band%252BNO%252BSynthases%252B%252528NOS%252529-Based%252BTargeted%252BTherapy%252Bfor%252BColon%252BCancer%26aulast%3DWang%26aufirst%3DHao%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D1881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianhua  Feng</span>, <span class="hlFld-ContribAuthor ">Yuzhen  Li</span>, <span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Yutong  Hao</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>, <span class="hlFld-ContribAuthor ">Zeying  Wang</span>, <span class="hlFld-ContribAuthor ">Xueli  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenzhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A Biomimetic Nanogenerator of Reactive Nitrogen Species Based on Battlefield Transfer Strategy for Enhanced Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Small</span><span> <strong>2020,</strong> <em>16 </em>
                                    (25)
                                     , 2002138. <a href="https://doi.org/10.1002/smll.202002138" title="DOI URL">https://doi.org/10.1002/smll.202002138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/smll.202002138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsmll.202002138%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall%26atitle%3DA%252BBiomimetic%252BNanogenerator%252Bof%252BReactive%252BNitrogen%252BSpecies%252BBased%252Bon%252BBattlefield%252BTransfer%252BStrategy%252Bfor%252BEnhanced%252BImmunotherapy%26aulast%3DFeng%26aufirst%3DQianhua%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D25%26spage%3D2002138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana C.  Pieretti</span>, <span class="hlFld-ContribAuthor ">Milena T.  Pelegrino</span>, <span class="hlFld-ContribAuthor ">Mônica H.M.  Nascimento</span>, <span class="hlFld-ContribAuthor ">Gonzalo R.  Tortella</span>, <span class="hlFld-ContribAuthor ">Olga  Rubilar</span>, <span class="hlFld-ContribAuthor ">Amedea B.  Seabra</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>176 </em>, 113740. <a href="https://doi.org/10.1016/j.bcp.2019.113740" title="DOI URL">https://doi.org/10.1016/j.bcp.2019.113740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2019.113740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2019.113740%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DSmall%252Bmolecules%252Bfor%252Bgreat%252Bsolutions%25253A%252BCan%252Bnitric%252Boxide-releasing%252Bnanomaterials%252Bovercome%252Bdrug%252Bresistance%252Bin%252Bchemotherapy%25253F%26aulast%3DPieretti%26aufirst%3DJoana%2BC.%26date%3D2020%26volume%3D176%26spage%3D113740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadire  Özenver</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics). </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>176 </em>, 113792. <a href="https://doi.org/10.1016/j.bcp.2020.113792" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113792%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DSmall%252Bmolecule%252Binhibitors%252Band%252Bstimulators%252Bof%252Binducible%252Bnitric%252Boxide%252Bsynthase%252Bin%252Bcancer%252Bcells%252Bfrom%252Bnatural%252Borigin%252B%252528phytochemicals%25252C%252Bmarine%252Bcompounds%25252C%252Bantibiotics%252529%26aulast%3D%25C3%2596zenver%26aufirst%3DNadire%26date%3D2020%26volume%3D176%26spage%3D113792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niharika  Nath</span>, <span class="hlFld-ContribAuthor ">Khosrow  Kashfi</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor associated macrophages and ‘NO’. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>176 </em>, 113899. <a href="https://doi.org/10.1016/j.bcp.2020.113899" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113899%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DTumor%252Bassociated%252Bmacrophages%252Band%252B%2525E2%252580%252598NO%2525E2%252580%252599%26aulast%3DNath%26aufirst%3DNiharika%26date%3D2020%26volume%3D176%26spage%3D113899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiyu  Ding</span>, <span class="hlFld-ContribAuthor ">Liying  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Baohua  Zhu</span>, <span class="hlFld-ContribAuthor ">Lili  Hou</span>, <span class="hlFld-ContribAuthor ">Guicheng  Huang</span>, <span class="hlFld-ContribAuthor ">Ziqing  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">RGD-modified ZnO nanoparticles loaded with nitric oxide precursor for targeted cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2020,</strong> <em>749 </em>, 137445. <a href="https://doi.org/10.1016/j.cplett.2020.137445" title="DOI URL">https://doi.org/10.1016/j.cplett.2020.137445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2020.137445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2020.137445%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DRGD-modified%252BZnO%252Bnanoparticles%252Bloaded%252Bwith%252Bnitric%252Boxide%252Bprecursor%252Bfor%252Btargeted%252Bcancer%252Btherapy%26aulast%3DDing%26aufirst%3DHuiyu%26date%3D2020%26volume%3D749%26spage%3D137445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Dandan  Xi</span>, <span class="hlFld-ContribAuthor ">Han  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Peng</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids of MEK inhibitor and NO donor as multitarget antitumor drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>196 </em>, 112271. <a href="https://doi.org/10.1016/j.ejmech.2020.112271" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112271%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHybrids%252Bof%252BMEK%252Binhibitor%252Band%252BNO%252Bdonor%252Bas%252Bmultitarget%252Bantitumor%252Bdrugs%26aulast%3DWang%26aufirst%3DChao%26date%3D2020%26volume%3D196%26spage%3D112271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dobričić</span>, <span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Elena  Gazzano</span>, <span class="hlFld-ContribAuthor ">Miguel  Machuqueiro</span>, <span class="hlFld-ContribAuthor ">Ilza  Pajeva</span>, <span class="hlFld-ContribAuthor ">Ivanka  Tsakovska</span>, <span class="hlFld-ContribAuthor ">Nace  Zidar</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>. </span><span class="cited-content_cbyCitation_article-title">Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2020,</strong> <em>50 </em>, 100682. <a href="https://doi.org/10.1016/j.drup.2020.100682" title="DOI URL">https://doi.org/10.1016/j.drup.2020.100682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2020.100682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2020.100682%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DImprovement%252Bof%252Bconventional%252Banti-cancer%252Bdrugs%252Bas%252Bnew%252Btools%252Bagainst%252Bmultidrug%252Bresistant%252Btumors%26aulast%3DDallavalle%26aufirst%3DSabrina%26date%3D2020%26volume%3D50%26spage%3D100682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia L.  Merkulova</span>, <span class="hlFld-ContribAuthor ">Ivan D.  Nesterov</span>, <span class="hlFld-ContribAuthor ">Vjacheslav L.  Korolev</span>, <span class="hlFld-ContribAuthor ">Vitaliy M.  Danilenko</span>, <span class="hlFld-ContribAuthor ">Tatyana S.  Pivina</span>. </span><span class="cited-content_cbyCitation_article-title">The tautomerism of imidazo[4,5-e]benzo[1,2-c,3,4-c] difuroxans: A quantum chemical and experimental study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1207 </em>, 127775. <a href="https://doi.org/10.1016/j.molstruc.2020.127775" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127775%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DThe%252Btautomerism%252Bof%252Bimidazo%25255B4%25252C5-e%25255Dbenzo%25255B1%25252C2-c%25252C3%25252C4-c%25255D%252Bdifuroxans%25253A%252BA%252Bquantum%252Bchemical%252Band%252Bexperimental%252Bstudy%26aulast%3DMerkulova%26aufirst%3DNatalia%2BL.%26date%3D2020%26volume%3D1207%26spage%3D127775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyan  Huang</span>, <span class="hlFld-ContribAuthor ">Keguang  Cheng</span>, <span class="hlFld-ContribAuthor ">Lilin  Liu</span>, <span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Haonan  Li</span>, <span class="hlFld-ContribAuthor ">Fanxing  Xu</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and apoptosis-related antiproliferative activities of chelidonine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126913. <a href="https://doi.org/10.1016/j.bmcl.2019.126913" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126913%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bapoptosis-related%252Bantiproliferative%252Bactivities%252Bof%252Bchelidonine%252Bderivatives%26aulast%3DHuang%26aufirst%3DXueyan%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya  Hu</span>, <span class="hlFld-ContribAuthor ">Jing  Xiang</span>, <span class="hlFld-ContribAuthor ">Linlin  Su</span>, <span class="hlFld-ContribAuthor ">Xi  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">The regulation of nitric oxide in tumor progression and therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of International Medical Research</span><span> <strong>2020,</strong> <em>48 </em>
                                    (2)
                                     , 030006052090598. <a href="https://doi.org/10.1177/0300060520905985" title="DOI URL">https://doi.org/10.1177/0300060520905985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0300060520905985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0300060520905985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520International%2520Medical%2520Research%26atitle%3DThe%252Bregulation%252Bof%252Bnitric%252Boxide%252Bin%252Btumor%252Bprogression%252Band%252Btherapy%26aulast%3DHu%26aufirst%3DYa%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D2%26spage%3D030006052090598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo Pereira  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Juliana Santa  Ardisson</span>, <span class="hlFld-ContribAuthor ">Rita de Cássia  Ribeiro Gonçalves</span>, <span class="hlFld-ContribAuthor ">Tiago Branquinho  Oliveira</span>, <span class="hlFld-ContribAuthor ">Vinicius  Barreto da Silva</span>, <span class="hlFld-ContribAuthor ">Daniel Fábio  Kawano</span>, <span class="hlFld-ContribAuthor ">Rodrigo Rezende  Kitagawa</span>. </span><span class="cited-content_cbyCitation_article-title">Search for Potential Inducible Nitric Oxide Synthase Inhibitors with Favorable ADMET Profiles for the Therapy of Helicobacter pylori Infections. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>19 </em>
                                    (30)
                                     , 2795-2804. <a href="https://doi.org/10.2174/1568026619666191112105650" title="DOI URL">https://doi.org/10.2174/1568026619666191112105650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191112105650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191112105650%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DSearch%252Bfor%252BPotential%252BInducible%252BNitric%252BOxide%252BSynthase%252BInhibitors%252Bwith%252BFavorable%252BADMET%252BProfiles%252Bfor%252Bthe%252BTherapy%252Bof%252BHelicobacter%252Bpylori%252BInfections%26aulast%3DRodrigues%26aufirst%3DRicardo%2BPereira%26date%3D2020%26volume%3D19%26issue%3D30%26spage%3D2795%26epage%3D2804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam C.  Midgley</span>, <span class="hlFld-ContribAuthor ">Yongzhen  Wei</span>, <span class="hlFld-ContribAuthor ">Zongjin  Li</span>, <span class="hlFld-ContribAuthor ">Deling  Kong</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric‐Oxide‐Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials</span><span> <strong>2020,</strong> <em>32 </em>
                                    (3)
                                     , 1805818. <a href="https://doi.org/10.1002/adma.201805818" title="DOI URL">https://doi.org/10.1002/adma.201805818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adma.201805818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadma.201805818%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%26atitle%3DNitric%2525E2%252580%252590Oxide%2525E2%252580%252590Releasing%252BBiomaterial%252BRegulation%252Bof%252Bthe%252BStem%252BCell%252BMicroenvironment%252Bin%252BRegenerative%252BMedicine%26aulast%3DMidgley%26aufirst%3DAdam%2BC.%26date%3D2020%26date%3D2019%26volume%3D32%26issue%3D3%26spage%3D1805818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamer S.  Kaoud</span>, <span class="hlFld-ContribAuthor ">Aliaa M.  Mohassab</span>, <span class="hlFld-ContribAuthor ">Heba A.  Hassan</span>, <span class="hlFld-ContribAuthor ">Chunli  Yan</span>, <span class="hlFld-ContribAuthor ">Sabrina X.  Van Ravenstein</span>, <span class="hlFld-ContribAuthor ">Dalia  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Dalby</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abdel-Aziz</span>. </span><span class="cited-content_cbyCitation_article-title">NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111885. <a href="https://doi.org/10.1016/j.ejmech.2019.111885" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111885%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNO-releasing%252BSTAT3%252Binhibitors%252Bsuppress%252BBRAF-mutant%252Bmelanoma%252Bgrowth%26aulast%3DKaoud%26aufirst%3DTamer%2BS.%26date%3D2020%26volume%3D186%26spage%3D111885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabel  Aranda-Olmedo</span>, <span class="hlFld-ContribAuthor ">Luis A.  Rubio</span>. </span><span class="cited-content_cbyCitation_article-title">Dietary legumes, intestinal microbiota, inflammation and colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2020,</strong> <em>64 </em>, 103707. <a href="https://doi.org/10.1016/j.jff.2019.103707" title="DOI URL">https://doi.org/10.1016/j.jff.2019.103707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2019.103707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2019.103707%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DDietary%252Blegumes%25252C%252Bintestinal%252Bmicrobiota%25252C%252Binflammation%252Band%252Bcolorectal%252Bcancer%26aulast%3DAranda-Olmedo%26aufirst%3DIsabel%26date%3D2020%26volume%3D64%26spage%3D103707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawei  Jiang</span>, <span class="hlFld-ContribAuthor ">Tao  Yue</span>, <span class="hlFld-ContribAuthor ">Guichen  Wang</span>, <span class="hlFld-ContribAuthor ">Chaochao  Wang</span>, <span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Hongliang  Cao</span>, <span class="hlFld-ContribAuthor ">Yun  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Peroxynitrite (ONOO
              −
              ) generation from the <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1c545d31484c4c5c52534e51">[email protected]</a> nanoparticles based on synergistic interactions between nitric oxide and photodynamic therapies for elevating anticancer efficiency. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (1)
                                     , 162-170. <a href="https://doi.org/10.1039/C9NJ04763H" title="DOI URL">https://doi.org/10.1039/C9NJ04763H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ04763H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ04763H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DPeroxynitrite%252B%252528ONOO%252B%2525E2%252588%252592%252B%252529%252Bgeneration%252Bfrom%252Bthe%252BHA-TPP%252540NORM%252Bnanoparticles%252Bbased%252Bon%252Bsynergistic%252Binteractions%252Bbetween%252Bnitric%252Boxide%252Band%252Bphotodynamic%252Btherapies%252Bfor%252Belevating%252Banticancer%252Befficiency%26aulast%3DJiang%26aufirst%3DDawei%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D1%26spage%3D162%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuma  Yamada</span>, <span class="hlFld-ContribAuthor ">Yuta  Takano</span>, <span class="hlFld-ContribAuthor ">Satrialdi</span>, <span class="hlFld-ContribAuthor ">Jiro  Abe</span>, <span class="hlFld-ContribAuthor ">Mitsue  Hibino</span>, <span class="hlFld-ContribAuthor ">Hideyoshi  Harashima</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 83. <a href="https://doi.org/10.3390/biom10010083" title="DOI URL">https://doi.org/10.3390/biom10010083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10010083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10010083%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DTherapeutic%252BStrategies%252Bfor%252BRegulating%252BMitochondrial%252BOxidative%252BStress%26aulast%3DYamada%26aufirst%3DYuma%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyu  Jiao</span>, <span class="hlFld-ContribAuthor ">Zemin  Wang</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Wen</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Stimuli‐Responsive Controlled Release Nanocarrier for Multidrug Resistance Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ChemPhysChem</span><span> <strong>2019,</strong> <em>20 </em>
                                    (24)
                                     , 3271-3275. <a href="https://doi.org/10.1002/cphc.201900935" title="DOI URL">https://doi.org/10.1002/cphc.201900935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cphc.201900935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcphc.201900935%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhysChem%26atitle%3DDual%252BStimuli%2525E2%252580%252590Responsive%252BControlled%252BRelease%252BNanocarrier%252Bfor%252BMultidrug%252BResistance%252BCancer%252BTherapy%26aulast%3DJiao%26aufirst%3DXiangyu%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D24%26spage%3D3271%26epage%3D3275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Liu</span>, <span class="hlFld-ContribAuthor ">Jingjing  Chen</span>, <span class="hlFld-ContribAuthor ">Mengyao  Cao</span>, <span class="hlFld-ContribAuthor ">Jiangang  Wang</span>, <span class="hlFld-ContribAuthor ">Shuying  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2019,</strong> <em>84 </em>
                                    (6)
                                     , 1303-1314. <a href="https://doi.org/10.1007/s00280-019-03965-5" title="DOI URL">https://doi.org/10.1007/s00280-019-03965-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-019-03965-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-019-03965-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DNO%252Bdonor%252Binhibits%252Bproliferation%252Band%252Binduces%252Bapoptosis%252Bby%252Btargeting%252BPI3K%25252FAKT%25252FmTOR%252Band%252BMEK%25252FERK%252Bpathways%252Bin%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DLiu%26aufirst%3DLing%26date%3D2019%26date%3D2019%26volume%3D84%26issue%3D6%26spage%3D1303%26epage%3D1314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. S.  Emel’yanova</span>, <span class="hlFld-ContribAuthor ">O. V.  Pokidova</span>, <span class="hlFld-ContribAuthor ">N. A.  Sanina</span>, <span class="hlFld-ContribAuthor ">S. M.  Aldoshin</span>. </span><span class="cited-content_cbyCitation_article-title">TDDFT-modeling of theoretical UV spectra of binuclear sulfur-containing iron nitrosyl clusters and products of their decomposition. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (12)
                                     , 2190-2196. <a href="https://doi.org/10.1007/s11172-019-2687-9" title="DOI URL">https://doi.org/10.1007/s11172-019-2687-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2687-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2687-9%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DTDDFT-modeling%252Bof%252Btheoretical%252BUV%252Bspectra%252Bof%252Bbinuclear%252Bsulfur-containing%252Biron%252Bnitrosyl%252Bclusters%252Band%252Bproducts%252Bof%252Btheir%252Bdecomposition%26aulast%3DEmel%25E2%2580%2599yanova%26aufirst%3DN.%2BS.%26date%3D2019%26date%3D2020%26volume%3D68%26issue%3D12%26spage%3D2190%26epage%3D2196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-Chieh  Sung</span>, <span class="hlFld-ContribAuthor ">Pei-Ru  Jin</span>, <span class="hlFld-ContribAuthor ">Li-An  Chu</span>, <span class="hlFld-ContribAuthor ">Fu-Fei  Hsu</span>, <span class="hlFld-ContribAuthor ">Mei-Ren  Wang</span>, <span class="hlFld-ContribAuthor ">Chih-Chun  Chang</span>, <span class="hlFld-ContribAuthor ">Show-Jen  Chiou</span>, <span class="hlFld-ContribAuthor ">Jiantai Timothy  Qiu</span>, <span class="hlFld-ContribAuthor ">Dong-Yu  Gao</span>, <span class="hlFld-ContribAuthor ">Chu-Chi  Lin</span>, <span class="hlFld-ContribAuthor ">Yu-Sing  Chen</span>, <span class="hlFld-ContribAuthor ">Yi-Chiung  Hsu</span>, <span class="hlFld-ContribAuthor ">Jane  Wang</span>, <span class="hlFld-ContribAuthor ">Fu-Nien  Wang</span>, <span class="hlFld-ContribAuthor ">Pei-Lun  Yu</span>, <span class="hlFld-ContribAuthor ">Ann-Shyn  Chiang</span>, <span class="hlFld-ContribAuthor ">Anthony Yan-Tang  Wu</span>, <span class="hlFld-ContribAuthor ">John Jun-Sheng  Ko</span>, <span class="hlFld-ContribAuthor ">Charles Pin-Kuang  Lai</span>, <span class="hlFld-ContribAuthor ">Tsai-Te  Lu</span>, <span class="hlFld-ContribAuthor ">Yunching  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Nature Nanotechnology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (12)
                                     , 1160-1169. <a href="https://doi.org/10.1038/s41565-019-0570-3" title="DOI URL">https://doi.org/10.1038/s41565-019-0570-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41565-019-0570-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41565-019-0570-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Nanotechnology%26atitle%3DDelivery%252Bof%252Bnitric%252Boxide%252Bwith%252Ba%252Bnanocarrier%252Bpromotes%252Btumour%252Bvessel%252Bnormalization%252Band%252Bpotentiates%252Banti-cancer%252Btherapies%26aulast%3DSung%26aufirst%3DYun-Chieh%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D12%26spage%3D1160%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Egor S.  Zhilin</span>, <span class="hlFld-ContribAuthor ">Dmitry M.  Bystrov</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Ananyev</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>, <span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (63)
                                     , 14284-14289. <a href="https://doi.org/10.1002/chem.201903526" title="DOI URL">https://doi.org/10.1002/chem.201903526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903526%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DStraightforward%252BAccess%252Bto%252Bthe%252BNitric%252BOxide%252BDonor%252BAzasydnone%252BScaffold%252Bby%252BCascade%252BReactions%252Bof%252BAmines%26aulast%3DZhilin%26aufirst%3DEgor%2BS.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D63%26spage%3D14284%26epage%3D14289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wuyang  Hua</span>, <span class="hlFld-ContribAuthor ">Jian  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wang</span>, <span class="hlFld-ContribAuthor ">Sinan  Pei</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">A lysosome specific theranostic NO donor inhibits cancer cells by stimuli responsive molecular self-decomposition with an on-demand fluorescence pattern. </span><span class="cited-content_cbyCitation_journal-name">The Analyst</span><span> <strong>2019,</strong> <em>144 </em>
                                    (22)
                                     , 6681-6688. <a href="https://doi.org/10.1039/C9AN01746A" title="DOI URL">https://doi.org/10.1039/C9AN01746A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9AN01746A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9AN01746A%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Analyst%26atitle%3DA%252Blysosome%252Bspecific%252Btheranostic%252BNO%252Bdonor%252Binhibits%252Bcancer%252Bcells%252Bby%252Bstimuli%252Bresponsive%252Bmolecular%252Bself-decomposition%252Bwith%252Ban%252Bon-demand%252Bfluorescence%252Bpattern%26aulast%3DHua%26aufirst%3DWuyang%26date%3D2019%26date%3D2019%26volume%3D144%26issue%3D22%26spage%3D6681%26epage%3D6688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Elena  Gazzano</span>, <span class="hlFld-ContribAuthor ">Marco  Blangetti</span>, <span class="hlFld-ContribAuthor ">Aurore  Fraix</span>, <span class="hlFld-ContribAuthor ">Federica  Sodano</span>, <span class="hlFld-ContribAuthor ">Giulia Maria  Picone</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, <span class="hlFld-ContribAuthor ">Alberto  Gasco</span>, <span class="hlFld-ContribAuthor ">Chiara  Riganti</span>, <span class="hlFld-ContribAuthor ">Salvatore  Sortino</span>. </span><span class="cited-content_cbyCitation_article-title">Combination of PDT and NOPDT with a Tailored BODIPY Derivative. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2019,</strong> <em>8 </em>
                                    (11)
                                     , 531. <a href="https://doi.org/10.3390/antiox8110531" title="DOI URL">https://doi.org/10.3390/antiox8110531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox8110531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox8110531%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DCombination%252Bof%252BPDT%252Band%252BNOPDT%252Bwith%252Ba%252BTailored%252BBODIPY%252BDerivative%26aulast%3DLazzarato%26aufirst%3DLoretta%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D11%26spage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junjie  Fu</span>, <span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Tingting  Meng</span>, <span class="hlFld-ContribAuthor ">Jing  Hu</span>, <span class="hlFld-ContribAuthor ">Jian  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Novel α-ketoamide based diazeniumdiolates as hydrogen peroxide responsive nitric oxide donors with anti-lung cancer activity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (86)
                                     , 12904-12907. <a href="https://doi.org/10.1039/C9CC05266F" title="DOI URL">https://doi.org/10.1039/C9CC05266F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC05266F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC05266F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DNovel%252B%2525CE%2525B1-ketoamide%252Bbased%252Bdiazeniumdiolates%252Bas%252Bhydrogen%252Bperoxide%252Bresponsive%252Bnitric%252Boxide%252Bdonors%252Bwith%252Banti-lung%252Bcancer%252Bactivity%26aulast%3DFu%26aufirst%3DJunjie%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D86%26spage%3D12904%26epage%3D12907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana Karla Cardoso Amorim  Reis</span>, <span class="hlFld-ContribAuthor ">Arnold  Stern</span>, <span class="hlFld-ContribAuthor ">Hugo Pequeno  Monteiro</span>. </span><span class="cited-content_cbyCitation_article-title">S-nitrosothiols and H2S donors: Potential chemo-therapeutic agents in cancer. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2019,</strong> <em>27 </em>, 101190. <a href="https://doi.org/10.1016/j.redox.2019.101190" title="DOI URL">https://doi.org/10.1016/j.redox.2019.101190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2019.101190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2019.101190%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3DS-nitrosothiols%252Band%252BH2S%252Bdonors%25253A%252BPotential%252Bchemo-therapeutic%252Bagents%252Bin%252Bcancer%26aulast%3DReis%26aufirst%3DAdriana%2BKarla%2BCardoso%2BAmorim%26date%3D2019%26volume%3D27%26spage%3D101190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sana  Waheed</span>, <span class="hlFld-ContribAuthor ">Robert YS  Cheng</span>, <span class="hlFld-ContribAuthor ">Yovanni  Casablanca</span>, <span class="hlFld-ContribAuthor ">G. Larry  Maxwell</span>, <span class="hlFld-ContribAuthor ">David A  Wink</span>, <span class="hlFld-ContribAuthor ">Viqar  Syed</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (20)
                                     , 3722. <a href="https://doi.org/10.3390/molecules24203722" title="DOI URL">https://doi.org/10.3390/molecules24203722</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24203722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24203722%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNitric%252BOxide%252BDonor%252BDETA%25252FNO%252BInhibits%252Bthe%252BGrowth%252Bof%252BEndometrial%252BCancer%252BCells%252Bby%252BUpregulating%252Bthe%252BExpression%252Bof%252BRASSF1%252Band%252BCDKN1A%26aulast%3DWaheed%26aufirst%3DSana%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D20%26spage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Houman  Alimoradi</span>, <span class="hlFld-ContribAuthor ">Khaled  Greish</span>, <span class="hlFld-ContribAuthor ">Allan B.  Gamble</span>, <span class="hlFld-ContribAuthor ">Gregory I.  Giles</span>. </span><span class="cited-content_cbyCitation_article-title">Controlled Delivery of Nitric Oxide for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Nanotechnology</span><span> <strong>2019,</strong> <em>7 </em>
                                    (4)
                                     , 279-303. <a href="https://doi.org/10.2174/2211738507666190429111306" title="DOI URL">https://doi.org/10.2174/2211738507666190429111306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/2211738507666190429111306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F2211738507666190429111306%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Nanotechnology%26atitle%3DControlled%252BDelivery%252Bof%252BNitric%252BOxide%252Bfor%252BCancer%252BTherapy%26aulast%3DAlimoradi%26aufirst%3DHouman%26date%3D2019%26volume%3D7%26issue%3D4%26spage%3D279%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana  Ingold</span>, <span class="hlFld-ContribAuthor ">Lucía  Colella</span>, <span class="hlFld-ContribAuthor ">Paola  Hernández</span>, <span class="hlFld-ContribAuthor ">Carlos  Batthyány</span>, <span class="hlFld-ContribAuthor ">David  Tejedor</span>, <span class="hlFld-ContribAuthor ">Adrián  Puerta</span>, <span class="hlFld-ContribAuthor ">Fernando  García‐Tellado</span>, <span class="hlFld-ContribAuthor ">José M.  Padrón</span>, <span class="hlFld-ContribAuthor ">Williams  Porcal</span>, <span class="hlFld-ContribAuthor ">Gloria. V.  López</span>. </span><span class="cited-content_cbyCitation_article-title">A Focused Library of NO‐Donor Compounds with Potent Antiproliferative Activity Based on Green Multicomponent Reactions. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (18)
                                     , 1669-1683. <a href="https://doi.org/10.1002/cmdc.201900385" title="DOI URL">https://doi.org/10.1002/cmdc.201900385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900385%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BFocused%252BLibrary%252Bof%252BNO%2525E2%252580%252590Donor%252BCompounds%252Bwith%252BPotent%252BAntiproliferative%252BActivity%252BBased%252Bon%252BGreen%252BMulticomponent%252BReactions%26aulast%3DIngold%26aufirst%3DMariana%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D18%26spage%3D1669%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily  Hays</span>, <span class="hlFld-ContribAuthor ">Benjamin  Bonavida</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2019,</strong> <em>8 </em>
                                    (9)
                                     , 407. <a href="https://doi.org/10.3390/antiox8090407" title="DOI URL">https://doi.org/10.3390/antiox8090407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox8090407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox8090407%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DNitric%252BOxide-Mediated%252BEnhancement%252Band%252BReversal%252Bof%252BResistance%252Bof%252BAnticancer%252BTherapies%26aulast%3DHays%26aufirst%3DEmily%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D9%26spage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Parisi</span>, <span class="hlFld-ContribAuthor ">Mariacristina  Failla</span>, <span class="hlFld-ContribAuthor ">Aurore  Fraix</span>, <span class="hlFld-ContribAuthor ">Barbara  Rolando</span>, <span class="hlFld-ContribAuthor ">Eleonora  Gianquinto</span>, <span class="hlFld-ContribAuthor ">Francesca  Spyrakis</span>, <span class="hlFld-ContribAuthor ">Elena  Gazzano</span>, <span class="hlFld-ContribAuthor ">Chiara  Riganti</span>, <span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, <span class="hlFld-ContribAuthor ">Alberto  Gasco</span>, <span class="hlFld-ContribAuthor ">Salvatore  Sortino</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (47)
                                     , 11080-11084. <a href="https://doi.org/10.1002/chem.201902062" title="DOI URL">https://doi.org/10.1002/chem.201902062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201902062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201902062%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFluorescent%252BNitric%252BOxide%252BPhotodonors%252BBased%252Bon%252BBODIPY%252Band%252BRhodamine%252BAntennae%26aulast%3DParisi%26aufirst%3DCristina%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D47%26spage%3D11080%26epage%3D11084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai  Li</span>, <span class="hlFld-ContribAuthor ">Rongrong  Liao</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Sheng</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Luo</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Wen</span>, <span class="hlFld-ContribAuthor ">Jin  Zhou</span>, <span class="hlFld-ContribAuthor ">Kang  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen Gas in Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2019,</strong> <em>9 </em><a href="https://doi.org/10.3389/fonc.2019.00696" title="DOI URL">https://doi.org/10.3389/fonc.2019.00696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2019.00696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2019.00696%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DHydrogen%252BGas%252Bin%252BCancer%252BTreatment%26aulast%3DLi%26aufirst%3DSai%26date%3D2019%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugo P.  Monteiro</span>, <span class="hlFld-ContribAuthor ">Elaine G.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Adriana K.C.  Amorim Reis</span>, <span class="hlFld-ContribAuthor ">Luiz S.  Longo</span>, <span class="hlFld-ContribAuthor ">Fernando T.  Ogata</span>, <span class="hlFld-ContribAuthor ">Ana I.S.  Moretti</span>, <span class="hlFld-ContribAuthor ">Paulo E.  da Costa</span>, <span class="hlFld-ContribAuthor ">Ana C.S.  Teodoro</span>, <span class="hlFld-ContribAuthor ">Maytê S.  Toledo</span>, <span class="hlFld-ContribAuthor ">Arnold  Stern</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: A redox signaling perspective. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>89 </em>, 1-13. <a href="https://doi.org/10.1016/j.niox.2019.04.009" title="DOI URL">https://doi.org/10.1016/j.niox.2019.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2019.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2019.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DNitric%252Boxide%252Band%252Binteractions%252Bwith%252Breactive%252Boxygen%252Bspecies%252Bin%252Bthe%252Bdevelopment%252Bof%252Bmelanoma%25252C%252Bbreast%25252C%252Band%252Bcolon%252Bcancer%25253A%252BA%252Bredox%252Bsignaling%252Bperspective%26aulast%3DMonteiro%26aufirst%3DHugo%2BP.%26date%3D2019%26volume%3D89%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jon  PeÑarando</span>, <span class="hlFld-ContribAuthor ">Enrique  Aranda</span>, <span class="hlFld-ContribAuthor ">Antonio  RodrÍguez-Ariza</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says “NO” to antitumor immune response. </span><span class="cited-content_cbyCitation_journal-name">Translational Research</span><span> <strong>2019,</strong> <em>210 </em>, 99-108. <a href="https://doi.org/10.1016/j.trsl.2019.03.003" title="DOI URL">https://doi.org/10.1016/j.trsl.2019.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trsl.2019.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trsl.2019.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Research%26atitle%3DImmunomodulatory%252Broles%252Bof%252Bnitric%252Boxide%252Bin%252Bcancer%25253A%252Btumor%252Bmicroenvironment%252Bsays%252B%2525E2%252580%25259CNO%2525E2%252580%25259D%252Bto%252Bantitumor%252Bimmune%252Bresponse%26aulast%3DPe%25C3%2591arando%26aufirst%3DJon%26date%3D2019%26volume%3D210%26spage%3D99%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.6b01672&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01672%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-18%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=138&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Tumors’ response to different concentrations of NO, which provides a therapeutic opportunity for cancer. Tumors require an optimal concentration of NO for proliferation (safe zone). Very low intratumoral levels of NO inhibit tumor growth (inhibition zone), and very high levels of NO induce tumor cell death (kill zone).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of some important NO donors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mechanism underlying NO release by compound <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Anticancer drugs used in combination with NO donors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <i>O</i><sup>2</sup>-(Carbonyloxymethyl) diazeniumdiolates <b>4</b> and <b>5</b> and their metabolic pathway by esterase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Rational design of JS-K and its mechanism of NO release in the presence of GSH/GST.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of PABA/NO and JS-K analogues <b>6</b>–<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. DT-diaphorase promoted NO release from INDQ/NO and 2-Me INDQ/NO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Prodrugs with 1,6-elimination-based linker systems, where XH is masked as a trigger. (B, C) <i>O</i><sup>2</sup>-(<i>p</i>-Substituted benzyl) diazeniumdiolate <b>10</b> and BORO/NO are activatable by NTR and H<sub>2</sub>O<sub>2</sub>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of <i>O</i><sup><b>2</b></sup><b>-</b>β-galactosyl diazeniumdiolates (β-Gal-NONOate) as well as <i>O</i><sup>2</sup>-sialated- and <i>O</i><sup>2</sup>-β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>-acetylglucosaminyl diazeniumdiolates <b>11</b>–<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Hybrids from NO donor(s) and cytotoxic drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Enzyme inhibitors and their hybrids with NO donor(s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Natural products/derivatives and their hybrids with NO donor(s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Hybrids from NO donor(s) and MDR reversal agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/medium/jm-2016-01672h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Hybrids (<b>51</b>–<b>55</b>) from NO donor(s) and NSAIDs as well as NOSH-aspirin from NO/H<sub>2</sub>S donors and aspirin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-18/acs.jmedchem.6b01672/20170922/images/large/jm-2016-01672h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01672&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 159 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Palmer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrige, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxing Factor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1038/327524a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2F327524a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=3495737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaL2sXktlCjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=1987&pages=524-526&author=R.+M.+Palmerauthor=A.+G.+Ferrigeauthor=S.+Moncada&title=Nitric+Oxide+Release+Accounts+for+the+Biological+Activity+of+Endothelium-Derived+Relaxing+Factor&doi=10.1038%2F327524a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor</span></div><div class="casAuthors">Palmer, R. M. J.; Ferrige, A. G.; Moncada, S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">6122</span>),
    <span class="NLM_cas:pages">524-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The release of endothelium-derived relaxing factor (EDRF) and NO from porcine aortic endothelial cells in culture was examd.  NO was detd. as the chemiluminescent product of its reaction with ozone.  The biol. activity of EDRF and of NO was measured by bioassay.  The relaxation of the bioassay tissues induced by EDRF was indistinguishable from that induced by NO.  Both substances were equally unstable.  Bradykinin caused concn.-dependent release of NO from the cells in amts. sufficient to account for the biol. activity of EDRF.  The relaxations induced by EDRF and NO were inhibited by Hb and enhanced by superoxide dismutase to a similar degree.  Thus, NO released from endothelial cells is indistinguishable from EDRF in terms of biol. activity, stability, and susceptibility to an inhibitor and to a potentiator.  EDRF and NO are probably identical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv1cVPcdhBb7Vg90H21EOLACvtfcHk0lhXHDJ2adXRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktlCjs70%253D&md5=6afcb0594f86da2a398d0b6b792a2d75</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F327524a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F327524a0%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DR.%2BM.%26aulast%3DFerrige%26aufirst%3DA.%2BG.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DNitric%2520Oxide%2520Release%2520Accounts%2520for%2520the%2520Biological%2520Activity%2520of%2520Endothelium-Derived%2520Relaxing%2520Factor%26jtitle%3DNature%26date%3D1987%26volume%3D327%26spage%3D524%26epage%3D526%26doi%3D10.1038%2F327524a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ignarro, L. J.</span><span> </span><span class="NLM_article-title">Signal Transduction Mechanisms Involving Nitric Oxide</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span><span class="refDoi"> DOI: 10.1016/0006-2952(91)90618-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2F0006-2952%2891%2990618-F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1991&pages=485-490&author=L.+J.+Ignarro&title=Signal+Transduction+Mechanisms+Involving+Nitric+Oxide&doi=10.1016%2F0006-2952%2891%2990618-F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2891%2990618-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252891%252990618-F%26sid%3Dliteratum%253Aachs%26aulast%3DIgnarro%26aufirst%3DL.%2BJ.%26atitle%3DSignal%2520Transduction%2520Mechanisms%2520Involving%2520Nitric%2520Oxide%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1991%26volume%3D41%26spage%3D485%26epage%3D490%26doi%3D10.1016%2F0006-2952%2891%2990618-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ignarro, L. J.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Mediated Vasorelaxation</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=7694386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK3sXks1ylurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1993&pages=148-151&author=L.+J.+Ignarro&title=Nitric+Oxide-Mediated+Vasorelaxation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-mediated vasorelaxation</span></div><div class="casAuthors">Ignarro, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">148-51</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    </div><div class="casAbstract">A review, with 45 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZRloAH1S_7Vg90H21EOLACvtfcHk0lg54ku0a5CGWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1ylurY%253D&md5=10babfe7712ca5e9775d944a7a0ee4b3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIgnarro%26aufirst%3DL.%2BJ.%26atitle%3DNitric%2520Oxide-Mediated%2520Vasorelaxation%26jtitle%3DThromb.%2520Haemostasis%26date%3D1993%26volume%3D70%26spage%3D148%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Thomas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridnour, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isenberg, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores-Santana, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Switzer, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donzelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolocci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colton, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, D. A.</span><span> </span><span class="NLM_article-title">The Chemical Biology of Nitric Oxide: Implications in Cellular Signaling</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2008.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.freeradbiomed.2008.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18439435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2008&pages=18-31&author=D.+D.+Thomasauthor=L.+A.+Ridnourauthor=J.+S.+Isenbergauthor=W.+Flores-Santanaauthor=C.+H.+Switzerauthor=S.+Donzelliauthor=P.+Hussainauthor=C.+Vecoliauthor=N.+Paolocciauthor=S.+Ambsauthor=C.+A.+Coltonauthor=C.+C.+Harrisauthor=D.+D.+Robertsauthor=D.+A.+Wink&title=The+Chemical+Biology+of+Nitric+Oxide%3A+Implications+in+Cellular+Signaling&doi=10.1016%2Fj.freeradbiomed.2008.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The chemical biology of nitric oxide: Implications in cellular signaling</span></div><div class="casAuthors">Thomas, Douglas D.; Ridnour, Lisa A.; Isenberg, Jeffrey S.; Flores-Santana, Wilmarie; Switzer, Christopher H.; Donzelli, Sonia; Hussain, Perwez; Vecoli, Cecilia; Paolocci, Nazareno; Ambs, Stefan; Colton, Carol A.; Harris, Curtis C.; Roberts, David D.; Wink, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-31</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  NO has earned the reputation of being a signaling mediator with many diverse and often opposing biol. activities.  The diversity in response to this simple diat. mol. comes from the enormous variety of chem. reactions and biol. properties assocd. with it.  In the past few years, the importance of steady-state NO concns. has emerged as a key determinant of its biol. function.  Precise cellular responses are differentially regulated by specific NO concn.  The authors propose 5 basic distinct concn. levels of NO activity: cGMP-mediated processes ([NO] < 1-30 nM), Akt phosphorylation ([NO] = 30-100 nM), stabilization of HIF-1α ([NO] = 100-300 nM), phosphorylation of p53 ([NO] > 400 nM), and nitrosative stress (1 μM).  In general, lower NO concns. promote cell survival and proliferation, whereas higher levels favor cell cycle arrest, apoptosis, and senescence.  Free radical interactions will also influence NO signaling.  One of the consequences of reactive O species generation is to reduce NO concns.  This antagonizes the signaling of NO and in some cases results in converting a cell-cycle arrest profile to a cell survival profile.  The resulting reactive N species that are generated from these reactions can also have biol. effects and increase oxidative and nitrosative stress responses.  A no. of factors det. the formation of NO and its concn., such as diffusion, consumption, and substrate availability, which are referred to as kinetic determinants for mol. target interactions.  These are the chem. and biochem. parameters that shape cellular responses to NO.  Here, the authors discuss signal transduction and the biochem. of NO in terms of the direct and indirect reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBy1CNbcvHq7Vg90H21EOLACvtfcHk0ljnQjur24nbGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFaqt7w%253D&md5=927163ba426538f3e1733797f69621f6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2008.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2008.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%2BD.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DIsenberg%26aufirst%3DJ.%2BS.%26aulast%3DFlores-Santana%26aufirst%3DW.%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DDonzelli%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DP.%26aulast%3DVecoli%26aufirst%3DC.%26aulast%3DPaolocci%26aufirst%3DN.%26aulast%3DAmbs%26aufirst%3DS.%26aulast%3DColton%26aufirst%3DC.%2BA.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DRoberts%26aufirst%3DD.%2BD.%26aulast%3DWink%26aufirst%3DD.%2BA.%26atitle%3DThe%2520Chemical%2520Biology%2520of%2520Nitric%2520Oxide%253A%2520Implications%2520in%2520Cellular%2520Signaling%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2008%26volume%3D45%26spage%3D18%26epage%3D31%26doi%3D10.1016%2Fj.freeradbiomed.2008.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Basudhar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridnour, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesarwala, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinecke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, D. A.</span><span> </span><span class="NLM_article-title">Biological Signaling by Small Inorganic Molecules</span> <span class="citation_source-journal">Coord. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1016/j.ccr.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.ccr.2015.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26688591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaqs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2016&pages=708-723&author=D.+Basudharauthor=L.+A.+Ridnourauthor=R.+Chengauthor=A.+H.+Kesarwalaauthor=J.+Heineckeauthor=D.+A.+Wink&title=Biological+Signaling+by+Small+Inorganic+Molecules&doi=10.1016%2Fj.ccr.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Biological signaling by small inorganic molecules</span></div><div class="casAuthors">Basudhar, Debashree; Ridnour, Lisa A.; Cheng, Robert; Kesarwala, Aparna H.; Heinecke, Julie; Wink, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">Part_2</span>),
    <span class="NLM_cas:pages">708-723</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small redox active mols. such as reactive nitrogen and oxygen species and hydrogen sulfide have emerged as important biol. mediators that are involved in various physiol. and pathophysiol. processes.  Advancement in understanding of cellular mechanisms that tightly regulate both generation and reactivity of these mols. is central to improved management of various disease states including cancer and cardiovascular dysfunction.  Imbalance in the prodn. of redox active mols. can lead to damage of crit. cellular components such as cell membranes, proteins and DNA and thus may trigger the onset of disease.  These small inorg. mols. react independently as well as in a concerted manner to mediate physiol. responses.  This review provides a general overview of the redox biol. of these key mols., their diverse chem. relevant to physiol. processes and their interrelated nature in cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqlgyvo8_XM7Vg90H21EOLACvtfcHk0ljnQjur24nbGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaqs7rP&md5=a2797cbb9b2c833d8205da8bad20383c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBasudhar%26aufirst%3DD.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DCheng%26aufirst%3DR.%26aulast%3DKesarwala%26aufirst%3DA.%2BH.%26aulast%3DHeinecke%26aufirst%3DJ.%26aulast%3DWink%26aufirst%3DD.%2BA.%26atitle%3DBiological%2520Signaling%2520by%2520Small%2520Inorganic%2520Molecules%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2016%26volume%3D306%26spage%3D708%26epage%3D723%26doi%3D10.1016%2Fj.ccr.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Geller, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussler, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Silvio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowenstein, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiar, T. R.</span><span> </span><span class="NLM_article-title">Cytokines, Endotoxin, and Glucocorticoids Regulate the Expression of Inducible Nitric Oxide Synthase in Hepatocytes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span><span class="refDoi"> DOI: 10.1073/pnas.90.2.522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1073%2Fpnas.90.2.522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=7678458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK3sXnvFWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=522-526&author=D.+A.+Gellerauthor=A.+K.+Nusslerauthor=M.+Di+Silvioauthor=C.+J.+Lowensteinauthor=R.+A.+Shapiroauthor=S.+C.+Wangauthor=R.+L.+Simmonsauthor=T.+R.+Billiar&title=Cytokines%2C+Endotoxin%2C+and+Glucocorticoids+Regulate+the+Expression+of+Inducible+Nitric+Oxide+Synthase+in+Hepatocytes&doi=10.1073%2Fpnas.90.2.522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes</span></div><div class="casAuthors">Geller, David A.; Nussler, Andreas K.; Silvio, Mauricio Di; Lowenstein, Charles J.; Shapiro, Richard A.; Wang, Stewart C.; Simmons, Richard L.; Billiar, Timothy R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">522-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The authors measured the levels of rat hepatocyte nitric oxide synthase (NOS) mRNA by Northern blot anal. after stimulation by various combinations of endotoxin (lipopolysaccharide) and cytokines in vitro.  The mRNA for hepatocyte NOS appeared as a single band at ≈4.5 kilobases and was maximally up-regulated (≈70-fold) by the combination of tumor necrosis factor (TNF), interleukin-1 (IL-1), interferon-γ (IFN-γ), and lipopolysaccharide (LPS).  Abundance of NOS mRNA peaked 6-8 h after stimulation and then declined by 25% at 24 h.  As single agents, TNF and IL-1 were the most effective inducers of hepatocyte NOS mRNA.  Combinations of 2 or 3 stimuli revealed strong synergy between TNF, IL-1, and IFN-γ.  Dexamethasone and cycloheximide inhibited induction of mRNA for hepatocyte NOS in a dose-dependent fashion.  Induction of mRNA correlated with increased NOS activity.  The inducible hepatocyte NOS mRNA was also detected in rat hepatocytes following chronic hepatic inflammation triggered by Corynebacterium parvum injection in vivo.  Thus, the inducible NOS is functional in rat hepatocytes both in vitro and in vivo and this pathway is under complex control.  Endotoxin and inflammatory cytokines act synergistically to up-regulate gene expression for hepatocyte NOS, whereas glucocorticoids down-regulate the mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAmNgc7G9Wl7Vg90H21EOLACvtfcHk0lhsa3fx2PJOcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXnvFWisQ%253D%253D&md5=c3bd81106e709aa0c00cba7a1f8f0ce3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.2.522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.2.522%26sid%3Dliteratum%253Aachs%26aulast%3DGeller%26aufirst%3DD.%2BA.%26aulast%3DNussler%26aufirst%3DA.%2BK.%26aulast%3DDi%2BSilvio%26aufirst%3DM.%26aulast%3DLowenstein%26aufirst%3DC.%2BJ.%26aulast%3DShapiro%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BC.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26atitle%3DCytokines%252C%2520Endotoxin%252C%2520and%2520Glucocorticoids%2520Regulate%2520the%2520Expression%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520in%2520Hepatocytes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D522%26epage%3D526%26doi%3D10.1073%2Fpnas.90.2.522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pervin, S.; Singh, R.; Sen, S.; Chaudhuri, G.</span><span> </span><span class="NLM_article-title">Dual Role of Nitric Oxide in Cancer Biology</span> In  <span class="citation_source-book">Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy</span>; <span class="NLM_contrib-group">Bonavida, B.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-1-4419-1432-3_3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2F978-1-4419-1432-3_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=39-57&author=S.+Pervin&author=R.+Singh&author=S.+Sen&author=G.+Chaudhuriauthor=B.+Bonavida&title=Nitric+Oxide+%28NO%29+and+Cancer%3A+Prognosis%2C+Prevention%2C+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-1432-3_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-1432-3_3%26sid%3Dliteratum%253Aachs%26aulast%3DPervin%26aufirst%3DS.%26atitle%3DDual%2520Role%2520of%2520Nitric%2520Oxide%2520in%2520Cancer%2520Biology%26btitle%3DNitric%2520Oxide%2520%2528NO%2529%2520and%2520Cancer%253A%2520Prognosis%252C%2520Prevention%252C%2520and%2520Therapy%26aulast%3DBonavida%26aufirst%3DB.%26pub%3DSpringer%26date%3D2010%26spage%3D39%26epage%3D57%26doi%3D10.1007%2F978-1-4419-1432-3_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Knowles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Nitric-Oxide Synthases in Mammals</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1042/bj2980249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1042%2Fbj2980249" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=1994&pages=249-258&author=R.+G.+Knowlesauthor=S.+Moncada&title=Nitric-Oxide+Synthases+in+Mammals&doi=10.1042%2Fbj2980249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2Fbj2980249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2980249%26sid%3Dliteratum%253Aachs%26aulast%3DKnowles%26aufirst%3DR.%2BG.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DNitric-Oxide%2520Synthases%2520in%2520Mammals%26jtitle%3DBiochem.%2520J.%26date%3D1994%26volume%3D298%26spage%3D249%26epage%3D258%26doi%3D10.1042%2Fbj2980249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kiechle, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinski, T.</span><span> </span><span class="NLM_article-title">Nitric Oxide. Biochemistry, Pathophysiology, and Detection</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1093/ajcp/100.5.567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1093%2Fajcp%2F100.5.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=7504395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVWgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1993&pages=567-575&author=F.+L.+Kiechleauthor=T.+Malinski&title=Nitric+Oxide.+Biochemistry%2C+Pathophysiology%2C+and+Detection&doi=10.1093%2Fajcp%2F100.5.567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide: biochemistry, pathophysiology, and detection</span></div><div class="casAuthors">Kiechle, Frederick L.; Malinski, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">567-75</span>CODEN:
                <span class="NLM_cas:coden">AJCPAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">A review, with 92 refs., on nitric oxide synthase, mol. interactions of nitric oxide, pathophysiol., and measurements of nitric oxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaccbeCtVoTLVg90H21EOLACvtfcHk0lgTHG9QeVBSGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVWgtr8%253D&md5=e88dc4bc2e6c68c2eabcf326f3f56a0d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fajcp%2F100.5.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcp%252F100.5.567%26sid%3Dliteratum%253Aachs%26aulast%3DKiechle%26aufirst%3DF.%2BL.%26aulast%3DMalinski%26aufirst%3DT.%26atitle%3DNitric%2520Oxide.%2520Biochemistry%252C%2520Pathophysiology%252C%2520and%2520Detection%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D1993%26volume%3D100%26spage%3D567%26epage%3D575%26doi%3D10.1093%2Fajcp%2F100.5.567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Malinski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopp, M.</span><span> </span><span class="NLM_article-title">Nitric Oxide Measured by a Porphyrinic Microsensor in Rat Brain after Transient Middle Cerebral Artery Occlusion</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1038/jcbfm.1993.48</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fjcbfm.1993.48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=8478395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFakt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=355-358&author=T.+Malinskiauthor=F.+Baileyauthor=Z.+G.+Zhangauthor=M.+Chopp&title=Nitric+Oxide+Measured+by+a+Porphyrinic+Microsensor+in+Rat+Brain+after+Transient+Middle+Cerebral+Artery+Occlusion&doi=10.1038%2Fjcbfm.1993.48"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion</span></div><div class="casAuthors">Malinski, T.; Bailey, F.; Zhang, Z. G.; Chopp, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-8</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">The authors measured, in vivo, the local concn. of nitric oxide (NO) in cerebral tissue, during and after transient middle cerebral artery occlusion in the rat (n = 8).  Baseline concn. of NO was <10-8 M; upon initiation of ischemia, NO concn. increased to ∼10-6 M and then declined.  Reperfusion likewise stimulated an increase in NO concn. to above baseline level.  Administration of N-nitro-L-arginine Me ester (n = 4), an inhibitor of nitric oxide synthase, before onset of ischemia, maintained NO at basal levels.  Data indicate that large increases in NO occur at onset of ischemia, which may affect tissue response to an ischemic insult.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkd5Mpn0yeyrVg90H21EOLACvtfcHk0lgpZ5BCf9T9Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFakt7g%253D&md5=f367fb921e1cba0c48334a2dd5d11376</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1993.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1993.48%26sid%3Dliteratum%253Aachs%26aulast%3DMalinski%26aufirst%3DT.%26aulast%3DBailey%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.%2BG.%26aulast%3DChopp%26aufirst%3DM.%26atitle%3DNitric%2520Oxide%2520Measured%2520by%2520a%2520Porphyrinic%2520Microsensor%2520in%2520Rat%2520Brain%2520after%2520Transient%2520Middle%2520Cerebral%2520Artery%2520Occlusion%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1993%26volume%3D13%26spage%3D355%26epage%3D358%26doi%3D10.1038%2Fjcbfm.1993.48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hanafy, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumenacker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murad, F.</span><span> </span><span class="NLM_article-title">NO, Nitrotyrosine, and Cyclic GMP in Signal Transduction</span> <span class="citation_source-journal">Med. Sci. Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11433215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Ojs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=801-819&author=K.+A.+Hanafyauthor=J.+S.+Krumenackerauthor=F.+Murad&title=NO%2C+Nitrotyrosine%2C+and+Cyclic+GMP+in+Signal+Transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">NO, nitrotyrosine, and cyclic GMP in signal transduction</span></div><div class="casAuthors">Hanafy, Khalid A.; Krumenacker, Joshua S.; Murad, Ferid</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">801-819</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1234-1010</span>.
    
            (<span class="NLM_cas:orgname">Medical Science International Publishing</span>)
        </div><div class="casAbstract">A review, with 203 refs.  Over the past 25 yr, the role of NO in biol. has evolved from being recognized as an environmental pollutant to an endogenously produced substance involved in cell communication and signal transduction.  NO is produced by a family of enzymes called nitric oxide synthases (NOSs), which can be stimulated by a variety of factors that mediate responses to various stimuli.  NO can initiate its biol. effects through activation of the heterodimeric enzyme, sol. guanylyl cyclase, (sGC), or through several other chem. reactions.  Activation of sGC results in the prodn. of cGMP, an intracellular second messenger signaling mol., which can subsequently mediate such diverse physiol. events such as vasodilatation and immunomodulation.  Chem. reactive NO can affect physiol. changes through modifications to cellular proteins, 1 of which is tyrosine nitration.  The demonstration that NO is involved in so many biol. pathways indicates the importance of this endogenously produced substance, and suggests that there is much more to be discovered about its role in biol. in years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqolBurvoNi6LVg90H21EOLACvtfcHk0ljm-FAKKq2Y0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Ojs78%253D&md5=866c48818cc042f2a03c0a5c9504eb9f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanafy%26aufirst%3DK.%2BA.%26aulast%3DKrumenacker%26aufirst%3DJ.%2BS.%26aulast%3DMurad%26aufirst%3DF.%26atitle%3DNO%252C%2520Nitrotyrosine%252C%2520and%2520Cyclic%2520GMP%2520in%2520Signal%2520Transduction%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2001%26volume%3D7%26spage%3D801%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Beckman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppenol, W. H.</span><span> </span><span class="NLM_article-title">Nitric Oxide, Superoxide, and Peroxynitrite: the Good, the Bad, and Ugly</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">C1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">C1437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1152%2Fajpcell.1996.271.5.C1424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=8944624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK28XntFymtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=C1424-C1437&author=J.+S.+Beckmanauthor=W.+H.+Koppenol&title=Nitric+Oxide%2C+Superoxide%2C+and+Peroxynitrite%3A+the+Good%2C+the+Bad%2C+and+Ugly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly</span></div><div class="casAuthors">Beckman, Joseph S.; Koppenol, Willem H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">5, Pt. 1</span>),
    <span class="NLM_cas:pages">C1424-C1437</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 109 refs., exploring why nitric oxide itself is far less reactive and toxic at baiol. relevant concns. than in vitro expts. suggest.  Nitric oxide contrasts with most intercellular messengers because it diffuses rapidly and isotropically through most tissues with little reaction but cannot be transported through the vasculature due to rapid destruction by oxyHb.  The rapid diffusion of nitric oxide between cells allows it to locally integrate the responses of blood vessels to turbulence, modulate synaptic plasticity in neurons, and control the oscillatory behavior of neuronal networks.  Nitric oxide is not necessarily short lived and is intrinsically no more reactive than oxygen.  The reactivity of nitric oxide per se has been greatly overestimated in vitro, because no drain is provided to remove nitric oxide.  Nitric oxide persists in soln. for several minutes in micromolar concns. before it reacts with oxygen to form much stronger oxidants like nitrogen dioxide.  Nitric oxide is removed within seconds in vivo by diffusion over 100 μm through tissues to enter red blood cells and react with oxyHb.  The direct toxicity of nitric oxide is modest but is greatly enhanced by reacting with superoxide to form peroxynitrite (ONOO-).  Nitric oxide is the only biol. mol. produced in high enough concns. to out-compete superoxide dismutase for superoxide.  Peroxynitrite reacts relatively slowly with most biol. mols., making peroxynitrite a selective oxidant.  Peroxynitrite modifies tyrosine in proteins to create nitrotyrosines, leaving a footprint detectable in vivo.  Nitration of structural proteins, including neurofilaments and actin, can disrupt filament assembly with major pathol. consequences.  Antibodies to nitrotyrosine have revealed nitration in human atherosclerosis, myocardial ischemia, septic and distressed lung, inflammatory bowel disease, and amyotrophic lateral sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtUe3HiUtAkbVg90H21EOLACvtfcHk0ljm-FAKKq2Y0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFymtrc%253D&md5=67f1fee41f7c4c905911b0300fa24e80</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.1996.271.5.C1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.1996.271.5.C1424%26sid%3Dliteratum%253Aachs%26aulast%3DBeckman%26aufirst%3DJ.%2BS.%26aulast%3DKoppenol%26aufirst%3DW.%2BH.%26atitle%3DNitric%2520Oxide%252C%2520Superoxide%252C%2520and%2520Peroxynitrite%253A%2520the%2520Good%252C%2520the%2520Bad%252C%2520and%2520Ugly%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1996%26volume%3D271%26spage%3DC1424%26epage%3DC1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Martinez-Ruiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, S.</span><span> </span><span class="NLM_article-title">S-Nitrosylation: A Potential New Paradigm in Signal Transduction</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.cardiores.2004.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.cardiores.2004.01.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=43-52&author=A.+Martinez-Ruizauthor=S.+Lamas&title=S-Nitrosylation%3A+A+Potential+New+Paradigm+in+Signal+Transduction&doi=10.1016%2Fj.cardiores.2004.01.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2004.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2004.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Ruiz%26aufirst%3DA.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DS-Nitrosylation%253A%2520A%2520Potential%2520New%2520Paradigm%2520in%2520Signal%2520Transduction%26jtitle%3DCardiovasc.%2520Res.%26date%3D2004%26volume%3D62%26spage%3D43%26epage%3D52%26doi%3D10.1016%2Fj.cardiores.2004.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Heinrich, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Silva, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Switzer, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuto, J. M.</span><span> </span><span class="NLM_article-title">Biological Nitric Oxide Signalling: Chemistry and Terminology</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span><span class="refDoi"> DOI: 10.1111/bph.12217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fbph.12217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23617570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=1417-1429&author=T.+A.+Heinrichauthor=R.+S.+da+Silvaauthor=K.+M.+Mirandaauthor=C.+H.+Switzerauthor=D.+A.+Winkauthor=J.+M.+Fukuto&title=Biological+Nitric+Oxide+Signalling%3A+Chemistry+and+Terminology&doi=10.1111%2Fbph.12217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biological nitric oxide signalling: chemistry and terminology</span></div><div class="casAuthors">Heinrich, Tassiele A.; da Silva, Roberto S.; Miranda, Katrina M.; Switzer, Christopher H.; Wink, David A.; Fukuto, Jon M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-1429</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Biol. nitrogen oxide signalling and stress is an area of extreme clin., pharmacol., toxicol., biochem. and chem. research interest.  The utility of nitric oxide and derived species as signalling agents is due to their novel and vast chem. interactions with a variety of biol. targets.  Herein, the chem. assocd. with the interaction of the biol. relevant nitrogen oxide species with fundamental biochem. targets is discussed.  Specifically, the chem. interactions of nitrogen oxides with nucleophiles (e.g. thiols), metals (e.g. hemeproteins) and paramagnetic species (e.g. dioxygen and superoxide) are addressed.  Importantly, the terms assocd. with the mechanisms by which NO (and derived species) react with their resp. biol. targets have been defined by numerous past chem. studies.  Thus, in order to assist researchers in referring to chem. processes assocd. with nitrogen oxide biol., the vernacular assocd. with these chem. interactions is addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHPDeOsvoA6LVg90H21EOLACvtfcHk0ljm-FAKKq2Y0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOjsrfE&md5=2c32c0bf3320ded8e2e2f167badc7d28</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fbph.12217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12217%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%2BA.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BS.%26aulast%3DMiranda%26aufirst%3DK.%2BM.%26aulast%3DSwitzer%26aufirst%3DC.%2BH.%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DFukuto%26aufirst%3DJ.%2BM.%26atitle%3DBiological%2520Nitric%2520Oxide%2520Signalling%253A%2520Chemistry%2520and%2520Terminology%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26spage%3D1417%26epage%3D1429%26doi%3D10.1111%2Fbph.12217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khineche, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta-Yepez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garban, H.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Nitric Oxide in Cancer</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.drup.2006.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.drup.2006.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16822706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslOguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=157-173&author=B.+Bonavidaauthor=S.+Khinecheauthor=S.+Huerta-Yepezauthor=H.+Garban&title=Therapeutic+Potential+of+Nitric+Oxide+in+Cancer&doi=10.1016%2Fj.drup.2006.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of nitric oxide in cancer</span></div><div class="casAuthors">Bonavida, Benjamin; Khineche, Soraya; Huerta-Yepez, Sara; Garban, Hermes</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-173</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, several novel approaches have been developed to overcome tumor cell resistance to conventional therapeutics.  Such approaches include genetic manipulations, vaccine development and exploitation of the anti-tumor host immune response.  The overall development of tumor cell resistance to therapeutics is, in large part, the result of the ability of tumor cells to develop specific mechanisms to overcome cell death or apoptosis.  Therefore, the possibility to interfere selectively in the regulation of the apoptotic signaling pathways may result in either the direct induction of cell death and/or sensitization of the cells to cytotoxic stimuli.  A novel approach based on modifying gene products that regulate resistance to apoptosis involves nitric oxide (NO).  NO is a ubiquitous mol. with diverse cellular effects that depend on the source, concn., latency, cell type and phenotype.  This review describes the role played by NO in cancer including carcinogenesis, pathogenesis, angiogenesis, chemoprevention and as a novel therapeutic to overcome resistance when used alone or as a sensitizing agent used in combination with other therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw6H3vMI8M27Vg90H21EOLACvtfcHk0lhFmh6pdeNh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslOguro%253D&md5=e2cfbf3f70666bcad40502e8beb200c7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2006.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2006.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DKhineche%26aufirst%3DS.%26aulast%3DHuerta-Yepez%26aufirst%3DS.%26aulast%3DGarban%26aufirst%3DH.%26atitle%3DTherapeutic%2520Potential%2520of%2520Nitric%2520Oxide%2520in%2520Cancer%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2006%26volume%3D9%26spage%3D157%26epage%3D173%26doi%3D10.1016%2Fj.drup.2006.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bonavida, B.; Baritaki, S.; Huerta-Yepez, S.; Vega, M. I.; Jazirehi, A. R.; Berenson, J.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors Are a New Class of Anti-Cancer Therapeutics for the Reversal of Resistance and Inhibition of Metastasis</span> In  <span class="citation_source-book">Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy</span>; <span class="NLM_contrib-group">Bonavida, B.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-1-4419-1432-3_24</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2F978-1-4419-1432-3_24" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=459-477&author=B.+Bonavida&author=S.+Baritaki&author=S.+Huerta-Yepez&author=M.+I.+Vega&author=A.+R.+Jazirehi&author=J.+Berensonauthor=B.+Bonavida&title=Nitric+Oxide+%28NO%29+and+Cancer%3A+Prognosis%2C+Prevention%2C+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-1432-3_24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-1432-3_24%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520Oxide%2520Donors%2520Are%2520a%2520New%2520Class%2520of%2520Anti-Cancer%2520Therapeutics%2520for%2520the%2520Reversal%2520of%2520Resistance%2520and%2520Inhibition%2520of%2520Metastasis%26btitle%3DNitric%2520Oxide%2520%2528NO%2529%2520and%2520Cancer%253A%2520Prognosis%252C%2520Prevention%252C%2520and%2520Therapy%26aulast%3DBonavida%26aufirst%3DB.%26pub%3DSpringer%26date%3D2010%26spage%3D459%26epage%3D477%26doi%3D10.1007%2F978-1-4419-1432-3_24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Alexandrova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mileva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvetkova, E.</span><span> </span><span class="NLM_article-title">Nitric Oxide and Cancer (Minirevew)</span> <span class="citation_source-journal">Exp. Pathol. Parasitol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=13-18&author=R.+Alexandrovaauthor=M.+Milevaauthor=E.+Zvetkova&title=Nitric+Oxide+and+Cancer+%28Minirevew%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and cancer</span></div><div class="casAuthors">Alexandrova, R.; Mileva, M.; Zvetkova, E.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Pathology and Parasitology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">13-18</span>CODEN:
                <span class="NLM_cas:coden">EPPXAN</span>;
        ISSN:<span class="NLM_cas:issn">1311-6851</span>.
    
            (<span class="NLM_cas:orgname">Akademichno Izdatelstvo "Prof. Marin Drinov"</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO), a potent biol. mediator, plays a key role in physiol. as well as pathol. processes.  An area of great interest is the role of nitric oxide in the growth and metastasis of solid tumors, where it seems to have a complex action including both inhibitory and tumor-promoting activities.  Modification of nitric oxide synthetase (NOS) activity in tumors, and hence NO biosynthesis, may be regarded as a promising means for selective tumor blood flow modification providing a novel approach for reducing tumor oxygenation aimed at enhancing the efficiency of hypoxia-mediated, bioreductively activated anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCe38FC4OrtLVg90H21EOLACvtfcHk0lhFmh6pdeNh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVSgu78%253D&md5=9cad6d2a9f779e31096d40ad876bdb35</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandrova%26aufirst%3DR.%26aulast%3DMileva%26aufirst%3DM.%26aulast%3DZvetkova%26aufirst%3DE.%26atitle%3DNitric%2520Oxide%2520and%2520Cancer%2520%2528Minirevew%2529%26jtitle%3DExp.%2520Pathol.%2520Parasitol%26date%3D2001%26volume%3D4%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fukumura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">The Role of Nitric Oxide in Tumour Progression</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span><span class="refDoi"> DOI: 10.1038/nrc1910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fnrc1910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16794635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=521-534&author=D.+Fukumuraauthor=S.+Kashiwagiauthor=R.+K.+Jain&title=The+Role+of+Nitric+Oxide+in+Tumour+Progression&doi=10.1038%2Fnrc1910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nitric oxide in tumour progression</span></div><div class="casAuthors">Fukumura, Dai; Kashiwagi, Satoshi; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">521-534</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) and nitric oxide synthases are ubiquitous in malignant tumors and are known to exert both pro- and anti-tumor effects.  We summarize our current understanding of the role of NO in tumor progression, esp. in relation to angiogenesis and vascular functions.  We also discuss potential strategies for cancer treatment that modulate NO prodn. and/or its downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorTlzSMm-9dbVg90H21EOLACvtfcHk0lj49kJbavri8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D&md5=ee546d1b8e37e216ef373374ba15209c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrc1910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1910%26sid%3Dliteratum%253Aachs%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DKashiwagi%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DThe%2520Role%2520of%2520Nitric%2520Oxide%2520in%2520Tumour%2520Progression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D521%26epage%3D534%26doi%3D10.1038%2Fnrc1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wink, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodovotz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deluca, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">The Role of Nitric Oxide Chemistry in Cancer Treatment</span> <span class="citation_source-journal">Biochemistry (Moscow)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=9721332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Cnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=802-809&author=D.+A.+Winkauthor=Y.+Vodovotzauthor=J.+A.+Cookauthor=M.+C.+Krishnaauthor=S.+Kimauthor=D.+Coffinauthor=W.+DeGraffauthor=A.+M.+Delucaauthor=J.+Liebmannauthor=J.+B.+Mitchell&title=The+Role+of+Nitric+Oxide+Chemistry+in+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nitric oxide chemistry in cancer treatment</span></div><div class="casAuthors">Wink, D. A.; Vodovotz, Y.; Cook, J. A.; Krishna, M. C.; Kim, S.; Coffin, D.; DeGraff, W.; Deluca, A. M.; Liebmann, J.; Mitchell, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry (Moscow)(Translation of Biokhimiya (Moscow))</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">802-809</span>CODEN:
                <span class="NLM_cas:coden">BIORAK</span>;
        ISSN:<span class="NLM_cas:issn">0006-2979</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">Over the last decade the role of nitric oxide (NO) in various disease states has become apparent.  In cancer, NO plays a variety of roles which are at times contradictory.  On one hand, NO is involved in different etiol. mechanisms as well as promoting tumor growth.  Yet, NO derived from leukocytes plays a seminal role in their tumoricidal activity.  In cancer treatment, NO also has diverse effects.  Whereas in vitro, NO can enhance the cytotoxic efficacy of some chemotherapeutic agents as well as radiation, NO donors can provide whole body protection against these same agents.  This manuscript will discuss some mechanisms involved with NO and cancer treatment modalities and the potential application of these findings to cancer therapy.  This article is reviewed by 65 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18igQCe3OrrVg90H21EOLACvtfcHk0lj49kJbavri8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Cnurs%253D&md5=8d039eea3d6f02b23e82e1177c645c16</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DVodovotz%26aufirst%3DY.%26aulast%3DCook%26aufirst%3DJ.%2BA.%26aulast%3DKrishna%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DCoffin%26aufirst%3DD.%26aulast%3DDeGraff%26aufirst%3DW.%26aulast%3DDeluca%26aufirst%3DA.%2BM.%26aulast%3DLiebmann%26aufirst%3DJ.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520Role%2520of%2520Nitric%2520Oxide%2520Chemistry%2520in%2520Cancer%2520Treatment%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26date%3D1998%26volume%3D63%26spage%3D802%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Forrester, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupold, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapust, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillare, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felley-Bosco, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geller, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiar, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Induced p53 Accumulation and Regulation of Inducible Nitric Oxide Synthase Expression by Wild-Type p53</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">2442</span><span class="NLM_x">–</span> <span class="NLM_lpage">2447</span><span class="refDoi"> DOI: 10.1073/pnas.93.6.2442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1073%2Fpnas.93.6.2442" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=2442-2447&author=K.+Forresterauthor=S.+Ambsauthor=S.+E.+Lupoldauthor=R.+B.+Kapustauthor=E.+A.+Spillareauthor=W.+C.+Weinbergauthor=E.+Felley-Boscoauthor=X.+W.+Wangauthor=D.+A.+Gellerauthor=E.+Tzengauthor=T.+R.+Billiarauthor=C.+C.+Harris&title=Nitric+Oxide-Induced+p53+Accumulation+and+Regulation+of+Inducible+Nitric+Oxide+Synthase+Expression+by+Wild-Type+p53&doi=10.1073%2Fpnas.93.6.2442"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.6.2442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.6.2442%26sid%3Dliteratum%253Aachs%26aulast%3DForrester%26aufirst%3DK.%26aulast%3DAmbs%26aufirst%3DS.%26aulast%3DLupold%26aufirst%3DS.%2BE.%26aulast%3DKapust%26aufirst%3DR.%2BB.%26aulast%3DSpillare%26aufirst%3DE.%2BA.%26aulast%3DWeinberg%26aufirst%3DW.%2BC.%26aulast%3DFelley-Bosco%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DX.%2BW.%26aulast%3DGeller%26aufirst%3DD.%2BA.%26aulast%3DTzeng%26aufirst%3DE.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26atitle%3DNitric%2520Oxide-Induced%2520p53%2520Accumulation%2520and%2520Regulation%2520of%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Expression%2520by%2520Wild-Type%2520p53%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D2442%26epage%3D2447%26doi%3D10.1073%2Fpnas.93.6.2442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Glockzin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Knethen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, B.</span><span> </span><span class="NLM_article-title">Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">19581</span><span class="NLM_x">–</span> <span class="NLM_lpage">19586</span><span class="refDoi"> DOI: 10.1074/jbc.274.28.19581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1074%2Fjbc.274.28.19581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10391892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1MXksFKmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=19581-19586&author=S.+Glockzinauthor=A.+von+Knethenauthor=M.+Scheffnerauthor=B.+Brune&title=Activation+of+the+Cell+Death+Program+by+Nitric+Oxide+Involves+Inhibition+of+the+Proteasome&doi=10.1074%2Fjbc.274.28.19581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the cell death program by nitric oxide involves inhibition of the proteasome</span></div><div class="casAuthors">Glockzin, Sandra; Von Knethen, Andreas; Scheffner, Martin; Brune, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">19581-19586</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The ubiquitin/proteasome pathway mediates the degrdn. of many short-lived proteins that are critically involved in the regulation of cell proliferation and cell death, including the tumor suppressor protein p53.  Accumulation of p53 and induction of apoptosis in RAW 264.7 macrophages in response to nitric oxide are well established.  However, the mol. mechanisms involved in nitric oxide-induced p53 accumulation are unknown.  Here we show that, similar to nitric oxide, treatment of macrophages with specific proteasome inhibitors, including clastolactacystin-β-lactone, induces p53 accumulation and apoptosis, suggesting that nitric oxide may affect the activity of the proteasome.  In support of this hypothesis, both exposure of cells to S-nitrosoglutathione and stimulation of endogenous nitric oxide prodn. by lipopolysaccharide/interferon-γ treatment result in inhibition of proteasome activity as measured in vitro by the degrdn. of the proteasome-specific substrate succinyl-Leu-Leu-Val-Tyr-4-methyl-coumarin-7-amide.  Moreover, chem. diverse nitric oxide donors interfere with proteasome-mediated degrdn. of polyubiquitinated p53 in vitro.  These data imply that nitric oxide-induced apoptosis and accumulation of p53 are, at least in part, mediated by inhibition of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj-iyl6E0VEbVg90H21EOLACvtfcHk0lg0hYU4o18zeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFKmtr0%253D&md5=ff981f62f6768ac01f4f9aed9fa56184</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.28.19581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.28.19581%26sid%3Dliteratum%253Aachs%26aulast%3DGlockzin%26aufirst%3DS.%26aulast%3Dvon%2BKnethen%26aufirst%3DA.%26aulast%3DScheffner%26aufirst%3DM.%26aulast%3DBrune%26aufirst%3DB.%26atitle%3DActivation%2520of%2520the%2520Cell%2520Death%2520Program%2520by%2520Nitric%2520Oxide%2520Involves%2520Inhibition%2520of%2520the%2520Proteasome%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D19581%26epage%3D19586%26doi%3D10.1074%2Fjbc.274.28.19581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Boyd, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadenas, E.</span><span> </span><span class="NLM_article-title">Nitric Oxide and Cell Signaling Pathways in Mitochondrial-Dependent Apoptosis</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1515/BC.2002.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1515%2FBC.2002.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2002&pages=411-423&author=C.+S.+Boydauthor=E.+Cadenas&title=Nitric+Oxide+and+Cell+Signaling+Pathways+in+Mitochondrial-Dependent+Apoptosis&doi=10.1515%2FBC.2002.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1515%2FBC.2002.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2002.045%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DC.%2BS.%26aulast%3DCadenas%26aufirst%3DE.%26atitle%3DNitric%2520Oxide%2520and%2520Cell%2520Signaling%2520Pathways%2520in%2520Mitochondrial-Dependent%2520Apoptosis%26jtitle%3DBiol.%2520Chem.%26date%3D2002%26volume%3D383%26spage%3D411%26epage%3D423%26doi%3D10.1515%2FBC.2002.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Li, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanigan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofseth, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wogan, G. N.</span><span> </span><span class="NLM_article-title">Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-Type or Mutant p53</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3022</span><span class="NLM_x">–</span> <span class="NLM_lpage">3029</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-1880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F0008-5472.CAN-03-1880" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3022-3029&author=C.+Q.+Liauthor=A.+I.+Roblesauthor=C.+L.+Haniganauthor=L.+J.+Hofsethauthor=L.+J.+Trudelauthor=C.+C.+Harrisauthor=G.+N.+Wogan&title=Apoptotic+Signaling+Pathways+Induced+by+Nitric+Oxide+in+Human+Lymphoblastoid+Cells+Expressing+Wild-Type+or+Mutant+p53&doi=10.1158%2F0008-5472.CAN-03-1880"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-1880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-1880%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BQ.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DHanigan%26aufirst%3DC.%2BL.%26aulast%3DHofseth%26aufirst%3DL.%2BJ.%26aulast%3DTrudel%26aufirst%3DL.%2BJ.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26aulast%3DWogan%26aufirst%3DG.%2BN.%26atitle%3DApoptotic%2520Signaling%2520Pathways%2520Induced%2520by%2520Nitric%2520Oxide%2520in%2520Human%2520Lymphoblastoid%2520Cells%2520Expressing%2520Wild-Type%2520or%2520Mutant%2520p53%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3022%26epage%3D3029%26doi%3D10.1158%2F0008-5472.CAN-03-1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lala, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, C.</span><span> </span><span class="NLM_article-title">Role of Nitric Oxide in Carcinogenesis and Tumour Progression</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1016/S1470-2045(00)00256-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS1470-2045%2800%2900256-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11902565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVymtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=149-156&author=P.+K.+Lalaauthor=C.+Chakraborty&title=Role+of+Nitric+Oxide+in+Carcinogenesis+and+Tumour+Progression&doi=10.1016%2FS1470-2045%2800%2900256-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Role of nitric oxide in carcinogenesis and tumour progression</span></div><div class="casAuthors">Lala, Peeyush K.; Chakraborty, Chandan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-156</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is a short-lived mol. required for many physiol. functions, produced from L-arginine by NO synthases (NOS).  It is a free radical, producing many reactive intermediates that account for its bioactivity.  Sustained induction of the inducible form of NOS (iNOS) in chronic inflammation may be mutagenic, through NO-mediated DNA damage or hindrance to DNA repair, and thus potentially carcinogenic.  Expression of iNOS is pos. assocd. with P53 mutation in tumors of the colon, lung, and oropharynx.  Progression of a large majority of human and exptl. tumors seems to be stimulated by NO resulting from activation of iNOS or constitutive NOS, whereas inhibition is documented in others.  This discrepancy is largely explained by differential sensitivity of tumor cells to NO-mediated cytostasis or apoptosis and clonal evolution of NO-resistant and NO-dependent cells.  P53 mutation or loss is one of many events linked with NO resistance and dependence.  NO can stimulate tumor growth and metastasis by promoting migratory, invasive, and angiogenic abilities of tumor cells, which may also be triggered by activation of cyclo-oxygenase (COX)-2.  Thus, selective inhibitors of NOS, COX, or both may have a therapeutic role in certain cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmbXiC9xpCQrVg90H21EOLACvtfcHk0lg0hYU4o18zeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVymtbc%253D&md5=41e1634ebe3047abb0c28e6e611351c7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2800%2900256-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252800%252900256-4%26sid%3Dliteratum%253Aachs%26aulast%3DLala%26aufirst%3DP.%2BK.%26aulast%3DChakraborty%26aufirst%3DC.%26atitle%3DRole%2520of%2520Nitric%2520Oxide%2520in%2520Carcinogenesis%2520and%2520Tumour%2520Progression%26jtitle%3DLancet%2520Oncol.%26date%3D2001%26volume%3D2%26spage%3D149%26epage%3D156%26doi%3D10.1016%2FS1470-2045%2800%2900256-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Schaer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschhorn-Cymerman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span> </span><span class="NLM_article-title">Targeting Tumor-Necrosis Factor Receptor Pathways for Tumor Immunotherapy</span> <span class="citation_source-journal">J. Immunother Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="refDoi"> DOI: 10.1186/2051-1426-2-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1186%2F2051-1426-2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24855562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvFagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=7&author=D.+A.+Schaerauthor=D.+Hirschhorn-Cymermanauthor=J.+D.+Wolchok&title=Targeting+Tumor-Necrosis+Factor+Receptor+Pathways+for+Tumor+Immunotherapy&doi=10.1186%2F2051-1426-2-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy</span></div><div class="casAuthors">Schaer David A; Hirschhorn-Cymerman Daniel; Wolchok Jedd D; Schaer David A; Wolchok Jedd D; Wolchok Jedd D; Wolchok Jedd D</div><div class="citationInfo"><span class="NLM_cas:title">Journal for immunotherapy of cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>
        ISSN:<span class="NLM_cas:issn">2051-1426</span>.
    </div><div class="casAbstract">With the success of ipilimumab and promise of programmed death-1 pathway-targeted agents, the field of tumor immunotherapy is expanding rapidly.  Newer targets for clinical development include select members of the tumor necrosis factor receptor (TNFR) family.  Agonist antibodies to these co-stimulatory molecules target both T and B cells, modulating T-cell activation and enhancing immune responses.  In vitro and in vivo preclinical data have provided the basis for continued development of 4-1BB, OX40, glucocorticoid-induced TNFR-related gene, herpes virus entry mediator, and CD27 as potential therapies for patients with cancer.  In this review, we summarize the immune response to tumors, consider preclinical and early clinical data on select TNFR family members, discuss potential translational challenges and suggest possible combination therapies with the aim of inducing durable antitumor responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9mMH7P4hI_5Pq5LRczm8ffW6udTcc2eYQJwvldZKz9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvFagtw%253D%253D&md5=62ae96d839cef7f86d060c844bd37975</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2F2051-1426-2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2051-1426-2-7%26sid%3Dliteratum%253Aachs%26aulast%3DSchaer%26aufirst%3DD.%2BA.%26aulast%3DHirschhorn-Cymerman%26aufirst%3DD.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26atitle%3DTargeting%2520Tumor-Necrosis%2520Factor%2520Receptor%2520Pathways%2520for%2520Tumor%2520Immunotherapy%26jtitle%3DJ.%2520Immunother%2520Cancer%26date%3D2014%26volume%3D2%26spage%3D7%26doi%3D10.1186%2F2051-1426-2-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pipili-Synetos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papageorgiou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakkoula, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karakiulakis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maragoudakis, M. E.</span><span> </span><span class="NLM_article-title">Inhibition of Angiogenesis, Tumour Growth and Metastasis by the NO-Releasing Vasodilators, Isosorbide Mononitrate and Dinitrate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb16670.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fj.1476-5381.1995.tb16670.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=8528567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK2MXosVaisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1995&pages=1829-1834&author=E.+Pipili-Synetosauthor=A.+Papageorgiouauthor=E.+Sakkoulaauthor=G.+Sotiropoulouauthor=T.+Fotsisauthor=G.+Karakiulakisauthor=M.+E.+Maragoudakis&title=Inhibition+of+Angiogenesis%2C+Tumour+Growth+and+Metastasis+by+the+NO-Releasing+Vasodilators%2C+Isosorbide+Mononitrate+and+Dinitrate&doi=10.1111%2Fj.1476-5381.1995.tb16670.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate</span></div><div class="casAuthors">Pipili-Synetos, Eva; Papageorgiou, A.; Sakkoula, Eleni; Sotiropoulou, Georgia; Fotsis, T.; Karakiulakis, G.; Maragoudakis, M. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1829-34</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The effect of the nitric oxide (NO)-producing nitro vasodilators isosorbide mononitrate (ISMN) and isosorbide dinitrate (ISDN) were assessed on (a) the in vivo model of angiogenesis of the chick chorioallantoic membrane (CAM) and (b) on the growth and metastatic properties of the Lewis Lung carcinoma (LLC) in mice.  Isosorbide 5-mononitrate (ISMN) and isosorbide dinitrate (ISDN) inhibited angiogenesis in the CAM dose-dependently.  ISMN was more potent in inhibiting this process.  Both compds. were capable of completely reversing the angiogenic effect of α-thrombin.  These effects of ISMN and ISDN on angiogenesis were comparable to those previously obsd. with sodium nitroprusside which generates NO nonenzymically.  Mice, implanted i.m. with LLC, received daily i.p. injections of ISMN for 14 days resulting in a significant decrease in the size of the primary tumor and a redn. in the no. and size of metastatic foci in the lungs.  ISDN had a similar but less pronounced effect than that obsd. with ISMN.  Addn. of ISMN or ISDN to cultures of bovine, rabbit and human endothelial cells and to cultures of LLC cells had no effect on their growth characteristics.  These results indicate that ISMN and ISDN inhibit angiogenesis and tumor growth and metastasis in an animal tumor model.  The possibility should therefore be considered that these nitro vasodilators which are widely used therapeutically and have well characterized pharmacol. profiles, may also possess antitumor properties in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjXi6RhNYZGrVg90H21EOLACvtfcHk0liHXOwP-OScmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosVaisbw%253D&md5=13c270f896c0fe31d8a536eaeccb3dac</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb16670.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb16670.x%26sid%3Dliteratum%253Aachs%26aulast%3DPipili-Synetos%26aufirst%3DE.%26aulast%3DPapageorgiou%26aufirst%3DA.%26aulast%3DSakkoula%26aufirst%3DE.%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DFotsis%26aufirst%3DT.%26aulast%3DKarakiulakis%26aufirst%3DG.%26aulast%3DMaragoudakis%26aufirst%3DM.%2BE.%26atitle%3DInhibition%2520of%2520Angiogenesis%252C%2520Tumour%2520Growth%2520and%2520Metastasis%2520by%2520the%2520NO-Releasing%2520Vasodilators%252C%2520Isosorbide%2520Mononitrate%2520and%2520Dinitrate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D116%26spage%3D1829%26epage%3D1834%26doi%3D10.1111%2Fj.1476-5381.1995.tb16670.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kroncke, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehsel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb-Bachofen, V.</span><span> </span><span class="NLM_article-title">Nitric Oxide: Cytotoxicity versus Cytoprotection--How, Why, When, and Where?</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1006/niox.1997.0118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1006%2Fniox.1997.0118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1997&pages=107-120&author=K.+D.+Kronckeauthor=K.+Fehselauthor=V.+Kolb-Bachofen&title=Nitric+Oxide%3A+Cytotoxicity+versus+Cytoprotection%2D%2DHow%2C+Why%2C+When%2C+and+Where%3F&doi=10.1006%2Fniox.1997.0118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1006%2Fniox.1997.0118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fniox.1997.0118%26sid%3Dliteratum%253Aachs%26aulast%3DKroncke%26aufirst%3DK.%2BD.%26aulast%3DFehsel%26aufirst%3DK.%26aulast%3DKolb-Bachofen%26aufirst%3DV.%26atitle%3DNitric%2520Oxide%253A%2520Cytotoxicity%2520versus%2520Cytoprotection--How%252C%2520Why%252C%2520When%252C%2520and%2520Where%253F%26jtitle%3DNitric%2520Oxide%26date%3D1997%26volume%3D1%26spage%3D107%26epage%3D120%26doi%3D10.1006%2Fniox.1997.0118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baritaki, S.</span><span> </span><span class="NLM_article-title">Dual Role of NO Donors in the Reversal of Tumor Cell Resistance and EMT: Downregulation of the NF-kappaB/Snail/YY1/RKIP Circuitry</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/j.niox.2010.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2010.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1-7&author=B.+Bonavidaauthor=S.+Baritaki&title=Dual+Role+of+NO+Donors+in+the+Reversal+of+Tumor+Cell+Resistance+and+EMT%3A+Downregulation+of+the+NF-kappaB%2FSnail%2FYY1%2FRKIP+Circuitry&doi=10.1016%2Fj.niox.2010.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2010.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2010.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DBaritaki%26aufirst%3DS.%26atitle%3DDual%2520Role%2520of%2520NO%2520Donors%2520in%2520the%2520Reversal%2520of%2520Tumor%2520Cell%2520Resistance%2520and%2520EMT%253A%2520Downregulation%2520of%2520the%2520NF-kappaB%252FSnail%252FYY1%252FRKIP%2520Circuitry%26jtitle%3DNitric%2520Oxide%26date%3D2011%26volume%3D24%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.niox.2010.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Huerta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors: Novel Cancer Therapeutics (Review)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span><span class="refDoi"> DOI: 10.3892/ijo_00000079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3892%2Fijo_00000079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18949354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaiu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=909-927&author=S.+Huertaauthor=S.+Chilkaauthor=B.+Bonavida&title=Nitric+Oxide+Donors%3A+Novel+Cancer+Therapeutics+%28Review%29&doi=10.3892%2Fijo_00000079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide donors: novel cancer therapeutics (review)</span></div><div class="casAuthors">Huerta, Sergio; Chilka, Sapna; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">909-927</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A review.  The development of cancer cell resistance to various cytotoxic stimuli continues to be a major challenge in oncol. and novel therapeutic approaches are urgently needed.  Nitric oxide (NO) is emerging as a potential anti-oncogenic agent to overcome tumor cell resistance to conventional therapeutic agents.  NO is a ubiquitous, water-sol., free radical gas that exerts a wide range of biol. effects.  The actions of nitric oxide are highly variable in oncol. with reports in the literature on both sides of the spectrum as an anti-neoplastic vs. a pro-neoplastic agent.  The final activity of NO in oncol. is dependent on its working microenvironment, including the type of cell exposed to the compd., the redox state of the reaction, as well as the final intracellular concn. and the duration of intracellular exposure to nitric oxide.  There is, however, no unifying mechanistic explanation for the biphasic role of nitric oxide in oncol.  Nitric oxide donors mimic continuous prodn. of NO in a wide range of time intervals (seconds to days).  Thus, multiple biol. and (pro- vs. anti-) neoplastic responses are elicited from NO donors depending on the half-life and the type of cell exposed to the compd.  The large variety of nitric oxide donors may serve as a tool to explore the wide range of oncol. properties of NO in cancer.  In the present report, we discuss classic nitric oxide donors and their potential therapeutic roles as cytotoxic agents or chemo-radio or -immune-sensitizing compds. in the treatment of drug-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMqnUJYvYinbVg90H21EOLACvtfcHk0ljEcUfCJVk-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaiu77F&md5=86082801f5789427802fed253ef0926b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3892%2Fijo_00000079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo_00000079%26sid%3Dliteratum%253Aachs%26aulast%3DHuerta%26aufirst%3DS.%26aulast%3DChilka%26aufirst%3DS.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520Oxide%2520Donors%253A%2520Novel%2520Cancer%2520Therapeutics%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2008%26volume%3D33%26spage%3D909%26epage%3D927%26doi%3D10.3892%2Fijo_00000079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span> </span><span class="NLM_article-title">The Implications of Hyponitroxia in Cancer</span> <span class="citation_source-journal">Transl. Oncol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.tranon.2014.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.tranon.2014.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24731473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2cnjsVanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=167-173&author=B.+Oronskyauthor=G.+R.+Fangerauthor=N.+Oronskyauthor=S.+Knoxauthor=J.+Scicinski&title=The+Implications+of+Hyponitroxia+in+Cancer&doi=10.1016%2Fj.tranon.2014.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The implications of hyponitroxia in cancer</span></div><div class="casAuthors">Oronsky Bryan; Fanger Gary R; Oronsky Neil; Knox Susan; Scicinski Jan</div><div class="citationInfo"><span class="NLM_cas:title">Translational oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumors are spatially heterogeneous, with regions of relative hypoxia and normoxia.  The tumor microenvironment is an important determinant of both tumor growth and response to a variety of cytotoxic and targeted therapies.  In the tumor microenvironment, reactive oxygen species and nitric oxide (NO) are important mediators of the level of expression of many transcription factors and signaling cascades that affect tumor growth and responses to therapy.  The primary objective of this review is to explore and discuss the seemingly dichotomous actions of NO in cancer biology as both a tumor promoter and suppressor with an emphasis on understanding the role of persistently low NO concentrations or hyponitroxia as a key mediator in tumor progression.  This review will also discuss the potential role of hyponitroxia as a novel therapeutic target to treat cancer and outline an approach that provides new opportunities for pharmacological intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxKrJmw2UWzPcsfMJQC1ZdfW6udTcc2eZZtMoRUcwKbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnjsVanuw%253D%253D&md5=caffba6e3afba83e514fb928db090005</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tranon.2014.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tranon.2014.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DFanger%26aufirst%3DG.%2BR.%26aulast%3DOronsky%26aufirst%3DN.%26aulast%3DKnox%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26atitle%3DThe%2520Implications%2520of%2520Hyponitroxia%2520in%2520Cancer%26jtitle%3DTransl.%2520Oncol%26date%3D2014%26volume%3D7%26spage%3D167%26epage%3D173%26doi%3D10.1016%2Fj.tranon.2014.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Abman, S. H.</span><span> </span><span class="NLM_article-title">Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1007/978-3-662-45805-1_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2F978-3-662-45805-1_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24092344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVOjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2013&pages=257-276&author=S.+H.+Abman&title=Inhaled+Nitric+Oxide+for+the+Treatment+of+Pulmonary+Arterial+Hypertension&doi=10.1007%2F978-3-662-45805-1_11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Abman, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">Pharmacotherapy of Pulmonary Hypertension</span>),
    <span class="NLM_cas:pages">257-276</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Following the recognition of nitric oxide (NO) as the "endothelium-derived relaxing factor," an explosion of lab. and clin. research led to the development of inhaled NO as a potential therapy for patients with pulmonary arterial hypertension (PAH).  Despite clear demonstration of its selective and potent pulmonary vasodilator properties, inhaled NO therapy has only been formally approved by the US Food and Drug Administration and European Medicine Evaluation Agency for clin. use in the treatment of term and near-term infants with severe persistent pulmonary hypertension of the newborn (PPHN) with acute hypoxemic respiratory failure.  Over the past decades, inhaled NO remains the central therapy for PPHN and is commonly used for acute pulmonary vasoreactivity testing during right heart catheterization and for treating pediatric and adult patients with PAH assocd. with postoperative cardiac surgery, severe respiratory failure, pulmonary hypertension crises, and other disorders.  This review will describe the current use of inhaled NO in clin. practice and briefly discuss its potential role for the treatment of chronic PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvZeLrmtGYarVg90H21EOLACvtfcHk0ljEcUfCJVk-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVOjtLY%253D&md5=62ca78771a6e1d36ed03943409e716db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F978-3-662-45805-1_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-662-45805-1_11%26sid%3Dliteratum%253Aachs%26aulast%3DAbman%26aufirst%3DS.%2BH.%26atitle%3DInhaled%2520Nitric%2520Oxide%2520for%2520the%2520Treatment%2520of%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D218%26spage%3D257%26epage%3D276%26doi%3D10.1007%2F978-3-662-45805-1_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mironov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mironov, A. A.</span><span> </span><span class="NLM_article-title">Clinical Features of Nonclostridium Anaerobic Infection in the Pathology of E.N.T. Organs</span> <span class="citation_source-journal">Vestn. Otorinolaringol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=2048254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADyaK3M3mtleisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=49-51&author=A.+Mironovauthor=A.+A.+Mironov&title=Clinical+Features+of+Nonclostridium+Anaerobic+Infection+in+the+Pathology+of+E.N.T.+Organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features of nonclostridium anaerobic infection in the pathology of E.N.T. organs</span></div><div class="casAuthors">Mironov A Iu; Mironov A A</div><div class="citationInfo"><span class="NLM_cas:title">Vestnik otorinolaringologii</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">49-51</span>
        ISSN:<span class="NLM_cas:issn">0042-4668</span>.
    </div><div class="casAbstract">The study of clinical features of nonclostridial anaerobic infection in 80 patients with purulent and inflammatory pathologies of ENT-organs (purulent sinusitis, purulent otitis media, paratonsillar abscesses) showed them to be as follows: prolonged, slow and often subclinical development of the disease; disseminated necrotic changes of tissues; disagreement between the level of clinical symptoms and destructive changes (prevalence of destructive changes over clinical symptoms); phenomenon of false anesthesia; existence of crumbs-like pus with a strong bad smell sometimes filled with air bubbles; limited bleeding from cut tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcQinY0YQcD75oR8RchjrrfW6udTcc2ebSeresUPVs7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3mtleisA%253D%253D&md5=242aed016359675d1f5a26966e1fb74d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMironov%26aufirst%3DA.%26aulast%3DMironov%26aufirst%3DA.%2BA.%26atitle%3DClinical%2520Features%2520of%2520Nonclostridium%2520Anaerobic%2520Infection%2520in%2520the%2520Pathology%2520of%2520E.N.T.%2520Organs%26jtitle%3DVestn.%2520Otorinolaringol.%26date%3D1991%26spage%3D49%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamler, J. S.</span><span> </span><span class="NLM_article-title">An Essential Role for Mitochondrial Aldehyde Dehydrogenase in Nitroglycerin Bioactivation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12159</span><span class="NLM_x">–</span> <span class="NLM_lpage">12164</span><span class="refDoi"> DOI: 10.1073/pnas.0503723102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1073%2Fpnas.0503723102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12159-12164&author=Z.+Chenauthor=M.+W.+Fosterauthor=J.+Zhangauthor=L.+Maoauthor=H.+A.+Rockmanauthor=T.+Kawamotoauthor=K.+Kitagawaauthor=K.+I.+Nakayamaauthor=D.+T.+Hessauthor=J.+S.+Stamler&title=An+Essential+Role+for+Mitochondrial+Aldehyde+Dehydrogenase+in+Nitroglycerin+Bioactivation&doi=10.1073%2Fpnas.0503723102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0503723102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0503723102%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFoster%26aufirst%3DM.%2BW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DKitagawa%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26aulast%3DHess%26aufirst%3DD.%2BT.%26aulast%3DStamler%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520Essential%2520Role%2520for%2520Mitochondrial%2520Aldehyde%2520Dehydrogenase%2520in%2520Nitroglycerin%2520Bioactivation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12159%26epage%3D12164%26doi%3D10.1073%2Fpnas.0503723102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Opelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eroglu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldeck-Weiermair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russwurm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koesling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassett, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrammel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, B.</span><span> </span><span class="NLM_article-title">Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is Necessary and Sufficient for Vascular Bioactivation of Nitroglycerin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">24076</span><span class="NLM_x">–</span> <span class="NLM_lpage">24084</span><span class="refDoi"> DOI: 10.1074/jbc.M116.752071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1074%2Fjbc.M116.752071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=24076-24084&author=M.+Opeltauthor=E.+Erogluauthor=M.+Waldeck-Weiermairauthor=M.+Russwurmauthor=D.+Koeslingauthor=R.+Malliauthor=W.+F.+Graierauthor=J.+T.+Fassettauthor=A.+Schrammelauthor=B.+Mayer&title=Formation+of+Nitric+Oxide+by+Aldehyde+Dehydrogenase-2+Is+Necessary+and+Sufficient+for+Vascular+Bioactivation+of+Nitroglycerin&doi=10.1074%2Fjbc.M116.752071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.752071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.752071%26sid%3Dliteratum%253Aachs%26aulast%3DOpelt%26aufirst%3DM.%26aulast%3DEroglu%26aufirst%3DE.%26aulast%3DWaldeck-Weiermair%26aufirst%3DM.%26aulast%3DRusswurm%26aufirst%3DM.%26aulast%3DKoesling%26aufirst%3DD.%26aulast%3DMalli%26aufirst%3DR.%26aulast%3DGraier%26aufirst%3DW.%2BF.%26aulast%3DFassett%26aufirst%3DJ.%2BT.%26aulast%3DSchrammel%26aufirst%3DA.%26aulast%3DMayer%26aufirst%3DB.%26atitle%3DFormation%2520of%2520Nitric%2520Oxide%2520by%2520Aldehyde%2520Dehydrogenase-2%2520Is%2520Necessary%2520and%2520Sufficient%2520for%2520Vascular%2520Bioactivation%2520of%2520Nitroglycerin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D24076%26epage%3D24084%26doi%3D10.1074%2Fjbc.M116.752071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wang, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janczuk, A. J.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors: Chemical Activities and Biological Applications</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span><span class="refDoi"> DOI: 10.1021/cr000040l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr000040l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=1091-1134&author=P.+G.+Wangauthor=M.+Xianauthor=X.+Tangauthor=X.+Wuauthor=Z.+Wenauthor=T.+Caiauthor=A.+J.+Janczuk&title=Nitric+Oxide+Donors%3A+Chemical+Activities+and+Biological+Applications&doi=10.1021%2Fcr000040l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Donors: Chemical Activities and Biological Applications</span></div><div class="casAuthors">Wang, Peng George; Xian, Ming; Tang, Xiaoping; Wu, Xuejun; Wen, Zhong; Cai, Tingwei; Janczuk, Adam J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1091-1134</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review that summarizes the syntheses, chem./enzymic mechanisms of NO release, biomedical applications, and current trends on the development of NO donor compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKMz2kGr2TM7Vg90H21EOLACvtfcHk0licifVUMqiSdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCqu78%253D&md5=92f50e5bf78c5244a217c0413e20b0cd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcr000040l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000040l%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%2BG.%26aulast%3DXian%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DJanczuk%26aufirst%3DA.%2BJ.%26atitle%3DNitric%2520Oxide%2520Donors%253A%2520Chemical%2520Activities%2520and%2520Biological%2520Applications%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D1091%26epage%3D1134%26doi%3D10.1021%2Fcr000040l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Miller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megson, I. L.</span><span> </span><span class="NLM_article-title">Recent Developments in Nitric Oxide Donor Drugs</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fsj.bjp.0707224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=17401442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslCqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2007&pages=305-321&author=M.+R.+Millerauthor=I.+L.+Megson&title=Recent+Developments+in+Nitric+Oxide+Donor+Drugs&doi=10.1038%2Fsj.bjp.0707224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in nitric oxide donor drugs</span></div><div class="casAuthors">Miller, M. R.; Megson, I. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-321</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial signalling mol., with wide-ranging functions in the cardiovascular, nervous and immune systems.  Aside from providing a credible explanation for the actions of org. nitrates and sodium nitroprusside that have long been used in the treatment of angina and hypertensive crises resp., the discovery generated great hopes for new NO-based treatments for a wide variety of ailments.  Decades later, however, we are still awaiting novel licensed agents in this arena, despite an enormous research effort to this end.  This review explores some of the most promising recent advances in NO donor drug development and addresses the challenges assocd. with NO as a therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUd52ordEe4rVg90H21EOLACvtfcHk0ljYWLXBDUun8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslCqtb0%253D&md5=72d55be79ab7ca606e82e8102e0aabcc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707224%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BR.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26atitle%3DRecent%2520Developments%2520in%2520Nitric%2520Oxide%2520Donor%2520Drugs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D151%26spage%3D305%26epage%3D321%26doi%3D10.1038%2Fsj.bjp.0707224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Yasuda, H.</span><span> </span><span class="NLM_article-title">Solid Tumor Physiology and Hypoxia-Induced Chemo/Radio-Resistance: Novel Strategy for Cancer Therapy: Nitric Oxide Donor as a Therapeutic Enhancer</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/j.niox.2008.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2008.04.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=205-216&author=H.+Yasuda&title=Solid+Tumor+Physiology+and+Hypoxia-Induced+Chemo%2FRadio-Resistance%3A+Novel+Strategy+for+Cancer+Therapy%3A+Nitric+Oxide+Donor+as+a+Therapeutic+Enhancer&doi=10.1016%2Fj.niox.2008.04.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2008.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2008.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DH.%26atitle%3DSolid%2520Tumor%2520Physiology%2520and%2520Hypoxia-Induced%2520Chemo%252FRadio-Resistance%253A%2520Novel%2520Strategy%2520for%2520Cancer%2520Therapy%253A%2520Nitric%2520Oxide%2520Donor%2520as%2520a%2520Therapeutic%2520Enhancer%26jtitle%3DNitric%2520Oxide%26date%3D2008%26volume%3D19%26spage%3D205%26epage%3D216%26doi%3D10.1016%2Fj.niox.2008.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sukhatme, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meheus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhatme, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantziarka, P.</span><span> </span><span class="NLM_article-title">Repurposing Drugs in Oncology (ReDO)-Nitroglycerin as an Anti-Cancer Agent</span> <span class="citation_source-journal">Ecancermedicalscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="refDoi"> DOI: 10.3332/ecancer.2015.568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3332%2Fecancer.2015.568" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=568&author=V.+Sukhatmeauthor=G.+Boucheauthor=L.+Meheusauthor=V.+P.+Sukhatmeauthor=P.+Pantziarka&title=Repurposing+Drugs+in+Oncology+%28ReDO%29-Nitroglycerin+as+an+Anti-Cancer+Agent&doi=10.3332%2Fecancer.2015.568"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3332%2Fecancer.2015.568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3332%252Fecancer.2015.568%26sid%3Dliteratum%253Aachs%26aulast%3DSukhatme%26aufirst%3DV.%26aulast%3DBouche%26aufirst%3DG.%26aulast%3DMeheus%26aufirst%3DL.%26aulast%3DSukhatme%26aufirst%3DV.%2BP.%26aulast%3DPantziarka%26aufirst%3DP.%26atitle%3DRepurposing%2520Drugs%2520in%2520Oncology%2520%2528ReDO%2529-Nitroglycerin%2520as%2520an%2520Anti-Cancer%2520Agent%26jtitle%3DEcancermedicalscience%26date%3D2015%26volume%3D9%26spage%3D568%26doi%3D10.3332%2Fecancer.2015.568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span> </span><span class="NLM_article-title">Novel Nitric Oxide Generating Compound Glycidyl Nitrate Enhances the Therapeutic Efficacy of Chemotherapy and Radiotherapy</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2014.04.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bbrc.2014.04.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2014&pages=537-542&author=S.+Ningauthor=M.+Bednarskiauthor=B.+Oronskyauthor=J.+Scicinskiauthor=S.+J.+Knox&title=Novel+Nitric+Oxide+Generating+Compound+Glycidyl+Nitrate+Enhances+the+Therapeutic+Efficacy+of+Chemotherapy+and+Radiotherapy&doi=10.1016%2Fj.bbrc.2014.04.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DS.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DNovel%2520Nitric%2520Oxide%2520Generating%2520Compound%2520Glycidyl%2520Nitrate%2520Enhances%2520the%2520Therapeutic%2520Efficacy%2520of%2520Chemotherapy%2520and%2520Radiotherapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D447%26spage%3D537%26epage%3D542%26doi%3D10.1016%2Fj.bbrc.2014.04.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Konter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abuo-Rahma, G. E.-D. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Emam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">Synthesis of Diazen-1-ium-1,2-diolates Monitored by the “NOtizer” Apparatus: Relationship between Formation Rates, Molecular Structure and the Release of Nitric Oxide</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1002/ejoc.200600662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fejoc.200600662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=616-624&author=J.+Konterauthor=G.+E.-D.+A.+A.+Abuo-Rahmaauthor=A.+El-Emamauthor=J.+Lehmann&title=Synthesis+of+Diazen-1-ium-1%2C2-diolates+Monitored+by+the+%E2%80%9CNOtizer%E2%80%9D+Apparatus%3A+Relationship+between+Formation+Rates%2C+Molecular+Structure+and+the+Release+of+Nitric+Oxide&doi=10.1002%2Fejoc.200600662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200600662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200600662%26sid%3Dliteratum%253Aachs%26aulast%3DKonter%26aufirst%3DJ.%26aulast%3DAbuo-Rahma%26aufirst%3DG.%2BE.-D.%2BA.%2BA.%26aulast%3DEl-Emam%26aufirst%3DA.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520Diazen-1-ium-1%252C2-diolates%2520Monitored%2520by%2520the%2520%25E2%2580%259CNOtizer%25E2%2580%259D%2520Apparatus%253A%2520Relationship%2520between%2520Formation%2520Rates%252C%2520Molecular%2520Structure%2520and%2520the%2520Release%2520of%2520Nitric%2520Oxide%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D616%26epage%3D624%26doi%3D10.1002%2Fejoc.200600662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hrabie, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Chemistry of the Nitric Oxide-Releasing Diazeniumdiolate ("Nitrosohydroxylamine") Functional Group and Its Oxygen-Substituted Derivatives</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1021/cr000028t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr000028t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=1135-1154&author=J.+A.+Hrabieauthor=L.+K.+Keefer&title=Chemistry+of+the+Nitric+Oxide-Releasing+Diazeniumdiolate+%28%22Nitrosohydroxylamine%22%29+Functional+Group+and+Its+Oxygen-Substituted+Derivatives&doi=10.1021%2Fcr000028t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fcr000028t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000028t%26sid%3Dliteratum%253Aachs%26aulast%3DHrabie%26aufirst%3DJ.%2BA.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DChemistry%2520of%2520the%2520Nitric%2520Oxide-Releasing%2520Diazeniumdiolate%2520%2528%2522Nitrosohydroxylamine%2522%2529%2520Functional%2520Group%2520and%2520Its%2520Oxygen-Substituted%2520Derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D1135%26epage%3D1154%26doi%3D10.1021%2Fcr000028t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1147</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span><span class="refDoi"> DOI: 10.1021/cb200274r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200274r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cqtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1147-1155&author=L.+K.+Keefer&title=Fifty+Years+of+Diazeniumdiolate+Research.+From+Laboratory+Curiosity+to+Broad-Spectrum+Biomedical+Advances&doi=10.1021%2Fcb200274r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances</span></div><div class="casAuthors">Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1147-1155</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A historical review.  Here I show that a "pure" research project, seemingly totally lacking in practical application when it was first published, can years later spark a whole new scientific field with the potential to revolutionize clin. practice.  A 1961 publication describing adducts of nitric oxide (NO) with certain nucleophiles attracted little notice at the time, but later work showing that the adducts could be hydrolyzed to regenerate the NO in bioactive form has provided the foundation for a host of biomedical applications.  Crucial to the discovery of widely used tools for studying NO's chem. biol. as well as for the design of a variety of promising therapeutic advances has been the increasingly detailed understanding of the physicochem. properties of these "diazeniumdiolates" (also known as NONOates).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-FydiOhE67Vg90H21EOLACvtfcHk0lgjFz5svKjiaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cqtb7K&md5=76d7360af80b21065daeaa6b4f0b4b8c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fcb200274r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200274r%26sid%3Dliteratum%253Aachs%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DFifty%2520Years%2520of%2520Diazeniumdiolate%2520Research.%2520From%2520Laboratory%2520Curiosity%2520to%2520Broad-Spectrum%2520Biomedical%2520Advances%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1147%26epage%3D1155%26doi%3D10.1021%2Fcb200274r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, D.</span><span> </span><span class="NLM_article-title">Sodium Nitroprusside (SNP) Sensitizes Human Gastric Cancer Cells to TRAIL-Induced Apoptosis</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.intimp.2013.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.intimp.2013.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23871247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=383-389&author=L.+Yangauthor=C.+Lanauthor=Y.+Fangauthor=Y.+Zhangauthor=J.+Wangauthor=J.+Guoauthor=S.+Wanauthor=S.+Yangauthor=R.+Wangauthor=D.+Fang&title=Sodium+Nitroprusside+%28SNP%29+Sensitizes+Human+Gastric+Cancer+Cells+to+TRAIL-Induced+Apoptosis&doi=10.1016%2Fj.intimp.2013.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium nitroprusside (SNP) sensitizes human gastric cancer cells to TRAIL-induced apoptosis</span></div><div class="casAuthors">Yang, Liuqin; Lan, Chunhui; Fang, Yu; Zhang, Yafei; Wang, Jun; Guo, Jun; Wan, Shunmei; Yang, Shiming; Wang, Rongquan; Fang, Dianchun</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-389</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To investigate the effects of the nitrous oxide (NO)-donor sodium nitroprusside (SNP) on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric cancer cells.  The MTT assay and flow cytometry were used to detect cellular proliferation and markers of apoptosis, resp.  Expression levels of caspases-8, and 9 were detd. by Western blot.  Changes in Nitric Oxide Synthase (NOS) activity, NO prodn., and caspase activation were also evaluated.  We found that TRAIL induced apoptosis and cell cycle arrest in human gastric cancer cell lines, and that this effect was mediated by NO prodn., and activation of both the extrinsic and intrinsic signaling pathways of apoptosis.  In addn., we found that the NO-donor SNP sensitizes gastric cancer cells to TRAIL-mediated apoptosis.  Treatment of cells with both TRAIL and SNP resulted in increased activation of caspase-8 and caspase-9 and NO release.  Inhibition of caspase-8 blocked cell TRAIL-induced apoptosis, while a selective caspase-9 inhibitor was unable to prevent apoptosis induced by either TRAIL or TRAIL plus SNP.  Inhibition of NOS could block the activation of caspase-9, but had no obvious effect on cell apoptosis.  SNP-sensitized gastric cancer cells to TRAIL-induced cytotoxicity by stimulating the release of NO, in turn facilitating the mitochondria-mediated signal transduction pathway.  The engagement of the mitochondria signaling pathways along with the TRAIL death receptor signaling pathway synergistically increase levels of apoptosis in these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmz3BORScZGLVg90H21EOLACvtfcHk0lgjFz5svKjiaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGrtb%252FN&md5=2d693f0bffcb051bae6bc41c0b2d465a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2013.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2013.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLan%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DD.%26atitle%3DSodium%2520Nitroprusside%2520%2528SNP%2529%2520Sensitizes%2520Human%2520Gastric%2520Cancer%2520Cells%2520to%2520TRAIL-Induced%2520Apoptosis%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2013%26volume%3D17%26spage%3D383%26epage%3D389%26doi%3D10.1016%2Fj.intimp.2013.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Pestana, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelippin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polizello, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorta, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uyemura, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tfouni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curti, C.</span><span> </span><span class="NLM_article-title">Effects on Mitochondria of Mitochondria-Induced Nitric Oxide Release from A Ruthenium Nitrosyl Complex</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.niox.2008.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2008.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=24-30&author=C.+R.+Pestanaauthor=D.+P.+Phelippinauthor=A.+C.+Polizelloauthor=D.+J.+Dortaauthor=S.+A.+Uyemuraauthor=A.+C.+Santosauthor=F.+G.+Doroauthor=F.+P.+Rodriguesauthor=E.+Tfouniauthor=C.+Curti&title=Effects+on+Mitochondria+of+Mitochondria-Induced+Nitric+Oxide+Release+from+A+Ruthenium+Nitrosyl+Complex&doi=10.1016%2Fj.niox.2008.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2008.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2008.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DPestana%26aufirst%3DC.%2BR.%26aulast%3DPhelippin%26aufirst%3DD.%2BP.%26aulast%3DPolizello%26aufirst%3DA.%2BC.%26aulast%3DDorta%26aufirst%3DD.%2BJ.%26aulast%3DUyemura%26aufirst%3DS.%2BA.%26aulast%3DSantos%26aufirst%3DA.%2BC.%26aulast%3DDoro%26aufirst%3DF.%2BG.%26aulast%3DRodrigues%26aufirst%3DF.%2BP.%26aulast%3DTfouni%26aufirst%3DE.%26aulast%3DCurti%26aufirst%3DC.%26atitle%3DEffects%2520on%2520Mitochondria%2520of%2520Mitochondria-Induced%2520Nitric%2520Oxide%2520Release%2520from%2520A%2520Ruthenium%2520Nitrosyl%2520Complex%26jtitle%3DNitric%2520Oxide%26date%3D2009%26volume%3D20%26spage%3D24%26epage%3D30%26doi%3D10.1016%2Fj.niox.2008.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Tfouni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truzzi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, D. W.</span><span> </span><span class="NLM_article-title">Biological Activity of Ruthenium Nitrosyl Complexes</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/j.niox.2011.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2011.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=22178685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=38-53&author=E.+Tfouniauthor=D.+R.+Truzziauthor=A.+Tavaresauthor=A.+J.+Gomesauthor=L.+E.+Figueiredoauthor=D.+W.+Franco&title=Biological+Activity+of+Ruthenium+Nitrosyl+Complexes&doi=10.1016%2Fj.niox.2011.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity of ruthenium nitrosyl complexes</span></div><div class="casAuthors">Tfouni, Elia; Truzzi, Daniela Ramos; Tavares, Aline; Gomes, Anderson Jesus; Figueiredo, Leonardo Elias; Franco, Douglas Wagner</div><div class="citationInfo"><span class="NLM_cas:title">Nitric Oxide</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-53</span>CODEN:
                <span class="NLM_cas:coden">NIOXF5</span>;
        ISSN:<span class="NLM_cas:issn">1089-8603</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide plays an important role in various biol. processes, such as neurotransmission, blood pressure control, immunol. responses, and antioxidant action.  The control of its local concn., which is crucial for obtaining the desired effect, can be achieved with exogenous NO-carriers.  Coordination compds., in particular ruthenium(III) and (II) amines, are good NO-captors and -deliverers.  The chem. and photochem. properties of several ruthenium amine complexes as NO-carriers in vitro and in vivo have been reviewed.  These nitrosyl complexes can stimulate mice hippocampus slices, promote the lowering of blood pressure in several in vitro and in vivo models, and control Trypanosoma cruzi and Leishmania major infections, and they are also effective against tumor cells in different models of cancer.  These complexes can be activated chem. or photochem., and the obsd. biol. effects can be attributed to the presence of NO in the compd.  Their efficiencies are explained on the basis of the [RuIINO+]3+/[RuIINO0]2+ redn. potential, the specific rate const. for NO liberation from the [RuNO]2+ moiety, and the quantum yield of NO release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh118z2McsV7Vg90H21EOLACvtfcHk0li9j6fydVp03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOisrg%253D&md5=d74d502aed5ef414e2d285c5cd870170</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2011.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2011.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DTfouni%26aufirst%3DE.%26aulast%3DTruzzi%26aufirst%3DD.%2BR.%26aulast%3DTavares%26aufirst%3DA.%26aulast%3DGomes%26aufirst%3DA.%2BJ.%26aulast%3DFigueiredo%26aufirst%3DL.%2BE.%26aulast%3DFranco%26aufirst%3DD.%2BW.%26atitle%3DBiological%2520Activity%2520of%2520Ruthenium%2520Nitrosyl%2520Complexes%26jtitle%3DNitric%2520Oxide%26date%3D2012%26volume%3D26%26spage%3D38%26epage%3D53%26doi%3D10.1016%2Fj.niox.2011.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Pauwels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boydens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanden Daele, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Voorde, J.</span><span> </span><span class="NLM_article-title">Ruthenium-Based Nitric Oxide-Donating and Carbon Monoxide-Donating Molecules</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1111/jphp.12511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fjphp.12511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26773555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=293-304&author=B.+Pauwelsauthor=C.+Boydensauthor=L.+Vanden+Daeleauthor=J.+Van+de+Voorde&title=Ruthenium-Based+Nitric+Oxide-Donating+and+Carbon+Monoxide-Donating+Molecules&doi=10.1111%2Fjphp.12511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules</span></div><div class="casAuthors">Pauwels, Bart; Boydens, Charlotte; Vanden Daele, Laura; Van de Voorde, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives : Over the past few years, the use of metallocomplexes for medical purposes has considerably grown.  Because of its favorable characteristics, ruthenium has taken a significant place in this expanding field of research.  Several ruthenium-contg. metal compds. have been developed as delivery agents of physiol. important mols. such as nitric oxide (NO) and carbon monoxide (CO).  Key findings : This review focuses on the (vaso)relaxant capacity of ruthenium-based NO-donating and CO-donating mols. in view of their potential usefulness in the treatment of cardiovascular diseases and erectile dysfunction.  Summary : Ruthenium seems to be a valuable candidate for the design of NO-donating and CO-donating mols.  To date, ruthenium remains of interest in drug research as the search for new alternatives is still necessary.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJlHNcv6XUWLVg90H21EOLACvtfcHk0li9j6fydVp03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslektg%253D%253D&md5=cb38cf9cc5d36cb7050028d02e4f87ae</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12511%26sid%3Dliteratum%253Aachs%26aulast%3DPauwels%26aufirst%3DB.%26aulast%3DBoydens%26aufirst%3DC.%26aulast%3DVanden%2BDaele%26aufirst%3DL.%26aulast%3DVan%2Bde%2BVoorde%26aufirst%3DJ.%26atitle%3DRuthenium-Based%2520Nitric%2520Oxide-Donating%2520and%2520Carbon%2520Monoxide-Donating%2520Molecules%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2016%26volume%3D68%26spage%3D293%26epage%3D304%26doi%3D10.1111%2Fjphp.12511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Chugunova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burilov, A. R.</span><span> </span><span class="NLM_article-title">Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans: Mini-Review</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span><span class="refDoi"> DOI: 10.2174/1568026616666160927145822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F1568026616666160927145822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27697059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVOqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=986-1005&author=E.+A.+Chugunovaauthor=A.+R.+Burilov&title=Novel+Structural+Hybrids+on+the+Base+of+Benzofuroxans+and+Furoxans%3A+Mini-Review&doi=10.2174%2F1568026616666160927145822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review</span></div><div class="casAuthors">Chugunova, Elena A.; Burilov, Alexander R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">986-1005</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Hybrid drug strategy is based on the combination of two or more pharmacophores into a new chem. entity to improve the properties of the original compds. or to obtain double action of resulting mol.  Hybrid mols., comprised of some pharmacophore and nitric oxide (NO) donor moiety, constitute one of the more promising approaches for the design of drugs.  Furoxans and benzofuroxans are considered NO releasing prodrugs and are of great interest for researchers.  In this review we will focus on furoxan and benzofuroxan hybrids described in literature during the last years (from 2005 to 2016).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou9SR5WqrUW7Vg90H21EOLACvtfcHk0lirEhsPWfiYEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVOqtrY%253D&md5=6b097e0e59fa3e2643f9da8b033fbf56</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160927145822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160927145822%26sid%3Dliteratum%253Aachs%26aulast%3DChugunova%26aufirst%3DE.%2BA.%26aulast%3DBurilov%26aufirst%3DA.%2BR.%26atitle%3DNovel%2520Structural%2520Hybrids%2520on%2520the%2520Base%2520of%2520Benzofuroxans%2520and%2520Furoxans%253A%2520Mini-Review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D986%26epage%3D1005%26doi%3D10.2174%2F1568026616666160927145822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jovene, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugunova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goumont, R.</span><span> </span><span class="NLM_article-title">The Properties and the Use of Substituted Benzofuroxans in Pharmaceutical and Medicinal Chemistry: a Comprehensive Review</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.2174/1389557511313080001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F1389557511313080001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1089-1136&author=C.+Joveneauthor=E.+A.+Chugunovaauthor=R.+Goumont&title=The+Properties+and+the+Use+of+Substituted+Benzofuroxans+in+Pharmaceutical+and+Medicinal+Chemistry%3A+a+Comprehensive+Review&doi=10.2174%2F1389557511313080001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F1389557511313080001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511313080001%26sid%3Dliteratum%253Aachs%26aulast%3DJovene%26aufirst%3DC.%26aulast%3DChugunova%26aufirst%3DE.%2BA.%26aulast%3DGoumont%26aufirst%3DR.%26atitle%3DThe%2520Properties%2520and%2520the%2520Use%2520of%2520Substituted%2520Benzofuroxans%2520in%2520Pharmaceutical%2520and%2520Medicinal%2520Chemistry%253A%2520a%2520Comprehensive%2520Review%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1089%26epage%3D1136%26doi%3D10.2174%2F1389557511313080001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hiskey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, D. E.</span><span> </span><span class="NLM_article-title">D. E. Preparation of 1-Substituted-3,3-Dinitroazetidines</span> <span class="citation_source-journal">J. Energ. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1080/07370659908216106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1080%2F07370659908216106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1MXktFWrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=233-252&author=M.+A.+Hiskeyauthor=M.+C.+Johnsonauthor=D.+E.+Chavez&title=D.+E.+Preparation+of+1-Substituted-3%2C3-Dinitroazetidines&doi=10.1080%2F07370659908216106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 1-substituted 3,3-dinitroazetidines</span></div><div class="casAuthors">Hiskey, Michael A.; Johnson, M. Catherine; Chavez, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Energetic Materials</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2 & 3</span>),
    <span class="NLM_cas:pages">233-252</span>CODEN:
                <span class="NLM_cas:coden">JOEMDK</span>;
        ISSN:<span class="NLM_cas:issn">0737-0652</span>.
    
            (<span class="NLM_cas:orgname">Dowden, Brodman & Devine, Inc.</span>)
        </div><div class="casAbstract">DNAZ (3,3-dinitroazetidine) readily undergoes nucleophilic addn. reactions with electron deficient haloaroms., cyanogen bromide, S-methyl-N-nitroisothiourea and dichloroglyoxime to afford novel, energetic 1-substituted 3,3-dinitroazetidines.  N-Nitrosation of DNAZ readily occurs, and Mannich condensations of DNAZ with polynitro alcs. are also described.  The synthesis and properties of the energetic materials derived from these reactions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYQA3m4RPcsbVg90H21EOLACvtfcHk0lirEhsPWfiYEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFWrtL4%253D&md5=502a56df049cdb7a7b8bec48629234eb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F07370659908216106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07370659908216106%26sid%3Dliteratum%253Aachs%26aulast%3DHiskey%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DM.%2BC.%26aulast%3DChavez%26aufirst%3DD.%2BE.%26atitle%3DD.%2520E.%2520Preparation%2520of%25201-Substituted-3%252C3-Dinitroazetidines%26jtitle%3DJ.%2520Energ.%2520Mater.%26date%3D1999%26volume%3D17%26spage%3D233%26epage%3D252%26doi%3D10.1080%2F07370659908216106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saul, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span> </span><span class="NLM_article-title">Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2600</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F0008-5472.CAN-11-2303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=22589277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2600-2608&author=S.+Ningauthor=M.+Bednarskiauthor=B.+Oronskyauthor=J.+Scicinskiauthor=G.+Saulauthor=S.+J.+Knox&title=Dinitroazetidines+Are+a+Novel+Class+of+Anticancer+Agents+and+Hypoxia-Activated+Radiation+Sensitizers+Developed+from+Highly+Energetic+Materials&doi=10.1158%2F0008-5472.CAN-11-2303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials</span></div><div class="casAuthors">Ning, Shoucheng; Bednarski, Mark; Oronsky, Bryan; Scicinski, Jan; Saul, Gordon; Knox, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2600-2608</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In an effort to develop cancer therapies that maximize cytotoxicity, while minimizing unwanted side effects, we studied a series of novel compds. based on the highly energetic heterocyclic scaffold, dinitroazetidine.  In this study, we report the preclin. validation of 1-bromoacetyl-3,3-dinitroazetidine (ABDNAZ), a representative lead compd. currently in a phase I clin. trial in patients with cancer.  In tumor cell culture, ABDNAZ generated reactive free radicals in a concn.- and time-dependent manner, modulating intracellular redox status and triggering apoptosis.  When administered to mice as a single agent, ABDNAZ exhibited greater cytotoxicity than cisplatin or tirapazamine under hypoxic conditions.  However, compared with cisplatin, ABDNAZ was better tolerated at submaximal doses, yielding significant tumor growth inhibition in the absence of systemic toxicity.  Similarly, when combined with radiation, ABDNAZ accentuated antitumor efficacy along with the therapeutic index.  Toxicity studies indicated that ABDNAZ was not myelosuppressive and no dose-limiting toxicity was apparent following daily administration for 14 days.  Taken together, our findings offer preclin. proof-of-concept for ABDNAZ as a promising new anticancer agent with a favorable toxicity profile, either as a chemotherapeutic agent or a radiosensitizer.  Cancer Res; 72(10); 2600-8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojcgmi5BKp-7Vg90H21EOLACvtfcHk0lirEhsPWfiYEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2ntbo%253D&md5=dc41734ee7a24c30a2ce2e20224d4db1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2303%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DS.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DSaul%26aufirst%3DG.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DDinitroazetidines%2520Are%2520a%2520Novel%2520Class%2520of%2520Anticancer%2520Agents%2520and%2520Hypoxia-Activated%2520Radiation%2520Sensitizers%2520Developed%2520from%2520Highly%2520Energetic%2520Materials%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2600%26epage%3D2608%26doi%3D10.1158%2F0008-5472.CAN-11-2303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S.</span><span> </span><span class="NLM_article-title">RRx-001, a Novel Dinitroazetidine Radiosensitizer</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1007/s10637-016-0326-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2Fs10637-016-0326-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=371-377&author=B.+Oronskyauthor=J.+Scicinskiauthor=S.+Ningauthor=D.+Peehlauthor=A.+Oronskyauthor=P.+Cabralesauthor=M.+Bednarskiauthor=S.+Knox&title=RRx-001%2C+a+Novel+Dinitroazetidine+Radiosensitizer&doi=10.1007%2Fs10637-016-0326-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0326-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0326-y%26sid%3Dliteratum%253Aachs%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DNing%26aufirst%3DS.%26aulast%3DPeehl%26aufirst%3DD.%26aulast%3DOronsky%26aufirst%3DA.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DKnox%26aufirst%3DS.%26atitle%3DRRx-001%252C%2520a%2520Novel%2520Dinitroazetidine%2520Radiosensitizer%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2016%26volume%3D34%26spage%3D371%26epage%3D377%26doi%3D10.1007%2Fs10637-016-0326-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuypers, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span> </span><span class="NLM_article-title">A Look Inside the Mechanistic Black Box: Are Red Blood Cells the Critical Effectors of RRx-001 Cytotoxicity?</span> <span class="citation_source-journal">Med. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="refDoi"> DOI: 10.1007/s12032-016-0775-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2Fs12032-016-0775-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27229330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FktFGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=63&author=P.+Cabralesauthor=J.+Scicinskiauthor=T.+Reidauthor=F.+Kuypersauthor=S.+Larkinauthor=M.+Fensauthor=A.+Oronskyauthor=B.+Oronsky&title=A+Look+Inside+the+Mechanistic+Black+Box%3A+Are+Red+Blood+Cells+the+Critical+Effectors+of+RRx-001+Cytotoxicity%3F&doi=10.1007%2Fs12032-016-0775-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?</span></div><div class="casAuthors">Cabrales Pedro; Scicinski Jan; Oronsky Bryan; Reid Tony; Kuypers Frans; Larkin Sandra; Fens Marcel; Oronsky Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The therapeutic potential of epi-immunotherapeutic anticancer agent RRx-001 in cancer has been validated with preclinical and clinical studies, since RRx-001 has successfully completed a phase 1 trial and multiple single-agent and combination phase 2 trials with preliminary evidence of promising activity are underway.  Previous experimental work has implicated diverse anticancer mechanisms such as oxidative stress, ATP and NADPH depletion, anti-angiogenesis and epigenetic modulation in the overall antitumor effect of RRx-001.  The hypothesis of this study was that the RRx-001 red blood cells are the essential and de facto intermediaries responsible for the reprograming of tumor behavior via transfer of their intracellular and membrane contents.  To test this hypothesis, and thereby resolve the "black box" incompleteness in the continuity of the mechanism, the fate of red blood cells incubated with RRx-001 was explored in vitro and in vivo both in healthy animals and in tumor-bearing mice.  The collective results establish that RRx-001-derivatized red blood cells are the critical "missing links" to explain the specificity and anticancer activity of RRx-001, including its immunomodulatory effects on tumor-associated macrophages.  These experimental results delineate a novel erythrocyte-based mechanism without precedent in the annals of oncology and open the door to rational combination strategies with RRx-001 both in cancer therapy and beyond, particularly in disease states that affect red blood cell and vascular function such as malaria, leishmaniasis, sickle-cell disease and hemorrhagic shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxqiQRMELtSvEeosoOnpOLfW6udTcc2eZyjwWMgmcTrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FktFGmsw%253D%253D&md5=3a01dd404fceb01d7ea8f6300c2f3d55</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs12032-016-0775-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-016-0775-3%26sid%3Dliteratum%253Aachs%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DReid%26aufirst%3DT.%26aulast%3DKuypers%26aufirst%3DF.%26aulast%3DLarkin%26aufirst%3DS.%26aulast%3DFens%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DA.%26aulast%3DOronsky%26aufirst%3DB.%26atitle%3DA%2520Look%2520Inside%2520the%2520Mechanistic%2520Black%2520Box%253A%2520Are%2520Red%2520Blood%2520Cells%2520the%2520Critical%2520Effectors%2520of%2520RRx-001%2520Cytotoxicity%253F%26jtitle%3DMed.%2520Oncol.%26date%3D2016%26volume%3D33%26spage%3D63%26doi%3D10.1007%2Fs12032-016-0775-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, W. L.</span><span> </span><span class="NLM_article-title">Preclinical Evaluation of the Metabolism and Disposition of RRx-001, a Novel Investigative Anticancer Agent</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1810</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span><span class="refDoi"> DOI: 10.1124/dmd.112.046755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1124%2Fdmd.112.046755" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1810-1816&author=J.+Scicinskiauthor=B.+Oronskyauthor=M.+Taylorauthor=G.+Luoauthor=T.+Musickauthor=J.+Mariniauthor=C.+M.+Adamsauthor=W.+L.+Fitch&title=Preclinical+Evaluation+of+the+Metabolism+and+Disposition+of+RRx-001%2C+a+Novel+Investigative+Anticancer+Agent&doi=10.1124%2Fdmd.112.046755"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046755%26sid%3Dliteratum%253Aachs%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DMusick%26aufirst%3DT.%26aulast%3DMarini%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DFitch%26aufirst%3DW.%2BL.%26atitle%3DPreclinical%2520Evaluation%2520of%2520the%2520Metabolism%2520and%2520Disposition%2520of%2520RRx-001%252C%2520a%2520Novel%2520Investigative%2520Anticancer%2520Agent%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1810%26epage%3D1816%26doi%3D10.1124%2Fdmd.112.046755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M.</span><span> </span><span class="NLM_article-title">Epigenetic Effects of RRx-001: A Possible Unifying Mechanism of Anticancer Activity</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">43172</span><span class="NLM_x">–</span> <span class="NLM_lpage">43181</span><span class="refDoi"> DOI: 10.18632/oncotarget.6526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.18632%2Foncotarget.6526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=43172-43181&author=H.+Zhaoauthor=S.+Ningauthor=J.+Scicinskiauthor=B.+Oronskyauthor=S.+J.+Knoxauthor=D.+M.+Peehl&title=Epigenetic+Effects+of+RRx-001%3A+A+Possible+Unifying+Mechanism+of+Anticancer+Activity&doi=10.18632%2Foncotarget.6526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6526%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DNing%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26atitle%3DEpigenetic%2520Effects%2520of%2520RRx-001%253A%2520A%2520Possible%2520Unifying%2520Mechanism%2520of%2520Anticancer%2520Activity%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D43172%26epage%3D43181%26doi%3D10.18632%2Foncotarget.6526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Reid, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scribner, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrouk, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J. R.</span><span> </span><span class="NLM_article-title">Safety and Activity of RRx-001 in Patients with Advanced Cancer: a First-in-Human, Open-Label, Dose-Escalation Phase 1 Study</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span><span class="refDoi"> DOI: 10.1016/S1470-2045(15)00089-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS1470-2045%2815%2900089-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26296952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKnurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1133-1142&author=T.+Reidauthor=B.+Oronskyauthor=J.+Scicinskiauthor=C.+L.+Scribnerauthor=S.+J.+Knoxauthor=S.+Ningauthor=D.+M.+Peehlauthor=R.+Kornauthor=M.+Stirnauthor=C.+A.+Carterauthor=A.+Oronskyauthor=M.+J.+Taylorauthor=W.+L.+Fitchauthor=P.+Cabralesauthor=M.+M.+Kimauthor=H.+A.+Burrisauthor=C.+D.+Laoauthor=N.+E.+Abroukauthor=G.+R.+Fangerauthor=J.+R.+Infante&title=Safety+and+Activity+of+RRx-001+in+Patients+with+Advanced+Cancer%3A+a+First-in-Human%2C+Open-Label%2C+Dose-Escalation+Phase+1+Study&doi=10.1016%2FS1470-2045%2815%2900089-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study</span></div><div class="casAuthors">Reid, Tony; Oronsky, Bryan; Scicinski, Jan; Scribner, Curt L.; Knox, Susan J.; Ning, Shoucheng; Peehl, Donna M.; Korn, Ron; Stirn, Meaghan; Carter, Corey A.; Oronsky, Arnold; Taylor, Michael J.; Fitch, William L.; Cabrales, Pedro; Kim, Michelle M.; Burris, Howard A., III; Lao, Christopher D.; Abrouk, Nacer E. D.; Fanger, Gary R.; Infante, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1133-1142</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Epigenetic alterations have been strongly assocd. with tumor formation and resistance to chemotherapeutic drugs, and epigenetic modifications are an attractive target in cancer research.  RRx-001 is activated by hypoxia and induces the generation of reactive oxygen and nitrogen species that can epigenetically modulate DNA methylation, histone deacetylation, and lysine demethylation.  The aim of this phase 1 study was to assess the safety, tolerability, and pharmacokinetics of RRx-001.  In this open-label, dose-escalation, phase 1 study, we recruited adult patients (aged >18 years) with histol. or cytol. confirmed diagnosis of advanced, malignant, incurable solid tumors from University of California at San Diego, CA, USA, and Sarah Cannon Research Institute, Nashville, TN, USA.  Key eligibility criteria included evaluable disease, Eastern Cooperative Group performance status of 2 or less, an estd. life expectancy of at least 12 wk, adequate lab. parameters, discontinuation of all previous antineoplastic therapies at least 6 wk before intervention, and no residual side-effects from previous therapies.  Patients were assigned to receive i.v. infusions of RRx-001 at increasing doses (10 mg/m2, 16·7 mg/m2, 24·6 mg/m2, 33 mg/m2, 55 mg/m2, and 83 mg/m2) either once or twice-weekly for at least 4 wk, with at least three patients per dose cohort and allowing a 2-wk observation period before dose escalation.  Samples for safety and pharmacokinetics anal., including std. chem. and haematol. panels, were taken on each treatment day.  The primary objective was to assess safety, tolerability, and dose-limiting toxic effects of RRx-001, to det. single-dose pharmacokinetics, and to identify a recommended dose for phase 2 trials.  All analyses were done per protocol.  Accrual is complete and follow-up is still on-going.  This trial is registered with ClinicalTrials.gov, no. NCT01359982.  Between Oct 10, 2011, and March 18, 2013, we enrolled 25 patients and treated six patients in the 10 mg/m2 cohort, three patients in the 16·7 mg/m2 cohort, three patients in the 24·6 mg/m2 cohort, four patients in the 33 mg/m2 cohort, three patients in the 55 mg/m2, and six patients in the 83 mg/m2 cohort.  Pain at the injection site, mostly grade 1 and grade 2, was the most common adverse event related to treatment, experienced by 21 (84%) patients.  Other common drug-related adverse events included arm swelling or edema (eight [32%] patients), and vein hardening (seven [28%] patients).  No dose-limiting toxicities were obsd.  Time constraints related to management of infusion pain from RRx-001 resulted in a maximally feasible dose of 83 mg/m2.  Of the 21 evaluable patients, one (5%) patient had a partial response, 14 (67%) patients had stable disease, and six (29%) patients had progressive disease; all responses were across a variety of tumor types.  Four patients who had received RRx-001 were subsequently rechallenged with a treatment that they had become refractory to; all four responded to the rechallenge.  RRx-001 is a well-tolerated novel compd. without clin. significant toxic effects at the tested doses.  Preliminary evidence of activity is promising and, on the basis of all findings, a dose of 16·7 mg/m2 was recommended as the targeted dose for phase 2 trials.EpicentRx (formerly RadioRx).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9rkaWij3XxLVg90H21EOLACvtfcHk0liWDP5mQjUEwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKnurzN&md5=7f48e9d2108e1aaad8fdf987360c19d8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2815%2900089-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252815%252900089-3%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DT.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DScribner%26aufirst%3DC.%2BL.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26aulast%3DNing%26aufirst%3DS.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DKorn%26aufirst%3DR.%26aulast%3DStirn%26aufirst%3DM.%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DOronsky%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DFitch%26aufirst%3DW.%2BL.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DM.%2BM.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DLao%26aufirst%3DC.%2BD.%26aulast%3DAbrouk%26aufirst%3DN.%2BE.%26aulast%3DFanger%26aufirst%3DG.%2BR.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26atitle%3DSafety%2520and%2520Activity%2520of%2520RRx-001%2520in%2520Patients%2520with%2520Advanced%2520Cancer%253A%2520a%2520First-in-Human%252C%2520Open-Label%252C%2520Dose-Escalation%2520Phase%25201%2520Study%26jtitle%3DLancet%2520Oncol.%26date%3D2015%26volume%3D16%26spage%3D1133%26epage%3D1142%26doi%3D10.1016%2FS1470-2045%2815%2900089-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caroen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degesys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzezniak, C.</span><span> </span><span class="NLM_article-title">Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets</span> <span class="citation_source-journal">Case Rep. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1159/000446209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1159%2F000446209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27403127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ps1Cksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=285-289&author=C.+A.+Carterauthor=B.+Oronskyauthor=S.+Caroenauthor=J.+Scicinskiauthor=A.+Degesysauthor=P.+Cabralesauthor=T.+R.+Reidauthor=C.+Brzezniak&title=Partial+Response+in+an+RRx-001-Primed+Patient+with+Refractory+Small-Cell+Lung+Cancer+after+a+Third+Introduction+of+Platinum+Doublets&doi=10.1159%2F000446209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets</span></div><div class="casAuthors">Carter Corey A; Degesys Aiste; Brzezniak Christina; Oronsky Bryan; Caroen Scott; Scicinski Jan; Cabrales Pedro; Reid Tony R</div><div class="citationInfo"><span class="NLM_cas:title">Case reports in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">285-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Small-cell lung cancer (SCLC), initially exquisitely sensitive to first-line cisplatin/etoposide, invariably relapses and acquires a multidrug chemoresistant phenotype that generally renders retreatment with first-line therapy both futile and counterproductive.  This report presents the case of a 77-year-old Caucasian male with extensive-stage refractory SCLC who was restarted on platinum doublets as part of a clinical trial called TRIPLE THREAT (NCT02489903) involving pretreatment with the epi-immunotherapeutic agent RRx-001, and who achieved a partial response after only 4 cycles.  The patient had received a platinum drug twice before, in 2009 for a diagnosis of non-small-cell lung cancer (squamous cell carcinoma) and in 2015 for SCLC, suggesting that RRx-001 pretreatment may sensitize or resensitize refractory SCLC patients to first-line chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVxgRO-rO9H2yYR5VtavbzfW6udTcc2eYVlP5yzWfPsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ps1Cksg%253D%253D&md5=3a204cb7b3028a54daae7306367bac9e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1159%2F000446209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000446209%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DCaroen%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DDegesys%26aufirst%3DA.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DReid%26aufirst%3DT.%2BR.%26aulast%3DBrzezniak%26aufirst%3DC.%26atitle%3DPartial%2520Response%2520in%2520an%2520RRx-001-Primed%2520Patient%2520with%2520Refractory%2520Small-Cell%2520Lung%2520Cancer%2520after%2520a%2520Third%2520Introduction%2520of%2520Platinum%2520Doublets%26jtitle%3DCase%2520Rep.%2520Oncol.%26date%3D2016%26volume%3D9%26spage%3D285%26epage%3D289%26doi%3D10.1159%2F000446209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Carter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caroen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degesys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzezniak, C.</span><span> </span><span class="NLM_article-title">Partial Response to Carboplatin in an RRx-001 Pretreated Patient with EGFR-Inhibitor-Resistance and T790M-Negative NSCLC</span> <span class="citation_source-journal">Respir. Med. Case Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.rmcr.2016.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.rmcr.2016.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27330954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC2s7isl2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=62-65&author=C.+A.+Carterauthor=B.+Oronskyauthor=S.+Caroenauthor=J.+Scicinskiauthor=P.+Cabralesauthor=A.+Degesysauthor=C.+Brzezniak&title=Partial+Response+to+Carboplatin+in+an+RRx-001+Pretreated+Patient+with+EGFR-Inhibitor-Resistance+and+T790M-Negative+NSCLC&doi=10.1016%2Fj.rmcr.2016.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC</span></div><div class="casAuthors">Carter Corey A; Degesys Aiste; Brzezniak Christina; Oronsky Bryan; Caroen Scott; Scicinski Jan; Cabrales Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine case reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Few therapeutic options are available for T790M-negative non-small cell lung cancer (NSCLC) after failure of primary epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy.  This report presents the case of a 71-year-old Asian female never smoker with EGFR mutated T790M negative non squamous cell lung cancer (NSCLC) pre-treated with the experimental epi-immunotherapeutic agent, RRx-001, that re-responded to single agent carboplatin after failure of platinum doublets, TKIs, pemetrexed and nivolumab.  The management of advanced EGFR mutation-positive NSCLC is briefly reviewed herein and the emerging paradigm of episensitization, which contradicts the long-standing and widely accepted tenet about the immutability of resistance and the futility of therapeutic rechallenge, is introduced as a strategy to avert treatment failure and thereby stave off deterioration and death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbyt8aJkvHFBjv2lLSLOxFfW6udTcc2eYCCXPKlX02j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7isl2mtA%253D%253D&md5=937af93aea51d096036ee2517220674d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.rmcr.2016.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.rmcr.2016.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BA.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DCaroen%26aufirst%3DS.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DCabrales%26aufirst%3DP.%26aulast%3DDegesys%26aufirst%3DA.%26aulast%3DBrzezniak%26aufirst%3DC.%26atitle%3DPartial%2520Response%2520to%2520Carboplatin%2520in%2520an%2520RRx-001%2520Pretreated%2520Patient%2520with%2520EGFR-Inhibitor-Resistance%2520and%2520T790M-Negative%2520NSCLC%26jtitle%3DRespir.%2520Med.%2520Case%2520Rep.%26date%3D2016%26volume%3D18%26spage%3D62%26epage%3D65%26doi%3D10.1016%2Fj.rmcr.2016.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Diez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calatayud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esplugues, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrachina, M. D.</span><span> </span><span class="NLM_article-title">Nitric Oxide, Derived from Inducible Nitric Oxide Synthase, Decreases Hypoxia Inducible Factor-1alpha in Macrophages during Aspirin-Induced Mesenteric Inflammation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1636</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00654.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fj.1476-5381.2010.00654.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=20233223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC3c3lvVCisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2010&pages=1636-1645&author=I.+Diezauthor=S.+Calatayudauthor=C.+Hernandezauthor=E.+Quintanaauthor=J.+E.+O%E2%80%99Connorauthor=J.+V.+Espluguesauthor=M.+D.+Barrachina&title=Nitric+Oxide%2C+Derived+from+Inducible+Nitric+Oxide+Synthase%2C+Decreases+Hypoxia+Inducible+Factor-1alpha+in+Macrophages+during+Aspirin-Induced+Mesenteric+Inflammation&doi=10.1111%2Fj.1476-5381.2010.00654.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor-1alpha in macrophages during aspirin-induced mesenteric inflammation</span></div><div class="casAuthors">Diez I; Calatayud S; Hernandez C; Quintana E; O'Connor J E; Esplugues J V; Barrachina M D</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1636-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Nitric oxide (NO) modulates expression of hypoxia inducible factor-1 (HIF-1), a transcription factor regulating function of myeloid cells.  Here, we have assessed the role played by NO, formed by inducible NOS (iNOS), in the inflammation induced by aspirin in the gut, by modulating HIF-1 activity.  EXPERIMENTAL APPROACH:  The role of iNOS-derived NO on leucocyte-endothelial interactions induced by aspirin was evaluated by intravital microscopy in mesenteric venules of rats pretreated with selective iNOS inhibitors, 1400W or l-N6-(1-iminoethyl)-lysine.  NO was localized by fluorescence microscopy, using DAF-FM. iNOS, HIF-1alpha and CD36 were localized by immunohistochemistry.  KEY RESULTS:  Leucocyte-endothelial interactions increased at 6 h and returned to normal levels 24 h after aspirin administration.  Numbers of migrated leucocytes were similar between 6 and 24 h after aspirin. iNOS expression and iNOS-derived NO synthesis were observed in leucocytes of the mesentery of aspirin-treated rats.  Blockade of iNOS activity in aspirin-treated rats: (i) did not modify leucocyte infiltration at 6 h, but reduced the number of polymorphonuclear leucocyte and increased that of macrophages at 24 h; (ii) increased HIF-1alpha immunostaining in macrophages of the mesentery; and (iii) prevented the decrease in CD36 immunostaining induced by aspirin in these cells.  CONCLUSIONS AND IMPLICATIONS:  NO, associated with acute gut inflammation induced by aspirin, diminished HIF-1alpha stabilization in macrophages.  Early inhibition of iNOS-derived NO synthesis, by increasing the activity of HIF-1 in these cells, may accelerate the clearance of leucocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSm3zG7MgWoa_6BottYdIAWfW6udTcc2eYCCXPKlX02j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3lvVCisw%253D%253D&md5=2f62dfc071a9b6268abe5fa8edf77ae8</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00654.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00654.x%26sid%3Dliteratum%253Aachs%26aulast%3DDiez%26aufirst%3DI.%26aulast%3DCalatayud%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DC.%26aulast%3DQuintana%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BE.%26aulast%3DEsplugues%26aufirst%3DJ.%2BV.%26aulast%3DBarrachina%26aufirst%3DM.%2BD.%26atitle%3DNitric%2520Oxide%252C%2520Derived%2520from%2520Inducible%2520Nitric%2520Oxide%2520Synthase%252C%2520Decreases%2520Hypoxia%2520Inducible%2520Factor-1alpha%2520in%2520Macrophages%2520during%2520Aspirin-Induced%2520Mesenteric%2520Inflammation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D159%26spage%3D1636%26epage%3D1645%26doi%3D10.1111%2Fj.1476-5381.2010.00654.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Hagen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span> </span><span class="NLM_article-title">Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1alpha</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span><span class="refDoi"> DOI: 10.1126/science.1088805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1126%2Fscience.1088805" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1975-1978&author=T.+Hagenauthor=C.+T.+Taylorauthor=F.+Lamauthor=S.+Moncada&title=Redistribution+of+Intracellular+Oxygen+in+Hypoxia+by+Nitric+Oxide%3A+Effect+on+HIF1alpha&doi=10.1126%2Fscience.1088805"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1126%2Fscience.1088805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1088805%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DC.%2BT.%26aulast%3DLam%26aufirst%3DF.%26aulast%3DMoncada%26aufirst%3DS.%26atitle%3DRedistribution%2520of%2520Intracellular%2520Oxygen%2520in%2520Hypoxia%2520by%2520Nitric%2520Oxide%253A%2520Effect%2520on%2520HIF1alpha%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1975%26epage%3D1978%26doi%3D10.1126%2Fscience.1088805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Dingemans, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herder, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahce, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgers, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Borne, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Noort, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aerts, J. G.</span><span> </span><span class="NLM_article-title">A Randomized Phase II Study Comparing Paclitaxel-Carboplatin-Bevacizumab with or without Nitroglycerin Patches in Patients with Stage IV Nonsquamous Nonsmall-Cell Lung Cancer: NVALT12 (NCT01171170)Dagger</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2286</span><span class="NLM_x">–</span> <span class="NLM_lpage">2293</span><span class="refDoi"> DOI: 10.1093/annonc/mdv370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1093%2Fannonc%2Fmdv370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26347109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC287pvFCksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2286-2293&author=A.+M.+Dingemansauthor=H.+J.+Groenauthor=G.+J.+Herderauthor=J.+A.+Stigtauthor=E.+F.+Smitauthor=I.+Bahceauthor=J.+A.+Burgersauthor=B.+E.+van+den+Borneauthor=B.+Biesmaauthor=A.+Vincentauthor=V.+van+der+Noortauthor=J.+G.+Aerts&title=A+Randomized+Phase+II+Study+Comparing+Paclitaxel-Carboplatin-Bevacizumab+with+or+without+Nitroglycerin+Patches+in+Patients+with+Stage+IV+Nonsquamous+Nonsmall-Cell+Lung+Cancer%3A+NVALT12+%28NCT01171170%29Dagger&doi=10.1093%2Fannonc%2Fmdv370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†</span></div><div class="casAuthors">Dingemans A-M C; Groen H J M; Herder G J M; Stigt J A; Smit E F; Bahce I; Burgers J A; van den Borne B E E M; Biesma B; Vincent A; van der Noort V; Aerts J G</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2286-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Nitroglycerin (NTG) increases tumor blood flow and oxygenation by inhibiting hypoxia-inducible-factor (HIF)-1.  A randomized phase II study has shown improved outcome when NTG patches were added to vinorelbine/cisplatin in patients with advanced nonsmall-cell lung cancer (NSCLC).  In addition, there is evidence that the combination of bevacizumab and HIF-1 inhibitors increases antitumor activity.  PATIENTS AND METHODS:  In this randomized phase II trial, chemo-naive patients with stage IV nonsquamous NSCLC were randomized to four cycles of carboplatin (area under the curve 6)-paclitaxel (200 mg/m(2))-bevacizumab 15 mg/kg on day 1 every 3 weeks with or without NTG patches 15 mg (day -2 to +2) followed by bevacizumab with or without NTG until progression.  Response was assessed every two cycles.  Primary end point was progression-free survival (PFS).  The study was powered (80%) to detect a decrease in the hazard of tumor progression of 33% at α = 0.05 with a two-sided log-rank test when 222 patients were enrolled and followed until 195 events were observed.  RESULTS:  Between 1 January 2011 and 1 January 2013, a total of 223 patients were randomized; 112 control arm and 111 experimental arm; response rate was 54% in control arm and 38% in experimental arm.  Median [95% confidence interval (CI)] PFS in control arm was 6.8 months (5.6-7.3) and 5.1 months (4.2-5.8) in experimental arm, hazard ratio (HR) 1.27 (95% CI 0.96-1.67).  Overall survival (OS) was 11.6 months (8.8-13.6) in control arm and 9.4 months (7.8-11.3) in experimental arm, HR 1.02 (95% CI 0.71-1.46).  In the experimental arm, no additional toxicity was observed except headache (6% versus 52% in patients treated with NTG).  CONCLUSION:  Adding NTG to first-line carboplatin-paclitaxel-bevacizumab did not improve PFS and OS in patients with stage IV nonsquamous NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwXOyvA6ZXA9j_Vg2vObihfW6udTcc2eb40iwJR_dVILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287pvFCksQ%253D%253D&md5=7c6b3acf8525690f078bc993ffbd5446</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv370%26sid%3Dliteratum%253Aachs%26aulast%3DDingemans%26aufirst%3DA.%2BM.%26aulast%3DGroen%26aufirst%3DH.%2BJ.%26aulast%3DHerder%26aufirst%3DG.%2BJ.%26aulast%3DStigt%26aufirst%3DJ.%2BA.%26aulast%3DSmit%26aufirst%3DE.%2BF.%26aulast%3DBahce%26aufirst%3DI.%26aulast%3DBurgers%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2Bden%2BBorne%26aufirst%3DB.%2BE.%26aulast%3DBiesma%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BNoort%26aufirst%3DV.%26aulast%3DAerts%26aufirst%3DJ.%2BG.%26atitle%3DA%2520Randomized%2520Phase%2520II%2520Study%2520Comparing%2520Paclitaxel-Carboplatin-Bevacizumab%2520with%2520or%2520without%2520Nitroglycerin%2520Patches%2520in%2520Patients%2520with%2520Stage%2520IV%2520Nonsquamous%2520Nonsmall-Cell%2520Lung%2520Cancer%253A%2520NVALT12%2520%2528NCT01171170%2529Dagger%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3D2286%26epage%3D2293%26doi%3D10.1093%2Fannonc%2Fmdv370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Yasuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span> </span><span class="NLM_article-title">Randomized Phase II Trial Comparing Nitroglycerin plus Vinorelbine and Cisplatin with Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span><span class="refDoi"> DOI: 10.1200/JCO.2005.04.0436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1200%2FJCO.2005.04.0436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16446342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFKhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=688-694&author=H.+Yasudaauthor=M.+Yamayaauthor=K.+Nakayamaauthor=T.+Sasakiauthor=S.+Ebiharaauthor=A.+Kandaauthor=M.+Asadaauthor=D.+Inoueauthor=T.+Suzukiauthor=T.+Okazakiauthor=H.+Takahashiauthor=M.+Yoshidaauthor=T.+Kanetaauthor=K.+Ishizawaauthor=S.+Yamandaauthor=N.+Tomitaauthor=M.+Yamasakiauthor=A.+Kikuchiauthor=H.+Kuboauthor=H.+Sasaki&title=Randomized+Phase+II+Trial+Comparing+Nitroglycerin+plus+Vinorelbine+and+Cisplatin+with+Vinorelbine+and+Cisplatin+Alone+in+Previously+Untreated+Stage+IIIB%2FIV+Non-Small-Cell+Lung+Cancer&doi=10.1200%2FJCO.2005.04.0436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer</span></div><div class="casAuthors">Yasuda, Hiroyasu; Yamaya, Mutsuo; Nakayama, Katsutoshi; Sasaki, Takahiko; Ebihara, Satoru; Kanda, Akio; Asada, Masanori; Inoue, Daisuke; Suzuki, Tomoko; Okazaki, Tatsuma; Takahashi, Hidenori; Yoshida, Motoki; Kaneta, Tomohiro; Ishizawa, Kota; Yamanda, Shinsuke; Tomita, Naoki; Yamasaki, Miyako; Kikuchi, Akiko; Kubo, Hiroshi; Sasaki, Hidetada</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">688-694</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To investigate the efficacy and safety of nitroglycerin plus vinorelbine and cisplatin in patients with previously untreated stage IIIB/IV non-small-cell lung cancer (NSCLC) as the exptl. arm for the next phase III trial.  Patients and Methods: One hundred twenty patients with stage IIIB/IV NSCLC were randomly assigned to vinorelbine 25 mg/m2 on days 1 and 8 and cisplatin 80 mg/m2 on day 1, with transdermally applied nitroglycerin (25 mg/patient daily for 5 days; arm A) or with placebo patch (arm B) every 3 wk for a max. of four cycles in a double-blind and controlled trial.  Primary efficacy end points were the best confirmed response rate and time to disease progression (TTP).  Results: The response rate in arm A (72%; 43 of 60 patients) was significantly higher than that for patients in arm B (42%; 25 of 60 patients; P < .001).  Median TTP in arm A was longer than that in arm B (327 v 185 days).  No severe adverse effect was recognized for either arm.  The rate of grade 1 to 2 headache in arm A (30%; 18 of 60 patients) was significantly higher than that in arm B (2%; one of 60 patients; P < .001, χ2 test).  Conclusion: Use of nitroglycerin combined with vinorelbine and cisplatin may improve overall response and TTP in patients with stage IIIB/IV NSCLC.  The arm A regimen is being evaluated in a large phase III trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_eytTE64OzLVg90H21EOLACvtfcHk0lg_L_tMeFOymQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFKhtLc%253D&md5=6a409beea03b7207333c7a53a35fa02e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.04.0436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.04.0436%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DH.%26aulast%3DYamaya%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DEbihara%26aufirst%3DS.%26aulast%3DKanda%26aufirst%3DA.%26aulast%3DAsada%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DD.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKaneta%26aufirst%3DT.%26aulast%3DIshizawa%26aufirst%3DK.%26aulast%3DYamanda%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DKubo%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DH.%26atitle%3DRandomized%2520Phase%2520II%2520Trial%2520Comparing%2520Nitroglycerin%2520plus%2520Vinorelbine%2520and%2520Cisplatin%2520with%2520Vinorelbine%2520and%2520Cisplatin%2520Alone%2520in%2520Previously%2520Untreated%2520Stage%2520IIIB%252FIV%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D688%26epage%3D694%26doi%3D10.1200%2FJCO.2005.04.0436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Reinmuth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwigsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huebner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skock-Lober, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerecke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Held, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reck, M.</span><span> </span><span class="NLM_article-title">Randomized, Double-Blind Phase II Study to Compare Nitroglycerin plus Oral Vinorelbine plus Cisplatin with Oral Vinorelbine plus Cisplatin Alone in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)</span> <span class="citation_source-journal">Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1016/j.lungcan.2014.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.lungcan.2014.01.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=363-368&author=N.+Reinmuthauthor=A.+Meyerauthor=D.+Hartwigsenauthor=C.+Schaeperauthor=G.+Huebnerauthor=R.+Skock-Loberauthor=A.+Bierauthor=U.+Gereckeauthor=C.+P.+Heldauthor=M.+Reck&title=Randomized%2C+Double-Blind+Phase+II+Study+to+Compare+Nitroglycerin+plus+Oral+Vinorelbine+plus+Cisplatin+with+Oral+Vinorelbine+plus+Cisplatin+Alone+in+Patients+with+Stage+IIIB%2FIV+Non-Small+Cell+Lung+Cancer+%28NSCLC%29&doi=10.1016%2Fj.lungcan.2014.01.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2014.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2014.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DReinmuth%26aufirst%3DN.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DHartwigsen%26aufirst%3DD.%26aulast%3DSchaeper%26aufirst%3DC.%26aulast%3DHuebner%26aufirst%3DG.%26aulast%3DSkock-Lober%26aufirst%3DR.%26aulast%3DBier%26aufirst%3DA.%26aulast%3DGerecke%26aufirst%3DU.%26aulast%3DHeld%26aufirst%3DC.%2BP.%26aulast%3DReck%26aufirst%3DM.%26atitle%3DRandomized%252C%2520Double-Blind%2520Phase%2520II%2520Study%2520to%2520Compare%2520Nitroglycerin%2520plus%2520Oral%2520Vinorelbine%2520plus%2520Cisplatin%2520with%2520Oral%2520Vinorelbine%2520plus%2520Cisplatin%2520Alone%2520in%2520Patients%2520with%2520Stage%2520IIIB%252FIV%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520%2528NSCLC%2529%26jtitle%3DLung%2520Cancer%26date%3D2014%26volume%3D83%26spage%3D363%26epage%3D368%26doi%3D10.1016%2Fj.lungcan.2014.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Arrieta, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Mata-Moya, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corona, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander-Alatorre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Rincon, D.</span><span> </span><span class="NLM_article-title">Phase II Study. Concurrent Chemotherapy and Radiotherapy with Nitroglycerin in Locally Advanced Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Radiother. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1016/j.radonc.2014.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.radonc.2014.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24836861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVaqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=311-315&author=O.+Arrietaauthor=M.+Blakeauthor=M.+D.+de+la+Mata-Moyaauthor=F.+Coronaauthor=J.+Turcottauthor=D.+Ortaauthor=J.+Alexander-Alatorreauthor=D.+Gallardo-Rincon&title=Phase+II+Study.+Concurrent+Chemotherapy+and+Radiotherapy+with+Nitroglycerin+in+Locally+Advanced+Non-Small+Cell+Lung+Cancer&doi=10.1016%2Fj.radonc.2014.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer</span></div><div class="casAuthors">Arrieta, Oscar; Blake, Monika; de la Mata-Moya, Maria Dolores; Corona, Francisco; Turcott, Jenny; Orta, David; Alexander-Alatorre, Jorge; Gallardo-Rincon, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-315</span>CODEN:
                <span class="NLM_cas:coden">RAONDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Nitroglycerin, a nitric oxide donor agent, reduces the expression of hypoxia-inducible factor-1α (HIF-1α) and could be a normalizer of the tumor microenvironment.  Both factors are assocd. with chemo-radio-resistance.  The aim of this study was to det. the safety profile and efficacy of nitroglycerin administration with chemo-radiotherapy in patients with locally advanced non-small cell lung cancer (NSCLC).  This is a phase II trial of locally advanced NSCLC patients treated with cisplatin and vinorelbine plus concurrent nitroglycerin with radiotherapy.  A 25-mg NTG patch was administered to the patients for 5 days (1 day before and 4 days after chemotherapy induction and consolidation) and all day during chemo-radiotherapy.  VEGF plasmatic level was detd. before and after two cycles of chemotherapy.  Thirty-five patients were enrolled in this trial.  Sixty-three percent of patients achieved an overall response after induction of chemotherapy, and 75% achieved an overall response after chemo-radiotherapy.  The median progression-free survival was 13.5 mo (95% CI, 8.8-18.2), and the median overall survival was 26.9 mo (95% CI, 15.3-38.5).  Redn. of VEGF level was assocd. with better OS.  The toxicity profile related to nitroglycerin included headache (20%) and hypotension (2.9%).  The addn. of nitroglycerin to induction chemotherapy and concurrent chemoradiotherapy in patients with locally advanced NSCLC has an acceptable toxicity profile and supports the possibility to add nitroglycerin to chemotherapy and radiotherapy.  A randomized trial is warranted to confirm these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJPoRgcw7V4rVg90H21EOLACvtfcHk0limiD8vNoFQzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVaqsb4%253D&md5=f15e376b5dd9889921b5a875395a3664</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2014.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2014.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DArrieta%26aufirst%3DO.%26aulast%3DBlake%26aufirst%3DM.%26aulast%3Dde%2Bla%2BMata-Moya%26aufirst%3DM.%2BD.%26aulast%3DCorona%26aufirst%3DF.%26aulast%3DTurcott%26aufirst%3DJ.%26aulast%3DOrta%26aufirst%3DD.%26aulast%3DAlexander-Alatorre%26aufirst%3DJ.%26aulast%3DGallardo-Rincon%26aufirst%3DD.%26atitle%3DPhase%2520II%2520Study.%2520Concurrent%2520Chemotherapy%2520and%2520Radiotherapy%2520with%2520Nitroglycerin%2520in%2520Locally%2520Advanced%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DRadiother.%2520Oncol.%26date%3D2014%26volume%3D111%26spage%3D311%26epage%3D315%26doi%3D10.1016%2Fj.radonc.2014.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Illum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hittson, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrisi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta, S.</span><span> </span><span class="NLM_article-title">Phase I Dose Escalation Trial of Nitroglycerin in Addition to 5-Fluorouracil and Radiation Therapy for Neoadjuvant Treatment of Operable Rectal Cancer</span> <span class="citation_source-journal">Surgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1016/j.surg.2015.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.surg.2015.04.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2015&pages=460-465&author=H.+Illumauthor=D.+H.+Wangauthor=J.+E.+Dowellauthor=W.+J.+Hittsonauthor=J.+R.+Torrisiauthor=J.+Meyerauthor=S.+Huerta&title=Phase+I+Dose+Escalation+Trial+of+Nitroglycerin+in+Addition+to+5-Fluorouracil+and+Radiation+Therapy+for+Neoadjuvant+Treatment+of+Operable+Rectal+Cancer&doi=10.1016%2Fj.surg.2015.04.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.surg.2015.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.surg.2015.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DIllum%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%2BH.%26aulast%3DDowell%26aufirst%3DJ.%2BE.%26aulast%3DHittson%26aufirst%3DW.%2BJ.%26aulast%3DTorrisi%26aufirst%3DJ.%2BR.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DHuerta%26aufirst%3DS.%26atitle%3DPhase%2520I%2520Dose%2520Escalation%2520Trial%2520of%2520Nitroglycerin%2520in%2520Addition%2520to%25205-Fluorouracil%2520and%2520Radiation%2520Therapy%2520for%2520Neoadjuvant%2520Treatment%2520of%2520Operable%2520Rectal%2520Cancer%26jtitle%3DSurgery%26date%3D2015%26volume%3D158%26spage%3D460%26epage%3D465%26doi%3D10.1016%2Fj.surg.2015.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Weyerbrock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walbridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluta, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E. H.</span><span> </span><span class="NLM_article-title">Selective Opening of the Blood-Tumor Barrier by a Nitric Oxide Donor and Long-Term Survival in Rats with C6 Gliomas</span> <span class="citation_source-journal">J. Neurosurg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">737</span><span class="refDoi"> DOI: 10.3171/jns.2003.99.4.0728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3171%2Fjns.2003.99.4.0728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=14567609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=728-737&author=A.+Weyerbrockauthor=S.+Walbridgeauthor=R.+M.+Plutaauthor=J.+E.+Saavedraauthor=L.+K.+Keeferauthor=E.+H.+Oldfield&title=Selective+Opening+of+the+Blood-Tumor+Barrier+by+a+Nitric+Oxide+Donor+and+Long-Term+Survival+in+Rats+with+C6+Gliomas&doi=10.3171%2Fjns.2003.99.4.0728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas</span></div><div class="casAuthors">Weyerbrock, Astrid; Walbridge, Stuart; Pluta, Ryszard M.; Saavedra, Joseph E.; Keefer, Larry K.; Oldfield, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurosurgery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">728-737</span>CODEN:
                <span class="NLM_cas:coden">JONSAC</span>;
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neurological Surgeons</span>)
        </div><div class="casAbstract">Object: The response of brain tumors to systemic chemotherapy is limited by the blood-tumor barrier (BTB).  Nitric oxide (NO) has been implicated in the regulation of vascular permeability and blood flow.  The authors evaluated the effects of exogenous NO, which was released from a short-acting NO donor (Proli/NO), and those of NO metabolites on the capillary permeability of tumors and normal brain tissue by using quant. autoradiog. in a C6 glioma model in rats.  Methods: The Proli/NO was infused at a wide dose range (10-2 to 10-12 M) either i.v. or into the internal carotid artery (ICA) and demonstrated substantial tumor-selective increases in blood-brain barrier (BBB) permeability in response to various-sized tracers ([14C]aminoisobutyric acid, [14C]sucrose, [14C]dextran).  Internal carotid artery or i.v. administration of sodium nitrite had a comparable effect on BTB permeability.  The NO effect on microvascular permeability could be obtained without causing hemodynamic side effects.  The effect of NO on the efficacy of carboplatin chemotherapy was investigated in intracerebral C6 gliomas.  Simultaneous i.v. infusions of Proli/NO (10-6M) and carboplatin (20 mg/kg) led to long-term survival in 40% of rats harboring intracerebral C6 gliomas compared with control animals receiving ICA or i.v. infusions of carboplatin, Proli/NO, or vehicle alone.  No residual tumor was demonstrated on histol. or magnetic resonance imaging studies performed in rats treated with Proli/NO and carboplatin, and no toxicity was obsd.  Conclusions: This new approach demonstrated the in vivo efficacy and safety of NO and nitrite in enhancing the delivery of systemically delivered radiolabeled tracers and carboplatin into rat gliomas.  The NO-induced tumor-selective BBB disruption and i.v. carboplatin chemotherapy may be more efficacious than current chemotherapy strategies against brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq65ERaBxc3tLVg90H21EOLACvtfcHk0liha3fEiCcSqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlGht7Y%253D&md5=eadaf39862f167b837939aebe68c6b00</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.3171%2Fjns.2003.99.4.0728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252Fjns.2003.99.4.0728%26sid%3Dliteratum%253Aachs%26aulast%3DWeyerbrock%26aufirst%3DA.%26aulast%3DWalbridge%26aufirst%3DS.%26aulast%3DPluta%26aufirst%3DR.%2BM.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DOldfield%26aufirst%3DE.%2BH.%26atitle%3DSelective%2520Opening%2520of%2520the%2520Blood-Tumor%2520Barrier%2520by%2520a%2520Nitric%2520Oxide%2520Donor%2520and%2520Long-Term%2520Survival%2520in%2520Rats%2520with%2520C6%2520Gliomas%26jtitle%3DJ.%2520Neurosurg.%26date%3D2003%26volume%3D99%26spage%3D728%26epage%3D737%26doi%3D10.3171%2Fjns.2003.99.4.0728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Pervin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gau, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edamatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, G.</span><span> </span><span class="NLM_article-title">Potentiation of Nitric Oxide-Induced Apoptosis of MDA-MB-468 Cells by Farnesyltransferase Inhibitor: Implications in Breast Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4701-4706&author=S.+Pervinauthor=R.+Singhauthor=C.+L.+Gauauthor=H.+Edamatsuauthor=F.+Tamanoiauthor=G.+Chaudhuri&title=Potentiation+of+Nitric+Oxide-Induced+Apoptosis+of+MDA-MB-468+Cells+by+Farnesyltransferase+Inhibitor%3A+Implications+in+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPervin%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGau%26aufirst%3DC.%2BL.%26aulast%3DEdamatsu%26aufirst%3DH.%26aulast%3DTamanoi%26aufirst%3DF.%26aulast%3DChaudhuri%26aufirst%3DG.%26atitle%3DPotentiation%2520of%2520Nitric%2520Oxide-Induced%2520Apoptosis%2520of%2520MDA-MB-468%2520Cells%2520by%2520Farnesyltransferase%2520Inhibitor%253A%2520Implications%2520in%2520Breast%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4701%26epage%3D4706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollica, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, L.</span><span> </span><span class="NLM_article-title">Nitric Oxide in Cancer Metastasis</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/j.canlet.2014.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.canlet.2014.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=25079686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2014&pages=1-7&author=H.+Chengauthor=L.+Wangauthor=M.+Mollicaauthor=A.+T.+Reauthor=S.+Wuauthor=L.+Zuo&title=Nitric+Oxide+in+Cancer+Metastasis&doi=10.1016%2Fj.canlet.2014.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide in cancer metastasis</span></div><div class="casAuthors">Cheng, Huiwen; Wang, Lei; Mollica, Molly; Re, Anthony T.; Wu, Shiyong; Zuo, Li</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer metastasis is the spread and growth of tumor cells from the original neoplasm to further organs.  This review analyzes the role of nitric oxide (NO·), a signaling mol., in the regulation of cancer formation, progression, and metastasis.  The action of NO· on cancer relies on multiple factors including cell type, metastasis stage, and organs involved.  Various chemotherapy drugs cause cells to release NO·, which in turn induces cytotoxic death of breast, liver, and skin tumors.  However, NO· has also been clin. connected to a poor cancer prognosis because of its role in angiogenesis and intravasation.  This supports the claim that NO· can be characterized as both pro-metastatic and anti-metastatic, depending on specific factors.  The inhibition of cell proliferation and anti-apoptosis pathways by NO· donors has been proposed as a novel therapy to various cancers.  Studies suggest that NO·-releasing non-steroidal anti-inflammatory drugs act on cancer cells in several ways that may make them ideal for cancer therapy.  This review summarizes the biol. significance of NO· in each step of cancer metastasis, its controversial effects for cancer progression, and its therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojyaaZ0M2vlrVg90H21EOLACvtfcHk0liha3fEiCcSqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kgsr3P&md5=f711f0dcfb072e6e847a1000b84f673e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMollica%26aufirst%3DM.%26aulast%3DRe%26aufirst%3DA.%2BT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DL.%26atitle%3DNitric%2520Oxide%2520in%2520Cancer%2520Metastasis%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D353%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.canlet.2014.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Huerta-Yepez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazirehi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garban, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hongo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span> </span><span class="NLM_article-title">Nitric Oxide Sensitizes Prostate Carcinoma Cell Lines to TRAIL-Mediated Apoptosis via Inactivation of NF-kappa B and Inhibition of Bcl-xl Expression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4993</span><span class="NLM_x">–</span> <span class="NLM_lpage">5003</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2Fsj.onc.1207655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15048072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVOgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4993-5003&author=S.+Huerta-Yepezauthor=M.+Vegaauthor=A.+Jazirehiauthor=H.+Garbanauthor=F.+Hongoauthor=G.+Chengauthor=B.+Bonavida&title=Nitric+Oxide+Sensitizes+Prostate+Carcinoma+Cell+Lines+to+TRAIL-Mediated+Apoptosis+via+Inactivation+of+NF-kappa+B+and+Inhibition+of+Bcl-xl+Expression&doi=10.1038%2Fsj.onc.1207655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression</span></div><div class="casAuthors">Huerta-Yepez, Sara; Vega, Mario; Jazirehi, Ali; Garban, Hermes; Hongo, Fumiya; Cheng, Genhong; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">4993-5003</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be selective in the induction of apoptosis in cancer cells with minimal toxicity to normal tissues and this prompted its potential therapeutic application in cancer.  However, not all cancers are sensitive to TRAIL-mediated apoptosis and, therefore, TRAIL-resistant cancer cells must be sensitized first to become sensitive to TRAIL.  Treatment of prostate cancer (CaP) cell lines (DU145, PC-3, CL-1, and LNCaP) with nitric oxide donors (e.g. (Z)-1-[2-(2-aminoethyl)-N-(2-ammonio-ethyl)amino]diazen-1-ium-1, 2-diolate (DETANONOate)) sensitized CaP cells to TRAIL-induced apoptosis and synergy was achieved.  The mechanism by which DETANONOate mediated the sensitization was examd.  DETANONOate inhibited the constitutive NF-κB activity as assessed by EMSA.  Also, p50 was S-nitrosylated by DETANONOate resulting in inhibition of NF-κB.  Inhibition of NF-κB activity by the chem. inhibitor Bay 11-7085, like DETANONOate, sensitized CaP to TRAIL apoptosis.  In addn., DETANONOate downregulated the expression of Bcl-2 related gene (Bcl-xL) which is under the transcriptional regulation of NF-κB.  The regulation of NF-κB and Bcl-xL by DETANONOate was corroborated by the use of Bcl-xL and Bcl-x κB reporter systems.  DETANONOate inhibited luciferase activity in the wild type and had no effect on the mutant cells.  Inhibition of NF-κB resulted in downregulation of Bcl-xL expression and sensitized CaP to TRAIL-induced apoptosis.  The role of Bcl-xL in the regulation of TRAIL apoptosis was corroborated by inhibiting Bcl-xL function by the chem. inhibitor 2-methoxyantimycin A3 and this resulted in sensitization of the cells to TRAIL apoptosis.  Signaling by DETANONOate and TRAIL for apoptosis was examd.  DETANONOate altered the mitochondria by inducing membrane depolarization and releasing modest amts. of cytochrome c and Smac/DIABLO in the absence of downstream activation of caspases 9 and 3.  However, the combination of DETANONOate and TRAIL resulted in activation of the mitochondrial pathway and activation of caspases 9 and 3, and induction of apoptosis.  These findings demonstrate that DETANONOate-mediated sensitization of CaP to TRAIL-induced apoptosis is via inhibition of constitutive NF-κB activity and Bcl-xL expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvoc0SpgHnVbVg90H21EOLACvtfcHk0li_S34AEWbYaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVOgu7k%253D&md5=e03b48d73ce4da043cefc45fefacace3</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207655%26sid%3Dliteratum%253Aachs%26aulast%3DHuerta-Yepez%26aufirst%3DS.%26aulast%3DVega%26aufirst%3DM.%26aulast%3DJazirehi%26aufirst%3DA.%26aulast%3DGarban%26aufirst%3DH.%26aulast%3DHongo%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DNitric%2520Oxide%2520Sensitizes%2520Prostate%2520Carcinoma%2520Cell%2520Lines%2520to%2520TRAIL-Mediated%2520Apoptosis%2520via%2520Inactivation%2520of%2520NF-kappa%2520B%2520and%2520Inhibition%2520of%2520Bcl-xl%2520Expression%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D4993%26epage%3D5003%26doi%3D10.1038%2Fsj.onc.1207655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Perez-Sala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cernuda-Morollon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Cazorla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Pascual, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, S.</span><span> </span><span class="NLM_article-title">Posttranscriptional Regulation of Human iNOS by the NO/cGMP Pathway</span> <span class="citation_source-journal">Am. J. Physiol.: Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">F466</span><span class="NLM_x">–</span> <span class="NLM_lpage">F473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11181408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD3M7lvVyiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2001&pages=F466-F473&author=D.+Perez-Salaauthor=E.+Cernuda-Morollonauthor=M.+Diaz-Cazorlaauthor=F.+Rodriguez-Pascualauthor=S.+Lamas&title=Posttranscriptional+Regulation+of+Human+iNOS+by+the+NO%2FcGMP+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranscriptional regulation of human iNOS by the NO/cGMP pathway</span></div><div class="casAuthors">Perez-Sala D; Cernuda-Morollon E; Diaz-Cazorla M; Rodriguez-Pascual F; Lamas S</div><div class="citationInfo"><span class="NLM_cas:title">American journal of physiology. Renal physiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">F466-73</span>
        ISSN:<span class="NLM_cas:issn">1931-857X</span>.
    </div><div class="casAbstract">Nitric oxide (NO) and cGMP may exert positive or negative effects on inducible NO synthase (iNOS) expression.  We have explored the influence of the NO/cGMP pathway on iNOS levels in human mesangial cells.  Inhibition of NOS activity during an 8-h stimulation with IL-1beta plus tumor necrosis factor (TNF)-alpha reduced iNOS levels, while NO donors amplified iNOS induction threefold.  However, time-course studies revealed a subsequent inhibitory effect of NO donors on iNOS protein and mRNA levels.  This suggests that NO may contribute both to iNOS induction and downregulation.  Soluble guanylyl cyclase (sGC) activation may be involved in these effects.  Inhibition of sGC attenuated IL-1beta/TNF-alpha-elicited iNOS induction and reduced NO-driven amplification.  Interestingly, cGMP analogs also modulated iNOS protein and mRNA levels in a biphasic manner.  Inhibition of transcription unveiled a negative posttranscriptional modulation of the iNOS transcript by NO and cGMP at late times of induction.  Supplementation with 8-bromo-cGMP (8-BrcGMP) reduced iNOS mRNA stability by 50%.  These observations evidence a complex feedback regulation of iNOS expression, in which posttranscriptional mechanisms may play an important role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtD3RE95x5gHqj_yg7twvpfW6udTcc2ebfn-U0hLsCU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7lvVyiug%253D%253D&md5=e3b6661482094369a26b0c4320ace409</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Sala%26aufirst%3DD.%26aulast%3DCernuda-Morollon%26aufirst%3DE.%26aulast%3DDiaz-Cazorla%26aufirst%3DM.%26aulast%3DRodriguez-Pascual%26aufirst%3DF.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DPosttranscriptional%2520Regulation%2520of%2520Human%2520iNOS%2520by%2520the%2520NO%252FcGMP%2520Pathway%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Renal%2520Physiol.%26date%3D2001%26volume%3D280%26spage%3DF466%26epage%3DF473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Somasundaram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadhan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">K. Hemalatha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Sengodan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivas, P.</span><span> </span><span class="NLM_article-title">Nitric Oxide and Reactive Oxygen Species: Clues to Target Oxidative Damage Repair Defective Breast Cancers</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1016/j.critrevonc.2016.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.critrevonc.2016.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=27017408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BC28fktFCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=184-192&author=V.+Somasundaramauthor=R.+Nadhanauthor=S.+K.+Hemalathaauthor=S.+Kumar+Sengodanauthor=P.+Srinivas&title=Nitric+Oxide+and+Reactive+Oxygen+Species%3A+Clues+to+Target+Oxidative+Damage+Repair+Defective+Breast+Cancers&doi=10.1016%2Fj.critrevonc.2016.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers</span></div><div class="casAuthors">Somasundaram Veena; Nadhan Revathy; K Hemalatha Sreelatha; Kumar Sengodan Satheesh; Srinivas Priya</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">184-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The identification of various biomolecules in cancer progression and therapy has led to the exploration of the roles of two cardinal players, namely Nitric Oxide (NO) and Reactive Oxygen Species (ROS) in cancer.  Both ROS and NO display bimodal fashions of functional activity in a concentration dependent manner, by inducing either pro- or anti- tumorigenic signals.  Researchers have identified the potential capability of NO and ROS in therapies owing to their role in eliciting pro-apoptotic signals at higher concentrations and their ability to sensitize cancer cells to one another as well as to other therapeutics.  We review the prospects of NO and ROS in cancer progression and therapy, and analyze the role of a combinatorial therapy wherein an NO donor (SNAP) is used to sensitize the oxidative damage repair defective, triple negative breast cancer cells (HCC 1937) to a potent ROS inducer.  Preliminary findings support the potential to employ various combinatorial regimes for anti-cancer therapies with regard to exploiting the chemo-sensitization property of NO donors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHDyAqvzDMu56KlWarZTAzfW6udTcc2ebfn-U0hLsCU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fktFCruw%253D%253D&md5=7b4d294d5f3f0d680c0d44197d791db7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2016.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSomasundaram%26aufirst%3DV.%26aulast%3DNadhan%26aufirst%3DR.%26aulast%3DK.%2BHemalatha%26aufirst%3DS.%26aulast%3DKumar%2BSengodan%26aufirst%3DS.%26aulast%3DSrinivas%26aufirst%3DP.%26atitle%3DNitric%2520Oxide%2520and%2520Reactive%2520Oxygen%2520Species%253A%2520Clues%2520to%2520Target%2520Oxidative%2520Damage%2520Repair%2520Defective%2520Breast%2520Cancers%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2016%26volume%3D101%26spage%3D184%26epage%3D192%26doi%3D10.1016%2Fj.critrevonc.2016.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Leung, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Exercise, Vascular Wall and Cardiovascular Diseases: an Update (Part 1)</span> <span class="citation_source-journal">Sports Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span><span class="refDoi"> DOI: 10.2165/00007256-200838120-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2165%2F00007256-200838120-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=19026018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD1cjmtVemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1009-1024&author=F.+P.+Leungauthor=L.+M.+Yungauthor=I.+Laherauthor=X.+Yaoauthor=Z.+Y.+Chenauthor=Y.+Huang&title=Exercise%2C+Vascular+Wall+and+Cardiovascular+Diseases%3A+an+Update+%28Part+1%29&doi=10.2165%2F00007256-200838120-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Exercise, vascular wall and cardiovascular diseases: an update (Part 1)</span></div><div class="casAuthors">Leung Fung Ping; Yung Lai Ming; Laher Ismail; Yao Xiaoqiang; Chen Zhen Yu; Huang Yu</div><div class="citationInfo"><span class="NLM_cas:title">Sports medicine (Auckland, N.Z.)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1009-24</span>
        ISSN:<span class="NLM_cas:issn">0112-1642</span>.
    </div><div class="casAbstract">Cardiovascular disease (CVD) remains the leading cause of morbidity and premature mortality in both women and men in most industrialized countries, and has for some time also established a prominent role in developing nations.  In fact, obesity, diabetes mellitus and hypertension are now commonplace even in children and youths.  Regular exercise is rapidly gaining widespread advocacy as a preventative measure in schools, medical circles and in the popular media.  There is overwhelming evidence garnered from a number of sources, including epidemiological, prospective cohort and intervention studies, suggesting that CVD is largely a disease associated with physical inactivity.  A rapidly advancing body of human and animal data confirms an important beneficial role for exercise in the prevention and treatment of CVD.  In Part 1 of this review we discuss the impact of exercise on CVD, and we highlight the effects of exercise on (i) endothelial function by regulation of endothelial genes mediating oxidative metabolism, inflammation, apoptosis, cellular growth and proliferation, increased superoxide dismutase (SOD)-1, down-regulation of p67phox, changes in intracellular calcium level, increased vascular endothelial nitric oxide synthase (eNOS), expression and eNOS Ser-1177 phosphorylation; (ii) vascular smooth muscle function by either an increased affinity of the Ca2+ extrusion mechanism or an augmented Ca2+ buffering system by the superficial sarcoplasmic reticulum to increase Ca2+ sequestration, increase in K+ channel activity and/or expression, and increase in L-type Ca2+ current density; (iii) antioxidant systems by elevation of Mn-SOD, Cu/Zn-SOD and catalase, increases in glutathione peroxidase activity and activation of vascular nicotinamide adenine dinucleotide phosphate [(NAD(P)H] oxidase and p22phox expression; (iv) heat shock protein (HSP) expression by stimulating HSP70 expression in myocardium, skeletal muscle and even in human leucocytes, probably through heat shock transcription factor 1 activity; (v) inflammation by reducing serum inflammatory cytokines such as high-sensitivity C-reactive protein (hCRP), interleukin (IL)-6, IL-18 and tumour necrosis factor-alpha and by regulating Toll-like receptor 4 pathway.  Exercise also alters vascular remodelling, which involves two forms of vessel growth including angiogenesis and arteriogenesis.  Angiogenesis refers to the formation of new capillary networks.  Arteriogenesis refers to the growth of pre-existent collateral arterioles leading to formation of large conductance arteries that are well capable to compensate for the loss of function of occluded arteries.  Another aim of this review is to focus on exercise-related cardiovascular protection against CVD and associated risk factors such as aging, coronary heart disease, hypertension, heart failure, diabetes mellitus and peripheral arterial diseases mediated by vascular remodelling.  Lastly, this review examines the benefits of exercise in mitigating pre-eclampsia during pregnancy by mechanisms that include improved blood flow, reduced blood pressure, enhanced placental growth and vascularity, increased activity of antioxidant enzymes, reduced oxidative stress and restored vascular endothelial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4BLIm92IRbJVVjGoY74BafW6udTcc2eb6v1clitGLwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjmtVemtA%253D%253D&md5=f180f24da17acc3c04872470100bf219</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2165%2F00007256-200838120-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00007256-200838120-00005%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DF.%2BP.%26aulast%3DYung%26aufirst%3DL.%2BM.%26aulast%3DLaher%26aufirst%3DI.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%2BY.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DExercise%252C%2520Vascular%2520Wall%2520and%2520Cardiovascular%2520Diseases%253A%2520an%2520Update%2520%2528Part%25201%2529%26jtitle%3DSports%2520Med.%26date%3D2008%26volume%3D38%26spage%3D1009%26epage%3D1024%26doi%3D10.2165%2F00007256-200838120-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Esterase-Sensitive Nitric Oxide Donors of the Diazeniumdiolate Family: in Vitro Antileukemic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1021/jm9903850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9903850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=261-269&author=J.+E.+Saavedraauthor=P.+J.+Shamiauthor=L.+Y.+Wangauthor=K.+M.+Daviesauthor=M.+N.+Boothauthor=M.+L.+Citroauthor=L.+K.+Keefer&title=Esterase-Sensitive+Nitric+Oxide+Donors+of+the+Diazeniumdiolate+Family%3A+in+Vitro+Antileukemic+Activity&doi=10.1021%2Fjm9903850"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm9903850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9903850%26sid%3Dliteratum%253Aachs%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DBooth%26aufirst%3DM.%2BN.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DEsterase-Sensitive%2520Nitric%2520Oxide%2520Donors%2520of%2520the%2520Diazeniumdiolate%2520Family%253A%2520in%2520Vitro%2520Antileukemic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D261%26epage%3D269%26doi%3D10.1021%2Fjm9903850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trikha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honn, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Synthesis of Peptide-Diazeniumdiolate Conjugates: Towards Enzyme Activated Antitumor Agents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2625</span><span class="NLM_x">–</span> <span class="NLM_lpage">2629</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)00263-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS0040-4039%2801%2900263-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=2625-2629&author=X.+Tangauthor=M.+Xianauthor=M.+Trikhaauthor=K.+V.+Honnauthor=P.+G.+Wang&title=Synthesis+of+Peptide-Diazeniumdiolate+Conjugates%3A+Towards+Enzyme+Activated+Antitumor+Agents&doi=10.1016%2FS0040-4039%2801%2900263-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900263-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900263-5%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXian%26aufirst%3DM.%26aulast%3DTrikha%26aufirst%3DM.%26aulast%3DHonn%26aufirst%3DK.%2BV.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520of%2520Peptide-Diazeniumdiolate%2520Conjugates%253A%2520Towards%2520Enzyme%2520Activated%2520Antitumor%2520Agents%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D2625%26epage%3D2629%26doi%3D10.1016%2FS0040-4039%2801%2900263-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Cai, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagorski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauschweiger, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and Cytotoxicity of 5-Fluorouracil/Diazeniumdiolate Conjugates</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4971</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span><span class="refDoi"> DOI: 10.1016/j.bmc.2003.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2003.09.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4971-4975&author=T.+B.+Caiauthor=X.+Tangauthor=J.+Nagorskiauthor=P.+G.+Brauschweigerauthor=P.+G.+Wang&title=Synthesis+and+Cytotoxicity+of+5-Fluorouracil%2FDiazeniumdiolate+Conjugates&doi=10.1016%2Fj.bmc.2003.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2003.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2003.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DT.%2BB.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DNagorski%26aufirst%3DJ.%26aulast%3DBrauschweiger%26aufirst%3DP.%2BG.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520Cytotoxicity%2520of%25205-Fluorouracil%252FDiazeniumdiolate%2520Conjugates%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4971%26epage%3D4975%26doi%3D10.1016%2Fj.bmc.2003.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifant, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diwan, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">JS-K, a Glutathione/Glutathione S-Transferase-Activated Nitric Oxide Donor of the Diazeniumdiolate Class with Potent Antineoplastic Activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=12700285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=409-417&author=P.+J.+Shamiauthor=J.+E.+Saavedraauthor=L.+Y.+Wangauthor=C.+L.+Bonifantauthor=B.+A.+Diwanauthor=S.+V.+Singhauthor=Y.+Guauthor=S.+D.+Foxauthor=G.+S.+Buzardauthor=M.+L.+Citroauthor=D.+J.+Waterhouseauthor=K.+M.+Daviesauthor=X.+Jiauthor=L.+K.+Keefer&title=JS-K%2C+a+Glutathione%2FGlutathione+S-Transferase-Activated+Nitric+Oxide+Donor+of+the+Diazeniumdiolate+Class+with+Potent+Antineoplastic+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity</span></div><div class="casAuthors">Shami, Paul J.; Saavedra, Joseph E.; Wang, Lai Y.; Bonifant, Challice L.; Diwan, Bhalchandra A.; Singh, Shivendra V.; Gu, Yijun; Fox, Stephen D.; Buzard, Gregory S.; Citro, Michael L.; Waterhouse, David J.; Davies, Keith M.; Ji, Xinhua; Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have previously shown that nitric oxide (NO) inhibits growth and induces differentiation and apoptosis in acute myeloid leukemia cells, with the HL-60 human myeloid leukemia line being particularly sensitive to NO-mediated cytolysis.  With the goal of identifying a prodrug that can target NO to the leukemia cells without inducing NO-mediated systemic hypotension, we have screened a series of O2-aryl diazeniumdiolates designed to be stable at physiol. pH but to release NO upon reaction with glutathione.  O2-(2,4-Dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate (JS-K) proved to be the most active antiproliferative agent among those tested in HL-60 cells, with an IC50 of 0.2-0.5 μM.  After 5 days of exposure to 0.5 μM JS-K, HL-60 cells had differentiated and acquired some of the phenotypic features of normal monocytes.  One- to 2-day treatment with JS-K at concns. of 0.5-1 μM resulted in apoptosis induction in a concn.- and caspase-dependent manner.  JS-K also inhibited the growth of solid tumor cell lines but to a lesser extent than HL-60 cells.  JS-K was administered i.v. to nonobese diabetic-severe combined immune deficient mice at doses of up to 4 μmol/kg without inducing significant hypotension.  The growth of s.c. implanted HL-60 cells was reduced by ∼50% when the mice received i.v. injections three times/wk with 4 μmol/kg boluses of JS-K.  Histol. examn. of tumor explants from JS-K-treated animals revealed extensive necrosis.  Similar results were seen with s.c. human prostate cancer (PPC-1) xenografts.  Our data indicate that JS-K is a promising lead compd. for the possible development of a novel class of antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq3gucZoE5B7Vg90H21EOLACvtfcHk0lhlsETLkMfuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVykurw%253D&md5=8fce66d93ad3af64032d4216ce03663c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DBonifant%26aufirst%3DC.%2BL.%26aulast%3DDiwan%26aufirst%3DB.%2BA.%26aulast%3DSingh%26aufirst%3DS.%2BV.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DFox%26aufirst%3DS.%2BD.%26aulast%3DBuzard%26aufirst%3DG.%2BS.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DWaterhouse%26aufirst%3DD.%2BJ.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DJS-K%252C%2520a%2520Glutathione%252FGlutathione%2520S-Transferase-Activated%2520Nitric%2520Oxide%2520Donor%2520of%2520the%2520Diazeniumdiolate%2520Class%2520with%2520Potent%2520Antineoplastic%2520Activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifant, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanklin, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flippen-Anderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">The Secondary Amine/Nitric Oxide Complex Ion R(2)N[N(O)NO](-) as Nucleophile and Leaving Group in S<sub>N</sub>Ar Reactions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">3090</span><span class="NLM_x">–</span> <span class="NLM_lpage">3098</span><span class="refDoi"> DOI: 10.1021/jo0016529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0016529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=3090-3098&author=J.+E.+Saavedraauthor=A.+Srinivasanauthor=C.+L.+Bonifantauthor=J.+Chuauthor=A.+P.+Shanklinauthor=J.+L.+Flippen-Andersonauthor=W.+G.+Riceauthor=J.+A.+Turpinauthor=K.+M.+Daviesauthor=L.+K.+Keefer&title=The+Secondary+Amine%2FNitric+Oxide+Complex+Ion+R%282%29N%5BN%28O%29NO%5D%28-%29+as+Nucleophile+and+Leaving+Group+in+SNAr+Reactions&doi=10.1021%2Fjo0016529"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjo0016529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0016529%26sid%3Dliteratum%253Aachs%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DBonifant%26aufirst%3DC.%2BL.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DShanklin%26aufirst%3DA.%2BP.%26aulast%3DFlippen-Anderson%26aufirst%3DJ.%2BL.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DTurpin%26aufirst%3DJ.%2BA.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DThe%2520Secondary%2520Amine%252FNitric%2520Oxide%2520Complex%2520Ion%2520R%25282%2529N%255BN%2528O%2529NO%255D%2528-%2529%2520as%2520Nucleophile%2520and%2520Leaving%2520Group%2520in%2520SNAr%2520Reactions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D3090%26epage%3D3098%26doi%3D10.1021%2Fjo0016529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifant, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udupi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaviya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Antitumor Activity of JS-K [O<sup>2</sup>-(2,4-Dinitrophenyl) 1-[(4-Ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and Related O<sup>2</sup>-Aryl Diazeniumdiolates in Vitro and in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4366</span><span class="refDoi"> DOI: 10.1021/jm060022h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060022h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4356-4366&author=P.+J.+Shamiauthor=J.+E.+Saavedraauthor=C.+L.+Bonifantauthor=J.+Chuauthor=V.+Udupiauthor=S.+Malaviyaauthor=B.+I.+Carrauthor=S.+Karauthor=M.+Wangauthor=L.+Jiaauthor=X.+Jiauthor=L.+K.+Keefer&title=Antitumor+Activity+of+JS-K+%5BO2-%282%2C4-Dinitrophenyl%29+1-%5B%284-Ethoxycarbonyl%29piperazin-1-yl%5Ddiazen-1-ium-1%2C2-diolate%5D+and+Related+O2-Aryl+Diazeniumdiolates+in+Vitro+and+in+Vivo&doi=10.1021%2Fjm060022h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm060022h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060022h%26sid%3Dliteratum%253Aachs%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DBonifant%26aufirst%3DC.%2BL.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DUdupi%26aufirst%3DV.%26aulast%3DMalaviya%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DB.%2BI.%26aulast%3DKar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DAntitumor%2520Activity%2520of%2520JS-K%2520%255BO2-%25282%252C4-Dinitrophenyl%2529%25201-%255B%25284-Ethoxycarbonyl%2529piperazin-1-yl%255Ddiazen-1-ium-1%252C2-diolate%255D%2520and%2520Related%2520O2-Aryl%2520Diazeniumdiolates%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4356%26epage%3D4366%26doi%3D10.1021%2Fjm060022h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">McMurtry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieves-Alicea, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, A. M.</span><span> </span><span class="NLM_article-title">JS-K, a Nitric Oxide-Releasing Prodrug, Induces Breast Cancer Cell Death while Sparing Normal Mammary Epithelial Cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span><span class="refDoi"> DOI: 10.3892/ijo.2011.925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3892%2Fijo.2011.925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21271218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ansbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=963-971&author=V.+McMurtryauthor=J.+E.+Saavedraauthor=R.+Nieves-Aliceaauthor=A.+M.+Simeoneauthor=L.+K.+Keeferauthor=A.+M.+Tari&title=JS-K%2C+a+Nitric+Oxide-Releasing+Prodrug%2C+Induces+Breast+Cancer+Cell+Death+while+Sparing+Normal+Mammary+Epithelial+Cells&doi=10.3892%2Fijo.2011.925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells</span></div><div class="casAuthors">McMurtry, Vanity; Saavedra, Joseph E.; Nieves-Alicea, Rene; Simeone, Ann-Marie; Keefer, Larry K.; Tari, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">963-971</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Targeted therapy with reduced side effects is a major goal in cancer research.  We investigated the effects of JS-K, a nitric oxide (NO) prodrug designed to release high levels of NO when suitably activated, on human breast cancer cell lines, on non-transformed human MCF-10A mammary cells, and on normal human mammary epithelial cells (HMECs).  Cell viability assay, flow cytometry, electron microscopy, and Western blot anal. were used to study the effects of JS-K on breast cancer and on mammary epithelial cells.  After a 3-day incubation, the IC50s of JS-K against the breast cancer cells ranged from 0.8 to 3 μM.  However, JS-K decreased the viability of the MCF-10A cells by only 20% at 10-μM concn., and HMECs were unaffected by 10 μM JS-K.  Flow cytometry indicated that JS-K increased the percentages of breast cancer cells under-going apoptosis.  Interestingly, flow cytometry indicated that JS-K increased acidic vesicle organelle formation in breast cancer cells, suggesting that JS-K induced autophagy in breast cancer cells.  Electron microscopy confirmed that JS-K-treated breast cancer cells underwent autophagic cell death.  Western blot anal. showed that JS-K induced the expression of microtubule light chain 3-II, another autophagy marker, in breast cancer cells.  However, JS-K did not induce apoptosis or autophagy in normal human mammary epithelial cells.  These data indicate that JS-K selectively induces programmed cell death in breast cancer cells while sparing normal mammary epithelial cells under the same conditions.  The selective antitumor activity of JS-K warrants its further investigation in breast tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTq-8Uk8jxErVg90H21EOLACvtfcHk0lhlsETLkMfuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ansbY%253D&md5=2b6454ea99b81468c4d99c8efb8fbc94</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3892%2Fijo.2011.925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2011.925%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurtry%26aufirst%3DV.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DNieves-Alicea%26aufirst%3DR.%26aulast%3DSimeone%26aufirst%3DA.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DTari%26aufirst%3DA.%2BM.%26atitle%3DJS-K%252C%2520a%2520Nitric%2520Oxide-Releasing%2520Prodrug%252C%2520Induces%2520Breast%2520Cancer%2520Cell%2520Death%2520while%2520Sparing%2520Normal%2520Mammary%2520Epithelial%2520Cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3D963%26epage%3D971%26doi%3D10.3892%2Fijo.2011.925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuellar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span><span class="refDoi"> DOI: 10.1021/jm050700k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050700k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1157-1164&author=J.+E.+Saavedraauthor=A.+Srinivasanauthor=G.+S.+Buzardauthor=K.+M.+Daviesauthor=D.+J.+Waterhouseauthor=K.+Inamiauthor=T.+C.+Wildeauthor=M.+L.+Citroauthor=M.+Cuellarauthor=J.+R.+Deschampsauthor=D.+Parrishauthor=P.+J.+Shamiauthor=V.+J.+Findlayauthor=D.+M.+Townsendauthor=K.+D.+Tewauthor=S.+Singhauthor=L.+Jiaauthor=X.+Jiauthor=L.+K.+Keefer&title=PABA%2FNO+as+an+Anticancer+Lead%3A+Analogue+Synthesis%2C+Structure+Revision%2C+Solution+Chemistry%2C+Reactivity+toward+Glutathione%2C+and+in+Vitro+Activity&doi=10.1021%2Fjm050700k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity</span></div><div class="casAuthors">Saavedra, Joseph E.; Srinivasan, Aloka; Buzard, Gregory S.; Davies, Keith M.; Waterhouse, David J.; Inami, Keiko; Wilde, Thomas C.; Citro, Michael L.; Cuellar, Matthew; Deschamps, Jeffrey R.; Parrish, Damon; Shami, Paul J.; Findlay, Victoria J.; Townsend, Danyelle M.; Tew, Kenneth D.; Singh, Shivendra; Jia, Lee; Ji, Xinhua; Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1157-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PABA/NO is a diazeniumdiolate of structure Me2NN(O):NOAr (where Ar is a 5-substituted-2,4-dinitrophenyl ring whose 5-substituent is N-methyl-p-aminobenzoic acid).  It has shown activity against human ovarian cancer xenografts in mice rivaling that of cisplatin, but it is poorly sol. and relatively unstable in water.  Here the authors report structure-based optimization efforts resulting in three analogs with improved soly. and stability in aq. soln.  The authors sought to explain PABA/NO's physicochem. uniqueness among these four compds., whose aminobenzoic acid precursors differ structurally only in the presence or absence of the N-Me group and/or the position of the carboxyl moiety (meta or para).  Studies revealed that PABA/NO's N-methyl-p-aminobenzoic acid substituent is bound to the dinitrobenzene ring via its carboxyl oxygen while the other three are linked through the aniline nitrogen.  This constitutes a revision of the previously published PABA/NO structure.  All four analogs reacted with GSH to produce bioactive nitric oxide (NO), but PABA/NO was the most reactive.  Consistent with PABA/NO's potent suppression of A2780 human ovarian cancer xenograft growth in mice, it was the most potent of the four in the OVCAR-3 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6_G3hkDYlCrVg90H21EOLACvtfcHk0lixJ9OAZMHrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGnsg%253D%253D&md5=93c8ea5bcdf33ee7d920099bac125794</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm050700k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050700k%26sid%3Dliteratum%253Aachs%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DBuzard%26aufirst%3DG.%2BS.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DWaterhouse%26aufirst%3DD.%2BJ.%26aulast%3DInami%26aufirst%3DK.%26aulast%3DWilde%26aufirst%3DT.%2BC.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DCuellar%26aufirst%3DM.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DParrish%26aufirst%3DD.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DFindlay%26aufirst%3DV.%2BJ.%26aulast%3DTownsend%26aufirst%3DD.%2BM.%26aulast%3DTew%26aufirst%3DK.%2BD.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DPABA%252FNO%2520as%2520an%2520Anticancer%2520Lead%253A%2520Analogue%2520Synthesis%252C%2520Structure%2520Revision%252C%2520Solution%2520Chemistry%252C%2520Reactivity%2520toward%2520Glutathione%252C%2520and%2520in%2520Vitro%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1157%26epage%3D1164%26doi%3D10.1021%2Fjm050700k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Chakrapani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodblatt, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span> </span><span class="NLM_article-title">Synthesis, Nitric Oxide Release, and Anti-Leukemic Activity of Glutathione-Activated Nitric Oxide Prodrugs: Structural Analogues of PABA/NO, an Anti-Cancer Lead Compound</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2657</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span><span class="refDoi"> DOI: 10.1016/j.bmc.2007.11.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2007.11.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2657-2664&author=H.+Chakrapaniauthor=T.+C.+Wildeauthor=M.+L.+Citroauthor=M.+M.+Goodblattauthor=L.+K.+Keeferauthor=J.+E.+Saavedra&title=Synthesis%2C+Nitric+Oxide+Release%2C+and+Anti-Leukemic+Activity+of+Glutathione-Activated+Nitric+Oxide+Prodrugs%3A+Structural+Analogues+of+PABA%2FNO%2C+an+Anti-Cancer+Lead+Compound&doi=10.1016%2Fj.bmc.2007.11.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.035%26sid%3Dliteratum%253Aachs%26aulast%3DChakrapani%26aufirst%3DH.%26aulast%3DWilde%26aufirst%3DT.%2BC.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DGoodblatt%26aufirst%3DM.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%252C%2520Nitric%2520Oxide%2520Release%252C%2520and%2520Anti-Leukemic%2520Activity%2520of%2520Glutathione-Activated%2520Nitric%2520Oxide%2520Prodrugs%253A%2520Structural%2520Analogues%2520of%2520PABA%252FNO%252C%2520an%2520Anti-Cancer%2520Lead%2520Compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2657%26epage%3D2664%26doi%3D10.1016%2Fj.bmc.2007.11.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Maciag, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandurdikar, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diwan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span> </span><span class="NLM_article-title">Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7751</span><span class="NLM_x">–</span> <span class="NLM_lpage">7758</span><span class="refDoi"> DOI: 10.1021/jm2004128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2004128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7751-7758&author=A.+E.+Maciagauthor=R.+S.+Nandurdikarauthor=S.+Y.+Hongauthor=H.+Chakrapaniauthor=B.+Diwanauthor=N.+L.+Morrisauthor=P.+J.+Shamiauthor=Y.+H.+Shiaoauthor=L.+M.+Andersonauthor=L.+K.+Keeferauthor=J.+E.+Saavedra&title=Activation+of+the+c-Jun+N-terminal+Kinase%2FActivating+Transcription+Factor+3+%28ATF3%29+Pathway+Characterizes+Effective+Arylated+Diazeniumdiolate-Based+Nitric+Oxide-Releasing+Anticancer+Prodrugs&doi=10.1021%2Fjm2004128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm2004128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004128%26sid%3Dliteratum%253Aachs%26aulast%3DMaciag%26aufirst%3DA.%2BE.%26aulast%3DNandurdikar%26aufirst%3DR.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BY.%26aulast%3DChakrapani%26aufirst%3DH.%26aulast%3DDiwan%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DN.%2BL.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DShiao%26aufirst%3DY.%2BH.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26atitle%3DActivation%2520of%2520the%2520c-Jun%2520N-terminal%2520Kinase%252FActivating%2520Transcription%2520Factor%25203%2520%2528ATF3%2529%2520Pathway%2520Characterizes%2520Effective%2520Arylated%2520Diazeniumdiolate-Based%2520Nitric%2520Oxide-Releasing%2520Anticancer%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7751%26epage%3D7758%26doi%3D10.1021%2Fjm2004128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Nandurdikar, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shami, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span> </span><span class="NLM_article-title">Structural Modifications Modulate Stability of Glutathione-Activated Arylated Diazeniumdiolate Prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3094</span><span class="NLM_x">–</span> <span class="NLM_lpage">3099</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.02.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2012.02.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3094-3099&author=R.+S.+Nandurdikarauthor=A.+E.+Maciagauthor=R.+J.+Hollandauthor=Z.+Caoauthor=P.+J.+Shamiauthor=L.+M.+Andersonauthor=L.+K.+Keeferauthor=J.+E.+Saavedra&title=Structural+Modifications+Modulate+Stability+of+Glutathione-Activated+Arylated+Diazeniumdiolate+Prodrugs&doi=10.1016%2Fj.bmc.2012.02.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.02.045%26sid%3Dliteratum%253Aachs%26aulast%3DNandurdikar%26aufirst%3DR.%2BS.%26aulast%3DMaciag%26aufirst%3DA.%2BE.%26aulast%3DHolland%26aufirst%3DR.%2BJ.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DShami%26aufirst%3DP.%2BJ.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26atitle%3DStructural%2520Modifications%2520Modulate%2520Stability%2520of%2520Glutathione-Activated%2520Arylated%2520Diazeniumdiolate%2520Prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3094%26epage%3D3099%26doi%3D10.1016%2Fj.bmc.2012.02.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Xue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Diazeniumdiolate-Based DNA Cross-Linking Agents Activatable by Glutathione S-Transferase</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5196</span><span class="NLM_x">–</span> <span class="NLM_lpage">5199</span><span class="refDoi"> DOI: 10.1021/acs.orglett.6b02222</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b02222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=5196-5199&author=R.+Xueauthor=J.+Wuauthor=X.+Luoauthor=Y.+Gongauthor=Y.+Huangauthor=X.+Shenauthor=H.+Zhangauthor=Y.+Zhangauthor=Z.+Huang&title=Design%2C+Synthesis%2C+and+Evaluation+of+Diazeniumdiolate-Based+DNA+Cross-Linking+Agents+Activatable+by+Glutathione+S-Transferase&doi=10.1021%2Facs.orglett.6b02222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b02222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b02222%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Diazeniumdiolate-Based%2520DNA%2520Cross-Linking%2520Agents%2520Activatable%2520by%2520Glutathione%2520S-Transferase%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D5196%26epage%3D5199%26doi%3D10.1021%2Facs.orglett.6b02222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Danson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranson, M.</span><span> </span><span class="NLM_article-title">DT-Diaphorase: a Target for New Anticancer Drugs</span> <span class="citation_source-journal">Cancer Treat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1016/j.ctrv.2004.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.ctrv.2004.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15245776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=437-449&author=S.+Dansonauthor=T.+H.+Wardauthor=J.+Butlerauthor=M.+Ranson&title=DT-Diaphorase%3A+a+Target+for+New+Anticancer+Drugs&doi=10.1016%2Fj.ctrv.2004.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase: a target for new anticancer drugs</span></div><div class="casAuthors">Danson, S.; Ward, T. H.; Butler, J.; Ranson, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">437-449</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  DT-diaphorase (DTD) is an obligate two-electron reductase which bioactivates chemotherapeutic quinones.  DTD levels are elevated in a no. of tumor types, including non-small cell lung carcinoma, colorectal carcinoma, liver cancers and breast carcinomas, when compared to the surrounding normal tissue.  The differential in DTD between tumor and normal tissue should allow targeted activation of chemotherapeutic quinones in the tumor while minimizing normal tissue toxicity.  The prototypical bioreductive drug is Mitomycin C (MMC) which is widely used in clin. practice.  However, MMC is actually a relatively poor substrate for DTD and its metab. is pH-dependent.  Other bioreductive drugs have failed because of poor soly. and inability to surpass other agents in use.  RH1, a novel diaziridinylbenzoquinone, is a more efficient substrate for DTD.  It has been demonstrated to have antitumor effects both in vitro and in vivo and demonstrates a relation between DTD expression levels and drug response.  RH1 has recently entered a phase I clin. trial in solid tumors under the auspices of Cancer Research UK.  Recent work has demonstrated that DTD is present in the nucleus and is assocd. with both p53 and the heat shock protein, HSP-70.  Furthermore, DTD is inducible by several non-toxic compds. and therefor much interest has focused on increasing the differential in DTD levels between tumor and normal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTa2ivqkvQC7Vg90H21EOLACvtfcHk0lgv-cbu-ZZd6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyiu7o%253D&md5=9a43dc5c2a78dbf513a7a775b80082b3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2004.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2004.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DDanson%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DT.%2BH.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DRanson%26aufirst%3DM.%26atitle%3DDT-Diaphorase%253A%2520a%2520Target%2520for%2520New%2520Anticancer%2520Drugs%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2004%26volume%3D30%26spage%3D437%26epage%3D449%26doi%3D10.1016%2Fj.ctrv.2004.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Hernick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borch, R. F.</span><span> </span><span class="NLM_article-title">Studies on the Mechanisms of Activation of Indolequinone Phosphoramidate Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span><span class="refDoi"> DOI: 10.1021/jm0203229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0203229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=148-154&author=M.+Hernickauthor=R.+F.+Borch&title=Studies+on+the+Mechanisms+of+Activation+of+Indolequinone+Phosphoramidate+Prodrugs&doi=10.1021%2Fjm0203229"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm0203229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0203229%26sid%3Dliteratum%253Aachs%26aulast%3DHernick%26aufirst%3DM.%26aulast%3DBorch%26aufirst%3DR.%2BF.%26atitle%3DStudies%2520on%2520the%2520Mechanisms%2520of%2520Activation%2520of%2520Indolequinone%2520Phosphoramidate%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D148%26epage%3D154%26doi%3D10.1021%2Fjm0203229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Hernick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flader, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borch, R. F.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Indolequinone Phosphoramidate Prodrugs Targeted to DT-Diaphorase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3540</span><span class="NLM_x">–</span> <span class="NLM_lpage">3548</span><span class="refDoi"> DOI: 10.1021/jm020191b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020191b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3540-3548&author=M.+Hernickauthor=C.+Fladerauthor=R.+F.+Borch&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Indolequinone+Phosphoramidate+Prodrugs+Targeted+to+DT-Diaphorase&doi=10.1021%2Fjm020191b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm020191b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020191b%26sid%3Dliteratum%253Aachs%26aulast%3DHernick%26aufirst%3DM.%26aulast%3DFlader%26aufirst%3DC.%26aulast%3DBorch%26aufirst%3DR.%2BF.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Indolequinone%2520Phosphoramidate%2520Prodrugs%2520Targeted%2520to%2520DT-Diaphorase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3540%26epage%3D3548%26doi%3D10.1021%2Fjm020191b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">The Synthesis of a c(RGDyK) Targeted SN38 Prodrug with an Indolequinone Structure for Bioreductive Drug Release</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1021/ol1002626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol1002626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1384-1387&author=B.+Huangauthor=A.+Desaiauthor=S.+Tangauthor=T.+P.+Thomasauthor=J.+R.+Baker&title=The+Synthesis+of+a+c%28RGDyK%29+Targeted+SN38+Prodrug+with+an+Indolequinone+Structure+for+Bioreductive+Drug+Release&doi=10.1021%2Fol1002626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release</span></div><div class="casAuthors">Huang, Baohua; Desai, Ankur; Tang, Shengzhuang; Thomas, Thommey P.; Baker, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1384-1387</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prepn. of a novel c(RGDyK) targeted SN38 prodrug incorporating an indolequinone structure for bioreductively triggered drug release is described.  This design yields a prodrug that targets surface mols. on tumor cells (αvβ3 integrins) and releases drug under bioreductive conditions.  There are three moieties in the prodrug design, namely a therapeutic drug SN38, an indolequinone structure serving as a drug releasing trigger, and an αvβ3 integrin targeting peptide c(RGDyK).  Preliminary studies showed that SN38 is released in the presence of a bioreductive enzyme (DT-diaphorase).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMclRawXbgtLVg90H21EOLACvtfcHk0liZqK_yAstvYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D&md5=36b6b14c51b9834b7f656e3cc72fce2f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fol1002626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1002626%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DDesai%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DT.%2BP.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Synthesis%2520of%2520a%2520c%2528RGDyK%2529%2520Targeted%2520SN38%2520Prodrug%2520with%2520an%2520Indolequinone%2520Structure%2520for%2520Bioreductive%2520Drug%2520Release%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1384%26epage%3D1387%26doi%3D10.1021%2Fol1002626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Sharma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2636</span><span class="NLM_x">–</span> <span class="NLM_lpage">2639</span><span class="refDoi"> DOI: 10.1021/ol400884v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol400884v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2636-2639&author=K.+Sharmaauthor=A.+Iyerauthor=K.+Senguptaauthor=H.+Chakrapani&title=INDQ%2FNO%2C+a+Bioreductively+Activated+Nitric+Oxide+Prodrug&doi=10.1021%2Fol400884v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug</span></div><div class="casAuthors">Sharma, Kavita; Iyer, Aishwarya; Sengupta, Kundan; Chakrapani, Harinath</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2636-2639</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and development of INDQ/NO (I), a novel nitric oxide (NO) prodrug targeted by a bioreductive trigger, are described.  INDQ/NO, an indolequinone-diazeniumdiolate is found to be metabolized to produce NO by DT-diaphorase, a bioreductive enzyme that is overexpressed in certain cancers and hypoxic tumors.  Cell-based assays revealed that INDQ/NO induces DNA damage and is a potent inhibitor of cancer cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRYc6gjSC-QLVg90H21EOLACvtfcHk0liZqK_yAstvYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D&md5=3ccdb7f8bc30a84663f69eacae91b506</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fol400884v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol400884v%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DSengupta%26aufirst%3DK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DINDQ%252FNO%252C%2520a%2520Bioreductively%2520Activated%2520Nitric%2520Oxide%2520Prodrug%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D2636%26epage%3D2639%26doi%3D10.1021%2Fol400884v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Tranoy-Opalinski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papot, S.</span><span> </span><span class="NLM_article-title">Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.2174/187152008785133065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F187152008785133065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18690826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ogsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=618-637&author=I.+Tranoy-Opalinskiauthor=A.+Fernandesauthor=M.+Thomasauthor=J.+P.+Gessonauthor=S.+Papot&title=Design+of+Self-Immolative+Linkers+for+Tumour-Activated+Prodrug+Therapy&doi=10.2174%2F187152008785133065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Design of self-immolative linkers for tumour-activated prodrug therapy</span></div><div class="casAuthors">Tranoy-Opalinski, I.; Fernandes, A.; Thomas, M.; Gesson, J.-P.; Papot, S.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-637</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The main drawback of most cancer chemotherapy is its relatively low ability to target tumor cells vs. normal cells.  As a consequence, chemotherapy is usually connected with severe side effects due to the toxicity of traditional cytostatic agents towards normal tissues.  A few years ago, the site-specific activation of nontoxic prodrugs in tumors has been proposed in order to enhance the selectivity for the killing of cancer cells.  Within this framework, most of the prodrugs that have been designed were three part compds. comprising trigger, linker and effector units.  The main function of the linker is to release the effector unit after selective trigger activation via a spontaneous chem. breakdown.  However, its structure also affects significantly many prodrug properties such as stability, pharmacokinetic, organ distribution, bioavailability or trigger activation.  This review, focussed on the linker unit, is an update of the previous article published in 2002.  It deals with recent advances in the design of prodrug linkers including new delivery systems such as elongated linkers or self-immolative dendrimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeb-2jcsWQx7Vg90H21EOLACvtfcHk0lj1k61NfS9ocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ogsr8%253D&md5=c11a530c32537ef25c5789e0a8573d91</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.2174%2F187152008785133065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152008785133065%26sid%3Dliteratum%253Aachs%26aulast%3DTranoy-Opalinski%26aufirst%3DI.%26aulast%3DFernandes%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DPapot%26aufirst%3DS.%26atitle%3DDesign%2520of%2520Self-Immolative%2520Linkers%2520for%2520Tumour-Activated%2520Prodrug%2520Therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D618%26epage%3D637%26doi%3D10.2174%2F187152008785133065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Sharma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">Nitroreductase-Activated Nitric Oxide (NO) Prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5964</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2013.08.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5964-5967&author=K.+Sharmaauthor=K.+Senguptaauthor=H.+Chakrapani&title=Nitroreductase-Activated+Nitric+Oxide+%28NO%29+Prodrugs&doi=10.1016%2Fj.bmcl.2013.08.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.066%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DSengupta%26aufirst%3DK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DNitroreductase-Activated%2520Nitric%2520Oxide%2520%2528NO%2529%2520Prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5964%26epage%3D5967%26doi%3D10.1016%2Fj.bmcl.2013.08.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Dharmaraja, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrapani, H.</span><span> </span><span class="NLM_article-title">Arylboronate Ester Based Diazeniumdiolates (BORO/NO), a Class of Hdrogen Peroxide Inducible Nitric Oxide (NO) Donors</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2610</span><span class="NLM_x">–</span> <span class="NLM_lpage">2613</span><span class="refDoi"> DOI: 10.1021/ol5010643</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5010643" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=2610-2613&author=A.+T.+Dharmarajaauthor=G.+Ravikumarauthor=H.+Chakrapani&title=Arylboronate+Ester+Based+Diazeniumdiolates+%28BORO%2FNO%29%2C+a+Class+of+Hdrogen+Peroxide+Inducible+Nitric+Oxide+%28NO%29+Donors&doi=10.1021%2Fol5010643"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fol5010643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5010643%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26aulast%3DRavikumar%26aufirst%3DG.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DArylboronate%2520Ester%2520Based%2520Diazeniumdiolates%2520%2528BORO%252FNO%2529%252C%2520a%2520Class%2520of%2520Hdrogen%2520Peroxide%2520Inducible%2520Nitric%2520Oxide%2520%2528NO%2529%2520Donors%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D2610%26epage%3D2613%26doi%3D10.1021%2Fol5010643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Glycosylated Diazeniumdiolates: a Novel Class of Enzyme-Activated Nitric Oxide Donors</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3779</span><span class="NLM_x">–</span> <span class="NLM_lpage">3782</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)00614-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2FS0040-4039%2801%2900614-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=3779-3782&author=X.+Wuauthor=X.+Tangauthor=M.+Xianauthor=P.+G.+Wang&title=Glycosylated+Diazeniumdiolates%3A+a+Novel+Class+of+Enzyme-Activated+Nitric+Oxide+Donors&doi=10.1016%2FS0040-4039%2801%2900614-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900614-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900614-1%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXian%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DGlycosylated%2520Diazeniumdiolates%253A%2520a%2520Novel%2520Class%2520of%2520Enzyme-Activated%2520Nitric%2520Oxide%2520Donors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D3779%26epage%3D3782%26doi%3D10.1016%2FS0040-4039%2801%2900614-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">A Glycosylated Nitric Oxide Donor, beta-Gal-NONOate, and Its Site-Specific Antitumor Activity</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span><span class="refDoi"> DOI: 10.1002/ardp.200500262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fardp.200500262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16783837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVCntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2006&pages=366-371&author=C.+Chenauthor=Y.+Shiauthor=S.+Liauthor=Q.+Qiauthor=L.+Guauthor=J.+Songauthor=P.+G.+Wang&title=A+Glycosylated+Nitric+Oxide+Donor%2C+beta-Gal-NONOate%2C+and+Its+Site-Specific+Antitumor+Activity&doi=10.1002%2Fardp.200500262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A glycosylated nitric oxide donor, β-Gal-NONOate, and its site-specific antitumor activity</span></div><div class="casAuthors">Chen, Chang; Shi, Yanqiu; Li, Song; Qi, Qingsheng; Gu, Li; Song, Jing; Wang, Peng George</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">366-371</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">So far, nitric oxide (NO) donors have been applied to various aspects of antitumor therapy.  To selectively sensitize tumor cells and avoid unwanted side effects, we recently synthesized a β-galactosidase-activatable NO-releasing compd., β-galactosyl-pyrrolidinyl diazeniumdiolate (β-Gal-NONOate).  In this study, we first verified its superiority over its parent diazeniumdiolate (NONOate) in terms of targeted intracellular NO-releasing and antitumor activity with 9L/LacZ cells (rat glioma cell line 9L with transformed LacZ gene) in vitro.  β-Gal-NONOate only released NO when hydrolyzed by induced β-galactosidase in 9L/LacZ cells, which led to its more powerful cytotoxicity than that of NONOate.  The results showed that β-Gal-NONOate produced higher NO levels than NONOate in 9L/LacZ cells at equal concn., and hence induced optimal NO levels for antitumor activity.  However, in 9L cells, β-Gal-NONOate showed less toxicity than NONOate.  Therefore, it is demonstrated that β-Gal-NONOate is a site-specific prodrug for targeting NO intracellularly as a β-galactosidase-sensitive NO donor, and it is also expected to be a promising probe in numerous exptl. settings and a potential therapeutic drug for antitumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAn8ARlq47MrVg90H21EOLACvtfcHk0lj1k61NfS9ocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVCntb4%253D&md5=b2405c0574573df391bc1afb38024aa0</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fardp.200500262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200500262%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DA%2520Glycosylated%2520Nitric%2520Oxide%2520Donor%252C%2520beta-Gal-NONOate%252C%2520and%2520Its%2520Site-Specific%2520Antitumor%2520Activity%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2006%26volume%3D339%26spage%3D366%26epage%3D371%26doi%3D10.1002%2Fardp.200500262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Cai, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landerholm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. G.</span><span> </span><span class="NLM_article-title">Sialated Diazeniumdiolate: A New Sialidase-Activated Nitric Oxide Donor</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4203</span><span class="NLM_x">–</span> <span class="NLM_lpage">4205</span><span class="refDoi"> DOI: 10.1021/ol048397p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol048397p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4203-4205&author=T.+B.+Caiauthor=D.+Luauthor=M.+Landerholmauthor=P.+G.+Wang&title=Sialated+Diazeniumdiolate%3A+A+New+Sialidase-Activated+Nitric+Oxide+Donor&doi=10.1021%2Fol048397p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fol048397p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048397p%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DT.%2BB.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DLanderholm%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DP.%2BG.%26atitle%3DSialated%2520Diazeniumdiolate%253A%2520A%2520New%2520Sialidase-Activated%2520Nitric%2520Oxide%2520Donor%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4203%26epage%3D4205%26doi%3D10.1021%2Fol048397p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Valdez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citro, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Gayar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleicher, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Hydrolytic Reactivity Trends among Potential Prodrugs of the O<sup>2</sup>-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3961</span><span class="NLM_x">–</span> <span class="NLM_lpage">3970</span><span class="refDoi"> DOI: 10.1021/jm8000482</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8000482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3961-3970&author=C.+A.+Valdezauthor=J.+E.+Saavedraauthor=B.+M.+Showalterauthor=K.+M.+Daviesauthor=T.+C.+Wildeauthor=M.+L.+Citroauthor=J.+J.+Barchiauthor=J.+R.+Deschampsauthor=D.+Parrishauthor=S.+El-Gayarauthor=U.+Schleicherauthor=C.+Bogdanauthor=L.+K.+Keefer&title=Hydrolytic+Reactivity+Trends+among+Potential+Prodrugs+of+the+O2-Glycosylated+Diazeniumdiolate+Family.+Targeting+Nitric+Oxide+to+Macrophages+for+Antileishmanial+Activity&doi=10.1021%2Fjm8000482"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm8000482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8000482%26sid%3Dliteratum%253Aachs%26aulast%3DValdez%26aufirst%3DC.%2BA.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DShowalter%26aufirst%3DB.%2BM.%26aulast%3DDavies%26aufirst%3DK.%2BM.%26aulast%3DWilde%26aufirst%3DT.%2BC.%26aulast%3DCitro%26aufirst%3DM.%2BL.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DParrish%26aufirst%3DD.%26aulast%3DEl-Gayar%26aufirst%3DS.%26aulast%3DSchleicher%26aufirst%3DU.%26aulast%3DBogdan%26aufirst%3DC.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DHydrolytic%2520Reactivity%2520Trends%2520among%2520Potential%2520Prodrugs%2520of%2520the%2520O2-Glycosylated%2520Diazeniumdiolate%2520Family.%2520Targeting%2520Nitric%2520Oxide%2520to%2520Macrophages%2520for%2520Antileishmanial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3961%26epage%3D3970%26doi%3D10.1021%2Fjm8000482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Naimi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalili, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiebe, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, E. E.</span><span> </span><span class="NLM_article-title">Synthesis of 3′- and 5′-Nitrooxy Pyrimidine Nucleoside Nitrate Esters: "Nitric Oxide Donor" Agents for Evaluation as Anticancer and Antiviral Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1021/jm020299r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020299r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=995-1004&author=E.+Naimiauthor=A.+Zhouauthor=P.+Khaliliauthor=L.+I.+Wiebeauthor=J.+Balzariniauthor=E.+De+Clercqauthor=E.+E.+Knaus&title=Synthesis+of+3%E2%80%B2-+and+5%E2%80%B2-Nitrooxy+Pyrimidine+Nucleoside+Nitrate+Esters%3A+%22Nitric+Oxide+Donor%22+Agents+for+Evaluation+as+Anticancer+and+Antiviral+Agents&doi=10.1021%2Fjm020299r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm020299r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020299r%26sid%3Dliteratum%253Aachs%26aulast%3DNaimi%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DKhalili%26aufirst%3DP.%26aulast%3DWiebe%26aufirst%3DL.%2BI.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26atitle%3DSynthesis%2520of%25203%25E2%2580%25B2-%2520and%25205%25E2%2580%25B2-Nitrooxy%2520Pyrimidine%2520Nucleoside%2520Nitrate%2520Esters%253A%2520%2522Nitric%2520Oxide%2520Donor%2522%2520Agents%2520for%2520Evaluation%2520as%2520Anticancer%2520and%2520Antiviral%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D995%26epage%3D1004%26doi%3D10.1021%2Fjm020299r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Li, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Nitric Oxide-Releasing Hybrids from Gemcitabine and Phenylsulfonyl Furoxans as Anti-Tumor Agents</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.1039/C5MD00158G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FC5MD00158G" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1130-1136&author=X.+H.+Liauthor=X.+M.+Wangauthor=C.+J.+Xuauthor=J.+K.+Huangauthor=C.+N.+Wangauthor=X.+Y.+Wangauthor=L.+Q.+Heauthor=Y.+Ling&title=Synthesis+and+Biological+Evaluation+of+Nitric+Oxide-Releasing+Hybrids+from+Gemcitabine+and+Phenylsulfonyl+Furoxans+as+Anti-Tumor+Agents&doi=10.1039%2FC5MD00158G"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1039%2FC5MD00158G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00158G%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DXu%26aufirst%3DC.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DC.%2BN.%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DHe%26aufirst%3DL.%2BQ.%26aulast%3DLing%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520Hybrids%2520from%2520Gemcitabine%2520and%2520Phenylsulfonyl%2520Furoxans%2520as%2520Anti-Tumor%2520Agents%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1130%26epage%3D1136%26doi%3D10.1039%2FC5MD00158G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Antitumor Platinum(II) Complexes Containing Platinum-Based Moieties of Present Platinum Drugs and Furoxan Groups as Nitric Oxide Donors: Synthesis, DNA Interaction, and Cytotoxicity</span> <span class="citation_source-journal">Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">10317</span><span class="NLM_x">–</span> <span class="NLM_lpage">10324</span><span class="refDoi"> DOI: 10.1021/ic301374z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic301374z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=10317-10324&author=J.+Zhaoauthor=S.+Gouauthor=Y.+Sunauthor=L.+Fangauthor=Z.+Wang&title=Antitumor+Platinum%28II%29+Complexes+Containing+Platinum-Based+Moieties+of+Present+Platinum+Drugs+and+Furoxan+Groups+as+Nitric+Oxide+Donors%3A+Synthesis%2C+DNA+Interaction%2C+and+Cytotoxicity&doi=10.1021%2Fic301374z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fic301374z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic301374z%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAntitumor%2520Platinum%2528II%2529%2520Complexes%2520Containing%2520Platinum-Based%2520Moieties%2520of%2520Present%2520Platinum%2520Drugs%2520and%2520Furoxan%2520Groups%2520as%2520Nitric%2520Oxide%2520Donors%253A%2520Synthesis%252C%2520DNA%2520Interaction%252C%2520and%2520Cytotoxicity%26jtitle%3DInorg.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D10317%26epage%3D10324%26doi%3D10.1021%2Fic301374z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. M.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donor-Based Platinum Complexes as Potential Anticancer Agents</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">14276</span><span class="NLM_x">–</span> <span class="NLM_lpage">14281</span><span class="refDoi"> DOI: 10.1002/chem.201201605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fchem.201201605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23015473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=14276-14281&author=J.+Zhaoauthor=S.+H.+Gouauthor=Y.+Y.+Sunauthor=R.+T.+Yinauthor=Z.+M.+Wang&title=Nitric+Oxide+Donor-Based+Platinum+Complexes+as+Potential+Anticancer+Agents&doi=10.1002%2Fchem.201201605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Donor-Based Platinum Complexes as Potential Anticancer Agents</span></div><div class="casAuthors">Zhao, Jian; Gou, Shaohua; Sun, Yanyan; Yin, Runting; Wang, Zhimei</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14276-14281, S14276/1-S14276/14</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Several platinum complexes contg. nitrooxy acetate or 3-(nitrooxy)cyclobutane-1,1-dicarboxylate were synthesized and characterized.  The human anticancer activity of the complexes were studied.  The DNA binding activity of the complexes was also studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfqxDcMs5D7Vg90H21EOLACvtfcHk0lg4om3lFZb-GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtr%252FL&md5=a97e8528f669f61a284ef43e27550d51</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1002%2Fchem.201201605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201201605%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DY.%2BY.%26aulast%3DYin%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DZ.%2BM.%26atitle%3DNitric%2520Oxide%2520Donor-Based%2520Platinum%2520Complexes%2520as%2520Potential%2520Anticancer%2520Agents%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2012%26volume%3D18%26spage%3D14276%26epage%3D14281%26doi%3D10.1002%2Fchem.201201605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Bian, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. F.</span><span> </span><span class="NLM_article-title">Novel Antileukemic Agents Derived from Tamibarotene and Nitric Oxide Donors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7025</span><span class="NLM_x">–</span> <span class="NLM_lpage">7029</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2011.09.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7025-7029&author=H.+Y.+Bianauthor=J.+H.+Fengauthor=M.+Y.+Liauthor=W.+F.+Xu&title=Novel+Antileukemic+Agents+Derived+from+Tamibarotene+and+Nitric+Oxide+Donors&doi=10.1016%2Fj.bmcl.2011.09.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.103%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DH.%2BY.%26aulast%3DFeng%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DM.%2BY.%26aulast%3DXu%26aufirst%3DW.%2BF.%26atitle%3DNovel%2520Antileukemic%2520Agents%2520Derived%2520from%2520Tamibarotene%2520and%2520Nitric%2520Oxide%2520Donors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7025%26epage%3D7029%26doi%3D10.1016%2Fj.bmcl.2011.09.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. X.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Nitric Oxide-Donating Thalidomide Analogues as Anticancer Agents</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1002/cbdv.200800014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fcbdv.200800014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=19353543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=466-474&author=T.+Wangauthor=Y.+H.+Zhangauthor=X.+W.+Kongauthor=Y.+S.+Laiauthor=H.+Jiauthor=Y.+P.+Chenauthor=S.+X.+Peng&title=Synthesis+and+Biological+Evaluation+of+Nitric+Oxide-Donating+Thalidomide+Analogues+as+Anticancer+Agents&doi=10.1002%2Fcbdv.200800014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents</span></div><div class="casAuthors">Wang, Tao; Zhang, Yi-Hua; Kong, Xiang-Wen; Lai, Yi-Sheng; Ji, Hui; Chen, Yan-Ping; Peng, Si-Xun</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-474</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">In search of more potent anticancer agents, 15 nitric oxide (NO)-donating thalidomide analogs, e.g. I [X = (CH2)2, (CH2)3, CHMe(CH2)2, (CH2)4] were designed and synthesized.  Cytotoxicity of these compds. was evaluated in vitro against three human tumor cell lines (HepG2, A549, and PC-3).  The results indicated that I [X = (CH2)2, (CH2)3, CHMe(CH2)2, (CH2)4] exhibited notable anticancer activities comparable to or stronger than that of 5-fluorouracil (5-FU).  Structure-activity relationships were also discussed, based on the exptl. data obtained.  Generally, the cytotoxic activity of target compds. is closely related to the type of NO donors, and the length of the spacers connecting to NO donors also appears important for the bioactivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAx3kHdVYDP7Vg90H21EOLACvtfcHk0lg4om3lFZb-GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWgs78%253D&md5=5550fed1a768a0185674524948f4577e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200800014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200800014%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DKong%26aufirst%3DX.%2BW.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Nitric%2520Oxide-Donating%2520Thalidomide%2520Analogues%2520as%2520Anticancer%2520Agents%26jtitle%3DChem.%2520Biodiversity%26date%3D2009%26volume%3D6%26spage%3D466%26epage%3D474%26doi%3D10.1002%2Fcbdv.200800014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Nortcliffe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Hagan, D.</span><span> </span><span class="NLM_article-title">Synthesis and Anticancer Properties of RGD Peptides Conjugated to Nitric Oxide Releasing Functional Groups and Abiraterone</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8343</span><span class="NLM_x">–</span> <span class="NLM_lpage">8347</span><span class="refDoi"> DOI: 10.1016/j.tet.2014.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.tet.2014.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=8343-8347&author=A.+Nortcliffeauthor=I.+N.+Flemingauthor=N.+P.+Bottingauthor=D.+O%E2%80%99Hagan&title=Synthesis+and+Anticancer+Properties+of+RGD+Peptides+Conjugated+to+Nitric+Oxide+Releasing+Functional+Groups+and+Abiraterone&doi=10.1016%2Fj.tet.2014.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer properties of RGD peptides conjugated to nitric oxide releasing functional groups and abiraterone</span></div><div class="casAuthors">Nortcliffe, Andrew; Fleming, Ian N.; Botting, Nigel P.; O'Hagan, David</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">8343-8347</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of analogs of the integrin binding aspartic acid-glycine-arginine (RGD) peptide sequence were synthesized conjugated to nitric oxide (NO) donating functional groups.  Also, the cytotoxicity of abiraterone, a prostate cancer drug, was explored when it was conjugated in three part constructs to RGD sequences and NO releasing heterocycles.  In general the analogs showed integrin binding affinity comparable to RGD ref. compds., and all released NO by the Griess test assay.  Two analogs exhibited significant cytotoxic effects against PC3 and MCF7 cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraS8pJE0xG-LVg90H21EOLACvtfcHk0lhYSrxrqEN8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamt7nN&md5=f4fe0b3c9d8622b6affbc3b175665a6f</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2014.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2014.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DNortcliffe%26aufirst%3DA.%26aulast%3DFleming%26aufirst%3DI.%2BN.%26aulast%3DBotting%26aufirst%3DN.%2BP.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Anticancer%2520Properties%2520of%2520RGD%2520Peptides%2520Conjugated%2520to%2520Nitric%2520Oxide%2520Releasing%2520Functional%2520Groups%2520and%2520Abiraterone%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26spage%3D8343%26epage%3D8347%26doi%3D10.1016%2Fj.tet.2014.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Novel Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid: Synthesis and Evaluation of Antihepatocellular Carcinoma Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3251</span><span class="NLM_x">–</span> <span class="NLM_lpage">3259</span><span class="refDoi"> DOI: 10.1021/jm1014814</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1014814" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3251-3259&author=Y.+Lingauthor=X.+Yeauthor=Z.+Zhangauthor=Y.+Zhangauthor=Y.+Laiauthor=H.+Jiauthor=S.+Pengauthor=J.+Tian&title=Novel+Nitric+Oxide-Releasing+Derivatives+of+Farnesylthiosalicylic+Acid%3A+Synthesis+and+Evaluation+of+Antihepatocellular+Carcinoma+Activity&doi=10.1021%2Fjm1014814"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm1014814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014814%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DNovel%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Farnesylthiosalicylic%2520Acid%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Antihepatocellular%2520Carcinoma%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3251%26epage%3D3259%26doi%3D10.1021%2Fjm1014814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid as Anti-Tumor Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3456</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2010.03.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3448-3456&author=Y.+Lingauthor=X.+Yeauthor=H.+Jiauthor=Y.+Zhangauthor=Y.+Laiauthor=S.+Pengauthor=J.+Tian&title=Synthesis+and+Evaluation+of+Nitric+Oxide-Releasing+Derivatives+of+Farnesylthiosalicylic+Acid+as+Anti-Tumor+Agents&doi=10.1016%2Fj.bmc.2010.03.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.077%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Farnesylthiosalicylic%2520Acid%2520as%2520Anti-Tumor%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3448%26epage%3D3456%26doi%3D10.1016%2Fj.bmc.2010.03.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Han, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Novel Hybrids of (Phenylsulfonyl)Furoxan and Anilinopyrimidine as Potent and Selective Epidermal Growth Factor Receptor Inhibitors for Intervention of Non-Small-Cell Lung Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4748</span><span class="refDoi"> DOI: 10.1021/jm400463q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400463q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4738-4748&author=C.+Hanauthor=Z.+Huangauthor=C.+Zhengauthor=L.+Wanauthor=L.+Zhangauthor=S.+Pengauthor=K.+Dingauthor=H.+Jiauthor=J.+Tianauthor=Y.+Zhang&title=Novel+Hybrids+of+%28Phenylsulfonyl%29Furoxan+and+Anilinopyrimidine+as+Potent+and+Selective+Epidermal+Growth+Factor+Receptor+Inhibitors+for+Intervention+of+Non-Small-Cell+Lung+Cancer&doi=10.1021%2Fjm400463q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm400463q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400463q%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNovel%2520Hybrids%2520of%2520%2528Phenylsulfonyl%2529Furoxan%2520and%2520Anilinopyrimidine%2520as%2520Potent%2520and%2520Selective%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Inhibitors%2520for%2520Intervention%2520of%2520Non-Small-Cell%2520Lung%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4738%26epage%3D4748%26doi%3D10.1021%2Fjm400463q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Duan, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inks, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide Donor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4325</span><span class="NLM_x">–</span> <span class="NLM_lpage">4338</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00317</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4325-4338&author=W.+W.+Duanauthor=J.+Liauthor=E.+S.+Inksauthor=C.+J.+Chouauthor=Y.+P.+Jiaauthor=X.+J.+Chuauthor=X.+Y.+Liauthor=W.+F.+Xuauthor=Y.+J.+Zhang&title=Design%2C+Synthesis%2C+and+Antitumor+Evaluation+of+Novel+Histone+Deacetylase+Inhibitors+Equipped+with+a+Phenylsulfonylfuroxan+Module+as+a+Nitric+Oxide+Donor&doi=10.1021%2Facs.jmedchem.5b00317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00317%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DW.%2BW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DInks%26aufirst%3DE.%2BS.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DJia%26aufirst%3DY.%2BP.%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DXu%26aufirst%3DW.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antitumor%2520Evaluation%2520of%2520Novel%2520Histone%2520Deacetylase%2520Inhibitors%2520Equipped%2520with%2520a%2520Phenylsulfonylfuroxan%2520Module%2520as%2520a%2520Nitric%2520Oxide%2520Donor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4325%26epage%3D4338%26doi%3D10.1021%2Facs.jmedchem.5b00317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Maciag, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehareen, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keefer, L. K.</span><span> </span><span class="NLM_article-title">Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2292</span><span class="NLM_x">–</span> <span class="NLM_lpage">2302</span><span class="refDoi"> DOI: 10.1021/jm401550d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401550d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2292-2302&author=A.+E.+Maciagauthor=R.+J.+Hollandauthor=Y.+Kimauthor=V.+Kumariauthor=C.+E.+Luthersauthor=W.+S.+Sehareenauthor=D.+Biswasauthor=N.+L.+Morrisauthor=X.+H.+Jiauthor=L.+M.+Andersonauthor=J.+E.+Saavedraauthor=L.+K.+Keefer&title=Nitric+Oxide+%28NO%29+Releasing+Poly+ADP-ribose+Polymerase+1+%28PARP-1%29+Inhibitors+Targeted+to+Glutathione+S-Transferase+P1-Overexpressing+Cancer+Cells&doi=10.1021%2Fjm401550d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells</span></div><div class="casAuthors">Maciag, Anna E.; Holland, Ryan J.; Kim, Youseung; Kumari, Vandana; Luthers, Christina E.; Sehareen, Waheed S.; Biswas, Debanjan; Morris, Nicole L.; Ji, Xinhua; Anderson, Lucy M.; Saavedra, Joseph E.; Keefer, Larry K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2292-2302</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the antitumor effects of nitric oxide (NO) releasing derivs. of the PARP-1 inhibitor olaparib.  One compd. was prepd. by coupling the carboxyl group of another compd. and the free amino group of arylated diazeniumdiolated piperazine.  Anather analog has the same structure except that the F is replaced by H.  The resulting prodrugs are activated by glutathione in a reaction accelerated by glutathione S-transferase P1 (GSTP1), an enzyme frequently overexpressed in cancers.  This metab. generates NO plus a PARP-1 inhibitor simultaneously, consuming reducing equiv., leading to DNA damage concomitant with inhibition of DNA repair, and in the case of one of the compds. inducing crosslinking glutathionylation of proteins.  Two of the compds. reduced the growth rates of A549 human lung adenocarcinoma xenografts with no evidence of systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnGqAkHrJCMLVg90H21EOLACvtfcHk0liCcnPZRtfPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVWhsrc%253D&md5=01d074f9fa2adc7870bca6cdef9abab3</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm401550d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401550d%26sid%3Dliteratum%253Aachs%26aulast%3DMaciag%26aufirst%3DA.%2BE.%26aulast%3DHolland%26aufirst%3DR.%2BJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKumari%26aufirst%3DV.%26aulast%3DLuthers%26aufirst%3DC.%2BE.%26aulast%3DSehareen%26aufirst%3DW.%2BS.%26aulast%3DBiswas%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DN.%2BL.%26aulast%3DJi%26aufirst%3DX.%2BH.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DSaavedra%26aufirst%3DJ.%2BE.%26aulast%3DKeefer%26aufirst%3DL.%2BK.%26atitle%3DNitric%2520Oxide%2520%2528NO%2529%2520Releasing%2520Poly%2520ADP-ribose%2520Polymerase%25201%2520%2528PARP-1%2529%2520Inhibitors%2520Targeted%2520to%2520Glutathione%2520S-Transferase%2520P1-Overexpressing%2520Cancer%2520Cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2292%26epage%3D2302%26doi%3D10.1021%2Fjm401550d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Carradori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollica, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Monte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5667</span><span class="NLM_x">–</span> <span class="NLM_lpage">5679</span><span class="refDoi"> DOI: 10.3390/molecules20045667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3390%2Fmolecules20045667" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=5667-5679&author=S.+Carradoriauthor=A.+Mollicaauthor=C.+De+Monteauthor=A.+Graneseauthor=C.+T.+Supuran&title=Nitric+Oxide+Donors+and+Selective+Carbonic+Anhydrase+Inhibitors%3A+A+Dual+Pharmacological+Approach+for+the+Treatment+of+Glaucoma%2C+Cancer+and+Osteoporosis&doi=10.3390%2Fmolecules20045667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20045667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20045667%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DMollica%26aufirst%3DA.%26aulast%3DDe%2BMonte%26aufirst%3DC.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNitric%2520Oxide%2520Donors%2520and%2520Selective%2520Carbonic%2520Anhydrase%2520Inhibitors%253A%2520A%2520Dual%2520Pharmacological%2520Approach%2520for%2520the%2520Treatment%2520of%2520Glaucoma%252C%2520Cancer%2520and%2520Osteoporosis%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D5667%26epage%3D5679%26doi%3D10.3390%2Fmolecules20045667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Mojic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocca, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCubrey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1124/mol.112.077842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1124%2Fmol.112.077842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=700-710&author=M.+Mojicauthor=S.+Mijatovicauthor=D.+Maksimovic-Ivanicauthor=D.+Miljkovicauthor=S.+Stosic-Grujicicauthor=M.+Stankovicauthor=K.+Manganoauthor=S.+Travaliauthor=M.+Doniaauthor=P.+Fagoneauthor=M.+B.+Zoccaauthor=Y.+Al-Abedauthor=J.+A.+McCubreyauthor=F.+Nicoletti&title=Therapeutic+Potential+of+Nitric+Oxide-Modified+Drugs+in+Colon+Cancer+Cells&doi=10.1124%2Fmol.112.077842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.077842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.077842%26sid%3Dliteratum%253Aachs%26aulast%3DMojic%26aufirst%3DM.%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26aulast%3DStankovic%26aufirst%3DM.%26aulast%3DMangano%26aufirst%3DK.%26aulast%3DTravali%26aufirst%3DS.%26aulast%3DDonia%26aufirst%3DM.%26aulast%3DFagone%26aufirst%3DP.%26aulast%3DZocca%26aufirst%3DM.%2BB.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DTherapeutic%2520Potential%2520of%2520Nitric%2520Oxide-Modified%2520Drugs%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D700%26epage%3D710%26doi%3D10.1124%2Fmol.112.077842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antihepatocellular Carcinoma Activity of Nitric Oxide Releasing Derivatives of Oleanolic Acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4834</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span><span class="refDoi"> DOI: 10.1021/jm800167u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800167u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4834-4838&author=L.+Chenauthor=Y.+Zhangauthor=X.+Kongauthor=E.+Lanauthor=Z.+Huangauthor=S.+Pengauthor=D.+L.+Kaufmanauthor=J.+Tian&title=Design%2C+Synthesis%2C+and+Antihepatocellular+Carcinoma+Activity+of+Nitric+Oxide+Releasing+Derivatives+of+Oleanolic+Acid&doi=10.1021%2Fjm800167u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm800167u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800167u%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DKaufman%26aufirst%3DD.%2BL.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antihepatocellular%2520Carcinoma%2520Activity%2520of%2520Nitric%2520Oxide%2520Releasing%2520Derivatives%2520of%2520Oleanolic%2520Acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4834%26epage%3D4838%26doi%3D10.1021%2Fjm800167u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Synthesis and Anti-Human Hepatocellular Carcinoma Activity of New Nitric Oxide-Releasing Glycosyl Derivatives of Oleanolic Acid</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1039/B918846K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FB918846K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=632-639&author=Z.+Huangauthor=Y.+Zhangauthor=L.+Zhaoauthor=Y.+Jingauthor=Y.+Laiauthor=L.+Zhangauthor=Q.+Guoauthor=S.+Yuanauthor=J.+Zhangauthor=L.+Chenauthor=S.+Pengauthor=J.+Tian&title=Synthesis+and+Anti-Human+Hepatocellular+Carcinoma+Activity+of+New+Nitric+Oxide-Releasing+Glycosyl+Derivatives+of+Oleanolic+Acid&doi=10.1039%2FB918846K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1039%2FB918846K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB918846K%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DJing%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Anti-Human%2520Hepatocellular%2520Carcinoma%2520Activity%2520of%2520New%2520Nitric%2520Oxide-Releasing%2520Glycosyl%2520Derivatives%2520of%2520Oleanolic%2520Acid%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D632%26epage%3D639%26doi%3D10.1039%2FB918846K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Glycosylated Diazeniumdiolate-Based Oleanolic Acid Derivatives: Synthesis, in Vitro and in Vivo Biological Evaluation as Anti-Human Hepatocellular Carcinoma Agents</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3882</span><span class="NLM_x">–</span> <span class="NLM_lpage">3891</span><span class="refDoi"> DOI: 10.1039/c2ob25252j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2Fc2ob25252j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=3882-3891&author=Z.+Huangauthor=J.+Fuauthor=L.+Liuauthor=Y.+Sunauthor=Y.+Laiauthor=H.+Jiauthor=E.+E.+Knausauthor=J.+Tianauthor=Y.+Zhang&title=Glycosylated+Diazeniumdiolate-Based+Oleanolic+Acid+Derivatives%3A+Synthesis%2C+in+Vitro+and+in+Vivo+Biological+Evaluation+as+Anti-Human+Hepatocellular+Carcinoma+Agents&doi=10.1039%2Fc2ob25252j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25252j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25252j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DGlycosylated%2520Diazeniumdiolate-Based%2520Oleanolic%2520Acid%2520Derivatives%253A%2520Synthesis%252C%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Biological%2520Evaluation%2520as%2520Anti-Human%2520Hepatocellular%2520Carcinoma%2520Agents%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D3882%26epage%3D3891%26doi%3D10.1039%2Fc2ob25252j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Fu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Hybrid Molecule from O<sup>2</sup>-(2,4-Dinitrophenyl)diazeniumdiolate and Oleanolic Acid: A Glutathione S-Transferase π-Activated Nitric Oxide Prodrug with Selective Anti-Human Hepatocellular Carcinoma Activity and Improved Stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4641</span><span class="NLM_x">–</span> <span class="NLM_lpage">4655</span><span class="refDoi"> DOI: 10.1021/jm400393u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400393u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4641-4655&author=J.+J.+Fuauthor=L.+Liuauthor=Z.+J.+Huangauthor=Y.+S.+Laiauthor=H.+Jiauthor=S.+X.+Pengauthor=J.+D.+Tianauthor=Y.+H.+Zhang&title=Hybrid+Molecule+from+O2-%282%2C4-Dinitrophenyl%29diazeniumdiolate+and+Oleanolic+Acid%3A+A+Glutathione+S-Transferase+%CF%80-Activated+Nitric+Oxide+Prodrug+with+Selective+Anti-Human+Hepatocellular+Carcinoma+Activity+and+Improved+Stability&doi=10.1021%2Fjm400393u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm400393u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400393u%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DTian%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DHybrid%2520Molecule%2520from%2520O2-%25282%252C4-Dinitrophenyl%2529diazeniumdiolate%2520and%2520Oleanolic%2520Acid%253A%2520A%2520Glutathione%2520S-Transferase%2520%25CF%2580-Activated%2520Nitric%2520Oxide%2520Prodrug%2520with%2520Selective%2520Anti-Human%2520Hepatocellular%2520Carcinoma%2520Activity%2520and%2520Improved%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4641%26epage%3D4655%26doi%3D10.1021%2Fjm400393u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Fu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Identification of Nitric Oxide-Releasing Derivatives of Oleanolic Acid as Potential Anti-Colon Cancer Agents</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">19445</span><span class="NLM_x">–</span> <span class="NLM_lpage">19454</span><span class="refDoi"> DOI: 10.1039/C5RA00270B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FC5RA00270B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXis1Sksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=19445-19454&author=J.+J.+Fuauthor=Y.+Zouauthor=Z.+J.+Huangauthor=C.+Yanauthor=Q.+M.+Zhouauthor=H.+B.+Zhangauthor=Y.+S.+Laiauthor=S.+Pengauthor=Y.+H.+Zhang&title=Identification+of+Nitric+Oxide-Releasing+Derivatives+of+Oleanolic+Acid+as+Potential+Anti-Colon+Cancer+Agents&doi=10.1039%2FC5RA00270B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of nitric oxide-releasing derivatives of oleanolic acid as potential anti-colon cancer agents</span></div><div class="casAuthors">Fu, Junjie; Zou, Yu; Huang, Zhangjian; Yan, Chang; Zhou, Qimeng; Zhang, Huibin; Lai, Yisheng; Peng, Sixun; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">19445-19454</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A group of nitric oxide (NO)-releasing derivs. of oleanolic acid (OA) (5-13) were designed, synthesized and biol. evaluated for their anti-colon cancer activity.  It was found that the most potent compd. 6 preferably released high levels of NO in colon cancer cells but not in normal cells, leading to potent cytotoxicity against colon cancer cells.  In addn., 6 was more prone to produce NO catalyzed by GSTπ relative to GSTα.  Furthermore, 6 significantly inhibited the tumor growth in a mouse xenograft model.  Finally, 6 induced nitration of tyrosine residues in mitochondrial protein, down-regulated Wnt/β-catenin pathway, and inhibited COX-2 centered signaling loop in colon cancer cells.  Collectively, our findings suggested that 6 could be a promising candidate for the intervention of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzi5ww8O1WP7Vg90H21EOLACvtfcHk0lhYvRzFnebCDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXis1Sksb0%253D&md5=24e752bc643fe8b81bce9d8c67f5b20c</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1039%2FC5RA00270B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA00270B%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DQ.%2BM.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DIdentification%2520of%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Oleanolic%2520Acid%2520as%2520Potential%2520Anti-Colon%2520Cancer%2520Agents%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D19445%26epage%3D19454%26doi%3D10.1039%2FC5RA00270B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, F.</span><span> </span><span class="NLM_article-title">Combination of Amino Acid/Dipeptide with Nitric Oxide Donating Oleanolic Acid Derivatives as PepT1 Targeting Antitumor Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1120</span><span class="refDoi"> DOI: 10.1021/jm401634d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401634d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1116-1120&author=L.+Fangauthor=M.+Wangauthor=S.+H.+Gouauthor=X.+Y.+Liuauthor=H.+Zhangauthor=F.+Cao&title=Combination+of+Amino+Acid%2FDipeptide+with+Nitric+Oxide+Donating+Oleanolic+Acid+Derivatives+as+PepT1+Targeting+Antitumor+Prodrugs&doi=10.1021%2Fjm401634d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Amino Acid/Dipeptide with Nitric Oxide Donating Oleanolic Acid Derivatives as PepT1 Targeting Antitumor Prodrugs</span></div><div class="casAuthors">Fang, Lei; Wang, Meng; Gou, Shaohua; Liu, Xuying; Zhang, Huan; Cao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1116-1120</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of the cytotoxic effect of nitric oxide (NO) and PepT1 for mol.-targeted drug delivery, a series of amino acid/dipeptide diester prodrugs of NO-donating oleanolic acid derivs. were designed and synthesized.  Two prodrugs 6a and 8a showed potent cytotoxcity, which is probably due to their high PepT1 affinity and NO-releasing ability.  Furthermore, the aq. soly. of the prodrugs was also significantly enhanced because of the hydrophilic amino acid/dipeptide promoiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9pR7AdIqo7Vg90H21EOLACvtfcHk0lhYvRzFnebCDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D&md5=34d4a03853bb2b0bc6400f85c885ff4c</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm401634d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401634d%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGou%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DF.%26atitle%3DCombination%2520of%2520Amino%2520Acid%252FDipeptide%2520with%2520Nitric%2520Oxide%2520Donating%2520Oleanolic%2520Acid%2520Derivatives%2520as%2520PepT1%2520Targeting%2520Antitumor%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1116%26epage%3D1120%26doi%3D10.1021%2Fjm401634d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S.</span><span> </span><span class="NLM_article-title">Oleanolic Acid-NO Donor-Platinum(II) Trihybrid Molecules: Targeting Cytotoxicity on Hepatoma Cells with Combined Action Mode and Good Safety</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4619</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.07.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2016.07.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=4611-4619&author=L.+Fangauthor=M.+Fengauthor=F.+Chenauthor=X.+Liuauthor=H.+Shenauthor=J.+Zhaoauthor=S.+Gou&title=Oleanolic+Acid-NO+Donor-Platinum%28II%29+Trihybrid+Molecules%3A+Targeting+Cytotoxicity+on+Hepatoma+Cells+with+Combined+Action+Mode+and+Good+Safety&doi=10.1016%2Fj.bmc.2016.07.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.07.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.07.066%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DS.%26atitle%3DOleanolic%2520Acid-NO%2520Donor-Platinum%2528II%2529%2520Trihybrid%2520Molecules%253A%2520Targeting%2520Cytotoxicity%2520on%2520Hepatoma%2520Cells%2520with%2520Combined%2520Action%2520Mode%2520and%2520Good%2520Safety%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D4611%26epage%3D4619%26doi%3D10.1016%2Fj.bmc.2016.07.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Ai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Synthesis of CDDO-Amino Acid-Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2452</span><span class="NLM_x">–</span> <span class="NLM_lpage">2464</span><span class="refDoi"> DOI: 10.1021/jm5019302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2452-2464&author=Y.+Aiauthor=F.+H.+Kangauthor=Z.+J.+Huangauthor=X.+W.+Xueauthor=Y.+S.+Laiauthor=S.+X.+Pengauthor=J.+D.+Tianauthor=Y.+H.+Zhang&title=Synthesis+of+CDDO-Amino+Acid-Nitric+Oxide+Donor+Trihybrids+as+Potential+Antitumor+Agents+against+Both+Drug-Sensitive+and+Drug-Resistant+Colon+Cancer&doi=10.1021%2Fjm5019302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm5019302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019302%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DF.%2BH.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DXue%26aufirst%3DX.%2BW.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DPeng%26aufirst%3DS.%2BX.%26aulast%3DTian%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DSynthesis%2520of%2520CDDO-Amino%2520Acid-Nitric%2520Oxide%2520Donor%2520Trihybrids%2520as%2520Potential%2520Antitumor%2520Agents%2520against%2520Both%2520Drug-Sensitive%2520and%2520Drug-Resistant%2520Colon%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2452%26epage%3D2464%26doi%3D10.1021%2Fjm5019302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Glycyrrhetinic Acid as Anti-Hepatocellular Carcinoma Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6416</span><span class="NLM_x">–</span> <span class="NLM_lpage">6420</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2010.09.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6416-6420&author=Y.+Laiauthor=L.+Shenauthor=Z.+Zhangauthor=W.+Liuauthor=Y.+Zhangauthor=H.+Jiauthor=J.+Tian&title=Synthesis+and+Biological+Evaluation+of+Furoxan-Based+Nitric+Oxide-Releasing+Derivatives+of+Glycyrrhetinic+Acid+as+Anti-Hepatocellular+Carcinoma+Agents&doi=10.1016%2Fj.bmcl.2010.09.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.070%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Furoxan-Based%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Glycyrrhetinic%2520Acid%2520as%2520Anti-Hepatocellular%2520Carcinoma%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6416%26epage%3D6420%26doi%3D10.1016%2Fj.bmcl.2010.09.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Li, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Y.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin as Potential Anti-Tumor Agents</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7556</span><span class="NLM_x">–</span> <span class="NLM_lpage">7568</span><span class="refDoi"> DOI: 10.3390/molecules17067556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3390%2Fmolecules17067556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=7556-7568&author=D.+H.+Liauthor=L.+Wangauthor=H.+Caiauthor=Y.+H.+Zhangauthor=J.+Y.+Xu&title=Synthesis+and+Biological+Evaluation+of+Novel+Furozan-Based+Nitric+Oxide-Releasing+Derivatives+of+Oridonin+as+Potential+Anti-Tumor+Agents&doi=10.3390%2Fmolecules17067556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3390%2Fmolecules17067556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules17067556%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DXu%26aufirst%3DJ.%2BY.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Furozan-Based%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Oridonin%2520as%2520Potential%2520Anti-Tumor%2520Agents%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D7556%26epage%3D7568%26doi%3D10.3390%2Fmolecules17067556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Xu, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Y.</span><span> </span><span class="NLM_article-title">Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2795</span><span class="NLM_x">–</span> <span class="NLM_lpage">2800</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2016.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2795-2800&author=S.+T.+Xuauthor=G.+Y.+Wangauthor=Y.+Linauthor=Y.+J.+Zhangauthor=L.+L.+Peiauthor=H.+Yaoauthor=M.+Huauthor=Y.+Y.+Qiuauthor=Z.+J.+Huangauthor=Y.+H.+Zhangauthor=J.+Y.+Xu&title=Novel+Anticancer+Oridonin+Derivatives+Possessing+a+Diazen-1-ium-1%2C2-diolate+Nitric+Oxide+Donor+Moiety%3A+Design%2C+Synthesis%2C+Biological+Evaluation+and+Nitric+Oxide+Release+Studies&doi=10.1016%2Fj.bmcl.2016.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%2BT.%26aulast%3DWang%26aufirst%3DG.%2BY.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DPei%26aufirst%3DL.%2BL.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DY.%2BY.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DXu%26aufirst%3DJ.%2BY.%26atitle%3DNovel%2520Anticancer%2520Oridonin%2520Derivatives%2520Possessing%2520a%2520Diazen-1-ium-1%252C2-diolate%2520Nitric%2520Oxide%2520Donor%2520Moiety%253A%2520Design%252C%2520Synthesis%252C%2520Biological%2520Evaluation%2520and%2520Nitric%2520Oxide%2520Release%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2795%26epage%3D2800%26doi%3D10.1016%2Fj.bmcl.2016.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">He, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. S.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives as Anticancer Agents</span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1016/j.cclet.2009.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.cclet.2009.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=381-384&author=L.+Q.+Heauthor=J.+Liuauthor=D.+K.+Yinauthor=Y.+H.+Zhangauthor=X.+S.+Wangauthor=L.+Q.+Heauthor=J.+Liuauthor=D.+K.+Yinauthor=Y.+H.+Zhangauthor=X.+S.+Wang&title=Synthesis+and+Biological+Evaluation+of+Nitric+Oxide-Releasing+Matrine+Derivatives+as+Anticancer+Agents&doi=10.1016%2Fj.cclet.2009.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of nitric oxide-releasing matrine derivatives as anticancer agents</span></div><div class="casAuthors">He, Li Qin; Liu, Jing; Yin, Deng Ke; Zhang, Yi Hua; Wang, Xiao Shan</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-384</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of furoxan-based nitric oxide-releasing matrine derivs. I [X = O(CH2)n, OCH(Me)(CH2)2, O(CH2)2O(CH2)2O, NH(CH2)2, n = 2, 3, 4] was synthesized.  The biol. evaluation showed that compds.. I [X = O(CH2)n, O(CH2)2O(CH2)2O, NH(CH2)2, n = 2, 3] had stronger cytotoxic activities than 5-fluorouracil against human hepatoma cells (HepG2) in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWmZF74h9p0LVg90H21EOLACvtfcHk0lhEyoQsO0XR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKjur0%253D&md5=ad3af7e99fe4f4e68f3c5bde374117b2</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2009.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2009.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BS.%26aulast%3DHe%26aufirst%3DL.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BS.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520Matrine%2520Derivatives%2520as%2520Anticancer%2520Agents%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D21%26spage%3D381%26epage%3D384%26doi%3D10.1016%2Fj.cclet.2009.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viarisio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costamagna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescarmona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span> </span><span class="NLM_article-title">Nitric Oxide Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15695394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=516-525&author=C.+Rigantiauthor=E.+Miragliaauthor=D.+Viarisioauthor=C.+Costamagnaauthor=G.+Pescarmonaauthor=D.+Ghigoauthor=A.+Bosia&title=Nitric+Oxide+Reverts+the+Resistance+to+Doxorubicin+in+Human+Colon+Cancer+Cells+by+Inhibiting+the+Drug+Efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span></div><div class="casAuthors">Riganti, Chiara; Miraglia, Erica; Viarisio, Daniele; Costamagna, Costanzo; Pescarmona, Gianpiero; Ghigo, Dario; Bosia, Amalia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon by which cancer cells evade the cytotoxic effects of chemotherapeutic agents.  It may occur through different mechanisms, but it often correlates with the overexpression of integral membrane transporters, such as P-glycoprotein (Pgp) and MDR-assocd. proteins (MRPs), with resulting decrease of drug accumulation and cellular death.  Doxorubicin is a substrate of Pgp; it has been suggested that its ability to induce synthesis of nitric oxide (NO) could explain, at least in part, its cytotoxic effects.  Culturing the human epithelial colon cell line HT29 in the presence of doxorubicin, we obtained a doxorubicin-resistant (HT29-dx) cell population: these cells accumulated less intracellular doxorubicin, were less sensitive to the cytotoxic effects of doxorubicin and cisplatin, overexpressed Pgp and MRP3, and exhibited a lower NO prodn. (both under basal conditions and after doxorubicin stimulation).  The resistance to doxorubicin could be reversed when HT29-dx cells were incubated with inducers of NO synthesis (cytokines mix, atorvastatin).  Some NO donors increased the drug accumulation in HT29-dx cells in a guanosine-3':5'-cyclic monophosphate-independent way; this effect was assocd. with a marked redn. of doxorubicin efflux rate in HT29 and HT29-dx cells, and tyrosine nitration in the MRP3 protein.  Our results suggest that onset of MDR and impairment of NO synthesis are related; this finding could point to a new strategy to reverse doxorubicin resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTu2bqm5O1DbVg90H21EOLACvtfcHk0lhEyoQsO0XR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D&md5=e0e7757d954680c9b9eb3470a1758da6</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DMiraglia%26aufirst%3DE.%26aulast%3DViarisio%26aufirst%3DD.%26aulast%3DCostamagna%26aufirst%3DC.%26aulast%3DPescarmona%26aufirst%3DG.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26atitle%3DNitric%2520Oxide%2520Reverts%2520the%2520Resistance%2520to%2520Doxorubicin%2520in%2520Human%2520Colon%2520Cancer%2520Cells%2520by%2520Inhibiting%2520the%2520Drug%2520Efflux%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D516%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaro, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span> </span><span class="NLM_article-title">Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-glycoprotein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5475</span><span class="refDoi"> DOI: 10.1021/jm100066y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100066y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFenu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5467-5475&author=R.+Frutteroauthor=M.+Crosettiauthor=K.+Chegaevauthor=S.+Guglielmoauthor=A.+Gascoauthor=F.+Berardiauthor=M.+Nisoauthor=R.+Perroneauthor=M.+A.+Panaroauthor=N.+A.+Colabufo&title=Phenylsulfonylfuroxans+as+Modulators+of+Multidrug-Resistance-Associated+Protein-1+and+P-glycoprotein&doi=10.1021%2Fjm100066y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein</span></div><div class="casAuthors">Fruttero, Roberta; Crosetti, Marco; Chegaev, Konstantin; Guglielmo, Stefano; Gasco, Alberto; Berardi, Francesco; Niso, Mauro; Perrone, Roberto; Panaro, Maria Antonietta; Colabufo, Nicola Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5467-5475</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of furoxan derivs. were studied for their ability to interact with P-gp and MRP1 transporters in MDCK cells overexpressing these proteins. 3-Phenylsulfonyl substituted furoxans emerged as the most interesting compds.  All of them were capable of inhibiting P-gp, and a few also were capable of inhibiting MRP1.  Substituents at the 4-position of 3-phenylsulfonylfuroxan scaffold were able to modulate the selectivity and the intensity of inhibition.  In some cases, they reverted MRP1 inhibitor activity, namely, they were capable of potentiating MRP1 dependent efflux.  When compds. 16 and 17 were coadministered with doxorubicin, they restored a high degree of the activity of the antibiotic.  Preliminary immunoblotting studies carried out on these two compds. indicate that they are capable of nitrating P-gp, which in this form is likely unable to efflux the antibiotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq7VVVj1GhhrVg90H21EOLACvtfcHk0lhEyoQsO0XR4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFenu74%253D&md5=6c302bacdb93a4e5d95603e2bf070f83</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm100066y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100066y%26sid%3Dliteratum%253Aachs%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DCrosetti%26aufirst%3DM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DPanaro%26aufirst%3DM.%2BA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26atitle%3DPhenylsulfonylfuroxans%2520as%2520Modulators%2520of%2520Multidrug-Resistance-Associated%2520Protein-1%2520and%2520P-glycoprotein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5467%26epage%3D5475%26doi%3D10.1021%2Fjm100066y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">De Boo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span> </span><span class="NLM_article-title">iNOS Activity Is Necessary for the Cytotoxic and Immunogenic Effects of Doxorubicin in Human Colon Cancer Cells</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="refDoi"> DOI: 10.1186/1476-4598-8-108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1186%2F1476-4598-8-108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=19925669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD1MjptFSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=108&author=S.+De+Booauthor=J.+Kopeckaauthor=D.+Brusaauthor=E.+Gazzanoauthor=L.+Materaauthor=D.+Ghigoauthor=A.+Bosiaauthor=C.+Riganti&title=iNOS+Activity+Is+Necessary+for+the+Cytotoxic+and+Immunogenic+Effects+of+Doxorubicin+in+Human+Colon+Cancer+Cells&doi=10.1186%2F1476-4598-8-108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells</span></div><div class="casAuthors">De Boo Sara; Kopecka Joanna; Brusa Davide; Gazzano Elena; Matera Lina; Ghigo Dario; Bosia Amalia; Riganti Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Doxorubicin is one of the few chemotherapeutic drugs able to exert both cytotoxic and pro-immunogenic effects against cancer cells.  Following the drug administration, the intracellular protein calreticulin is translocated with an unknown mechanism onto the plasma membrane, where it triggers the phagocytosis of tumour cells by dendritic cells.  Moreover doxorubicin up-regulates the inducible nitric oxide (NO) synthase (iNOS) gene in cancer cells, leading to huge amounts of NO, which in turn acts as a mediator of the drug toxicity and as a chemosensitizer agent in colon cancer.  Indeed by nitrating tyrosine on the multidrug resistance related protein 3, NO decreases the doxorubicin efflux from tumour cells and enhances the drug toxicity.  It is not clear if NO, beside playing a role in chemosensitivity, may also play a role in doxorubicin pro-immunogenic effects.  To clarify this issue, we compared the doxorubicin-sensitive human colon cancer HT29 cells with the drug-resistant HT29-dx cells and the HT29 cells silenced for iNOS (HT29 iNOS-).  RESULTS:  In both HT29-dx and HT29 iNOS- cells, doxorubicin did not induce NO synthesis, had a lower intracellular accumulation and a lower toxicity.  Moreover the drug failed to promote the translocation of calreticulin and the phagocytosis of HT29-dx and HT29 iNOS-cells, which resulted both chemoresistant and immunoresistant.  However, if NO levels were exogenously increased by sodium nitroprusside, the chemosensitivity to doxorubicin was restored in HT29 iNOS-cells.  In parallel the NO donor per se was sufficient to induce the exposure of calreticulin and to increase the phagocytosis of HT29 iNOS- cells by DCs and their functional maturation, thus mimicking the pro-immunogenic effects exerted by doxorubicin in the parental drug-sensitive HT29 cells.  CONCLUSION:  Our data suggest that chemo- and immuno-resistance to anthracyclines are associated in colon cancer cells and rely on a common mechanism, that is the inability of doxorubicin to induce iNOS.  Therefore NO donors might represent a promising strategy to restore both chemosensitivity and immunosensitivity to doxorubicin in resistant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3vmkIwk_wJcK3uFsUIZtkfW6udTcc2ea_vD3AlTYloLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjptFSrsQ%253D%253D&md5=04906da262a5f0e6c93120591f46cb2d</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-8-108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-8-108%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBoo%26aufirst%3DS.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DBrusa%26aufirst%3DD.%26aulast%3DGazzano%26aufirst%3DE.%26aulast%3DMatera%26aufirst%3DL.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DiNOS%2520Activity%2520Is%2520Necessary%2520for%2520the%2520Cytotoxic%2520and%2520Immunogenic%2520Effects%2520of%2520Doxorubicin%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26spage%3D108%26doi%3D10.1186%2F1476-4598-8-108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span> </span><span class="NLM_article-title">Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1021/ml100302t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100302t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=494-497&author=K.+Chegaevauthor=C.+Rigantiauthor=L.+Lazzaratoauthor=B.+Rolandoauthor=S.+Guglielmoauthor=I.+Campiaauthor=R.+Frutteroauthor=A.+Bosiaauthor=A.+Gasco&title=Nitric+Oxide+Donor+Doxorubicins+Accumulate+into+Doxorubicin-Resistant+Human+Colon+Cancer+Cells+Inducing+Cytotoxicity&doi=10.1021%2Fml100302t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fml100302t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100302t%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNitric%2520Oxide%2520Donor%2520Doxorubicins%2520Accumulate%2520into%2520Doxorubicin-Resistant%2520Human%2520Colon%2520Cancer%2520Cells%2520Inducing%2520Cytotoxicity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D494%26epage%3D497%26doi%3D10.1021%2Fml100302t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span> </span><span class="NLM_article-title">Mitochondrial-Targeting Nitrooxy-Doxorubicin: A New Approach to Overcome Drug Resistance</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1021/mp300311b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300311b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslelsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=161-174&author=C.+Rigantiauthor=B.+Rolandoauthor=J.+Kopeckaauthor=I.+Campiaauthor=K.+Chegaevauthor=L.+Lazzaratoauthor=A.+Federicoauthor=R.+Frutteroauthor=D.+Ghigo&title=Mitochondrial-Targeting+Nitrooxy-Doxorubicin%3A+A+New+Approach+to+Overcome+Drug+Resistance&doi=10.1021%2Fmp300311b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial-Targeting Nitrooxy-doxorubicin: A New Approach To Overcome Drug Resistance</span></div><div class="casAuthors">Riganti, Chiara; Rolando, Barbara; Kopecka, Joanna; Campia, Ivana; Chegaev, Konstantin; Lazzarato, Loretta; Federico, Antonella; Fruttero, Roberta; Ghigo, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In previous studies, we showed that nitric oxide (NO) donors and synthetic doxorubicins (DOXs) modified with moieties contg. NO-releasing groups-such as nitrooxy-DOX (NitDOX) or 3-phenylsulfonylfuroxan-DOX (FurDOX)-overcome drug resistance by decreasing the activity of ATP-binding cassette (ABC) transporters that can extrude the drug.  Here, we have investigated the biochem. mechanisms by which NitDOX and FurDOX exert antitumor effects.  Both NitDOX and FurDOX were more cytotoxic than DOX against drug-resistant cells.  Interestingly, NitDOX exhibited a faster uptake and an extranuclear distribution.  NitDOX was preferentially localized in the mitochondria, where it nitrated and inhibited the mitochondria-assocd. ABC transporters, decreased the flux through the tricarboxylic acid cycle, slowed down the activity of complex I, lowered the synthesis of ATP, induced oxidative and nitrosative stress, and elicited the release of cytochrome c and the activation of caspase-9 and -3 in DOX-resistant cells.  We suggest that NitDOX may represent the prototype of a new class of multifunctional anthracyclines, which have cellular targets different from conventional anthracyclines and greater efficacy against drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc2qh0P8HLcbVg90H21EOLACvtfcHk0lhZeSwiSSh6BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslelsr%252FL&md5=87c3ab54d7cb864d2b0788e268c09e47</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fmp300311b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300311b%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DKopecka%26aufirst%3DJ.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DFederico%26aufirst%3DA.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGhigo%26aufirst%3DD.%26atitle%3DMitochondrial-Targeting%2520Nitrooxy-Doxorubicin%253A%2520A%2520New%2520Approach%2520to%2520Overcome%2520Drug%2520Resistance%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D161%26epage%3D174%26doi%3D10.1021%2Fmp300311b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Gazzano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blangetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaratone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span> </span><span class="NLM_article-title">Overcoming Multidrug Resistance by Targeting Mitochondria with NO-Donating Doxorubicins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmc.2016.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26822567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=967-975&author=E.+Gazzanoauthor=K.+Chegaevauthor=B.+Rolandoauthor=M.+Blangettiauthor=L.+Annaratoneauthor=D.+Ghigoauthor=R.+Frutteroauthor=C.+Riganti&title=Overcoming+Multidrug+Resistance+by+Targeting+Mitochondria+with+NO-Donating+Doxorubicins&doi=10.1016%2Fj.bmc.2016.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins</span></div><div class="casAuthors">Gazzano, Elena; Chegaev, Konstantin; Rolando, Barbara; Blangetti, Marco; Annaratone, Lorenzo; Ghigo, Dario; Fruttero, Roberta; Riganti, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A library of nitric oxide-donor doxorubicins (NO-DOXOs) was synthesized by linking appropriate NO-donor moieties at C-14 position through an ester bridge.  Their hydrolytic stability was evaluated.  The intracellular accumulation and cytotoxicity of these novel NO-DOXOs were studied in DOXO-sensitive (HT29) and DOXO-resistant (HT29/dx) tumor-cells.  Hydrolytically-stable compds. accumulated in HT29 and HT29/dx cells, thanks to the nitration of plasma-membrane efflux transporters.  Surprisingly, no close correlation was found between intracellular accumulation and cytotoxicity.  Only compds. with high mitochondria retention (due to nitration of mitochondrial efflux transporter) exert high cytotoxicity, through the activation of a mitochondrial-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl_r1-a1b_TbVg90H21EOLACvtfcHk0ljFj5iFTuNUsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKlu7Y%253D&md5=5d407feeb33c34b1aa76d32ad82af858</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DGazzano%26aufirst%3DE.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DBlangetti%26aufirst%3DM.%26aulast%3DAnnaratone%26aufirst%3DL.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DRiganti%26aufirst%3DC.%26atitle%3DOvercoming%2520Multidrug%2520Resistance%2520by%2520Targeting%2520Mitochondria%2520with%2520NO-Donating%2520Doxorubicins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D967%26epage%3D975%26doi%3D10.1016%2Fj.bmc.2016.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Zou, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline as Anticancer and Multidrug Resistance Reversal Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5934</span><span class="NLM_x">–</span> <span class="NLM_lpage">5938</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2011.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21843940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKisr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5934-5938&author=Z.+H.+Zouauthor=X.+B.+Lanauthor=H.+Qianauthor=W.+L.+Huangauthor=Y.+M.+Li&title=Synthesis+and+Evaluation+of+Furoxan-Based+Nitric+Oxide-Releasing+Derivatives+of+Tetrahydroisoquinoline+as+Anticancer+and+Multidrug+Resistance+Reversal+Agents&doi=10.1016%2Fj.bmcl.2011.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents</span></div><div class="casAuthors">Zou, Zhi-hong; Lan, Xiao-bu; Qian, Hai; Huang, Wen-long; Li, Yun-man</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5934-5938</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multidrug resistance in tumor cells poses a major obstacle to efficient chemotherapy.  Several types of agents have been recognized as multidrug resistance inhibitors, among which the tetrahydroisoquinolines are the most studied.  In the current study, 16 furoxan-based nitric oxide-releasing derivs. of tetrahydroisoquinoline were synthesized.  Their cytotoxic activities and effects in reversing multidrug resistance have been evaluated.  The results revealed that these compds. had moderate cytotoxic effects.  Eight of the synthesized compds. showed higher cytotoxicities than the rest, but lower than adriamycin on the K562 cell line.  Compds. I-III exhibited potent MDR reversal activities on the K562/A02 cell line.  The accumulation assay indicated that compds. I-III significantly increased the intracellular accumulation of rhodamine123 in K562/A02 cells.  Furthermore, these three compds. produced high concns. of NO in K562/A02 cells.  Potentially, the high concns. of NO produced by NO donor moieties leads to an increased cytotoxicity to K562/A02 cells.  The results suggested that compds. I-III had anticancer effects, as well as multidrug resistance reversal effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7rOVI37YOCLVg90H21EOLACvtfcHk0ljFj5iFTuNUsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKisr3K&md5=1097433fc2682ee6f2f37efbb2f4b08a</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DZ.%2BH.%26aulast%3DLan%26aufirst%3DX.%2BB.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DLi%26aufirst%3DY.%2BM.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Furoxan-Based%2520Nitric%2520Oxide-Releasing%2520Derivatives%2520of%2520Tetrahydroisoquinoline%2520as%2520Anticancer%2520and%2520Multidrug%2520Resistance%2520Reversal%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5934%26epage%3D5938%26doi%3D10.1016%2Fj.bmcl.2011.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Tang, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Nitric Oxide-Releasing DDB Derivatives as Potential Pgp-Mediated MDR Reversal Agents in MCF-7/Adr Cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2011.12.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=801-805&author=X.+B.+Tangauthor=X.+K.+Guauthor=H.+Aiauthor=G.+J.+Wangauthor=H.+Pengauthor=Y.+S.+Laiauthor=Y.+H.+Zhang&title=Synthesis+and+Evaluation+of+Nitric+Oxide-Releasing+DDB+Derivatives+as+Potential+Pgp-Mediated+MDR+Reversal+Agents+in+MCF-7%2FAdr+Cells&doi=10.1016%2Fj.bmcl.2011.12.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.065%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%2BB.%26aulast%3DGu%26aufirst%3DX.%2BK.%26aulast%3DAi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DY.%2BS.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Nitric%2520Oxide-Releasing%2520DDB%2520Derivatives%2520as%2520Potential%2520Pgp-Mediated%2520MDR%2520Reversal%2520Agents%2520in%2520MCF-7%252FAdr%2520Cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D801%26epage%3D805%26doi%3D10.1016%2Fj.bmcl.2011.12.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Ren, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span> </span><span class="NLM_article-title">Anticancer Efficacy of a Nitric Oxide-Modified Derivative of Bifendate against Multidrug-Resistant Cancer Cells</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1095</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1111/jcmm.12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1111%2Fjcmm.12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26864945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1095-1105&author=Z.+G.+Renauthor=X.+K.+Guauthor=B.+Luauthor=Y.+Q.+Chenauthor=G.+J.+Chenauthor=J.+N.+Fengauthor=J.+Z.+Linauthor=Y.+H.+Zhangauthor=H.+Peng&title=Anticancer+Efficacy+of+a+Nitric+Oxide-Modified+Derivative+of+Bifendate+against+Multidrug-Resistant+Cancer+Cells&doi=10.1111%2Fjcmm.12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells</span></div><div class="casAuthors">Ren, Zhiguang; Gu, Xiaoke; Lu, Bin; Chen, Yaqiong; Chen, Guojiang; Feng, Jiannan; Lin, Jizhen; Zhang, Yihua; Peng, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1105</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The development of multidrug resistance (MDR) not only actively transports a wide range of cytotoxic drugs across drug transporters but is also a complex interaction between a no. of important cellular signalling pathways.  Nitric oxide donors appear to be a new class of anticancer therapeutics for satisfying all the above conditions.  Previously, we reported furoxan-based nitric oxide-releasing compds. that exhibited selective antitumor activity in vitro and in vivo.  Herein, we demonstrate that bifendate (DDB)-nitric oxide, a synthetic furoxan-based nitric oxide-releasing deriv. of bifendate, effectively inhibits the both sensitive and MDR tumor cell viability at a comparatively low concn.  Interestingly, the potency of DDB-nitric oxide is the independent of inhibition of the functions and expressions of three major ABC transporters.  The mechanism of DDB-nitric oxide appears to be in two modes of actions by inducing mitochondrial tyrosine nitration and apoptosis, as well as by down-regulating HIF-1α expression and protein kinase B (AKT), extracellular signal-regulated kinases (ERK), nuclear factor κB (NF-κB) activation in MDR cells.  Moreover, the addn. of a typical nitric oxide scavenger significantly attenuated all the effects of DDB-nitric oxide, indicating that the cytotoxicity of DDB-nitric oxide is as a result of higher levels of nitric oxide release in MDR cancer cells.  Given that acquired MDR to nitric oxide donors is reportedly difficult to achieve and genetically unstable, compd. like DDB-nitric oxide may be a new type of therapeutic agent for the treatment of MDR tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplHi8uVSb7J7Vg90H21EOLACvtfcHk0lhnFQAC_5MB5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Srt78%253D&md5=b0bbc08e2f956075b8adf5759ca47c46</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.12796%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DZ.%2BG.%26aulast%3DGu%26aufirst%3DX.%2BK.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BQ.%26aulast%3DChen%26aufirst%3DG.%2BJ.%26aulast%3DFeng%26aufirst%3DJ.%2BN.%26aulast%3DLin%26aufirst%3DJ.%2BZ.%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DPeng%26aufirst%3DH.%26atitle%3DAnticancer%2520Efficacy%2520of%2520a%2520Nitric%2520Oxide-Modified%2520Derivative%2520of%2520Bifendate%2520against%2520Multidrug-Resistant%2520Cancer%2520Cells%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2016%26volume%3D20%26spage%3D1095%26epage%3D1105%26doi%3D10.1111%2Fjcmm.12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">928</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms1yhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=928-940&author=X.+Guauthor=Z.+Huangauthor=Z.+Renauthor=X.+Tangauthor=R.+Xueauthor=X.+Luoauthor=S.+Pengauthor=H.+Pengauthor=B.+Luauthor=J.+Tianauthor=Y.+Zhang&title=Potent+Inhibition+of+Nitric+Oxide-Releasing+Bifendate+Derivatives+against+Drug-Resistant+K562%2FA02+Cells+in+Vitro+and+in+Vivo&doi=10.1021%2Facs.jmedchem.6b01075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo</span></div><div class="casAuthors">Gu, Xiaoke; Huang, Zhangjian; Ren, Zhiguang; Tang, Xiaobo; Xue, Rongfang; Luo, Xiaojun; Peng, Sixun; Peng, Hui; Lu, Bin; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance is a major obstacle to successful chemotherapy for leukemia.  In this study, a series of nitric oxide (NO)-releasing bifendate derivs. (7a-n) were synthesized.  Biol. evaluation indicated that the most active compd. (7a) produced relatively high levels of NO and significantly inhibited the proliferation of drug-resistant K562/A02 cells in vitro and in vivo.  In addn., 7a induced the mitochondrial tyrosine nitration and the intracellular accumulation of rhodamine 123 by inhibiting P-gp activity in K562/A02 cells.  Furthermore, 7a remarkably down-regulated AKT, NF-κB, and ERK activation and HIF-1α expression in K562/A02 cells, which are assocd. with the tumor cell proliferation and drug resistance.  Notably, the antitumor effects were dramatically attenuated by an NO scavenger or elimination of the NO-releasing capability of 7a, indicating that NO produced by 7a contributed to, at least partly, its cytotoxicity against drug-resistant K562/A02 cells.  Overall, 7a may be a potential agent against drug-resistant myelogenous leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhlGzOkF0JEbVg90H21EOLACvtfcHk0lhnFQAC_5MB5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms1yhtw%253D%253D&md5=0eb01f9dbe382d1f83783a043c8e5306</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01075%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DXue%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPotent%2520Inhibition%2520of%2520Nitric%2520Oxide-Releasing%2520Bifendate%2520Derivatives%2520against%2520Drug-Resistant%2520K562%252FA02%2520Cells%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D928%26epage%3D940%26doi%3D10.1021%2Facs.jmedchem.6b01075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Thatcher, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolescu, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, V.</span><span> </span><span class="NLM_article-title">Nitrates and NO Release: Contemporary Aspects in Biological and Medicinal Chemistry</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2004.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.freeradbiomed.2004.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15451053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2004&pages=1122-1143&author=G.+R.+Thatcherauthor=A.+C.+Nicolescuauthor=B.+M.+Bennettauthor=V.+Toader&title=Nitrates+and+NO+Release%3A+Contemporary+Aspects+in+Biological+and+Medicinal+Chemistry&doi=10.1016%2Fj.freeradbiomed.2004.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrates and NO release: Contemporary aspects in biological and medicinal chemistry</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Nicolescu, Adrian C.; Bennett, Brian M.; Toader, Violeta</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1122-1143</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nitroglycerin has been used clin. in the treatment of angina for 130 yr, yet important details on the mechanism of action, biotransformation, and the assocd. phenomenon of nitrate tolerance remain unanswered.  The biol. activity of org. nitrates can be said to be nitric oxide mimetic, leading to recent, exciting progress in realizing the therapeutic potential of nitrates.  Unequivocally, nitroglycerin and most other org. nitrates, including NO-NSAIDs, do not behave as NO donors in the most fundamental action: in vitro activation of sGC to produce cGMP.  The question as to whether the biol. activity of nitrates results primarily or exclusively from NO donation will not be satisfactorily answered until the location, the app., and the mechanism of redn. of nitrates to NO are defined.  Similarly, the therapeutic potential of nitrates will not be unlocked until this knowledge is attained.  Aspects of the therapeutic and biol. activity of nitrates are reviewed in the context of the chem. of nitrates and the elusive efficient 3e- redn. required to generate NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9yTqvI4h67Vg90H21EOLACvtfcHk0lhnFQAC_5MB5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFaitbw%253D&md5=4cf397615197ffc1a76d3eec5f5c9bb6</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2004.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2004.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26aulast%3DNicolescu%26aufirst%3DA.%2BC.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DToader%26aufirst%3DV.%26atitle%3DNitrates%2520and%2520NO%2520Release%253A%2520Contemporary%2520Aspects%2520in%2520Biological%2520and%2520Medicinal%2520Chemistry%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2004%26volume%3D37%26spage%3D1122%26epage%3D1143%26doi%3D10.1016%2Fj.freeradbiomed.2004.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Rigas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">Nitric-Oxide-Donating NSAIDs as Agents for Cancer Prevention</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1016/j.molmed.2004.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.molmed.2004.05.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=324-330&author=B.+Rigasauthor=K.+Kashfi&title=Nitric-Oxide-Donating+NSAIDs+as+Agents+for+Cancer+Prevention&doi=10.1016%2Fj.molmed.2004.05.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2004.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2004.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DRigas%26aufirst%3DB.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DNitric-Oxide-Donating%2520NSAIDs%2520as%2520Agents%2520for%2520Cancer%2520Prevention%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D324%26epage%3D330%26doi%3D10.1016%2Fj.molmed.2004.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigas, B.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Donating Aspirin Inhibits the Growth of Pancreatic Cancer Cells through Redox-Dependent Signaling</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.canlet.2008.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.canlet.2008.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18805632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2gtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2009&pages=292-299&author=H.+Zhouauthor=L.+Huangauthor=Y.+Sunauthor=B.+Rigas&title=Nitric+Oxide-Donating+Aspirin+Inhibits+the+Growth+of+Pancreatic+Cancer+Cells+through+Redox-Dependent+Signaling&doi=10.1016%2Fj.canlet.2008.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling</span></div><div class="casAuthors">Zhou, Hui; Huang, Liqun; Sun, Yu; Rigas, Basil</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">292-299</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The novel chemopreventive nitric oxide-donating aspirin (NO-ASA) prevents nearly 90% of ductal adenocarcinomas in a animal tumor model.  To decipher the mechanism of this effect, we studied in BxPC-3 human pancreatic cancer cells the sequence of signaling events leading from NO-ASA treatment to cell growth inhibition.  NO-ASA inhibited the growth of BxPC-3 cells (IC50 = 13 μM), by inhibiting proliferation modestly and inducing apoptosis, necrosis and G1/S cell cycle block.  At 15 min of treatment with NO-ASA, the intracellular levels of reactive oxygen species (ROS) began increasing (peak at 8 h, baseline levels by 24 h).  ROS activated almost immediately in a time- and concn.-dependent manner the MAPK pathways p38, ERK and JNK (their activation was abrogated by the antioxidant N-acetylcysteine).  MAPK activation induced p21cip-1, which suppressed the levels of cyclin D1 that controls the G1/S cell cycle transition.  NO-ASA induced COX-2 expression starting 90 min after p21cip-1 was induced.  When COX-2 expression was knocked down using siRNA against cox-2, the expression of p21cip-1 was induced by NO-ASA, regardless of the level of expression of COX-2, suggesting a marginal, if any, role for COX-2 in the growth inhibitory effect of NO-ASA.  These findings along with the temporal sequence of individual changes indicate a signaling sequence that involves ROS → MAPKs → p21cip-1 → cyclin D1 → cell death.  Our findings establish the crit. role of ROS as proximal signaling mols. in the action of anticancer compds. and may be useful in designing mechanism-driven approaches to cancer control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUEyGWJ6_-WbVg90H21EOLACvtfcHk0li6DnqPwnSsfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2gtbvL&md5=2dca592a252cab7b13d37d65332ad84e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DRigas%26aufirst%3DB.%26atitle%3DNitric%2520Oxide-Donating%2520Aspirin%2520Inhibits%2520the%2520Growth%2520of%2520Pancreatic%2520Cancer%2520Cells%2520through%2520Redox-Dependent%2520Signaling%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D273%26spage%3D292%26epage%3D299%26doi%3D10.1016%2Fj.canlet.2008.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Nath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodes, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazarenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Releasing Aspirin Suppresses NF-kappa B Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">12481</span><span class="NLM_x">–</span> <span class="NLM_lpage">12499</span><span class="refDoi"> DOI: 10.3390/molecules200712481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3390%2Fmolecules200712481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=12481-12499&author=N.+Nathauthor=M.+Chattopadhyayauthor=D.+B.+Rodesauthor=A.+Nazarenkoauthor=R.+Kodelaauthor=K.+Kashfi&title=Nitric+Oxide-Releasing+Aspirin+Suppresses+NF-kappa+B+Signaling+in+Estrogen+Receptor+Negative+Breast+Cancer+Cells+in+Vitro+and+in+Vivo&doi=10.3390%2Fmolecules200712481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200712481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200712481%26sid%3Dliteratum%253Aachs%26aulast%3DNath%26aufirst%3DN.%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DRodes%26aufirst%3DD.%2BB.%26aulast%3DNazarenko%26aufirst%3DA.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DNitric%2520Oxide-Releasing%2520Aspirin%2520Suppresses%2520NF-kappa%2520B%2520Signaling%2520in%2520Estrogen%2520Receptor%2520Negative%2520Breast%2520Cancer%2520Cells%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D12481%26epage%3D12499%26doi%3D10.3390%2Fmolecules200712481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Chaudhary, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmets, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopelovich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athar, M.</span><span> </span><span class="NLM_article-title">Nitric Oxide-Releasing Sulindac Is a Novel Skin Cancer Chemopreventive Agent for UVB-Induced Photocarcinogenesis</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/j.taap.2012.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.taap.2012.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23274568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVGit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2013&pages=249-255&author=S.+C.+Chaudharyauthor=T.+Singhauthor=P.+Kapurauthor=Z.+P.+Wengauthor=A.+Arumugamauthor=C.+A.+Elmetsauthor=L.+Kopelovichauthor=M.+Athar&title=Nitric+Oxide-Releasing+Sulindac+Is+a+Novel+Skin+Cancer+Chemopreventive+Agent+for+UVB-Induced+Photocarcinogenesis&doi=10.1016%2Fj.taap.2012.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis</span></div><div class="casAuthors">Chaudhary, Sandeep C.; Singh, Tripti; Kapur, Puneet; Weng, Zhiping; Arumugam, Aadithya; Elmets, Craig A.; Kopelovich, Levy; Athar, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-255</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nitric oxide (NO)-releasing non-steroidal anti-inflammatory drugs (NO-NSAIDs) which have been synthesized to reduce gastro-intestinal and cardiovascular toxicities of NSAIDs, possess anti-proliferative, pro-apoptotic and anti-cancer activities.  Here, we show that NO-sulindac inhibited UVB-induced skin tumorigenesis in SKH-1 hairless mice.  Topical application of NO-sulindac reduced tumor incidence, no. (p < 0.05) and vol. (p < 0.005) as compared to UVB (alone)-irradiated vehicle-treated mice.  An increase in TUNEL-pos. cells in skin lesions was accompanied by the enhanced Bax:Bcl-2 ratio.  The expression of pro-apoptotic Bax was increased whereas anti-apoptotic Bcl-2 reduced.  However, proliferation was identified as the major target of NO-sulindac in this study.  A reduced expression of PCNA and cyclin D1 assocd. with the dampening of cell cycle progression was obsd.  The mechanism of this inhibition was related to the redn. in UVB-induced Notch signaling pathway.  UVB-induced inflammatory responses were diminished by NO-sulindac as obsd. by a remarkable redn. in the levels of phosphorylated MAP Kinases Erk1/2, p38 and JNK1/2.  In this regard, NO-sulindac also inhibited NFκB by enhancing IκBα as evidenced by the reduced expression of iNOS and COX-2, the direct NFκB transcription target proteins.  NO-sulindac significantly diminished the progression of benign lesions to invasive carcinomas by suppressing the tumor aggressiveness and retarding epithelial-mesenchymal transition.  A marked decrease in the expression of mesenchymal markers such as Fibronectin, N-cadherin, SNAI, Slug and Twist and an increase in epithelial cell polarity marker E-cadherin were noted in NO-sulindac-treated tumors.  Our data suggest that NO-sulindac is a potent inhibitor of UVB-induced skin carcinogenesis and acts by targeting proliferation-regulatory pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrClQbPNEDE-7Vg90H21EOLACvtfcHk0liXPoouXlu69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVGit7k%253D&md5=28cc92f41e451fc4e28c7bcbc1714d03</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2012.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2012.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DS.%2BC.%26aulast%3DSingh%26aufirst%3DT.%26aulast%3DKapur%26aufirst%3DP.%26aulast%3DWeng%26aufirst%3DZ.%2BP.%26aulast%3DArumugam%26aufirst%3DA.%26aulast%3DElmets%26aufirst%3DC.%2BA.%26aulast%3DKopelovich%26aufirst%3DL.%26aulast%3DAthar%26aufirst%3DM.%26atitle%3DNitric%2520Oxide-Releasing%2520Sulindac%2520Is%2520a%2520Novel%2520Skin%2520Cancer%2520Chemopreventive%2520Agent%2520for%2520UVB-Induced%2520Photocarcinogenesis%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D268%26spage%3D249%26epage%3D255%26doi%3D10.1016%2Fj.taap.2012.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Hulsman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongejan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span> </span><span class="NLM_article-title">Chemical Insights in the Concept of Hybrid Drugs: The Antitumor Effect of Nitric Oxide-Donating Aspirin Involves a Quinone Methide but Not Nitric Oxide nor Aspirin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2424</span><span class="NLM_x">–</span> <span class="NLM_lpage">2431</span><span class="refDoi"> DOI: 10.1021/jm061371e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061371e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Oqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2424-2431&author=N.+Hulsmanauthor=J.+P.+Medemaauthor=C.+Bosauthor=A.+Jongejanauthor=R.+Leursauthor=M.+J.+Smitauthor=I.+J.+de+Eschauthor=D.+Richelauthor=M.+Wijtmans&title=Chemical+Insights+in+the+Concept+of+Hybrid+Drugs%3A+The+Antitumor+Effect+of+Nitric+Oxide-Donating+Aspirin+Involves+a+Quinone+Methide+but+Not+Nitric+Oxide+nor+Aspirin&doi=10.1021%2Fjm061371e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Insights in the Concept of Hybrid Drugs: The Antitumor Effect of Nitric Oxide-Donating Aspirin Involves A Quinone Methide but Not Nitric Oxide nor Aspirin</span></div><div class="casAuthors">Hulsman, Niels; Medema, Jan Paul; Bos, Carina; Jongejan, Aldo; Leurs, Rob; Smit, Martine J.; de Esch, Iwan J. P.; Richel, Dick; Wijtmans, Maikel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2424-2431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hybrid drug (NO-ASA, I) continues to attract intense research from chemists and biologists alike.  It consists of ASA and a -ONO2 group connected through a spacer and is in preclin. development as an antitumor drug.  The authors report that, contrary to current beliefs, neither ASA nor NO contributes to this antitumor effect.  Rather, an unsubstituted QM was identified as the sole cytotoxic agent.  QM forms from I after carboxylic ester hydrolysis and, in accordance with the HSAB theory, selectively reacts with cellular GSH, which in turn triggers cell death.  Remarkably, a deriv. lacking ASA and the -ONO2 group is 10 times more effective than I.  Thus, our data provide a conclusive mol. mechanism for the antitumor activity of I.  Equally importantly, the authors show for the first time that a "presumed invisible" linker in a hybrid drug is not so invisible after all and is in fact solely responsible for the biol. effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKPVcYZ7n5LVg90H21EOLACvtfcHk0liXPoouXlu69A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Oqtro%253D&md5=821a046928c142a7adfe410919de0878</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm061371e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061371e%26sid%3Dliteratum%253Aachs%26aulast%3DHulsman%26aufirst%3DN.%26aulast%3DMedema%26aufirst%3DJ.%2BP.%26aulast%3DBos%26aufirst%3DC.%26aulast%3DJongejan%26aufirst%3DA.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26aulast%3DRichel%26aufirst%3DD.%26aulast%3DWijtmans%26aufirst%3DM.%26atitle%3DChemical%2520Insights%2520in%2520the%2520Concept%2520of%2520Hybrid%2520Drugs%253A%2520The%2520Antitumor%2520Effect%2520of%2520Nitric%2520Oxide-Donating%2520Aspirin%2520Involves%2520a%2520Quinone%2520Methide%2520but%2520Not%2520Nitric%2520Oxide%2520nor%2520Aspirin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2424%26epage%3D2431%26doi%3D10.1021%2Fjm061371e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Stewart, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddick, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, F. K.</span><span> </span><span class="NLM_article-title">No-Sulindac Inhibits the Hypoxia Response of PC-3 Prostate Cancer Cells via the Akt Signalling Pathway</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1002/ijc.23934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fijc.23934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18924134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD1cjovFSgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=223-232&author=G.+D.+Stewartauthor=J.+Nandaauthor=D.+J.+Brownauthor=A.+C.+Riddickauthor=J.+A.+Rossauthor=F.+K.+Habib&title=No-Sulindac+Inhibits+the+Hypoxia+Response+of+PC-3+Prostate+Cancer+Cells+via+the+Akt+Signalling+Pathway&doi=10.1002%2Fijc.23934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway</span></div><div class="casAuthors">Stewart Grant D; Nanda Jyoti; Brown David J G; Riddick Antony C P; Ross James A; Habib Fouad K</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">223-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nitric oxide-donating non-steroidal anti-inflammatory drugs are safer than traditional NSAIDs and inhibit the growth of prostate cancer cells with greater potency than NSAIDs.  In vivo, prostate cancer deposits are found in a hypoxic environment which induces resistance to chemotherapy.  The aim of this study was to assess the effects and mechanism of action of a NO-NSAID called NO-sulindac on the PC-3 prostate cancer cell line under hypoxic conditions.  NO-sulindac was found to have pro-apoptotic, cytotoxic, and anti-invasive effect on PC-3 cells under normoxia and hypoxia.  NO-sulindac was significantly more cytotoxic than sulindac at all oxygen levels.  The sulindac/linker and NO-releasing subunits both contributed to the cytotoxic effects of NO-sulindac.  Resistance of PC-3 cells to NO-sulindac was induced as the oxygen concentration declined.  Hypoxia-induced chemoresistance was reversed by knocking-down hypoxia-inducible factor-1alpha (HIF-1alpha) mRNA using RNAi.  Nuclear HIF-1alpha levels were upregulated at 0.2% oxygen but reduced by treatment with NO-sulindac, as was Akt phosphorylation.  NO-sulindac treatment of hypoxic PC-3 cells transfected with a reporter construct, downregulated activation of the hypoxia response element (HRE) promoter.  Co-transfection of PC-3 cells with the HRE promoter reporter construct and myr-Akt (constitutively active Akt) plasmids reversed the NO-sulindac induced reduction in HRE activation.  Real-time polymerase chain reaction analysis of hypoxic, NO-sulindac treated PC-3 cells showed downregulation of lysyl oxidase and carbonic anhydrase IX mRNA expression.  Collectively, these novel findings demonstrate that NO-sulindac directly inhibits the hypoxia response of PC-3 prostate cancer cells by inhibiting HIF-1alpha translation via the Akt signalling pathway.  The ability of NO-sulindac to inhibit tumour adaption to hypoxia has considerable relevance to the future management of prostate cancer with the same cellular properties as PC-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_bELpR82egAqdek-gHSrIfW6udTcc2eZG1egalGRqKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjovFSgsA%253D%253D&md5=3321ba8a6e0cd421f95203203f53aae1</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fijc.23934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23934%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DG.%2BD.%26aulast%3DNanda%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BJ.%26aulast%3DRiddick%26aufirst%3DA.%2BC.%26aulast%3DRoss%26aufirst%3DJ.%2BA.%26aulast%3DHabib%26aufirst%3DF.%2BK.%26atitle%3DNo-Sulindac%2520Inhibits%2520the%2520Hypoxia%2520Response%2520of%2520PC-3%2520Prostate%2520Cancer%2520Cells%2520via%2520the%2520Akt%2520Signalling%2520Pathway%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2009%26volume%3D124%26spage%3D223%26epage%3D232%26doi%3D10.1002%2Fijc.23934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mojic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harhaji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabideen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevelacqua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garotta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Novel Nitric Oxide-Donating Compound (S,R)-3-Phenyl-4,5-Dihydro-5-Isoxazole Acetic Acid-Nitric Oxide (GIT-27NO) Induces p53 Mediated Apoptosis in Human A375 Melanoma Cells</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1016/j.niox.2008.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.niox.2008.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=177-183&author=S.+Mijatovicauthor=D.+Maksimovic-Ivanicauthor=M.+Mojicauthor=G.+Malaponteauthor=M.+Libraauthor=V.+Cardileauthor=D.+Miljkovicauthor=L.+Harhajiauthor=D.+Dabideenauthor=K.+F.+Chengauthor=Y.+Bevelacquaauthor=M.+Doniaauthor=G.+Garottaauthor=Y.+Al-Abedauthor=S.+Stosic-Grujicicauthor=F.+Nicoletti&title=Novel+Nitric+Oxide-Donating+Compound+%28S%2CR%29-3-Phenyl-4%2C5-Dihydro-5-Isoxazole+Acetic+Acid-Nitric+Oxide+%28GIT-27NO%29+Induces+p53+Mediated+Apoptosis+in+Human+A375+Melanoma+Cells&doi=10.1016%2Fj.niox.2008.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.niox.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.niox.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMojic%26aufirst%3DM.%26aulast%3DMalaponte%26aufirst%3DG.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DHarhaji%26aufirst%3DL.%26aulast%3DDabideen%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DK.%2BF.%26aulast%3DBevelacqua%26aufirst%3DY.%26aulast%3DDonia%26aufirst%3DM.%26aulast%3DGarotta%26aufirst%3DG.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DNovel%2520Nitric%2520Oxide-Donating%2520Compound%2520%2528S%252CR%2529-3-Phenyl-4%252C5-Dihydro-5-Isoxazole%2520Acetic%2520Acid-Nitric%2520Oxide%2520%2528GIT-27NO%2529%2520Induces%2520p53%2520Mediated%2520Apoptosis%2520in%2520Human%2520A375%2520Melanoma%2520Cells%26jtitle%3DNitric%2520Oxide%26date%3D2008%26volume%3D19%26spage%3D177%26epage%3D183%26doi%3D10.1016%2Fj.niox.2008.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Maksimovic-Ivanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harhaji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miljkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabideen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Abed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garotta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stosic-Grujicic, S.</span><span> </span><span class="NLM_article-title">Anticancer Properties of the Novel Nitric Oxide-Donating Compound (S,R)-3-Phenyl-4,5-Dihydro-5-Isoxazole Acetic Acid-Nitric Oxide in Vitro and in Vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">510</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-2037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F1535-7163.MCT-07-2037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=18347138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=510-520&author=D.+Maksimovic-Ivanicauthor=S.+Mijatovicauthor=L.+Harhajiauthor=D.+Miljkovicauthor=D.+Dabideenauthor=K.+Fan+Chengauthor=K.+Manganoauthor=G.+Malaponteauthor=Y.+Al-Abedauthor=M.+Libraauthor=G.+Garottaauthor=F.+Nicolettiauthor=S.+Stosic-Grujicic&title=Anticancer+Properties+of+the+Novel+Nitric+Oxide-Donating+Compound+%28S%2CR%29-3-Phenyl-4%2C5-Dihydro-5-Isoxazole+Acetic+Acid-Nitric+Oxide+in+Vitro+and+in+Vivo&doi=10.1158%2F1535-7163.MCT-07-2037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo</span></div><div class="casAuthors">Maksimovic-Ivanic, Danijela; Mijatovic, Sanja; Harhaji, Ljubica; Miljkovic, Djordje; Dabideen, Darrin; Cheng, Kai Fan; Mangano, Katia; Malaponte, Graziella; Al-Abed, Yousef; Libra, Massimo; Garotta, Gianni; Nicoletti, Ferdinando; Stosic-Grujicic, Stanislava</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">510-520</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Preclin. studies have shown that nitric oxide (NO)-donating nonsteroidal anti-inflammatory drugs possess anticancer activities.  Here, the authors report in vitro and in vivo studies showing the antitumor effect of the NO-donating isoxazole deriv. (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid (GIT-27NO).  GIT-27NO, but not the NO-deprived parental compd. VGX-1027, significantly affected viability of both rodent (L929, B16, and C6) and human (U251, BT20, HeLa, and LS174) tumor cell lines.  GIT-27NO triggered either apoptotic cell death (e.g., L929 cells) or autophagic cell death (C6 and B16 cells).  Moreover, GIT-27NO hampered the viability of cisplatin-resistant B16 cells.  NO scavenger Hb completely prevented GIT-27NO-induced death, indicating that NO release mediated the tumoricidal effect of the compd.  Increase in intracellular NO upon on the treatment was assocd. with intensified prodn. of reactive oxygen species, whereas their neutralization by antioxidant N-acetylcysteine resulted in partial recovery of cell viability.  The antitumor activity of the drug was mediated by the selective activation of mitogen-activated protein kinases in a cell-specific manner and was neutralized by their specific inhibitors.  In vivo treatment with GIT-27NO significantly reduced the B16 melanoma growth in syngeneic C57BL/6 mice.  The therapeutic effect occurred at dose (0.5 mg/mouse) up to 160 times lower than those needed to induce acute lethality (80 mg/mouse).  In addn., a dose of GIT-27NO five times higher than that found effective in the melanoma model was well tolerated by the mice when administered for 4 consecutive weeks.  These data warrant addnl. studies to evaluate the possible translation of these findings to the clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowlAWTcDL2abVg90H21EOLACvtfcHk0lgGpf-WUUZPeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWhu78%253D&md5=7e8309d0122f74aa980f12cd743e6cb2</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2037%26sid%3Dliteratum%253Aachs%26aulast%3DMaksimovic-Ivanic%26aufirst%3DD.%26aulast%3DMijatovic%26aufirst%3DS.%26aulast%3DHarhaji%26aufirst%3DL.%26aulast%3DMiljkovic%26aufirst%3DD.%26aulast%3DDabideen%26aufirst%3DD.%26aulast%3DFan%2BCheng%26aufirst%3DK.%26aulast%3DMangano%26aufirst%3DK.%26aulast%3DMalaponte%26aufirst%3DG.%26aulast%3DAl-Abed%26aufirst%3DY.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DGarotta%26aufirst%3DG.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DStosic-Grujicic%26aufirst%3DS.%26atitle%3DAnticancer%2520Properties%2520of%2520the%2520Novel%2520Nitric%2520Oxide-Donating%2520Compound%2520%2528S%252CR%2529-3-Phenyl-4%252C5-Dihydro-5-Isoxazole%2520Acetic%2520Acid-Nitric%2520Oxide%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D510%26epage%3D520%26doi%3D10.1158%2F1535-7163.MCT-07-2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">NOSH-aspirin (NBS-1120), a Novel Nitric Oxide- and Hydrogen Sulfide-Releasing Hybrid is a Potent Inhibitor of Colon Cancer Cell Growth in Vitro and in a Xenograft Mouse Model</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2012.02.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bbrc.2012.02.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2012&pages=523-528&author=M.+Chattopadhyayauthor=R.+Kodelaauthor=K.+R.+Olsonauthor=K.+Kashfi&title=NOSH-aspirin+%28NBS-1120%29%2C+a+Novel+Nitric+Oxide-+and+Hydrogen+Sulfide-Releasing+Hybrid+is+a+Potent+Inhibitor+of+Colon+Cancer+Cell+Growth+in+Vitro+and+in+a+Xenograft+Mouse+Model&doi=10.1016%2Fj.bbrc.2012.02.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.02.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.02.051%26sid%3Dliteratum%253Aachs%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DOlson%26aufirst%3DK.%2BR.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DNOSH-aspirin%2520%2528NBS-1120%2529%252C%2520a%2520Novel%2520Nitric%2520Oxide-%2520and%2520Hydrogen%2520Sulfide-Releasing%2520Hybrid%2520is%2520a%2520Potent%2520Inhibitor%2520of%2520Colon%2520Cancer%2520Cell%2520Growth%2520in%2520Vitro%2520and%2520in%2520a%2520Xenograft%2520Mouse%2520Model%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D419%26spage%3D523%26epage%3D528%26doi%3D10.1016%2Fj.bbrc.2012.02.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Wang, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M. L.</span><span> </span><span class="NLM_article-title">Synthesis and Antitumor Activity of ATB-429 Derivatives Containing a Nitric Oxide-Releasing Moiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2355</span><span class="NLM_x">–</span> <span class="NLM_lpage">2359</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2016.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26995527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlGhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2355-2359&author=C.+L.+Wangauthor=G.+M.+Xiaauthor=X.+J.+Liuauthor=R.+Zhangauthor=Y.+Chaiauthor=J.+Zhangauthor=X.+N.+Liauthor=Y.+Yangauthor=J.+X.+Wangauthor=M.+L.+Liu&title=Synthesis+and+Antitumor+Activity+of+ATB-429+Derivatives+Containing+a+Nitric+Oxide-Releasing+Moiety&doi=10.1016%2Fj.bmcl.2016.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitumor activity of ATB-429 derivatives containing a nitric oxide-releasing moiety</span></div><div class="casAuthors">Wang, Chunlan; Xia, Guimin; Liu, Xiujun; Zhang, Rui; Chai, Yun; Zhang, Jun; Li, Xiaoning; Yang, Yang; Wang, Juxian; Liu, Mingliang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2355-2359</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel ATB-429 (an anti-inflammatory candidate) derivs. contg. a nitric oxide (NO)-releasing moiety were designed, synthesized and evaluated for their in vitro activity against six human cancer cell lines.  Our results reveal that phenylsulfonylfuroxan-based derivs. have considerable antitumor activity, and compds. 7 [VII; n = 2 (a), 3 (b)], 8 [VIII; n = 2 (a), 3 (b)], 9 (IX; IC50s: 0.256-3.024 μM) against HT-29 and PANC-1, 8a,b (IC50s: 2.677-3.051 μM) against MCF-7 and 8a (IC50: 1.270 μM) against DU145 are more active than Vandetanib (IC50s: 1.925-4.107 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoivLW50C-LfrVg90H21EOLACvtfcHk0lgGpf-WUUZPeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlGhs7o%253D&md5=e801db25b629cfb91dd8e6f0ae84d176</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BL.%26aulast%3DXia%26aufirst%3DG.%2BM.%26aulast%3DLiu%26aufirst%3DX.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DChai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%2BN.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%2BX.%26aulast%3DLiu%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520and%2520Antitumor%2520Activity%2520of%2520ATB-429%2520Derivatives%2520Containing%2520a%2520Nitric%2520Oxide-Releasing%2520Moiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2355%26epage%3D2359%26doi%3D10.1016%2Fj.bmcl.2016.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Vannini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKessack-Leitch, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbach, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashfi, K.</span><span> </span><span class="NLM_article-title">Synthesis and Anti-Cancer Potential of the Positional Isomers of NOSH-aspirin (NBS-1120) a Dual Nitric Oxide and Hydrogen Sulfide Releasing Hybrid</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4677</span><span class="NLM_x">–</span> <span class="NLM_lpage">4682</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.bmcl.2015.08.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4677-4682&author=F.+Vanniniauthor=A.+C.+MacKessack-Leitchauthor=E.+K.+Eschbachauthor=M.+Chattopadhyayauthor=R.+Kodelaauthor=K.+Kashfi&title=Synthesis+and+Anti-Cancer+Potential+of+the+Positional+Isomers+of+NOSH-aspirin+%28NBS-1120%29+a+Dual+Nitric+Oxide+and+Hydrogen+Sulfide+Releasing+Hybrid&doi=10.1016%2Fj.bmcl.2015.08.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DVannini%26aufirst%3DF.%26aulast%3DMacKessack-Leitch%26aufirst%3DA.%2BC.%26aulast%3DEschbach%26aufirst%3DE.%2BK.%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DKashfi%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Anti-Cancer%2520Potential%2520of%2520the%2520Positional%2520Isomers%2520of%2520NOSH-aspirin%2520%2528NBS-1120%2529%2520a%2520Dual%2520Nitric%2520Oxide%2520and%2520Hydrogen%2520Sulfide%2520Releasing%2520Hybrid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4677%26epage%3D4682%26doi%3D10.1016%2Fj.bmcl.2015.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Kashfi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodela, R.</span><span> </span><span class="NLM_article-title">NOSH-sulindac (AVT-18A) Is a Novel Nitric Oxide- and Hydrogen Sulfide-Releasing Hybrid That Is Gastrointestinal Safe and Has Potent Anti-Inflammatory, Analgesic, Antipyretic, Anti-Platelet, and Anti-Cancer Properties</span> <span class="citation_source-journal">Redox Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.1016/j.redox.2015.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.redox.2015.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=26298203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCrurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=287-296&author=K.+Kashfiauthor=M.+Chattopadhyayauthor=R.+Kodela&title=NOSH-sulindac+%28AVT-18A%29+Is+a+Novel+Nitric+Oxide-+and+Hydrogen+Sulfide-Releasing+Hybrid+That+Is+Gastrointestinal+Safe+and+Has+Potent+Anti-Inflammatory%2C+Analgesic%2C+Antipyretic%2C+Anti-Platelet%2C+and+Anti-Cancer+Properties&doi=10.1016%2Fj.redox.2015.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties</span></div><div class="casAuthors">Kashfi, Khosrow; Chattopadhyay, Mitali; Kodela, Ravinder</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">287-296</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulindac is chemopreventive and has utility in patients with familial adenomatous polyposis; however, side effects preclude its long-term use.  NOSH-sulindac (AVT-18A) releases nitric oxide and hydrogen sulfide, was designed to be a safer alternative.  Here we compare the gastrointestinal safety, anti-inflammatory, analgesic, anti-pyretic, anti-platelet, and anti-cancer properties of sulindac and NOSH-sulindac administered orally to rats at equimolar doses.  Gastrointestinal safety: 6 h post-administration, no./size of hemorrhagic lesions in stomachs were counted.  Tissue samples were frozen for PGE2, SOD, and MDA detn.  Anti-inflammatory: 1 h after drug administration, the vol. of carrageenan-induced rat paw edemas was measured for 5 h.  Anti-pyretic: fever was induced by LPS (i.p.) an hour before administration of the test drugs, core body temp. was measured hourly for 5 h.  Analgesic: time-dependent analgesic effects were evaluated by carrageenan-induced hyperalgesia.  Antiplatelet: anti-aggregatory effects were studied on collagen-induced platelet aggregation of human platelet-rich plasma.  Anti-cancer: We examd. the effects of NOSH-sulindac on the growth properties of 12 human cancer cell lines of six different tissue origins.  Both agents reduced PGE2 levels in stomach tissue; however, NOSH-sulindac did not cause any stomach ulcers, whereas sulindac caused significant bleeding.  Lipid peroxidn. induced by sulindac was higher than that from NOSH-sulindac.  SOD activity was significantly lowered by sulindac but increased by NOSH-sulindac.  Both agents showed similar anti-inflammatory, analgesic, anti-pyretic, and anti-platelet activities.  Sulindac increased plasma TNFα whereas this rise was lower in the NOSH-sulindac-treated animals.  NOSH-sulindac inhibited the growth of all cancer cell lines studied, with potencies of 1000- to 9000-fold greater than that of sulindac.  NOSH-sulindac inhibited cell proliferation, induced apoptosis, and caused G2/M cell cycle block.  These results demonstrate that NOSH-sulindac is gastrointestinal safe, and maintains the anti-inflammatory, analgesic, antipyretic, and antiplatelet properties of its parent compd. sulinsac, with anti-growth activity against a wide variety of human cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Qvv3YXAQurVg90H21EOLACvtfcHk0lg0AIm-z_cR8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCrurbM&md5=71c8577d2d2857c51c460c46877a7e8d</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2015.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DKashfi%26aufirst%3DK.%26aulast%3DChattopadhyay%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DR.%26atitle%3DNOSH-sulindac%2520%2528AVT-18A%2529%2520Is%2520a%2520Novel%2520Nitric%2520Oxide-%2520and%2520Hydrogen%2520Sulfide-Releasing%2520Hybrid%2520That%2520Is%2520Gastrointestinal%2520Safe%2520and%2520Has%2520Potent%2520Anti-Inflammatory%252C%2520Analgesic%252C%2520Antipyretic%252C%2520Anti-Platelet%252C%2520and%2520Anti-Cancer%2520Properties%26jtitle%3DRedox%2520Biol.%26date%3D2015%26volume%3D6%26spage%3D287%26epage%3D296%26doi%3D10.1016%2Fj.redox.2015.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A. K.</span><span> </span><span class="NLM_article-title">Nitric Oxide: Role in Tumour Biology and iNOS/NO-Based Anticancer Therapies</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span><span class="refDoi"> DOI: 10.1007/s00280-011-1654-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1007%2Fs00280-011-1654-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21544630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=1211-1224&author=S.+Singhauthor=A.+K.+Gupta&title=Nitric+Oxide%3A+Role+in+Tumour+Biology+and+iNOS%2FNO-Based+Anticancer+Therapies&doi=10.1007%2Fs00280-011-1654-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies</span></div><div class="casAuthors">Singh, Simendra; Gupta, Alok K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1211-1224</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Purpose The diat. radical nitric oxide (NO) has been the cause of intense debate with implication in carcinogenesis, tumor progression, invasion, angiogenesis and modulation of therapeutic responses.  The tumor biol. of NO is highly complex, and this review summarises the various protective and damaging mode of action of NO.  Methods We reviewed all published literature addressing the complexities of the role of NO in the altered biol. of cancer and evaluating promising therapeutic roles of NO/iNOS for anti-cancer therapy.  Results The available exptl. evidences highlight contrasting pro- and anti-tumor effects of iNOS expression, which appear to be reconciled by consideration of the concns. of NO involved, the temporo-spatial mode of NO action, intracellular targets, cellular redox state and the timing of an apoptotic stimulus.  Several clin. and exptl. studies indicate that the presence of NO in tumor microenvironment is detrimental to tumor cell survival and metastasis.  In contrast, numerous reports suggest that NO can have tumor-promoting effects.  NO is a double-edged sword' in cancer, and this review offers insight into the dichotomous nature of NO and discuss the therapeutic gain that can be achieved by manipulating tumor NO.  Conclusions NO may exert a biphasic response, such that when NO levels go beyond a crit. concn. that would be suitable for tumor growth and survival, growth arrest and/or apoptotic pathways are initiated.  These characteristics of NO have been exploited therapeutically with impressive effects in pre-clin. models of cancer to slow tumor growth and to enhance the efficacy of both chemotherapy and radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZAxpANjQm1bVg90H21EOLACvtfcHk0lg0AIm-z_cR8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGht7Y%253D&md5=5221d561ab8ceb256506067a8863e18e</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs00280-011-1654-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-011-1654-4%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26atitle%3DNitric%2520Oxide%253A%2520Role%2520in%2520Tumour%2520Biology%2520and%2520iNOS%252FNO-Based%2520Anticancer%2520Therapies%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D1211%26epage%3D1224%26doi%3D10.1007%2Fs00280-011-1654-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. H.</span><span> </span><span class="NLM_article-title">Apoptosis of Bladder Transitional Cell Carcinoma T24 Cells Induced by Adenovirus-Mediated Inducible Nitric Oxide Synthase Gene Transfection</span> <span class="citation_source-journal">Chin. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span><span class="refDoi"> DOI: 10.3978/j.issn.1000-9604.2013.10.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3978%2Fj.issn.1000-9604.2013.10.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=24255584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVWmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=593-599&author=J.+Tanauthor=Q.+Zengauthor=X.+Z.+Jiangauthor=L.+Y.+Heauthor=J.+R.+Wangauthor=K.+Yaoauthor=C.+H.+Wang&title=Apoptosis+of+Bladder+Transitional+Cell+Carcinoma+T24+Cells+Induced+by+Adenovirus-Mediated+Inducible+Nitric+Oxide+Synthase+Gene+Transfection&doi=10.3978%2Fj.issn.1000-9604.2013.10.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis of bladder transitional cell carcinoma T24 cells induced by adenovirus-mediated inducible nitric oxide synthase gene transfection</span></div><div class="casAuthors">Tan, Jing; Zeng, Qing; Jiang, Xian-Zheng; He, Le-Ye; Wang, Jin-Rong; Yao, Kun; Wang, Chang-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-599</span>CODEN:
                <span class="NLM_cas:coden">CJCRFH</span>;
        ISSN:<span class="NLM_cas:issn">1000-9604</span>.
    
            (<span class="NLM_cas:orgname">AME Publishing Company</span>)
        </div><div class="casAbstract">Objectives: To investigate the effects of adenovirus-mediated inducible nitric oxide synthase gene transfection on bladder transitional cell carcinoma T24 cells, and to provide novel insights and approaches to clin. therapies against bladder transitional cell carcinoma.  Methods: Firstly, construct recombinant adenovirus vector pAd-iNOS of iNOS, followed by transfection of pAd-iNOS into HECK293 packaging cells.  Thirdly, harvest recombinant adenovirus rAd-iNOS after amplification and purifn. procedures.  Finally, transfect the recombinant adenovirus rAd-iNOS into human bladder carcinoma T24 cells and examine the effect of rAd-iNOS transfection on apoptosis of T24 and possible mechanism.  Results: As shown by this study, the recombinant adenovirus rAd-iNOS was constructed successfully.  The virus titer was 5.8×108 PFU/mL and recombinant was verified by PCR anal.  Transfection of adenovirus rAd-iNOS into T24 cells could induce secretion of high NO concn., P53 protein expression up-regulation, as well as promotion of T24 cell apoptosis.  Conclusions: The transfection of human bladder carcinoma T24 cells from recombinant adenovirus rAd-iNOS was confirmed to induce intracellular iNOS over-expression, high prodn. of NO, up-regulation of intracellular P53 expression and promotion of cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotDMwUX4vXcbVg90H21EOLACvtfcHk0ljblaJlneeX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVWmsb0%253D&md5=347fc2a1ad8cf037e191a04be809e992</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.1000-9604.2013.10.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.1000-9604.2013.10.11%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DX.%2BZ.%26aulast%3DHe%26aufirst%3DL.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BR.%26aulast%3DYao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DC.%2BH.%26atitle%3DApoptosis%2520of%2520Bladder%2520Transitional%2520Cell%2520Carcinoma%2520T24%2520Cells%2520Induced%2520by%2520Adenovirus-Mediated%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Gene%2520Transfection%26jtitle%3DChin.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D25%26spage%3D593%26epage%3D599%26doi%3D10.3978%2Fj.issn.1000-9604.2013.10.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span> </span><span class="NLM_article-title">Cationic Liposome-Mediated Nitric Oxide Synthase Gene Therapy Enhances the Antitumor Effects of Cisplatin in Lung Cancer</span> <span class="citation_source-journal">Int. J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.3892/ijmm.2012.1171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.3892%2Fijmm.2012.1171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23128378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=33-42&author=S.+Yeauthor=W.+Yangauthor=Y.+Wangauthor=W.+Ouauthor=Q.+Maauthor=C.+Yuauthor=J.+Renauthor=G.+Zhongauthor=H.+Shiauthor=Z.+Yuanauthor=X.+Suauthor=W.+Zhu&title=Cationic+Liposome-Mediated+Nitric+Oxide+Synthase+Gene+Therapy+Enhances+the+Antitumor+Effects+of+Cisplatin+in+Lung+Cancer&doi=10.3892%2Fijmm.2012.1171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer</span></div><div class="casAuthors">Ye, Sujuan; Yang, Weihan; Wang, Yu; Ou, Wenjing; Ma, Qingping; Yu, Chuanjiang; Ren, Jiang; Zhong, Guoxing; Shi, Huashan; Yuan, Zhu; Su, Xiaolan; Zhu, Wen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">Cisplatin is one of the most effective antitumor drugs for non-small cell lung carcinoma (NSCLC) patients.  However, its efficacy has encountered a plateau due to its side effects and drug resistance.  Inducible nitric oxide (NO) synthase (iNOS) gene therapy has been reported to have antitumor effects in several types of cancers and enhances sensitivity to cisplatin, but the effects of iNOS gene therapy alone or its combination with cisplatin in lung cancer remain unclear.  In the current study, we evaluated the effects of cationic liposome (LP)-mediated iNOS gene transfection on enhancing low-dose cisplatin-mediated antitumor effects in the A549 human lung adenocarcinoma cell line in vitro.  Furthermore, we examd. whether iNOS gene therapy enhances the antitumor effects of low-dose cisplatin in two A549 human lung cancer cell xenograft mouse models.  The results revealed that iNOS gene therapy may significantly enhance low-dose cisplatin-mediated inhibition of cell proliferation, invasion, migration and promotion of cell apoptosis in A549 cells.  Intratumoral administration of the LP-pVAX-iNOS complex significantly enhanced low-dose cisplatin-mediated suppression of s.c. tumor growth.  Moreover, i.v. injection of the LP-pVAX-iNOS complex greatly enhanced low-dose cisplatin-mediated inhibition of exptl. lung metastasis and prolonged the life span of mice without significant organ-related toxicity in a nude mouse model of lung metastasis compared to the cisplatin alone-treated group.  Furthermore, iNOS gene-mediated enhancement of cisplatin-mediated antitumor effects in lung cancer may be related to the attenuation of p-mTOR, MMP2 and the activation of p-p53.  Thus, the combination treatment with iNOS gene therapy and cisplatin may be a novel and effective therapeutic strategy for lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo03qp8DzeberVg90H21EOLACvtfcHk0ljblaJlneeX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCisrg%253D&md5=3b06819cd5e9f70099f4785ce0d61849</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2012.1171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2012.1171%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DCationic%2520Liposome-Mediated%2520Nitric%2520Oxide%2520Synthase%2520Gene%2520Therapy%2520Enhances%2520the%2520Antitumor%2520Effects%2520of%2520Cisplatin%2520in%2520Lung%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2013%26volume%3D31%26spage%3D33%26epage%3D42%26doi%3D10.3892%2Fijmm.2012.1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">McCarthy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zholobenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatefi, A.</span><span> </span><span class="NLM_article-title">Evaluation of a Multi-Functional Nanocarrier for Targeted Breast Cancer iNOS Gene Therapy</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1016/j.ijpharm.2010.11.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.ijpharm.2010.11.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=21134429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVWhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2011&pages=196-202&author=H.+O.+McCarthyauthor=A.+V.+Zholobenkoauthor=Y.+Wangauthor=B.+Canineauthor=T.+Robsonauthor=D.+G.+Hirstauthor=A.+Hatefi&title=Evaluation+of+a+Multi-Functional+Nanocarrier+for+Targeted+Breast+Cancer+iNOS+Gene+Therapy&doi=10.1016%2Fj.ijpharm.2010.11.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy</span></div><div class="casAuthors">McCarthy, Helen O.; Zholobenko, Alek V.; Wang, Yuhua; Canine, Brenda; Robson, Tracy; Hirst, David G.; Hatefi, Arash</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">196-202</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study dets. whether the novel designer biomimetic vector (DBV) can condense and deliver the cytotoxic iNOS gene to breast cancer cells to achieve a therapeutic effect.  We have previously shown the benefits of iNOS for cancer gene therapy but the stumbling block to future development has been the delivery system.  The DBV was expressed, purified and complexed with the iNOS gene.  The particle size and charge were detd. via dynamic light scattering techniques.  The toxicity of the DBV/iNOS nanoparticles was quantified using the cell toxicity and clonogenic assays.  Over expression of iNOS was confirmed via Western blotting and Griess test.  The DBV delivery system fully condensed the iNOS gene with nanoparticles less than 100 nm.  Transfection with the DBV/iNOS nanoparticles resulted in a max. of 62% cell killing and less than 20% clonogenicity.  INOS overexpression was confirmed and total nitrite levels were in the range of 18 μM.  We report for the first time that the DBV can successfully deliver iNOS and achieve a therapeutic effect.  There is significant cytotoxicity coupled with evidence of a bystander effect.  We conclude that the success of the DBV fusion protein in the delivery of iNOS in vitro is worthy of future in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqdHWXntBRJrVg90H21EOLACvtfcHk0ljblaJlneeX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVWhsw%253D%253D&md5=a6bf9f734a7de6dfb3eca2d016915566</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2010.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2010.11.051%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DH.%2BO.%26aulast%3DZholobenko%26aufirst%3DA.%2BV.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCanine%26aufirst%3DB.%26aulast%3DRobson%26aufirst%3DT.%26aulast%3DHirst%26aufirst%3DD.%2BG.%26aulast%3DHatefi%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520a%2520Multi-Functional%2520Nanocarrier%2520for%2520Targeted%2520Breast%2520Cancer%2520iNOS%2520Gene%2520Therapy%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D405%26spage%3D196%26epage%3D202%26doi%3D10.1016%2Fj.ijpharm.2010.11.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Soler, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benihoud, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaire, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lausson, S.</span><span> </span><span class="NLM_article-title">Gene Therapy of Rat Medullary Thyroid Cancer by Naked Nitric Oxide Synthase II DNA Injection</span> <span class="citation_source-journal">J. Gene Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1002/1521-2254(200009/10)2:5<344::AID-JGM124>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=11045428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A280%3ADC%252BD3crgtVSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=344-352&author=M.+N.+Solerauthor=P.+Bobeauthor=K.+Benihoudauthor=G.+Lemaireauthor=B.+A.+Roosauthor=S.+Lausson&title=Gene+Therapy+of+Rat+Medullary+Thyroid+Cancer+by+Naked+Nitric+Oxide+Synthase+II+DNA+Injection&doi=10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection</span></div><div class="casAuthors">Soler M N; Bobe P; Benihoud K; Lemaire G; Roos B A; Lausson S</div><div class="citationInfo"><span class="NLM_cas:title">The journal of gene medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">344-52</span>
        ISSN:<span class="NLM_cas:issn">1099-498X</span>.
    </div><div class="casAbstract">BACKGROUND:  Nitric oxide (NO), produced by NO synthase II (NOS II), is the main mediator of the tumoricidal action of activated macrophages.  In the present study we examined the potential of the NOS II gene as a suicide gene for medullary thyroid cancer (MTC) therapy.  METHODS:  We orthotopically transplanted rMTC 6-23 cells into the inbred strain of Wag/Rij rats and constructed a plasmid carrying the NOS II gene under the control of the cytomegalovirus (CMV) promoter.  RESULTS:  Successive injections of tumor cells (Day 0) and naked DNA (Day 2) caused strong inhibition of tumor growth (50%, p < 0.05).  Plasmid injection into established tumors (14-day tumors) resulted in the development of large cavities due to tumor cell destruction, with a significant reduction in tumor tissue volume (35%, p < 0.05).  Adjacent quiescent tissues were unaffected.  Cell death occurred by apoptosis as demonstrated by specific labeling.  Macrophages and CD4+ lymphocytes were recruited in the treated tumors.  However, tumor-specific T lymphocytes were undetectable in the spleen of treated rats.  In control experiments using Lac Z as a reporter gene, expression of beta-galactosidase was detected in only 1% of the tumor cells.  CONCLUSIONS:  Despite a low gene transfer efficiency, NOS II plasmid produced a strong anti-tumor action resulting from its marked 'bystander' effect mainly due to NO production and diffusion.  Therefore the NOS II gene appears to be a promising suicide gene therapy of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNvgTOQZ2Gw9XdcedVHT5tfW6udTcc2eaxmbbgCbhRw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3crgtVSmsg%253D%253D&md5=6cf49af62027d824241df55573903125</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-2254%2528200009%252F10%25292%253A5%253C344%253A%253AAID-JGM124%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DSoler%26aufirst%3DM.%2BN.%26aulast%3DBobe%26aufirst%3DP.%26aulast%3DBenihoud%26aufirst%3DK.%26aulast%3DLemaire%26aufirst%3DG.%26aulast%3DRoos%26aufirst%3DB.%2BA.%26aulast%3DLausson%26aufirst%3DS.%26atitle%3DGene%2520Therapy%2520of%2520Rat%2520Medullary%2520Thyroid%2520Cancer%2520by%2520Naked%2520Nitric%2520Oxide%2520Synthase%2520II%2520DNA%2520Injection%26jtitle%3DJ.%2520Gene%2520Med.%26date%3D2000%26volume%3D2%26spage%3D344%26epage%3D352%26doi%3D10.1002%2F1521-2254%28200009%2F10%292%3A5%3C344%3A%3AAID-JGM124%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovesdi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodovotz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiar, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumberg, D.</span><span> </span><span class="NLM_article-title">Adenoviral Gene Transfer of the Human Inducible Nitric Oxide Synthase Gene Enhances the Radiation Response of Human Colorectal Cancer Associated with Alterations in Tumor Vascularity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-1307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1158%2F0008-5472.CAN-03-1307" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1386-1395&author=Z.+Wangauthor=T.+Cookauthor=S.+Alberauthor=K.+Liuauthor=I.+Kovesdiauthor=S.+K.+Watkinsauthor=Y.+Vodovotzauthor=T.+R.+Billiarauthor=D.+Blumberg&title=Adenoviral+Gene+Transfer+of+the+Human+Inducible+Nitric+Oxide+Synthase+Gene+Enhances+the+Radiation+Response+of+Human+Colorectal+Cancer+Associated+with+Alterations+in+Tumor+Vascularity&doi=10.1158%2F0008-5472.CAN-03-1307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-1307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-1307%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCook%26aufirst%3DT.%26aulast%3DAlber%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DKovesdi%26aufirst%3DI.%26aulast%3DWatkins%26aufirst%3DS.%2BK.%26aulast%3DVodovotz%26aufirst%3DY.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DBlumberg%26aufirst%3DD.%26atitle%3DAdenoviral%2520Gene%2520Transfer%2520of%2520the%2520Human%2520Inducible%2520Nitric%2520Oxide%2520Synthase%2520Gene%2520Enhances%2520the%2520Radiation%2520Response%2520of%2520Human%2520Colorectal%2520Cancer%2520Associated%2520with%2520Alterations%2520in%2520Tumor%2520Vascularity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1386%26epage%3D1395%26doi%3D10.1158%2F0008-5472.CAN-03-1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Worthington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, D. G.</span><span> </span><span class="NLM_article-title">Use of the Radiation-Inducible WAF1 Promoter to Drive iNOS Gene Therapy as a Novel Anti-Cancer Treatment</span> <span class="citation_source-journal">J. Gene Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span><span class="refDoi"> DOI: 10.1002/jgm.567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fjgm.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=15170738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFSnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=673-680&author=J.+Worthingtonauthor=H.+O.+McCarthyauthor=E.+Barrettauthor=C.+Adamsauthor=T.+Robsonauthor=D.+G.+Hirst&title=Use+of+the+Radiation-Inducible+WAF1+Promoter+to+Drive+iNOS+Gene+Therapy+as+a+Novel+Anti-Cancer+Treatment&doi=10.1002%2Fjgm.567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment</span></div><div class="casAuthors">Worthington, Jenny; McCarthy, Helen O.; Barrett, Eimear; Adams, Catherine; Robson, Tracy; Hirst, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gene Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">673-680</span>CODEN:
                <span class="NLM_cas:coden">JGMEFG</span>;
        ISSN:<span class="NLM_cas:issn">1099-498X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Background: Inducible nitric oxide synthase (iNOS) gene therapy has been identified as a potential anti-tumor strategy.  A major problem common to most gene therapy strategies is targeting of treatment to the tumor vol.  In this study we report on the use of the x-ray-inducible WAF1 promoter to achieve targeting of iNOS expression to the tumor vol.  Methods: A WAF1/iNOS/liposome complex was injected directly into RIF-1 and HT29 tumors in mice.  A 4 Gy dose of X-rays was applied to induce the WAF1 promoter followed, 8 h later, by treatment doses of 10 or 20 Gy.  Tumor vol. was measured, and growth curves plotted.  Results: Intra-tumoral injection of WAF1/iNOS combined with a priming dose of X-rays to induce the WAF1 promoter, followed by a treatment dose, resulted in sensitizer enhancement ratios of 2.0 and 1.3 in RIF-1 and HT29 tumors, resp., compared with radiation treatment alone.  PCR anal. of organ tissue after intra-tumoral injection of WAF1/iNOS showed that vector sequences were detected in all tissue tested; however, Western blot anal. revealed that iNOS protein levels were significantly increased only in tumor and the surrounding dermal tissue that had been exposed to the 4 Gy inducing dose.  Conclusions: iNOS gene therapy in combination with an inducible promoter results in significant tumor cell radiosensitization.  The WAF1 promoter may be a good candidate for a gene therapy as it is silent in normal tissue yet can be induced by the tumor environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1kRU1YtD5bVg90H21EOLACvtfcHk0lhPE2OS7246Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFSnsrc%253D&md5=4ca6d837fd3bc9c3307400198dc9f434</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1002%2Fjgm.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjgm.567%26sid%3Dliteratum%253Aachs%26aulast%3DWorthington%26aufirst%3DJ.%26aulast%3DMcCarthy%26aufirst%3DH.%2BO.%26aulast%3DBarrett%26aufirst%3DE.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DRobson%26aufirst%3DT.%26aulast%3DHirst%26aufirst%3DD.%2BG.%26atitle%3DUse%2520of%2520the%2520Radiation-Inducible%2520WAF1%2520Promoter%2520to%2520Drive%2520iNOS%2520Gene%2520Therapy%2520as%2520a%2520Novel%2520Anti-Cancer%2520Treatment%26jtitle%3DJ.%2520Gene%2520Med.%26date%3D2004%26volume%3D6%26spage%3D673%26epage%3D680%26doi%3D10.1002%2Fjgm.567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Maeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span> </span><span class="NLM_article-title">The EPR Effect for Macromolecular Drug Delivery to Solid Tumors: Improvement of Tumor Uptake, Lowering of Systemic Toxicity, and Distinct Tumor Imaging in Vivo</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/j.addr.2012.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.addr.2012.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=23088862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=71-79&author=H.+Maedaauthor=H.+Nakamuraauthor=J.+Fang&title=The+EPR+Effect+for+Macromolecular+Drug+Delivery+to+Solid+Tumors%3A+Improvement+of+Tumor+Uptake%2C+Lowering+of+Systemic+Toxicity%2C+and+Distinct+Tumor+Imaging+in+Vivo&doi=10.1016%2Fj.addr.2012.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo</span></div><div class="casAuthors">Maeda, Hiroshi; Nakamura, Hideaki; Fang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-79</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The EPR effect results from the extravasation of macromols. or nanoparticles through tumor blood vessels.  We here provide a historical review of the EPR effect, including its features, vascular mediators found in both cancer and inflamed tissue.  In addn., architectural and physiol. differences of tumor blood vessels vs that of normal tissue are commented.  Furthermore, methods of augmentation of the EPR effect are described, that result in better tumor delivery and improved therapeutic effect, where nitroglycerin, angiotensin I-converting enzyme (ACE) inhibitor, or angiotensin II-induced hypertension are employed.  Consequently, better therapeutic effect and reduced systemic toxicity are generally obsd.  Obviously, the EPR effect based delivery of nanoprobes are also useful for tumor-selective imaging agents with using fluorescent or radio nuclei in nanoprobes.  We also commented a key difference between passive tumor targeting and the EPR effect in tumors, particularly as related to drug retention in tumors: passive targeting of low-mol.-wt. X-ray contrast agents involves a retention period of less than a few minutes, whereas the EPR effect of nanoparticles involves a prolonged retention time-days to weeks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXPSA0xq_UOrVg90H21EOLACvtfcHk0lhPE2OS7246Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsbnI&md5=26eadfb633ca2da86636493908e4cc99</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2012.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2012.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DThe%2520EPR%2520Effect%2520for%2520Macromolecular%2520Drug%2520Delivery%2520to%2520Solid%2520Tumors%253A%2520Improvement%2520of%2520Tumor%2520Uptake%252C%2520Lowering%2520of%2520Systemic%2520Toxicity%252C%2520and%2520Distinct%2520Tumor%2520Imaging%2520in%2520Vivo%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D71%26epage%3D79%26doi%3D10.1016%2Fj.addr.2012.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saravanakumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. J.</span><span> </span><span class="NLM_article-title">A Platform for Nitric Oxide Delivery</span> <span class="citation_source-journal">J. Mater. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1039/C3TB21259A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2FC3TB21259A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=32261379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFGktb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=341-356&author=J.+Kimauthor=G.+Saravanakumarauthor=H.+W.+Choiauthor=D.+Parkauthor=W.+J.+Kim&title=A+Platform+for+Nitric+Oxide+Delivery&doi=10.1039%2FC3TB21259A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">A platform for nitric oxide delivery</span></div><div class="casAuthors">Kim, Jihoon; Saravanakumar, Gurusamy; Choi, Hyung Woo; Park, Dongsik; Kim, Won Jong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-356</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is one of the structurally smallest pharmaceutical mols., which shows great potential as an anti-restenosis, wound healing, anticancer, and antibacterial agent.  To date, while most of the studies have focused mainly on demonstrating the versatility of the NO-releasing materials, little effort has been made on developing successful NO-delivery strategies for advancing NO-mediated therapy.  Thus, the quest for a rationally designed NO-delivery system is becoming one of the important issues in the biomedical applications of NO.  This feature article discusses the overall research trends in the NO-delivery, focusing mainly on the various particle-type and coating platforms.  The objective of this article is not only to highlight the fundamental principle and challenges assocd. with NO-delivery, but also to provide insight for the further development of novel NO-delivery platforms for clin. applications in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8l6wFDb9_LVg90H21EOLACvtfcHk0lggQw-qAnmD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFGktb%252FI&md5=a016da9e8de21d7c833566fa1a6e6eae</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1039%2FC3TB21259A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3TB21259A%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSaravanakumar%26aufirst%3DG.%26aulast%3DChoi%26aufirst%3DH.%2BW.%26aulast%3DPark%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26atitle%3DA%2520Platform%2520for%2520Nitric%2520Oxide%2520Delivery%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2014%26volume%3D2%26spage%3D341%26epage%3D356%26doi%3D10.1039%2FC3TB21259A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Riccio, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfisch, M. H.</span><span> </span><span class="NLM_article-title">Nitric Oxide Release: Part I. Macromolecular Scaffolds</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3731</span><span class="NLM_x">–</span> <span class="NLM_lpage">3741</span><span class="refDoi"> DOI: 10.1039/c2cs15272j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1039%2Fc2cs15272j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=22362355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1yktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=3731-3741&author=D.+A.+Riccioauthor=M.+H.+Schoenfisch&title=Nitric+Oxide+Release%3A+Part+I.+Macromolecular+Scaffolds&doi=10.1039%2Fc2cs15272j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide release: Part I. Macromolecular scaffolds</span></div><div class="casAuthors">Riccio, Daniel A.; Schoenfisch, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3731-3741</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The roles of nitric oxide (NO) in physiol. and pathophysiol. merit the use of NO as a therapeutic for certain biomedical applications.  Unfortunately, limited NO payloads, too rapid NO release, and the lack of targeted NO delivery have hindered the clin. utility of NO gas and low mol. wt. NO donor compds.  A wide-variety of NO-releasing macromol. scaffolds has thus been developed to improve NO's pharmacol. potential.  In this tutorial review, the authors provide an overview of the most promising NO release scaffolds including protein, org., inorg., and hybrid org.-inorg. systems.  The NO release vehicles selected for discussion were chosen based on their enhanced NO storage, tunable NO release characteristics, and potential as therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmcwZKk_c6k7Vg90H21EOLACvtfcHk0lggQw-qAnmD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1yktLs%253D&md5=136715d2bc8373e486a92b602953dd02</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1039%2Fc2cs15272j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cs15272j%26sid%3Dliteratum%253Aachs%26aulast%3DRiccio%26aufirst%3DD.%2BA.%26aulast%3DSchoenfisch%26aufirst%3DM.%2BH.%26atitle%3DNitric%2520Oxide%2520Release%253A%2520Part%2520I.%2520Macromolecular%2520Scaffolds%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2012%26volume%3D41%26spage%3D3731%26epage%3D3741%26doi%3D10.1039%2Fc2cs15272j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. P.</span><span> </span><span class="NLM_article-title">Delivering Nitric Oxide with Nanoparticles</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2015.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1016%2Fj.jconrel.2015.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=25665865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlSnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2015&pages=190-205&author=J.+F.+Quinnauthor=M.+R.+Whittakerauthor=T.+P.+Davis&title=Delivering+Nitric+Oxide+with+Nanoparticles&doi=10.1016%2Fj.jconrel.2015.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Delivering nitric oxide with nanoparticles</span></div><div class="casAuthors">Quinn, John F.; Whittaker, Michael R.; Davis, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">190-205</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While best known for its important signalling functions in human physiol., nitric oxide is also of considerable therapeutic interest.  As such, nanoparticle-based systems which enable the sustained exogenous delivery of nitric oxide have been the subject of considerable investigation in recent years.  Herein we review the various nanoparticle systems that have been used to date for nitric oxide delivery, and explore the array of potential therapeutic applications that have been reported.  Specifically, we discuss the modification of sol-gel based silica particles, functionalised metal/metal oxide nanoparticles, polymer-coated metal nanoparticles, dendrimers, micelles and star polymers to impart nitric oxide release capability.  We also consider the various areas in which therapeutic applications are envisaged: wound healing, antimicrobial applications, cardiovascular treatments, sexual medicine and cancer treatment.  Finally, we discuss possible future directions for this versatile and potentially important technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnn__5jg-3GLVg90H21EOLACvtfcHk0lggQw-qAnmD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlSnurw%253D&md5=6fd7fa9aee9be18863127239ae14efcc</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2015.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2015.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DWhittaker%26aufirst%3DM.%2BR.%26aulast%3DDavis%26aufirst%3DT.%2BP.%26atitle%3DDelivering%2520Nitric%2520Oxide%2520with%2520Nanoparticles%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D205%26spage%3D190%26epage%3D205%26doi%3D10.1016%2Fj.jconrel.2015.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Seabra, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, M.</span><span> </span><span class="NLM_article-title">Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.2174/1568026615666150108122918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.2174%2F1568026615666150108122918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=25579351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislels7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=298-308&author=A.+B.+Seabraauthor=R.+de+Limaauthor=M.+Calderon&title=Nitric+Oxide+Releasing+Nanomaterials+for+Cancer+Treatment%3A+Current+Status+and+Perspectives&doi=10.2174%2F1568026615666150108122918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives</span></div><div class="casAuthors">Seabra, Amedea B.; de Lima, Renata; Calderon, Marcelo</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-308</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Nitric oxide (NO) is known to have dichotomous effects on cancer biol., acting as a pro- or antineoplastic agent.  Low concns. of NO are reported to promote tumor growth, whereas high NO influx acts as a potent tumor repressor, leading to cytotoxicity and apoptosis.  There is increasing interest in developing NO-releasing materials as potent tumoricidal agents in which high and localized concns. of NO may be directly released in a sustained manner to the tumor site.  Nanomaterials allied to NO donors have emerged as a promising strategy in cancer treatment.  In this context, this review summarizes the roles of NO in cancer biol. and highlights the therapeutic potential effects of NO-releasing nanomaterials based on polymeric nanoparticles, dendritic polymers, liposomes, silica nanoparticles, metallic nanoparticles and quantum dots in combating tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgmZicgaHg-rVg90H21EOLACvtfcHk0lhY9hlgymbNWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislels7Y%253D&md5=504a13af69d873fcac79decbefe00f26</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150108122918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150108122918%26sid%3Dliteratum%253Aachs%26aulast%3DSeabra%26aufirst%3DA.%2BB.%26aulast%3Dde%2BLima%26aufirst%3DR.%26aulast%3DCalderon%26aufirst%3DM.%26atitle%3DNitric%2520Oxide%2520Releasing%2520Nanomaterials%2520for%2520Cancer%2520Treatment%253A%2520Current%2520Status%2520and%2520Perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D298%26epage%3D308%26doi%3D10.2174%2F1568026615666150108122918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Chung, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, H. W.</span><span> </span><span class="NLM_article-title">A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">9890</span><span class="NLM_x">–</span> <span class="NLM_lpage">9893</span><span class="refDoi"> DOI: 10.1002/anie.201504444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fanie.201504444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWgu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=9890-9893&author=M.+F.+Chungauthor=H.+Y.+Liuauthor=K.+J.+Linauthor=W.+T.+Chiaauthor=H.+W.+Sung&title=A+pH-Responsive+Carrier+System+that+Generates+NO+Bubbles+to+Trigger+Drug+Release+and+Reverse+P-Glycoprotein-Mediated+Multidrug+Resistance&doi=10.1002%2Fanie.201504444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance</span></div><div class="casAuthors">Chung, Ming-Fan; Liu, Hung-Yi; Lin, Kun-Ju; Chia, Wei-Tso; Sung, Hsing-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">9890-9893</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) resulting from the overexpression of drug transporters such as P-glycoprotein (Pgp) increases the efflux of drugs and thereby limits the effectiveness of chemotherapy.  To address this issue, this work develops an injectable hollow microsphere (HM) system that carries the anticancer agent irinotecan (CPT-11) and a NO-releasing donor (NONOate).  Upon injection of this system into acidic tumor tissue, environmental protons infiltrate the shell of the HMs and react with their encapsulated NONOate to form NO bubbles that trigger localized drug release and serve as a Pgp-mediated MDR reversal agent.  The site-specific drug release and the NO-reduced Pgp-mediated transport can cause the intracellular accumulation of the drug at a concn. that exceeds the cell-killing threshold, eventually inducing its antitumor activity.  These results reveal that this pH-responsive HM carrier system provides a potentially effective method for treating cancers that develop MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkaRqtcsU7mrVg90H21EOLACvtfcHk0lhY9hlgymbNWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWgu7vN&md5=4a07181e23906bcfabf3c74bd0c97501</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fanie.201504444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201504444%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DM.%2BF.%26aulast%3DLiu%26aufirst%3DH.%2BY.%26aulast%3DLin%26aufirst%3DK.%2BJ.%26aulast%3DChia%26aufirst%3DW.%2BT.%26aulast%3DSung%26aufirst%3DH.%2BW.%26atitle%3DA%2520pH-Responsive%2520Carrier%2520System%2520that%2520Generates%2520NO%2520Bubbles%2520to%2520Trigger%2520Drug%2520Release%2520and%2520Reverse%2520P-Glycoprotein-Mediated%2520Multidrug%2520Resistance%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D9890%26epage%3D9893%26doi%3D10.1002%2Fanie.201504444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Lehrman, S.</span><span> </span><span class="NLM_article-title">Virus Treatment Questioned after Gene Therapy Death</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1038/43977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1038%2F43977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10524611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFCns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=517-518&author=S.+Lehrman&title=Virus+Treatment+Questioned+after+Gene+Therapy+Death&doi=10.1038%2F43977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Virus treatment questioned after gene therapy death</span></div><div class="casAuthors">Lehrman, Sally</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6753</span>),
    <span class="NLM_cas:pages">517-518</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUtFlQeEtD7Vg90H21EOLACvtfcHk0lhY9hlgymbNWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFCns7k%253D&md5=8812e61f3be8821bda8096469301d0b0</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2F43977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43977%26sid%3Dliteratum%253Aachs%26aulast%3DLehrman%26aufirst%3DS.%26atitle%3DVirus%2520Treatment%2520Questioned%2520after%2520Gene%2520Therapy%2520Death%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D517%26epage%3D518%26doi%3D10.1038%2F43977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Mocellin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronte, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitti, D.</span><span> </span><span class="NLM_article-title">Nitric Oxide, a Double Edged Sword in Cancer Biology: Searching for Therapeutic Opportunities</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1002/med.20092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=10.1002%2Fmed.20092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=16991100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVGrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=317-352&author=S.+Mocellinauthor=V.+Bronteauthor=D.+Nitti&title=Nitric+Oxide%2C+a+Double+Edged+Sword+in+Cancer+Biology%3A+Searching+for+Therapeutic+Opportunities&doi=10.1002%2Fmed.20092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities</span></div><div class="casAuthors">Mocellin, Simone; Bronte, Vincenzo; Nitti, Donato</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-352</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) is a pleiotropic mol. crit. to a no. of physiol. and pathol. processes.  The last decade has witnessed major advances in dissecting NO biol. and its role in cancer pathogenesis.  However, the complexity of the interactions between different levels of NO and several aspects of tumor development/progression has led to apparently conflicting findings.  Furthermore, both anti-NO and NO-based anticancer strategies appear effective in several preclin. models.  This paradoxical dichotomy is leaving investigators with a double challenge: to det. the net impact of NO on cancer behavior and to define the therapeutic role of NO-centered anticancer strategies.  Only a comprehensive and dynamic view of the cascade of mol. and cellular events underlying tumor biol. and affected by NO will allow investigators to exploit the potential antitumor properties of drugs interfering with NO metab.  Available data suggest that NO should be considered neither a universal target nor a magic bullet, but rather a signal transducer to be modulated according to the mol. makeup of each individual cancer and the interplay with conventional antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpraBBC61P0JLVg90H21EOLACvtfcHk0lhY9hlgymbNWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVGrt7g%253D&md5=d0cffe82313a609b2f3c6d1f3d1ff2bf</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fmed.20092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20092%26sid%3Dliteratum%253Aachs%26aulast%3DMocellin%26aufirst%3DS.%26aulast%3DBronte%26aufirst%3DV.%26aulast%3DNitti%26aufirst%3DD.%26atitle%3DNitric%2520Oxide%252C%2520a%2520Double%2520Edged%2520Sword%2520in%2520Cancer%2520Biology%253A%2520Searching%2520for%2520Therapeutic%2520Opportunities%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2007%26volume%3D27%26spage%3D317%26epage%3D352%26doi%3D10.1002%2Fmed.20092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01672&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01672%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-18%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01672" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677abfb11b063dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
